Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.7862500290935442,2.5828476958789666,0.0,0.0,0.0,61/87,12.28%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;ZFAND2B;RPS6;SRP68;SEC63;RPL4;RPL22;RPL15;RPL10;RPL32
prerank,cotranslational protein targeting to membrane (GO:0006613),0.7679735980184192,2.5404810033594973,0.0,0.0,0.0,60/91,12.28%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;RPS6;SRP68;SEC63;RPL4;RPL22;RPL15;RPL10;RPL32
prerank,cytoplasmic translation (GO:0002181),0.759349813283118,2.50594044256141,0.0,0.0,0.0,61/91,12.43%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPSA;RPL41;RPS28;RPL13;EIF3M;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;RPL22L1;RPS6;RPL4;EIF3I;RPL22;RPL15;RPL10;RPL32;ETF1
prerank,protein targeting to ER (GO:0045047),0.7370813920628029,2.4460784188493725,0.0,0.0,0.0,62/99,12.28%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;ZFAND2B;RPS6;SRP68;SEC63;RPL4;SRPRB;RPL22;RPL15;RPL10;RPL32
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.7159578206015437,2.4191710446160433,0.0,0.0,0.0,67/110,13.94%,DHX34;RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;EIF3E;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;SMG6;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;DCP1A;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;PPP2CA;RPL6;RPS6;RPL4;RPL22;RPL15;RPL10;RPL32;ETF1;MAGOHB;RPL19;RPL31
prerank,regulation of immune effector process (GO:0002697),0.79965081328959,2.3488249303604727,0.0,0.0,0.0,15/41,6.87%,C4B;FCGR2B;CFH;CFP;C1QC;IRF4;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,regulation of humoral immune response (GO:0002920),0.7871358335422914,2.3418778423623263,0.0,0.0,0.0,14/44,6.87%,C4B;FCGR2B;CFH;CFP;C1QC;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,regulation of complement activation (GO:0030449),0.7717075392154256,2.2792657578647173,0.0,0.0,0.0,13/40,6.87%,C4B;CFH;CFP;C1QC;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,receptor-mediated endocytosis (GO:0006898),0.6501829491772312,2.249565827336718,0.0,0.0,0.0,30/132,6.66%,MRC1;CD163;DAB2;STAB1;MSR1;AP2A2;FCGR2B;LRP6;APOE;COLEC12;SNX9;FCHO2;LDLR;EPS15;RAB31;CLTC;ITGB1;FCHSD2;CALCRL;ADRB2;CD36;FCER1G;LILRB1;SCARF1;ADM;INSR;PIKFYVE;AP2S1;SYK;LMBRD1
prerank,peptide biosynthetic process (GO:0043043),0.6187517107337351,2.174250925308508,0.0,0.0013938948682464603,0.012,68/153,12.70%,RPS29;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;MRPL13;RPS24;RPL24;RSL24D1;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;DARS1;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;MRRF;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;RPL6;RPS6;RPL4;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;MRPS17
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.6097341327620791,2.1487550160176676,0.0,0.0030217301339608583,0.029,98/168,19.98%,DHX34;RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;EIF3E;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;SAMD4A;RPL26;TUT7;ZFP36L1;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;SMG6;RPS8;RPL18A;RC3H1;RPL37A;RPS11;RPL28;TENT2;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;DCP1A;TUT4;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;PPP2CA;RPL6;RPS6;RPL4;DCP2;RPL22;RPL15;RPL10;RPL32;ZC3H12A;ETF1;EXOSC8;DIS3L2;MAGOHB;RPL19;RPL31;CNOT9;POLR2D;RPL11;PPP2R2A;TUT1;CSDE1;CNOT11;RPL35;CNOT6L;PYM1;CNOT4;NBDY;RPL7;NBAS;DXO;THRAP3;GSPT1;RPL21;CNOT8;SMG8;CNOT1
prerank,acylglycerol catabolic process (GO:0046464),-0.6668491211484128,-2.088410564952443,0.0,0.0318293792398669,0.033,10/30,17.01%,ABHD12;MGLL;FABP5;LYPLA2;LIPH;LPL;DAGLA;FABP4;ABHD16A;FAAH
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.47288106285176856,-2.058090718188048,0.0,0.030945229816537263,0.065,45/159,13.67%,CADM1;GRID2;PTPRM;CDH23;PTPRS;ADGRL3;CDH10;SDK1;PTPRD;NLGN1;ROBO2;CDH2;CLDN11;LRRC4C;CDH13;TENM3;LRFN5;CDH8;FAT4;CD84;ACVR1;ROBO1;PALLD;CNTN4;CNTN6;BSG;TENM2;IGSF11;TENM4;CNTN2;PTPRT;UNC5D;NTNG1;NECTIN2;MAG;CELSR2;PECAM1;LRRC4;CDH9;IL1RAPL1;CDH22;ATP2C1;DSCAML1;IGSF21;TGFBR2
prerank,regulation of B cell activation (GO:0050864),0.7925487376206495,2.052315771361734,0.0,0.024571864664601064,0.183,6/25,4.97%,BANK1;FCGR2B;AHR;ZFP36L2;ZFP36L1;THEMIS2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.7364324225322215,2.0356939224934503,0.0,0.03101209884382657,0.241,9/34,3.96%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;S100A10
prerank,positive regulation of ATP metabolic process (GO:1903580),0.7213372456783294,2.0213822207065877,0.0,0.037374763500234755,0.284,11/32,9.95%,PID1;P2RX7;APP;NUPR1;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;BEND3;IGF1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5528221249445637,-2.016238088494263,0.0,0.04715463591091392,0.14,21/59,13.41%,CADM1;PTPRM;SDK1;ROBO2;CDH2;CDH13;TENM3;CD84;ROBO1;PALLD;CNTN4;CNTN6;BSG;IGSF11;CNTN2;PTPRT;NECTIN2;CELSR2;PECAM1;DSCAML1;IGSF21
prerank,regulation of interleukin-12 production (GO:0032655),0.6716470512175425,1.987341288967026,0.0,0.06447657287991318,0.443,15/47,10.08%,IL16;LILRA5;FOXP1;TLR8;CMKLR1;IRAK3;LILRB1;TLR4;PIBF1;CCL19;TLR2;CD40;SYK;MAPK14;RIPK2
prerank,translation (GO:0006412),0.5504598737207308,1.9807111687556573,0.0,0.06741626141615091,0.479,85/208,15.15%,RPS29;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;EEFSEC;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;MRPL13;RPS24;RPL24;RSL24D1;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;FARS2;DARS1;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;MRRF;RPL5;RPL36;RPL14;RPS14;RPL9;NDUFA7;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;EEF1D;RPL6;RPL22L1;RPS6;RARS2;RPL4;RPL22;EIF4EBP2;MRPL16;WARS2;RPL15;RPL10;RPL32;ETF1;MRPS17;GTPBP1;RPL19;RPL31;MRPS34;MRPS14;RARS1;RPL11;SRBD1
prerank,Notch signaling involved in heart development (GO:0061314),0.8710182170133048,1.9777864644391643,0.0,0.06666727944509088,0.496,4/11,4.52%,RBPJ;NOTCH2;JAG1;HEY2
prerank,cellular potassium ion homeostasis (GO:0030007),-0.7865135434620255,-1.9766801438260555,0.0,0.06586913203805789,0.24,5/13,4.05%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;ATP1B2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.6451630627334906,-1.9720932363007546,0.0,0.055170924015769285,0.251,16/25,25.82%,ABI3;ARHGAP24;PRKCD;EVL;CEP97;CCP110;EVI5L;CDK10;LIMK2;TBC1D7;PLXNB3;ARHGAP44;CAPZB;ODF2L;KANK1;TCHP
prerank,purine-containing compound catabolic process (GO:0072523),0.8469453199440317,1.9706404630449141,0.005504587155963303,0.07201790152606712,0.545,4/13,3.68%,GDA;DPYD;XDH;DNPH1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.7898126891503763,1.966541145713493,0.0017793594306049821,0.07370148574614888,0.574,5/17,4.52%,RBPJ;NOTCH2;JAG1;BMP2;HEY2
prerank,regulation of B cell proliferation (GO:0030888),0.6810624937495922,1.9611025407509288,0.001488095238095238,0.07736116518767855,0.598,12/44,6.29%,VAV3;CD38;FCGR2B;AHR;LYN;BST1;MEF2C;CD74;IRS2;RC3H1;CD40;BCL2
prerank,icosanoid biosynthetic process (GO:0046456),0.8885409938216393,1.956693236540039,0.0,0.08016171952919204,0.621,4/10,3.82%,ALOX5;LTC4S;ALOX5AP;MGST3
prerank,purine nucleotide catabolic process (GO:0006195),0.8463827233016741,1.9557432756624953,0.0018484288354898336,0.07749275666125426,0.624,4/13,3.68%,GDA;HINT1;XDH;DNPH1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.7327385340115505,1.9541187715856054,0.0035335689045936395,0.07542882598069474,0.631,7/25,10.54%,RBPJ;HIP1;ARAP1;CBL;RTN4;PDE6H;NUP62
prerank,response to molecule of bacterial origin (GO:0002237),0.6163429502750789,1.9338207755603882,0.0013966480446927375,0.10065529288972036,0.731,15/69,5.51%,C4B;FCGR2B;FOXP1;FER;IRAK3;PTPN22;IFNAR1;TLR4;PELI1;RPS6KA3;TNFRSF11A;LBP;GCH1;MAPKAPK2;LY96
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6881506013278541,-1.9304830311697017,0.0,0.08812022585852039,0.41,6/20,4.05%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;SLC8A1;ATP1B2
prerank,inflammatory response (GO:0006954),0.5397746364048004,1.9268025188599927,0.0,0.1071369040270664,0.77,35/195,8.24%,HDAC9;FOLR2;PF4;NLRC4;FCGR2B;NRROS;SIGLEC1;ADGRE5;CYBB;HRH1;CCR1;CMKLR1;C5AR1;ALOX15;C3AR1;MFHAS1;CEBPB;CD44;BMP2;CCL8;TLR4;CCL19;ADM;TUSC2;TLR2;IL10RB;MAPKAPK2;CD40;CCRL2;PLA2G2D;TNF;CXCR4;REL;CCR2;CCL24
prerank,regulation of platelet activation (GO:0010543),0.7563835122526547,1.917570737966926,0.003472222222222222,0.11596545471920254,0.806,7/21,6.52%,APOE;C1QTNF1;LYN;FCER1G;TLR4;PDGFRA;SYK
prerank,negative regulation of interleukin-12 production (GO:0032695),0.8250694792657515,1.9067487486842292,0.0,0.12969973332458518,0.847,6/14,3.21%,LILRA5;TLR8;CMKLR1;IRAK3;LILRB1;PIBF1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6907184236181678,-1.9012856624646761,0.0,0.11834971566569558,0.549,7/18,5.58%,RIMS1;PTK2B;NLGN1;RIMS2;NRXN1;DLG4;SHANK1
prerank,lipoxygenase pathway (GO:0019372),0.8258311027901482,1.8987876826209338,0.0,0.1400787754957569,0.864,4/14,3.19%,ALOX5;LTC4S;ALOX15;ALOX5AP
prerank,peptide cross-linking (GO:0018149),0.7155287414457634,1.8986548128070755,0.0015772870662460567,0.13580307297265912,0.866,3/25,4.49%,F13A1;TGM7;KRT10
prerank,negative regulation of multicellular organismal process (GO:0051241),0.5308036435409448,1.8969415926497686,0.0,0.133921130033833,0.873,45/199,10.88%,RBPJ;HDAC9;PAEP;FCGR2B;EGFR;RAB11FIP5;SPRED1;ATP2B1;IL15;GAS6;MEF2C;NR1H4;BMP2;TNNT1;TLR4;NR1D1;GRN;RGCC;HMGCR;SRGN;ADM;IL17RD;MCC;NPR3;HEY2;GRHL2;SPI1;GSK3B;RB1;LNPEP;ROCK1;PLCL2;TNF;ARRDC3;VASN;TRPV3;FOXC2;USF3;RPS6KA6;PPP2CA;CORO1C;SFRP1;DOCK7;SPRED2;PTGER4
prerank,neuron cell-cell adhesion (GO:0007158),-0.7413941175449424,-1.8961795864530129,0.002257336343115124,0.11173438337328276,0.577,6/14,6.69%,NCAM2;NRXN3;NLGN1;NRXN1;ASTN2;CNTN4
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.5018759165912304,1.8901296697159435,0.0,0.14222569970792667,0.901,104/306,14.41%,EXT1;APOE;RBMS1;RPS29;MEF2A;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RBBP8;RPS16;RPS3;RPS27A;ORC5;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;EEFSEC;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;MRPL13;FAM111A;RPS24;RPL24;RSL24D1;RPL12;RPL36A;RPS8;RPL18A;RPL37A;THRB;RPS11;RPL28;POLE2;ORC2;MCM9;EPC1;DARS1;RPL30;RPL8;RPL35A;RPS4X;CHEK1;RPS15A;RPS17;RPL38;RPLP0;TOPBP1;MRRF;RPL5;RPL36;TIPIN;RPA1;NR4A2;RPL14;RPS14;RPL9;RPS9;BRIP1;RPS5;RPS7;TOP1MT;RPL34;RPL27;MRPS11;MED20;EEF1D;POLR2B;RPL6;RPS6;RPL4;B4GALT5;RHNO1;POLE3;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;RPA3;MRPS17;GTPBP1;NFKBIB;KAT7;RPL19;KIN;RPL31;MRPS14;POLR2D;MMS19
prerank,modulation by symbiont of host process (GO:0044003),0.8595626921064592,1.8896439843170518,0.0019880715705765406,0.138652330884708,0.902,4/10,4.25%,MRC1;RPS27A;B2M;TLR2
prerank,clathrin-dependent endocytosis (GO:0072583),0.7206203956620033,1.8733578641001472,0.0017006802721088435,0.16424565405561437,0.935,10/26,7.75%,ITSN1;AP2A2;SIGLEC1;FCHO2;CLTC;FCHSD2;AP2S1;LMBRD1;ITSN2;CANX
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6795524132685986,1.8713627129971562,0.006379585326953748,0.16360919856250306,0.939,8/26,7.43%,EGFR;IQGAP1;ZFP36L2;PTPN12;EEF1A1;ZFP36L1;PDE8A;DUSP22
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.7428792711263127,1.8698616448321281,0.008403361344537815,0.16209006039323123,0.943,6/20,1.80%,P2RX7;APP;TXNIP;PSTPIP1;C3AR1;ANO6
prerank,potassium ion homeostasis (GO:0055075),-0.6271913448495797,-1.8678091307398674,0.002506265664160401,0.1498142078419661,0.726,6/23,4.42%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;ATP1B2;SLC12A9
prerank,lipid oxidation (GO:0034440),0.8222884973945698,1.8672386360032334,0.001893939393939394,0.16348480623514575,0.947,4/12,5.86%,ALOX5;ALOX15;PLA2G7;ADIPOR2
prerank,positive regulation of immune effector process (GO:0002699),0.6914892400731468,1.8654263417535626,0.0015822784810126582,0.16280460228292334,0.951,7/27,7.60%,PTPRJ;DDX60;LILRB1;ANKRD17;CD46;LBP;CCR2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6854195760813486,-1.8644710210137436,0.0,0.14172915255974064,0.739,7/17,5.61%,CACNB2;KCNJ2;SCN1B;SLC8A1;ANK2;CACNA2D1;CACNA1D
prerank,regulation of ERBB signaling pathway (GO:1901184),0.7997098569118495,1.861936305190402,0.0,0.1662233738631558,0.963,5/15,1.96%,RBPJ;EGFR;PTPN18;FER;PTPN12
prerank,B cell activation (GO:0042113),0.590114476895897,1.8610055844521298,0.0014144271570014145,0.16380326676553078,0.965,18/68,11.10%,BANK1;HDAC9;ITGA4;PTPRJ;ITGB1;MEF2C;KLF6;CD40;BCL2;CR2;ZAP70;LYL1;CHRNA4;PRKCB;CEBPG;NHEJ1;SLC25A5;CASP8
prerank,immunoglobulin mediated immune response (GO:0016064),0.8358475209985897,1.8605924305996866,0.005917159763313609,0.16053916088323175,0.965,4/10,2.78%,FCGR2B;TLR8;FCER1G;CD74
prerank,leukotriene metabolic process (GO:0006691),0.7473728938606586,1.8562756670150324,0.0035587188612099642,0.16425991871399656,0.969,8/19,8.37%,ALOX5;LTC4S;ALOX15;ALOX5AP;MGST3;MAPKAPK2;ABCC1;DPEP2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.7967635374363526,1.8560647773588548,0.0035460992907801418,0.16060426036883668,0.97,3/13,5.16%,RBPJ;HEY2;SMAD4
prerank,negative regulation of lymphocyte activation (GO:0051250),0.7375411051329248,1.855549214632322,0.003367003367003367,0.15764227830150485,0.97,4/21,3.21%,BANK1;FCGR2B;PTPN22;PIBF1
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.5613987031705195,-1.8541885573694648,0.0,0.14612578651029806,0.781,10/33,11.39%,CX3CR1;GRID2;NRG3;GRIK2;NLGN1;LRRC4C;FABP5;BDNF;ABR;LRRC4
prerank,positive regulation of endocytosis (GO:0045807),0.622558342631282,1.8532812098626241,0.0,0.15766608037682864,0.974,10/45,4.03%,DAB2;HIP1;APOE;RAB31;ANKFY1;ANO6;CDC42;CBL;CCL19;B2M
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7246890542433332,1.8502248465381181,0.008503401360544218,0.1596188328612485,0.979,8/23,4.31%,MPP1;RIPOR2;BST1;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.7062994368754423,-1.8496050602135463,0.0021691973969631237,0.14256909451190383,0.801,8/15,23.06%,ABHD12;GGT5;GGT7;ABHD16A;SARDH;ALDH4A1;PRODH;HOGA1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.6497443076328329,1.8482586201465714,0.009523809523809525,0.15978510571621213,0.98,10/35,6.04%,PDE7B;APOE;ADGRG6;AHR;IRAG1;CD36;RAPGEF2;PDE2A;PDE4D;PDE7A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6239169761977252,1.8388677877237296,0.004694835680751174,0.17445358522881638,0.987,11/40,7.64%,NELL1;P2RX7;ALOX5;ATP2B1;ANO6;MEF2C;CEBPB;OSR1;BMP2;ACVR2A;WNT6
prerank,negative regulation of ossification (GO:0030279),0.72881901876543,1.8387774173158271,0.0016556291390728477,0.17106485418319542,0.987,5/23,3.79%,RBPJ;CCR1;MEF2C;FGF23;SRGN
prerank,response to muscle stretch (GO:0035994),-0.6982979295117286,-1.8368280042675516,0.0,0.15438609161217492,0.857,3/15,2.57%,CTNNB1;SLC8A1;CDH2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7990240392594908,1.8356166108025647,0.0036429872495446266,0.1738320382001551,0.989,5/12,10.05%,DAB2;FOXP1;PIAS2;NCOR1;SFRP1
prerank,negative regulation of B cell activation (GO:0050869),0.7342270306499866,1.8355309186895832,0.0033613445378151263,0.17056984280049764,0.989,4/21,5.30%,BANK1;FCGR2B;LYN;RC3H1
prerank,nucleotide catabolic process (GO:0009166),0.7620436615386224,1.8347953677418434,0.012048192771084338,0.1686970199518793,0.992,3/16,3.68%,GDA;XDH;DNPH1
prerank,positive regulation of glycolytic process (GO:0045821),0.7261691230182176,1.834538742458777,0.010135135135135136,0.1627761699551672,0.992,8/20,9.95%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.7261691230182176,1.834538742458777,0.010135135135135136,0.1627761699551672,0.992,8/20,9.95%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,linoleic acid metabolic process (GO:0043651),0.7560008642728722,1.8297843860923808,0.0053475935828877,0.16889558047442152,0.993,4/17,7.36%,ALOX5;ALOX15;PNPLA8;ELOVL5
prerank,positive regulation of interleukin-1 production (GO:0032732),0.6113747492899001,1.8235056037403503,0.0,0.17873046366550416,0.996,16/51,11.10%,NLRC4;P2RX7;APP;IL16;LILRA5;TLR8;CD36;TLR4;CCL19;TMED10;TMEM106A;HSPB1;TNF;RIPK2;TRIM16;CASP8
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6193668361291726,-1.8220955649544943,0.002386634844868735,0.17323013344237084,0.89,6/21,5.61%,SCN1B;SNTA1;NOS1AP;ANK2;CACNA2D1;CACNA1D
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7271863440686235,1.821709113572776,0.008635578583765112,0.1792533483038923,0.997,6/18,6.94%,CMKLR1;C5AR1;C3AR1;LYN;FCER1G;SPG21
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6720478049972056,-1.8216042902084935,0.002304147465437788,0.16280138048243034,0.891,9/16,18.82%,SIRPA;TREM2;CUEDC2;PDCD4;APOD;ADCY7;ABCD2;CHID1;PYCARD
prerank,barbed-end actin filament capping (GO:0051016),0.7378285217685338,1.821190859407166,0.006837606837606838,0.17421837186146738,0.997,3/18,1.04%,EPS8;ADD3;FLII
prerank,actin filament capping (GO:0051693),0.7378285217685338,1.821190859407166,0.006837606837606838,0.17421837186146738,0.997,3/18,1.04%,EPS8;ADD3;FLII
prerank,positive regulation of ossification (GO:0045778),0.619813536816294,1.81487039116306,0.004709576138147566,0.18320539982780396,0.998,9/39,2.61%,NELL1;P2RX7;ALOX5;ATP2B1;ZBTB16;ANO6;MEF2C;OSR1;BMP2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.6146193042720995,1.8148404034120247,0.001488095238095238,0.18016984694436938,0.998,10/47,3.96%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;ITGB1BP1;S100A10
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6254908374833495,1.8042127655189837,0.004608294930875576,0.1984498494640925,0.998,11/42,10.26%,PF4;CCR1;OXSR1;CCL8;THPO;CCL19;WNK1;CCR2;CCL24;SH2B3;RBM15
prerank,B cell mediated immunity (GO:0019724),0.8311011746451049,1.8014371381646448,0.0038461538461538464,0.20086958926405254,0.998,4/10,2.78%,FCGR2B;TLR8;FCER1G;CD74
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5638354759821745,1.7960486546437042,0.0,0.20978202864476028,1.0,8/72,2.50%,ARHGEF3;EPS8;STARD8;NRP1;APOE;RIPOR2;OPHN1;GPR65
prerank,regulation of endocytosis (GO:0030100),0.5817139351226681,1.7923576813185125,0.00141643059490085,0.21347365878841823,1.0,9/61,6.23%,DAB2;MCTP1;HIP1;APOE;OPHN1;LILRB1;CCL19;ROCK1;AP2S1
prerank,positive regulation of bone mineralization (GO:0030501),0.6270579551002863,1.7917841031920065,0.003316749585406302,0.21144312924477074,1.0,8/35,2.61%,NELL1;P2RX7;ALOX5;ATP2B1;ANO6;MEF2C;OSR1;BMP2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5629429227873142,1.7915367185502333,0.0014005602240896359,0.20864559199171664,1.0,18/66,8.18%,MTSS1;APOE;ALOX5;FBXW7;CASK;NUPR1;XDH;CNMD;RGCC;TNMD;B2M;MCC;CDK6;KLF9;GHRL;PTPRK;SYNJ2BP;CDC73
prerank,cellular response to peptide (GO:1901653),0.5870300970573992,1.7896234316102353,0.0015037593984962407,0.20903622008077227,1.0,23/56,14.01%,FCGR2B;ITGA4;APP;RPL23;PTPN22;ADRB2;CD36;TLR4;SNX6;ZFP36L1;VIM;GSK3B;ABCC1;DDX11;PSEN1;FYN;MDM2;IGF1;RIPK2;CHMP5;NOD2;GJA1;ATP1A3
prerank,cellular protein metabolic process (GO:0044267),0.4697894175210033,1.787091475005634,0.0,0.21141790037837713,1.0,118/396,15.86%,APOE;PADI4;IGFBP4;APP;ST8SIA4;CP;RPS29;RPS23;GAS6;MRPL23;RPL17;RPL23;MRPS12;RPS12;DNAJC3;RPS16;RPS3;RPS27A;SHISA5;RPL39;RPS18;RPS21;EEF1A1;RIPK1;RPL23A;SIAH2;FGF23;RPS15;RPL37;RPLP1;RPL26;ST3GAL1;CLN5;RPS10;RPS20;RPS13;RPLP2;PRKN;RPSA;RPL41;LOX;DUSP12;RPS28;RPL13;MRPL13;SERP1;RPS24;RPL24;RSL24D1;RPL12;MANBA;RPL36A;RPS8;RPL18A;NOTUM;RPL37A;PARL;RPS11;RPL28;DARS1;RPL30;RPL8;RPL35A;RPS4X;MSRA;RPS15A;RPS17;RPL38;RPLP0;MRRF;RPL5;RPL36;PSEN1;RPL14;RPS14;RPL9;RPS9;RPS5;UBE2D3;RPS7;RPL34;RPL27;MRPS11;RPL6;IGF1;FBXO11;RPS6;GNMT;PPP4R2;RPL4;IGFALS;WFS1;RPL22;EIF4EBP2;RPL15;RPL10;DENND3;RPL32;STK38;NUCB1;LOXL2;ERO1A;MRPS17;RPL19;RPL31;SERPIND1;MRPS14;RPN2;GPC3;RPL11;SRBD1;FN1;MELTF;ICMT;USP25;NCSTN;ZDHHC2;FBXW2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6579499399084361,1.7855275018710797,0.00794912559618442,0.2114928557060683,1.0,9/31,9.13%,FCGR2B;VSIG4;LYN;CEBPB;LILRB1;RC3H1;PLA2G2D;CD80;SDC4
prerank,dendritic cell migration (GO:0036336),0.7679698756885285,1.7847987150433875,0.0,0.20963566117385773,1.0,6/16,7.60%,EPS8;ALOX5;CCR1;CCL19;CXCR4;CCR2
prerank,retrograde axonal transport (GO:0008090),-0.6821667461204131,-1.7819952418193874,0.007075471698113208,0.24612509571938745,0.967,7/16,11.36%,DST;DLG2;DYNC1H1;KIF1A;KIF5A;TMEM108;KIF1C
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.6546652373324602,-1.7770439035542476,0.0024096385542168677,0.24412925841819483,0.975,5/17,4.82%,SCN1B;SNTA1;NOS1AP;ANK2;CACNA2D1
prerank,actin nucleation (GO:0045010),0.718615914653294,1.7762806766322738,0.008460236886632826,0.22482029147979474,1.0,5/21,8.71%,IQGAP2;ACTR3;ARPC2;ARPC5;TRIM27
prerank,leukotriene biosynthetic process (GO:0019370),0.7539699655135454,1.7754905734072612,0.013157894736842105,0.2235295082519163,1.0,4/14,3.82%,ALOX5;LTC4S;ALOX5AP;MGST3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6855330450138639,1.774632463131956,0.01507537688442211,0.22237690521866607,1.0,8/23,9.95%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6114878177767633,1.7732111765969605,0.006144393241167435,0.22244359685363468,1.0,9/40,7.65%,DAB2;HIP1;TBC1D5;CBL;CCL19;B2M;INSR;ANXA2;HFE
prerank,embryonic appendage morphogenesis (GO:0035113),0.7677082405026399,1.7721676900022791,0.015180265654648957,0.22206532295868994,1.0,2/12,1.14%,LRP6;MBNL1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6156739859758893,1.7708131279781556,0.006482982171799027,0.2220497098312858,1.0,9/38,5.18%,NEDD9;APP;LILRA5;GAS6;SH3BP5;RAP2B;CASS4;DOK7;GPRC5B
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7349223151607909,1.7695538551041334,0.010398613518197574,0.22178385181379992,1.0,6/16,9.45%,NRP1;PTPRJ;FER;PDGFRA;PIK3C2A;PDGFC
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5385560970240567,-1.7674594999230069,0.0,0.25586301922911525,0.986,11/37,14.52%,CADM1;GRID2;PTPRD;NLGN1;TENM3;FAT4;TENM2;TENM4;IL1RAPL1;IGSF21;CXADR
prerank,plasma membrane invagination (GO:0099024),0.654462640071338,1.7672048304734853,0.012718600953895072,0.22431534970459308,1.0,8/29,3.78%,MSR1;FCGR2B;SNX9;DOCK1;CD36;HAVCR1;CDC42;RHOA
prerank,regulation of ossification (GO:0030278),0.6393277404857197,1.7660905080891889,0.0093603744149766,0.2238103834214618,1.0,9/36,10.50%,RBPJ;LRP6;ZBTB16;MEF2C;BMP2;NOTUM;DDR2;SFRP1;S1PR1
prerank,positive regulation of B cell proliferation (GO:0030890),0.6584326599166074,1.7649137250214417,0.006289308176100629,0.22347887531866806,1.0,8/29,6.29%,VAV3;CD38;BST1;MEF2C;CD74;IRS2;CD40;BCL2
prerank,positive regulation of phagocytosis (GO:0050766),0.5859489980397807,1.763009132444157,0.0030911901081916537,0.22469108730878837,1.0,11/47,3.39%,C4B;FCGR2B;PTPRJ;IL15;GAS6;DOCK2;RAB31;ANO6;FCER1G;C2;CAMK1D
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.765242068754981,1.7612067029752663,0.010676156583629894,0.22545530317359724,1.0,5/15,8.71%,IQGAP2;ACTR3;ARPC2;ARPC5;TRIM27
prerank,epithelial cell migration (GO:0010631),0.6235287240019575,1.7585508786177588,0.0077279752704791345,0.2280871899328962,1.0,12/37,12.82%,ZEB2;PLEKHG5;NRP1;RHOA;PKN2;ROCK1;TNFSF12;STARD13;PXN;KANK2;LOXL2;PLXND1
prerank,cellular response to chemokine (GO:1990869),0.603546470556723,1.754699076794218,0.004491017964071856,0.23338803819613813,1.0,12/46,9.29%,PF4;CCR1;RIPOR2;OXSR1;CCL8;CCL19;RHOA;DUSP1;WNK1;CCR2;CCL24;SH2B3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5974089660050451,1.7524214241423275,0.0030165912518853697,0.2354736244846758,1.0,16/45,13.95%,NLRC4;P2RX7;APP;LILRA5;TLR8;CD36;TLR4;CCL19;TMEM106A;HSPB1;TNF;RIPK2;TRIM16;CASP8;NOD2;STAT3
prerank,regulation of inflammatory response (GO:0050727),0.4893253867279322,1.7511694358456928,0.0,0.2350545612795216,1.0,35/190,7.60%,AOAH;APOE;ALOX5;APP;IL16;LILRA5;FOXP1;IL15;ALOX15;BST1;C1QTNF3;MFHAS1;NR1H4;PLA2G7;TSLP;METRNL;TNFRSF1B;RIPK1;TLR4;NR1D1;GRN;SNX6;NFKBIZ;PDE2A;TLR2;IL17RA;BIRC3;RB1;GHRL;CD200R1;GPRC5B;TNF;ABCC1;KLF4;CCR2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7346086797248245,1.7509115922465028,0.008912655971479501,0.23288273590084094,1.0,6/16,11.28%,IGFBP4;BMP2;MYORG;IGF1;ZFAND2B;PHIP
prerank,myeloid cell development (GO:0061515),0.6960827668882826,1.7490798419232296,0.006837606837606838,0.23403787263354903,1.0,7/18,9.29%,NRROS;APP;FOXP1;THPO;TLR2;ANXA2;SH2B3
prerank,smooth muscle cell differentiation (GO:0051145),0.7750033855704267,1.746136743053514,0.013333333333333334,0.23803435442362628,1.0,3/12,4.52%,EDNRB;MEF2C;HEY2
prerank,regulation of response to oxidative stress (GO:1902882),0.7832676777130817,1.7455480648571537,0.007827788649706457,0.23678342313161022,1.0,3/11,4.05%,MCTP1;ALOX5;PRKN
prerank,synaptic vesicle cycle (GO:0099504),-0.5591184684755894,-1.745002375665357,0.008426966292134831,0.3079632043997648,0.996,19/30,33.49%,RIMS1;NLGN1;SNAP25;PIP5K1C;PCLO;SYNDIG1;CPLX1;VAMP2;SLC17A6;CPLX2;BRSK1;SYT7;DNAJC5;WNT7A;SLC18A2;RAB3A;SNAPIN;STX1A;SLC17A8
prerank,aorta morphogenesis (GO:0035909),0.7233113293401938,1.7440397269668952,0.011320754716981131,0.23735095710867873,1.0,3/17,4.52%,RBPJ;JAG1;HEY2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8152830419158146,1.7429871755347324,0.011152416356877323,0.23696212760189825,1.0,5/10,3.93%,GAS6;LYN;LILRB1;CCL19;RAPGEF2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6508165856980803,1.7428096858581883,0.010050251256281407,0.23477155667578717,1.0,11/26,16.91%,DAB2;FOXP1;CLOCK;PIAS2;NCOR1;SFRP1;KANK2;CNOT9;PER1;STRN3;ZBTB7A
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5416366752204466,1.741030992669572,0.006993006993006993,0.2358784941118539,1.0,15/76,7.19%,EGFR;APP;SASH1;C1QTNF3;RPS3;PTPN22;RASSF2;TLR4;CCL19;RHOA;TLR2;SPI1;UACA;TNF;PPM1B
prerank,ephrin receptor signaling pathway (GO:0048013),0.5344484388860468,1.7396300324629,0.005571030640668524,0.23628493171449103,1.0,19/82,8.05%,ITSN1;VAV3;AP2A2;LYN;ACTR3;RASA1;CDC42;ANKS1A;CRK;RHOA;ROCK1;ACTB;AP2S1;NGEF;SDCBP;ARPC2;ARPC5;PSEN1;FYN
prerank,substrate-dependent cell migration (GO:0006929),0.7412794342748263,1.7369322349388798,0.009208103130755065,0.23951983533289536,1.0,5/14,6.84%,NRP1;OPHN1;ANKS1A;ITGB1BP1;SDCBP
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5964148877799559,1.73612973062818,0.009508716323296355,0.238929719089193,1.0,7/39,3.48%,EGFR;PTPRJ;PTPN18;EPS15;PTPN12;CDC42;CBL
prerank,cellular response to estradiol stimulus (GO:0071392),0.7010595952384115,1.7358028909494048,0.021897810218978103,0.23722471376232143,1.0,6/18,10.05%,EGFR;ESR1;NCOA3;NRIP1;LCOR;SFRP1
prerank,cellular response to zinc ion (GO:0071294),-0.6670107562187289,-1.7324118341962682,0.004545454545454545,0.3375240423560885,0.996,13/15,26.46%,GLRA1;ATP13A2;HVCN1;MT2A;GLRA2;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of defense response (GO:0031349),0.5301154193018667,1.7301814664314592,0.0013679890560875513,0.24630891292665893,1.0,21/89,8.58%,APP;IL16;LILRA5;TLR8;IL15;MEF2C;PLA2G7;TSLP;RIPK1;TLR4;GRN;NFKBIZ;PDE2A;TLR2;IL17RA;GPRC5B;RIOK3;TNF;ABCC1;CCR2;NINJ1
prerank,sulfur compound catabolic process (GO:0044273),-0.5267662523743002,-1.7300805555147387,0.002688172043010753,0.3299982466694137,0.997,16/38,23.92%,HEXB;GNS;CSPG5;GGT5;CSPG4;HYAL1;GGT7;VCAN;IDUA;BCAN;BGN;TST;NCAN;FMOD;DCN;PRELP
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6795126530783283,1.7290725276670647,0.012280701754385965,0.24358657846089132,1.0,9/23,16.03%,DAB2;ZEB2;SMAD4;SDCBP;RNF111;CREBBP;EP300;SNW1;HSP90AB1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6795126530783283,1.7290725276670647,0.012280701754385965,0.24358657846089132,1.0,9/23,16.03%,DAB2;ZEB2;SMAD4;SDCBP;RNF111;CREBBP;EP300;SNW1;HSP90AB1
prerank,heterocycle biosynthetic process (GO:0018130),0.7294337586370087,1.728831322705,0.014109347442680775,0.2417135641060264,1.0,4/14,4.58%,ALOX5;MOCS1;HDC;GCH1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.8042286362054907,1.727582009272694,0.01160541586073501,0.24211506232767868,1.0,4/10,3.64%,NPL;ST6GAL1;GNPDA1;ST3GAL1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.7149087740734756,1.7274526129851524,0.021621621621621623,0.24008601920750977,1.0,3/17,2.08%,PID1;NUPR1;CBFA2T3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.6824268166989808,1.7268221213115937,0.007067137809187279,0.23924954482158473,1.0,8/21,10.78%,FCGR2B;FOXP1;LYN;PTPN22;ELF2;CBFB;PRKCB;ELF1
prerank,response to amyloid-beta (GO:1904645),0.5897567289637207,1.7235048560871673,0.004594180704441042,0.24394171729050534,1.0,12/44,9.95%,FCGR2B;ITGA4;APP;ADRB2;CD36;TLR4;SNX6;GSK3B;ABCC1;PSEN1;FYN;IGF1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6971528533354054,1.7227910105915374,0.012522361359570662,0.24326521798383227,1.0,6/19,4.31%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,cellular response to amyloid-beta (GO:1904646),0.6203429470640013,1.721944606906812,0.009630818619582664,0.24257146236371627,1.0,12/35,9.95%,FCGR2B;ITGA4;APP;ADRB2;CD36;TLR4;SNX6;GSK3B;ABCC1;PSEN1;FYN;IGF1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.704646983886592,1.7203455643530299,0.018302828618968387,0.2434938579654526,1.0,6/17,8.68%,ADRB2;DRD1;RAPGEF2;ADCY9;ADRA1D;ADRA1A
prerank,regulation of interleukin-10 production (GO:0032653),0.5942506701619864,1.7167361289396224,0.008708272859216255,0.24935122115113775,1.0,9/44,6.52%,FCGR2B;LILRA5;IRF4;TSLP;LILRB1;TLR4;PIBF1;CD46;SYK
prerank,synaptic membrane adhesion (GO:0099560),-0.6908168446520282,-1.7165558360499988,0.01160092807424594,0.36314428132757237,1.0,7/14,16.99%,PTPRS;PTPRD;LRRC4C;LRFN5;NTNG1;LRRC4;GPC6
prerank,adrenergic receptor signaling pathway (GO:0071875),0.6809593519836038,1.7165452252884046,0.015228426395939087,0.24749120179724574,1.0,8/20,12.79%,ADRB2;DRD1;RAPGEF2;ADCY9;PDE4D;ADRA1D;ADRA1A;LMBRD2
prerank,positive regulation of inflammatory response (GO:0050729),0.5335953139512365,1.7147624262694698,0.004132231404958678,0.2491395607915239,1.0,20/86,8.58%,APP;IL16;LILRA5;IL15;NUPR1;PLA2G7;TSLP;RIPK1;TLR4;GRN;NFKBIZ;LBP;PDE2A;TLR2;IL17RA;GPRC5B;TNF;ABCC1;CCR2;NINJ1
prerank,Rho protein signal transduction (GO:0007266),0.5667584003747012,1.7141009765916217,0.006153846153846154,0.24840553952228783,1.0,9/53,7.97%,ARHGEF3;EPS8;PLEKHG5;CDC42;RHOA;ROCK1;CELSR1;ARHGAP29;ARHGDIA
prerank,rRNA metabolic process (GO:0016072),0.4859130091524427,1.7132874128656177,0.0,0.24793834427695638,1.0,56/160,14.90%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RPL28;WDR36;NOP53;RPL30;RPL8;NOL9;RPL35A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;HEATR1;RPL6;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;RPL31;EXOSC1;RPL11
prerank,ribosomal small subunit biogenesis (GO:0042274),0.5990416959069713,1.7130808349071196,0.021671826625386997,0.24612733599979972,1.0,15/39,10.21%,RPS16;RPS15;ERAL1;RPSA;SNU13;RPS28;RPS24;RIOK3;LTV1;RPS17;RPS14;RPS5;RPS7;MRPS11;RPS6
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5529160395009103,1.7118311978006064,0.004120879120879121,0.2467230890134915,1.0,12/63,7.01%,VAV3;CD38;IL15;BST1;MEF2C;CD74;CD46;CCL19;IRS2;CD40;BCL2;CD80
prerank,negative regulation of hormone secretion (GO:0046888),0.7920346192060019,1.7081812746034781,0.01858736059479554,0.2523490407102862,1.0,2/10,2.94%,RAB11FIP5;FGF23
prerank,monocyte chemotaxis (GO:0002548),0.6230150202478029,1.7066177378841545,0.009478672985781991,0.2537724633662786,1.0,7/32,8.26%,FOLR2;CCL8;MSMP;CCL19;TNFRSF11A;CCL24;IL6R
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.6218963021585431,1.7056800247897352,0.01592356687898089,0.2537933856102007,1.0,7/33,6.99%,PF4;CCR1;RIPK1;CD74;DCSTAMP;ZFP36L1;TNF
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.5781807832941105,-1.7048115759506348,0.005479452054794521,0.39198572476923044,1.0,16/24,29.10%,FGF13;NCKAP5L;MAPT;STMN3;NCKAP5;TPPP;STMN4;CKAP5;KIF2A;KATNB1;PIN1;KIF14;HDGFL3;MAP7D3;TPPP3;KIF2C
prerank,T cell activation involved in immune response (GO:0002286),0.7665391841362594,1.7040382296484022,0.01282051282051282,0.25513637223018865,1.0,4/12,4.01%,FCER1G;LILRB1;CD74;LCP1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6892150157118814,-1.7039650527887864,0.008888888888888889,0.3787475092188328,1.0,10/13,22.89%,HEXB;CSPG5;CSPG4;HYAL1;VCAN;IDUA;BCAN;BGN;NCAN;DCN
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.7669605468413737,1.7027397533515285,0.014571948998178506,0.25594320076009225,1.0,8/12,14.97%,KLF2;DHRS3;CYP26C1;ASXL1;CYP26B1;TRIM16;CTBP2;SNW1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6971582245533083,1.7022436837347523,0.02120141342756184,0.2548911662603016,1.0,6/17,4.31%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6791751301795964,1.7018265721175183,0.017421602787456445,0.2537254786440367,1.0,3/20,5.16%,RBPJ;BMP2;SMAD4
prerank,regulation of mitochondrial fusion (GO:0010635),0.7626558439633873,1.7016841686737108,0.011406844106463879,0.2519819500965887,1.0,2/11,4.05%,PID1;PRKN
prerank,purine ribonucleotide catabolic process (GO:0009154),0.6711111216410034,1.7014683426209565,0.02385008517887564,0.2502920514496213,1.0,8/21,14.85%,HINT1;XDH;PDE2A;PDE4D;AMPD3;NT5C2;ACAT1;NUDT18
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6639586590271169,1.698761507632497,0.013628620102214651,0.25390501333253745,1.0,3/23,1.41%,ALOX5;LTC4S;ALOX15
prerank,neurotransmitter secretion (GO:0007269),-0.4949328080206141,-1.6950557184324324,0.002824858757062147,0.3964526014210088,1.0,17/44,22.21%,RIMS1;RIMS2;SNAP25;NRXN1;PIP5K1C;PCLO;DVL1;SYN3;CPLX1;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;CPLX2;BRSK1;GAD1
prerank,cardiac muscle cell development (GO:0055013),0.6692228041812327,1.6949203306667489,0.025089605734767026,0.25992635559481386,1.0,5/20,5.36%,PDLIM5;MYH6;ALPK3;HEY2;PDGFRA
prerank,cellular response to fluid shear stress (GO:0071498),0.7490561343294726,1.694860212342316,0.021621621621621623,0.2580548396105797,1.0,8/12,16.19%,MTSS1;KLF2;MEF2C;KLF4;ASS1;SREBF2;PKD2;MAPK7
prerank,membrane organization (GO:0061024),0.4636746153543779,1.693012482939795,0.0,0.25991941815703673,1.0,42/227,10.83%,DAB2;ITSN1;TMCC1;AP2A2;HIP1;EGFR;SNX9;FCHO2;MYADM;LDLR;REEP3;EPS15;REPS2;CLTC;ACTR3;RPS27A;ADRB2;SPTBN1;SYNJ1;DCSTAMP;CBL;AGFG1;MYOF;SERP1;SNX3;OCRL;ACTB;AP2S1;GAPVD1;EPN2;ARPC2;VPS4B;FNBP1;ARPC5;PIK3C2A;RABEP1;GLTP;CORO1C;ARRB1;PACSIN2;CHMP5;ATP10B
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.7151906511476113,1.6924630156917788,0.02142857142857143,0.25905000012949597,1.0,5/15,7.64%,LRP6;BMP2;ANKRD11;EDA;WNT6
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.529509502483667,-1.6917149850121893,0.002506265664160401,0.39392257384040397,1.0,14/32,12.06%,ADGRB3;CUX1;SEMA4D;PTPRD;YWHAH;HECW2;SS18L1;NSMF;KNDC1;SDC2;HECW1;CAPRIN1;SS18L2;IL1RAPL1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.6004072145747695,1.6913841754129704,0.014240506329113924,0.25940522642005326,1.0,9/40,5.36%,RASGRP4;EGFR;FGFR1;GNAQ;C5AR1;ESR1;ANG;P2RY6;PDGFRA
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6214479896615893,1.6882643984002135,0.012578616352201259,0.26400336312866085,1.0,7/30,6.52%,LILRA5;IRF4;TSLP;TLR4;PIBF1;CD46;SYK
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7609879772712422,1.6877950897808294,0.01694915254237288,0.2631147878250996,1.0,6/12,10.78%,LYN;PTPN22;RC3H1;ELF2;CBFB;ELF1
prerank,macrophage activation (GO:0042116),0.6174586763062193,1.6856697778608867,0.009630818619582664,0.2654561553046861,1.0,10/34,6.99%,APP;FOXP1;C1QA;C5AR1;CD93;TLR4;LBP;TMEM106A;SYK;TNF
prerank,endothelial cell development (GO:0001885),0.6399288844290011,1.6843209214168395,0.018612521150592216,0.2665158757770839,1.0,10/25,8.44%,RAP1B;MYADM;CNMD;TNMD;RAPGEF2;PDE2A;RAP1A;PDE4D;COL22A1;MSN
prerank,regulation of protein kinase activity (GO:0045859),0.5028476970980118,1.684099112393125,0.0013351134846461949,0.26505289352702344,1.0,27/106,9.69%,LRP6;GNAQ;SPRED1;DEPTOR;IQGAP1;SNX9;PRKAG2;GAS6;C5AR1;RAP2B;RASSF2;UVRAG;CCL19;ITGB1BP1;RAPGEF2;RAP1A;RB1;CAMKK2;PAK2;SFN;CEP85;HSPB1;TNF;DDR2;TRIM27;SMCR8;CACUL1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.61971319286876,-1.6839197999571542,0.007177033492822967,0.41057279517433254,1.0,5/18,4.01%,GRID2;GRIA2;UNC13C;GRIK2;CDH8
prerank,actin cytoskeleton reorganization (GO:0031532),0.5402409318564495,1.6835202871705068,0.005772005772005772,0.26442522188980855,1.0,15/63,10.50%,NRP1;NEDD9;CDC42BPG;FER;CASS4;GPR65;RHOA;MCU;S1PR2;EFS;NRK;GAB1;ANTXR1;PIP5K1A;S1PR1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.638771134690915,1.6828441504675027,0.02329450915141431,0.2640319699707426,1.0,7/23,15.49%,NUPR1;C1QTNF3;CBFA2T3;C1QTNF12;NCOR1;EP300;HDAC4
prerank,B cell differentiation (GO:0030183),0.5664543886147612,1.6825118977204268,0.012307692307692308,0.2628112792537737,1.0,12/46,10.42%,HDAC9;ITGA4;PTPRJ;ITGB1;KLF6;IRF2BP2;CR2;LYL1;CEBPG;FNIP1;NHEJ1;SLC25A5
prerank,activation of phospholipase C activity (GO:0007202),0.6302314818371832,1.682200281739404,0.02030456852791878,0.2615850506865816,1.0,6/29,3.29%,RASGRP4;EGFR;GNAQ;C5AR1;ANG;P2RY6
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4948279009625178,1.6814463785927916,0.0013227513227513227,0.2613039577887881,1.0,22/121,7.01%,BANK1;NRP1;NEDD9;LILRA5;PTPRJ;CLEC6A;IL15;GAS6;LYN;TSLP;CD44;CASS4;PARP14;CD74;THBS4;PIBF1;DOK7;PAK2;GPRC5B;CD40;TNF;CD80
prerank,sterol transport (GO:0015918),0.6927660993736856,1.6800818304699177,0.01601423487544484,0.2623029248816118,1.0,3/19,2.65%,MSR1;LDLR;CD36
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.6095019958565999,-1.6783698260788118,0.006864988558352402,0.41665541574409104,1.0,11/19,21.75%,RPTOR;POLR3C;AR;ICE2;ZNF76;MAF1;BRF2;MTOR;PRDX5;POLR3G;ELL
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5760969465736375,1.6777353959297467,0.01579778830963665,0.26520743136028674,1.0,5/41,4.52%,RBPJ;JAG1;MEF2C;MYH6;HEY2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5086126245681327,1.6763714128456422,0.002777777777777778,0.2660537261608668,1.0,10/86,7.65%,RBPJ;DAB2;ZEB2;BMP2;GDF3;SMAD4;GDF10;ACVR2A;SDCBP;HFE
prerank,positive regulation of B cell activation (GO:0050871),0.5676830430673062,1.676030979055462,0.0072254335260115606,0.2649065769764519,1.0,19/50,17.76%,VAV3;CD38;BST1;MEF2C;CD74;IRS2;PPP2R3C;CD40;BCL2;SYK;NFATC2;KMT5B;NOD2;GPR183;TIRAP;SHLD3;CHRNB2;XBP1;IL6
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.48437084659125357,1.6758220774846568,0.0012315270935960591,0.26351810148798466,1.0,25/151,5.36%,NRP1;EGFR;APOE;APP;NOTCH2;CCR1;FBXW7;GAS6;C5AR1;ALOX15;MFHAS1;PTPN22;CD44;BMP2;CD36;CD74;CCL8;P2RY6;THPO;CCL19;RAPGEF2;TNFRSF11A;PDE8A;RAP1A;PDGFRA
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5415480537337999,1.6731005796233756,0.007132667617689016,0.2673710637909066,1.0,14/67,4.84%,NRP1;NEDD9;MYADM;RREB1;ALOX15;CASS4;DOCK1;CD36;CDC42;CRK;UTRN;S100A10;CDK6;GSK3B
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5325068987226182,1.6714843453866897,0.004207573632538569,0.2689767919614674,1.0,23/66,13.95%,NLRC4;P2RX7;APP;LILRA5;FOXP1;TLR8;CD36;TLR4;CCL19;GHRL;TMEM106A;HSPB1;TNF;CD33;CARD16;IGF1;RIPK2;TRIM16;CASP8;ZC3H12A;NOD2;FFAR1;STAT3
prerank,positive regulation of response to external stimulus (GO:0032103),0.48558486563641023,1.6710237532134904,0.00129366106080207,0.26821502080166265,1.0,28/128,8.58%,APP;IL16;LILRA5;SASH1;TLR8;IL15;PLA2G7;TSLP;DDX60;RIPK1;TLR4;GRN;ANKRD17;CCL19;SCARF1;NFKBIZ;PDE2A;TLR2;IL17RA;GPRC5B;PUM2;LY96;RIOK3;TNF;ABCC1;USP15;CCR2;NINJ1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49937194115851546,1.6705940206955834,0.0,0.26732044301442504,1.0,27/112,8.76%,PF4;APP;LILRA5;PTPRJ;FOXP1;OAS2;GAS6;IRAK3;NR1H4;PTPN22;RIPK1;LILRB1;TLR4;CCL19;LBP;TLR2;NFKBIL1;GHRL;MAPKAPK2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1;TRIM27;CD33
prerank,response to interferon-alpha (GO:0035455),0.6937779464748927,1.6695630042528795,0.021352313167259787,0.2677797726767308,1.0,8/16,9.49%,IFITM3;GAS6;IFNAR1;LAMP3;BST2;IFNAR2;RO60;IFITM2
prerank,cAMP-mediated signaling (GO:0019933),0.6280648937729782,1.6692695121832217,0.02508361204013378,0.26664588066657996,1.0,7/24,6.04%,PDE7B;ADGRG6;AHR;RAPGEF2;PDE2A;PDE4D;PDE7A
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4959170626004564,-1.665121181719579,0.0028653295128939827,0.4560991507934951,1.0,15/40,19.36%,RIMS1;UNC13C;RIMS2;SNAP25;PIP5K1C;PCLO;SNAP47;STX3;CPLX1;VAMP2;SYT8;STX2;RIMS3;SYT1;CPLX2
prerank,negative regulation of cell activation (GO:0050866),0.7187092259086948,1.6636241095885913,0.028680688336520075,0.27681672848534533,1.0,5/14,5.36%,APOE;LDLR;C1QTNF1;NR1D1;PDGFRA
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.6513156342674042,1.6621466430606855,0.029556650246305417,0.2783542604276985,1.0,3/20,1.61%,DAB2;PID1;CLTC
prerank,regulation of bone mineralization (GO:0030500),0.5483573110410003,1.661976221829808,0.013513513513513514,0.27693889407135874,1.0,13/55,6.32%,NELL1;P2RX7;ALOX5;ATP2B1;CCR1;ANO6;MEF2C;OSR1;BMP2;FGF23;SRGN;NOTUM;ACVR2A
prerank,amide transport (GO:0042886),0.624355632695995,1.6619582711795522,0.017241379310344827,0.27519801099467467,1.0,3/26,4.18%,PLTP;FOLR2;SLC14A1
prerank,rRNA processing (GO:0006364),0.46767971293330335,1.6600095938476735,0.001182033096926714,0.2774472269598846,1.0,58/172,14.90%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RIOK3;RPL28;WDR36;NOP53;RPL30;RPL8;NOL9;RPL35A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;HEATR1;RPL6;RPS6;MRPL1;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;RPL31;EXOSC1;RPL11
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6096673756889681,1.6586132205428559,0.02321981424148607,0.27876540115787773,1.0,7/32,12.06%,PF4;ANG;RPL39;RPL30;RNASE6;ROMO1;FAM3A
prerank,positive regulation of protein binding (GO:0032092),0.542061916968948,1.6573295037075413,0.013432835820895522,0.2796488935235242,1.0,19/56,14.90%,APOE;APP;TCF7L2;BMP2;RAPGEF2;B2M;PRKN;GSK3B;STK3;NMD3;HFE;PSEN1;PPP2CA;PPP2CB;RIPK2;AMFR;RALB;ADD1;RPL11
prerank,triglyceride catabolic process (GO:0019433),-0.6053937753803675,-1.6564582727198003,0.019753086419753086,0.47770593342500234,1.0,4/19,15.16%,FABP5;LIPH;LPL;FABP4
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5573684619075343,1.6547083237889915,0.01664145234493192,0.28365090427051887,1.0,9/48,3.96%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;S100A10
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.6202380569002105,1.653040310808319,0.02666666666666667,0.28546540674876386,1.0,3/25,6.32%,RBPJ;SMAD4;ACVR2A
prerank,negative regulation of protein transport (GO:0051224),0.6348113894934049,1.652376465100656,0.027538726333907058,0.285298377472762,1.0,6/25,6.44%,APOE;HMGCR;NDFIP1;SNX3;RHBDF1;DPH3
prerank,adenine nucleotide transport (GO:0051503),0.6939973067962877,1.6519066292556182,0.02422145328719723,0.2845611047922304,1.0,7/17,18.67%,LRRC8D;SLC25A17;SLC25A24;ABCC4;SLC25A5;LRRC8C;SLC25A4
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6298863160597772,1.6516724981152178,0.024013722126929673,0.28329670983108524,1.0,10/26,16.03%,KLF2;CD36;TLR4;INSR;TMEM106A;TNF;KLF4;ASS1;PKD2;HSP90AB1
prerank,negative regulation of B cell proliferation (GO:0030889),0.7473234224268887,1.6509303314425159,0.03278688524590164,0.2832238412011828,1.0,3/11,5.30%,FCGR2B;LYN;RC3H1
prerank,endothelial tube morphogenesis (GO:0061154),0.7695530606680834,1.650722113807001,0.016885553470919325,0.2819504397304274,1.0,3/10,4.45%,RBPJ;RHOA;CCM2
prerank,innate immune response (GO:0045087),0.45822776531007914,1.650477819749308,0.0,0.2809170067728576,1.0,46/217,11.12%,NRROS;APP;CFP;CYBB;COLEC12;TLR8;CLEC6A;IFITM3;LYN;ANG;MFHAS1;FER;ALPK1;RPL39;FCER1G;CD74;TLR4;ANKRD17;SERINC3;B2M;LBP;BCL10;TLR2;FRK;TRIM56;GCH1;TRIM32;CD40;SYK;CR2;ZAP70;BST2;RNASE6;REL;FYN;CXCL16;TRIM68;MFAP4;CLEC4D;TRIM27;IFITM2;RIPK2;STYK1;SP100;NCF2;SLA
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5201024354261459,1.650420513924326,0.01037037037037037,0.2793980569927898,1.0,10/65,6.02%,HIP1;EGFR;PTPRJ;EPS15;ARAP1;FER;PTPN12;CDC42;CBL;RHBDF1
prerank,superoxide anion generation (GO:0042554),0.7088383075917372,1.6498300228341516,0.026690391459074734,0.2789375870844589,1.0,4/13,15.14%,CYBB;NCF2;CYBA;NOX4
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.7179516786463246,-1.6484903458845144,0.023206751054852322,0.49757647869060745,1.0,4/10,9.37%,HK2;PFKL;GFPT1;PFKP
prerank,regulation of epithelial cell proliferation (GO:0050678),0.501199120552244,1.6479294925279164,0.014824797843665768,0.2812009448230778,1.0,16/85,10.05%,MTSS1;EGFR;TCF7L2;C5AR1;NUPR1;OSR1;NR1D1;GRN;ZFP36L1;B2M;MCC;CDK6;NR4A1;CDC73;IGF1;SFRP1
prerank,mitochondrion morphogenesis (GO:0070584),0.7344606814587897,1.6471222470333675,0.02722323049001815,0.28116169991979884,1.0,2/11,2.47%,PID1;MTM1
prerank,toll-like receptor signaling pathway (GO:0002224),0.5077669882643955,1.6464088167939857,0.009308510638297872,0.2810231693226763,1.0,23/84,11.10%,COLEC12;TLR8;IRAK3;NR1H4;RPS27A;S100A1;CD36;RIPK1;TLR4;MAP3K1;RPS6KA3;RFTN1;LBP;BCL10;TLR2;BIRC3;MAPKAPK2;CTSB;LY96;EPG5;UBE2D3;RIPK2;CASP8
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7326740969610586,1.644820684088216,0.030965391621129327,0.28277038447699643,1.0,1/13,0.05%,PID1
prerank,positive regulation of MAPK cascade (GO:0043410),0.45173134032860507,1.643338166130641,0.0,0.28402302551877806,1.0,43/245,10.24%,NRP1;EGFR;APOE;FGFR1;APP;LILRA5;PTPRJ;NOTCH2;CCR1;IQGAP1;FBXW7;GAS6;C5AR1;ALOX15;MFHAS1;PTPN22;CD44;ADRB2;BMP2;CD36;CD74;CCL8;P2RY6;THPO;CCL19;RAPGEF2;PDE8A;GSDME;RAP1A;INSR;PDGFRA;ROCK1;TMEM106A;CD40;PIK3R6;TNF;CCL24;ADRA1D;ADRA1A;PDGFC;MYDGF;IGF1;ARRB1
prerank,regulation of interleukin-13 production (GO:0032656),0.7218394268978621,1.643091891579583,0.020477815699658702,0.28287794361349816,1.0,3/13,2.15%,LILRA5;IRF4;TSLP
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7175650038235363,1.6429540873520763,0.02389705882352941,0.2814960938907165,1.0,2/13,2.02%,RBPJ;MEF2C
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6560304616060482,1.6428884163179467,0.02138157894736842,0.2800268760519812,1.0,6/22,6.99%,APOE;SNX9;TNFRSF1B;ADAM9;ROCK1;TNF
prerank,dopaminergic neuron differentiation (GO:0071542),0.6564079482841106,1.6421554486056391,0.035650623885918005,0.28001384161813614,1.0,5/19,7.90%,LRP6;PHOX2A;WNT2;MANF;NR4A2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5507062297165944,1.641698889515816,0.008995502248875561,0.279443874080643,1.0,9/50,6.99%,EGFR;APP;SASH1;RPS3;TLR4;CCL19;RHOA;TLR2;TNF
prerank,positive regulation of transport (GO:0051050),0.4994542982248599,1.6413202371704956,0.006830601092896175,0.27874918957091066,1.0,14/85,6.99%,DAB2;FCGR2B;APOE;IL15;GAS6;DOCK2;KMT2A;FCER1G;CAMK1D;CCL19;GSK3B;ACTB;ANXA2;TNF
prerank,negative regulation of viral life cycle (GO:1903901),0.683054199391357,1.6399728223760024,0.04317789291882556,0.28005261324416236,1.0,7/15,15.00%,IFITM3;SNX3;BST2;IFITM2;LY6E;MID2;PPIA
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.7053238851875645,1.639935564252162,0.025974025974025976,0.2786199070328818,1.0,6/13,13.69%,FCGR2B;ALOX5;NUPR1;MANF;WFS1;NR1H2
prerank,regulation of Notch signaling pathway (GO:0008593),0.5082981964404811,1.639811061735326,0.011204481792717087,0.27733761956106745,1.0,22/76,15.74%,RBPJ;EGFR;FBXW7;JAG1;CD46;ITGB1BP1;NRARP;EPN2;SYNJ2BP;POGLUT1;ARRB1;MAML1;EGFL7;CREBBP;SREBF2;NIBAN2;NOD2;EP300;STAT3;LFNG;SNW1;TSPAN14
prerank,embryonic eye morphogenesis (GO:0048048),0.7413842032072662,1.6397476082468574,0.018083182640144666,0.2759876875209892,1.0,2/11,1.95%,LRP6;RARG
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6504771169807262,1.6387494976435353,0.023465703971119134,0.27663452000583594,1.0,5/19,11.75%,APOE;RAPSN;CHRNA4;ACHE;COLQ
prerank,response to tumor necrosis factor (GO:0034612),0.5023809074346428,1.637612134580813,0.005532503457814661,0.27756839497959906,1.0,21/91,11.10%,PID1;GBP3;ZFP36L2;RPS3;RIPK1;CCL8;NR1D1;DCSTAMP;ADAM9;CCL19;ZFP36L1;TNFRSF11A;GSDME;GCH1;TRIM32;CD40;CXCL16;CCL24;IGBP1;SFRP1;CASP8
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.677427233234354,1.6375111159397528,0.025974025974025976,0.27633062684245846,1.0,1/15,0.03%,DAB2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7028244376837169,1.6375009655850772,0.026455026455026454,0.2749064097559232,1.0,3/15,2.65%,MSR1;PF4;CD36
prerank,negative regulation of inflammatory response (GO:0050728),0.45918659975577997,1.6371427420207043,0.0024449877750611247,0.27410996479065614,1.0,39/182,13.35%,CD163;AOAH;APOE;ALOX5;LYN;C1QTNF3;CYSLTR1;MFHAS1;NR1H4;GNG2;METRNL;TNFRSF1B;CALCRL;ADRB2;DRD1;NR1D1;GRN;ADM;RB1;GHRL;CD200R1;ADCY9;ADCYAP1R1;SYK;KLF4;GNB1;FYN;FCGR3A;MAPK14;IGF1;TSHR;PTGER4;PRKACB;HTR6;RAMP2;TNFRSF1A;GLP2R;CREB1;GPR27
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6383468384183862,1.6355734226121736,0.03135313531353135,0.27557357978223135,1.0,7/19,10.93%,APP;KLF2;TMEM106A;TNF;KLF4;MTPN;WFS1
prerank,mesenchymal cell differentiation (GO:0048762),0.5360957306356192,1.6324460815489286,0.019908116385911178,0.2807381734439679,1.0,10/51,5.43%,RBPJ;LRP6;FGFR1;S100A4;MEF2C;FBXL17;BMP2;HEY2;GSK3B;ROCK1
prerank,positive regulation of cell cycle (GO:0045787),0.5262607685989398,1.631501111223042,0.01355421686746988,0.2813757729831647,1.0,21/62,15.84%,EGFR;LRP6;APP;NUPR1;ANKRD17;RGCC;PKN2;TRIM32;CHEK1;RPS15A;CCND3;CCNYL1;MDM2;CCND2;TTL;EIF4EBP1;CCNY;RARA;PKD2;USP22;HCFC1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6359609745305406,1.6314137378197435,0.02697841726618705,0.28010120154344376,1.0,2/21,0.49%,PLTP;APOE
prerank,positive regulation of neutrophil migration (GO:1902624),0.6651826458246847,1.6313908762385503,0.03826086956521739,0.27869606951359144,1.0,6/18,4.31%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,regulation of interleukin-6 production (GO:0032675),0.4923496883066031,1.6303896862754053,0.00516795865633075,0.2792298587743264,1.0,23/96,8.26%,APP;IL16;LILRA5;TLR8;GAS6;C1QTNF3;IRAK3;PTPN22;TSLP;CD74;TLR4;LBP;BCL10;TLR2;IL17RA;GHRL;CD200R1;MAPKAPK2;TMEM106A;SYK;TNF;RAB7B;IL6R
prerank,second-messenger-mediated signaling (GO:0019932),0.505158133750705,1.63015695773006,0.012096774193548387,0.2781334493382517,1.0,13/82,7.85%,MCTP1;EDNRB;APOE;HRH1;CCR1;RCAN3;CD36;MCU;CAMKK2;CCRL2;CXCR4;CCR2;MCTP2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.6531940525590432,1.6284851584794289,0.022222222222222223,0.2799818270888956,1.0,3/20,1.61%,DAB2;PID1;CLTC
prerank,purine ribonucleotide transport (GO:0015868),0.6898814359649246,1.6282086744632267,0.030874785591766724,0.2791201367289328,1.0,4/16,6.91%,LRRC8D;SLC25A17;SLC25A24;ABCC4
prerank,positive regulation of protein metabolic process (GO:0051247),0.48385534256906587,1.6277099893579212,0.0066050198150594455,0.2787250929044816,1.0,32/110,15.41%,WWP1;PAEP;APOE;APP;KLF2;SMURF2;RILP;AXIN1;PRKN;BCL10;GSK3B;TRIM32;TNF;CD80;KLF4;MTPN;PSEN1;RAB7A;TNFSF12;RANBP9;RAB1A;NKD1;ATG7;WFS1;ROCK2;FOXO1;TFR2;NR1H2;NEDD4L;GPC3;PRMT1;RNF41
prerank,signal release from synapse (GO:0099643),-0.47563531185645846,-1.6276492276727295,0.005633802816901409,0.5813558755087148,1.0,16/43,22.21%,RIMS1;SNAP25;NRXN1;PIP5K1C;PCLO;DVL1;SYN3;CPLX1;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;CPLX2;BRSK1;GAD1
prerank,B cell receptor signaling pathway (GO:0050853),0.5886933859045795,1.6276422086281264,0.023734177215189875,0.27752446826787025,1.0,8/32,9.33%,VAV3;CD38;MEF2C;RFTN1;BCL2;SYK;PRKCB;NFATC2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7020788040950924,1.627349941442917,0.03214285714285714,0.2766665267766338,1.0,2/15,0.49%,PLTP;APOE
prerank,heart trabecula morphogenesis (GO:0061384),0.6575017207127131,1.6262483816946995,0.025594149908592323,0.27754750522037663,1.0,2/18,0.88%,RBPJ;ADGRG6
prerank,membrane depolarization during action potential (GO:0086010),-0.5223139818849434,-1.6243974590837629,0.01020408163265306,0.580698624280198,1.0,8/26,14.24%,KCNJ2;YWHAH;SCN1B;SLC8A1;CACNA1D;SCN8A;CACNA1C;SCN1A
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.541185456940273,1.6238322885242404,0.017118402282453638,0.28127731496297365,1.0,9/55,6.68%,PID1;ALOX5;BST1;XDH;RIPK1;PRKN;PARL;PIKFYVE;FOXM1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6359704870566233,1.6233934361502755,0.04012841091492777,0.2807920269469481,1.0,3/24,2.20%,RBPJ;KLF2;CEBPB
prerank,cardiac muscle cell contraction (GO:0086003),-0.5716721219526744,-1.6217741277774709,0.012376237623762377,0.576283393247296,1.0,9/19,22.62%,FGF12;KCNJ2;SCN1B;CACNA2D1;CACNA1D;CACNA1C;SCN1A;CAMK2D;SCN2B
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4668799386306771,1.6208427833832129,0.0012674271229404308,0.2846474541077255,1.0,26/140,7.97%,ARHGEF3;ITSN1;ARHGAP15;STARD8;VAV3;PLEKHG5;FGD4;ARHGAP9;OPHN1;ARAP1;ARHGAP21;ARHGAP10;ARHGAP18;CDC42;ARHGAP31;RHOA;TRIO;OCRL;ARHGAP29;NGEF;FOXM1;DEPDC1B;ARHGAP12;ARHGAP23;ARHGEF12;ARHGDIA
prerank,negative regulation of protein localization to membrane (GO:1905476),0.6216332891270692,1.6207618698945545,0.0380794701986755,0.2834582547790664,1.0,4/24,3.87%,DAB2;PID1;CLTC;ITGB1BP1
prerank,Golgi localization (GO:0051645),0.7355690952328207,1.6203746303258608,0.040145985401459854,0.28287622686662,1.0,3/11,3.30%,ARHGAP21;UVRAG;CDC42
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5837130824811555,1.6203553564403206,0.027243589743589744,0.2815523295631848,1.0,10/32,12.16%,HDAC9;RHOA;HMOX1;ITGB1BP1;KLF4;PIK3C2A;FOXC2;STARD13;MMRN2;MAP3K3
prerank,spliceosomal complex assembly (GO:0000245),-0.4770687351528309,-1.6199061188373365,0.002967359050445104,0.5680028509590533,1.0,19/46,20.14%,LUC7L3;SETX;SRSF5;DDX39B;SRPK1;PUF60;SRSF10;CELF4;SNRNP200;SRPK2;PRPF19;SF3B1;DDX1;NCBP1;PRPF6;DDX23;RBM5;SRSF9;CELF6
prerank,negative regulation of gene expression (GO:0010629),0.43621046468969626,1.6188942673843065,0.0022471910112359553,0.2833500458892906,1.0,70/302,13.83%,HDAC9;MSR1;FCGR2B;APOE;APP;NOTCH2;ATP2B1;CCR1;FOXP1;FBXW7;MYADM;ESR1;ZFP36L2;RPS3;DAPK1;MEF2C;PTPN22;BMP2;XDH;PARP14;ERN1;PPHLN1;CD46;SAMD4A;RGCC;SRGN;RPS13;JARID2;PRKN;PTBP3;MRPL13;HEY2;SPI1;RB1;NDFIP1;RACK1;EPC1;SETDB2;TNF;ZNF148;KLF4;MALSU1;YY1;REL;PSEN1;PTBP2;NCOR1;RBM4;TRIM27;SMCR8;ILF3;H3-3A;IGF1;SFRP1;PTGER4;DDX6;EMILIN1;DCP2;HINFP;NANOS3;ROCK2;TRIM71;ZC3H12D;ZC3H12A;ATP2B4;DIS3L2;LSM2;SHMT1;NDFIP2;TNRC6C
prerank,regulation of protein binding (GO:0043393),0.4766352178781411,1.618585711405386,0.009247027741083224,0.28269004862759534,1.0,28/114,11.33%,DAB2;APP;TCF7L2;BMP2;NES;CRK;ITGB1BP1;RAPGEF2;B2M;PRKN;BTBD1;GSK3B;RACK1;ROCK1;CFHR2;DISC1;ACTB;STK3;NMD3;DDX11;HFE;PSEN1;CARD16;PPP2CA;RIPK2;MARK2;PPP1CA;AMFR
prerank,energy reserve metabolic process (GO:0006112),0.6569368491195321,1.615726002028357,0.036585365853658534,0.2871941756245605,1.0,6/19,9.42%,PID1;PRKAG2;GBE1;GSK3B;GFPT2;PPP1R3C
prerank,regulation of immune response (GO:0050776),0.4667643007100799,1.6150617182728144,0.0049079754601227,0.28728092311780545,1.0,26/135,9.05%,FCGR2B;ITGA4;COLEC12;IRF4;FOXP1;IL15;AHR;LYN;ITGB1;PTPN22;CD300LG;CLEC2D;LILRB1;DENND1B;CD300LD;B2M;KIR3DL2;BIRC3;CD200R1;CD40;SYK;ZMPSTE24;FCGR3B;FCGR3A;CD33;RAET1E
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6839628165456071,1.613613074467442,0.03860294117647059,0.28872601684053434,1.0,5/14,7.07%,DDX60;ANKRD17;TLR2;PUM2;USP15
prerank,keratan sulfate catabolic process (GO:0042340),-0.6777771893209241,-1.6129849415074142,0.02040816326530612,0.5852332391256082,1.0,2/11,2.49%,HEXB;GNS
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5118723619687457,1.6126811677689645,0.008207934336525308,0.28934591928959325,1.0,17/73,7.74%,PF4;APP;LILRA5;PTPRJ;OAS2;RIPK1;TLR4;CCL19;LBP;BCL10;TLR2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1
prerank,clathrin coat assembly (GO:0048268),0.6835551667388556,1.6124705167074618,0.04092526690391459,0.2884290150448445,1.0,6/15,8.24%,HIP1;FCHO2;EPS15;CLTC;AP2S1;PIK3C2A
prerank,regulation of cellular respiration (GO:0043457),0.6566929285061495,1.6124445567241568,0.0313588850174216,0.2871582277005742,1.0,4/17,6.26%,CBFA2T3;IFNAR1;IL10RB;NOP53
prerank,cellular response to cytokine stimulus (GO:0071345),0.4248915171686846,1.6119445797909107,0.0,0.2868083219686841,1.0,70/416,9.55%,F13A1;PID1;PF4;LIFR;ALOX5;IL16;PTPRJ;IRF4;CCR1;PTPN18;GAS6;RIPOR2;ALOX15;PTPN20;GBP3;ZFP36L2;ITGB1;FER;PTPN12;RPS3;DAPK1;IRAK3;IFNAR1;RPS27A;OXSR1;TNFRSF1B;CD36;RIPK1;CCL8;TLR4;NR1D1;DCSTAMP;CBL;CCL19;CRK;ZFP36L1;RHOA;HMOX1;LBP;VIM;PDE2A;TLR2;DUSP1;GSDME;MCL1;GSK3B;IL10RB;GBP7;RC3H1;WNK1;TCF7;CD40;BCL2;SYK;TNF;CD80;CXCR4;CCR2;IL20RB;STAT4;IFNAR2;FYN;CCL24;IL6R;RO60;UBE2K;SH2B3;NDN;IFITM2;STAT6
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5522626474639118,1.6070210343145863,0.020700636942675158,0.29540340785773606,1.0,20/44,17.97%,GAS6;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;SFN;TNF;KLF4;FNIP1;IGBP1;CARD16;PCID2;YWHAE;LAMTOR5;CAST;USP47;BEX3;HGF;RAF1
prerank,defense response to bacterium (GO:0042742),0.4843827045765459,1.605911237628966,0.0064516129032258064,0.29621857154424774,1.0,23/105,11.70%,STAB1;NLRC4;CFP;COLEC12;OAS2;ANG;CEBPB;RPL39;FCER1G;TLR4;ANKRD17;LBP;TLR2;GBP7;DROSHA;RPL30;SYK;RNASE6;IL6R;RAB1A;SHC1;ROMO1;CHGA
prerank,polarized epithelial cell differentiation (GO:0030859),0.6871799484707609,1.6051292069110914,0.04127579737335835,0.296631550231064,1.0,6/13,11.47%,OPHN1;CDC42;RAB10;RHOA;MSN;MYO9A
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.670356614765707,1.6035024217933473,0.027985074626865673,0.29841867579569537,1.0,10/16,18.72%,ALOX5;FUT4;RHOA;TNF;ITGB2;MDK;ST3GAL4;RELA;IL6;TRAF6
prerank,"phototransduction, visible light (GO:0007603)",0.6864361703167166,1.603274262913571,0.0297951582867784,0.2975477728800812,1.0,4/14,7.96%,GNAQ;RP1;PDE6A;GNB1
prerank,positive regulation of lipid storage (GO:0010884),0.630504513175867,1.6022794509008542,0.0462046204620462,0.29820887762509046,1.0,6/21,12.36%,MSR1;EHD1;OSBPL11;VSTM2A;SREBF2;ZC3H12A
prerank,placenta development (GO:0001890),0.7185929257388408,1.6014087822165775,0.03825136612021858,0.2985433689480202,1.0,5/12,16.99%,ADAM19;ANG;PLAC1;E2F8;CUL7
prerank,cellular response to organic cyclic compound (GO:0071407),0.4612913030266911,1.6009449936587037,0.010403120936280884,0.2982410818267913,1.0,36/141,12.36%,EGFR;P2RX7;RAP1B;HRH1;CTNNA1;AHR;DIAPH1;ESR1;NCOA3;MEF2C;NR1H4;GNG2;DRD1;P2RY6;ZFP36L1;RAPGEF2;PDE2A;AOC1;NR3C1;RAP1A;RIOK3;ACTB;TNF;EPG5;GNB1;NRIP1;MSN;HCN3;LCOR;SFRP1;SPIDR;TRPM2;JUP;ROCK2;KCNQ1;ZC3H12A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5474861639576392,1.6007510331824157,0.017133956386292833,0.29723930357559214,1.0,11/46,10.16%,RBPJ;IL15;TLR4;NR1D1;NPR3;RB1;LNPEP;PLCL2;ARRDC3;FOXC2;DOCK7
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.5945098238269276,-1.5990121055928779,0.02654867256637168,0.6378301731760716,1.0,12/16,36.97%,DCPS;WBP4;SNRNP200;SRSF12;SFSWAP;DDX23;SART1;PSIP1;SNRPC;RBM22;SRSF1;NCBP2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6608712591000275,1.5976580370663782,0.034482758620689655,0.30266081863015987,1.0,2/16,2.02%,RBPJ;MEF2C
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6082844567133331,1.5973952467385886,0.03559870550161812,0.3018976888054985,1.0,11/27,15.21%,GAS6;LIG4;CD74;WNT2;CDK6;PDGFRA;DDR2;PDGFC;IGF1;FN1;MYC
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5107141050130731,1.5963728828842583,0.011049723756906077,0.30280340955447377,1.0,16/69,7.74%,PF4;APP;LILRA5;PTPRJ;OAS2;RIPK1;TLR4;CCL19;LBP;TLR2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1
prerank,positive regulation of proteolysis (GO:0045862),0.527389869874697,1.596321999547199,0.01875901875901876,0.3016034193848595,1.0,11/55,6.99%,NLRC4;APOE;CTSC;SNX9;TNFRSF1B;RCN3;ADAM9;CLN6;RHBDD1;TRIM32;TNF
prerank,negative regulation of protein secretion (GO:0050709),0.5573164386854832,1.5961350451631864,0.029827315541601257,0.3007526609828876,1.0,9/38,11.95%,APOE;RAB11FIP5;HMGCR;PRKN;RHBDF1;DPH3;SFRP1;CHGA;KCNB1
prerank,hemidesmosome assembly (GO:0031581),-0.6661789013484517,-1.595674147023061,0.025477707006369428,0.6400078470402184,1.0,4/11,17.66%,DST;ITGA6;LAMA3;ITGB4
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5352728788903699,1.5951756453833488,0.017027863777089782,0.30144825192763713,1.0,8/45,7.65%,DAB2;BMP2;GDF3;SMAD4;GDF10;ACVR2A;SDCBP;HFE
prerank,protein localization to synapse (GO:0035418),-0.6487537981890875,-1.595151349049923,0.02268041237113402,0.6264538721760983,1.0,5/12,5.58%,NLGN1;NRXN1;DLG4;PCLO;SHANK1
prerank,regulation of interleukin-8 production (GO:0032677),0.5157593439449908,1.5951393493759063,0.012517385257301807,0.30020510275644136,1.0,26/69,19.46%,TLR8;PTPN22;RIPK1;CD74;TLR4;LBP;BCL10;TLR2;SYK;TNF;KLF4;CD33;RAB1A;SSC5D;ARRB1;LAMTOR5;NOD2;STAT3;PRKD2;RELA;TIRAP;TLR7;IL6;F2R;MAPKBP1;BCL3
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4884845193699794,1.5948481992572099,0.01226158038147139,0.299609499852607,1.0,19/86,10.08%,BANK1;NRP1;EGFR;APP;PTPRJ;CLEC6A;IL15;RAP2B;BST1;CD44;CD74;THBS4;PAK2;CD80;FYN;IL6R;IGF1;SFRP1;RIPK2
prerank,negative regulation of protein catabolic process (GO:0042177),0.5569998071973751,1.594247194985845,0.01355421686746988,0.2994615446403271,1.0,9/40,5.43%,NELL1;EGFR;IRAK3;RILP;HMGCR;RIC1;SF3B3;SNX3;ROCK1
prerank,response to fatty acid (GO:0070542),0.6660563714290394,1.5919419237346288,0.03949730700179533,0.30294042381009606,1.0,7/17,13.56%,PID1;NR1H4;CD36;KCNK4;FOXO3;FOXO1;FFAR1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5855201548775547,-1.5914638898848874,0.02054794520547945,0.6299564641223657,1.0,9/16,21.12%,ARHGAP24;PIK3CB;RASGRF1;CADM4;STMN3;AUTS2;ARF6;SH3BP1;ARHGAP44
prerank,regulation of keratinocyte proliferation (GO:0010837),0.6213465289289104,1.5912559820378789,0.04,0.3031054024274849,1.0,5/22,5.28%,NOTCH2;CASK;ZFP36L1;KLF9;PTPRK
prerank,cholesterol transport (GO:0030301),0.5520896619390594,1.5907756693127906,0.02252252252252252,0.30280946888919713,1.0,4/45,2.65%,MSR1;APOE;LDLR;CD36
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5812780227484468,1.590667963439545,0.03686635944700461,0.3017982030312444,1.0,11/31,16.82%,IL16;TLR4;CCL19;TLR2;CD40;SYK;MAPK14;RIPK2;MDK;SCIMP;TIRAP
prerank,negative regulation of protein processing (GO:0010955),-0.645457994804389,-1.5901535700824183,0.0502092050209205,0.6212120106794348,1.0,5/12,18.57%,SERPINE2;TMEM59;PRNP;GAS1;SERPINE1
prerank,negative regulation of defense response (GO:0031348),0.4978607973810195,1.5895168177333223,0.0223463687150838,0.3028638686323583,1.0,13/77,7.23%,AOAH;APOE;ALOX5;C1QTNF3;MFHAS1;IRAK3;NR1H4;METRNL;NR1D1;RB1;GHRL;PPM1B;KLF4
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6805095465429566,1.5889810915744358,0.03430531732418525,0.3026971951995409,1.0,5/15,6.99%,APOE;SNX9;TNFRSF1B;ADAM9;TNF
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6141753224890715,1.5880607635515247,0.03620689655172414,0.30336929951950137,1.0,9/25,16.03%,KLF2;CD36;TLR4;INSR;TNF;KLF4;ASS1;PKD2;HSP90AB1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6201026703439685,1.58761331684683,0.031413612565445025,0.30302983213578316,1.0,6/21,6.05%,SGPP1;GDF3;ZFP36L1;ROCK1;CBFB;SFN
prerank,defense response to protozoan (GO:0042832),0.7118775232338207,1.5868305031053267,0.0450281425891182,0.30335669747685334,1.0,5/12,6.15%,PF4;IRF4;GBP7;BATF2;CD40
prerank,intraciliary retrograde transport (GO:0035721),-0.6431845001266728,-1.5860154099277055,0.028761061946902654,0.6289460076385605,1.0,6/12,18.31%,IFT140;DYNLT2B;WDR19;DYNC2H1;IFT43;DYNC2I1
prerank,ribosome biogenesis (GO:0042254),0.4444958640785641,1.5858327832786714,0.001182033096926714,0.30428046626239136,1.0,62/187,16.28%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RPL28;WDR36;LTV1;NOP53;RPL30;RPL8;NOL9;RPL35A;RPS17;RPL38;RPLP0;MALSU1;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;HEATR1;RPL6;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;RPL31;EXOSC1;RPL11;XPO1;NOP58;MPHOSPH6;LSG1
prerank,gene expression (GO:0010467),0.4230461188390156,1.585252541135288,0.001122334455667789,0.30428576779869254,1.0,104/348,15.15%,DHX8;RBMS1;RPS29;MEF2A;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;AGFG1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;MRPL13;RPS24;RPL24;RSL24D1;RPL12;RPL36A;SMG6;RPS8;RPL18A;DROSHA;RPL37A;THRB;RPS11;RPL28;RNASEL;ATXN1;EPC1;DARS1;RPL30;HNRNPF;RPL8;NOL9;RPL35A;RPS4X;RPS15A;RPS17;RPL38;RPLP0;CPSF3;MRRF;SRSF4;RPL5;RPL36;RNGTT;NR4A2;RPL14;NUP133;RBM4;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;MED20;APOBEC1;POLR2B;RPL6;RPS6;NUP62;RPL4;THOC6;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;NUP98;MRPS17;MRPL44;MAGOHB;NFKBIB;RPL19;RPL31;MRPS14;POLR2D;MMS19;RPL11;NOVA1;NOX4;SRBD1
prerank,mRNA splice site selection (GO:0006376),-0.5051267281142067,-1.5822580057649422,0.010282776349614395,0.6339145749128531,1.0,15/30,29.98%,LUC7L3;SETX;SRSF5;PUF60;SRSF10;CELF4;SRSF12;SFSWAP;SRSF9;CELF6;CELF5;SRSF6;ISY1;PSIP1;SNRPC
prerank,negative regulation of macrophage activation (GO:0043031),0.6716788747298821,1.5814397284635324,0.04909090909090909,0.31123662525277623,1.0,4/16,3.28%,FCGR2B;LDLR;NR1D1;GRN
prerank,regulation of histone modification (GO:0031056),-0.6432907655891827,-1.5802478974708563,0.024282560706401765,0.6298559925969873,1.0,7/13,20.98%,CDK9;AKAP8L;FLCN;HPF1;AKAP8;PARK7;PARG
prerank,cellular response to fatty acid (GO:0071398),0.7046759073640714,1.5796010156427667,0.056925996204933584,0.3138079321559075,1.0,2/12,2.04%,PID1;NR1H4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5231783767217613,1.5790942065627702,0.030627871362940276,0.31354237578507727,1.0,22/50,20.51%,GAS6;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;PAK2;SFN;TNF;KLF4;FNIP1;IGBP1;CARD16;YWHAE;LAMTOR5;USP47;BEX3;HGF;RAF1;PLAUR;CSNK2A1;SNCA
prerank,myoblast fusion (GO:0007520),-0.6393316151718847,-1.5787811954042454,0.038461538461538464,0.6229323881481358,1.0,3/12,1.66%,CD9;ADGRB3;JAM2
prerank,negative regulation of T cell activation (GO:0050868),0.5703689000775216,1.5786363484404287,0.035256410256410256,0.31323176588505763,1.0,9/35,9.13%,FCGR2B;VSIG4;RIPOR2;PTPN22;CEBPB;LILRB1;PLA2G2D;CD80;SDC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.7317947952443128,1.5775015157063945,0.045889101338432124,0.31324766207317656,1.0,4/10,15.49%,NUPR1;CBFA2T3;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),0.7317947952443128,1.5775015157063945,0.045889101338432124,0.31324766207317656,1.0,4/10,15.49%,NUPR1;CBFA2T3;NCOR1;HDAC4
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6761419010682411,1.5772138029086673,0.04869565217391304,0.3126621888260341,1.0,3/16,2.44%,AHR;PTPN22;TNFRSF1B
prerank,calcium-mediated signaling (GO:0019722),0.48040427196865965,1.5769041330804026,0.006493506493506494,0.3121150965279786,1.0,14/93,7.85%,MCTP1;EDNRB;EGFR;P2RX7;PTPRJ;CCR1;PPP3CA;RCAN3;MCU;CAMKK2;CCRL2;CXCR4;CCR2;MCTP2
prerank,positive regulation of binding (GO:0051099),0.48333802760283523,1.5768792125306579,0.015151515151515152,0.3109373686790023,1.0,26/84,15.35%,APOE;APP;TCF7L2;BMP2;CLN5;RAPGEF2;B2M;PRKN;GSK3B;STK3;NMD3;DPH3;DDX11;HFE;PSEN1;CEBPG;GMNN;KDM4D;IGF1;RIPK2;AMFR;RARA;RALB;ADD1;RPL11;STMN1
prerank,actin filament polymerization (GO:0030041),0.5780837882491446,1.57660236143531,0.023026315789473683,0.31036359264402325,1.0,5/29,1.75%,PSTPIP2;DIAPH1;GAS7;PSTPIP1;ANG
prerank,cellular response to nitrogen compound (GO:1901699),0.613479357818019,1.5740987488701594,0.04692556634304207,0.3145421188471629,1.0,9/20,12.39%,NR1H4;AOC1;RIOK3;EPG5;DDX11;ATRX;SPIDR;ROCK2;ATP2B4
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4872286810291367,1.5737284087946926,0.010854816824966078,0.3140918081617851,1.0,10/80,5.33%,EPS8;NRP1;P2RX7;RIPOR2;ARAP1;ACTR3;WASF2;CDC42;CCL19;DOCK11
prerank,positive regulation of nervous system process (GO:0031646),-0.5687509208474265,-1.5727672452103654,0.03341288782816229,0.6391439298691389,1.0,8/18,12.11%,RIMS1;RIMS2;PARD3;ITGAX;CST7;TENM4;TPPP;RNF10
prerank,cardiac muscle cell action potential (GO:0086001),-0.501405058589567,-1.572326921007576,0.01662049861495845,0.6280094542220548,1.0,8/30,5.61%,FGF12;KCNJ2;ATP1B1;SCN1B;SLC8A1;ANK2;CACNA2D1;CACNA1D
prerank,regulation of vasculogenesis (GO:2001212),0.6685488017599478,1.5722259365186149,0.038128249566724434,0.316037820736367,1.0,5/14,4.82%,RIN2;XDH;RAPGEF2;HEY2;RAP1A
prerank,endocrine system development (GO:0035270),-0.5509664857258428,-1.5716320303895746,0.03286384976525822,0.618425682059775,1.0,6/21,19.19%,TGFBR1;SALL1;NF1;PAX8;WNT4;DKK3
prerank,negative regulation of protein metabolic process (GO:0051248),0.5311973880008606,1.5710590815991723,0.03172205438066465,0.31737089133287305,1.0,10/48,5.43%,EDNRB;EGFR;APOE;LDLR;IRAK3;RILP;HMGCR;SF3B3;SNX3;ROCK1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5010046787807193,1.5695072652106554,0.017955801104972375,0.3196427291884832,1.0,16/68,8.26%,APP;IL16;LILRA5;TLR8;TSLP;CD74;TLR4;LBP;BCL10;TLR2;IL17RA;TMEM106A;SYK;TNF;RAB7B;IL6R
prerank,regulation of macrophage differentiation (GO:0045649),0.6649364081385994,1.5680709741325434,0.037800687285223365,0.3214143134537301,1.0,3/15,2.69%,PF4;C1QC;RIPK1
prerank,autonomic nervous system development (GO:0048483),0.6474150037128621,1.5680629843879577,0.05366726296958855,0.3202044365222148,1.0,3/17,2.92%,NRP1;EDNRB;PHOX2A
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5882771930817838,1.5680410597199679,0.05016722408026756,0.31902403265119816,1.0,8/25,9.16%,NRP1;EGFR;APP;ANG;BCL10;SDCBP;PSEN1;KCTD20
prerank,establishment of apical/basal cell polarity (GO:0035089),0.6632969507957526,1.566870168217159,0.05514705882352941,0.3205351276124371,1.0,5/14,11.47%,OPHN1;CDC42;RHOA;MSN;MYO9A
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.5583896390983796,1.566369888717972,0.040783034257748776,0.32045473722014267,1.0,4/31,4.58%,ALOX5;MOCS1;HDC;GCH1
prerank,alcohol catabolic process (GO:0046164),0.7243154525737082,1.5661605716661084,0.04291044776119403,0.31957178284447363,1.0,3/10,6.27%,APOE;SCARF1;CYP27A1
prerank,positive regulation of cell differentiation (GO:0045597),0.43125404485977137,1.5661307061750578,0.0023014959723820483,0.31843536266783085,1.0,34/237,6.84%,DAB2;MSR1;PF4;NELL1;FGFR1;TCF4;CTNNA1;CMKLR1;MEF2A;ZBTB16;RIPOR2;WDFY2;MEF2C;RIN2;CEBPB;KITLG;BMP2;CD36;ALX1;CDC42;GDF3;RGCC;ZFP36L1;RHOA;RPS6KA3;RAPGEF2;RAP1A;SMAD4;GPRC5B;MEDAG;TRIM32;BLOC1S5;ACVR2A;SDCBP
prerank,regulation of developmental growth (GO:0048638),0.5706491994290809,1.5652025364501154,0.03656597774244833,0.31916485527661015,1.0,7/29,13.91%,APOE;APP;GSK3B;INSR;IGF1;LATS2;MFSD2A
prerank,positive regulation of heart rate (GO:0010460),0.6485772380658936,1.5643838053082233,0.05110732538330494,0.31975789429155765,1.0,7/17,14.29%,ADM;PDE4D;ADRA1D;ADRA1A;KCNQ1;SCN3B;ATP2A2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.617430022348753,1.5626582724852407,0.03577512776831346,0.32216657264216936,1.0,3/22,2.10%,FCGR2B;PTPRJ;PTPN22
prerank,glycolipid metabolic process (GO:0006664),-0.456647079664605,-1.562603214885612,0.02064896755162242,0.6499400454761937,1.0,12/47,10.04%,HEXB;CERK;ST3GAL6;ST6GALNAC3;SMPD4;ESYT1;NEU1;ASAH1;ST6GALNAC4;ESYT2;SCCPDH;GBA2
prerank,cGMP-mediated signaling (GO:0019934),0.6836666761741536,1.5620771795444903,0.045454545454545456,0.32231847823012394,1.0,4/13,4.21%,APOE;IRAG1;CD36;PDE2A
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4946958957016514,1.5614877692109774,0.024320457796852647,0.3224771260981794,1.0,18/67,11.89%,VAV3;NRP1;CYBB;ABI1;WASF2;DOCK1;CDC42;CRK;RHOA;PAK2;MAPKAPK2;ROCK1;HSPB1;FYN;MAPK14;PXN;NCF2;ROCK2
prerank,regulation of glycolytic process (GO:0006110),0.5020000926805582,1.5613084176875895,0.02180232558139535,0.32162891415265743,1.0,21/68,17.04%,P2RX7;APP;PRKAG2;NUPR1;ZBTB20;CBFA2T3;PGAM1;INSR;PFKFB4;PSEN1;SLC4A4;NCOR1;NUP133;IGF1;NUP62;NUP98;EP300;HDAC4;ARNT;ZBTB7A;NUP153
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5986484678681473,1.5611995226388573,0.032148900169204735,0.3207127898954198,1.0,6/24,7.60%,CCR1;LYN;ANO6;PLA2G7;DUSP1;CCR2
prerank,positive regulation of T cell migration (GO:2000406),0.6199750120619182,1.5609703417868621,0.03595890410958904,0.3200674760453996,1.0,5/20,7.60%,APP;OXSR1;RHOA;WNK1;CCR2
prerank,regulation of biosynthetic process (GO:0009889),0.7133502767523975,1.560458847248955,0.06133828996282528,0.3200926085529146,1.0,2/11,6.13%,ALOX5;PIKFYVE
prerank,protein localization to mitochondrion (GO:0070585),-0.6625453585152998,-1.5598410132304534,0.035634743875278395,0.6509284884437446,1.0,2/11,8.74%,HK2;MTCH2
prerank,negative regulation of immune system process (GO:0002683),0.6515870209437302,1.5594089292759605,0.05132743362831858,0.3211396469695767,1.0,3/16,3.83%,FCGR2B;LYN;HMOX1
prerank,regulation of axon guidance (GO:1902667),0.740262288047112,1.5592241611647475,0.036734693877551024,0.3203613901765231,1.0,3/10,6.27%,NRP1;ZSWIM6;MYCBP2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.6420721102358864,-1.5590224529700065,0.0367965367965368,0.6424645780229997,1.0,7/12,19.30%,TMEM119;BHLHE41;BDNF;HDAC5;NOTCH1;HDAC3;HDAC1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4331657842604485,1.5585684892438318,0.0011560693641618498,0.32074133619392037,1.0,42/214,11.32%,NRP1;EGFR;APOE;APP;SPRED1;NOTCH2;CCR1;FBXW7;GAS6;C5AR1;ALOX15;LYN;MFHAS1;PTPN22;CD44;BMP2;CD36;CD74;CCL8;TLR4;P2RY6;THPO;CCL19;ITGB1BP1;RAPGEF2;PDE8A;RAP1A;SMAD4;PDGFRA;SYK;TNF;SYNJ2BP;CCL24;RANBP9;ADRA1A;CNKSR3;PDGFC;RPS6KA6;ARRB1;SPRED2;EMILIN1;SHC1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.4705835976522712,-1.5567785370281464,0.0169971671388102,0.641212366396293,1.0,11/42,10.04%,HEXB;LARGE1;CERK;ST3GAL5;ST6GALNAC3;SMPD4;ESYT1;NEU1;ASAH1;ESYT2;GBA2
prerank,Notch signaling pathway (GO:0007219),0.5003823865615469,1.5566432302486233,0.01764705882352941,0.3236903960398227,1.0,19/59,15.77%,RBPJ;NOTCH2;JAG1;BMP2;NRARP;HEY2;GMDS;DTX2;PSEN1;MAML1;CREBBP;MIB1;PLXND1;EP300;MDK;WWC1;SNW1;MYC;NCSTN
prerank,detection of visible light (GO:0009584),0.6587911111404251,1.5555591312762098,0.043795620437956206,0.32494556254795137,1.0,5/16,18.33%,GNAQ;RP1;GNA11;REEP6;ABCA4
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5082770754238802,1.555100121291052,0.026874115983026876,0.32468392125373374,1.0,13/56,5.51%,TLR8;RPS27A;ALPK1;S100A1;CD36;TLR4;RPS6KA3;LBP;BCL10;TLR2;MAPKAPK2;CTSB;LY96
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4961837844419947,1.5539150044463592,0.024205748865355523,0.3259871573777692,1.0,23/62,18.43%,PF4;ZBTB16;KMT2A;LYN;MEF2C;CDK6;SPI1;CBFB;PRKCB;CDC73;ASH2L;KMT2C;H3-3A;RBM15;CREBBP;KMT2E;EP300;TNRC6C;PRMT1;PRKCQ;FES;CNOT4;MAFB
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.6099751111141003,1.5504789391949343,0.030744336569579287,0.3321608205738508,1.0,6/22,4.77%,SASH1;RELL1;MFHAS1;BMP2;XDH;SPI1
prerank,keratinocyte differentiation (GO:0030216),0.5691455197594447,1.549686855389554,0.03826955074875208,0.33274647399466,1.0,6/29,5.25%,TXNIP;JAG1;EXPH5;ADAM9;KRT10;CLIC4
prerank,regulation of microtubule polymerization (GO:0031113),-0.45904343643651535,-1.5491718587484817,0.011560693641618497,0.6663817521570876,1.0,13/40,15.90%,NAV3;MAP2;PAK1;TBCD;CAMSAP1;MAPT;MAPRE3;GBA2;TOGARAM1;NUMA1;EML2;MAPRE1;CLIP3
prerank,response to cytokine (GO:0034097),0.4486315147028529,1.549025978834883,0.005108556832694764,0.33293203211949424,1.0,29/141,9.49%,PID1;LIFR;APP;IFITM3;PTPN18;PTPN20;PTPN12;IRAK3;RIPK1;CD74;LAMP3;ADAM9;RHOA;TNFRSF11A;TRIM56;GCH1;MCL1;MAPKAPK2;TRIM32;CD40;BCL2;BST2;CXCR4;REL;IFNAR2;CXCL16;IL6R;IGBP1;IFITM2
prerank,response to reactive oxygen species (GO:0000302),0.5143441966180895,1.5468545010891486,0.03581661891117478,0.3366047618266532,1.0,15/54,12.92%,EGFR;APOE;FER;RPS3;ADAM9;HMOX1;CAMKK2;PTPRK;PDGFRA;STK24;FYN;TXNRD2;PXN;ROMO1;AGAP3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4392856429602132,1.5457469221446634,0.008610086100861008,0.3378033906280861,1.0,57/158,18.98%,PLEKHG5;CLEC6A;S100A4;SHISA5;ALPK1;RIPK1;CD74;ANKRD17;CCL19;PELI1;RHOA;HMOX1;PRKN;BCL10;BIRC3;NDFIP1;GPRC5B;TRIM32;TMEM106A;CD40;TNF;BST2;PRKCB;MIER1;REL;TRIM68;TRIM27;TFG;CARD16;EEF1D;RIPK2;WLS;NUP62;CASP8;MAP3K3;LAMTOR5;VAPA;TERF2IP;NOD2;TNFRSF1A;GJA1;UBE2N;NDFIP2;MID2;RHOC;TRIM25;PPM1A;RELA;TAB3;BRD4;TIRAP;IRAK4;F2R;ECM1;TRAF6;PLK2;DDX21
prerank,histone deubiquitination (GO:0016578),0.6134802952683999,1.544922740053743,0.040293040293040296,0.33845394227925985,1.0,11/18,21.90%,USP3;ATXN7;BRCC3;USP15;USP21;USP16;ENY2;USP22;USP7;UIMC1;ATXN7L3
prerank,negative regulation of metabolic process (GO:0009892),0.5156855713647568,1.5448439934757514,0.03463855421686747,0.33747878635358586,1.0,11/54,10.16%,RBPJ;IL15;TLR4;NR1D1;NPR3;RB1;LNPEP;PLCL2;ARRDC3;FOXC2;DOCK7
prerank,lipid catabolic process (GO:0016042),-0.5671973869541231,-1.5421492495756677,0.026200873362445413,0.689358206860142,1.0,5/18,9.60%,LIPH;LPL;PPT1;ACADL;SIRT2
prerank,regulation of glucose import (GO:0046324),0.5707956953059548,1.541899737000235,0.05351170568561873,0.34289593438283117,1.0,5/30,4.94%,PID1;PRKAG2;C1QTNF12;IRS2;INSR
prerank,neuron fate commitment (GO:0048663),-0.6091406804767733,-1.5416962249446593,0.039735099337748346,0.6792678887780687,1.0,2/14,2.73%,TGFBR1;MYT1L
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.6731187874392746,1.5408358504052055,0.04275092936802974,0.34411162023055764,1.0,4/13,10.40%,NRROS;BMP2;CD46;DAND5
prerank,amyloid fibril formation (GO:1990000),0.5115442793427997,1.5400216244738225,0.028189910979228485,0.34483033408574326,1.0,10/51,5.13%,TGFBI;APP;ITM2B;RPS27A;CD36;RIPK1;SIAH2;B2M;PRKN;USP9X
prerank,neuron migration (GO:0001764),0.523750383693052,1.5388786897708766,0.03412462908011869,0.34626020474150526,1.0,14/48,10.63%,NRP1;FGFR1;NAV1;MEF2C;SH3RF1;RAPGEF2;LRP12;USP9X;CELSR1;DISC1;NR4A2;TUBGCP2;CCK;MARK2
prerank,blood vessel morphogenesis (GO:0048514),0.5057493719744285,1.538723972945515,0.02514792899408284,0.34541642166452563,1.0,8/54,6.52%,RBPJ;NRP1;RASA1;ADM;LOX;CCM2;HEY2;SYK
prerank,platelet degranulation (GO:0002576),0.45575856463469755,1.5381004807084189,0.013123359580052493,0.3454592073102921,1.0,18/118,10.64%,F13A1;PF4;APP;PHACTR2;GAS6;SELENOP;LYN;CD36;SRGN;MANF;FAM3C;APOOL;ABCC4;VCL;PROS1;IGF1;LAMP2;CALM1
prerank,ncRNA processing (GO:0034470),0.4308105026292504,1.538068515261098,0.004739336492890996,0.34438630206334975,1.0,61/200,13.94%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;PRKRA;RPS15;RPL37;RPLP1;RPL26;TUT7;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;DROSHA;RPL37A;RPL28;WDR36;FARS2;NOP53;RPL30;RPL8;NOL9;RPL35A;RPS17;RPL38;RPLP0;RPL5;RPL36;RPL14;TUT4;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;HEATR1;RPL6;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;MRPL44;RPP30;RPL19;RPL31
prerank,cellular response to oxygen-containing compound (GO:1901701),0.41500808203122735,1.536825045134484,0.004581901489117984,0.3461894077457597,1.0,67/291,13.59%,PID1;PF4;EGFR;P2RX7;RAP1B;AHR;ESR1;LYN;NCOA3;FER;RPS3;DAPK1;MEF2C;NR1H4;GNG2;TNFRSF1B;LILRB1;DRD1;WNT2;TLR4;NR1D1;P2RY6;ADAM9;ZFP36L1;RHOA;RAPGEF2;LBP;BCL10;VIM;PDE2A;TLR2;NFKBIL1;AOC1;RAP1A;CAMKK2;PTPRK;PDGFRA;MTR;LY96;ACTB;CD80;WNT6;GNB1;NRIP1;CDC73;HCN3;MAPK14;CARD16;LCOR;SFRP1;TSHR;CHMP5;PXN;CD68;KCNK4;ROMO1;ROCK2;KCNQ1;LAMTOR5;ZC3H12A;ATP2B4;NOD2;FOXO1;AGAP3;CREB1;NFKBIB;SHMT1
prerank,regulation of protein kinase B signaling (GO:0051896),0.42934232733602956,1.5367965948976021,0.007317073170731708,0.34509977666257746,1.0,34/193,9.83%,BANK1;HIP1;EGFR;FGFR1;PTPRJ;TCF7L2;GAS6;ESR1;ITGB1;MFHAS1;CASS4;KITLG;RCN3;XDH;FGF23;MYORG;THPO;CCL19;ITGB1BP1;FRS2;ICOS;IRS2;INSR;RACK1;PDGFRA;NOP53;TNF;CD80;GAB1;FYN;TSPYL5;SH2B3;MYDGF;RTN4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6601284167204502,1.5361585726018607,0.051756007393715345,0.34539952521061407,1.0,4/14,6.15%,ITGA4;ANO6;RGCC;CD40
prerank,myofibril assembly (GO:0030239),0.5309365006044553,1.5359865733990334,0.04229607250755287,0.344614410587382,1.0,7/42,5.36%,FLII;TMOD1;MYH6;MYOM2;TNNT1;TMOD3;PDGFRA
prerank,ribosomal small subunit assembly (GO:0000028),0.6535811814570442,1.535788039995278,0.06976744186046512,0.3439477167151128,1.0,7/16,9.28%,RPS15;ERAL1;RPSA;RPS28;RPS14;RPS5;MRPS11
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6441123085658329,1.5354489711564963,0.05762081784386617,0.3435922633732216,1.0,4/17,8.05%,PRKAG2;UGT1A8;ADIPOR2;NCOR1
prerank,negative regulation of immune response (GO:0050777),0.43997841593102754,1.5354214367478651,0.012674271229404309,0.34251143283325186,1.0,33/154,13.35%,CD163;FCGR2B;ALOX15;LYN;CYSLTR1;FER;IRAK3;GNG2;CALCRL;ADRB2;LILRB1;DRD1;ADM;SPI1;RC3H1;ADCY9;ADCYAP1R1;SYK;PPM1B;CCR2;GNB1;FYN;FCGR3A;TRIM27;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,regulation of cartilage development (GO:0061035),0.6279117419634233,1.5348279328867165,0.03859060402684564,0.34268509382797213,1.0,3/18,2.61%,TRPS1;ZBTB16;BMP2
prerank,regulation of chromatin organization (GO:1902275),-0.5953796483379465,-1.5346719434288871,0.040339702760084924,0.7033250778761662,1.0,7/14,24.53%,CDK9;HNRNPU;SSRP1;HPF1;TLK2;PARG;MKI67
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.6910698565854069,1.5342794345329318,0.07307692307692308,0.3427598308064128,1.0,1/11,0.03%,DAB2
prerank,positive chemotaxis (GO:0050918),0.6434213655733982,1.5339981014977944,0.04145077720207254,0.3423014503248494,1.0,2/17,0.76%,NRP1;PTPRJ
prerank,cardiac atrium morphogenesis (GO:0003209),0.6350919468529913,1.5333789967037215,0.05380333951762523,0.34251921471182434,1.0,4/16,4.52%,NOTCH2;BMP2;MYH6;HEY2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6216927599948268,1.533177164850153,0.05663716814159292,0.341735982065724,1.0,7/18,12.36%,ESR1;RPS13;PTBP3;TNF;PTBP2;NCOR1;ZC3H12A
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6498002628210635,-1.5330748980638262,0.04535637149028078,0.6986486697577218,1.0,4/10,4.82%,CACNB2;PDE4B;NOS1AP;CACNA2D1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.6083685757022669,1.5325259213014912,0.052346570397111915,0.3421334433472811,1.0,3/20,4.52%,RBPJ;BMP2;HEY2
prerank,transition metal ion homeostasis (GO:0055076),0.573006492224555,1.5317567210606935,0.05203252032520325,0.3427654838856847,1.0,12/28,17.84%,CP;HMOX1;B2M;PRKN;FTL;FBXL5;HFE;HMOX2;TFR2;ABCB7;NEO1;PICALM
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.7013095630015866,1.5313188771903812,0.0631163708086785,0.342571331074914,1.0,5/10,11.47%,OPHN1;CDC42;RHOA;MSN;MYO9A
prerank,acute inflammatory response (GO:0002526),0.5907140300575475,1.5312930400961884,0.04130808950086059,0.3415315606011911,1.0,4/23,8.26%,ANO6;CEBPB;LBP;IL6R
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.558868824452322,-1.53110692018573,0.030973451327433628,0.6970298686508208,1.0,12/19,28.58%,CUX1;PTPRD;SS18L1;CAPRIN1;SS18L2;IL1RAPL1;CDKL5;DBN1;FBXW8;CDKL3;CUX2;CAMK2B
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.48482593252935186,-1.5309754095572348,0.03580562659846547,0.6858152264183185,1.0,22/32,32.42%,PRKCD;CALM2;MAGI2;PPP1R16B;NSMF;CAMTA1;PPP1R7;ANKLE2;PPP2R5A;CDCA2;PTPA;MTOR;SPPL3;CALM3;TGFB1;PIN1;PDGFRB;PTBP1;SYMPK;CDH5;SMPD1;PPP1R15A
prerank,neutrophil activation involved in immune response (GO:0002283),0.4013033485021171,1.5306989637731263,0.001076426264800861,0.34176123676813025,1.0,90/428,11.76%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;CTSC;IQGAP1;CLEC12A;ARHGAP9;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;BST1;ANO6;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;CD36;FCER1G;LILRB3;GRN;ATP8B4;ARL8A;RAB10;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;PGAM1;FTL;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;SYK;CNN2;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;OSTF1;CD53;RAB7A;FCGR3B;VCL;CLEC4D;CD33;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;ENPP4;LAMP2;AMPD3;ATG7;CD68;FTH1;TRPM2;JUP;STK10;SNAP23;NPC2;CDK13
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.45895892442252184,-1.5305688804833875,0.03058103975535168,0.6764627237895046,1.0,8/38,8.22%,CACNB2;BIN1;KCNJ2;SCN1B;ANK2;CACNA2D1;CACNA1D;CTNNA3
prerank,negative regulation of cilium assembly (GO:1902018),-0.6235977251266627,-1.5295222881682526,0.04943820224719101,0.6704171709293276,1.0,9/12,25.82%,CEP97;CCP110;EVI5L;MAP4;CDK10;LIMK2;TBC1D7;ODF2L;TCHP
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.531757200778577,1.5292749025316061,0.03609022556390978,0.34396086366636724,1.0,15/41,14.58%,GAS6;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;LBP;NFKBIL1;GHRL;TRIM27;CD33;IGF1;ZC3H12A;RARA;ARG2
prerank,RNA transport (GO:0050658),-0.40186912246043605,-1.527580776306387,0.0030303030303030303,0.6690729458674172,1.0,30/71,21.90%,THOC1;RBFOX1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;FLOT1;KIF5C;SRSF2;FMR1;RNPS1;U2AF1;CKAP5;UPF3B;CASC3;SIDT2;TGFBR2;NCBP1;HNRNPA1;ATXN2;THOC3;SRSF11;SRSF9;SIDT1;TST;POLDIP3;ALYREF;U2AF2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5202530446210301,1.5275222086991391,0.036231884057971016,0.34662691628980585,1.0,19/49,18.10%,TLR8;RIPK1;CD74;TLR4;LBP;BCL10;TLR2;SYK;TNF;RAB1A;LAMTOR5;NOD2;STAT3;PRKD2;RELA;TIRAP;TLR7;IL6;F2R
prerank,negative regulation of transport (GO:0051051),0.5102438358368528,1.5272306102501876,0.031203566121842496,0.3460696361688726,1.0,16/51,13.83%,MCTP1;FCGR2B;LILRB1;PRKN;TLR2;NDFIP1;SNX3;RACK1;BST2;RAB7A;CRYAB;PIP4P2;SNX33;RUBCN;NR1H2;NDFIP2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5171944725826408,1.526991309314892,0.0319634703196347,0.3454687929906907,1.0,6/43,3.48%,EGFR;PTPRJ;EPS15;SNX6;CDC42;CBL
prerank,triglyceride homeostasis (GO:0070328),0.5722931185383673,1.5262888294889416,0.0453781512605042,0.3459338797776468,1.0,4/26,4.98%,APOE;C1QTNF3;NR1H4;PNPLA8
prerank,actin filament organization (GO:0007015),0.43931196524398647,1.5261193396560033,0.014943960149439602,0.3452570365964309,1.0,35/151,14.30%,EPS8;HIP1;NEDD9;MYO5A;FLII;ABI1;TMOD1;NRAP;CASS4;CDC42;RHOA;LCP1;MCU;TMOD3;GHRL;EFS;MYO7A;ARHGAP12;DSTN;RHOBTB1;PLS1;RFLNB;CORO1C;MYO1C;MYO1E;GAS2L1;SVIL;ARHGAP17;CORO7;NEB;RND3;CGNL1;TPM3;WASL;RHOC
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.43011837882979187,1.5257876830464552,0.00853658536585366,0.34485744896100434,1.0,20/161,5.73%,DAB2;LRP6;APOE;IGFBP4;TCF7L2;TLE4;PSMA7;TNN;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;MCC;UBAC2;ZNRF3;GSK3B;NOTUM;CTNND1;STK3
prerank,neutrophil degranulation (GO:0043312),0.3997486432904433,1.5252265142139525,0.0010799136069114472,0.3450346242216452,1.0,89/425,11.76%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;CTSC;IQGAP1;CLEC12A;ARHGAP9;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;BST1;ANO6;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;CD36;FCER1G;LILRB3;GRN;ATP8B4;ARL8A;RAB10;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;PGAM1;FTL;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;CNN2;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;OSTF1;CD53;RAB7A;FCGR3B;VCL;CLEC4D;CD33;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;ENPP4;LAMP2;AMPD3;ATG7;CD68;FTH1;TRPM2;JUP;STK10;SNAP23;NPC2;CDK13
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5780065636842845,1.525193881051709,0.044142614601018676,0.34404250806688097,1.0,12/25,19.61%,OPHN1;RPL23;LAMP3;RPL5;HFE;RPS7;RPL11;PRKCG;HSP90AB1;EFNA1;CSNK2A2;CSNK2A1
prerank,regulation of protein transport (GO:0051223),0.5719700116688458,1.524718136849449,0.037520391517128875,0.3440924333100617,1.0,10/27,13.83%,LCP1;NDFIP1;SNX3;RHBDF1;GAPVD1;STXBP5;TNF;DNAJC1;DISP1;NDFIP2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6225548789645335,1.524383252127231,0.06028368794326241,0.3437375004257611,1.0,5/18,12.16%,HDAC9;HMOX1;PIK3C2A;FOXC2;MAP3K3
prerank,negative regulation of protein binding (GO:0032091),0.4831550175401313,1.5230989181952728,0.029829545454545456,0.34535868501072314,1.0,14/71,7.65%,DAB2;ITGA4;ADRB2;NES;ITGB1BP1;B2M;GSK3B;RACK1;ROCK1;CFHR2;DISC1;ACTB;DDX11;HFE
prerank,negative regulation of type I interferon production (GO:0032480),-0.4534546487903643,-1.5225127727011059,0.018421052631578946,0.6833211971733331,1.0,15/40,15.04%,SIRPA;PTPRS;HAVCR2;CYLD;OTUD5;IRF3;MAVS;UBA7;NLRC5;RNF216;IKBKE;UFD1;NPLOC4;ITCH;PCBP2
prerank,glycolytic process (GO:0006096),-0.49347900413030965,-1.521660698050514,0.04381443298969072,0.6767611242198783,1.0,13/28,21.69%,HK2;PFKL;PGM1;PKM;ALDOA;PGK1;ENO1;ENO3;TPI1;GAPDHS;GAPDH;PFKFB2;LDHA
prerank,regulation of establishment of cell polarity (GO:2000114),0.6287649409743632,1.520535600665156,0.05950095969289827,0.350019946594168,1.0,7/16,12.88%,RAP1B;KIF20B;RIPOR2;RACK1;ROCK1;ROCK2;BCAS3
prerank,cell part morphogenesis (GO:0032990),0.6539971382439494,1.5204583119376975,0.06126126126126126,0.34912878572777717,1.0,2/13,2.47%,PID1;MTM1
prerank,actin crosslink formation (GO:0051764),0.684610804112805,1.520081521387789,0.06981132075471698,0.34899033543935676,1.0,2/12,4.01%,EPS8;LCP1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5014925802900568,1.5198976796528527,0.04192546583850932,0.34835062153525354,1.0,17/49,18.95%,PF4;KMT2A;MEF2C;THPO;CBFB;RAB7B;ASH2L;KMT2C;H3-3A;RBM15;KMT2E;EP300;TNRC6C;PRMT1;PRKCQ;CNOT4;PITHD1
prerank,protein hydroxylation (GO:0018126),-0.5812987388489984,-1.5198126017641664,0.03225806451612903,0.6752997272403556,1.0,7/15,19.13%,ASPH;P3H2;OGFOD1;PLOD3;P3H3;VIPAS39;P3H4
prerank,regulation of mRNA processing (GO:0050684),-0.47608106394148386,-1.519292092756093,0.045,0.6674926260037239,1.0,16/32,19.48%,SON;PABPN1;SAFB;SRSF3;TIA1;SAFB2;SRPK1;SRSF10;KHDRBS3;SRPK2;QKI;NCBP1;CDK11B;RBM39;DHX9;AHCYL1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4356949186576088,1.518979466539332,0.012953367875647668,0.3490776520485522,1.0,38/138,17.49%,RBPJ;HDAC9;NOTCH2;ESR1;RARG;NR1H4;NR2C1;NR1D1;NR3C1;THRB;NR4A1;TBL1XR1;NR4A2;NCOR1;GTF2A2;ESRRB;TBL1X;ESR2;NR2F1;POLR2B;MED26;MAML1;GTF2E2;CREBBP;GTF2A1;NR1H2;RARA;MED27;POLR2D;SNW1;NR2C2;GTF2H3;GTF2B;MED17;NR5A2;TAF12;GTF2H1;NR6A1
prerank,positive regulation of immune response (GO:0050778),0.48695909899053824,1.5188742306995309,0.030927835051546393,0.348245104135661,1.0,8/64,5.64%,FCGR2B;TLR8;IL15;LILRB1;CD74;GRN;CD46;RIOK3
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5801784795973646,-1.5186451301813644,0.05161290322580645,0.6606311706078842,1.0,4/15,4.05%,SLC12A2;ATP1B1;SLC8A1;ATP1B2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5351031973046341,1.5177713593794357,0.05172413793103448,0.3495459438833431,1.0,9/35,7.85%,APOE;ALOX5;MEF2C;XDH;CNMD;RGCC;TNMD;GHRL;SYNJ2BP
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.47941319852554204,1.517484439431059,0.01643835616438356,0.34913305654005083,1.0,17/80,9.23%,SNX2;TBC1D5;SNX8;CLTC;ANKFY1;EVI5;SNX6;CLN5;RIC1;SNX3;TBC1D14;PIKFYVE;RAB7B;RAB7A;TRIM27;DENND5A;TRAPPC10
prerank,regulation of hydrolase activity (GO:0051336),0.48224058880207504,1.516893792523629,0.024355300859598854,0.3493353279005037,1.0,13/71,7.34%,ARHGAP15;VAV3;FGD4;FGD6;ARHGAP9;PLXNC1;CRK;ITGB1BP1;OCRL;PLXNA4;NGEF;PPP1R17;ARHGAP12
prerank,odontogenesis (GO:0042476),0.5380205843054048,1.5167228189715494,0.060221870047543584,0.34864234620568507,1.0,7/35,7.64%,LRP6;OSR1;BMP2;ANKRD11;EDA;TUFT1;WNT6
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.44600331850246294,1.5162431739426325,0.016645326504481434,0.3485879187349352,1.0,20/110,10.88%,PF4;ADGRE5;GNAQ;ADGRG6;ADGRE1;GNG2;CALCRL;GPR65;ADRB2;DRD1;ADM;RAPGEF2;S1PR2;ADCY9;GNB1;ADRA1D;ADRA1A;TSHR;S1PR1;PTGER4
prerank,gluconeogenesis (GO:0006094),-0.45061435418075624,-1.5154596435403083,0.04411764705882353,0.6661675838866751,1.0,16/39,21.03%,PGM1;ALDOA;MDH1;CRTC2;PGK1;ENO1;PCK2;ENO3;SLC37A4;TPI1;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,regulation of dendrite development (GO:0050773),-0.45952944203393387,-1.5139970963980698,0.017902813299232736,0.6632273913350527,1.0,10/37,9.13%,CSMD3;ADGRB3;SEMA4D;HECW2;NSMF;KNDC1;SDC2;BCL11A;ALK;HECW1
prerank,intestinal lipid absorption (GO:0098856),0.6959760889677709,1.5132495330468123,0.051923076923076926,0.3540847211375607,1.0,2/11,2.65%,LDLR;CD36
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4087546368124567,1.5130901747671115,0.0011261261261261261,0.35334604188387925,1.0,52/248,14.80%,DAB2;ZEB2;EGFR;LRP6;APOE;IGFBP4;GNAQ;TCF7L2;TLE4;SMURF2;PSMA7;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;NRARP;MCC;UBAC2;ZNRF3;GSK3B;GPRC5B;NOTUM;CTNND1;FRAT1;STK3;WNK1;PPM1B;PSMB2;TBL1XR1;PSEN1;CDK14;LIMD1;TBL1X;CUL3;NKD1;SFRP1;WLS;PPP1CA;JUP;AMFR;PSMA6;LRRK1;PLEKHA4;LATS2;CCNY;MDK;PSMD5;PSMD1;PSMA3;GPC3;NPHP3
prerank,negative regulation of kinase activity (GO:0033673),0.48206636559597427,1.5127356929130462,0.040059347181008904,0.3530927821675344,1.0,14/62,8.94%,LRP6;GNAQ;SPRED1;DEPTOR;PRKAG2;ITGB1BP1;IRS2;RB1;PAK2;SFN;CEP85;HSPB1;TRIM27;SMCR8
prerank,sensory perception of smell (GO:0007608),-0.6375196610101712,-1.5125948089955819,0.039832285115303984,0.6600680673397635,1.0,4/11,21.37%,ADCY3;SLC24A4;BBS4;MKKS
prerank,neutrophil mediated immunity (GO:0002446),0.39571525777198113,1.5124569205550287,0.0021551724137931034,0.35262467703812944,1.0,89/432,11.76%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;CTSC;IQGAP1;CLEC12A;ARHGAP9;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;BST1;ANO6;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;CD36;FCER1G;LILRB3;GRN;ATP8B4;ARL8A;RAB10;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;PGAM1;FTL;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;CNN2;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;OSTF1;CD53;RAB7A;FCGR3B;VCL;CLEC4D;CD33;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;ENPP4;LAMP2;AMPD3;ATG7;CD68;FTH1;TRPM2;JUP;STK10;SNAP23;NPC2;CDK13
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.4783402907432368,1.511747900652029,0.03443526170798898,0.35305021871470504,1.0,17/71,8.29%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;FCER1G;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,regulation of Ras protein signal transduction (GO:0046578),0.46786818577606476,1.5114401268049515,0.02627939142461964,0.3527501565947862,1.0,19/85,12.08%,EPS8;STARD8;DENND1A;RASGRP4;NOTCH2;OPHN1;LYN;SYNGAP1;IRS2;FOXM1;ARHGDIA;DENND4C;IGF1;STARD13;NUP62;SHC1;KANK2;DENND3;ARHGAP17
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3927047759977282,1.5112522986991004,0.0,0.3521348277746459,1.0,139/572,16.91%,RBPJ;DAB2;HDAC9;ZEB2;TRPS1;EDNRB;KLF2;TCF7L2;FOXP1;MEF2A;ZBTB16;RREB1;TFEC;ESR1;RPL23;SMURF2;RARG;MEF2C;NR1H4;RPS27A;CEBPB;MITF;OSR1;NCOA5;BMP2;ALX1;NR2C1;NR1D1;PRKN;LARP7;PDE2A;NR3C1;FRK;NKAP;IRF2BP2;HEY2;SPI1;RB1;SAP130;NFIC;USP9X;SMAD4;ARID5A;TRIM33;THRB;IRX2;CBFB;ORC2;PHF21A;ATXN1;DMAP1;EPC1;NOP53;BAG3;FOXM1;SDCBP;ZNF568;TNF;ZNF148;KLF4;YY1;BRMS1L;DUSP22;THAP11;MIER1;GATAD2A;TBL1XR1;PSEN1;NR4A2;ZBTB5;NRIP1;NCOR1;IRF2;KLF10;CDC73;RPS14;FNIP1;ATRX;FOXC2;BACH1;TRIM27;MDM2;HIVEP1;TBL1X;UBE2D3;ESR2;LRRFIP1;IGBP1;BEND3;LCOR;NR2F1;PURA;ZNF205;HSBP1;SPEN;MIER3;SP100;WFS1;ETS2;CREBBP;SREBF2;KANK2;FOXO3;RPL10;LOXL2;NFIX;PEG3;WWOX;CTBP2;NR1H2;EP300;RARA;STAT3;BCOR;NEDD4L;WWC1;SNW1;GATAD2B;MYC;NR2C2;HDAC4;ZHX1;SFPQ;HEXIM2;RUNX3;HCFC1;E2F8;KDM1A;ZGPAT;PPM1A;RELA;LIN37;PER1;TBX2;NFATC3;ZNF177;GLIS2;FOXP2;ZBTB7A
prerank,acute-phase response (GO:0006953),0.6701676423060784,1.5110007788111586,0.08221797323135756,0.35165321046939824,1.0,6/12,23.72%,CEBPB;LBP;IL6R;IL6;IL22;PLSCR1
prerank,amino acid import (GO:0043090),-0.519796435174992,-1.5107139300435963,0.04819277108433735,0.6595754698039086,1.0,6/21,21.80%,SLC1A3;SLC36A1;SLC1A1;SLC7A8;SLC6A1;SLC22A4
prerank,cardiac conduction system development (GO:0003161),0.5831310752576896,1.5095369769567941,0.05360134003350084,0.353729791481671,1.0,8/24,20.23%,NOTCH2;HEY2;SMAD4;MAML1;GJA1;BMPR1A;SMAD1;SMAD5
prerank,regulation of monocyte differentiation (GO:0045655),0.6435631260145382,1.5094193753711527,0.06846846846846846,0.3529721399343821,1.0,5/14,4.48%,FOXP1;CD74;DCSTAMP;ZFP36L1;CDK6
prerank,regulation of cholesterol efflux (GO:0010874),0.5430479669094277,1.508873114231287,0.06040268456375839,0.35318045485785393,1.0,2/30,0.49%,PLTP;APOE
prerank,regulation of MAPK cascade (GO:0043408),0.42673106430498414,1.5088220054143946,0.013546798029556651,0.3522969715573768,1.0,27/157,9.95%,EGFR;P2RX7;FGFR1;LILRA5;SPRED1;PTPRJ;IQGAP1;LYN;ADRB2;BMP2;CD74;THPO;DUSP1;GSDME;INSR;PAK2;ROCK1;STK3;TMEM106A;VRK2;SYK;NRK;ADRA1D;ADRA1A;LBH;MYDGF;IGF1
prerank,response to prostaglandin E (GO:0034695),0.7013278348933893,1.508692026743675,0.0599250936329588,0.35153154910876544,1.0,5/10,10.88%,GNG2;CCL19;GNB1;SFRP1;PTGER4
prerank,positive regulation of phosphorylation (GO:0042327),0.40913702483891523,1.5084232929746655,0.0045871559633027525,0.35104767065354747,1.0,42/240,10.24%,DAB2;NRP1;EGFR;P2RX7;FGFR1;APP;GAS6;WDFY2;ZBTB20;LYN;ANG;KRAS;BMP2;RIPK1;CD74;FGF23;AXIN1;NIBAN1;THPO;BCL10;PDE8A;INSR;CAMKK2;RACK1;PFKFB4;PDGFRA;CD40;ACVR2A;SDCBP;TNF;FAM20A;CCND3;PSEN1;SLC4A4;FNIP1;DDR2;KCTD20;CCND2;MYDGF;EPHB4;IGF1;ARRB1
prerank,epithelial cell differentiation (GO:0030855),0.4635745938515831,1.5074121511574212,0.023709902370990237,0.35229485400703686,1.0,7/88,5.42%,DAB2;MAF;JAG1;DNPH1;RAB10;GRHL2;CTSB
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6131275796704807,1.506516497613829,0.06272401433691756,0.35325027553016064,1.0,5/20,13.71%,C1QTNF3;C1QTNF12;UGT1A8;NCOR1;EP300
prerank,thyroid hormone generation (GO:0006590),0.6935824264142629,1.5058740096817627,0.06525911708253358,0.35370799616599446,1.0,2/10,3.47%,CPQ;TPO
prerank,granulocyte differentiation (GO:0030851),0.6161405902917916,1.5055456682382387,0.059027777777777776,0.3534252364293704,1.0,6/18,13.77%,CBFA2T3;SPI1;LBR;DEK;EP300;RARA
prerank,regulation of cell size (GO:0008361),0.5830590541845581,1.5049518375006852,0.06070826306913996,0.35371471371123814,1.0,6/23,8.44%,VAV3;DEPTOR;RARG;RHOA;MTPN;MSN
prerank,regulation of cellular component size (GO:0032535),0.5571034833893581,1.5048616252550473,0.04376012965964344,0.35290638660395446,1.0,13/30,18.08%,EPS8;VAV3;RARG;MTPN;MSN;PPP1CA;LAMTOR5;NEB;RAB3B;PTEN;LARS1;PICALM;RAB22A
prerank,regulation of keratinocyte differentiation (GO:0045616),0.570237677624863,1.5047958972372093,0.04130808950086059,0.3520368552184996,1.0,8/24,11.89%,SGPP1;NCOA3;ZFP36L1;GRHL2;ROCK1;CBFB;TRIM16;ROCK2
prerank,cellular response to cAMP (GO:0071320),0.5532315657589622,1.504645539578218,0.05806451612903226,0.3513538374410901,1.0,7/30,8.48%,RAP1B;AHR;ZFP36L1;RAPGEF2;PDE2A;RAP1A;HCN3
prerank,early endosome to Golgi transport (GO:0034498),0.6988250540575338,1.5038461893965678,0.07575757575757576,0.35197850279468734,1.0,2/11,1.46%,SNX2;SNX8
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.47466772115534517,1.5032460655503463,0.033012379642365884,0.352336103181873,1.0,17/73,8.29%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;FCER1G;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5989821324797485,1.5031751023770281,0.06761565836298933,0.3514924934026785,1.0,2/19,2.02%,RBPJ;MEF2C
prerank,regulation of protein metabolic process (GO:0051246),0.5195439850782032,1.5029976647668217,0.027820710973724884,0.3509068471570748,1.0,16/44,16.19%,APOE;APP;KLF2;LDLR;SPOP;PARL;KLF4;MTPN;SPOPL;MDM2;WFS1;ROCK2;NEDD4L;ZDHHC2;HSP90AB1;MAPK7
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5521919500773602,1.5026599305028456,0.06200317965023847,0.35063579635145575,1.0,10/27,12.36%,GAS6;C1QTNF3;IRAK3;PTPN22;TLR4;GHRL;CD200R1;TNF;ARRB1;ZC3H12A
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6035321208245785,1.5020685198739618,0.057724957555178265,0.350925776760485,1.0,8/18,13.30%,CTNNA1;MDFIC;MFHAS1;GSK3B;POLR1A;RAB23;UFM1;LATS2
prerank,cyclooxygenase pathway (GO:0019371),-0.6419935010843969,-1.5017200992951707,0.05947136563876652,0.6923626775857159,1.0,5/10,24.93%,HPGDS;PTGS1;PTGES3;PTGIS;PTGDS
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6552850446093652,1.501122428507253,0.06846846846846846,0.35179265349072425,1.0,3/13,6.24%,APOE;BMP2;ERLIN1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4699747263299179,1.5007224277522702,0.027377521613832854,0.35170205216616585,1.0,18/75,12.39%,STAB1;PF4;ALOX5;SPRED1;THBS4;CNMD;RGCC;TNMD;GHRL;ROCK1;KLF4;CCR2;SYNJ2BP;AMOT;EMILIN1;ROCK2;NIBAN2;ATP2B4
prerank,negative regulation of reproductive process (GO:2000242),0.6277873669910056,1.5006976849495994,0.07222222222222222,0.35080995111220953,1.0,6/17,14.77%,PAEP;DUSP1;IGF1;GJA1;NPPC;ARHGDIB
prerank,ceramide transport (GO:0035627),0.6739805637332992,1.5005718092271585,0.05849056603773585,0.350163198783419,1.0,2/12,1.54%,PLTP;SGPP1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.44085706745472597,1.500373061841429,0.013071895424836602,0.3495950755705921,1.0,24/116,13.35%,CD163;FCGR2B;LYN;CYSLTR1;GNG2;CALCRL;ADRB2;DRD1;ADM;ADCY9;ADCYAP1R1;SYK;GNB1;FYN;FCGR3A;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4775195708200231,1.4995956283497887,0.03133903133903134,0.3502521147739973,1.0,11/70,4.85%,NRP1;ITGA4;ATRNL1;PEAK1;OPHN1;FER;MEF2C;RHOA;GRHL2;SPI1;RB1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.41944017343156836,1.499436978410043,0.01699029126213592,0.34962355815730195,1.0,39/182,12.39%,MSR1;APOE;APP;NOTCH2;CCR1;FOXP1;FBXW7;MYADM;LDLR;ESR1;MEF2C;PTPN22;BMP2;XDH;PARP14;CD46;PRKN;HEY2;SPI1;RB1;NDFIP1;RACK1;SETDB2;SDCBP;TNF;ZNF148;KLF4;YY1;REL;PSEN1;SMCR8;APOBEC1;IGF1;SFRP1;EMILIN1;HINFP;ROCK2;ZC3H12A;ATP2B4
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4624133136586751,1.499254317695049,0.024,0.3490843703050056,1.0,16/93,7.43%,FCGR2B;APP;MAP3K5;SASH1;RELL1;MFHAS1;RASSF2;SH3RF1;BMP2;XDH;RIPK1;AXIN1;CCL19;SPI1;SDCBP;DUSP22
prerank,negative regulation of catabolic process (GO:0009895),0.5087027058635409,1.498780345189036,0.05014749262536873,0.34914278659837333,1.0,10/47,8.05%,EGFR;NUPR1;IRAK3;CBFA2T3;RILP;HMGCR;SF3B3;SNX3;TNF;NCOR1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.4174274452573172,1.4983100054625915,0.006082725060827251,0.349186633831381,1.0,32/190,9.29%,BANK1;P2RX7;SPRED1;PTPRJ;DEPTOR;MYADM;ESR1;LYN;C1QTNF3;NR1H4;XDH;RIPK1;NR1D1;PDE2A;DUSP1;NPRL3;MCL1;SPI1;RACK1;BCL2L2;RIOK3;PDE4D;NOP53;BCL2;UACA;PPM1B;ARHGAP12;FNIP1;LIMD1;MDM2;MAPK14;SH2B3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5068388479474243,1.4977631204928246,0.05341246290801187,0.3493610771899417,1.0,14/47,12.98%,CMKLR1;ZBTB16;RREB1;WDFY2;METRNL;CEBPB;BMP2;GDF3;ZFP36L1;MEDAG;VSTM2A;SFRP1;ZC3H12A;CREB1
prerank,Rap protein signal transduction (GO:0032486),0.6872142764826231,1.497634581399796,0.08582089552238806,0.348689297057518,1.0,4/10,4.82%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,regulation of muscle cell differentiation (GO:0051147),0.5394694215208692,1.4970917284272305,0.061488673139158574,0.3488499866323006,1.0,7/31,9.12%,HDAC9;CTNNA1;MEF2A;MEF2C;CDC42;RBM4;MAPK14
prerank,negative regulation of angiogenesis (GO:0016525),0.46237328492633517,1.496619468931539,0.033566433566433566,0.34890825108936796,1.0,22/84,12.39%,STAB1;PF4;ALOX5;KLF2;SPRED1;THBS4;CNMD;RGCC;TNMD;GHRL;ROCK1;TNF;EPN2;KLF4;CCR2;SYNJ2BP;AMOT;ADAMTS9;EMILIN1;ROCK2;NIBAN2;ATP2B4
prerank,neuron maturation (GO:0042551),0.600777353980439,1.4961932721967097,0.06620209059233449,0.3489071105801088,1.0,6/18,4.22%,APP;C1QA;ANKS1A;SCARF1;CLN5;B4GALT6
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3898785698127567,1.4947407314085688,0.0,0.3509830646496383,1.0,94/532,11.88%,F13A1;PF4;TNFRSF25;LIFR;ALOX5;IL16;RAP1B;PTPRJ;IRF4;CCR1;IFITM3;IL15;OAS2;ALOX15;SERPINB2;PSMA7;ITGB1;FER;IRAK3;IFNAR1;TSLP;RPS27A;CD44;TNFRSF1B;CD36;RIPK1;FCER1G;CCL8;PLVAP;CDC42;CBL;CCL19;CRK;PELI1;PITPNA;HMOX1;IL17RB;TNFRSF11A;IL17RC;LCP1;B2M;LBP;VIM;MCL1;IL17RA;BIRC3;IRS2;SPI1;IL10RB;PAK2;SMAD4;ADIPOR2;RNASEL;ANXA2;CD40;EDARADD;BCL2;HNRNPF;SYK;CNN2;MAP3K8;RPLP0;TNF;CD80;BST2;EDA;PSMB2;CCR2;IL20RB;STAT4;CANX;IFNAR2;FYN;IRF2;CCL24;IL6R;TRIM68;MSN;TNFSF12;SH2B3;NDN;IFITM2;STAT6;IL1RL1;RIPK2;S1PR1;SP100;PLP2;SLA;SHC1;IL15RA;PSMA6;FOXO3;JAK1
prerank,neuromuscular junction development (GO:0007528),-0.49531193528838,-1.4943534384543826,0.03865979381443299,0.7200609796684044,1.0,5/24,6.45%,CACNB2;CACNB4;UNC13C;DVL1;DNAJA3
prerank,synaptic vesicle endocytosis (GO:0048488),0.5373974541069471,1.4941081268452017,0.060995184590690206,0.35145243596061937,1.0,6/33,7.75%,ITSN1;FCHO2;OPHN1;SYNJ1;ITSN2;CANX
prerank,establishment of epithelial cell polarity (GO:0090162),0.5956344727887197,1.4938334039562997,0.06104129263913824,0.351129153799801,1.0,11/19,20.50%,OPHN1;CDC42;RHOA;MSN;CLASP1;CYTH1;MYO9A;SIPA1L3;GOLPH3;EZR;CYTH3
prerank,purine nucleotide metabolic process (GO:0006163),0.5797768143854166,1.4932757089007653,0.08888888888888889,0.35138683201103726,1.0,3/24,3.68%,GDA;XDH;DNPH1
prerank,actin filament bundle assembly (GO:0051017),0.5413267493962699,1.4928691143675896,0.04983922829581994,0.35132095149755094,1.0,3/33,4.01%,EPS8;NEDD9;LCP1
prerank,response to chemokine (GO:1990868),0.654581983167918,1.49256728724338,0.07295373665480427,0.35112796330248186,1.0,7/13,12.36%,RIPOR2;OXSR1;RHOA;DUSP1;WNK1;SH2B3;ZC3H12A
prerank,regulation of T cell migration (GO:2000404),0.5992111106342546,1.4912827087522151,0.06217616580310881,0.35285381889779793,1.0,4/18,5.12%,APP;RIPOR2;RHOA;CD200R1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6904403861573181,1.4910406912825644,0.07782101167315175,0.3524787185319771,1.0,1/10,0.05%,PID1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4009450967991366,-1.490650880560088,0.009868421052631578,0.729172366978167,1.0,30/63,25.15%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC25A3;SLC37A2;SLC12A9;GABRB1;ANO3;GLRB;SLC1A1;SLC25A14;GABRA2;SLC12A6;GLRA1;SLC37A4;GABRG2;SLC6A1;GLRA3;CFTR;SLC25A10;SLC20A2;SLC37A3;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3959198773286863,1.490510681821581,0.00331858407079646,0.35253718178601007,1.0,59/348,12.37%,RBPJ;PID1;PF4;P2RX7;APP;KLF2;TBC1D5;GAS6;ADAM19;RPL23;C1QTNF1;RPS3;MEF2C;PTPN22;KRAS;MITF;OSR1;BMP2;CD36;LILRB1;CD74;FGF23;DRD1;LAMP3;TLR4;PPHLN1;CD46;RGCC;PRKN;PDE2A;TLR2;HEY2;GSK3B;INSR;ROCK1;ANXA2;SETDB2;TNF;KLF4;MTPN;RPL5;WNT6;HFE;PSEN1;VSTM2A;MSN;RPS7;MAPK14;IGF1;ARRB1;SP1;MED26;WFS1;EMILIN1;HINFP;ROCK2;LAMTOR5;ZC3H12A;SLC38A2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5359033127055811,1.4882523349575187,0.04617834394904458,0.35612738729036947,1.0,9/30,10.19%,DAB2;FOXP1;NCOA2;PIAS2;NCOR1;TRIM68;H3-3A;SFRP1;RNF14
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6755916632633323,1.488233238492338,0.07196969696969698,0.3552626634175564,1.0,2/11,4.06%,CLEC6A;NFKBIZ
prerank,synapse assembly (GO:0007416),-0.39306056549236373,-1.4875990842968665,0.020202020202020204,0.7349639439664822,1.0,17/67,14.06%,GRID2;DNM3;ADGRL3;SDK1;GABRB3;NLGN1;CDH2;NRXN1;FARP1;FGF13;DVL1;BDNF;SHANK2;GABRA2;LRRC4;SPOCK2;GABRG2
prerank,regulation of cell development (GO:0060284),0.5304494878628585,1.4873095497012274,0.0701468189233279,0.35639400831728046,1.0,5/36,4.52%,HDAC9;NOTCH2;GRN;HEY2;CLOCK
prerank,chloride transmembrane transport (GO:1902476),-0.42169391134254625,-1.4872247335615572,0.020833333333333332,0.7270965652381877,1.0,23/48,25.15%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC12A9;GABRB1;ANO3;GLRB;SLC1A1;GABRA2;SLC12A6;GLRA1;GABRG2;SLC6A1;GLRA3;CFTR;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6589712056724846,1.4869910954923435,0.06109979633401222,0.3561317025345661,1.0,4/12,12.36%,ESR1;TNF;NCOR1;ZC3H12A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6284371901355594,1.48698407499197,0.07358490566037736,0.35525181927390603,1.0,4/14,10.65%,NRP1;GAB1;NUS1;MYO1C
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5039457760835756,-1.486324188670532,0.05235602094240838,0.7219481927587992,1.0,6/25,5.86%,CACNB2;CAPN3;PLCG1;ANK2;TRPC1;AKAP6
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6911352526656676,1.4861120673927195,0.07664233576642336,0.35618508571889157,1.0,3/10,5.45%,ZEB2;RAPGEF2;ATP7A
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.529871716184933,1.4860397774087395,0.06779661016949153,0.3554175335821763,1.0,12/36,14.04%,EGFR;APOE;S100A1;CYGB;NPR3;GCH1;NOSTRIN;TNF;NUS1;CALM1;ATP2B4;WASL
prerank,carbohydrate derivative catabolic process (GO:1901136),0.6068907944122807,1.4858876259189766,0.07768595041322314,0.3548558912844134,1.0,8/18,21.21%,AOAH;MANBA;ADAMTS9;NGLY1;SAMHD1;NEU4;DERA;FBXO6
prerank,glycerolipid catabolic process (GO:0046503),-0.5362006895112642,-1.485026130665972,0.04719101123595506,0.7192895616257101,1.0,4/19,5.00%,ABHD12;MGLL;SMPD4;LYPLA2
prerank,neuron remodeling (GO:0016322),0.686562716242105,1.484172385480458,0.08241758241758242,0.35755405398045986,1.0,4/10,3.57%,APP;C1QA;ANKS1A;SCARF1
prerank,positive regulation of filopodium assembly (GO:0051491),0.5653369762927126,1.4833178263816476,0.06440677966101695,0.358421301400197,1.0,5/24,5.33%,NRP1;RIPOR2;ARAP1;CDC42;DOCK11
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5627366402976575,1.483160449175361,0.05263157894736842,0.3578510224576257,1.0,7/27,5.51%,IRAK3;RPS27A;CD36;TLR4;MAP3K1;TLR2;LY96
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.38479192108294535,-1.4831294671784396,0.010752688172043012,0.719787164709142,1.0,34/84,20.14%,DDX5;SON;DDX17;RBM25;NCL;RBFOX1;SRRM4;FXR2;SRSF3;TIA1;HNRNPU;SRPK1;PUF60;SRSF10;FMR1;CELF4;KHDRBS3;RNPS1;SRPK2;CIRBP;NOVA2;C1QBP;SRSF12;QKI;NCBP1;RBMXL1;SFSWAP;HNRNPA1;RBM5;RBM39;SRSF9;MBNL3;FXR1;CELF6
prerank,phasic smooth muscle contraction (GO:0014821),0.6790959741543368,1.4830129111425085,0.08395522388059702,0.35728091349282404,1.0,4/10,19.67%,EDNRB;HTR1D;GDNF;TIFAB
prerank,positive regulation of cellular respiration (GO:1901857),0.6807121627364008,1.4825901595665447,0.07243816254416961,0.357275023082152,1.0,3/11,4.95%,NUPR1;IFNAR1;IL10RB
prerank,positive regulation of transmembrane transport (GO:0034764),0.6277633193062971,1.4823433011986469,0.1001890359168242,0.356868403787174,1.0,2/13,1.80%,P2RX7;ANO6
prerank,positive regulation of cholesterol transport (GO:0032376),0.5538241302540796,1.482157520926359,0.05663716814159292,0.35642937533147373,1.0,2/27,0.49%,PLTP;APOE
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5388067946804279,1.4819775690096668,0.060955518945634266,0.3559212038529281,1.0,11/33,12.39%,APOE;MEF2C;RGCC;RHOA;ITGB1BP1;TNF;KLF4;STARD13;JUP;MMRN2;ATP2B4
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5918805404408016,1.4818735835065018,0.07107438016528926,0.3552759029429463,1.0,6/21,5.43%,CCR1;GAS6;FGF23;SRGN;HEY2;ROCK1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4709546600338312,-1.4817248252552389,0.03684210526315789,0.7173435827507085,1.0,10/30,11.02%,F11R;TJP1;MBP;SLC12A2;JAM2;TJP2;LAMA2;WNK3;PECAM1;SLC1A1
prerank,protein localization to cell junction (GO:1902414),-0.5102656818535602,-1.48114341738526,0.04279279279279279,0.7112381762313056,1.0,7/22,5.58%,TJP1;NLGN1;DLG4;PCLO;FERMT2;TJP2;SHANK1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4607834329873883,-1.480939110597468,0.03513513513513514,0.7034810362892533,1.0,7/30,5.61%,FGF12;KCNJ2;SCN1B;SNTA1;ANK2;CACNA2D1;CACNA1D
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6020293933910599,1.48091996272553,0.06457242582897033,0.3563577378096154,1.0,4/18,3.17%,FBXW7;LILRB1;LILRB3;TLR4
prerank,regulation of T cell proliferation (GO:0042129),0.48542600912927497,1.4803019295045206,0.04293628808864266,0.35667402390358405,1.0,10/61,9.13%,VSIG4;IL15;CEBPB;TNFRSF1B;LILRB1;CD46;CCL19;PLA2G2D;CD80;SDC4
prerank,regulation of adaptive immune response (GO:0002819),0.6031189440738142,1.480269353684881,0.058287795992714025,0.3558616213820583,1.0,3/18,1.41%,FCGR2B;AHR;ALOX15
prerank,blood vessel diameter maintenance (GO:0097746),0.5400510264670642,1.4796459382601315,0.046357615894039736,0.35626627549592566,1.0,6/34,11.92%,EDNRB;KLF2;ITGB1BP1;ROCK1;ROCK2;GCLM
prerank,regulation of B cell apoptotic process (GO:0002902),0.6590458209252452,1.4793991543970688,0.08935361216730038,0.3559246524757107,1.0,4/12,8.23%,FOXP1;LYN;IRS2;FNIP1
prerank,actin filament bundle organization (GO:0061572),0.5367755937450682,1.4792449630174853,0.05546492659053834,0.3553510266276141,1.0,5/33,9.65%,EPS8;NEDD9;LCP1;PLS1;RFLNB
prerank,regulation of multicellular organism growth (GO:0040014),0.6274663377298076,1.4785169881799738,0.06217616580310881,0.35596635521441516,1.0,4/15,13.91%,APP;GHRL;IGF1;MFSD2A
prerank,negative regulation of viral entry into host cell (GO:0046597),0.660409267241229,1.4783341107498702,0.09158878504672897,0.35549874050325014,1.0,5/12,13.93%,IFITM3;SNX3;IFITM2;LY6E;MID2
prerank,positive regulation of cell death (GO:0010942),0.48503971820867015,1.478275360302477,0.043478260869565216,0.3547343876144454,1.0,11/59,10.08%,FCGR2B;MAP3K5;C1QA;RARG;CD36;RIPK1;GSK3B;TNF;HTATIP2;FYN;RIPK2
prerank,dendritic cell chemotaxis (GO:0002407),0.6476964570227448,1.4775409023826687,0.08450704225352113,0.35545990477057215,1.0,7/14,16.92%,CCR1;CCL19;CXCR4;CCR2;TRPM2;GPR183;CCL5
prerank,negative regulation of response to stimulus (GO:0048585),0.47449797032533475,1.47731215177128,0.038748137108792845,0.3551302448185153,1.0,11/60,12.16%,MCTP1;FCGR2B;ALOX5;CASK;LYN;CDK6;KLF4;SH2B3;WFS1;VPS13C;MAP3K3
prerank,regulation of sensory perception of pain (GO:0051930),-0.6064212038706296,-1.4768978308601222,0.0737527114967462,0.7140305523588616,1.0,4/11,10.56%,MGLL;CCL3;ZFHX2;TMEM100
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4218311047262435,1.4767750349247877,0.017676767676767676,0.35530884317339456,1.0,28/150,9.83%,HIP1;EGFR;FGFR1;PTPRJ;TCF7L2;GAS6;ESR1;ITGB1;MFHAS1;CASS4;KITLG;FGF23;MYORG;THPO;CCL19;ITGB1BP1;FRS2;ICOS;IRS2;INSR;PDGFRA;TNF;CD80;GAB1;FYN;TSPYL5;MYDGF;RTN4
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6378096009859303,-1.4762746027706946,0.060041407867494824,0.7084984045614817,1.0,4/10,32.08%,ACTN2;PLEK;WDR1;CARMIL2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6472238135873529,1.4758497816598724,0.08166969147005444,0.3563622429643285,1.0,2/12,7.01%,PAEP;CD80
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.557773950919946,1.474915429712246,0.06711409395973154,0.35733423276895915,1.0,3/27,2.65%,MSR1;PF4;CD36
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.4834250950846572,-1.4744056229072586,0.03389830508474576,0.7094727025534646,1.0,13/27,22.89%,CHST11;XYLT1;CSPG5;CHPF2;CSPG4;VCAN;PXYLP1;BCAN;BGN;NCAN;UGDH;B3GAT1;DCN
prerank,negative regulation of secretion by cell (GO:1903531),0.5244969999369145,1.4743385778223792,0.05069124423963134,0.3577350127137447,1.0,8/38,6.44%,APOE;TNFRSF1B;LILRB1;FGF23;HMGCR;STXBP6;RHBDF1;DPH3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.6209064451384069,-1.4739989080123663,0.06578947368421052,0.7033100238369815,1.0,6/11,20.09%,LRP5;STAT1;FGFR2;TGFBR2;PDGFA;WNT5A
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3899044557126384,1.4734264264627885,0.0032858707557502738,0.3587143703944314,1.0,74/390,11.32%,ITSN1;VAV3;MTSS1;AP2A2;NRP1;NEDD9;RASGRP4;EGFR;FGFR1;CYBB;SPRED1;PTPRJ;LYN;FER;ACTR3;ABI1;WASF2;RASA1;CASS4;DOCK1;ADRB2;ATP6V1B1;FGF23;CDC42;ANKS1A;CBL;CRK;RHOA;RAPGEF2;FRS2;FRK;IRS2;GSK3B;INSR;PAK2;MAPKAPK2;PDGFRA;ROCK1;EFS;ATP6V0A1;ACTB;KIF16B;AP2S1;HNRNPF;SYK;NGEF;SDCBP;ZAP70;ARPC2;ARPC5;GAB1;PSEN1;FYN;PIK3C2A;AP3S1;ATP6V1A;FOXC2;DDR2;SULF2;RAB14;MAPK14;PDGFC;ZNF106;POLR2B;EPHB4;IGF1;NUS1;STYK1;PXN;SPRED2;NCF2;SLA;PHIP;SHC1
prerank,positive regulation of cell population proliferation (GO:0008284),0.387859215600922,1.4732016582759218,0.002136752136752137,0.3583412384257255,1.0,102/423,17.83%,RBPJ;PID1;FOLR2;EGFR;LIFR;FGFR1;CHP2;TCF7L2;FOXP1;IL15;KIF20B;GAS6;C5AR1;RPL23;LYN;GRK5;BST1;FER;LIG4;MEF2C;TSLP;KRAS;OSR1;KITLG;BMP2;CD74;FGF23;WNT2;GRN;NES;THPO;HMOX1;ITGB1BP1;TNFRSF11A;CDK6;IRS2;INSR;S1PR2;PDGFRA;ACER3;BCL2;RPS4X;FOXM1;RPS15A;SDCBP;TNF;BST2;TIPIN;IL6R;DDR2;RPS9;ADRA1D;TSPYL5;ASH2L;MDM2;PDGFC;CCND2;CACUL1;CUL3;IGF1;SFRP1;RPS6;TSHR;SLC25A5;PHIP;SHC1;ROMO1;CDK13;MAP3K3;NAMPT;NOD2;GLP2R;RBPMS2;GJA1;CRLF2;RNF187;RARA;DERL2;MDK;HMGN5;BMPR1A;PRMT1;IL13RA1;FN1;MYC;HDAC4;KDM1A;PTEN;RELA;EAPP;TBX2;IGF1R;PRDX3;CCL5;NACC1;CNOT6L;GDF9;XBP1;GAREM1;S100A6;IL6;UBE2A
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.5843584214355688,1.4716514436818142,0.0625,0.36076269788193815,1.0,4/20,6.15%,ITGA4;ANO6;RGCC;CD40
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5348446247624612,1.4716294405277393,0.07532051282051282,0.3599561085187121,1.0,4/32,5.86%,APOE;PRKAG2;ZBTB20;ADIPOR2
prerank,neuromuscular process controlling balance (GO:0050885),-0.593776086565888,-1.470751421047358,0.0640495867768595,0.7102463781340415,1.0,5/12,6.50%,CDH23;NRXN1;CLN3;SHANK1;PCDH15
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3828968192892068,1.4707503748016777,0.001040582726326743,0.36096377844633476,1.0,105/509,13.17%,PLEKHG5;HIP1;EGFR;FGFR1;APP;LILRA5;PTPRJ;TCF7L2;IQGAP1;SASH1;CLEC6A;GAS6;NUPR1;ESR1;RPL23;S100A4;LYN;ITGB1;MFHAS1;RPS3;SHISA5;DDX60;ALPK1;CASS4;KITLG;ADRB2;BMP2;RIPK1;CD74;FGF23;MYORG;TLR4;RPS15;RPL37;ANKRD17;THPO;CBL;CCL19;PELI1;RHOA;HMOX1;ITGB1BP1;RAPGEF2;RPS20;FRS2;PRKN;BCL10;TLR2;ICOS;GSDME;BIRC3;IRS2;NDFIP1;INSR;RACK1;GPRC5B;PUM2;PDGFRA;ROCK1;TRIM32;TMEM106A;CD40;BCL2;MIOS;TNF;CD80;USP15;BST2;PRKCB;MIER1;REL;GAB1;FYN;FNIP1;TRIM68;ADRA1D;ADRA1A;TSPYL5;TRIM27;SMCR8;TFG;CARD16;PDGFC;MYDGF;EEF1D;RTN4;IGF1;RIPK2;WLS;NUP62;F10;CASP8;SHC1;ROCK2;DHX33;STRN;MAP3K3;LAMTOR5;HTR6;VAPA;TERF2IP;NOD2;TNFRSF1A;GJA1;UBE2N
prerank,ceramide catabolic process (GO:0046514),-0.5839812251624505,-1.4699779475945325,0.058823529411764705,0.7059330316134874,1.0,5/14,13.05%,HEXB;NEU1;ASAH1;ASAH2;ACER2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6638255530040793,1.4698077862619783,0.0784313725490196,0.36202686450448596,1.0,3/11,3.98%,MEF2C;BMP2;FRS2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.506917811872421,1.4695974514026582,0.05803571428571429,0.36158037779154956,1.0,15/43,14.58%,GAS6;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;LBP;NFKBIL1;GHRL;TRIM27;CD33;IGF1;ZC3H12A;RARA;ARG2
prerank,female gamete generation (GO:0007292),0.5469513792520995,1.4693776694081022,0.061191626409017714,0.3611708774714737,1.0,10/29,17.70%,DIAPH2;USP9X;MCM9;NANOS3;HORMAD1;PIWIL2;MDK;MCM8;GDF9;DMC1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.6322365792684468,1.4688090873102773,0.06839186691312385,0.36152950908117143,1.0,6/14,9.95%,LDLR;TNFRSF1B;NR1D1;GRN;CD200R1;IGF1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.4598953359986957,1.4684773350443614,0.0364656381486676,0.3614024890856461,1.0,13/76,8.68%,HRH1;CMKLR1;C5AR1;ESR1;C3AR1;GPR65;DRD1;P2RY6;ANO1;P2RY10;HOMER1;ADRA1D;ADRA1A
prerank,positive regulation of neuron death (GO:1901216),0.4912574279222028,1.4682798600334712,0.050974512743628186,0.36094175874152434,1.0,9/46,8.05%,FCGR2B;MAP3K5;C1QA;NUPR1;TLR4;GRN;GSK3B;TNF;FYN
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.6062473273829413,-1.467889839583394,0.07709251101321586,0.7074685526114611,1.0,3/11,5.86%,TREM2;NOS1AP;AKAP6
prerank,endocytic recycling (GO:0032456),0.4831574262965935,1.4676593234091833,0.050445103857566766,0.36133796835363796,1.0,11/50,9.78%,DENND1A;EHD4;EPS15;DENND1B;SNX27;EHD1;SNX3;EIPR1;RAB7A;RAB14;CMTM6
prerank,positive regulation of cilium assembly (GO:0045724),-0.5303061670437125,-1.4670206777675776,0.07529411764705882,0.7036650543806131,1.0,9/18,24.62%,CEP135;CROCC;CCP110;WRAP73;ENTR1;KCTD17;HAP1;BBS4;TAPT1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.6364749627805739,-1.4666952468633245,0.05928853754940711,0.6976424746457274,1.0,3/10,11.73%,SALL1;BASP1;PAX8
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6016305326737947,-1.4666915179084723,0.06637168141592921,0.6900594042691434,1.0,8/12,26.26%,RIMS1;UNC13C;RIMS2;SYT8;RIMS3;SYT1;SYT7;SYT5
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.46537206627806005,1.4666902780795614,0.04281767955801105,0.3625383750955926,1.0,16/70,8.29%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,positive regulation of protein catabolic process (GO:0045732),0.45651160984169703,1.4666371518514274,0.040787623066104076,0.3618003160224964,1.0,23/84,15.58%,WWP1;APOE;SNX9;SMURF2;TNFRSF1B;RILP;AXIN1;ADAM9;PRKN;GSK3B;TRIM32;TNF;RAB7A;MSN;TNFSF12;NKD1;ATG7;SNX33;FOXO1;NEDD4L;GPC3;RNF41;VGLL4
prerank,regulation of myelination (GO:0031641),-0.4812769309806511,-1.4656554800703374,0.03676470588235294,0.6871362136558722,1.0,9/25,12.11%,JAM2;PARD3;ITGAX;CST7;TENM4;NSUN5;SIRT2;TPPP;RNF10
prerank,respiratory system development (GO:0060541),-0.45871346303230076,-1.4652038650597075,0.05483028720626632,0.6818108872161561,1.0,16/32,29.41%,BASP1;CHD7;FGF2;FGFR2;LOXL3;BAG6;CCDC39;SPEF2;PROX1;PDPN;CCDC40;FGF1;WNT7B;FGF7;BMP4;SMCHD1
prerank,response to glucocorticoid (GO:0051384),0.5486097131739941,1.4651389696100245,0.07093425605536333,0.36414736680348864,1.0,7/26,11.19%,ZFP36L2;ADAM9;ZFP36L1;NR3C1;TNF;PDCD7;SLIT3
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.36082123314997344,-1.4648116985985011,0.0,0.6763370815030315,1.0,30/107,12.36%,CX3CR1;GRID2;NRG3;SLC12A2;DGKI;RIMS1;SNCAIP;DLGAP2;GRM7;GRIK2;NLGN1;RIMS2;CDH2;LRRC4C;DLG4;DLGAP1;GRM3;CLN3;USP46;BDNF;KCTD13;FMR1;DGKZ;SYN3;CPLX1;ABR;TMEM108;LRRC4;NPTX1;LGI1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6199043794304756,-1.4646395248424358,0.04739336492890995,0.6700102749771635,1.0,4/11,4.82%,CACNB2;BIN1;NOS1AP;CACNA2D1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.42699889607861674,1.464350738622563,0.03430079155672823,0.36498552051493854,1.0,21/113,10.85%,NRP1;EGFR;TCF7L2;NOTCH2;RREB1;C5AR1;ANG;NRAS;OSR1;BMP2;THBS4;GRN;NRARP;NR4A1;CCL24;TNFSF12;MYDGF;RTN4;IGF1;SFRP1;EGFL7
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4982549777524168,1.4641922856546876,0.060240963855421686,0.3644789616237651,1.0,11/48,12.16%,HDAC9;FGFR1;HMOX1;CD40;HSPB1;PIK3C2A;FOXC2;MAPK14;NUS1;SP1;MAP3K3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5266646219892297,1.464117441621719,0.07202680067001675,0.3638016868540455,1.0,13/34,17.50%,NRP1;ERN1;ITGB1BP1;MAPKAPK2;NR4A1;HSPB1;GAB1;MAPK14;NUS1;RAMP2;PRKD2;RELA;SPRY2
prerank,cell-matrix adhesion (GO:0007160),0.44643372257307623,1.4635291605061016,0.04341926729986431,0.36421429856698323,1.0,18/95,11.24%,LYVE1;ITGA4;SIGLEC1;PEAK1;ITGB1;TNN;CD44;ADAM9;ITGB1BP1;ITGBL1;PTPRK;VCL;RCC2;ADAMTS9;PIP5K1A;THSD1;PPFIA1;EMILIN1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4444924566628129,1.4630998602119378,0.030598052851182198,0.36430725657613755,1.0,19/95,11.65%,DAB2;ZEB2;SPRED1;SMURF2;RPS27A;SNX6;IL17RD;SMAD4;TRIM33;SNX25;HTRA3;SDCBP;VASN;DAND5;RNF111;SPRED2;EMILIN1;CREBBP;PMEPA1
prerank,embryonic organ development (GO:0048568),0.4682450517335465,1.4630523738489551,0.03868194842406877,0.36357928725214494,1.0,7/61,4.68%,RBPJ;KMT2A;KITLG;NES;TPO;HEY2;PBX3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.6124957779449888,1.4629806379906023,0.09009009009009009,0.3629222149769279,1.0,1/16,0.05%,PID1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4571925890949675,1.4623628432960645,0.045205479452054796,0.36343670259629185,1.0,16/76,10.19%,DAB2;FBXW7;CBFA2T3;ARIH1;PIAS1;PRICKLE1;AXIN1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;RNF19B;MDM2;COP1;RNF14
prerank,limb morphogenesis (GO:0035108),0.5649042156044711,1.4620722646143598,0.08392857142857142,0.36322525019642066,1.0,2/20,1.14%,LRP6;MBNL1
prerank,regulation of microtubule depolymerization (GO:0031114),-0.4873508166431218,-1.4615283728339932,0.047979797979797977,0.6769303203401933,1.0,6/25,8.60%,NAV3;CLASP2;CAMSAP1;MAP1B;FGF13;ARHGEF2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5342804028367273,1.4603990168332948,0.065,0.3658188449093007,1.0,5/28,4.05%,CTSC;FBXW7;NUPR1;AXIN1;PRKN
prerank,positive regulation of calcium ion transport (GO:0051928),0.5077236640298719,1.4598855241946347,0.05680119581464873,0.36614870607603833,1.0,5/36,2.74%,P2RX7;LILRA5;ATP2B1;CCR1;STIM2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5518488405676016,1.4593312519264479,0.0711864406779661,0.3664890380930547,1.0,8/26,10.27%,APOE;S100A1;FGF23;NPR3;GCH1;ATP7A;TNF;NUS1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.6734852365618714,1.458611738185384,0.07707509881422925,0.36721147645288027,1.0,3/10,1.80%,RAB31;ALOX15;ANO6
prerank,positive regulation of nervous system development (GO:0051962),-0.43030934322239733,-1.4581012193857774,0.026239067055393587,0.6849451450937344,1.0,11/42,9.21%,CX3CR1;NUMB;GRID2;PTPRD;NLGN1;NRXN1;TGM2;EPHB1;BDNF;NUMBL;SYNDIG1
prerank,negative regulation of complement activation (GO:0045916),0.6541271333001791,1.4578497055246862,0.09479553903345725,0.36800916671602607,1.0,3/10,6.87%,VSIG4;CD46;CR2
prerank,positive regulation of protein maturation (GO:1903319),0.6664012153947969,1.4578357194041693,0.09140767824497258,0.36722345334245243,1.0,2/11,4.90%,NLRC4;RHBDD1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.44834019421630544,1.4576113320226867,0.051209103840682786,0.3669003965476037,1.0,18/80,9.38%,MAP3K5;GAS6;DAPK1;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;BCL10;SFN;SYK;UACA;TNF;KLF4;FNIP1;IGBP1;CARD16;CYCS
prerank,negative regulation of response to external stimulus (GO:0032102),0.43657092334577424,1.4574691423867696,0.030913978494623656,0.3663780155980034,1.0,17/105,7.23%,AOAH;APOE;ALOX5;CASK;C1QTNF3;MFHAS1;IRAK3;NR1H4;METRNL;DRD1;NR1D1;CRK;NFKBIL1;RB1;GHRL;PPM1B;KLF4
prerank,regulation of fat cell differentiation (GO:0045598),0.4561162620685892,1.4570505394804025,0.040983606557377046,0.36636930054337935,1.0,19/74,12.98%,ALOX5;CMKLR1;ZBTB16;ZFP36L2;WDFY2;CEBPB;BMP2;NR1D1;GDF3;ZFP36L1;TRIO;MEDAG;TNF;ASXL1;SFRP1;TRIB2;ZC3H12A;FOXO1;CREB1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5915012916278297,1.4558181535924688,0.08419243986254296,0.3680865326757239,1.0,5/17,4.47%,NELL1;TNN;BMP2;RHOA;NPR3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.37467493866524676,-1.4556344314235299,0.007142857142857143,0.6888327779940892,1.0,38/94,28.89%,CSNK1E;SDCCAG8;CEP135;TMEM67;SCLT1;ODF2;DYNC1H1;CEP97;RAB3IP;CEP162;CEP192;AHI1;HAUS8;CEP250;CEP63;MKS1;CCP110;HAUS7;CKAP5;HAUS3;TCTN1;MAPRE1;B9D2;DCTN2;CEP89;IQCB1;CNTRL;HAUS2;PLK4;DCTN1;HAUS6;CDK1;YWHAG;TTBK2;TUBA4A;TCTN2;CEP152;B9D1
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.49982203772276146,-1.45543415067396,0.07407407407407407,0.676120444161265,1.0,9/24,12.94%,HK2;PFKL;PKM;ALDOA;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,canonical glycolysis (GO:0061621),-0.49982203772276146,-1.45543415067396,0.07407407407407407,0.676120444161265,1.0,9/24,12.94%,HK2;PFKL;PKM;ALDOA;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6771991854373102,1.454316643887301,0.11066398390342053,0.3703851531406484,1.0,3/10,5.94%,NELL1;RIC1;ANXA2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6436412921145397,1.4541842143459154,0.096045197740113,0.3698831368972111,1.0,3/11,7.90%,LRP6;WNT2;NR4A2
prerank,actin polymerization or depolymerization (GO:0008154),0.48868600990370165,1.4538540785301182,0.05829596412556054,0.3698248132502738,1.0,8/50,4.91%,PSTPIP2;FLII;DIAPH1;GAS7;PSTPIP1;ANG;ABI1;GHRL
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5073668285955284,1.4535858454156187,0.07075471698113207,0.3696082400890242,1.0,12/39,15.74%,RBPJ;JAG1;ITGB1BP1;EPN2;POGLUT1;MAML1;CREBBP;NOD2;EP300;STAT3;SNW1;TSPAN14
prerank,regulation of protein phosphorylation (GO:0001932),0.39759878051125075,1.453536379837807,0.01380897583429229,0.36889952172195284,1.0,41/256,9.67%,DAB2;PID1;EGFR;LRP6;APP;MYADM;GAS6;WDFY2;LYN;BST1;FER;CEBPB;KRAS;BMP2;XDH;RIPK1;CD74;FGF23;AXIN1;NIBAN1;THPO;PRKN;PDE8A;INSR;CAMKK2;RACK1;CD40;NOP53;ACVR2A;HSPB1;TNF;FAM20A;CCND3;MOB1B;FYN;FNIP1;KDM4D;CCND2;MYDGF;PPP2CA;CORO1C
prerank,response to axon injury (GO:0048678),-0.5357527862861016,-1.4530719193781918,0.07142857142857142,0.6797635483032686,1.0,4/18,6.66%,RTN4RL1;TREM2;APOD;P2RY12
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6051475207240157,1.4527567726490802,0.08703374777975133,0.3697140198158469,1.0,4/18,6.52%,DOCK2;FCER1G;LBP;SYK
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.6360443419518846,-1.4524289569347077,0.06262626262626263,0.6759107741980473,1.0,4/10,16.09%,DIP2B;DIP2A;FLCN;PARK7
prerank,protein deneddylation (GO:0000338),-0.6262076139795638,-1.4523744257916646,0.07966457023060797,0.6697346867354366,1.0,6/10,21.19%,COPS7A;COPS8;COPS4;COPS6;GPS1;TOR1A
prerank,sterol homeostasis (GO:0055092),0.4615901539266772,1.4518088842129397,0.0458970792767733,0.37080984599372524,1.0,5/65,3.91%,HDAC9;APOE;LDLR;NR1D1;EHD1
prerank,regulation of BMP signaling pathway (GO:0030510),0.45699926158187065,1.4515722562456825,0.05021520803443329,0.3705768410914184,1.0,9/73,6.42%,RBPJ;SMURF2;CRIM1;BMP2;GDF3;SMAD4;TRIM33;ACVR2A;HTRA3
prerank,negative regulation of cyclase activity (GO:0031280),0.6172866444448198,1.4515167285846768,0.09930313588850175,0.369890583126583,1.0,3/14,7.60%,EDNRB;GNAI3;CCR2
prerank,negative regulation of T cell proliferation (GO:0042130),0.5526637570434586,1.4513643545338661,0.07003257328990228,0.36940284832865,1.0,7/28,9.13%,VSIG4;CEBPB;LILRB1;RC3H1;PLA2G2D;CD80;SDC4
prerank,cholesterol homeostasis (GO:0042632),0.46196214302930333,1.4513460314285493,0.046089385474860335,0.36865775558369485,1.0,5/64,3.91%,HDAC9;APOE;LDLR;NR1D1;EHD1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6456059231948648,1.4507170734723023,0.10456273764258556,0.3690774260526413,1.0,2/11,3.09%,C1QTNF3;C1QTNF12
prerank,superoxide metabolic process (GO:0006801),0.5322514001772425,1.4501336544499448,0.07298136645962733,0.36950216547580383,1.0,7/29,17.17%,NRROS;CYBB;ATP7A;NCF2;CYBA;NOX4;PRDX2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4095383796748371,1.4495957279948737,0.013142174432497013,0.36975627880608514,1.0,45/166,17.76%,ZEB2;EGFR;KLF2;LDLR;EIF3E;CD36;TLR4;NR1D1;NIBAN1;SAMD4A;CCL19;RGCC;RPL26;VIM;IRS2;INSR;ATP7A;NMD3;RPS4X;TNF;KLF4;ELOVL5;RPL5;LARP4B;ZNF205;IGF1;SP1;ASS1;ARPP19;LARP4;PIWIL2;NR1H2;KAT7;MFSD2A;PRKD2;PKD2;PRMT1;MYC;HSP90AB1;ARNT;CCL5;ABCB10;PYM1;IL6;HGF
prerank,positive regulation of phospholipid transport (GO:2001140),0.6686236595906783,1.449006980880337,0.11798839458413926,0.370175496873788,1.0,1/10,0.49%,APOE
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5843313152914342,1.4485921441711065,0.09386281588447654,0.37024991687747316,1.0,2/19,1.02%,HRH1;PPP3CA
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5503546658066877,1.448109045057053,0.08617886178861789,0.3705031044898458,1.0,5/26,6.99%,PF4;FGFR1;MCL1;BCL2;TNF
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.6277592581014929,1.4478575207187259,0.0985663082437276,0.3702055378977782,1.0,3/13,7.60%,EDNRB;GNAI3;CCR2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5657023565493159,-1.4478027758189833,0.0738255033557047,0.6835064475286974,1.0,7/14,29.48%,PKM;CPEB2;FMR1;UNK;DHX9;CPEB1;CNBP
prerank,response to insulin (GO:0032868),0.4492942853744353,1.4474187302199777,0.05322128851540616,0.3703584308229907,1.0,11/80,4.94%,HDAC9;MYO5A;TBC1D4;RAB31;FER;RAB8B;RAB10;ZFP36L1;SLC2A4;IRS2;INSR
prerank,organophosphate catabolic process (GO:0046434),-0.5967468214262723,-1.4474066458301076,0.09453781512605042,0.6788682775035448,1.0,2/11,2.38%,ABHD12;ENPP2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.515501686461161,1.447199340048902,0.061128526645768025,0.3700421452507875,1.0,7/36,7.65%,NRP1;FBXW7;NCOA3;ITGB1;ADRB2;CCR2;HFE
prerank,brain development (GO:0007420),-0.34351351519062623,-1.4469614853840245,0.00423728813559322,0.6744655376622263,1.0,57/136,21.46%,CX3CR1;ADGRL3;CTNNA2;ROBO2;EPHA7;ZFHX3;CNTNAP2;CDH2;PBX2;BPTF;PITPNM1;AFF2;AATK;NDRG4;APOD;NF1;CIC;CNTN4;SYNJ2;PPT1;BAG6;RAB18;ZFHX2;UTP3;SPEF2;SHROOM2;MEIS3;GRIN2A;NKX2-2;SMARCA1;CTNS;PROX1;EML1;MEIS1;DSCAML1;EEF1AKMT4-ECE2;ZIC1;TGFBR2;POU6F1;SHROOM4;SMG9;ADGRL2;DNAJC30;TBC1D23;CDK5RAP3;EGR2;PBX1;PLXNB2;PTPN11;ROGDI;PAFAH1B3;HAP1;BBS4;CDK5RAP1;NNAT;MKKS;PBX4
prerank,lipid droplet formation (GO:0140042),-0.6192258664587537,-1.4468468500505676,0.08281573498964803,0.6686216282555683,1.0,6/10,29.18%,AUP1;CDS1;SQLE;CDS2;BSCL2;ZFYVE1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3838595553021795,1.4467587651150333,0.0077777777777777776,0.37009358618400573,1.0,57/348,10.24%,DAB2;BANK1;NRP1;EGFR;APP;PTPRJ;IQGAP1;SNX9;CLEC6A;IL15;PRKAG2;GAS6;WDFY2;LYN;KRAS;RASSF2;CD44;BMP2;RIPK1;CD74;FGF23;THBS4;GDF3;AXIN1;NIBAN1;THPO;CCL19;RAPGEF2;PDE8A;RAP1A;INSR;CAMKK2;PAK2;SMAD4;RACK1;S1PR2;GDF10;CD40;ACVR2A;SDCBP;TNF;FAM20A;CD80;CCND3;HFE;FNIP1;IL6R;DDR2;UBE2K;PDGFC;CCND2;MYDGF;CACUL1;IGF1;RIPK2;DOCK7;ARRB1
prerank,negative regulation of receptor binding (GO:1900121),0.6774882441869612,1.4467279185127526,0.11376146788990826,0.36936419486653826,1.0,3/10,14.29%,B2M;HFE;ATP2A2
prerank,regulation of inclusion body assembly (GO:0090083),-0.6235640805884192,-1.4461401706815562,0.06318082788671024,0.6653427197120495,1.0,6/11,20.47%,SNCAIP;SACS;DNAJB2;DNAJB1;BAG5;DNAJA4
prerank,regulation of cell junction assembly (GO:1901888),0.545003310325019,1.446031602594367,0.09563758389261745,0.3700212230865716,1.0,7/27,5.76%,PDLIM5;RAP1B;MEF2C;RAPGEF2;RAP1A;ROCK1;CBFB
prerank,regulation of macrophage migration (GO:1905521),-0.6238491581596588,-1.4458770160819283,0.06369426751592357,0.6605560718916015,1.0,6/10,13.02%,CX3CR1;PTK2B;CSF1;P2RY12;MTUS1;CD200
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5917415808358013,1.4456959958035045,0.0962962962962963,0.3699875014784126,1.0,7/17,14.61%,EGFR;RGCC;CCND3;CCNYL1;CCND2;CCNY;PKD2
prerank,heme catabolic process (GO:0042167),0.6259792927955323,1.4456780427878635,0.0774526678141136,0.36848565168457253,1.0,6/14,7.84%,BLVRB;UGT1A4;UGT1A1;HMOX1;ABCC1;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6259792927955323,1.4456780427878635,0.0774526678141136,0.36848565168457253,1.0,6/14,7.84%,BLVRB;UGT1A4;UGT1A1;HMOX1;ABCC1;HMOX2
prerank,integrin-mediated signaling pathway (GO:0007229),0.45293597807786795,1.4455905859976352,0.04834254143646409,0.36789367614334784,1.0,12/73,6.52%,DAB2;NRP1;NEDD9;ITGB1;DOCK1;CDC42;ADAM9;ITGB1BP1;ITGBL1;CCM2;PTPRA;SYK
prerank,toxin transport (GO:1901998),0.6631869038794558,1.4455222272156505,0.08812260536398467,0.36726427057793176,1.0,3/10,9.34%,ANTXR2;ANTXRL;ANTXR1
prerank,myeloid leukocyte differentiation (GO:0002573),0.46074446616225156,1.4438874170194262,0.050505050505050504,0.36981655775638317,1.0,16/65,13.77%,FOXP1;IL15;CBFA2T3;CDC42;DCSTAMP;CCL19;TNFRSF11A;SPI1;GLO1;BATF2;MAPK14;CASP8;SNX10;DEK;EP300;RARA
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6400696124999689,1.4432207295626547,0.09481216457960644,0.37026683752463896,1.0,6/13,12.23%,CNMD;TNMD;EPN2;EMILIN1;MMRN2;NIBAN2
prerank,negative regulation of apoptotic process (GO:0043066),0.3781870238674497,1.4429031242494514,0.004301075268817204,0.37018686062605444,1.0,78/444,12.36%,DAB2;CD38;EGFR;APOE;TNFAIP8;NOTCH2;TPT1;GAS6;NUPR1;GRK5;DNAJC3;ITGB1;LIG4;MEF2C;NR1H4;TSLP;RPS27A;BABAM2;RASA1;CD44;OSR1;SH3RF1;RIPK1;ARHGAP10;SIAH2;CD74;LAMP3;GRN;SNX6;CBL;RPS6KA3;PRKN;MCL1;BIRC3;GSK3B;RB1;RHBDD1;GHRL;GLO1;PAK2;BCL2L2;TXNDC5;SFN;BCL2;HIGD1A;BAG3;HSPB1;TNF;KLF4;HTATIP2;PSEN1;BIRC6;NR4A2;ARHGDIA;FNIP1;MAPK8IP2;TRIM27;IGBP1;CARD16;CCND2;MYDGF;IGF1;SFRP1;RIPK2;NUP62;THOC6;PCID2;WFS1;DFFA;PHIP;SHC1;CRYAB;YWHAE;RPL10;LAMTOR5;UFM1;NIBAN2;ZC3H12A
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3760914428953517,1.442312896839186,0.0010672358591248667,0.37071143768192155,1.0,146/497,20.24%,RBPJ;HDAC9;WWP1;CD38;TCF7L2;MDFIC;FOXP1;AHR;ZBTB16;GAS6;SMURF2;RPS3;DAPK1;CBFA2T3;TSHZ3;BMP2;PRICKLE1;ALX1;NR1D1;SNX6;SAMD4A;S100A11;YWHAQ;JARID2;NR3C1;NKAP;MRPL13;HEY2;CLOCK;SPI1;GSK3B;RB1;SMAD4;ARID5A;RACK1;PTPRK;TRIM33;ATXN1;DMAP1;EPC1;SETDB2;FOXM1;ZNF568;TNF;ZNF148;KLF4;MALSU1;GATAD2A;GMNN;NCOR1;KLF10;BTAF1;RBM4;LIMD1;MIDEAS;MDM2;LBH;ILF3;GCFC2;SFRP1;SPEN;RBM15;RCOR2;ZMYND15;DDX6;PHC3;SHC1;CRYAB;FOXK2;HINFP;NANOS3;TRIM71;NIBAN2;FOXK1;KDM5C;LOXL2;SP3;FOXO1;PSPC1;CTBP2;SHMT1;NR1H2;RARA;KAT7;MBD1;EHMT1;BCOR;CNOT9;TERF1;KAT6A;NAB1;SNW1;PEX14;HDAC4;VGLL4;ZHX1;SFPQ;HEXIM2;KDM1A;USP47;CREB3L1;ZGPAT;ATR;RELA;PER1;RCOR1;TBX2;GLIS2;FOXP2;ZBTB7A;SYNCRIP;NACC1;LHX1;NR2F2;PA2G4;MECOM;ARID4A;GZF1;RFX3;EIF2AK2;EIF2AK1;ZBTB14;TRAF6;ID3;THRA;SUMO1;RNF139;BRMS1;TLE1;SET;MECP2;CTCF;SFMBT1;INPP5K;CIART;ENPP1;BCL3;CREBZF;EIF2AK3;ERN2;CNOT8;CNOT1;GIGYF2;ZBTB21;BRD7;ACVRL1
prerank,regulation of apoptotic process (GO:0042981),0.37173879454024794,1.4419693620779037,0.0,0.3706791179279543,1.0,115/676,13.30%,DAB2;ARHGEF3;ITSN1;VAV3;CD38;TNFRSF25;PLEKHG5;HIP1;NLRC4;FGD4;EGFR;TNFAIP8;MAP3K5;STK17B;NOTCH2;IFT57;TPT1;GAS6;NUPR1;GRK5;DNAJC3;ANO6;ITGB1;RARG;RPS3;DAPK1;MEF2C;NR1H4;TSLP;RPS27A;BABAM2;STEAP3;RASA1;RASSF2;CD44;OSR1;SH3RF1;RYBP;BMP2;RIPK1;ARHGAP10;LILRB1;SIAH2;CD74;CBL;RPS6KA3;PRKN;BCL10;MCL1;BIRC3;TRIO;GSK3B;RHBDD1;GHRL;GLO1;PAK2;RACK1;BCL2L2;TXNDC5;CTSB;STK3;NOP53;BCL2;HIGD1A;BAG3;NGEF;TRIM24;HSPB1;TNF;HTATIP2;ARHGEF12;PSEN1;BIRC6;ARHGDIA;ATF6;MAP3K20;CCND2;MYDGF;RTN4;IGF1;SFRP1;RIPK2;FBXO11;RPS6;NUP62;ATG7;THOC6;PCID2;CTNNBL1;WFS1;CASP8;CHM;DFFA;PHIP;SHC1;CREBBP;CRYAB;FOXO3;RPL10;MAP3K11;UFM1;NIBAN2;DIABLO;ITGB3BP;PPP1R13B;FBXO10;ARHGEF9;FAM162A;GLS2;FOXO1;DDX42;NET1;TMBIM4;SOS2;LATS2
prerank,endoplasmic reticulum organization (GO:0007029),0.4510719030741254,1.4400773970716736,0.05021520803443329,0.3736207183581431,1.0,8/72,4.64%,TMCC1;APP;REEP3;ATL1;VCPIP1;RAB10;HMOX1;SERP1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.634486243735652,1.4397727558615674,0.07846715328467153,0.37347341697025593,1.0,4/12,18.19%,CLEC6A;CCR2;PRKCQ;ZBTB1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.39855507587113964,1.4387608851082703,0.01773049645390071,0.37473673622552706,1.0,68/208,19.07%,PLEKHG5;CLEC6A;ESR1;S100A4;NR1H4;SHISA5;ALPK1;RIPK1;CD74;NR1D1;ANKRD17;CCL19;PELI1;RHOA;HMOX1;PRKN;BCL10;BIRC3;NDFIP1;GPRC5B;RIOK3;TRIM32;TMEM106A;CD40;HSPB1;TNF;PPM1B;BST2;PRKCB;MIER1;REL;TRIM68;TRIM27;TFG;CARD16;EEF1D;RIPK2;WLS;NUP62;CASP8;MAP3K3;LAMTOR5;ZC3H12A;VAPA;TERF2IP;NOD2;TNFRSF1A;GJA1;UBE2N;NDFIP2;MID2;RHOC;TRIM25;PPM1A;RELA;PER1;TAB3;BRD4;TIRAP;IRAK4;F2R;ECM1;NLRX1;TRAF6;PLK2;DDX21;TLE1;MAPKBP1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5400789117152164,1.4387042799193257,0.08374384236453201,0.37408971606022146,1.0,6/25,12.26%,CNRIP1;SNX6;CBL;TNF;HFE;CBLB
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5774648043684942,1.438114339190928,0.08231173380035026,0.3745631227239048,1.0,5/20,12.20%,MCUB;MCU;PARL;SLC8B1;MICU3
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5587136176639482,1.4379689188965321,0.07401032702237521,0.3741205161914334,1.0,5/23,6.99%,MAP3K5;SASH1;RPS3;TNFRSF11A;TNF
prerank,regulation of neuron projection development (GO:0010975),-0.33271087569640767,-1.4378931083828614,0.0,0.6883302393374219,1.0,55/163,21.12%,CSMD3;ABI3;RTN4RL1;MYLIP;TANC2;PTPRS;PTK2B;CTNNA2;SETX;ITGA6;SCN1B;MAGI2;PAK1;ULK4;CDH2;LRRC4C;TENM3;PRAG1;PPFIA2;FBXO7;ATP1B2;KIF1A;NDRG4;SCARB2;NTRK3;TWF2;BDNF;KNDC1;SERPINI1;NTNG1;MAG;EFNB2;SPOCK1;IL1RAPL1;NDNF;EPHA3;RAPGEF1;MINAR1;CDKL5;BRSK2;FUT9;SRCIN1;GPC2;NCS1;PAK3;ZDHHC15;DBN1;PLXNB2;FKBP4;PLA2G3;PLXNB3;WNT5A;BAG5;TWF1;ARHGAP44
prerank,regulation of chemokine production (GO:0032642),0.5141640141668536,1.4376237407383228,0.08846761453396525,0.3741228526257346,1.0,9/36,8.26%,APP;FOXP1;TSLP;CD74;TLR4;HMOX1;TLR2;TNF;IL6R
prerank,positive regulation of interleukin-4 production (GO:0032753),0.5978486169771549,1.4372857365375595,0.0913884007029877,0.3740237819503982,1.0,4/17,6.52%,IRF4;CEBPB;FCER1G;SYK
prerank,epithelial to mesenchymal transition (GO:0001837),0.4815663468348902,1.4354017842985272,0.07086614173228346,0.377238677580263,1.0,7/47,5.43%,RBPJ;FGFR1;S100A4;BMP2;HEY2;GSK3B;ROCK1
prerank,regulation of aerobic respiration (GO:1903715),0.6010479400510349,1.4353218853903649,0.11229946524064172,0.3766502908358032,1.0,4/15,9.88%,CBFA2T3;ATP7A;NOP53;COX7A2L
prerank,embryonic hemopoiesis (GO:0035162),0.6146382705916056,1.4343770005454952,0.11330935251798561,0.37773907593386036,1.0,4/12,9.29%,KMT2A;KITLG;TPO;SH2B3
prerank,lymphocyte proliferation (GO:0046651),0.566130716127369,1.4342498199304317,0.07781456953642384,0.3772483470379296,1.0,5/22,8.44%,MEF2C;CD40;BCL2;CR2;MSN
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.37621634117060987,1.4341761184320119,0.0065005417118093175,0.37660792362695733,1.0,116/417,19.46%,RBPJ;HDAC9;WWP1;CD38;TCF7L2;MDFIC;FOXP1;AHR;ZBTB16;GAS6;SMURF2;CBFA2T3;TSHZ3;BMP2;PRICKLE1;ALX1;NR1D1;SNX6;YWHAQ;JARID2;NR3C1;NKAP;HEY2;CLOCK;SPI1;RB1;SMAD4;ARID5A;PTPRK;TRIM33;ATXN1;DMAP1;EPC1;SETDB2;FOXM1;ZNF568;TNF;ZNF148;KLF4;GATAD2A;GMNN;NCOR1;KLF10;BTAF1;LIMD1;MIDEAS;MDM2;LBH;ILF3;GCFC2;SFRP1;SPEN;RBM15;RCOR2;ZMYND15;PHC3;SHC1;CRYAB;FOXK2;HINFP;NIBAN2;FOXK1;KDM5C;LOXL2;SP3;FOXO1;PSPC1;CTBP2;NR1H2;RARA;KAT7;MBD1;EHMT1;BCOR;KAT6A;NAB1;SNW1;PEX14;HDAC4;VGLL4;ZHX1;SFPQ;HEXIM2;KDM1A;USP47;CREB3L1;ZGPAT;RELA;PER1;RCOR1;TBX2;GLIS2;FOXP2;ZBTB7A;NACC1;LHX1;NR2F2;PA2G4;MECOM;ARID4A;GZF1;RFX3;ZBTB14;TRAF6;ID3;THRA;SUMO1;BRMS1;TLE1;SET;MECP2;CTCF;SFMBT1;INPP5K;CIART;BCL3
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6549162097908997,1.4338567079754834,0.11428571428571428,0.3764539342822957,1.0,2/10,3.03%,LRP6;WNT2
prerank,protein deacylation (GO:0035601),-0.4809901802198708,-1.4327523800980189,0.06172839506172839,0.7039645073698241,1.0,13/23,21.15%,ABHD17C;LYPLA2;PPT1;SIRT7;HDAC7;SIRT2;ABHD17A;HDAC5;ABHD10;SIRT5;HDAC3;HDAC1;HDAC6
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4361529161878738,-1.432742612237665,0.022792022792022793,0.6977895032865806,1.0,14/37,11.01%,GRID2;PTK2B;GRM7;GRIA2;GRIK2;DAGLB;GRM3;GRIA4;CLN3;GRIN3A;FMR1;DAGLA;PLCB1;GRIN2A
prerank,positive regulation of neuron differentiation (GO:0045666),0.4942927328016771,1.4325264757866627,0.07656967840735068,0.37842586274238715,1.0,7/40,5.91%,FGFR1;TCF4;MEF2C;BMP2;RHOA;GPRC5B;TRIM32
prerank,"phagocytosis, engulfment (GO:0006911)",0.5093083745262076,1.4319151983081333,0.07424960505529225,0.3789376981272666,1.0,8/36,8.03%,MSR1;FCGR2B;DOCK1;CD36;HAVCR1;CDC42;ARHGAP12;RHOBTB1
prerank,striated muscle cell development (GO:0055002),0.618435621514974,1.4311056044825647,0.08514492753623189,0.37984164916050894,1.0,4/14,4.82%,FLII;TMOD1;MYH6;TMOD3
prerank,response to lipopolysaccharide (GO:0032496),0.4189884386926669,1.4284083327400638,0.030927835051546393,0.38465872873768386,1.0,29/138,10.75%,PF4;FOXP1;FER;IRAK3;MEF2C;PTPN22;IFNAR1;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;PELI1;RHOA;RPS6KA3;TNFRSF11A;LBP;BCL10;VIM;NFKBIL1;GCH1;MAPKAPK2;LY96;CD80;CDC73;MAPK14;CARD16;CHMP5;CD68
prerank,phospholipid metabolic process (GO:0006644),-0.37889482500175126,-1.427287715963586,0.006172839506172839,0.715253616383588,1.0,21/71,22.07%,ABHD12;LPCAT1;PLCB2;ENPP2;PCYT2;PLPP3;LPL;GNPAT;PLPPR1;GPX4;PIP4K2B;ANGPTL3;SMPD2;LGALS13;PLA2G3;ABCA2;ACP6;PLPP2;AGPAT3;GDE1;TNFAIP8L3
prerank,negative regulation of programmed cell death (GO:0043069),0.37865945223868347,1.4272223042429502,0.005494505494505495,0.38646600602048287,1.0,58/355,12.23%,DAB2;CD38;EGFR;TNFAIP8;NOTCH2;TPT1;GAS6;NUPR1;GRK5;DNAJC3;NR1H4;TSLP;RPS27A;BABAM2;RASA1;CD44;OSR1;SH3RF1;RIPK1;ARHGAP10;SIAH2;CD74;CBL;RPS6KA3;MCL1;BIRC3;GSK3B;RHBDD1;GHRL;GLO1;PAK2;BCL2L2;TXNDC5;BCL2;HIGD1A;BAG3;HSPB1;HTATIP2;PSEN1;BIRC6;ARHGDIA;RAB7A;CCND2;MYDGF;IGF1;SFRP1;RIPK2;NUP62;THOC6;PCID2;WFS1;PHIP;SHC1;KANK2;CRYAB;RPL10;UFM1;NIBAN2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5688221493926762,1.426901893984974,0.08881578947368421,0.3863787257652977,1.0,6/20,6.99%,LYN;PTPN22;TLR4;LBP;BCL10;TNF
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5290384473571808,1.426736399998562,0.09220985691573927,0.38590704757312067,1.0,8/28,16.91%,EGFR;FBXW7;NRARP;ARRB1;EGFL7;NIBAN2;LFNG;ZBTB7A
prerank,mitochondrial protein processing (GO:0034982),0.6531997958029977,1.4265404591877695,0.11842105263157894,0.3855400317501198,1.0,1/11,0.60%,IMMP2L
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6597663654485585,1.426467247746058,0.10843373493975904,0.3849168638423015,1.0,4/11,8.44%,DAB2;PRKN;EIPR1;MSN
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.41770418959780264,1.4252148461416767,0.04062909567496723,0.3867122934817215,1.0,24/117,13.35%,CD163;LYN;CYSLTR1;GNG2;CALCRL;ADRB2;DRD1;ADM;ADCY9;ADCYAP1R1;SYK;PLA2G2D;GNB1;FYN;FCGR3A;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5699106127460302,1.4246408376507016,0.08419243986254296,0.38720113135223994,1.0,4/19,3.39%,CMKLR1;MPP1;BST1;CAMK1D
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4831506678611131,1.4243895081799707,0.07738095238095238,0.3869552089955946,1.0,6/46,3.78%,NRP1;ITGA4;ATRNL1;PEAK1;FER;RHOA
prerank,myeloid cell differentiation (GO:0030099),0.4735587018359458,1.423454439838348,0.06134969325153374,0.3881087062043297,1.0,13/47,16.82%,RASGRP4;ZBTB16;LYN;MFHAS1;SPI1;RPS14;NCOA6;SLC25A5;KMT2E;TET2;KAT6A;PRDX3;TIRAP
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4868823603610701,1.423082180749316,0.06116207951070336,0.3882083276563687,1.0,7/41,5.18%,NEDD9;LILRA5;FBXW7;GAS6;CASS4;DOK7;GPRC5B
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3643678754580806,1.4230638156830253,0.0,0.38751477900102177,1.0,182/807,16.67%,RBPJ;DAB2;HDAC9;WWP1;CD38;ZEB2;TRPS1;EDNRB;KLF2;TCF7L2;MDFIC;FOXP1;MEF2A;AHR;ZBTB16;RREB1;GAS6;TFEC;ESR1;RPL23;SMURF2;RARG;MEF2C;NR1H4;CBFA2T3;RPS27A;CEBPB;MITF;OSR1;NCOA5;TSHZ3;BMP2;PRICKLE1;ALX1;NR2C1;NR1D1;SNX6;YWHAQ;JARID2;PRKN;LARP7;PDE2A;NR3C1;FRK;NKAP;IRF2BP2;HEY2;CLOCK;SPI1;RB1;SAP130;NFIC;USP9X;SMAD4;ARID5A;PTPRK;TRIM33;THRB;IRX2;CBFB;ORC2;PHF21A;ATXN1;DMAP1;EPC1;NOP53;SETDB2;FOXM1;SDCBP;ZNF568;TNF;ZNF148;KLF4;YY1;BRMS1L;DUSP22;THAP11;MIER1;GATAD2A;TBL1XR1;PSEN1;NR4A2;GMNN;ZBTB5;NRIP1;NCOR1;IRF2;KLF10;BTAF1;CDC73;RPS14;FNIP1;FOXC2;LIMD1;MIDEAS;BACH1;TRIM27;MDM2;HIVEP1;TBL1X;UBE2D3;ESR2;LBH;LRRFIP1;IGBP1;BEND3;LCOR;NR2F1;PURA;ILF3;ZNF205;GCFC2;SFRP1;HSBP1;SPEN;RBM15;MIER3;RCOR2;SP100;ZMYND15;WFS1;PHC3;ETS2;SHC1;CREBBP;SREBF2;KANK2;CRYAB;FOXK2;HINFP;FOXO3;RPL10;NIBAN2;FOXK1;KDM5C;LOXL2;SP3;FOXO1;NFIX;CREB1;PEG3;PSPC1;WWOX;CTBP2;NR1H2;EP300;RARA;KAT7;STAT3;MBD1;EHMT1;BCOR;NEDD4L;KAT6A;WWC1;NAB1;SNW1;GATAD2B;MYC;NR2C2;PEX14;HDAC4;KDM2A;VGLL4;ZHX1;SFPQ;HEXIM2;RUNX3;HCFC1;E2F8;KDM1A;USP47;CREB3L1;ZGPAT;PPM1A;RELA;LIN37;PER1;RCOR1;TBX2;ZNF177;GLIS2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3950346794072144,1.4228308305911002,0.02527075812274368,0.3873011368834973,1.0,20/186,5.73%,DAB2;LRP6;APOE;IGFBP4;TCF7L2;TLE4;PSMA7;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;MCC;UBAC2;ZNRF3;GSK3B;RACK1;NOTUM;CTNND1;STK3
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5851194145923295,1.4224400206734864,0.0984182776801406,0.3873192576280279,1.0,5/17,10.24%,PTPN22;KLF4;CD33;SSC5D;ARRB1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.4783444654955997,-1.4219986182998907,0.07808564231738035,0.7322909936808799,1.0,11/23,24.59%,PREB;AUP1;SURF4;UFD1;NPLOC4;SYVN1;SEC13;SELENOS;TMEM129;FAF2;SEC61B
prerank,AMP metabolic process (GO:0046033),0.6276826761385811,1.4215404252907775,0.09851301115241635,0.3884280577852778,1.0,6/13,18.39%,XDH;ADSS2;AMPD3;ADSS1;AK3;AK4
prerank,glycogen biosynthetic process (GO:0005978),0.6211218300685883,1.421063506209907,0.11732851985559567,0.3879718469801859,1.0,5/12,9.42%,GBE1;GYG1;NR1D1;PGM2L1;PPP1R3C
prerank,glucan biosynthetic process (GO:0009250),0.6211218300685883,1.421063506209907,0.11732851985559567,0.3879718469801859,1.0,5/12,9.42%,GBE1;GYG1;NR1D1;PGM2L1;PPP1R3C
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4984407454908133,1.4207995548076144,0.07692307692307693,0.3877736948060976,1.0,8/40,6.84%,DAB2;TCF7L2;JAG1;BMP2;ALX1;RGCC;SMAD4;SDCBP
prerank,icosanoid metabolic process (GO:0006690),0.49940804398972194,1.4199560706813528,0.0768,0.38887522370432787,1.0,8/40,8.37%,ALOX5;LTC4S;ALOX15;ALOX5AP;PNPLA8;MAPKAPK2;ABCC1;DPEP2
prerank,collagen fibril organization (GO:0030199),-0.3570884098865088,-1.4195136595537872,0.018518518518518517,0.7372662893901067,1.0,39/88,25.79%,DST;TGFBR1;COL27A1;COL11A1;ITGA6;TLL1;P3H2;NF1;ADAMTS3;LOXL3;PLOD3;COL23A1;LAMA3;COL25A1;COL1A2;COL19A1;COL11A2;COL8A1;COL26A1;ITGB4;COL6A2;COL16A1;COLGALT2;COL4A2;COL6A3;P3H4;COL4A6;COL9A3;TGFB2;ADAMTS2;COL9A1;COL3A1;COL20A1;COL6A1;COL13A1;COL5A3;P4HA1;P4HA3;COL4A4
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5912242145309123,1.419143202704325,0.08992805755395683,0.38986860312403226,1.0,4/16,6.99%,APOE;HMGCR;ROCK1;TNF
prerank,regulation of endothelial cell proliferation (GO:0001936),0.42781217715226816,1.4190173078901807,0.050271739130434784,0.3893607573072447,1.0,18/88,9.60%,NRP1;APOE;ALOX5;ANG;NRAS;BMP2;XDH;THBS4;CNMD;RGCC;TNMD;NRARP;GHRL;NR4A1;SYNJ2BP;CCL24;TNFSF12;MYDGF
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.6400748357149988,1.4188208645623155,0.0965391621129326,0.3889868327689532,1.0,5/11,11.10%,NUPR1;RIPK1;PELI1;BIRC3;CASP8
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5703409296275019,-1.4187717292980428,0.08849557522123894,0.7345468068026548,1.0,3/13,8.70%,BIN1;PTK2B;ACTN2
prerank,sodium ion homeostasis (GO:0055078),-0.503375415001442,-1.4180113223555448,0.07125890736342043,0.7316486333887201,1.0,4/21,4.05%,SLC12A2;ATP1B1;SLC8A1;ATP1B2
prerank,positive regulation of programmed cell death (GO:0043068),0.3852386609827942,1.4179336423534932,0.018140589569160998,0.39009800819773444,1.0,46/272,13.30%,ARHGEF3;ITSN1;VAV3;PLEKHG5;NLRC4;FGD4;TNFAIP8;MAP3K5;STK17B;ANO6;ITGB1;RARG;DAPK1;RPS27A;RASSF2;RYBP;BMP2;RIPK1;LILRB1;BCL10;TRIO;RACK1;STK3;SYK;NGEF;TNF;HTATIP2;ARHGEF12;PSEN1;ATF6;MAP3K20;SFRP1;RPS6;ATG7;CTNNBL1;CASP8;FOXO3;MAP3K11;DIABLO;ITGB3BP;ARHGEF9;FAM162A;FOXO1;NET1;SOS2;LATS2
prerank,pyruvate metabolic process (GO:0006090),-0.40547907406406847,-1.4177426763899392,0.04807692307692308,0.7267113873602664,1.0,15/52,12.94%,HK2;PFKL;PGM1;SLC16A3;PKM;ALDOA;BSG;PGK1;ENO1;SLC16A1;VDAC1;PCK2;ENO3;PDHX;TPI1
prerank,response to histamine (GO:0034776),0.6518752920472791,1.4177348582753737,0.13372093023255813,0.3898110956434437,1.0,3/10,4.28%,HRH1;DIAPH1;AOC1
prerank,fat cell differentiation (GO:0045444),0.4583652580157716,1.4174706513170616,0.06437125748502993,0.3895818030065107,1.0,9/57,7.90%,PID1;TCF7L2;C1QTNF3;METRNL;NR4A1;TRIM32;OSBPL11;KLF4;NR4A2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4830379737638866,-1.4172240621093504,0.0916030534351145,0.7230647663108374,1.0,7/23,11.36%,CCDC88B;KIF1A;KIF5A;MYO10;KIF5C;MAP6;KIF1C
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.5161838907147983,-1.4169704090150272,0.07380952380952381,0.718133928304435,1.0,12/20,31.94%,HSPA4;BBS12;PTGES3;PSMG2;NDUFAF1;HOPX;TMEM35A;CCT2;MKKS;PSMG1;BBS10;HSPA1A
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5906502171247074,1.4166550136894265,0.12252252252252252,0.3905545888865396,1.0,7/17,14.97%,RBPJ;MAML1;CREBBP;PLXND1;EP300;WWC1;SNW1
prerank,ovarian follicle development (GO:0001541),0.6205036648095569,1.4162399870413667,0.11247803163444639,0.3906727828015573,1.0,2/13,2.20%,ANG;CEBPB
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.39430817094759074,-1.416175238783795,0.0425531914893617,0.7154725558870354,1.0,9/54,5.86%,KCNMA1;BIN1;DPP10;KCNJ2;DPP6;KCNIP4;NOS1AP;CACNA1D;AKAP6
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4879472383899344,1.4159917113855385,0.0705521472392638,0.3904431646791425,1.0,4/40,6.29%,PID1;RTL10;TUSC2;BCL2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.44481864414068656,-1.415950656249579,0.0653950953678474,0.7105470434691967,1.0,11/32,16.38%,NAV3;MAP2;CLASP2;TBCD;CAMSAP1;FGF13;ARHGEF2;EML2;MAPRE1;CLIP3;APC2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.49856559509070897,-1.4155857861712013,0.06132075471698113,0.7063284356811055,1.0,8/20,20.92%,CALM2;ATP1B1;SLC8A1;ANK2;CACNA1C;SLC9A1;CAMK2D;CALM3
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5970474171600008,-1.4152601967225644,0.08281573498964803,0.7021985452037837,1.0,7/11,18.46%,SAFB;SAFB2;SRPK1;SRPK2;NCBP1;CDK11B;DHX9
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.6224565941341658,-1.4151779092226309,0.07789473684210527,0.696927274410128,1.0,5/10,20.47%,SORL1;SACS;DNAJB2;DNAJB1;DNAJA4
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5626145947818086,-1.414533432911131,0.0881057268722467,0.6942591897017688,1.0,9/13,27.37%,SRSF10;DDX20;PRPF19;CD2BP2;SRSF12;PRPF6;SART3;PRPF31;AAR2
prerank,response to UV-A (GO:0070141),0.6094772879101351,1.4144972601870456,0.10546139359698682,0.392986161380456,1.0,1/14,0.45%,EGFR
prerank,microvillus organization (GO:0032528),0.6168118415196949,1.4139304654523428,0.10476190476190476,0.3933992207227503,1.0,4/13,4.82%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,regulation of establishment of protein localization (GO:0070201),-0.5660652327216631,-1.4137664435341586,0.09151785714285714,0.6920886833633819,1.0,3/13,2.06%,CTSD;CEP135;TREM2
prerank,dopamine metabolic process (GO:0042417),0.5815264171801691,1.4137318483490797,0.11150442477876106,0.3930719634119273,1.0,6/18,5.45%,DRD1;PRKN;DAO;GCH1;MOXD1;ATP7A
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.5727597750271165,-1.4137003572333906,0.09030837004405286,0.6869566864411325,1.0,10/13,35.54%,GRIK2;SYNGR1;SLC4A10;CLN3;SHISA7;SHISA9;SHISA8;SYP;RAB3A;SHISA6
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3970902885534635,1.413505795630581,0.026184538653366583,0.39279375435081265,1.0,43/166,17.49%,RBPJ;HDAC9;NOTCH2;ESR1;RARG;NR1H4;NR2C1;NR1D1;NR3C1;THRB;NR4A1;TBL1XR1;POLR1A;NR4A2;NCOR1;GTF2A2;NCOA6;ESRRB;TBL1X;ESR2;POLR1B;NR2F1;POLR2B;MED26;MAML1;GTF2E2;CREBBP;POLR1G;GTF2A1;NR1H2;RARA;MED27;POLR2D;SNW1;NR2C2;GTF2H3;GTF2B;MED17;CRCP;NR5A2;TAF12;GTF2H1;NR6A1
prerank,lymphocyte differentiation (GO:0030098),0.4481793979460845,1.4133692907395112,0.056851311953352766,0.39236539163417095,1.0,17/68,15.49%,HDAC9;ITGA4;PTPRJ;ITGB1;PTPN22;KLF6;CR2;ZAP70;LYL1;CEBPG;NHEJ1;SLC25A5;LY6D;KAT7;LFNG;NFAM1;HDAC4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.5046674971980548,-1.4133395182491546,0.07881773399014778,0.6831482536597587,1.0,8/20,16.96%,GRK2;GRK3;YWHAB;APLP1;RGS2;MRAP2;GPRASP1;PLEK
prerank,regulation of cellular component movement (GO:0051270),0.465085566751032,1.413290495078646,0.08841463414634146,0.3918393351848383,1.0,11/49,6.27%,EGFR;ZSWIM6;DIAPH1;LYN;ARAP1;ARHGAP18;RHOA;CDK6;PKN2;ROCK1;MYCBP2
prerank,regulation of cilium assembly (GO:1902017),-0.3880847107755794,-1.4130397662418266,0.04377104377104377,0.6791549925297046,1.0,34/62,26.12%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;CEP97;IFT140;IFT88;TBC1D10A;CROCC;TBC1D22A;IFT20;DYNLT2B;TBC1D22B;TBC1D9B;CCP110;EVI5L;ENTR1;TBC1D24;TBC1D20;CDK10;LIMK2;CDKL5;TBC1D7;TBC1D1;KCTD17;BBS4;TBC1D2;TBC1D10B;ODF2L;TBC1D15;TAPT1;TCHP;TBC1D10C
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4066852666069883,1.4120604060223894,0.02753441802252816,0.39365192482740213,1.0,48/149,18.72%,NLRC4;APP;FER;RPS3;IRAK3;RPS27A;CD36;RIPK1;TLR4;TNFRSF11A;BCL10;TLR2;CLOCK;TRIM32;CD40;TNF;EDA;MTPN;PRKCB;RAB7B;TRIM68;TRIM27;CARD16;RIPK2;PSMA6;DHX33;LAMTOR5;TERF2IP;NOD2;UBE2N;NFKBIB;EP300;MID2;STAT3;PRKD2;PPIA;TRIM25;RELA;TAB3;PRDX3;TIRAP;FLOT2;ZBTB7A;PRKCQ;IL6;EIF2AK2;CAMK2A;TRAF6
prerank,regulation of amyloid fibril formation (GO:1905906),0.6006096178318993,1.4116904615548511,0.11861313868613138,0.39360417920936763,1.0,3/15,1.25%,APOE;APP;LDLR
prerank,cellular response to organonitrogen compound (GO:0071417),0.4239349484818232,1.411199912945613,0.06089309878213803,0.3938843988650771,1.0,22/99,12.19%,P2RX7;RAP1B;HRH1;CTNNA1;AHR;DIAPH1;MEF2C;NR1H4;P2RY6;ZFP36L1;RAPGEF2;PDE2A;AOC1;RAP1A;ACTB;HCN3;SFRP1;TSHR;TRPM2;JUP;KCNQ1;LAMTOR5
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.47525022735986483,1.410023172742762,0.0830860534124629,0.39569308832657607,1.0,12/47,15.41%,PID1;CD36;XDH;RIPK1;TLR4;SYK;MAPK14;ROMO1;ZC3H12A;ITGB2;CYBA;RNF41
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4860510814005726,1.409703886278947,0.0949367088607595,0.3956536646063128,1.0,9/38,7.07%,SASH1;TLR8;DDX60;GRN;ANKRD17;PUM2;LY96;RIOK3;USP15
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5075415863104616,1.4095472857245452,0.08278145695364239,0.3952177006469496,1.0,3/31,5.16%,RBPJ;MYH6;SMAD4
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6127973536465824,1.4094675961201981,0.09926470588235294,0.3946755199649607,1.0,8/12,20.42%,APOE;ROCK1;TMED10;RANBP9;ROCK2;FLOT2;PICALM;FKBP1A
prerank,cellular response to growth factor stimulus (GO:0071363),0.40128048748020206,1.4092889244535378,0.04040404040404041,0.39430945707220116,1.0,28/151,8.13%,NRP1;EGFR;IQGAP1;ZFP36L2;PTPN12;MEF2C;CD44;EEF1A1;BMP2;WNT2;ERN1;ZFP36L1;ITGB1BP1;EHD1;RAPGEF2;PDE2A;NR3C1;PDE8A;RAP1A;SMAD4;RACK1;MAPKAPK2;NR4A1;ACVR2A;HSPB1;KLF4;DUSP22;VSTM2A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6158288898203869,1.4077573048174095,0.12126865671641791,0.39681571759242124,1.0,4/12,6.29%,CD44;CD74;RPL26;BCL2
prerank,neural crest cell differentiation (GO:0014033),0.567749480406079,1.4074590630336152,0.11578947368421053,0.39672782304600157,1.0,4/18,6.93%,LRP6;MEF2C;FBXL17;CYP26C1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.47645526583919673,-1.4070769992529053,0.10319410319410319,0.6988866286336178,1.0,9/25,12.94%,HK2;PFKL;PKM;ALDOA;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6498444415613407,1.4070402063931882,0.1154562383612663,0.39687765528967933,1.0,6/10,23.72%,IRAK3;KLF4;SH2B3;MAPK7;PTPRC;TLE5
prerank,cellular response to lipid (GO:0071396),0.39209166987975513,1.4069324351373318,0.035452322738386305,0.3963548604594345,1.0,42/191,14.01%,PID1;PF4;EGFR;AHR;ESR1;LYN;NCOA3;MEF2C;NR1H4;TNFRSF1B;LILRB1;WNT2;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;NFKBIL1;NR3C1;LY96;CD80;WNT6;NRIP1;CDC73;MSN;MGST1;MAPK14;CARD16;LCOR;SFRP1;CHMP5;CD68;KCNK4;ROCK2;ZC3H12A;NOD2;CREB1;NFKBIB;ATP1A3;ATP1A1
prerank,retinoic acid metabolic process (GO:0042573),0.6076456227614226,1.4058127869405086,0.12695652173913044,0.3979900435955949,1.0,5/14,10.01%,UGT1A7;UGT1A8;UGT1A1;CYP26C1;CYP26B1
prerank,lymphocyte migration (GO:0072676),0.5110611192043898,1.4051534863099782,0.08133971291866028,0.39862838467580386,1.0,10/32,17.11%,CCL8;MSMP;CCL19;ZAP70;CCL24;MSN;S1PR1;CKLF;CCL5;CCL25
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4884646302409401,1.4050791288289783,0.08372093023255814,0.398076282192908,1.0,9/42,5.43%,NRP1;PTPRJ;RIN2;CD36;UTRN;S100A10;CDK6;GSK3B;ROCK1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6693717166616913,1.4050100978232962,0.12454212454212454,0.3975068810350994,1.0,3/10,5.76%,IRF4;SH3RF1;CBFB
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5975023813636285,1.4046557690379575,0.13508771929824562,0.39755745045554997,1.0,6/15,9.12%,RIPOR2;DCSTAMP;ADAM9;EHD1;CD53;MAPK14
prerank,regulation of protein export from nucleus (GO:0046825),0.5441065379645879,1.4045376433123216,0.10623946037099494,0.39707748987306524,1.0,9/23,16.16%,TCF7L2;GAS6;GSK3B;BAG3;SP100;YWHAE;UHMK1;PTPN14;ANP32B
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6174287136132766,1.4044423903313858,0.1391941391941392,0.39658390157428564,1.0,2/12,1.61%,PF4;CLTC
prerank,regulated exocytosis (GO:0045055),0.3969417509959378,1.4035152272412186,0.02902055622732769,0.39783635936691997,1.0,16/173,6.02%,F13A1;PF4;RAB11FIP5;APP;PHACTR2;GAS6;RAB31;SELENOP;LYN;CD36;RAB10;SRGN;MANF;TMED10;FAM3C;APOOL
prerank,regulation of protein kinase A signaling (GO:0010738),-0.49205205597711493,-1.4034247512134326,0.072992700729927,0.708655734408741,1.0,8/20,18.17%,PRKAR1A;PRKAR1B;AKAP6;AKAP7;IAPP;MIF;ADGRV1;PJA2
prerank,androgen receptor signaling pathway (GO:0030521),-0.5912979198603392,-1.4026350592510335,0.08686868686868687,0.7064617817604787,1.0,4/11,9.50%,DDX5;DDX17;KDM3A;AR
prerank,receptor catabolic process (GO:0032801),0.5361012667578392,1.4020935498893101,0.10333863275039745,0.40016613527989797,1.0,10/24,14.11%,AP2A2;CLTC;UVRAG;ZNRF3;KIF16B;SNX25;AP2S1;VLDLR;AP2B1;CLTA
prerank,RNA polyadenylation (GO:0043631),0.534673378616813,1.4018365902898617,0.08660130718954248,0.3992549887748595,1.0,10/26,16.48%,APP;TENT2;CPSF3;CDC73;GRSF1;SCAF8;PAPOLA;WDR33;TUT1;CPSF2
prerank,mRNA polyadenylation (GO:0006378),0.534673378616813,1.4018365902898617,0.08660130718954248,0.3992549887748595,1.0,10/26,16.48%,APP;TENT2;CPSF3;CDC73;GRSF1;SCAF8;PAPOLA;WDR33;TUT1;CPSF2
prerank,manganese ion transport (GO:0006828),-0.5437449137608463,-1.401727276629196,0.08552631578947369,0.7050731442029529,1.0,7/14,15.68%,TRPC4;TRPC1;TRPC3;SLC11A2;ATP2C1;TRPC5;SLC39A14
prerank,homeostasis of number of cells (GO:0048872),-0.5784172986132576,-1.401687097105044,0.10179640718562874,0.6999862993290337,1.0,5/12,23.67%,CX3CR1;OCIAD1;LPCAT3;NOTCH1;NAPEPLD
prerank,macrophage chemotaxis (GO:0048246),0.6397196884763825,1.4011555460937193,0.11721611721611722,0.39987786782882184,1.0,1/10,0.44%,EDNRB
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6564487231585907,1.400676534347351,0.11623616236162361,0.4001911070540623,1.0,2/10,2.15%,IRF4;TSLP
prerank,regulation of biomineral tissue development (GO:0070167),0.541216266035077,1.3997112348305,0.09090909090909091,0.4014693802026788,1.0,8/26,11.89%,GAS6;CEBPB;HEY2;NOTUM;ROCK1;DDR2;S1PR1;ROCK2
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5371539413487467,-1.399636473694358,0.084070796460177,0.7030924009098336,1.0,3/15,5.72%,CX3CR1;CTNNB1;NF1
prerank,carbohydrate derivative transport (GO:1901264),0.577092768439353,1.3990445269503173,0.1048951048951049,0.4022760544601771,1.0,7/18,13.91%,PLTP;LBP;SLC29A1;VLDLR;SLC10A7;NPC2;MFSD2A
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5187808880961591,1.3989979854344845,0.08250825082508251,0.4016735344734809,1.0,6/29,7.60%,CCR1;GAS6;ANO6;PLA2G7;TNF;CCR2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5954896862639305,1.3988759470987502,0.13012477718360071,0.401218231543457,1.0,4/14,3.38%,SPRED1;OSR1;XDH;GDF3
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6075314659801515,-1.3987263587500232,0.09316770186335403,0.7018352494871135,1.0,5/10,24.40%,SLC1A3;SLC1A1;SLC25A22;SLC1A2;SLC25A13
prerank,microvillus assembly (GO:0030033),0.5958666580693031,1.398510090029872,0.11460258780036968,0.40130063957843737,1.0,4/14,4.82%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4351716754407779,1.3976324857165172,0.06064880112834979,0.40249817531225585,1.0,15/75,10.85%,NRP1;ITGA4;FGFR1;ANG;NRAS;BMP2;THBS4;HMOX1;NRARP;NR4A1;CCL24;TNFSF12;MYDGF;SP1;EGFL7
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.46810789605506414,-1.397285462738596,0.08454106280193237,0.7030005641425519,1.0,8/24,11.16%,PEX5L;PDE3B;PRKAR1A;UBE2B;GNAI1;PRKAR1B;CGAS;PDE3A
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5006954050404279,1.3968925699093584,0.08688524590163935,0.40331849389748775,1.0,6/33,10.54%,HIP1;FBXW7;ARAP1;CBL;PDE6H;NUP62
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5568495343343429,1.39684763209215,0.11829944547134935,0.4026950859732937,1.0,8/20,16.03%,EGFR;RGCC;CCND3;CCNYL1;CCND2;CCNY;PKD2;HSP90AB1
prerank,cardiac myofibril assembly (GO:0055003),0.5825470102515513,1.3961213135528636,0.11713286713286714,0.40358505490384944,1.0,3/15,5.36%,MEF2A;NRAP;PDGFRA
prerank,endothelial cell migration (GO:0043542),0.48697415264650884,1.395850677969709,0.09717868338557993,0.40344632002603736,1.0,9/37,12.82%,PLEKHG5;NRP1;RHOA;NR4A1;TNFSF12;STARD13;PXN;LOXL2;PLXND1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.537184103147867,1.3958305385811511,0.11221122112211221,0.4027942915144729,1.0,7/22,8.58%,LYN;MFHAS1;PTPN22;NR1D1;LBP;RAB7B;NINJ1
prerank,ATP transport (GO:0015867),0.6392616176372224,1.3956499117422472,0.10946196660482375,0.4024511390559557,1.0,5/10,22.76%,SLC25A17;SLC25A24;SLC25A5;SLC25A4;CD47
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.6537612259985754,1.3955870810255944,0.11877394636015326,0.40189584165006537,1.0,4/10,12.73%,RPS27A;TUT7;TUT4;DIS3L2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4585088051006312,-1.3948598753928838,0.08997429305912596,0.7079321279070158,1.0,14/26,26.46%,SLC30A9;ATP13A2;SLC39A13;SLC39A14;MT2A;SLC39A6;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5785730094735201,1.3945420387385805,0.10307414104882459,0.4034239527803306,1.0,7/14,15.69%,PPP3CA;DUSP1;PPP2CA;PPP2CB;PPP1CA;PPP2R2A;PPP1R15B
prerank,glycoprotein biosynthetic process (GO:0009101),-0.35988603252142937,-1.394481973689435,0.02181818181818182,0.704447620678709,1.0,27/79,18.54%,LARGE1;CHST11;ST3GAL5;XYLT1;GCNT2;ST3GAL6;BMPR1B;COG3;B3GALNT2;B3GALT1;CANT1;B3GALT5;ALG1;GAL3ST4;B3GALT2;ST8SIA1;SERP2;ST3GAL3;B3GNT2;ST8SIA3;B4GALT7;MGAT1;FUT9;ALG3;CHST10;GOLGA2;ST3GAL2
prerank,negative regulation of cell development (GO:0010721),0.5340883636217321,1.3941908440426785,0.10160427807486631,0.40341979567437536,1.0,7/25,9.95%,FBXW7;LILRB1;B2M;GSK3B;TNF;RFLNB;IGF1
prerank,adherens junction organization (GO:0034332),-0.4094020343381844,-1.393499982631061,0.05202312138728324,0.7035338847948045,1.0,16/48,12.06%,CADM1;TJP1;CTNNB1;CDH10;SMAD7;TBCD;CDH2;PIP5K1C;CDH13;CDH8;FERMT2;CADM2;NECTIN2;AFDN;CDH9;CDH22
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.6511895761802609,1.3928842783130841,0.13137254901960785,0.40544014999294264,1.0,4/10,9.61%,PARP14;PIBF1;SH2B3;PPP2CA
prerank,Ras protein signal transduction (GO:0007265),0.40453222827529045,1.392766758210135,0.04597701149425287,0.4049609104997656,1.0,16/137,6.00%,ARHGEF3;EPS8;PLEKHG5;RAP1B;RREB1;RAP2B;NRAS;KRAS;RHOA;RAPGEF2;GRAP;RAP1A;RB1;ROCK1;CELSR1;ARHGAP29
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3970423281936544,1.3925564037225109,0.038605230386052306,0.404707691849191,1.0,34/150,12.64%,PID1;LRP6;GNAQ;SPRED1;DEPTOR;MYADM;PRKAG2;LYN;DNAJC3;RASSF2;XDH;NIBAN1;ITGB1BP1;PRKN;RB1;PAK2;RACK1;PDE4D;SFN;CEP85;SNX25;HSPB1;TRIM27;CNKSR3;SMCR8;CORO1C;SFRP1;CALM1;SPRED2;EMILIN1;PMEPA1;TRIB2;ZC3H12A;TERF2IP
prerank,negative regulation of phosphorylation (GO:0042326),0.432416631273681,1.391412386744576,0.07320441988950276,0.4064694376861793,1.0,24/85,16.80%,PID1;LRP6;MYADM;NUPR1;LYN;CBFA2T3;XDH;NIBAN1;PRKN;IRS2;ROCK1;NCOR1;CORO1C;ZC3H12A;CDKN2C;TERF2IP;IBTK;PPIA;HDAC4;NPRL2;PTPN13;PPP1R15B;PTEN;PRDX3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4530458786681258,1.3913371885777157,0.06994047619047619,0.40590475164627593,1.0,9/56,7.65%,DAB2;BMP2;GDF3;SMAD4;GDF10;SNX25;ACVR2A;SDCBP;HFE
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5270189255471243,-1.391294674654276,0.10538116591928251,0.7074493787888132,1.0,8/16,19.58%,DDX5;DDX17;PUF60;CELF4;PQBP1;SRSF9;DHX9;RBM17
prerank,regulation of type I interferon production (GO:0032479),-0.35487948503684147,-1.3909496978333198,0.04727272727272727,0.7040530977386299,1.0,34/84,23.95%,IRF8;CTNNB1;XRCC5;CYLD;DTX4;OTUD5;IRF3;MAVS;UBA7;POLR3E;POLR3C;DDX41;NLRC5;RNF216;CGAS;IRF7;NLRP4;IKBKE;UFD1;PQBP1;XRCC6;NPLOC4;ITCH;PCBP2;DHX9;TRIM21;POLR3G;GAPDH;POLR2L;PIN1;G3BP1;POLR1C;POLR3A;ILRUN
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5607517751339047,1.39088115613414,0.10486891385767791,0.40619648079037735,1.0,5/18,5.43%,RAP1B;KIF20B;RIPOR2;RACK1;ROCK1
prerank,mesonephros development (GO:0001823),0.6368217263219169,1.390792640183397,0.10377358490566038,0.4057017687221597,1.0,2/11,2.40%,ZBTB16;OSR1
prerank,response to amino acid (GO:0043200),-0.4345683857341228,-1.390511862633125,0.06188118811881188,0.7007158571087709,1.0,14/31,27.27%,RPTOR;IPO5;NSMF;RRAGD;GLRB;GLRA1;GLRA3;RRAGB;MTOR;SESN2;GLRA2;CPEB1;RRAGA;SH3BP4
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.35382816328831207,1.390450196570879,0.0010214504596527069,0.40570291191384805,1.0,181/834,16.67%,RBPJ;DAB2;PID1;ZEB2;PF4;ETV1;EGFR;LRP6;APP;KLF2;CHP2;TCF7L2;TCF4;IRF4;PPP3CA;MEF2A;AHR;RREB1;TFEC;KMT2A;ESR1;NCOA3;JAG1;RARG;TCF12;ACTR3;MEF2C;NR1H4;NCOA2;RPS27A;CEBPB;MITF;OSR1;BMP2;RIPK1;KLF6;LILRB1;HOXD8;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;TLR4;NR1D1;RGCC;CDK12;ITGB1BP1;RPS6KA3;PRKN;LARP7;TLR2;NR3C1;HEY2;CLOCK;GRHL2;SPI1;NCOA7;NFIC;SMAD4;THRB;NR4A1;RNASEL;FOSL2;CD40;EPC1;ACVR2A;FOXM1;TNF;KLF4;YY1;HTATIP2;REL;MED16;SATB2;TBL1XR1;CEBPG;E2F5;FIZ1;NR4A2;NRIP1;IRF2;KLF10;ATF6;CDC73;TET3;ATRX;NCOA6;FOXC2;ESRRB;KMT2C;HIVEP1;TBL1X;FOXJ3;MED6;MLXIP;STAT6;ASXL1;MYDGF;USP16;NR2F1;IGF1;RIPK2;ARRB1;SP1;RNF111;ZNF296;CREBRF;MAML1;ELF1;TFDP1;JUP;MLLT10;PHIP;CREBBP;SREBF2;EAF2;BCL11B;MYBL2;FOXK2;NFIA;HINFP;CDK13;FOXO3;CRTC3;DCAF6;ZC3H12A;NAMPT;NOD2;PLXND1;SP3;FOXO1;BCAS3;TNFRSF1A;NFIX;CREB1;PEG3;WWOX;CTBP2;TFR2;NR1H2;EP300;RARA;TET2;KAT7;STAT3;JUND;WASL;KLF5;CRLF3;USF1;KAT6A;PRKD2;PKD2;BMPR1A;WWC1;RTRAF;SNW1;MYC;MTF1;NR2C2;SMARCD1;HDAC4;SENP1;SFPQ;ELK1;HCFC1;E2F8;KDM1A;HOXB3;MAPK7;PPARGC1B;RELA;ACTR2;PER1;EAPP;ARNT;NFATC3;BRD4;GLIS2
prerank,response to lipid (GO:0033993),0.4218160502029292,1.3902707464111237,0.05466666666666667,0.40542370668969685,1.0,26/105,14.39%,FOXP1;ESR1;FER;RARG;IRAK3;PTPN22;IFNAR1;CD36;TLR4;PELI1;RPS6KA3;TNFRSF11A;LBP;GCH1;MAPKAPK2;LY96;OVCA2;VPS4B;ASXL1;TRIM16;FOXO3;FOXO1;FFAR1;RARA;STAT3;RBP4
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.565748273290029,1.3897493805978198,0.12386156648451731,0.4058505733592386,1.0,3/18,8.44%,DAB2;SNX3;MSN
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5624834948728352,1.3894749073902495,0.12115732368896925,0.40571720382838883,1.0,6/18,7.07%,DDX60;ANKRD17;BIRC3;PUM2;NOP53;USP15
prerank,dendrite morphogenesis (GO:0048813),-0.4324494515767556,-1.3893897362676064,0.09574468085106383,0.7005794132653124,1.0,14/35,13.38%,MAP2;CTNNA2;DOCK10;DLG4;FARP1;DIP2A;SHANK1;DVL1;EPHB1;SDC2;MAP6;CELSR2;MINK1;CTNND2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4066855891686357,1.3888026677113943,0.043859649122807015,0.40637758782284084,1.0,32/132,12.88%,APOE;P2RX7;APP;SNX9;ZBTB20;DAPK1;TNFRSF1B;ADAM9;TRIM65;IRS2;GSK3B;INSR;PFKFB4;RC3H1;ROCK1;TNF;PSEN1;SLC4A4;ATF6;PIK3C2A;TRIM68;MSN;TRIM27;GRSF1;TPCN1;IGF1;ZC3H18;FOXO3;SNX33;ZC3H12A;FOXO1;GTPBP1
prerank,positive regulation of JNK cascade (GO:0046330),0.4495579108904719,1.3881434192742799,0.0759493670886076,0.4070104305972369,1.0,11/70,7.43%,FCGR2B;APP;MAP3K5;MFHAS1;RASSF2;SH3RF1;RIPK1;AXIN1;CCL19;SDCBP;DUSP22
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6328448867466889,1.3879525857858082,0.13259668508287292,0.40674220494946245,1.0,5/11,9.15%,ALOX5;KLF2;EPN2;SYNJ2BP;ADAMTS9
prerank,positive regulation of organelle organization (GO:0010638),0.5038233962337744,1.3879195761391054,0.10793650793650794,0.40610726027591143,1.0,8/32,8.94%,P2RX7;LIG4;ADRB2;UVRAG;SYNJ1;GSK3B;ANXA2;SMCR8
prerank,regulation of p38MAPK cascade (GO:1900744),0.4930480672739723,1.387530540513189,0.0819423368740516,0.4062516308311082,1.0,8/35,4.77%,SASH1;RELL1;MFHAS1;PTPN22;BMP2;XDH;DUSP1;SPI1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.590346458518502,-1.3872365611394768,0.11134453781512606,0.7044806371139701,1.0,2/10,0.89%,CX3CR1;CTNNB1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.49789652789225963,-1.3867406284354633,0.0700218818380744,0.7016980210464576,1.0,9/19,28.47%,HK2;SKP1;HNRNPU;SUPT7L;ARL2BP;BBS4;TAF8;TAPT1;AKT1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5227404160883553,1.3866135408937976,0.09666666666666666,0.4075485656717975,1.0,5/24,5.43%,NRP1;PTPRJ;MAPRE2;S100A10;ROCK1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.5990789029195001,-1.3863639077679295,0.10642570281124498,0.6986145238715977,1.0,2/10,8.52%,DNMT3A;PCGF5
prerank,synaptic vesicle localization (GO:0097479),-0.560336776423087,-1.3860171365952563,0.08647450110864745,0.6954012044372254,1.0,6/13,9.21%,NLGN1;RAB27A;KIF5A;SPG11;KIF5C;SYNDIG1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5891416495415797,1.385064771231449,0.13464991023339318,0.41006041751766015,1.0,5/15,11.64%,TCF7L2;GAS6;GSK3B;BAG3;YWHAE
prerank,relaxation of muscle (GO:0090075),-0.5526193400523229,-1.3846079652720964,0.1032258064516129,0.6965399420521204,1.0,4/13,8.36%,KCNJ2;ATP1B1;SLC8A1;RGS2
prerank,positive regulation of cytokine production (GO:0001819),0.3750144651042264,1.384201415434665,0.0145413870246085,0.4111980911186643,1.0,63/292,14.60%,PAEP;APP;IL16;LILRA5;IRF4;FOXP1;TLR8;CLEC6A;IL15;C1QTNF3;RPS3;NR1H4;PTPN22;TSLP;CEBPB;SPTBN1;RIPK1;FCER1G;LILRB1;CD74;TLR4;PIBF1;CD46;CCL19;RGCC;HMOX1;RFTN1;LBP;BCL10;TLR2;IL17RA;PDE4D;TMED10;TMEM106A;CD40;SYK;TNF;CD80;CCR2;CEBPG;RAB7B;IL6R;TRIM27;SULF2;MAPK14;LRRFIP1;RAB1A;STAT6;RIPK2;PTGER4;CREBBP;ROCK2;DHX33;LAMTOR5;POLR3D;NOD2;CRLF2;EP300;RARA;STAT3;MDK;CYBA;PRKD2
prerank,histone H4 deacetylation (GO:0070933),0.613304385739233,1.3837876506778821,0.1266540642722117,0.41135445902185636,1.0,1/10,0.10%,HDAC9
prerank,activin receptor signaling pathway (GO:0032924),-0.5343520166295912,-1.3837075895259,0.09395973154362416,0.6954707730365874,1.0,4/15,16.13%,TGFBR1;ACVR1;ACVR1C;ACVR1B
prerank,positive regulation of gene expression (GO:0010628),0.3621656462060053,1.3834337936407473,0.007575757575757576,0.4115031702809664,1.0,79/442,13.95%,RBPJ;PID1;PF4;EGFR;P2RX7;APP;CLEC6A;IL15;GAS6;ADAM19;RPL23;C1QTNF1;C1QTNF3;RPS3;MEF2C;PTPN22;EIF3E;KRAS;MITF;OSR1;BMP2;CD36;RIPK1;LILRB1;CD74;FGF23;DRD1;LAMP3;ERN1;TLR4;NIBAN1;CD46;SAMD4A;RGCC;RPL26;PRKN;VIM;PDE2A;TLR2;HEY2;GSK3B;ROCK1;ACTB;RPS4X;TNF;KLF4;RPL5;WNT6;HFE;PSEN1;POLR1A;LARP4B;VSTM2A;MSN;RPS7;MAPK14;POLR1B;DYRK1A;IGF1;SP1;MYO1C;MED26;PTGER4;EMILIN1;HINFP;ROCK2;LAMTOR5;DEK;ZC3H12A;SLC38A2;POLR1G;RAMP2;GJA1;LARP4;TFR2;PIWIL2;EP300;TNRC6C;STAT3
prerank,negative regulation of protein depolymerization (GO:1901880),-0.4799052753800025,-1.3833250477788528,0.08728179551122195,0.692485476116734,1.0,6/24,8.60%,NAV3;CLASP2;CAMSAP1;FGF13;PLEKHH2;ARHGEF2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5509007525021078,1.3830978913737684,0.10720562390158173,0.41154986434513174,1.0,4/19,5.43%,NRP1;PTPRJ;S100A10;ROCK1
prerank,response to interferon-gamma (GO:0034341),0.4451348876805124,1.3829907175189746,0.0692090395480226,0.4110522884332156,1.0,16/67,10.66%,IFITM3;GBP3;DAPK1;CD74;CCL8;TLR4;CCL19;TLR2;GCH1;GBP7;CD40;BST2;CXCL16;CCL24;IFITM2;SP100
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4821755335324917,1.3828902146680848,0.08588957055214724,0.41060074037290056,1.0,6/39,6.99%,ITGA4;GAS6;ANO6;RGCC;CD40;TNF
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5345681832529119,1.3826270802950495,0.11056105610561057,0.410483872872264,1.0,6/22,16.76%,TNFRSF1B;LILRB1;TNF;CCR2;NOD2;SCIMP
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5932512348803886,-1.3819930427839329,0.1206140350877193,0.6935405866118184,1.0,5/10,18.63%,LRP5;STAT1;FGFR2;TGFBR2;PDGFA
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4256945173520168,-1.3819784960816168,0.08033240997229917,0.6891060605431185,1.0,12/35,22.91%,CTNNB1;XRCC5;HNRNPA2B1;ATM;MAPK3;MAP2K7;MAP3K4;HNRNPA1;CCT7;CCT2;ACD;CCT8
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5941524755144407,1.3818462701800585,0.12248628884826325,0.4115033145375526,1.0,6/14,16.43%,ADK;ADSS2;LHPP;IMPDH2;ADSS1;GMPS
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3923230659188559,1.3817076097286,0.04642857142857143,0.4111186132819831,1.0,24/175,8.51%,PID1;TNFRSF25;GBP3;ZFP36L2;PSMA7;RPS3;TNFRSF1B;RIPK1;CCL8;NR1D1;PLVAP;DCSTAMP;CCL19;ZFP36L1;TNFRSF11A;GSDME;BIRC3;CD40;EDARADD;TNF;EDA;PSMB2;CCL24;TNFSF12
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3795183256523436,-1.381467683133078,0.050955414012738856,0.6868764170614654,1.0,20/54,21.90%,IVNS1ABP;SENP2;CTNNB1;CAPN3;SMAD7;HDAC8;SIRT7;ARRB2;UBXN1;ADGRB1;N4BP1;MINAR1;PARK7;SQSTM1;GNL3L;TRIM21;PRR7;BAG5;COPS9;U2AF2
prerank,T cell differentiation (GO:0030217),0.4734499687594603,1.3812070046589882,0.0904836193447738,0.4114599887143106,1.0,9/40,9.43%,ZFP36L2;LIG4;PTPN22;FCER1G;ZFP36L1;SPI1;TCF7;ZAP70;NHEJ1
prerank,transport along microtubule (GO:0010970),0.6134789788028362,1.3807285998066972,0.11172161172161173,0.41172101446216774,1.0,6/13,13.24%,APP;ARHGAP21;CDC42;BAG3;DYNC1I2;BORCS5
prerank,catecholamine biosynthetic process (GO:0042423),0.635946980941904,1.3802547292963097,0.13246268656716417,0.4120585253389763,1.0,3/11,4.61%,DAO;GCH1;MOXD1
prerank,vitamin transport (GO:0051180),0.5132787459167817,1.3800821492346502,0.09935897435897435,0.41178248108888343,1.0,7/29,17.29%,FOLR2;TCN2;AFM;SLC2A2;SLC23A1;SLC35F3;SLC5A6
prerank,protein insertion into membrane (GO:0051205),0.5048933204291864,1.3790647029244525,0.09562398703403566,0.41323306348568983,1.0,5/32,8.20%,EGFR;APP;HMOX1;SERP1;TRAM2
prerank,prostanoid metabolic process (GO:0006692),-0.5580531426523708,-1.3782123696723054,0.08656036446469248,0.6953976002612323,1.0,3/13,7.99%,HPGDS;PTGS1;PTGR2
prerank,regulation of JUN kinase activity (GO:0043506),0.49637683281623446,1.3780930599516712,0.0998389694041868,0.4145564728934023,1.0,6/33,6.99%,MAP3K5;SASH1;RPS3;PTPN22;TNFRSF11A;TNF
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.46805313936056386,1.378082529983342,0.06995230524642289,0.4139214643331521,1.0,12/46,8.44%,RAP1B;SERPINB2;CDC42;PITPNA;LCP1;PAK2;ANXA2;HNRNPF;CNN2;RPLP0;STAT4;MSN
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4050307226865711,1.3776965041272033,0.06711409395973154,0.4140783074271511,1.0,23/108,11.07%,APP;GNAQ;MDFIC;ESR1;BMP2;AXIN1;PRKN;TLR2;SNX3;RACK1;NOTUM;DISC1;CBFB;DEPDC1B;PSEN1;CDC73;CDK14;SULF2;PPP2CA;NKD1;SFRP1;WLS;PPP1CA
prerank,mRNA processing (GO:0006397),-0.29868763315696634,-1.3773870517491793,0.0,0.6940125302543553,1.0,92/287,22.36%,DDX5;GTF2H2;SNRNP70;SON;SRRM2;FUS;CPSF6;ZCCHC8;HNRNPA3;HNRNPUL1;ELAVL2;THOC1;AKAP8L;SRRM4;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;RPRD1A;HNRNPU;DHX35;SNRNP48;CCNH;PUF60;PPIL3;SRSF2;GEMIN2;PNN;SNRPA1;SRSF10;CCAR1;PPIE;PRPF4;WBP4;SNRNP200;SYF2;TCERG1;ERCC2;DNAJC8;DDX41;CSTF2;CWC25;RNPS1;XAB2;USP49;RAVER2;SNRPN;SRRT;PRPF19;CD2BP2;U2AF1;PQBP1;UPF3B;NOVA2;CASC3;SF3B1;SRSF12;NCBP1;POLR2C;PCBP1;PCBP2;PRPF6;HNRNPA1;DDX23;SNIP1;ZMAT5;HNRNPH1;RBM5;CLP1;SNRPB2;THOC3;SRSF11;SRSF9;DHX9;SART1;RBM17;POLDIP3;PRMT9;RBM14;GTF2H4;ALYREF;ESS2;SART3;TFIP11;U2AF2;IK;POLR2L;METTL3;UBL5;ALKBH5
prerank,bile acid and bile salt transport (GO:0015721),0.5279235478259758,1.3768445148590172,0.10509031198686371,0.41515369285180664,1.0,5/24,8.57%,SLC10A6;NR1H4;NCOA2;ABCC4;SLC10A3
prerank,keratan sulfate metabolic process (GO:0042339),-0.44116502744576097,-1.3767877205047612,0.09067357512953368,0.6922167095205436,1.0,5/31,2.97%,HEXB;ST3GAL6;GNS;CHST1;B4GALT4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5616452411830744,1.3762491810196997,0.12478031634446397,0.4157442199288641,1.0,4/17,7.60%,CCR1;ANO6;PLA2G7;CCR2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.41546752754000055,1.3756270579964072,0.06942590120160214,0.41642652563734434,1.0,24/95,13.44%,PF4;FCGR2B;MEF2C;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;TLR2;NFKBIL1;LY96;CD80;CDC73;MAPK14;CARD16;CHMP5;CD68;ZC3H12A;NOD2;NFKBIB
prerank,L-amino acid transport (GO:0015807),-0.4565844329366733,-1.3753935740360188,0.08354430379746836,0.6932836665683508,1.0,7/28,12.70%,SLC1A3;SLC36A1;SLC36A4;SLC1A1;SLC25A22;SLC7A8;CTNS
prerank,regulation of signal transduction (GO:0009966),0.38495875104564126,1.3747780420999902,0.03869407496977025,0.41753101383355695,1.0,37/190,11.34%,RASGRP4;LIFR;IGFBP4;APP;MDFIC;ALOX15;ESR1;CDC42SE2;GRK5;BST1;FBXL17;CD36;DHRS3;AXIN1;CD46;CRK;ITGB1BP1;INTU;SNX3;CBFB;RGS8;CD80;SYNJ2BP;FYN;HOMER1;MAPK8IP2;ZDHHC3;PPP2CA;ZFAND2B;NUP62;PXN;SP100;ELF1;WDR11;CREBBP;AMFR;SREBF2
prerank,lipid transport (GO:0006869),0.4237864828755693,1.373972373086199,0.06089309878213803,0.41855065745394116,1.0,15/97,9.21%,PLTP;APOE;SLC10A6;LDLR;NR1H4;NCOA2;CD36;ABCA9;PITPNA;SLC25A17;LBP;ABCC4;ABCA6;SLC10A3;GLTP
prerank,aortic valve development (GO:0003176),0.49981929426424976,1.3734712769951947,0.10909090909090909,0.41886601222269515,1.0,10/34,12.91%,JAG1;TNFRSF1B;BMP2;HEY2;RB1;ROCK1;SLIT3;EMILIN1;ROCK2;TNFRSF1A
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.41813623331911215,1.3733679318747676,0.06593406593406594,0.418385663978018,1.0,16/85,10.19%,DAB2;FBXW7;NUPR1;CBFA2T3;ARIH1;PIAS1;PRICKLE1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;RNF19B;MDM2;COP1;RNF14
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3933923206692859,1.373138657952802,0.048407643312101914,0.4182166504434539,1.0,17/152,5.85%,PF4;ADGRE5;GNAQ;ADGRG6;ADGRE1;GRK5;WASF2;GNAI3;CALCRL;GPR65;ADRB2;DRD1;ADM;PDE2A;S1PR2;ADCY9;ADCYAP1R1
prerank,organophosphate ester transport (GO:0015748),0.522788354285981,1.3730980024769566,0.12418300653594772,0.4176289104386454,1.0,7/24,15.62%,PLTP;LDLR;PITPNA;EPG5;NPC2;OSBPL8;OSBPL5
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.4311421874177528,-1.373079368603447,0.08579088471849866,0.698373703815237,1.0,13/32,27.87%,CTNNB1;XRCC5;ATM;MAPK3;MAP2K7;MAP3K4;HNRNPA1;CCT7;CCT2;ACD;CCT8;FBXO4;AURKB
prerank,regulation of lamellipodium organization (GO:1902743),0.5929094060340688,1.3725032349118842,0.14183123877917414,0.41820277173223336,1.0,3/14,3.30%,FER;CD44;CDC42
prerank,positive regulation of ion transport (GO:0043270),0.4709419758739616,1.3724800810556068,0.08127721335268505,0.41758096239110626,1.0,20/48,19.01%,P2RX7;LILRA5;ATP2B1;CCR1;ANO6;STIM2;DRD1;CNKSR3;WFS1;SCN3B;FFAR1;SNX4;RAB3B;CCL5;CHRNB2;F2R;GDNF;CAMK2A;VAMP8;P2RX4
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.30446762493036805,-1.3716002294296665,0.007142857142857143,0.6999461690901388,1.0,47/224,12.51%,CACNB2;PLP1;SLC1A3;KCND2;MBP;DLG2;GRM7;CACNB4;GRIA2;UNC13C;GRIK2;GABRB3;NLGN1;SNAP25;NRXN1;DLG4;DLGAP1;GRM3;HTR2C;PRKAR1A;PTCHD1;GRIA4;PRKAR1B;KCNQ3;KIF5A;GABRB1;HCRTR2;SPG11;RPS6KA1;APBA1;DTNA;HRH2;GLRB;CACNA1E;CHRM3;CAMK4;KCNA1;HTR7;CPLX1;GRIN2A;SLC1A1;MINK1;GABRA2;RPS6KA2;SLC12A6;NPTX1;GLRA1
prerank,lymphocyte chemotaxis (GO:0048247),0.4963973118096652,1.3712892183997427,0.09891808346213292,0.4194202468112665,1.0,12/34,17.11%,GAS6;CCL8;MSMP;CCL19;HSD3B7;CXCL16;CCL24;CKLF;CYP7B1;GPR183;CCL5;CCL25
prerank,regulation of metal ion transport (GO:0010959),0.5813290910472916,1.3711276538815043,0.11538461538461539,0.41906995054061386,1.0,4/16,8.84%,IL16;BCL2;STIM1;PLN
prerank,endothelial cell proliferation (GO:0001935),0.56315817096438,1.3702121361507107,0.12457337883959044,0.4202140442355814,1.0,4/17,4.23%,ERN1;HMOX1;ITGB1BP1;NRARP
prerank,thymus development (GO:0048538),-0.558042270763973,-1.3701510801190306,0.10329670329670329,0.701493916082997,1.0,1/13,0.14%,TGFBR1
prerank,lipoprotein biosynthetic process (GO:0042158),0.6234250625065971,1.3700397181561974,0.1586998087954111,0.41989934091472764,1.0,7/11,20.14%,APOE;WIPI1;ATG7;ATG10;WIPI2;UGCG;PIK3C3
prerank,cellular response to calcium ion (GO:0071277),0.4368250138062577,1.369829583713757,0.0708215297450425,0.4196722968245392,1.0,11/67,6.43%,CHP2;IQGAP1;MEF2A;ALOX15;MEF2C;ALOX5AP;CPNE2;SLC25A24;CLIC4;CPNE7;CPNE8
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.3044405019752408,-1.3693042699195048,0.0,0.7005320744931478,1.0,86/264,22.33%,DDX5;SNRNP70;SRRM2;FUS;DDX17;ZCCHC8;HNRNPA3;HNRNPUL1;ELAVL2;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;HNRNPU;DHX35;SNRNP48;SRPK1;PUF60;PPIL3;SRSF2;GEMIN2;PNN;SNRPA1;SRSF10;DCPS;CCAR1;PPIE;PRPF4;CELF4;WBP4;SNRNP200;SYF2;DNAJC8;DDX41;CSTF2;CWC25;RNPS1;DDX20;XAB2;USP49;SRPK2;RAVER2;SNRPN;SRRT;PRPF19;CD2BP2;U2AF1;PQBP1;UPF3B;NOVA2;CASC3;SF3B1;DDX1;SRSF12;NCBP1;POLR2C;STRAP;TGS1;PCBP1;PCBP2;PRPF6;HNRNPA1;DDX23;SNIP1;ZMAT5;HNRNPH1;RBM5;CLP1;SNRPB2;SRSF11;SRSF9;DHX9;SART1;RBM17;RBM14;ALYREF;ESS2;SART3;TFIP11;U2AF2;IK;POLR2L;METTL3;UBL5
prerank,establishment of spindle localization (GO:0051293),-0.5429662910681197,-1.369254802637993,0.11409395973154363,0.6964900478482592,1.0,7/14,22.34%,CLASP2;DYNC1H1;LLGL1;MAP4;LLGL2;NUSAP1;ESPL1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5528227996592181,1.3689914271027244,0.12220309810671257,0.42081509629972247,1.0,7/19,16.82%,NR1H4;TLR4;LBP;LY96;ITGB2;SCIMP;TIRAP
prerank,regulation of protein catabolic process (GO:0042176),0.41482675431521965,1.368702760451364,0.057455540355677154,0.42076009876342285,1.0,26/99,15.81%,WWP1;EGFR;SMURF2;IRAK3;EEF1A1;RILP;AXIN1;HMGCR;PRKN;GSK3B;SF3B3;SNX3;TRIM32;TNF;RAB7A;TNFSF12;MDM2;NKD1;ATG7;FOXO1;NEDD4L;GPC3;WDR91;RNF41;PRKCG;ZDHHC2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6336420540880675,1.3686710022129815,0.12992125984251968,0.42019114703353855,1.0,3/10,13.30%,PRKRA;DROSHA;MRPL44
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5318057353809603,1.3679115109283362,0.138353765323993,0.4211031537277386,1.0,2/21,5.16%,DAB2;SMAD4
prerank,receptor metabolic process (GO:0043112),0.4534702359487652,1.3677852164426147,0.09226190476190477,0.42072932925098977,1.0,12/53,6.52%,RAB31;CLTC;ITGB1;CALCRL;CD36;FCER1G;LILRB1;UVRAG;ADM;KIF16B;SNX25;SYK
prerank,regulation of macrophage activation (GO:0043030),0.5046995879574456,1.3676886671249007,0.11532385466034756,0.4202809324696503,1.0,5/30,4.13%,FCGR2B;MFHAS1;CD74;TLR4;LBP
prerank,T cell differentiation in thymus (GO:0033077),0.5950504015408465,1.367648062894999,0.12476007677543186,0.4196978122102587,1.0,3/14,3.73%,ZFP36L2;LIG4;ZFP36L1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5208889828107075,1.3672143388283624,0.11305732484076433,0.4199051658894131,1.0,4/26,3.48%,APP;FBXW7;SNX6;CBL
prerank,positive regulation of ruffle assembly (GO:1900029),0.5912635619642269,1.3666054521833875,0.13250883392226148,0.42055416515228305,1.0,1/13,0.09%,EPS8
prerank,folic acid-containing compound metabolic process (GO:0006760),0.5464402522963702,1.3657513139512243,0.13162393162393163,0.42169125249665146,1.0,2/19,6.52%,FOLR2;MTHFD2L
prerank,calcium import into the mitochondrion (GO:0036444),0.6328028641974358,1.3656661570864626,0.11970534069981584,0.4211847247107619,1.0,3/10,12.20%,MCUB;MCU;MICU3
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4429624842306637,1.364171585265815,0.0970464135021097,0.42371135620554623,1.0,8/61,5.63%,ARHGEF3;RASGRP4;NOTCH2;LYN;MAPRE2;GPR65;IRS2;P2RY10
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4234076229803165,1.3638919980376671,0.07464788732394366,0.42364281107928253,1.0,6/78,2.56%,DAB2;PID1;EGFR;CLTC;ITGB1;SPTBN1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5800724758172259,1.3638845198643943,0.12915129151291513,0.4230092736597863,1.0,2/16,2.65%,APOE;CD36
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.48424244168122865,1.3637655512960658,0.09178743961352658,0.42257521312360985,1.0,5/38,6.26%,BANK1;PTPRJ;XDH;RACK1;NOP53
prerank,cranial nerve development (GO:0021545),-0.5904452957311306,-1.3631460858457256,0.11392405063291139,0.7165551717965618,1.0,3/11,11.22%,SALL1;CHD7;TMEM126A
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3907080801237605,1.3627598041770554,0.05759803921568627,0.4241046528625468,1.0,19/140,8.68%,P2RX7;CCR1;CMKLR1;C5AR1;ESR1;C3AR1;C1QTNF1;CYSLTR1;GPR65;CD36;DRD1;GHRL;PDGFRA;P2RY10;CCRL2;CXCR4;CCR2;ADRA1D;ADRA1A
prerank,hexose biosynthetic process (GO:0019319),-0.39907542236004195,-1.3626844710644297,0.0771513353115727,0.7141280186541396,1.0,17/42,21.03%,PGM1;ALDOA;MDH1;CRTC2;PGK1;ENO1;AKR1B1;PCK2;ENO3;SLC37A4;TPI1;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4166362617083599,-1.3625581819317336,0.07772020725388601,0.710266703408141,1.0,18/37,22.34%,PRKCD;CALM2;PPP1R16B;NSMF;YWHAB;CAMTA1;PPP1R7;TSC1;ANKLE2;PPP6R1;PPP1R16A;PPP2R5A;CDCA2;PTPA;SPPL3;CALM3;TGFB1;PIN1
prerank,negative regulation of MAPK cascade (GO:0043409),0.4196676428395475,1.3623068750126994,0.06564245810055866,0.4244628290385268,1.0,26/87,16.14%,APOE;P2RX7;SPRED1;PTPRJ;LYN;IRAK3;TLR4;ITGB1BP1;DUSP1;SMAD4;FOXM1;SYNJ2BP;RANBP9;CNKSR3;IGBP1;SH2B3;RPS6KA6;SPRED2;EMILIN1;STK38;FOXO1;PPIA;RGS14;MYC;DUSP7;PTEN
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5343096379900754,-1.3617298559755153,0.1095890410958904,0.709291871992675,1.0,3/13,9.26%,LARGE1;CHST1;CHST2
prerank,mesonephric tubule development (GO:0072164),-0.5102796870079651,-1.3607388090783832,0.12147505422993492,0.7091762524527011,1.0,4/15,4.84%,SALL1;NPNT;ROBO2;FGFR2
prerank,regulation of phagocytosis (GO:0050764),0.44906055454359783,1.3607313776459569,0.07515337423312883,0.42691313931431796,1.0,11/53,6.99%,FCGR2B;IL15;GAS6;DOCK2;FCER1G;CAMK1D;TLR2;SNX3;RACK1;SYK;TNF
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5493367717708046,1.3605760727491403,0.12828947368421054,0.4265846162346404,1.0,4/20,6.29%,MCL1;GSK3B;BCL2L2;BCL2
prerank,telomere organization (GO:0032200),-0.40123109232367504,-1.3597907893470627,0.06722689075630252,0.7087724391780692,1.0,14/43,13.31%,DNA2;XRCC5;CTC1;ATM;PARP1;STN1;PTGES3;DOT1L;BLM;LTO1;HUS1;PARP3;TERF2;XRCC6
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.41072349846600964,-1.359555741939453,0.08994708994708994,0.7055975034496657,1.0,13/35,15.00%,DDX5;DDX17;SRC;SAFB;KDM3A;TRIP4;PGR;WBP2;AR;EGLN2;CALCOCO1;PADI2;NCOA4
prerank,response to cAMP (GO:0051591),0.48695338047377135,1.3594857090465498,0.10443037974683544,0.42818414603911203,1.0,7/37,8.48%,RAP1B;AHR;ZFP36L1;RAPGEF2;PDE2A;RAP1A;HCN3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.5818167594040318,-1.3592683271569854,0.12708333333333333,0.7026432570316475,1.0,4/10,9.12%,THOC1;DDX39B;ETAA1;CCAR2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.583734262761266,1.3592440124196667,0.14100185528756956,0.4280388675046309,1.0,2/13,5.16%,DAB2;SMAD4
prerank,regulation of intracellular signal transduction (GO:1902531),0.3561878699108383,1.3591415306108885,0.0075107296137339056,0.4276033997046415,1.0,58/420,9.12%,ARHGEF3;ITSN1;ARHGAP15;STARD8;VAV3;PLEKHG5;FGD4;EGFR;MOB3B;SPRED1;CLEC6A;CMKLR1;SGMS1;ARHGAP9;PRKAG2;OPHN1;RBBP8;LYN;BST1;ARAP1;PTPN22;RASSF2;RCN3;ARHGAP21;ARHGAP10;PRKAG3;ARHGAP18;CDC42;CRK;ARHGAP31;RHOA;PHF20;PDE2A;BIRC3;TRIO;PAK2;OCRL;STK3;ARHGAP29;VRK2;NOP53;CHEK1;NGEF;DEPDC1B;HSPB1;TNF;NRK;TOPBP1;ARHGAP12;ARHGAP23;RPL5;ARHGEF12;RPA1;ARHGDIA;BRIP1;MDM2;LBH;MAPK14
prerank,embryonic limb morphogenesis (GO:0030326),0.4888906581420154,1.3584175093513937,0.10935023771790808,0.42842511337413786,1.0,8/34,11.33%,LRP6;MBNL1;RARG;OSR1;INTU;MAP3K20;CYP26B1;CREBBP
prerank,T-helper cell differentiation (GO:0042093),0.6008367095811479,1.358284373087848,0.12844036697247707,0.428031310246322,1.0,6/14,18.05%,FOXP1;ATP7A;PTGER4;GPR183;IL6;BATF
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5597127597464099,1.3580248226374383,0.11945392491467577,0.42797541311169457,1.0,3/18,2.02%,ITGA4;FGFR1;MEF2C
prerank,positive regulation of MAP kinase activity (GO:0043406),0.43293811165504015,1.3577239206505334,0.09444444444444444,0.4279376381830158,1.0,9/66,6.99%,EGFR;FGFR1;MAP3K5;SASH1;RPS3;TNFRSF11A;CD40;PIK3R6;TNF
prerank,regulation of cell morphogenesis (GO:0022604),-0.4308287940758693,-1.3577096821527093,0.08488063660477453,0.7047179035789689,1.0,13/30,18.59%,EFNA5;FMNL2;SPARC;CAMSAP1;FERMT2;MACF1;ZMYM6;NTNG1;BCL9L;ZMYM3;STRIP1;PDPN;MOV10
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4562508647537247,-1.3575453275945228,0.10421836228287841,0.701221433783944,1.0,9/25,17.14%,ATP1B1;ATP1B2;ANK2;CTSS;ACTN2;WNK3;GLRX;STAC;CFTR
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5494374294283302,1.3572655740513546,0.14051094890510948,0.42833506099181234,1.0,4/18,4.84%,ZFP36L2;ZFP36L1;NR3C1;KLF9
prerank,presynapse assembly (GO:0099054),-0.5152812953803526,-1.3570426544247216,0.09843400447427293,0.699126085769103,1.0,5/16,12.06%,PTPRD;NLGN1;PCLO;DVL1;IL1RAPL1
prerank,vasculogenesis (GO:0001570),0.48679482149412096,1.3570075964593904,0.11442006269592477,0.42819109662241267,1.0,5/32,4.52%,SPRED1;RASA1;ADM;CCM2;HEY2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5193021100315293,1.3569048361718155,0.14,0.42773077422044,1.0,7/23,16.29%,SH3BP5;SNX6;CBL;DUSP22;CBLB;SH3BP5L;ZGPAT
prerank,positive regulation of biosynthetic process (GO:0009891),0.47948717961985843,1.3568029095338607,0.10543130990415335,0.4272556233412913,1.0,13/40,18.10%,APOE;ZBTB20;CD36;TLR4;RGCC;VIM;MTPN;CREB1;CYBA;CREB3L1;CCL5;SLC5A3;F2R
prerank,carboxylic acid catabolic process (GO:0046395),0.6042874662056448,1.3567417589078248,0.1397459165154265,0.42675113408169774,1.0,2/12,2.53%,NPL;GNPDA1
prerank,axon extension (GO:0048675),0.5259145086865898,1.3565858701845892,0.10950080515297907,0.4264487038031199,1.0,8/23,16.03%,NRP1;USP9X;ALCAM;ULK2;SLIT3;SLIT1;SLC9A6;HSP90AB1
prerank,membrane lipid metabolic process (GO:0006643),-0.4644213577263865,-1.3561777650363234,0.09420289855072464,0.6986528762372857,1.0,10/22,22.37%,CERK;ST3GAL6;B4GALT4;ST6GALNAC4;TECR;CERKL;SERINC1;SPTLC1;ARV1;AGK
prerank,negative regulation of establishment of protein localization (GO:1904950),0.6320293608476497,1.3560807623799833,0.17054263565891473,0.4268254002198477,1.0,4/10,14.46%,NDFIP1;SNX3;NDFIP2;TERF1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.38833162963068535,1.3560114554886011,0.05667506297229219,0.4263286709171947,1.0,26/138,11.32%,MTSS1;NEDD9;RASGRP4;EGFR;LIFR;FGFR1;LYN;FER;ABI1;CASS4;FRS2;FRK;TRIO;INSR;GUCY2D;PDGFRA;EFS;ACVR2A;SYK;ZAP70;FYN;DDR2;EPHB4;STYK1;SLA;SHC1
prerank,folic acid metabolic process (GO:0046655),0.5453992526122681,1.355796582991322,0.13612565445026178,0.42611195467574914,1.0,2/18,6.52%,FOLR2;MTHFD2L
prerank,regulation of mitochondrion organization (GO:0010821),0.45642304761849145,1.3554659195374816,0.10425844346549193,0.42613701872777,1.0,6/47,5.77%,PID1;FBXW7;PRKN;PDE2A;GSK3B;PARL
prerank,cellular response to alkaloid (GO:0071312),-0.5017967194718086,-1.355330595865399,0.09443099273607748,0.6978571529814451,1.0,5/17,10.52%,SLC8A1;TGM2;CASP7;BLM;CASP6
prerank,lipid droplet organization (GO:0034389),-0.4672485595007985,-1.3551919914540955,0.09975669099756691,0.6945117204810624,1.0,7/22,23.00%,AUP1;RAB18;CDS1;SQLE;CDS2;BSCL2;FAF2
prerank,heme biosynthetic process (GO:0006783),-0.4667265159262747,-1.3547190403648788,0.09112709832134293,0.6921367282886428,1.0,12/22,25.37%,FECH;CPOX;FXN;ABCG2;COX15;FLVCR1;HMBS;ALAS2;UROD;PGRMC1;PPOX;ALAS1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6263449408290582,1.3543940436113122,0.13398058252427184,0.4277494812806667,1.0,2/10,1.96%,PTPRJ;PTPN12
prerank,cardiac cell development (GO:0055006),0.6099514570607251,1.3535896994682166,0.13359528487229863,0.42881059215745715,1.0,3/11,2.92%,JAG1;MYH6;ALPK3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5787860853894671,1.35349964306308,0.12454873646209386,0.4283338108793359,1.0,2/14,7.01%,PAEP;CD80
prerank,pinocytosis (GO:0006907),0.6308642597698058,1.3519235917957044,0.16252390057361377,0.43095049079733994,1.0,4/10,11.84%,DOCK2;MAPKAPK2;SNX33;SNX5
prerank,exit from mitosis (GO:0010458),0.598156343298828,1.3514316902895063,0.1417910447761194,0.4313431284307959,1.0,1/12,0.09%,EPS8
prerank,myoblast differentiation (GO:0045445),0.5697532809362016,1.3508822987564244,0.1482889733840304,0.43181744588514787,1.0,7/14,11.72%,TCF7L2;MBNL1;JAG1;PLEKHM3;RB1;IGF1;HINFP
prerank,zymogen activation (GO:0031638),-0.40480213978598656,-1.3505668208392878,0.07923497267759563,0.704720823231602,1.0,8/39,7.31%,ASPH;KLK2;LGMN;VSIR;TBC1D10A;PLAU;CYFIP2;PGK1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.5377175080626102,-1.3504990535458614,0.1275626423690205,0.7011596404835881,1.0,10/13,32.41%,YWHAB;MDFI;GET4;DBN1;GOPC;FLNA;SUFU;LATS1;PKD1;NFKBIE
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5585651290532335,1.350449868290913,0.1488970588235294,0.43210104579247555,1.0,6/16,10.27%,APOE;S100A1;NPR3;GCH1;TNF;NUS1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4779891251488021,1.3497390403019192,0.11514195583596215,0.43294295183526044,1.0,7/34,7.51%,PTPRJ;PTPN18;PTPN12;PTPN22;DUSP1;DUSP22;DUSP2
prerank,glucose homeostasis (GO:0042593),0.4187467821462779,1.3497008920219598,0.0728862973760933,0.4323818103992414,1.0,19/83,14.52%,ALOX5;TCF7L2;FOXA3;NR1D1;LRRC8D;SLC2A4;MCU;INSR;ADIPOR2;RPS6;WFS1;FOXK2;KCNB1;SLC8B1;FOXK1;FOXO1;STAT3;RBP4;USF1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4000409549744687,1.3493897944516375,0.07490144546649145,0.4324542594872128,1.0,13/108,6.99%,HIP1;NLRC4;MAP3K5;IFT57;RPS3;DAPK1;XDH;RIPK1;BCL10;RACK1;SYK;UACA;TNF
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5842776869898797,1.3476315220811013,0.15992647058823528,0.43554391193459596,1.0,7/13,15.70%,ARID1B;SPI1;CHEK1;ELOF1;SERTAD2;SMARCD1;ARID1A
prerank,chloride transport (GO:0006821),-0.34947001127689664,-1.3470850437964603,0.044673539518900345,0.7106677110700884,1.0,30/74,25.15%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC4A10;SLC12A9;TTYH1;GABRB1;PACC1;ANO3;GLRB;SLC1A1;GABRA2;CLCN2;SLC12A6;GLRA1;GABRG2;CLCN4;SLC6A1;GLRA3;CFTR;FXYD1;ANO8;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,endoderm development (GO:0007492),0.5953051836030072,1.3470594577052748,0.16007194244604317,0.4360710164060896,1.0,3/13,7.51%,DUSP1;KIF16B;DUSP2
prerank,stem cell differentiation (GO:0048863),0.47613326092615926,1.345914171287407,0.10096153846153846,0.43778863450741173,1.0,5/39,4.04%,LRP6;MEF2C;OSR1;FBXL17;JARID2
prerank,regulation of steroid metabolic process (GO:0019218),0.5189037596701747,1.3456861480662017,0.1482758620689655,0.43765433293459344,1.0,4/23,3.64%,APOE;NR1H4;UGT1A8;UGT1A1
prerank,regulation of tube diameter (GO:0035296),0.5870159081560908,1.3452537918474863,0.15858208955223882,0.4373335337384417,1.0,5/13,15.73%,ITGB1BP1;ROCK1;ROCK2;GCLM;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),0.5870159081560908,1.3452537918474863,0.15858208955223882,0.4373335337384417,1.0,5/13,15.73%,ITGB1BP1;ROCK1;ROCK2;GCLM;SCPEP1
prerank,regulation of cytokine production (GO:0001817),0.3930270799840439,1.3447884247771753,0.0697084917617237,0.437636274653822,1.0,17/126,7.60%,HDAC9;FCGR2B;ALOX5;ATP2B1;FOXP1;CLEC6A;IL15;LYN;C1QTNF3;TNFRSF1B;RGCC;SRGN;TRIM56;MAPKAPK2;TRIM32;TNF;CCR2
prerank,negative regulation of lyase activity (GO:0051350),0.5655341549437469,1.3444145472932787,0.1543859649122807,0.437758122771641,1.0,3/16,7.60%,EDNRB;GNAI3;CCR2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5970779566332227,1.3441326510687837,0.140597539543058,0.4376936171168342,1.0,5/12,7.23%,FOXP1;CD74;TLR4;TNF;KLF4
prerank,regulation of cellular amide metabolic process (GO:0034248),0.48673074837613906,1.3434614266231573,0.14057507987220447,0.4383909392645207,1.0,9/32,11.97%,APP;NR1H4;PGAM1;ROCK1;TMED10;MTPN;FOXO3;NANOS3;RPL10
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4796676122582372,-1.3434331859385724,0.08983451536643026,0.7212112559617849,1.0,10/21,22.89%,CHST11;CSPG5;CHPF2;CSPG4;VCAN;BCAN;BGN;NCAN;UGDH;DCN
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.431046133206367,-1.3427221912771639,0.10761154855643044,0.7198744604749897,1.0,13/28,19.96%,MAP2;CLASP2;CAMSAP1;MAP1B;MAPT;MAPRE3;STMN3;GBA2;STMN4;MAPRE1;SKA2;FKBP4;PRUNE1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.41656445998185965,1.342266540538103,0.09065550906555091,0.44036417907139563,1.0,14/78,10.19%,DAB2;CBFA2T3;ARIH1;PIAS1;PRICKLE1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;RNF19B;MDM2;COP1;RNF14
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.47486550086429635,-1.3417366333332676,0.11138613861386139,0.7197974539123126,1.0,5/21,8.60%,NAV3;CLASP2;CAMSAP1;FGF13;ARHGEF2
prerank,regulation of plasminogen activation (GO:0010755),-0.5569001445063191,-1.3413426196484353,0.12017167381974249,0.7175794544317587,1.0,3/12,7.90%,PLGRKT;SERPINE2;ENO1
prerank,pulmonary valve development (GO:0003177),0.5530992664941295,1.3398584892673604,0.13612565445026178,0.4448558592632185,1.0,4/18,4.52%,NOTCH2;JAG1;TNFRSF1B;HEY2
prerank,regulation of angiogenesis (GO:0045765),0.3721569098021275,1.3394995862137584,0.04866180048661801,0.44504716675717,1.0,41/192,12.84%,STAB1;PF4;ALOX5;SPRED1;SASH1;ITGB1;THBS4;GRN;CNMD;RGCC;TNMD;HMOX1;GHRL;ROCK1;CD40;PIK3R6;HSPB1;STIM1;KLF4;PRKCB;HTATIP2;CCR2;GAB1;SYNJ2BP;ADAM12;AMOT;TNFSF12;NINJ1;MYDGF;SFRP1;SP1;SP100;JUP;CEMIP2;EMILIN1;ROCK2;NIBAN2;ZC3H12A;ATP2B4;PLXND1;RAMP2
prerank,regulation of interleukin-1 production (GO:0032652),0.5723840064723859,1.3394835720021014,0.14604810996563575,0.444443448567022,1.0,4/15,5.81%,FOXP1;GAS6;TLR4;TMED10
prerank,ribosome assembly (GO:0042255),0.4553040591734903,1.339320808570699,0.12079510703363915,0.4441374222256173,1.0,15/47,11.97%,RPL23A;RPS15;ERAL1;RPSA;RPS28;RPL24;RSL24D1;NOP53;RPLP0;RPL5;RPS14;RPS5;MRPS11;RPL6;RPL10
prerank,acyl-CoA metabolic process (GO:0006637),-0.409366890450451,-1.3391931707445466,0.09016393442622951,0.7222654262559515,1.0,12/35,26.38%,ACOT9;ACACA;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1;SUCLG2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.44526910920183216,1.338580630386314,0.11246200607902736,0.4450499450348372,1.0,13/54,12.39%,APOE;FGFR1;MEF2C;RGCC;PRCP;CD40;HSPB1;TNF;MAPK14;NUS1;SP1;JUP;ATP2B4
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6215061668270196,1.3381634741548034,0.15964912280701754,0.44460078009504106,1.0,6/10,14.11%,AP2A2;CLTC;AP2S1;VLDLR;AP2B1;CLTA
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6215061668270196,1.3381634741548034,0.15964912280701754,0.44460078009504106,1.0,6/10,14.11%,AP2A2;CLTC;AP2S1;VLDLR;AP2B1;CLTA
prerank,organic acid transport (GO:0015849),0.4069407677903454,1.3373990026965368,0.077733860342556,0.44552564998578664,1.0,21/94,17.68%,FOLR2;SLC10A6;NR1H4;SLC16A10;NCOA2;LRRC8D;SLC43A2;SLC25A17;ABCC4;SLC10A3;SLC38A1;SLC38A2;MFSD2A;SLC23A1;SLC23A2;SLC26A7;SLC7A7;SLC25A30;SLC6A6;SLC5A6;SLC36A2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.40465392414014867,1.3373339239037774,0.077733860342556,0.4450064362728871,1.0,19/100,10.19%,DAB2;CBFA2T3;ARIH1;PIAS1;RYBP;PRICKLE1;WAC;PRKN;GSK3B;RACK1;ANKIB1;NOP53;SDCBP;HFE;RNF19B;MDM2;COP1;UBQLN4;RNF14
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4437348089262449,1.33719538750312,0.1125,0.44465000514409536,1.0,10/47,15.10%,EDNRB;APOE;APP;KLF4;MTPN;FOXO3;NANOS3;RPL10;NR1H2;WDR91
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5044160463199626,1.33676055412555,0.12376237623762376,0.4449557236897276,1.0,5/24,6.29%,TPT1;CD44;CD74;TRIM32;BCL2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5969776488781798,1.336555289683186,0.15913200723327306,0.44475815390019124,1.0,9/12,19.57%,B4GALT6;MYCBP2;B4GALT5;HSP90AB1;PTEN;EPHB6;CHRNB2;ARHGAP35;SPTBN4
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.36154320840210386,-1.3363881993291808,0.044585987261146494,0.7293250354221354,1.0,20/67,9.35%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;FXR2;PPP1R16B;IFT140;MYO10;ATP8B1;IFT88;TBC1D10A;TWF2;RDX;TBC1D22A;FMR1;IFT20;DYNLT2B;TBC1D22B;TBC1D9B
prerank,regulation of defense response (GO:0031347),0.42045164382711975,1.3363827995252917,0.0988538681948424,0.4444861989827153,1.0,11/76,7.60%,FCGR2B;APOE;ALOX5;FOXP1;ALOX15;BST1;PTPN22;GRN;BIRC3;ZMPSTE24;CCR2
prerank,ERBB2 signaling pathway (GO:0038128),0.47303848941977716,1.3361502682815267,0.14521452145214522,0.4443173539041149,1.0,8/31,17.75%,EGFR;PTPN18;PTPN12;GAB1;SHC1;NRG2;CUL5;SOS1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5173815820582229,1.33603230069588,0.15993537964458804,0.44331400710281593,1.0,4/21,6.99%,PF4;MCL1;BCL2;TNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5173815820582229,1.33603230069588,0.15993537964458804,0.44331400710281593,1.0,4/21,6.99%,PF4;MCL1;BCL2;TNF
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6188386452335178,1.3360239764211674,0.1840607210626186,0.44270192268854114,1.0,1/10,0.49%,APOE
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4303450689118433,1.3357861459813924,0.09431137724550898,0.44253808027768915,1.0,15/63,11.28%,FGFR1;DEPTOR;TCF7L2;SH3RF1;RIPK1;SIAH2;BCL10;PAK2;TNF;BIRC6;TNFSF12;IGF1;SP100;CASP8;PHIP
prerank,retina homeostasis (GO:0001895),0.5165756116089769,1.3357168776568185,0.13013698630136986,0.44206076789897863,1.0,5/23,6.97%,SLC28A2;B2M;POTEF;ACTB;HSPB1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.583292702080265,1.3355014635252345,0.14954954954954955,0.4418816350143586,1.0,4/13,8.94%,NUPR1;MTM1;FEZ2;SMCR8
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.4309134708555167,1.3351045837939535,0.1144578313253012,0.4420463015011089,1.0,7/53,6.02%,APOE;FBXW7;OPHN1;NUPR1;LAMP3;PRKN;RHBDF1
prerank,regulation of insulin secretion (GO:0050796),0.4020210566711266,1.334811956827852,0.07366984993178717,0.4420549557405191,1.0,25/101,14.94%,ALOX5;TCF7L2;NR1H4;NR1D1;PRKN;MCU;CLOCK;IRS2;RAP1A;GHRL;EIPR1;TNF;KCNG2;SFRP1;HADH;CHGA;DOC2B;SLC2A2;KCNB1;SLC8B1;GLUD1;FFAR1;RBP4;TRH;ITPR3
prerank,negative regulation of wound healing (GO:0061045),0.4984938766116792,1.3347969158319661,0.12798634812286688,0.4414543315770362,1.0,6/28,9.35%,APOE;ALOX5;CASK;CRK;TNF;CLASP1
prerank,regulation of fibroblast proliferation (GO:0048145),0.46030241262804095,1.3347786199749032,0.11710323574730354,0.44085840643317464,1.0,13/45,10.94%,GAS6;LIG4;CD74;WNT2;CDK6;PDGFRA;TRIM32;CDC73;DDR2;PDGFC;IGF1;SFRP1;FTH1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5286822295659686,1.3343464374022347,0.14646464646464646,0.4411378748849818,1.0,11/20,21.27%,ADSS2;LHPP;IMPDH2;AMPD3;ADSS1;NT5C2;GMPS;AK3;AK4;HPRT1;PAICS
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5606810074136066,1.3340025662403852,0.15985790408525755,0.441263385251747,1.0,3/16,9.88%,NUPR1;ATP7A;COX7A2L
prerank,positive regulation of apoptotic process (GO:0043065),0.36080721736947324,1.3338969546590462,0.02944507361268403,0.44086067902832804,1.0,48/293,13.30%,ARHGEF3;ITSN1;VAV3;PLEKHG5;NLRC4;FGD4;TNFAIP8;MAP3K5;STK17B;NUPR1;ANO6;ITGB1;RARG;RPS3;DAPK1;RPS27A;RASSF2;RYBP;BMP2;RIPK1;LILRB1;GRN;BCL10;TRIO;RACK1;STK3;NGEF;TNF;ARHGEF12;PSEN1;ATF6;MAP3K20;SFRP1;RPS6;ATG7;CTNNBL1;CASP8;FOXO3;MAP3K11;DIABLO;ZC3H12A;ITGB3BP;ARHGEF9;FAM162A;FOXO1;NET1;SOS2;LATS2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5445879426284979,1.3332637677099533,0.14128440366972478,0.4415822403031532,1.0,6/16,12.36%,ZFP36L2;ZFP36L1;RC3H1;TRIM71;ZC3H12D;ZC3H12A
prerank,protein autophosphorylation (GO:0046777),0.3782060424222833,1.3332010499396543,0.06976744186046512,0.44110394550161314,1.0,32/157,12.16%,EGFR;FGFR1;STK17B;PEAK1;LYN;GRK5;FER;DAPK1;OXSR1;RIPK1;ERN1;CDK12;GSK3B;INSR;CAMKK2;PAK2;MAPKAPK2;PDGFRA;STK24;PIKFYVE;VRK2;HTATIP2;ULK2;DDR2;VRK1;DYRK1A;EPHB4;MARK2;STK10;MAP3K11;MKNK1;MAP3K3
prerank,regulation of viral entry into host cell (GO:0046596),0.4932012275583531,1.3328406531076915,0.1525974025974026,0.4412467241271208,1.0,9/30,15.75%,IFITM3;CD74;SNX3;TRIM68;TRIM27;IFITM2;LY6E;MID2;TRIM25
prerank,negative regulation of cytokine production (GO:0001818),0.37931881446516513,1.3326650454603897,0.05224787363304982,0.44096558345551895,1.0,19/163,5.12%,HDAC9;FCGR2B;VSIG4;LILRA5;ATP2B1;TLR8;CMKLR1;GAS6;C1QTNF3;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;PIBF1;RGCC;SRGN;GHRL;CD200R1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.338154947211117,1.332612713725104,0.002026342451874367,0.44047673518155767,1.0,230/1082,16.67%,RBPJ;DAB2;PID1;CD38;ZEB2;PF4;ETV1;EGFR;LRP6;APOE;APP;MAP3K5;KLF2;CHP2;TCF7L2;TCF4;IRF4;MDFIC;PPP3CA;FLI1;MEF2A;AHR;ZBTB16;RREB1;TFEC;KMT2A;ESR1;NCOA3;JAG1;RARG;TCF12;ACTR3;MEF2C;NR1H4;NCOA2;RPS27A;CEBPB;MITF;OSR1;RYBP;BMP2;RIPK1;KLF6;LILRB1;CD74;PHF8;HOXD8;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;TLR4;NR1D1;AXIN1;WAC;RGCC;ITGB1BP1;RPS6KA3;PRKN;BCL10;TLR2;NR3C1;TRIM56;HEY2;CLOCK;RASL11A;GRHL2;ARID1B;SPI1;NCOA7;NFIC;CAMKK2;SMAD4;ELF2;THRB;NR4A1;RNASEL;FOSL2;CD40;EPC1;ACVR2A;CHEK1;FOXM1;TNF;CD80;LYL1;KLF4;YY1;HTATIP2;REL;MED16;SATB2;TBL1XR1;PSEN1;CEBPG;E2F5;FIZ1;NR4A2;NRIP1;IRF2;KLF10;ATF6;TET3;ATRX;NCOA6;FOXC2;ESRRB;KMT2C;HIVEP1;SCAF8;TBL1X;ESR2;LBH;FOXJ3;NFATC2;DYRK1A;MED6;MLXIP;STAT6;ASXL1;MYDGF;USP21;USP16;NR2F1;ILF3;HEATR1;IGF1;SFRP1;RIPK2;RNF14;ARRB1;SP1;ANKRD49;RNF111;NUP62;ZNF296;SP100;CREBRF;TRIM16;MAML1;ELOF1;ELF1;PCID2;TFDP1;SERTAD2;JUP;MLLT10;ETS2;PHIP;SHC1;CREBBP;SREBF2;EAF2;BCL11B;MYBL2;FOXK2;NFIA;HINFP;FOXO3;CRTC3;SNX5;DCAF6;DHX33;NIBAN2;FOXK1;ZC3H12A;NAMPT;NOD2;KMT2E;SP3;FOXO1;BCAS3;TNFRSF1A;NFIX;CREB1;SFR1;PEG3;WWOX;CTBP2;TFR2;XPC;RNF187;NR1H2;EP300;RARA;TET2;KAT7;STAT3;JUND;WASL;KLF5;CRLF3;MMS19;USF1;KAT6A;HMGN5;PRKD2;PKD2;BMPR1A;RTRAF;SNW1;ENY2;MYC;NSD3;MTF1;NR2C2;USP22;SMARCD1;HDAC4;SENP1;SFPQ;ARID1A;RUNX3;ELK1;HCFC1;E2F8;KDM1A;HOXB3;MAPK7;PPARGC1B;PPM1A;RELA;ACTR2;PER1;ARNT;NFATC3;BRD4;GLIS2
prerank,regulation of GTPase activity (GO:0043087),0.37720536799438503,1.3323328441257443,0.04935370152761457,0.44045471727063223,1.0,30/177,7.34%,ARHGAP15;VAV3;FGD4;FGD6;SNX9;ARHGAP9;ARAP1;ITGB1;EVI5;MAPRE2;USP6NL;CCL8;PLXNC1;CCL19;CRK;ITGB1BP1;RAPGEF2;S100A10;RIC1;RAP1A;GSK3B;RACK1;DOCK11;OCRL;RGS8;WNK1;CD40;PLXNA4;NGEF;ARHGAP12
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5187675517610064,1.331832007897969,0.1404399323181049,0.4408782839612861,1.0,3/22,4.05%,IL15;NR1H4;RFTN1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.5049569634934007,1.3316763854972116,0.14983164983164984,0.44058586107869757,1.0,6/24,9.12%,CTNNA1;MEF2A;MEF2C;CDC42;RBM4;MAPK14
prerank,positive regulation of lyase activity (GO:0051349),-0.5193507197153384,-1.3312479181801027,0.12121212121212122,0.745468259571374,1.0,6/14,16.09%,CACNA1D;NF1;ISCU;FXN;CACNA1C;PARK7
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.40807096067864546,1.3308747333984052,0.08678237650200267,0.44157529047036315,1.0,31/88,21.31%,NELL1;EDNRB;APOE;RPS3;DAPK1;SAMD4A;RIC1;MRPL13;RACK1;MALSU1;RBM4;DNAJC1;ILF3;DDX6;NANOS3;TRIM71;SHMT1;CNOT9;CLN8;SYNCRIP;TM4SF20;EIF2AK2;RNF139;EIF2AK3;CNOT8;CNOT1;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7
prerank,neuron apoptotic process (GO:0051402),0.5385924328566722,1.3301873305424645,0.14646464646464646,0.4424658597210692,1.0,5/19,12.78%,APP;LIG4;BCL2;DIABLO;FAM162A
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.5939893562375969,1.3299174154948152,0.17790262172284643,0.44239694671422536,1.0,3/11,3.93%,LYN;MEF2C;RAPGEF2
prerank,neuron projection organization (GO:0106027),0.5547123509637366,1.329343997453229,0.15916955017301038,0.44294619170506755,1.0,5/15,9.13%,APP;GSK3B;INSR;PSEN1;PLS1
prerank,cobalamin metabolic process (GO:0009235),0.5421852261531668,1.3290205784510765,0.15398230088495576,0.44296517856544,1.0,5/17,12.25%,TCN2;MTR;LMBRD1;ABCC1;MMAB
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3466246819748363,1.3284683350701876,0.014861995753715499,0.44355479098563366,1.0,125/476,19.46%,CD38;EGFR;LRP6;APOE;MAP3K5;KLF2;TCF4;IRF4;MDFIC;FLI1;AHR;ZBTB16;RREB1;KMT2A;ESR1;MEF2C;NR1H4;CEBPB;MITF;RYBP;BMP2;KLF6;CD74;PHF8;ALX1;NR1D1;AXIN1;WAC;BCL10;TRIM56;HEY2;CLOCK;ARID1B;CAMKK2;SMAD4;ELF2;EPC1;FOXM1;TNF;CD80;LYL1;KLF4;MED16;TBL1XR1;PSEN1;NCOA6;FOXC2;ESRRB;TBL1X;ESR2;LBH;NFATC2;DYRK1A;USP21;USP16;ILF3;IGF1;SFRP1;RNF14;SP1;ANKRD49;RNF111;NUP62;SP100;TRIM16;ELF1;PCID2;ETS2;PHIP;SHC1;CREBBP;FOXK2;HINFP;FOXO3;SNX5;NIBAN2;FOXK1;KMT2E;SP3;FOXO1;CREB1;SFR1;XPC;RNF187;NR1H2;EP300;RARA;STAT3;CRLF3;MMS19;KAT6A;HMGN5;ENY2;MYC;NSD3;USP22;HDAC4;ARID1A;RUNX3;ELK1;HCFC1;PPM1A;RELA;BRD4;GLIS2;MED17;NR5A2;LHX1;NR2F2;GTF2H1;MECOM;IL6;PICALM;F2R;RFX3;MAFB;PHF5A;DVL3;PITHD1;RAI1;THRAP3;CTCF;INPP5K;RNF6;BCL3
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5111442384237755,1.3284362191452181,0.14309484193011648,0.44302209068004805,1.0,9/27,13.51%,RNASE4;ERN1;NYNRIN;CPSF3;RNASE6;LACTB2;ZC3H12D;ZC3H12A;RPP30
prerank,mRNA destabilization (GO:0061157),0.46820979309283434,1.327944572500475,0.11006289308176101,0.4435132036376028,1.0,12/38,14.38%,ZFP36L2;TUT7;ZFP36L1;RC3H1;ROCK1;TUT4;ROCK2;TRIM71;ZC3H12D;ZC3H12A;DIS3L2;POLR2D
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3600435369412057,1.3275461652338176,0.04100227790432802,0.443739312423264,1.0,59/259,16.50%,MTSS1;NRP1;FGD4;EMP1;P2RX7;RAP1B;EHD4;FGD6;EMP3;RAP2B;OPHN1;ANO6;ITGB1;ACTR3;RILP;PIBF1;RAB8B;EHD1;RAPGEF2;INTU;RAP1A;PMP22;S1PR2;OCRL;DISC1;SDCBP;ABCC4;EXOC4;VCL;TEKT5;FHDC1;RAB1A;RAB23;PIP5K1A;RFX2;PCNT;S1PR1;PDE6D;WDR11;SNX10;CEP19;STK36;PARVB;EXOC2;NTN1;SPEF1;RAB11A;IFT80;PCM1;PARVA;NPHP3;TXNDC15;FXYD5;FGD3;EXOC8;ATP6V0D1;FAM161A;GOLPH3;ACTR2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5018352360125954,-1.327540233465557,0.13439635535307518,0.7562255002211833,1.0,8/15,24.59%,AUP1;UFD1;NPLOC4;SYVN1;SELENOS;TMEM129;FAF2;SEC61B
prerank,regulation of neuron projection arborization (GO:0150011),-0.5068211988110292,-1.3273900936472045,0.13219616204690832,0.752954542753275,1.0,9/15,23.75%,DLG4;MACF1;DVL1;NTNG1;DVL2;GRIP1;MOV10;WNT5A;FZD4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4334317367379544,1.3272506456818,0.0968208092485549,0.44378488080422673,1.0,15/59,12.91%,TLR8;RPS27A;RIPK1;TLR4;BCL10;TLR2;NFKBIL1;BIRC3;ROCK1;LY96;TNF;REL;RIPK2;ROCK2;TNFRSF1A
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.48936806442574976,-1.326445761790771,0.1506172839506173,0.7530754165922913,1.0,4/17,8.98%,SORL1;PDE3B;APOC1;ALK
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6123399163387166,1.3247225522604427,0.16091954022988506,0.4485063441710063,1.0,2/10,7.34%,LRP6;ARHGAP12
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.49631325921254177,-1.3246494346160254,0.13394919168591224,0.7565812454511832,1.0,6/16,20.92%,CALM2;SLC8A1;ANK2;CACNA1C;CAMK2D;CALM3
prerank,histone H3-K4 trimethylation (GO:0080182),0.5902338777633279,1.3246493337667398,0.14836223506743737,0.44806973008612827,1.0,5/11,13.79%,KMT2A;TET3;WDR82;BEND3;TET2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5510910530853739,1.3243955424351532,0.1522491349480969,0.4480087077422202,1.0,2/17,2.10%,PTPRJ;PTPN22
prerank,phagosome acidification (GO:0090383),-0.44517453681758945,-1.3243426656693045,0.10852713178294573,0.7539844918170864,1.0,11/26,15.41%,TCIRG1;ATP6V1C1;ATP6V1D;ATP6V0A2;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C;RAB20
prerank,cellular response to glucose stimulus (GO:0071333),0.4825652548115442,1.3240262677787449,0.12218649517684887,0.44818644692266907,1.0,5/30,5.17%,RAB11FIP5;GAS6;ZBTB20;ERN1;RACK1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.4926075791683753,1.3239907156584723,0.13682432432432431,0.4476474336620981,1.0,3/29,0.63%,MCTP1;APOE;APP
prerank,regulation of macrophage cytokine production (GO:0010935),0.5682709284374674,1.3236550440996324,0.15770609318996415,0.4477468312286714,1.0,4/13,5.18%,IRAK3;LILRB1;CD74;GPRC5B
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5186303601770578,1.322457186882747,0.15066225165562913,0.4495876042608988,1.0,2/22,1.69%,APOE;ZBTB20
prerank,pyroptosis (GO:0070269),0.5506440333501547,1.322158894308109,0.16376306620209058,0.44954375625737836,1.0,3/15,11.10%,NLRC4;GSDME;CASP8
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4049183482493919,1.3221372258366821,0.10206896551724139,0.4489884788753071,1.0,16/87,10.79%,FGFR1;SPRED1;ZFP36L2;CD44;FGF23;CBL;ZFP36L1;ITGB1BP1;FRS2;KIF16B;NR4A1;HNRNPF;RAB14;POLR2B;SFRP1;SPRED2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5840014520931481,1.3214436463775505,0.1711229946524064,0.4497955439530657,1.0,3/12,5.33%,FCGR2B;NOTCH2;DOCK11
prerank,B cell homeostasis (GO:0001782),0.6082848327382784,1.3203798048683417,0.17836812144212524,0.4513613746648525,1.0,4/10,6.09%,LYN;MEF2C;DOCK11;PPP2R3C
prerank,tetrapyrrole metabolic process (GO:0033013),0.5286271650569955,1.3202923653733627,0.15478260869565216,0.45093254583855413,1.0,5/18,12.25%,TCN2;MTR;LMBRD1;ABCC1;MMAB
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5145634460906723,1.3188204329883988,0.16526138279932545,0.4534498971937214,1.0,7/22,10.79%,SPRED1;RPL23;RPS15;RPL37;RPS20;RPS7;SPRED2
prerank,ventricular septum development (GO:0003281),-0.3998729050149543,-1.318589443188132,0.1043956043956044,0.7733465545273612,1.0,10/37,13.67%,TGFBR1;SALL1;SMAD7;ROBO2;ACVR1;ROBO1;TGFBR3;MDM4;PROX1;TGFBR2
prerank,regulation of response to biotic stimulus (GO:0002831),0.49890626822081197,1.3183049335810209,0.13464696223316913,0.45392801443606773,1.0,6/28,6.71%,FCGR2B;FOXP1;PTPN22;CD36;BIRC3;ZMPSTE24
prerank,synaptic vesicle membrane organization (GO:0048499),-0.48408039611448145,-1.317977096247283,0.12614678899082568,0.7720913380418475,1.0,6/17,14.90%,SYNGR1;SNAP25;SNAP47;AP3D1;STX3;STX2
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.36919755393095116,-1.3177859671285614,0.058823529411764705,0.7689956590426429,1.0,18/50,21.90%,IVNS1ABP;SENP2;SMAD7;HDAC8;SIRT7;ARRB2;UBXN1;ADGRB1;LIMK1;N4BP1;MINAR1;PARK7;SQSTM1;GNL3L;PRR7;BAG5;TAF1;U2AF2
prerank,phospholipid translocation (GO:0045332),0.4927321992882366,1.3176127997136033,0.14119601328903655,0.45482342311886836,1.0,9/28,13.91%,P2RX7;ATP11C;ANO6;PLSCR5;ATP8B4;ABCC1;ATP10B;PLSCR4;MFSD2A
prerank,B cell proliferation (GO:0042100),0.5386094274621921,1.3174916473091351,0.15570934256055363,0.45449533340874565,1.0,4/17,6.87%,MEF2C;CD40;BCL2;CR2
prerank,cell-cell junction assembly (GO:0007043),-0.3543187587193203,-1.3166239176970231,0.07766990291262135,0.7695609922889595,1.0,13/63,5.48%,CD9;TJP1;CTNNB1;EPB41L3;CDH10;SMAD7;TBCD;CDH2;CLDN11;PIP5K1C;TLN2;CDH8;FLCN
prerank,regulation of phosphatase activity (GO:0010921),0.5070097538427223,1.3157378481112545,0.15448504983388706,0.4576264075135301,1.0,4/24,7.06%,CHP2;BMP2;PPP1R26;PPP1R17
prerank,modified amino acid transport (GO:0072337),0.5624875537732393,1.3153808613769942,0.17708333333333334,0.45778374359309665,1.0,1/15,0.22%,FOLR2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5830591724470973,1.315323697739378,0.17721518987341772,0.4572719452956025,1.0,7/12,16.78%,ADRB2;UVRAG;INSR;TNF;SMCR8;BNIP3;IGF1R
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5272077252242549,1.3153024201598316,0.1619217081850534,0.45670882057605133,1.0,5/20,8.18%,PF4;ZBTB16;ZFP36L1;CDK6;CDC73
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.43127937489410084,-1.3152599123618405,0.11873350923482849,0.771389426625291,1.0,7/28,13.62%,NAV3;PAK1;MAPT;TOGARAM1;NUMA1;CKAP5;MAPRE1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5252504562514873,1.3152339175836794,0.1611785095320624,0.45624957726313614,1.0,8/18,17.76%,BMP2;RGCC;RB1;DDR2;CLASP1;EMILIN1;MELTF;IL6
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5907989002953383,1.3146668169521278,0.18164435946462715,0.4568055504235185,1.0,6/11,18.44%,LYN;SYK;JAK1;CCL5;PRKCQ;PLAUR
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4217132684804538,1.3145128475668901,0.10822510822510822,0.4565190071135232,1.0,14/67,9.33%,EGFR;FGFR1;IL15;LYN;FER;ABI1;PIBF1;INSR;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A
prerank,chemical synaptic transmission (GO:0007268),-0.28405021158082217,-1.3138229315827104,0.008849557522123894,0.7732568513786902,1.0,56/284,12.51%,CACNB2;PLP1;GRID2;SLC1A3;KCND2;MBP;DLG2;RIMS1;DLGAP2;GRM7;CACNB4;GRIA2;UNC13C;GRIK2;GABRB3;NLGN1;SNAP25;NRXN1;DLG4;DLGAP1;GRM3;HTR2C;PRKAR1A;PTCHD1;GRIA4;CDH8;PRKAR1B;KCNQ3;KIF5A;GABRB1;HCRTR2;SPG11;RPS6KA1;DVL1;APBA1;DTNA;HRH2;GLRB;CACNA1E;CHRM3;CAMK4;SYN3;KCNA1;HTR7;CPLX1;NAPA;GRIN2A;SLC1A1;MINK1;GABRA2;RPS6KA2;SLC12A6;PTPRN2;TBC1D24;NPTX1;GLRA1
prerank,neuron projection morphogenesis (GO:0048812),-0.3158270680778126,-1.3137536741085398,0.04838709677419355,0.7696652039404778,1.0,41/137,14.22%,MAP4K4;MAP2;CTNNB1;EPB41L3;NCKAP1;CTNNA2;NLGN1;DOCK10;PAK1;IMPACT;CNTNAP2;PARD3;DLG4;SGK1;MAP1B;NYAP2;FARP1;NEFH;DIP2A;FGFR2;NCKAP1L;ANKRD27;SHANK1;MYO16;DVL1;EPHB1;CNTN4;BDNF;SDC2;NTNG1;MAP6;S100B;LLGL1;CELSR2;MINK1;AFG3L2;DSCAML1;CTNND2;APBB1;SLITRK5;ADGRB1
prerank,primary neural tube formation (GO:0014020),0.47381784081767975,1.3135898052896362,0.14590163934426228,0.4577572843409115,1.0,5/30,5.61%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5258512635675024,-1.313457785356561,0.16052060737527116,0.7671455311703881,1.0,5/13,24.28%,SORL1;GCC2;BRSK2;CD81;TM9SF4
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6005389023930493,1.3133496477075581,0.17953667953667954,0.45769232541576305,1.0,2/11,6.11%,PF4;TMEM106A
prerank,proteasome assembly (GO:0043248),-0.5421148325262138,-1.311590195166119,0.14947368421052631,0.7709609608802401,1.0,5/11,14.92%,PSMD13;POMP;PSMD9;PSMG2;PSMD4
prerank,carbohydrate catabolic process (GO:0016052),-0.40540454600681075,-1.3113966467978777,0.09836065573770492,0.7680411958883817,1.0,14/38,21.69%,HK2;PFKL;PGM1;PKM;ALDOA;NEU1;PGK1;ENO1;ENO3;TPI1;GAPDHS;GAPDH;PFKFB2;LDHA
prerank,cellular glucan metabolic process (GO:0006073),0.6006707639578456,1.3113599646865939,0.1784313725490196,0.461431894486351,1.0,4/11,9.42%,PRKAG2;GBE1;GSK3B;PPP1R3C
prerank,regulation of myoblast fusion (GO:1901739),0.6049460968240468,1.3102273470484571,0.19144981412639406,0.46327817152384926,1.0,4/11,9.12%,RIPOR2;EHD1;CD53;MAPK14
prerank,electron transport chain (GO:0022900),0.5500638763331547,1.3098828639804598,0.17025089605734767,0.46337669937271087,1.0,6/15,17.85%,ENOX2;ETFA;ETFDH;SDHA;UQCRFS1;ETFB
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.39761859783398484,1.3096899504250687,0.10317460317460317,0.46320198698651605,1.0,26/88,16.33%,APP;MYO5A;EPS15;CLTC;EXOC6B;RAB10;FTL;TXNDC5;STXBP6;KIF16B;AP4S1;EXOC4;RABEP1;RAB14;ARRB1;FTH1;VPS13C;VPS13A;SNAP23;EXOC2;CORO7;CLTA;MON2;OSBPL5;EXOC8;RABIF
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.575251918454959,1.309545463860272,0.1728395061728395,0.4629181209078934,1.0,2/13,0.60%,ITGA4;FGFR1
prerank,skeletal system development (GO:0001501),0.37664140597686424,1.3092635664144054,0.07759699624530664,0.46290866839261396,1.0,26/148,11.18%,TRPS1;EXT1;FGFR1;CMKLR1;ZBTB16;CD44;BMP2;GDF3;CNMD;RPS6KA3;NPR3;RPL13;ANKRD11;GHRL;NOTUM;ATP7A;GDF10;VKORC1;COL9A2;PAPSS2;SULF2;RFLNB;IGF1;PTGER4;SLC10A7;ETS2
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.41774637102392254,-1.3086901594353977,0.1012987012987013,0.7747638301112909,1.0,15/29,24.23%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;DGKZ;FLT3;ATG14;EEF1A2;TGFB1;TNFAIP8L3;TEK;CD81;PDGFRB
prerank,Golgi to endosome transport (GO:0006895),0.5463137608354034,1.308468454755057,0.18134715025906736,0.4640275315590622,1.0,8/16,14.97%,EPS15;KIF16B;WIPI1;RAB14;VPS13C;VPS13A;CORO7;MON2
prerank,mitotic DNA replication (GO:1902969),-0.560850685560419,-1.3083583486056842,0.16099773242630386,0.7724775070351755,1.0,6/10,26.85%,LIG1;MCM3;GINS3;MCM6;MCM2;MCMDC2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4481395721303445,1.3081898289917373,0.14354066985645933,0.4640796452335441,1.0,11/39,17.13%,MYADM;JAG1;BMP2;RGCC;WNK1;KLF4;ASS1;FXYD5;MAPK7;MIA3;PODXL
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4110230737183669,1.3081255916116095,0.11033519553072625,0.4636059942244292,1.0,20/79,13.06%,CASK;SMURF2;CRIM1;BMP2;GDF3;CNMD;TNMD;SMAD4;TRIM33;ACVR2A;HTRA3;EPN2;SULF2;UBE2D3;DAND5;EMILIN1;MMRN2;NIBAN2;ATP2B4;RBPMS2
prerank,positive regulation of lipid transport (GO:0032370),0.5724901985286465,1.3078292350100387,0.1739961759082218,0.4635845262432263,1.0,1/12,0.49%,APOE
prerank,positive regulation of myelination (GO:0031643),-0.5365589028651485,-1.3076298431864612,0.16182572614107885,0.7715861498719818,1.0,7/11,17.63%,PARD3;ITGAX;CST7;TENM4;TPPP;RNF10;EGR2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.417129950944137,1.30746871743971,0.10027855153203342,0.46376528950404283,1.0,19/72,12.91%,LIFR;GAS6;IRAK3;TSLP;PIAS1;RIPK1;CD74;BIRC3;RACK1;CBFB;RNASEL;VRK2;SYK;TNF;IFNAR2;ELF1;CASP8;JAK1;TNFRSF1A
prerank,lipoprotein localization (GO:0044872),0.5891141304531176,1.3073610131032554,0.18738049713193117,0.463412254843764,1.0,8/11,27.85%,CD36;PRKCB;ZDHHC3;MIA3;UNC119;VMP1;PPARG;ZDHHC17
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4736769267057926,1.3072105048009695,0.14710485133020346,0.46310741964037144,1.0,5/33,5.30%,PTPRJ;RPS3;PTPN22;BCL10;RC3H1
prerank,negative regulation by host of viral process (GO:0044793),0.6079790796207979,1.3071898325037694,0.17729083665338646,0.462556150882755,1.0,4/10,12.63%,CCL8;PRKN;ZC3H12A;VAPA
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5450804079958231,1.306996325782605,0.19597069597069597,0.462307308720003,1.0,1/17,0.10%,HDAC9
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.43360582516165574,-1.3064491489141186,0.13480392156862744,0.7728650466305481,1.0,6/23,7.74%,PTK2B;NOS1AP;ANK2;CACNA2D1;UBASH3B;PRNP
prerank,glycogen metabolic process (GO:0005977),0.4848987165108693,1.3064339448408204,0.15824915824915825,0.4628722841653645,1.0,8/27,10.64%,PRKAG2;GBE1;GYG1;NR1D1;PGM2L1;GSK3B;PPP1R3C;CALM1
prerank,T cell activation (GO:0042110),0.4166505125920781,1.3064306779702244,0.12022630834512023,0.46227779664211044,1.0,11/69,11.10%,IRF4;PPP3CA;PTPN22;CD44;CD74;CCL19;LCP1;ZAP70;MSN;NHEJ1;CASP8
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4844673228591509,1.3064170893290723,0.16282894736842105,0.4617000403947397,1.0,4/26,4.48%,C1QC;LILRB3;TLR4;CDK6
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5770866546252401,1.3062114719145348,0.17636363636363636,0.4615667375865833,1.0,6/13,17.63%,RPS15;NMD3;LTV1;XPO1;LSG1;RRS1
prerank,negative regulation of cartilage development (GO:0061037),-0.5208963409122859,-1.3057444916074379,0.1368653421633554,0.7720603276281842,1.0,7/13,35.99%,TGFBR1;PTPN11;GREM1;EFEMP1;PTHLH;WNT9A;SNAI2
prerank,regulation of calcium ion transport (GO:0051924),0.43120383406695595,1.3053045723031385,0.12727272727272726,0.462861575643371,1.0,15/54,14.61%,IL16;LILRA5;ATP2B1;CCR1;STIM2;LILRB1;BCL2;STIM1;HOMER1;CD33;PLN;WFS1;SLC8B1;FFAR1;PKD2
prerank,regulation of platelet aggregation (GO:0090330),-0.46956917392691266,-1.3048510787500245,0.14027149321266968,0.7720677703665029,1.0,4/17,0.79%,F11R;CD9;PRKCD;SERPINE2
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5407704040634526,1.3047296644713011,0.1622103386809269,0.4635034217412765,1.0,5/15,11.89%,MEF2A;ROCK1;MTPN;IGF1;ROCK2
prerank,smooth muscle tissue development (GO:0048745),-0.5544482098725185,-1.304499297128579,0.1656441717791411,0.7697104602345173,1.0,8/10,36.57%,NF1;PROX1;SMO;ENG;BMP4;MYLK;SHH;EFEMP2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.41549612331443647,1.3041265985854378,0.11510791366906475,0.46422472641647194,1.0,15/74,14.77%,RBPJ;PSMA7;RPS27A;HIGD1A;PSMB2;LIMD1;BACH1;CREBBP;PSMA6;EP300;HIF3A;PSMD5;PSMD1;PSMA3;ELOC
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.40539952310278426,1.3027987942872072,0.11989100817438691,0.46646671858967775,1.0,22/87,14.77%,EPS8;IQGAP2;NOTCH2;IQGAP1;BST1;ARHGAP18;CRK;RHOA;PDGFRA;ROCK1;CELSR1;BST2;ARHGDIA;RHOBTB1;TRPM2;ROCK2;ARHGAP17;NEB;RND3;RHOC;MDK;ARHGDIB
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4301833435452846,-1.3021509567949916,0.12051282051282051,0.775361685833753,1.0,6/26,13.62%,NAV3;PAK1;MAPT;TOGARAM1;NUMA1;MAPRE1
prerank,tube closure (GO:0060606),0.4680331683766929,1.3019812407847067,0.15359477124183007,0.4676129252032668,1.0,5/31,5.61%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,cellular glucose homeostasis (GO:0001678),0.44948524090425457,1.3018840716379143,0.13043478260869565,0.4672252339880958,1.0,11/41,12.86%,GAS6;ZBTB20;FOXA3;ERN1;NR1D1;LRRC8D;RACK1;FOXK2;KCNB1;FOXK1;FOXO1
prerank,membrane repolarization (GO:0086009),-0.4989816951580765,-1.3012320344548274,0.15217391304347827,0.7753494657877547,1.0,3/15,4.05%,KCNJ2;ATP1B1;ATP1B2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4829677651878437,-1.3008491802207414,0.16279069767441862,0.7731701652487204,1.0,6/16,35.85%,CLDN11;CLDN12;CLDN18;CLDN1;CLDN5;CLDN14
prerank,miRNA metabolic process (GO:0010586),0.5202453260015865,1.3007103429875664,0.15425531914893617,0.46912111668605555,1.0,7/20,12.73%,PRKRA;TUT7;SND1;DROSHA;TUT4;TRIM71;DIS3L2
prerank,B cell activation involved in immune response (GO:0002312),0.552023685896269,1.3004244942802954,0.1841620626151013,0.4691313330159701,1.0,2/13,2.01%,FCGR2B;LIG4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5459036236716589,1.2998811007450453,0.16666666666666666,0.46971037651128,1.0,4/15,9.83%,REEP3;ATL1;RAB10;RTN4
prerank,negative regulation of immune effector process (GO:0002698),0.5733199529368136,1.2980831795188141,0.1871559633027523,0.472989633094895,1.0,4/13,5.30%,FER;LILRB1;GRN;RC3H1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4380475527444741,1.2979180691913295,0.13746223564954682,0.4727595011944066,1.0,11/49,13.95%,IL15;LYN;TSLP;PARP14;PIBF1;CD40;TNF;IL6R;IGF1;TNFRSF1A;STAT3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35417054641187273,1.2977855276333234,0.04994192799070848,0.47244433757532767,1.0,69/234,18.72%,NLRC4;LRP6;APP;ESR1;FER;RPS3;IRAK3;RPS27A;CD36;RIPK1;WNT2;TLR4;CAMK1D;RGCC;TNFRSF11A;BCL10;TLR2;CLOCK;STK3;TRIM32;CD40;TNF;EDA;MTPN;PRKCB;CEBPG;RAB7B;TRIM68;DDR2;TRIM27;ESR2;CARD16;RIPK2;TFDP1;JUP;PSMA6;BUD31;CRTC3;STK36;DHX33;LAMTOR5;TERF2IP;NOD2;UBE2N;NFKBIB;EP300;MID2;STAT3;PRKD2;NFAM1;PPIA;HDAC4;TRIM25;KDM1A;PTEN;PPARGC1B;RELA;TAB3;PRDX3;TIRAP;FLOT2;ZBTB7A;PRKCQ;TAF12;IL6;EIF2AK2;ATF2;CAMK2A;TRAF6
prerank,acylglycerol metabolic process (GO:0006639),-0.40130098736808817,-1.2977625277419347,0.12607449856733524,0.7814243588487078,1.0,10/37,9.15%,ABHD12;DGKI;MGLL;DGKB;LYPLA2;LPL;GK;APOC1;DGKZ;LMF1
prerank,positive regulation of cell migration (GO:0030335),0.35266312478638134,1.2974421152617095,0.05793742757821553,0.4726185815297428,1.0,36/253,9.95%,DAB2;NRP1;NEDD9;EGFR;SEMA4A;CCR1;PPP3CA;MYADM;RREB1;KIF20B;SMURF2;ITGB1;FER;CASS4;DOCK1;SYNE2;BMP2;DRD1;GRN;ADAM9;S100A11;RAPGEF2;INSR;RACK1;PDGFRA;TRIM32;SDCBP;CCR2;GAB1;CXCL16;CCL24;DDR2;CLASP1;PDGFC;RTN4;IGF1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4761289040785915,1.2968387969957795,0.15348837209302327,0.47330748756297947,1.0,7/29,13.91%,APOE;LDLR;ZBTB20;ELOVL5;CREB1;NR1H2;MFSD2A
prerank,cytosolic transport (GO:0016482),0.38865083252928795,1.2968099996796056,0.09922680412371133,0.47275726085994607,1.0,25/108,15.10%,SNX2;TBC1D5;EPS15;CLTC;ANKFY1;EVI5;RILP;SNX6;CLN5;RIC1;LAMP1;KIF16B;PIKFYVE;RAB7A;TRIM27;DENND5A;RAB14;SNX16;VPS13C;VPS13A;SNX5;CORO7;VPS26A;MON2;WDR91
prerank,microtubule depolymerization (GO:0007019),-0.4695647393148049,-1.2968036511287042,0.15,0.7818284810804327,1.0,12/17,34.61%,NCKAP5L;STMN3;NCKAP5;STMN4;CKAP5;KIF2A;KATNB1;KIF14;KIF2C;KIF18B;KIF19;KIF24
prerank,fatty acid transport (GO:0015908),0.5407526603666968,1.2967817457094912,0.16366906474820145,0.4722192387823601,1.0,3/17,4.00%,APOE;CD36;SLC25A17
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5445671734833948,1.296646380612393,0.1893939393939394,0.47192969724952405,1.0,3/15,4.35%,ZFP36L2;ZFP36L1;NR3C1
prerank,mesoderm development (GO:0007498),-0.46649336364430133,-1.296270217513953,0.12796208530805686,0.7803064791327003,1.0,6/18,19.26%,JAK2;IKZF1;BTK;TBX6;IKZF3;GDF11
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3906479337819101,1.2959408938323098,0.11037234042553191,0.472938346013,1.0,15/98,12.36%,PID1;APOE;TBC1D5;IFNAR1;XDH;RIPK1;INSR;IL10RB;ANXA2;KLF4;MAPK14;RAB1A;ARRB1;ROMO1;ZC3H12A
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.4874932165980163,-1.2959211840298999,0.14691943127962084,0.778208943797248,1.0,5/15,14.62%,GRM7;DAGLB;GRM3;DAGLA;GRM5
prerank,macrophage migration (GO:1905517),0.5593834369176688,1.2958113061695065,0.18198198198198198,0.4726297703097253,1.0,5/13,19.01%,EDNRB;CCR2;CKLF;CCL5;P2RX4
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.529737891780757,1.2956622851082886,0.17825311942959002,0.47239192603196684,1.0,2/17,3.30%,NRP1;CDC42
prerank,negative regulation of cellular protein localization (GO:1903828),0.4564151354669626,1.2956495323982524,0.1485623003194888,0.47182011083935277,1.0,10/34,14.33%,CTNNA1;RIPOR2;MFHAS1;SPI1;GSK3B;LEPROTL1;SNX33;ROCK2;LATS2;NEDD4L
prerank,synapse organization (GO:0050808),-0.31688423781962993,-1.295439584710267,0.02304147465437788,0.7763836652087989,1.0,23/125,8.15%,APBB2;CX3CR1;CACNB2;PTPRS;DNM3;ADGRL3;CACNB4;SDK1;PTPRD;UNC13C;NLGN1;CDH2;NRXN1;LRRC4C;PPFIA2;LRFN5;PPFIA4;FARP1;DVL1;BDNF;MAPT;CNTN2;NTNG1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.4844210997984501,-1.2950848024105102,0.16705336426914152,0.7743188617067017,1.0,5/17,10.16%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.3456718780780491,-1.2948068457804272,0.08013937282229965,0.7718863424971326,1.0,35/69,28.34%,TMEM67;MAN1B1;UBE4A;AUP1;RNF103;USP19;BAG6;DNAJB2;EDEM1;UFD1;FBXO44;UBE2J1;UBXN4;NPLOC4;ECPAS;TRIM13;DNAJB14;RNF5;STUB1;SYVN1;RNF103-CHMP3;FAM8A1;SELENOS;TMEM129;FOXRED2;FAF2;YOD1;UBQLN1;SEC61B;SGTA;UBQLN2;UBE2G2;FBXO2;DNAJC18;STT3B
prerank,relaxation of cardiac muscle (GO:0055119),-0.5140852657014765,-1.2945937415219062,0.17381974248927037,0.7692773998223287,1.0,4/13,8.36%,KCNJ2;ATP1B1;SLC8A1;RGS2
prerank,positive regulation of tissue remodeling (GO:0034105),0.6024312758490917,1.2945536812247207,0.19548872180451127,0.47351495710538966,1.0,3/10,11.89%,IL15;ROCK1;ROCK2
prerank,regulation of interleukin-4 production (GO:0032673),0.5110118724122564,1.2945010238212447,0.16938110749185667,0.47307451544757706,1.0,4/21,6.52%,IRF4;CEBPB;FCER1G;SYK
prerank,positive regulation of vasculogenesis (GO:2001214),0.5896349931816542,1.293952738902789,0.1948529411764706,0.47368330535621717,1.0,3/10,4.82%,RIN2;RAPGEF2;RAP1A
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4963902466371913,1.2938192482959856,0.15485996705107083,0.47337076155766755,1.0,7/22,11.89%,MEF2A;SMAD4;ROCK1;GLRX3;MTPN;IGF1;ROCK2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5938790160145155,1.293535715573322,0.18198198198198198,0.47336343918246926,1.0,2/11,2.69%,PF4;RIPK1
prerank,positive regulation of chemokine production (GO:0032722),0.4490715720367398,1.2934685612633317,0.15174506828528073,0.4729067066155148,1.0,10/44,8.26%,APP;TSLP;CD74;TLR4;HMOX1;TLR2;IL17RA;SYK;TNF;IL6R
prerank,activation of protein kinase A activity (GO:0034199),-0.4896207718554258,-1.2933930183577216,0.17123287671232876,0.7704967514753793,1.0,5/16,10.16%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,calcineurin-mediated signaling (GO:0097720),0.5889154932421016,1.2933927600053967,0.19889502762430938,0.4719115018771531,1.0,4/10,19.99%,PPP3CA;NFATC2;NFATC3;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5889154932421016,1.2933927600053967,0.19889502762430938,0.4719115018771531,1.0,4/10,19.99%,PPP3CA;NFATC2;NFATC3;NFATC1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.36286605906852076,-1.2931248023873414,0.06349206349206349,0.7680429210579884,1.0,18/57,13.24%,DLG2;DLGAP2;PTK2B;GRIA2;NLGN1;DLG4;DLGAP1;DLG3;GRIA4;SHANK1;GSG1L;ACTN2;CACNG7;GRIN2A;MINK1;NPTX1;CACNG8;SHISA7
prerank,intracellular pH reduction (GO:0051452),-0.4015063067136815,-1.2927878339185992,0.12894736842105264,0.7658064142335234,1.0,13/33,17.18%,TCIRG1;ATP6V1C1;DMXL2;ATP6V1D;ATP6V0A2;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C;RAB20;TMEM9
prerank,regulation of smooth muscle contraction (GO:0006940),0.50361156883604,1.2922385193597994,0.1733102253032929,0.47388971010173336,1.0,2/20,2.53%,ATP2B1;ADRB2
prerank,positive regulation of catabolic process (GO:0009896),0.4159363047216238,1.2922179484314813,0.13352685050798258,0.47334435035095596,1.0,16/65,15.41%,WWP1;SMURF2;RILP;AXIN1;PRKN;GSK3B;TRIM32;TNF;RAB7A;TNFSF12;NKD1;ATG7;FOXO1;NEDD4L;GPC3;RNF41
prerank,covalent chromatin modification (GO:0016569),-0.5008675664557398,-1.2920854373548076,0.15654205607476634,0.7649878926805308,1.0,8/14,33.67%,SIRT7;PARK7;HDAC1;AURKB;MBD2;HLCS;HELLS;SIRT1
prerank,regulation of response to external stimulus (GO:0032101),0.37986996078471064,1.2919556478230378,0.10947930574098798,0.4732814492599916,1.0,29/121,16.82%,FCGR2B;ALOX5;FOXP1;ALOX15;BST1;PTPN22;CD36;GRN;BIRC3;PDE6A;GUCY2D;PDGFRA;STK24;ZMPSTE24;CXCR4;CCR2;PPEF1;CALM1;CASP8;PSMA6;USP14;NOD2;SAMHD1;SEMA7A;ERAP1;GRK4;RELA;BRD4;TIRAP
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.4135600858685547,-1.2916187034241207,0.12010443864229765,0.7633350580496588,1.0,6/28,18.82%,SIRPA;CCDC88B;NCKAP1L;XRCC6;THY1;PYCARD
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5135599070691649,1.291154135065845,0.1978021978021978,0.47436903077429105,1.0,5/18,8.05%,EGFR;ESR1;RIPK1;TNF;NCOR1
prerank,response to sterol (GO:0036314),-0.5497672958587464,-1.2910039038282046,0.16875,0.7624727024727214,1.0,5/11,21.52%,TGFBR1;CCL3;TGFBR2;ABCA2;TGFB1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.545984616632798,1.2908885017557608,0.18673647469458987,0.47434865077688493,1.0,6/14,14.85%,RHOA;ITGB1BP1;KLF4;STARD13;MMRN2;TBXA2R
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3165416268150713,-1.2900295578566694,0.02830188679245283,0.7628479665767376,1.0,26/118,7.51%,ABI3;TANC2;ADGRB3;SEMA4D;CTNNB1;EFNA5;FMNL2;CLASP2;PAK1;CDH2;HECW2;LRRC4C;SPARC;CAMSAP1;PPFIA2;ETS1;FERMT2;FGF2;KIF1A;NSMF;FGFR2;NF1;KNDC1;SDC2;MAPT;ZMYM6
prerank,epithelial cell-cell adhesion (GO:0090136),0.5742148859917475,1.2897070271576556,0.1960431654676259,0.4762641393517054,1.0,4/11,11.13%,SERPINB8;THBS4;VCL;JUP
prerank,cellular protein catabolic process (GO:0044257),0.4194141202996002,1.2891083296883092,0.15129682997118155,0.47695761521606517,1.0,17/59,14.11%,AP2A2;CTSC;CLTC;RIPK1;SIAH2;PRKN;CTSB;AP2S1;RAB7A;MDM2;CLPX;VLDLR;CASP8;PSMA6;DENND3;AP2B1;CLTA
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4868499024155447,-1.2888633613523657,0.16210045662100456,0.763966341543703,1.0,8/16,15.00%,DDX5;DDX17;SAFB;TRIP4;AR;EGLN2;PADI2;NCOA4
prerank,ventricular septum morphogenesis (GO:0060412),-0.4156067165108643,-1.2887572204654965,0.14108910891089108,0.761023994153197,1.0,11/27,20.83%,TGFBR1;SMAD7;ROBO2;ACVR1;ROBO1;TGFBR3;PROX1;TGFBR2;NOTCH1;TGFB2;SOX11
prerank,regulation of focal adhesion assembly (GO:0051893),0.42229637415627796,1.2885592525642036,0.14069591527987896,0.47753347079536257,1.0,16/54,12.88%,NRP1;PTPRJ;PEAK1;RHOA;ITGB1BP1;S100A10;ROCK1;PTPRA;DUSP22;VCL;RCC2;CLASP1;CORO1C;SFRP1;ROCK2;BCAS3
prerank,regulation of chromatin binding (GO:0035561),0.598154414093736,1.2883616504706092,0.18968692449355432,0.4773764308850411,1.0,4/10,9.46%,DDX11;GMNN;BTAF1;KDM4D
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5617930097987598,1.2879547994447613,0.18330308529945555,0.47764682700031064,1.0,4/14,5.18%,LILRB1;CD74;BCL10;GPRC5B
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4635800656092503,1.2879406229904637,0.16149068322981366,0.4770871274686246,1.0,8/34,8.12%,LYN;MFHAS1;IRAK3;TLR4;NR1D1;NFKBIL1;LY96;RAB7B
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4934467503401952,1.2875984291604543,0.17616580310880828,0.4772182723223815,1.0,2/24,0.82%,NRP1;SEMA4A
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4969313023029447,1.2875548895326652,0.17558528428093645,0.47672592235702965,1.0,5/24,15.21%,PID1;GFPT2;CYCS;COX10;MYC
prerank,atrial septum morphogenesis (GO:0060413),0.594488724502094,1.287091975067325,0.1774193548387097,0.4771396280752956,1.0,2/10,4.52%,NOTCH2;HEY2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4420540418482678,1.2870751769651894,0.14126984126984127,0.4765989452536126,1.0,8/44,3.96%,NRP1;GPR65;CDC42;RGCC;ARHGEF10L;RHOA;ITGB1BP1;S100A10
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4813404654894959,1.286972988053044,0.17567567567567569,0.4762121941883597,1.0,6/25,7.60%,IRF4;RPS3;SPTBN1;PDE4D;CD80;CCR2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.528863669498356,1.2868413926985238,0.18421052631578946,0.47595666570427736,1.0,2/17,2.40%,CEBPB;OSR1
prerank,microtubule polymerization (GO:0046785),-0.42006588954625756,-1.2865941355805837,0.12814070351758794,0.7663071042673965,1.0,14/28,26.79%,CLASP2;FGF13;MAPT;TUBGCP5;CCDC57;TPPP;CKAP5;TUBGCP3;GOLGA2;TUBGCP6;PIN1;HDGFL3;MAP7D3;TPPP3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.28783375650313164,-1.2865349501895342,0.03968253968253968,0.7631720889870367,1.0,84/241,25.08%,DDX5;SNRNP70;SRRM2;FUS;ZCCHC8;HNRNPA3;HNRNPUL1;ELAVL2;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;HNRNPU;DHX35;SNRNP48;PUF60;PPIL3;SRSF2;PNN;SNRPA1;SRSF10;CCAR1;PPIE;PRPF4;WBP4;SNRNP200;SYF2;DNAJC8;DDX41;CSTF2;CWC25;RNPS1;XAB2;USP49;RAVER2;SNRPN;SRRT;PRPF19;CD2BP2;U2AF1;PQBP1;UPF3B;NOVA2;CASC3;SF3B1;SRSF12;NCBP1;POLR2C;PCBP1;PCBP2;PRPF6;HNRNPA1;DDX23;SNIP1;ZMAT5;HNRNPH1;RBM5;CLP1;SNRPB2;SRSF11;SRSF9;DHX9;SART1;RBM17;RBM14;ALYREF;ESS2;SART3;TFIP11;U2AF2;IK;POLR2L;METTL3;UBL5;PRPF31;ZCRB1;HNRNPA0;TRA2A;WDR83;SRSF6;TRA2B;ISY1
prerank,regulation of phosphorylation (GO:0042325),0.3867608759122862,1.2865095302761127,0.1102257636122178,0.4760582988781096,1.0,25/120,12.77%,NRP1;EGFR;APP;PRKAG2;LYN;ANG;FER;BCL10;PGAM1;ROCK1;NOP53;SDCBP;HSPB1;PSEN1;NUP133;FNIP1;KCTD20;KDM4D;PPP2CA;CORO1C;NUP62;PHIP;NUP98;CDKN2C;DSCAM
prerank,response to estrogen (GO:0043627),0.47471153327240617,1.2863685009689447,0.16555183946488294,0.4757710846749184,1.0,11/31,15.75%,ESR1;GHRL;ARID5A;TRIM24;ASH2L;SFRP1;BCAS3;SFR1;EP300;RARA;TRIM25
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6020093088700195,1.286328553102803,0.19807692307692307,0.47528855349633425,1.0,3/10,7.60%,OXSR1;WNK1;CCR2
prerank,pulmonary valve morphogenesis (GO:0003184),0.5265417393744752,1.2860280293991864,0.176056338028169,0.47535561966714324,1.0,3/17,4.52%,NOTCH2;JAG1;HEY2
prerank,negative regulation of signal transduction (GO:0009968),0.3533681973566778,1.2857044215916265,0.0755813953488372,0.47545360288068156,1.0,68/249,20.78%,PID1;EGFR;PTPRJ;FBXW7;PTPN18;LYN;HERC4;PTPN12;IRAK3;BMP2;TMEM25;XDH;SIAH2;CNMD;TNMD;NRARP;NFKBIL1;RB1;RACK1;NOTUM;BCL2;CYP26C1;TNF;EPN2;PRKCB;NR4A2;MAPK8IP2;SULF2;CARD16;ASXL1;NKD1;CYP26B1;SFRP1;ARRB1;EGFL7;EMILIN1;KANK2;MMRN2;NIBAN2;NTN1;WWOX;GPC3;RGS14;NLK;VGLL4;PALM;PTEN;CREB3L1;GLIS2;ZBTB7A;CCL5;PRKCQ;LGR4;SPRY2;PIP4K2A;TLE1;TRIB1;INPP5K;ENPP1;CSNK2A2;CSNK2A1;TMBIM6;CNOT1;NFATC1;GRB14;SNCA;PHACTR4;SIAH1
prerank,organic hydroxy compound transport (GO:0015850),0.45652909250812435,1.2855821683591822,0.1382488479262673,0.47517367753164846,1.0,8/36,14.39%,SLC10A6;NR1H4;NCOA2;GHRL;ABCC4;SLC10A3;NPC2;RBP4
prerank,protein depolymerization (GO:0051261),-0.41997784318210285,-1.2854226335570655,0.13178294573643412,0.7639803485162379,1.0,13/27,23.87%,NCKAP5L;TWF2;MICAL3;STMN3;NCKAP5;STMN4;CKAP5;KIF2A;MICAL2;TWF1;KATNB1;WDR1;KIF14
prerank,RNA processing (GO:0006396),-0.29491327311295606,-1.2850715444867271,0.01639344262295082,0.7619944398674067,1.0,49/176,16.83%,IVNS1ABP;SON;LUC7L3;FUS;CPSF6;DDX17;ZCCHC8;HNRNPUL1;THOC1;SETX;ADAR;AKAP8L;SRRM4;SRRM1;ADARB2;SRSF5;PABPN1;HNRNPA2B1;DDX39B;RP9;TARDBP;DDX47;HNRNPU;SNRNP48;ELAVL4;SRPK1;SRSF2;GEMIN2;SNRPA1;PRPF4;WBP4;TCERG1;CCAR2;RNPS1;DDX20;SRPK2;SNRPN;ADARB1;U2AF1;LIN28B;SF3B1;NCBP1;PRPF6;DDX23;ZMAT5;HNRNPH1;RBM5;RBM39;CLP1
prerank,endosome organization (GO:0007032),0.4498532091180854,1.284392222380188,0.14984709480122324,0.4771719398180426,1.0,8/41,11.80%,TMCC1;RILP;SNX3;PI4K2B;WASHC4;CORO1C;SNX10;SNX33
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3424402453415804,-1.2842178087531655,0.0944055944055944,0.7619055064365327,1.0,26/72,17.52%,RIMS1;PTK2B;ADCY8;SLC24A2;GRIK2;NLGN1;RIMS2;NRXN1;DLG4;LGMN;FLOT1;KCTD13;FMR1;SHANK2;CACNG7;GRIN2A;LGI1;CACNG8;SHISA7;VAMP2;EPHB2;ADCY1;RIMS3;CACNG4;SYT1;SQSTM1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4640692480258226,1.2832851399608998,0.17543859649122806,0.47903120317058306,1.0,8/33,16.19%,TCF7L2;GAS6;NUPR1;WFS1;CAST;RAMP2;MDK;MAPK7
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3859093639220616,1.283284779618377,0.11451398135818908,0.4784567332470868,1.0,22/101,10.75%,PF4;LYN;MEF2C;PTPN22;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;NFKBIL1;LY96;TNF;CD80;CDC73;MAPK14;CARD16;CHMP5;CD68
prerank,positive regulation of synapse assembly (GO:0051965),-0.42067402134601234,-1.282428895806992,0.1347708894878706,0.7652684750272339,1.0,12/27,18.98%,GRID2;SEMA4D;PTPRD;NLGN1;NRXN1;EPHB1;BDNF;SYNDIG1;IL1RAPL1;EPHB2;IL1RAP;VSTM5
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5837162160894449,1.2823889494386955,0.21062271062271062,0.4798234335038921,1.0,3/11,4.05%,COLEC12;RIPK1;RFTN1
prerank,cardiac muscle cell differentiation (GO:0055007),0.49298267974543136,1.2817175073738054,0.17443868739205526,0.48066874190257985,1.0,4/21,2.92%,MEF2C;BMP2;MYH6;ALPK3
prerank,regulation of cation transmembrane transport (GO:1904062),-0.404718990424839,-1.281546195819649,0.11936339522546419,0.765392248485586,1.0,7/29,9.31%,DPP10;FGF12;DPP6;SNTA1;KCNIP4;CACNA1D;WNK3
prerank,regulation of RNA metabolic process (GO:0051252),0.4190982552365561,1.2814535548962187,0.15683453237410072,0.480643971321285,1.0,12/59,8.76%,AHNAK;MBNL1;OAS2;RASA1;MITF;TNFRSF1B;PTBP3;RC3H1;MBNL2;HNRNPF;PTBP2;GRSF1
prerank,organonitrogen compound catabolic process (GO:1901565),0.4189010885119871,1.281227258778542,0.16220238095238096,0.4805397407857023,1.0,12/57,10.29%,NPL;CPQ;PLA2G7;GNPDA1;CLN5;CLN6;PNPLA8;LNPEP;SGPL1;TRIM24;CLPX;ENPEP
prerank,engulfment of apoptotic cell (GO:0043652),-0.4874696767399234,-1.2806099465670984,0.15217391304347827,0.7661412630066434,1.0,8/15,27.41%,XKR6;RHOBTB2;XKR4;RHOH;ADGRB1;RHOG;XKR8;MEGF10
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.42013615864491116,-1.2802190954870833,0.1387434554973822,0.764279306077053,1.0,12/27,27.20%,RIMS1;RIMS2;SYT6;VAMP2;SYT8;RIMS3;SYT1;SYT13;VAMP7;SYT7;SYT5;SYT17
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4086604799945581,1.280033836450354,0.13576642335766423,0.48244314213867284,1.0,18/68,20.35%,FOLR2;TPK1;TCN2;MTR;MTHFD2L;LMBRD1;ABCC1;AOX1;MMAB;SHMT1;SLC23A1;SLC23A2;BTD;SLC5A6;ENPP1;CYB5A;PDZD11;MTHFD1L
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5385508442291469,1.279977461909006,0.19584055459272098,0.48198770798485874,1.0,3/15,7.60%,NKAP;SYK;CCR2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5313860178342584,1.2795811573322649,0.20284697508896798,0.48227586697971153,1.0,2/16,4.11%,AOAH;PGM2L1
prerank,neuron projection development (GO:0031175),-0.29774484358739683,-1.2794482920218995,0.040229885057471264,0.7640366281173009,1.0,52/168,16.22%,PLP1;MAP4K4;PTPRM;MAP2;EPB41L3;NCKAP1;GRM7;GPM6B;NLGN1;ATXN10;WHRN;DOCK10;PAK1;CNTNAP2;DLG4;SGK1;CAMSAP1;NYAP2;NEFH;DIP2A;MICALL1;NCKAP1L;ANKRD27;ZFYVE27;SHANK1;IFT88;MYO16;EPHB1;CNTN4;BDNF;RASGRF1;MAPT;ERCC6;STX3;STMN3;ADCYAP1;TMEM108;MINK1;STMN4;TBC1D24;LGI1;PQBP1;PPP1R9A;CTNND2;OMG;RAB35;MAP4;ADGRV1;DCLK1;ULK1;EPHB2;TBC1D23
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5556948804077414,1.2793829196743456,0.2014260249554367,0.48212806685051807,1.0,3/13,2.78%,GAS6;TSLP;CD74
prerank,cartilage development (GO:0051216),0.4330656886999644,1.2783160018896491,0.15725190839694655,0.4838522341108075,1.0,7/49,5.45%,ZBTB16;MEF2C;CD44;OSR1;BMP2;GHRL;ATP7A
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5517624754475834,1.2779289576952808,0.1977818853974122,0.4840811211540374,1.0,4/13,9.33%,CD44;CD74;MDM2;DYRK1A
prerank,DNA replication initiation (GO:0006270),0.44404401007709826,1.277741213845335,0.16246056782334384,0.48388464457621916,1.0,13/37,16.92%,ORC5;POLE2;ORC2;PRIM2;TOPBP1;RPA1;GMNN;PURA;POLE3;RPA3;POLE4;MCM8;PRIM1
prerank,regulation of gene expression (GO:0010468),0.3264873799887417,1.2773315022132212,0.011144883485309016,0.4842056908296793,1.0,166/903,15.84%,RBPJ;PID1;MSR1;AHNAK;PF4;NELL1;APOE;P2RX7;APP;NOTCH2;CCR1;FOXP1;FBXW7;MBNL1;AHR;MYADM;RREB1;CRIP1;GAS6;FOXN2;ADAM19;NFXL1;ESR1;RPL23;C1QTNF1;LYN;HINT1;RPS3;MEF2C;PTPN22;NCOA2;CEBPB;KRAS;MITF;OSR1;RYBP;BMP2;CD36;XDH;PARP14;LILRB1;CD74;FGF23;DRD1;LAMP3;TLR4;CD46;RGCC;ZFP36L1;PRKN;NFKBIZ;PDE2A;TLR2;NR3C1;PTBP3;NKAP;CDK6;HEY2;CLOCK;SPI1;GSK3B;RB1;NDFIP1;INSR;RACK1;PUM2;RC3H1;ROCK1;TGFBRAP1;MBNL2;TCF7;ATXN1;SETDB2;HNRNPF;KDM6A;TNF;ZNF148;LYL1;KLF4;YY1;REL;RPL5;WNT6;HFE;PSEN1;PTBP2;IRF2;VSTM2A;TRIM68;RO60;ATRX;TDRD7;MSN;ZNF628;LIMD1;ESRRB;BACH1;TRIM27;GRSF1;SMCR8;LIN54;RPS7;ESR2;MAPK14;HMG20A;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;TESMIN;IGF1;SFRP1;JMJD1C;RNF14;SP1;MED26;ATXN1L;CASP8;EMILIN1;CREBBP;MYBL2;FOXK2;NFIA;HINFP;AFF1;ROCK2;LAMTOR5;TRIM71;ZC3H12A;SLC38A2;ATP2B4;TERF2IP;RAMP2;SP3;GJA1;PEG3;PSPC1;LARP4;ZNF326;RNF187;EP300;KAT7;NDFIP2;TNRC6C;STAT3;MLF2;HMGN5;ATXN7L3B;BMPR1A;WWC1;NAB1;RPL11;NOVA1;FN1;MYC;NSD3;MYT1;NR2C2;HDAC4;NLK;SFPQ;UBAP2;RUNX3;HCFC1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5692077496667317,1.2768912365593572,0.19454545454545455,0.48461606964152487,1.0,1/11,0.34%,NRP1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5690738973164893,1.2761991577167717,0.2114695340501792,0.4854855472461171,1.0,6/12,23.02%,MYO7A;NKD1;DSCAM;STAT3;SDK2;PROM1
prerank,cellular response to insulin stimulus (GO:0032869),0.3733834262325744,1.2760068956770205,0.12352168199737187,0.48530479726676595,1.0,25/124,12.86%,HDAC9;MYO5A;TBC1D4;RAB31;FER;ATP6V1B1;RAB8B;RAB10;ZFP36L1;SLC2A4;IRS2;GSK3B;INSR;ATP6V0A1;GAB1;PIK3C2A;AP3S1;ATP6V1A;FOXC2;DENND4C;ZNF106;PHIP;SHC1;NAMPT;FOXO1
prerank,positive regulation of neurogenesis (GO:0050769),-0.3386358967829583,-1.2755854441402095,0.053156146179401995,0.7752935284852901,1.0,17/68,12.06%,CX3CR1;NUMB;CUX1;CTNNB1;PTPRD;ROBO2;PLXNA2;TGM2;SS18L1;ROBO1;NUMBL;MAP6;TIAM1;TIAM2;CAPRIN1;SS18L2;IL1RAPL1
prerank,negative regulation of mRNA processing (GO:0050686),-0.4981325562802431,-1.2752551608900926,0.20449438202247192,0.7734024609311785,1.0,8/15,24.60%,SRSF10;RNPS1;C1QBP;SRSF12;SFSWAP;SRSF9;U2AF2;SRSF6
prerank,regulation of cholesterol storage (GO:0010885),0.5389550480628305,1.2746675831501912,0.20075046904315197,0.4876128490387349,1.0,2/15,3.91%,MSR1;EHD1
prerank,negative regulation of axon extension (GO:0030517),-0.4063324019171789,-1.2744814304454328,0.16145833333333334,0.7733167821488206,1.0,7/30,9.66%,MAP2;SEMA4D;PTPRS;SEMA4C;DIP2B;SEMA4G;MAG
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3976472031968079,1.2743856017529218,0.12661870503597122,0.4876144068498884,1.0,8/76,3.46%,NRP1;P2RX7;SNX9;ALOX15;FER;FCHSD2;CDC42;NES
prerank,transcription by RNA polymerase II (GO:0006366),0.33990519600979296,1.2741961873041818,0.052451539338654506,0.48740151563125816,1.0,87/305,20.02%,RBPJ;HDAC9;MAF;NOTCH2;RREB1;C5AR1;ESR1;RARG;NR1H4;NR2C1;NR1D1;CDK12;NR3C1;NFIC;THRB;CBFB;NR4A1;TRIM24;NELFA;CPSF3;MED16;TBL1XR1;RNGTT;NR4A2;IWS1;NCOR1;CDC73;GTF2A2;SNRPG;ESRRB;SCAF8;TBL1X;MED18;ESR2;RPRD2;MED20;NR2F1;POLR2B;SP1;MED26;MAML1;ELOF1;PCID2;TFDP1;GTF2E2;CREBBP;EAF2;CDK13;DEK;NFIX;ELP4;KLF13;GTF2A1;NR1H2;RARA;MBD1;MED27;POLR2D;ELOC;PAPOLA;SNW1;NR2C2;WDR33;GTF2H3;GTF2B;CPSF2;MED17;NR5A2;LHX1;TAF12;GTF2H1;XBP1;NR6A1;INTS1;ZBTB1;CSTF2T;POLR2F;THRA;DDX21;CCN2;TRIP11;AFF4;DTX1;NELFE;SNRPE;CTDP1;INTS2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.38609129587999114,-1.2741608311596013,0.10817941952506596,0.7713484897881702,1.0,8/35,12.33%,CDH23;CDH10;NLGN1;CDH13;CDH8;CDH9;CDH22;ATP2C1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.44595829200829556,1.273643669525893,0.17043740573152338,0.48804715819410155,1.0,14/40,19.61%,FBXW7;RPL23;AXIN1;RPL5;HFE;RPS7;UBQLN4;RPL11;XPO1;PTEN;GLMN;RNF139;CSNK2A2;CSNK2A1
prerank,intracellular cholesterol transport (GO:0032367),0.5481096837874725,1.273433862686011,0.18980667838312829,0.48792990344207277,1.0,4/15,12.09%,LRP6;LDLR;NPC2;RELCH
prerank,antibacterial humoral response (GO:0019731),0.5364314749864008,1.2729765666521622,0.1840277777777778,0.48836349260261247,1.0,3/16,7.33%,ANG;RPL39;RNASE6
prerank,cellular response to hormone stimulus (GO:0032870),0.40669227074917935,1.2728417932984903,0.1411589895988113,0.4881230996147128,1.0,20/69,14.01%,NCOA3;MEF2C;NCOA2;ZFP36L1;NR3C1;KLF9;ARID5A;CTSB;THRB;TRIM24;SFRP1;SLIT3;GAS2L1;RAMP2;BCAS3;SFR1;RARA;STAT3;ATP1A3;ATP1A1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.4951548472885221,-1.2725935626585638,0.12731481481481483,0.7740925076628627,1.0,6/13,21.01%,CACNB2;ANK2;CACNA1C;KCNN2;KCNJ3;GJC1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.44167109623968437,1.272465474181041,0.15527950310559005,0.4883736089347328,1.0,9/44,12.01%,PRKAG2;ALOX15;OSBPL9;HMGCR;HSD3B7;CYP27A1;PMVK;OSBPL1A;LBR
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.49293634306065703,1.2719161099819571,0.18585526315789475,0.48905818564785986,1.0,10/24,19.68%,ALOX5;PRKN;RACK1;WFS1;NR1H2;USP25;CREB3L1;XBP1;TXNDC12;TMBIM6
prerank,histone H3 deacetylation (GO:0070932),0.5324247854348919,1.2718663156217913,0.1781818181818182,0.48858260928006936,1.0,1/15,0.10%,HDAC9
prerank,lamellipodium organization (GO:0097581),0.46642842807119206,1.2707553826522648,0.1744186046511628,0.49044754545658004,1.0,13/29,24.28%,SNX2;ITGB1;VCL;S1PR1;PARVB;SPEF1;GOLPH3;ARFIP2;ARHGEF6;KIT;PTPRO;CCDC88A;SNX1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.4432038985900212,-1.2706740268433194,0.14903846153846154,0.7751575897991012,1.0,6/21,9.10%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.4432038985900212,-1.2706740268433194,0.14903846153846154,0.7751575897991012,1.0,6/21,9.10%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.514541503591418,1.2703325574780062,0.16607142857142856,0.4908090191357118,1.0,5/17,9.33%,CD44;CD74;PRKN;MDM2;DYRK1A
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.42790901383374813,-1.2701096148119722,0.14858490566037735,0.7741647716651227,1.0,9/23,29.78%,HSPA4;BCL2L11;SAMM50;BMF;TIMM8B;TIMM29;AGK;PMAIP1;TIMM13
prerank,receptor internalization (GO:0031623),0.43382993442954654,1.2700632894247708,0.16129032258064516,0.4908280357258765,1.0,10/44,6.66%,RAB31;CLTC;ITGB1;CALCRL;CD36;FCER1G;LILRB1;ADM;SYK;LMBRD1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5443951522677527,1.2699371873707408,0.20335820895522388,0.4905032978027111,1.0,5/15,8.74%,CD44;CD74;PRKN;BCL2;MDM2
prerank,regulation of programmed cell death (GO:0043067),0.3640165264469265,1.2698234824646442,0.09014423076923077,0.4901581673271987,1.0,30/161,13.00%,TNFRSF25;HIP1;NLRC4;IFT57;TPT1;RARG;RPS3;DAPK1;STEAP3;RIPK1;PRKN;BIRC3;ACER3;CTSB;NOP53;TRIM24;TNF;HTATIP2;RTN4;FBXO11;NUP62;WFS1;CHM;DFFA;CREBBP;KANK2;PPP1R13B;FBXO10;GLS2;DDX42
prerank,myelin assembly (GO:0032288),-0.5524014282686762,-1.2696534262219255,0.18336886993603413,0.7726937583751619,1.0,6/10,22.64%,CD9;EPB41L3;TENM4;TPPP;ABCA2;GPC1
prerank,regulation of response to stress (GO:0080134),-0.5537560580123997,-1.2695034733528099,0.18376068376068377,0.7701327415441472,1.0,2/10,1.42%,EIF4G1;ADCY8
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.41657098994356445,1.269338223995446,0.16468842729970326,0.4906487572284561,1.0,11/57,9.95%,IL15;LYN;TSLP;PARP14;PIBF1;CD40;TNF;IL6R;SH2B3;PPP2CA;IGF1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.509728435246432,1.268896390894749,0.1821561338289963,0.49097812208364233,1.0,2/18,0.97%,APOE;CTSC
prerank,cellular response to type I interferon (GO:0071357),0.4375521315858763,1.2686640458189604,0.16925465838509315,0.49035433594782785,1.0,11/41,11.88%,IRF4;IFITM3;OAS2;IFNAR1;RNASEL;BST2;IFNAR2;IRF2;IFITM2;SP100;JAK1
prerank,type I interferon signaling pathway (GO:0060337),0.4375521315858763,1.2686640458189604,0.16925465838509315,0.49035433594782785,1.0,11/41,11.88%,IRF4;IFITM3;OAS2;IFNAR1;RNASEL;BST2;IFNAR2;IRF2;IFITM2;SP100;JAK1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4922156416754251,1.2681681252309385,0.1973018549747049,0.49086098683420665,1.0,4/22,7.60%,EDNRB;GNAI3;STIM1;CCR2
prerank,negative regulation of DNA replication (GO:0008156),0.5471824582644933,1.2673496217403781,0.20390070921985815,0.49208540581790444,1.0,4/13,16.37%,S100A11;GMNN;TERF1;ATR
prerank,regulation of transport (GO:0051049),0.4549700504298849,1.2666265777848777,0.19047619047619047,0.4931392014578481,1.0,8/36,17.41%,NRP1;PRKN;ACTB;GAPVD1;RAB11A;WWC1;REEP6;FES
prerank,positive regulation of developmental growth (GO:0048639),-0.3635566019963856,-1.266288177298423,0.11239193083573487,0.7792082255700882,1.0,15/49,21.34%,SEMA4D;RIMS1;RIMS2;ZFYVE27;MACF1;TWF2;BDNF;MAPT;PLCB1;LIMK1;CDKL5;SYT1;DBN1;CPNE5;SMURF1
prerank,regulation of small molecule metabolic process (GO:0062012),0.4718548105498071,1.2643727551142865,0.20962199312714777,0.4974713421646425,1.0,6/28,12.28%,APOE;NR1H4;PRKN;FMO5;FOXK2;FOXK1
prerank,regulation of T cell chemotaxis (GO:0010819),0.5745084120903196,1.2643040539907169,0.20676691729323307,0.49708238490568857,1.0,3/11,7.60%,OXSR1;WNK1;CCR2
prerank,chromatin assembly or disassembly (GO:0006333),-0.5316034155965463,-1.2636129692732854,0.2065439672801636,0.7861619970826705,1.0,8/11,38.16%,HDAC8;TP53;HIRIP3;CHAF1A;MTA2;NOC2L;SUV39H2;M1AP
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4569306430177297,1.263338386867643,0.17197452229299362,0.49851415426448165,1.0,7/30,9.33%,TPT1;RPS3;CD44;CD74;TRIM32;MDM2;DYRK1A
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.47778749624075956,-1.2631775220857715,0.1938534278959811,0.7847051503472153,1.0,6/16,17.56%,GPR137B;GPR137C;RRAGD;FLCN;SEH1L;RRAGB
prerank,response to interleukin-6 (GO:0070741),0.5839359543263131,1.2631510600421436,0.20970873786407768,0.4983926432249489,1.0,1/10,0.05%,PID1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5490607953676612,1.2628299452337757,0.21908127208480566,0.49847137931816315,1.0,4/13,16.29%,SNX6;CBL;CBLB;ZGPAT
prerank,positive regulation of protein kinase activity (GO:0045860),0.3630187276203635,1.2624307812503812,0.09147869674185463,0.49876560620959187,1.0,29/148,10.64%,NEDD9;LILRA5;IQGAP1;SNX9;PRKAG2;GAS6;RASSF2;CASS4;ADRB2;AXIN1;CCL19;RHOA;RAPGEF2;DOK7;RAP1A;INSR;PAK2;GPRC5B;INCENP;STK3;TNF;NRK;IL6R;DDR2;PPP2CA;CACUL1;PARP16;MARK2;CALM1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4248484451589044,-1.261630913114861,0.16169154228855723,0.7874421264442723,1.0,13/25,24.61%,LDB1;THOC1;DDX39B;CCNT2;ERCC6;HTATSF1;CCAR2;HMGN1;EAF1;ALYREF;ELL;CCNK;CCNT1
prerank,myeloid dendritic cell activation (GO:0001773),0.5591623723608911,1.2601302882414471,0.19107142857142856,0.5032085322698279,1.0,3/12,5.20%,DOCK2;DCSTAMP;BATF2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3789067695887983,1.260107751326867,0.13674033149171272,0.5026922108654395,1.0,13/102,5.88%,HDAC9;MYO5A;TBC1D4;RAB31;FER;RAB8B;RAB10;ZFP36L1;SLC2A4;IRS2;INSR;ADCY9;NR4A1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5701064726685093,1.2600727948719617,0.1947069943289225,0.5022063747532268,1.0,2/10,2.75%,FCGR2B;LILRB1
prerank,regulation of wound healing (GO:0061041),0.4325634956250267,1.2598725991006272,0.16897081413210446,0.5020461177158766,1.0,4/42,3.53%,ALOX5;CASK;ITGB1;CRK
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5381824358406829,1.2598377425968883,0.22321428571428573,0.5015548093359861,1.0,7/14,20.69%,CMPK1;NMNAT3;NMNAT2;AK8;AK3;AK4;ME1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.49826551543159286,-1.2577578380125947,0.2106430155210643,0.7991575497757113,1.0,8/14,24.60%,SRSF10;RNPS1;C1QBP;SRSF12;SFSWAP;SRSF9;U2AF2;SRSF6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.40252017841505217,-1.2575752836293537,0.14171122994652408,0.7936896720987017,1.0,10/29,25.43%,ACOT9;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.40252017841505217,-1.2575752836293537,0.14171122994652408,0.7936896720987017,1.0,10/29,25.43%,ACOT9;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1
prerank,negative regulation of calcium ion transport (GO:0051926),0.5374174970507123,1.257380898107624,0.2250453720508167,0.5063417735052133,1.0,7/15,19.68%,LILRB1;TRIM27;CD33;PLN;SLC30A1;INPP5K;TMBIM6
prerank,estrogen metabolic process (GO:0008210),0.5251074374167154,1.2573232856571706,0.21960072595281308,0.5058929045586518,1.0,4/15,9.85%,UGT1A7;UGT1A1;SULT1A1;HSD17B7
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5492359056730046,1.2570288672988024,0.21511627906976744,0.5060024159621088,1.0,6/12,17.76%,ESR1;TNF;NCOR1;ZC3H12A;STAT3;IL6
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5577628903320446,1.256991022765164,0.20656370656370657,0.505520984509244,1.0,3/13,6.56%,NRP1;PLXNC1;PLXNA4
prerank,positive regulation of histone modification (GO:0031058),-0.3905457533511375,-1.2566575935360413,0.1497326203208556,0.7939831850235388,1.0,8/33,11.80%,CDK9;AKAP8L;MAPK3;FMR1;SAP30BP;BRCA1;PAF1;AKAP8
prerank,skeletal muscle organ development (GO:0060538),-0.40299019621155996,-1.2563685388586183,0.14043583535108958,0.7919404298314267,1.0,5/26,12.46%,LARGE1;BASP1;IGSF8;CFLAR;ZBTB18
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4196636622277174,1.2560397508578631,0.14923076923076922,0.50704334266002,1.0,12/51,11.89%,NRP1;GPR65;CDC42;RGCC;ARHGEF10L;RHOA;ITGB1BP1;S100A10;SFRP1;SYNPO;PXN;ROCK2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.4820827100230368,-1.2560104524707416,0.18863636363636363,0.7904025875277381,1.0,5/15,15.50%,HECW2;CENPE;NEK6;TACC3;RIOK2
prerank,import into cell (GO:0098657),-0.36780303935043207,-1.2553994513233273,0.1378299120234604,0.7896126707309568,1.0,13/41,24.02%,SLC1A3;TREM2;IL10RA;SNAP25;SLC36A1;SLC11A2;SLC7A8;SLC12A6;SLC39A14;LRSAM1;SLC12A4;SLC22A4;SLC27A1
prerank,phospholipid transport (GO:0015914),0.42220465121074924,1.2553201254169324,0.16592592592592592,0.5080079981012556,1.0,6/52,3.71%,PLTP;APOE;LDLR;ATP11C;ATP8B4;PITPNA
prerank,glial cell development (GO:0021782),0.474997642749394,1.2551050124917478,0.18619582664526485,0.5078281398362728,1.0,4/25,4.48%,NRROS;APP;TLR2;CDK6
prerank,positive regulation of macrophage migration (GO:1905523),-0.44984772373366844,-1.2548062925010808,0.16097560975609757,0.7888622286607921,1.0,7/19,10.25%,CSF1;TREM2;MAPK3;P2RY12;AKIRIN1;CCL3;CSF1R
prerank,membrane raft organization (GO:0031579),0.527511796343889,1.2547551862685569,0.20909090909090908,0.5080000582848632,1.0,4/15,5.94%,MYADM;S100A10;RFTN1;ANXA2
prerank,neutrophil chemotaxis (GO:0030593),0.4148754829509756,1.253734525384169,0.15666178623718888,0.5098010370250816,1.0,12/53,17.11%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24;CKLF;ITGB2;PPIA;CCL5;CCL25
prerank,regulation of histone deacetylation (GO:0031063),-0.5004239526137622,-1.2536853487284423,0.18906605922551253,0.7902794458753746,1.0,5/13,23.94%,AKAP8L;SAP30BP;AKAP8;CAMK2D;CTBP1
prerank,lymphocyte mediated immunity (GO:0002449),0.5445706040263125,1.2533196433056322,0.22324723247232472,0.510136607796495,1.0,2/12,3.44%,JAG1;CD46
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5302959564054053,1.2532496644275537,0.21635434412265758,0.5097361496906707,1.0,3/15,6.76%,DSE;UST;CHST12
prerank,regulation of potassium ion transport (GO:0043266),-0.39252286556046523,-1.2531325675546021,0.14882506527415143,0.7894191279728895,1.0,7/31,8.70%,DPP10;PTK2B;DPP6;KCNIP4;ANK2;CACNA1D;ACTN2
prerank,nuclear export (GO:0051168),-0.3246590485128748,-1.2527000160295343,0.09333333333333334,0.7882009980825343,1.0,37/80,32.12%,THOC1;SRRM1;SRSF5;NXF1;DDX39B;SRSF3;SRSF2;RANBP17;RANBP3L;RNPS1;U2AF1;UPF3B;CASC3;NCBP1;HNRNPA1;EGR2;THOC3;SRSF11;SRSF9;POLDIP3;SMURF1;ALYREF;TGFB1;U2AF2;RITA1;SRSF6;CSE1L;EIF4E;RANBP3;NUP214;CHP1;MALT1;NEMF;THOC7;U2AF1L4;STRADB;PKD1
prerank,negative regulation of binding (GO:0051100),0.38539722016961303,1.2524230734391655,0.1481994459833795,0.5109593542816452,1.0,15/81,11.07%,DAB2;NES;ITGB1BP1;GSK3B;RACK1;ROCK1;CFHR2;DISC1;ACTB;DDX11;BTAF1;PLN;CARD16;SP100;PPP1CA
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5783410300400462,1.252096352526677,0.22761194029850745,0.5105370831533402,1.0,3/10,7.23%,MYADM;WNK1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5783410300400462,1.252096352526677,0.22761194029850745,0.5105370831533402,1.0,3/10,7.23%,MYADM;WNK1;KLF4
prerank,regulation of cell killing (GO:0031341),0.5236714876386662,1.251732599613815,0.22287968441814596,0.5107621351382274,1.0,1/16,0.45%,CFH
prerank,protein localization to condensed chromosome (GO:1903083),-0.5117703094817366,-1.251203183520327,0.19870410367170627,0.7907726872179868,1.0,7/12,29.76%,KNL1;SPDL1;ZW10;IK;CDK1;AURKB;TTK
prerank,sodium-independent organic anion transport (GO:0043252),-0.5471065142414359,-1.2511101626433043,0.20444444444444446,0.7881485446805209,1.0,3/10,15.27%,SLCO2B1;SLCO4A1;SLCO4C1
prerank,organelle fission (GO:0048285),0.47392531638425744,1.2510274771141312,0.1890547263681592,0.511679563491207,1.0,2/24,4.05%,TMCC1;PRKN
prerank,proteoglycan metabolic process (GO:0006029),-0.416953554752921,-1.2509329485691327,0.14898989898989898,0.7859433447901703,1.0,10/26,17.84%,CHST11;XYLT1;BMPR1B;HS3ST4;SULF1;CANT1;GAL3ST4;HPSE;B4GALT7;CHST10
prerank,ERBB signaling pathway (GO:0038127),0.3984661819350536,1.2509261726384655,0.1511111111111111,0.5113422219825624,1.0,9/64,8.24%,EGFR;IQGAP1;PTPN18;REPS2;PTPN12;CBL;KIF16B;GAB1;PIK3C2A
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5592971325630981,1.2505107958376296,0.21693121693121692,0.5116850271828048,1.0,3/12,6.76%,DSE;UST;CHST12
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.48963311969726186,-1.250165687625281,0.19419642857142858,0.785695633116284,1.0,9/15,29.02%,COL11A1;WHRN;KCNA1;PIEZO2;SCN1A;ADGRV1;MKKS;HPN;TMC1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.562623365533735,1.24971887425034,0.2075812274368231,0.5128774565359856,1.0,3/11,7.65%,AHR;LILRB1;HFE
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.4010577122903234,1.2489853260831287,0.15602836879432624,0.5139528651851749,1.0,14/57,10.21%,RPS16;RPS15;RPL26;RPS28;RPS24;LTV1;RPL35A;RPS17;RPL38;MALSU1;RPL5;RPL14;RPS7;RPS6
prerank,female gonad development (GO:0008585),0.5008455061818219,1.2485940133672098,0.1899159663865546,0.5142071385728246,1.0,2/19,2.20%,ANG;CEBPB
prerank,regulation of neuroinflammatory response (GO:0150077),0.5001385376979418,1.2484221751866116,0.19434628975265017,0.5140103227008177,1.0,6/19,9.95%,NUPR1;TNFRSF1B;NR1D1;CD200R1;TNF;IGF1
prerank,circulatory system development (GO:0072359),0.36576266089188914,1.2482840714017367,0.12804097311139565,0.513761696919163,1.0,24/118,15.20%,HDAC9;PDLIM5;MEF2A;FBXW7;CRIP1;MEF2C;OSR1;BMP2;ALPK3;HEY2;PDLIM1;KDM6A;CACYBP;NCOA6;FOXC2;CASP8;WDR11;RAMP2;POPDC3;BCOR;RBP4;SMYD4;PKD2;FN1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.41696238588418383,1.2482477525455413,0.1676470588235294,0.5132740306879222,1.0,7/53,12.63%,HRH1;CCR1;CALCRL;DRD1;TSHR;HTR1D;HTR6
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.4465186092003398,-1.2481054645342249,0.18840579710144928,0.7905661075294147,1.0,5/19,17.97%,PRKCD;DAGLB;ABCD2;MTLN;ANGPTL3
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3694943981737555,-1.2477131560794947,0.19263456090651557,0.7891179342132936,1.0,11/39,12.50%,EFNA5;SMAD7;EPHA7;SRC;TENM3;FERMT3;CELSR2;AFDN;MINK1;PTPRG;ADAM8
prerank,protein catabolic process (GO:0030163),0.41022802286901405,1.2475600776490596,0.1854014598540146,0.514205625051235,1.0,14/59,12.03%,APOE;RIPK1;SIAH2;NR1D1;CLN5;CLN6;PRKN;MANBA;TRIM24;ADAMTS9;CLPX;LAMP2;NGLY1;DENND3
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5418071502543322,1.24737160545837,0.21908127208480566,0.5140321657869791,1.0,2/14,6.99%,CCR1;TNF
prerank,carbohydrate homeostasis (GO:0033500),0.39995086919858525,1.2470632304769627,0.15828402366863906,0.5141711814945698,1.0,13/67,14.52%,ALOX5;TCF7L2;SLC2A4;MCU;INSR;ADIPOR2;RPS6;WFS1;KCNB1;SLC8B1;STAT3;RBP4;USF1
prerank,establishment of endothelial barrier (GO:0061028),0.4697069316556306,1.2468667997000893,0.19725557461406518,0.514052462093623,1.0,9/29,9.51%,RAP1B;MYADM;RAP2B;RAPGEF2;PDE2A;RAP1A;PDE4D;MSN;RAB1A
prerank,regulation of leukocyte activation (GO:0002694),0.5440656182607898,1.246799996142633,0.20075046904315197,0.5136249572267897,1.0,4/14,8.76%,LYN;MFHAS1;CD74;CD33
prerank,regulation of phosphate metabolic process (GO:0019220),0.5211868396549398,1.2467127426241653,0.2003338898163606,0.5132855840023097,1.0,4/16,9.26%,PGAM1;SMG6;PSEN1;IGBP1
prerank,positive regulation of interferon-beta production (GO:0032728),0.44752451772267116,1.246130384701278,0.19047619047619047,0.5139968200768753,1.0,6/33,5.64%,TLR8;OAS2;TLR4;TLR2;TRIM56;RIOK3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4619188471916211,1.2459917461484495,0.19834710743801653,0.5137447842081044,1.0,6/30,13.19%,ARHGEF3;GPR65;P2RY10;ARRB1;GPR17;NET1
prerank,negative regulation of protein modification process (GO:0031400),0.38976707626289386,1.2453999073938995,0.13793103448275862,0.5144657033011392,1.0,9/79,4.84%,PID1;LRP6;MYADM;LYN;MFHAS1;XDH;NIBAN1;PRKN;GSK3B
prerank,cytosolic calcium ion transport (GO:0060401),0.4668521654581738,1.2450543884999723,0.18441971383147854,0.5146254691861318,1.0,8/28,14.94%,MCUB;ATP2B1;MCU;ADRA1A;MICU3;SLC35G1;ATP2A2;ITPR3
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5252056848410882,-1.2443042681023473,0.1887966804979253,0.7989354891278514,1.0,5/11,20.36%,SRC;MAPK3;ATP9A;MAP2K2;CHMP3
prerank,sterol metabolic process (GO:0016125),0.40031196504227234,1.243906080773065,0.1703056768558952,0.5165625558982191,1.0,13/60,16.11%,APOE;PRKAG2;HMGCR;CLN6;CYP27A1;CYP26C1;PMVK;OSBPL1A;CYP26B1;LBR;CLN8;OSBPL5;CYP7B1
prerank,neuron projection extension (GO:1990138),0.4477939293808071,1.2436304559080944,0.19968304278922344,0.5166002873725314,1.0,6/32,8.08%,NRP1;IQGAP1;TNN;USP9X;ALCAM;ULK2
prerank,negative regulation of protein kinase activity (GO:0006469),0.3779498836551286,1.243257866115017,0.14609929078014183,0.5168133280729184,1.0,15/88,9.67%,LRP6;GNAQ;SPRED1;DEPTOR;PRKAG2;SH3BP5;ITGB1BP1;RB1;PAK2;SFN;CEP85;HSPB1;TRIM27;SMCR8;CORO1C
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.41777876989042956,-1.2425558492556399,0.1856763925729443,0.8026276314098316,1.0,7/26,5.58%,RIMS1;PTK2B;NLGN1;RIMS2;NRXN1;DLG4;SHANK1
prerank,protein complex oligomerization (GO:0051259),0.38329191685544906,1.2414343609900123,0.16552667578659372,0.5202519291221203,1.0,12/85,9.47%,HGSNAT;NLRC4;EHD4;ATL1;LRRC8D;EHD1;BCL10;MCU;MPP2;HOMER1;NINJ1;BEND3
prerank,cellular response to interleukin-12 (GO:0071349),0.41830134890292203,1.241420220555993,0.17011128775834658,0.5197231579895557,1.0,12/48,8.44%,RAP1B;SERPINB2;CDC42;PITPNA;LCP1;PAK2;ANXA2;HNRNPF;CNN2;RPLP0;STAT4;MSN
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.5346405347948207,-1.2413505816194834,0.2266949152542373,0.8041306970783644,1.0,3/11,8.68%,TREM2;CDH13;CCL3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.31365653554390766,1.2412254773261393,0.004008016032064128,0.5195836358503614,1.0,361/1668,18.07%,RBPJ;DAB2;PID1;HDAC9;ZEB2;MAF;TRPS1;PF4;ETV1;EDNRB;EGFR;LRP6;APOE;APP;KLF2;CHP2;TCF7L2;TCF4;IRF4;FOXP1;PPP3CA;FLI1;MEF2A;AHR;ZBTB16;RREB1;TFEC;KMT2A;HIVEP2;ESR1;RPL23;SMURF2;ZBTB20;RBBP8;NCOA3;JAG1;RARG;TCF12;ACTR3;MEF2C;NR1H4;NCOA2;RPS27A;CEBPB;PIAS1;MITF;OSR1;NCOA5;TSHZ3;BMP2;RIPK1;ARID4B;KLF6;LILRB1;TBX15;PHF8;HOXD8;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;NR2C1;TLR4;NR1D1;CRK;RGCC;CDK12;ITGB1BP1;RPS6KA3;BAZ2B;TOX4;PRKN;PHF20;LARP7;PDE2A;TLR2;NR3C1;FRK;NKAP;IRF2BP2;HEY2;CLOCK;CTDSP1;GRHL2;PBX3;DMRTA2;ARID1B;SPI1;KLF9;RB1;SAP130;NCOA7;KDM7A;NFIC;USP9X;SMAD4;ARID5A;BATF2;ZFP2;ELF2;TRIM33;THRB;IRX2;CBFB;NR4A1;RNASEL;ORC2;PHF21A;FOSL2;TCF7;ATXN1;ZBTB25;DMAP1;CD40;EPC1;NOP53;ACVR2A;PIAS2;MED13L;FOXM1;ZNF235;SDCBP;ZNF568;TNF;KLF3;ZNF148;TSHZ1;LYL1;EPC2;KLF4;ZSCAN25;YY1;BRMS1L;DUSP22;PRKCB;HTATIP2;THAP11;MIER1;REL;MED16;SATB2;GATAD2A;TBL1XR1;STAT4;PSEN1;CEBPG;E2F5;FIZ1;NR4A2;LHX5;ZBTB5;NRIP1;NCOR1;IRF2;KLF10;IRX5;ATF6;CDC73;RPS14;FNIP1;TET3;ATRX;NCOA6;FOXC2;ESRRB;ARID3A;MIDEAS;BRIP1;BACH1;TRIM27;KMT2C;MDM2;HIVEP1;LCORL;OLIG2;TBL1X;MED18;UBE2D3;ESR2;MAPK14;LRRFIP1;MAMLD1;IGBP1;FOXJ3;ATF7;NFATC2;MED20;BEND3;MED6;LCOR;MLXIP;STAT6;ASXL1;MYDGF;USP16;NR2F1;PURA;ZNF205;IGF1;JMJD1C;RIPK2;RFX2;RNF14;HSBP1;ARRB1;SPEN;SP1;RNF111;MIER3;ZNF296;RCOR2;SP100;CREBRF;MED26;MAML1;ELF1;TFDP1;WFS1;JUP;MLLT10;ETS2;PHIP;CREBBP;SREBF2;KANK2;EAF2;BCL11B;MYBL2;MED15;FOXK2;BUD31;NFIA;HINFP;CDK13;FOXO3;CRTC3;DCAF6;RPL10;FOXK1;DEK;ZC3H12A;ATP2B4;LOXL2;TADA2B;NAMPT;ZBTB8B;CHD2;NOD2;ZFP3;SP3;FOXO1;BCAS3;TNFRSF1A;NFIX;ELP4;CREB1;KLF13;CCNQ;PEG3;WWOX;CTBP2;ZBTB7C;TFR2;NR1H2;EP300;ZBTB10;RARA;TET2;KAT7;TNRC6C;HIF3A;STAT3;JUND;WASL;PROX2;KLF5;BCOR;CRLF3;MED27;NEDD4L;USF1;KAT6A;PRKD2;PKD2;BMPR1A;ELOC;WWC1;RTRAF;SNW1;GATAD2B;ENY2;MYC;MTF1;MYT1;NR2C2;SMARCD1;HDAC4;KDM2A;SENP1;ZHX1;SFPQ;POU5F2;ARID1A;HEXIM2;RUNX3;ELK1;HCFC1;E2F8;GTF2H3;KDM1A;ZNF569;HOXB3;ZFP62;PTEN;CREB3L1;MAPK7;PPARGC1B;ZGPAT;PPM1A;RELA;LIN37;ACTR2;PER1;ARNT;RCOR1;TBX2;NFATC3;ZNF177;BRD4;GLIS2;MED17;FOXP2;ZBTB7A;NR5A2;NACC1;SP8;CARF;LHX1;NR2F2;ZNF22;GTF2H1;XBP1;MEF2B;NR6A1;MECOM;ARID4A;ZFP28;IL6;HGF;ZBTB8A;GMEB1;ZNF32;GZF1;ZBTB41;EFNA1;HSF5;BATF;SS18;ZBTB12
prerank,protein neddylation (GO:0045116),-0.4989097525445926,-1.24105017626612,0.19690265486725664,0.8022810169795211,1.0,8/13,39.15%,UBA3;RBX1;RNF7;DCUN1D2;DCUN1D5;DCUN1D3;DCUN1D4;NAE1
prerank,activation of GTPase activity (GO:0090630),-0.31900423453837967,-1.2407203357797576,0.08949416342412451,0.8006036636122037,1.0,22/89,11.37%,ARHGAP45;SIPA1L2;ARHGAP24;TBC1D16;TBC1D8;ARHGAP25;GARNL3;SGSM3;GMIP;SGSM2;NTRK3;TBC1D10A;RASGRF1;ARHGAP22;TBC1D22A;TBC1D22B;TIAM1;TBC1D9B;TIAM2;ABR;EVI5L;TSC1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5244104281405273,1.2406925880147368,0.2262295081967213,0.5201278012123969,1.0,2/16,2.75%,FCGR2B;LILRB1
prerank,embryonic heart tube development (GO:0035050),-0.4920802841999507,-1.2406823039376684,0.20495495495495494,0.7978545382160542,1.0,2/14,4.76%,NDRG4;ACVR1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.522238472125801,1.2405438917386706,0.21492007104795738,0.5199055744058629,1.0,2/15,1.25%,FBXW7;LDLR
prerank,positive regulation of protein modification process (GO:0031401),0.3432307199467856,1.2404127910992302,0.12023809523809524,0.5196280686894373,1.0,35/203,13.17%,DAB2;EGFR;APP;GAS6;WDFY2;LYN;KRAS;BMP2;RIPK1;CD74;FGF23;AXIN1;NIBAN1;THPO;PDE8A;INSR;CAMKK2;RACK1;CD40;ACVR2A;TNF;FAM20A;CCND3;FNIP1;DYRK1A;CCND2;MYDGF;ARRB1;CALM1;ATG7;ROCK2;TERF2IP;BRAT1;ATG10;UBE2N
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5593898250970394,1.2400856633980946,0.2260536398467433,0.5198002456477322,1.0,3/11,9.83%,ATL1;VCPIP1;RTN4
prerank,cellular response to osmotic stress (GO:0071470),0.4888448264809819,1.2399246918434808,0.21391304347826087,0.5196161869431221,1.0,4/21,3.73%,RCSD1;OXSR1;LRRC8D;ZFP36L1
prerank,histone H3-K4 methylation (GO:0051568),0.46473187142100986,1.2393826846301614,0.2152317880794702,0.5202129586869503,1.0,7/26,9.47%,KMT2A;KDM6A;TET3;ASH2L;KMT2C;WDR82;BEND3
prerank,lung epithelium development (GO:0060428),0.5773186621324604,1.2387868766438708,0.2123015873015873,0.5209981356684006,1.0,2/10,4.62%,RCN3;GRHL2
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3884143854742405,-1.2385448932020495,0.13756613756613756,0.8031550207996176,1.0,16/33,27.27%,RPTOR;IPO5;UBR1;NSMF;RRAGD;SESN3;CASTOR2;GLRA1;RRAGB;MTOR;SESN2;GLRA2;CASTOR1;CPEB1;RRAGA;SH3BP4
prerank,positive regulation of protein secretion (GO:0050714),0.3933597010212008,1.2382366631764339,0.16477272727272727,0.5215909766805105,1.0,21/69,15.00%,TCF7L2;ANG;C1QTNF3;EXPH5;TLR4;ADAM9;TLR2;MCU;IRS2;GHRL;TMED10;GOLPH3L;CD33;IGF1;WLS;ACHE;DOC2B;GLUD1;RBP4;TRH;PPIA
prerank,cell-cell junction organization (GO:0045216),-0.3238079304316224,-1.2371440800505487,0.1188118811881188,0.8055576642693953,1.0,27/79,21.52%,CADM1;TJP1;CDH10;SDK1;CDH2;CDH13;TLN2;CDH8;TJP2;FLCN;CADM2;NECTIN2;CSF1R;AFDN;TLN1;PKP4;CDH9;CDH22;CTNND2;CXADR;MARVELD2;CDH4;ARVCF;TGFB2;LIMS2;GJC1;TGFB1
prerank,body fluid secretion (GO:0007589),-0.47440321404757074,-1.2369136089643513,0.20422535211267606,0.8036134437655639,1.0,11/15,49.32%,ERBB4;SLC22A4;GUCA1B;NPR1;APLN;VEGFA;VIP;PRLR;OXTR;CSN3;SLC22A2
prerank,RNA export from nucleus (GO:0006405),-0.3037760625445548,-1.2367321966267326,0.10175438596491228,0.8013955366683095,1.0,37/100,26.40%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;MCM3AP;U2AF1;UPF3B;CASC3;NCBP1;SEH1L;HNRNPA1;NXT1;THOC3;SRSF11;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,secretion (GO:0046903),-0.4775793977662125,-1.2366962958155103,0.20353982300884957,0.7987138154971177,1.0,7/14,33.60%,RIMS1;TPD52;SLC22A4;PRKCI;GUCA1B;NPR1;FBLN5
prerank,cell junction assembly (GO:0034329),-0.30127751105944633,-1.236479541231283,0.088,0.7968078694193814,1.0,23/100,13.72%,TJP1;FBLIM1;DNM3;ADGRL3;CDH10;SDK1;NLGN1;ITGA6;CDH2;NRXN1;TLN2;FARP1;CDH8;FERMT2;FLCN;BDNF;SHANK2;TLN1;PKP4;CDH9;CDH22;CTNND2;SPOCK2
prerank,negative regulation of developmental growth (GO:0048640),-0.38876926019614955,-1.236223170204751,0.16844919786096257,0.7950141774454983,1.0,5/30,4.10%,MAP2;PTPRS;DUSP10;DIP2B;FGF13
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.4092191656345081,1.2359935280282288,0.2,0.5258793578734283,1.0,7/51,8.26%,CCR1;CMKLR1;GAS6;ANO6;PLA2G7;CCR2;IL6R
prerank,positive regulation of leukocyte activation (GO:0002696),0.5079328626307217,1.235974185767798,0.2281303602058319,0.5253600134809506,1.0,5/18,8.49%,TSLP;HAVCR1;TLR4;LBP;CLEC4D
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3563656901091107,1.2359562194192315,0.13096695226438188,0.5248233576595118,1.0,27/142,14.94%,ATP2B1;CCR1;CMKLR1;C5AR1;ESR1;C3AR1;C1QTNF1;CYSLTR1;CD36;GHRL;PDGFRA;CCRL2;CXCR4;CCR2;ADRA1D;ADRA1A;PLN;PTGER4;TRPC7;YWHAE;SLC8B1;ATP2B4;FFAR1;SLC35G1;CD52;TBXA2R;ITPR3
prerank,sphingolipid metabolic process (GO:0006665),-0.3018996100348551,-1.23589978066229,0.10460251046025104,0.7933746954277856,1.0,35/108,21.04%,HEXB;CERK;ENPP2;ST6GALNAC3;SPNS2;SMPD4;PPM1L;PLPP3;ESYT1;NSMAF;NEU1;ASAH1;PPT1;ASAH2;SAMD8;CERS4;ESYT2;GBA2;DEGS1;TECR;ACER2;CERS5;CERS1;CERKL;PSAP;SGMS2;SERINC1;SMPD2;SPTLC1;CERS2;ABCA2;ARV1;KDSR;PLPP2;ARSA
prerank,actin-myosin filament sliding (GO:0033275),0.4315913646746437,1.2354985315557918,0.2018348623853211,0.5246728770909227,1.0,7/38,15.26%,TMOD1;MYH6;TNNT1;VIM;NEB;TPM3;MYBPC3
prerank,muscle filament sliding (GO:0030049),0.4315913646746437,1.2354985315557918,0.2018348623853211,0.5246728770909227,1.0,7/38,15.26%,TMOD1;MYH6;TNNT1;VIM;NEB;TPM3;MYBPC3
prerank,regulation of cation channel activity (GO:2001257),-0.31738187628958864,-1.23544431985969,0.11029411764705882,0.7922869122383419,1.0,25/89,13.48%,CACNB2;FGF14;FGF12;DLG2;PTK2B;CACNB4;CALM2;GRIA2;NLGN1;DLG4;DLG3;GRIA4;FGF13;ANK2;CTSS;SHANK1;JPH1;GSG1L;ACTN2;CACNG7;GRIN2A;MINK1;CACNG8;SHISA7;VAMP2
prerank,cell chemotaxis (GO:0060326),0.4014158102225286,1.235053107014273,0.17672413793103448,0.5251512118054781,1.0,9/60,7.60%,PLEKHG5;NRP1;CCR1;PDGFRA;NR4A1;CCRL2;ABCC1;CXCR4;CCR2
prerank,regulation of vacuole organization (GO:0044088),0.4922635589893406,1.2347794199667026,0.2111913357400722,0.5251893117155939,1.0,6/20,6.13%,MTM1;MTMR3;NPRL3;TBC1D14;ANXA2;PIKFYVE
prerank,cytoplasmic microtubule organization (GO:0031122),-0.34847080991297597,-1.2343957976983375,0.12539184952978055,0.7934307975511111,1.0,20/54,20.34%,DST;CCDC88B;DYNC1H1;CAMSAP1;FIGN;CLIP2;CRIPT;MAPT;TUBGCP5;PLK3;STMN3;TPPP;NUMA1;TUBGCP3;CLIP3;LIMK2;WDR73;FSD1;TUBGCP6;CLIP4
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.43033607336167057,-1.2343557188819332,0.17777777777777778,0.790850317630555,1.0,7/21,20.92%,CALM2;SLC8A1;ANK2;AKAP6;CACNA1C;CAMK2D;CALM3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5321968578806379,-1.233331105472387,0.20934959349593496,0.7918788603155545,1.0,4/10,6.60%,CD9;PRKCD;SERPINE2;RDX
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.4211767457605754,-1.2332977396254687,0.16705882352941176,0.7892517278619164,1.0,5/22,9.55%,MVB12B;PTPN23;SNF8;TOM1L1;VPS37A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4803269197045772,1.2331328203030603,0.21105527638190955,0.5283317476161614,1.0,7/21,16.45%,FOXP1;RPS3;BCL10;PRKCB;PRKD2;NFAM1;RELA
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.3684020840193444,-1.2331214591383568,0.15835777126099707,0.7872490605925669,1.0,17/43,23.49%,NDRG4;ACVR1;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;NOTCH1;SRF;MICAL2;ENG;BBS4;MKKS;CCDC40;STIL
prerank,granulocyte chemotaxis (GO:0071621),0.4050435807248884,1.2328434893106344,0.1644640234948605,0.528386969561667,1.0,12/55,17.11%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24;CKLF;ITGB2;PPIA;CCL5;CCL25
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5488481926428823,1.232423828902309,0.22777777777777777,0.5287701431638302,1.0,4/12,15.74%,DPYD;DPYSL2;CRMP1;DPYSL5
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5569048763735979,1.2324125518442943,0.2390057361376673,0.5282355697105601,1.0,6/11,15.70%,ARID1B;CHEK1;ELOF1;SERTAD2;SMARCD1;ARID1A
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3944945996389543,1.2320812500411573,0.1649331352154532,0.5284082064163924,1.0,18/64,11.89%,PEAK1;CASK;BST1;JAG1;RASA1;CD36;RHOA;UTRN;CDK6;GSK3B;ROCK1;PTPRA;VCL;CLASP1;CORO1C;SFRP1;JUP;ROCK2
prerank,dendritic cell differentiation (GO:0097028),0.4938886699673315,1.2317089542623043,0.2222222222222222,0.5286385883873643,1.0,6/22,5.20%,GAS6;LYN;LILRB1;DCSTAMP;CCL19;BATF2
prerank,positive regulation of signal transduction (GO:0009967),0.3348660407018307,1.2316504843283436,0.1132286995515695,0.5282071608600709,1.0,54/238,15.27%,RBPJ;NRP1;KLF2;SASH1;CLEC6A;GAS6;JAG1;RPS3;TSLP;BMP2;CD74;MYORG;C1QTNF12;ERN1;P2RY6;ITGB1BP1;SLC2A4;TLR2;GHRL;LY96;DISC1;TTC23;DEPDC1B;CD80;EPN2;PRKCB;CDC73;HOMER1;SULF2;GKAP1;ASXL1;POGLUT1;IGF1;SFRP1;PDE6H;WLS;MYO1C;TRIM16;MAML1;PHIP;CREBBP;SNX5;STK36;NOD2;CTBP2;CRLF2;EP300;STAT3;PRKD2;PKD2;SNW1;NECAB2;DSTYK;TXNDC15
prerank,inner ear morphogenesis (GO:0042472),-0.4342668357876561,-1.2307774512351801,0.1925754060324826,0.7927843089412767,1.0,7/22,16.18%,CHD7;FGFR2;MYO6;PAX8;ZIC1;MYO3B;EPHB2
prerank,peptidyl-tyrosine modification (GO:0018212),0.40281876554450063,1.230726908048749,0.1824925816023739,0.5296857351235899,1.0,12/56,9.33%,EGFR;FGFR1;LYN;FER;ABI1;INSR;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A
prerank,response to calcium ion (GO:0051592),0.3698275042325849,1.2303998486182335,0.1455026455026455,0.5298504249582939,1.0,16/102,8.30%,CHP2;IQGAP1;PPP3CA;MEF2A;ALOX15;MEF2C;ALOX5AP;ADAM9;KCNMB1;CPNE2;SLC25A24;CLIC4;CPNE7;CPNE8;STIM1;HOMER1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.46183459332221954,1.2291158098064343,0.2057877813504823,0.5321762393599,1.0,4/28,6.29%,MAP3K5;CEBPB;ERN1;BCL2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5502231998094588,1.229053626855245,0.25794392523364484,0.5317519639189814,1.0,3/11,6.29%,CD44;CD74;BCL2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5600211295736661,1.2288885795986015,0.24817518248175183,0.5315708828716547,1.0,5/11,17.05%,LYN;MFHAS1;CYBA;TIRAP;ACOD1
prerank,response to glucagon (GO:0033762),-0.4440347877749476,-1.228854912752467,0.19953596287703015,0.7972300422246098,1.0,5/19,10.16%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,osteoclast differentiation (GO:0030316),0.4805246013321659,1.2280613621447198,0.2093425605536332,0.5328741095798153,1.0,7/22,11.43%,FOXP1;DCSTAMP;TNFRSF11A;GLO1;ANXA2;MAPK14;SNX10
prerank,cellular response to oxidative stress (GO:0034599),0.36099116739738374,1.2272411029779977,0.15012722646310434,0.5340649943963804,1.0,31/118,17.17%,EGFR;CYBB;FER;RPS3;DAPK1;HMOX1;CAMKK2;SLC25A24;PTPRK;PDGFRA;VRK2;MSRA;RAD52;CYCS;TXNRD2;PXN;NCF2;ROMO1;FOXO3;RBM11;ZC3H12A;ERO1A;FOXO1;AGAP3;CYBA;PKD2;PPIA;NOX4;ARNT;PRDX3;PRDX2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.3602836908433638,-1.2263112893819454,0.17008797653958943,0.8036350729720336,1.0,20/46,32.15%,HK2;FBXO7;TIMM44;GDAP1;TOMM40;TIMM8B;GRPEL1;AIP;TOMM20;TOMM40L;TIMM21;BCAP31;TOMM34;FIS1;TOMM5;AKT1;TIMM17B;TIMM13;DNLZ;CHCHD4
prerank,neurotransmitter uptake (GO:0001504),-0.5013175303876909,-1.2259197342362633,0.22371364653243847,0.8024206749522225,1.0,2/12,2.67%,SLC1A3;SNAP25
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.44521303445916527,-1.2257160568146566,0.2186046511627907,0.8004875258831626,1.0,6/17,21.01%,ATP1B1;SLC8A1;ATP1B2;CACNA1C;GJC1;GJD3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4736512630420588,1.225547572257824,0.20344827586206896,0.5372578719137413,1.0,12/23,21.89%,MTM1;SYNJ1;MTMR3;OCRL;PIP4P2;MTMR1;PTEN;INPP5K;PIP4P1;MTMR6;MTMR11;MTMR12
prerank,positive regulation of chromatin organization (GO:1905269),0.5364712568561043,1.2254056399654651,0.21455223880597016,0.5370266639929399,1.0,6/12,14.46%,MIER1;ATRX;H3-3A;TERF2IP;UBE2N;TERF1
prerank,response to estradiol (GO:0032355),0.43955811673165834,1.224863357326676,0.194675540765391,0.537649668621205,1.0,6/31,10.05%,EGFR;ESR1;NCOA3;NRIP1;LCOR;SFRP1
prerank,response to ethanol (GO:0045471),-0.4758030038904595,-1.2247999978379513,0.18140589569160998,0.8012315839330263,1.0,4/14,12.51%,GRIN3A;ADCY7;GRIN2A;GLRA1
prerank,regulation of JNK cascade (GO:0046328),0.3693703419531764,1.2247042348074093,0.1711590296495957,0.537473665037653,1.0,15/101,8.54%,FCGR2B;EGFR;APP;MAP3K5;MFHAS1;RASSF2;SH3RF1;RIPK1;AXIN1;CCL19;PRKN;SDCBP;DUSP22;NCOR1;MAPK8IP2
prerank,peptidyl-arginine modification (GO:0018195),0.5266217023902038,1.2242421412543978,0.24125874125874125,0.5379038273493616,1.0,1/15,0.54%,PADI4
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.34349897932658846,1.2232744772924697,0.1510353227771011,0.5395007494202049,1.0,34/163,14.92%,VAV3;CD38;PTPRJ;PSMA7;MEF2C;PTPN22;DENND1B;RFTN1;NFKBIZ;BCL10;THEMIS2;PAK2;RC3H1;PDE4D;WNK1;BCL2;SYK;SPG21;ZAP70;PRKCB;PSMB2;FYN;NFATC2;RIPK2;EIF2B1;PSMA6;ZC3H12A;UBE2N;FYB1;PSMD5;PSMD1;PSMA3;PRKD2;NFAM1
prerank,acylglycerol homeostasis (GO:0055090),0.489692091891158,1.2223321556943045,0.2218370883882149,0.5409855377610803,1.0,2/20,4.98%,APOE;PNPLA8
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3134394621718082,-1.2220863526654204,0.12213740458015267,0.8086872700484516,1.0,24/80,20.24%,RAB6B;PLPP3;ARF5;STX18;COG3;KIF5A;BICD2;ATP9A;CENPE;COG4;SURF4;NAPA;ERGIC3;KIF1C;KIF3A;KIF11;KIF15;KIF3B;USE1;KIF2A;TMED7;COPA;DNAJC28;ZW10
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5136038279429618,-1.2219848922073981,0.23060344827586207,0.8063383993296294,1.0,6/11,25.54%,P3H2;OGFOD1;EGLN2;P4HTM;P4HA1;P4HA3
prerank,lipoprotein transport (GO:0042953),0.5630883324208046,1.2218662612380042,0.244140625,0.5414667021432464,1.0,7/10,27.85%,CD36;PRKCB;MIA3;UNC119;VMP1;PPARG;ZDHHC17
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.43151771163849245,1.2216284880321249,0.2273449920508744,0.5414129870653617,1.0,10/39,14.46%,TCF7L2;MCU;IRS2;GHRL;HFE;DOC2B;GLUD1;TFR2;RBP4;TRH
prerank,positive regulation of axonogenesis (GO:0050772),-0.3608906873340109,-1.2215221803613263,0.1833810888252149,0.8053137422984427,1.0,17/43,20.01%,SEMA4D;ROBO2;PLXNA2;ROBO1;ZFYVE27;MACF1;TWF2;BDNF;MAPT;MAP6;TIAM1;TIAM2;LIMK1;CDKL5;DBN1;PLXNB2;PLXNB3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.36702027784492475,-1.221287314415605,0.14942528735632185,0.8034467150754191,1.0,13/37,13.62%,EFNA5;CYLD;CLASP2;BICD2;MAPT;MAP6;MAPRE3;STMN3;PHLDB1;TPPP;STMN4;EPHA3;MAPRE1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3037627385872229,-1.2210300055242491,0.10600706713780919,0.8017577489431056,1.0,36/96,26.40%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;MCM3AP;U2AF1;UPF3B;CASC3;NCBP1;SEH1L;NXT1;THOC3;SRSF11;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3977177616539334,-1.2200396344776656,0.18997361477572558,0.8025873637401193,1.0,8/27,9.67%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;AGAP2;FLT3
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5471027654335637,1.2198347079631602,0.2448210922787194,0.5448980679425605,1.0,2/12,1.25%,APOE;LDLR
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.506748722552837,1.219304936713203,0.23272727272727273,0.5455166167099903,1.0,6/17,16.92%,NRP1;S100A11;IGF1;DOCK7;MDK;CCL5
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3818396052665853,1.2191863124342852,0.17246175243393602,0.5452234337562286,1.0,11/73,12.78%,HIP1;NLRC4;IFT57;XDH;RIPK1;RACK1;TNF;CYCS;CASP8;DIABLO;FAM162A
prerank,myotube differentiation (GO:0014902),-0.4557382386576362,-1.218593159676589,0.21621621621621623,0.8050931737488447,1.0,3/17,1.66%,ADGRB3;SORT1;JAM2
prerank,fatty acid metabolic process (GO:0006631),0.3607088877780665,1.2185493301696508,0.15701415701415702,0.5460420974835174,1.0,10/115,5.86%,AOAH;ALOX5;LTC4S;ALOX15;CD36;ALOX5AP;UGT1A8;PNPLA8;SGPL1;ADIPOR2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.49146913736839887,-1.218468859795145,0.2413793103448276,0.8029775943506595,1.0,3/12,11.79%,BIN1;CTNNA3;CACNA1C
prerank,protein polymerization (GO:0051258),0.40151755230884983,1.2183495509846431,0.18676470588235294,0.5459471671355726,1.0,6/55,4.05%,PSTPIP2;DIAPH1;GAS7;PSTPIP1;ANG;PRKN
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5376047846319845,1.2178330983904146,0.25621414913957935,0.5465676223758716,1.0,3/13,8.13%,RREB1;METRNL;VSTM2A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5068736104690386,1.2174456585955575,0.24014336917562723,0.5468490124718328,1.0,3/16,5.91%,TPT1;RPS3;TRIM32
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5459797309741037,1.2166900320560008,0.2544731610337972,0.5479745038422694,1.0,2/11,4.52%,JAG1;HEY2
prerank,microglial cell activation (GO:0001774),0.4847287686215138,1.2164437414405282,0.24620573355817876,0.5479677820647414,1.0,5/21,6.99%,APP;C1QA;C5AR1;GRN;TNF
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3917849118720524,-1.2161092922174024,0.19759036144578312,0.8088962508212386,1.0,14/30,20.80%,HEXB;CHST11;CSPG5;CHPF2;CSPG4;HYAL1;DSEL;NDNF;VCAN;IDUA;BCAN;BGN;NCAN;UGDH
prerank,regulation of autophagosome maturation (GO:1901096),0.5368779241760071,1.2158826498120263,0.23877917414721722,0.5486201392153985,1.0,5/13,13.41%,ADRB2;UVRAG;SMCR8;UBQLN4;RUBCN
prerank,negative regulation of JNK cascade (GO:0046329),-0.3947186272898134,-1.2157462947286053,0.1984924623115578,0.8076261476742065,1.0,5/31,3.60%,SIRPA;CYLD;DUSP10;PDCD4;GPS2
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4604799117275751,-1.2156102423151671,0.22916666666666666,0.8055456875007175,1.0,3/15,4.76%,SMAD7;MAGI2;ACVR1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.48074034605629856,1.2152120546997136,0.23214285714285715,0.5496363045568389,1.0,5/20,13.30%,PRKRA;PUM2;DROSHA;TRIM71;MRPL44
prerank,positive regulation of cell communication (GO:0010647),-0.39627511611153177,-1.2151115172147673,0.20253164556962025,0.804698220970172,1.0,9/28,17.28%,RIMS1;GRIK2;PTPN23;RIMS2;DLG4;KCTD13;LGI1;RIMS3;SYT1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.5163058247620276,-1.215013518924847,0.23608017817371937,0.8024307793534928,1.0,4/10,9.06%,VSIR;NCKAP1L;PRNP;DDIT3
prerank,positive regulation of cell projection organization (GO:0031346),-0.2936599695329743,-1.2143357409483124,0.09737827715355805,0.8025308500462927,1.0,31/115,13.49%,CUX1;PTK2B;PTPRD;SETX;ITGA6;ROBO2;SCN1B;MAGI2;DLG4;TENM3;PLXNA2;ATP1B2;SS18L1;NDRG4;SCARB2;ROBO1;NTRK3;DVL1;TWF2;BDNF;SERPINI1;MAP6;TIAM1;TIAM2;CAPRIN1;SS18L2;DVL2;IL1RAPL1;NDNF;EPHA3;RAPGEF1
prerank,calcium ion homeostasis (GO:0055074),0.36475571127565454,1.214187036361637,0.17551020408163265,0.5514473598032102,1.0,16/95,12.39%,ATP2B1;CCR1;TPT1;STIM2;CCL8;ATP6V1B1;CCL19;CD40;FAM20A;STIM1;CCR2;TMEM165;WFS1;SLC10A7;SLC8B1;ATP2B4
prerank,regulation of lipid catabolic process (GO:0050994),-0.4282272585304007,-1.2141571793553414,0.21601941747572814,0.8006254604499323,1.0,6/19,22.53%,PDE3B;APOC1;ALK;TYSND1;ANGPTL3;BSCL2
prerank,vasoconstriction (GO:0042310),0.5491317930176335,1.2141231145153801,0.24334600760456274,0.551004223110164,1.0,2/11,8.24%,EDNRB;PIK3C2A
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4188554450118655,1.2141036097776778,0.1996879875195008,0.5504869864680524,1.0,11/46,11.24%,SPRED1;LYN;TLR4;ITGB1BP1;SMAD4;SYNJ2BP;RANBP9;CNKSR3;RPS6KA6;SPRED2;EMILIN1
prerank,negative regulation of bone mineralization (GO:0030502),0.5338981440455111,1.2140409668283103,0.2619047619047619,0.5500677872705414,1.0,7/13,19.44%,CCR1;FGF23;SRGN;RFLNB;BCOR;ECM1;ENPP1
prerank,protein autoubiquitination (GO:0051865),0.39627803771155523,1.2140164010532883,0.18330849478390462,0.5495580783935556,1.0,23/61,18.72%,SH3RF1;PRKN;RNF141;TRIM68;RNF19B;MDM2;UBE2D3;UHRF2;CUL3;AMFR;RNF185;TRIM71;RNF115;RNF187;BFAR;KLHL24;RNF122;ASB4;RNF41;RNF146;UBE2A;CNOT4;TRAF6
prerank,response to laminar fluid shear stress (GO:0034616),0.5641400272942586,1.2140037770459904,0.2513562386980108,0.5490142240390915,1.0,5/10,16.19%,KLF2;KLF4;ASS1;SREBF2;MAPK7
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5389901108657795,1.213818482079009,0.2559852670349908,0.5477281050863002,1.0,4/12,9.73%,RB1;CDC27;NSMCE2;CUL3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5389901108657795,1.213818482079009,0.2559852670349908,0.5477281050863002,1.0,4/12,9.73%,RB1;CDC27;NSMCE2;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5389901108657795,1.213818482079009,0.2559852670349908,0.5477281050863002,1.0,4/12,9.73%,RB1;CDC27;NSMCE2;CUL3
prerank,water transport (GO:0006833),-0.48959498542829105,-1.2137636793209723,0.24261603375527427,0.7995489542230375,1.0,5/12,47.11%,PDPN;CFTR;AQP4;AQP1;SLC5A1
prerank,negative regulation of receptor internalization (GO:0002091),-0.4936192412171044,-1.212742054262881,0.21548117154811716,0.8006728472377383,1.0,6/12,19.73%,RIN3;DLG4;ANKRD13B;ANKRD13D;ATXN2;ANKRD13A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.41974538668197653,-1.2124165994330858,0.21040723981900453,0.7993408065624934,1.0,10/22,23.11%,CALM2;ATP1B1;ANK2;AKAP6;STAC2;SLC9A1;STAC;HAP1;CALM3;STAC3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5313093566839238,1.2121680755367414,0.2326923076923077,0.550866112895358,1.0,5/12,16.54%,FUT4;WNK1;ASS1;MDK;MIA3
prerank,negative regulation of viral transcription (GO:0032897),0.544234772207732,1.2120207871853403,0.2224231464737794,0.5506212962274047,1.0,5/13,13.93%,IFITM3;LARP7;TRIM32;TRIM27;MID2
prerank,dermatan sulfate metabolic process (GO:0030205),0.5358213547386534,1.21201681360395,0.2526690391459075,0.550070940439423,1.0,3/13,6.76%,DSE;UST;CHST12
prerank,sarcomere organization (GO:0045214),0.45748219626075814,1.2116426268400349,0.2188006482982172,0.5503657292998849,1.0,3/27,3.13%,MYH6;MYOM2;TNNT1
prerank,regulation of autophagosome assembly (GO:2000785),0.43747444519571466,1.2116050948682782,0.2125,0.5498756548210352,1.0,8/33,8.94%,NUPR1;MTM1;MTMR3;NPRL3;FEZ2;TBC1D14;PIKFYVE;SMCR8
prerank,histone H3 acetylation (GO:0043966),-0.36717740191673803,-1.2112288502745583,0.18873239436619718,0.801047718568946,1.0,9/40,11.35%,PHF14;LDB1;ING4;TADA1;WDR5;NAA60;MBIP;SUPT7L;BRCA2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4665936555083018,1.2112224251573238,0.21652892561983472,0.5501471600886527,1.0,8/26,18.05%,ALOX5;CD36;TLR4;PIKFYVE;ABCB7;CYBA;TRAP1;SLC5A3
prerank,negative regulation of endocytosis (GO:0045806),0.46076946392690504,1.2103130362862364,0.2193126022913257,0.5515687168689926,1.0,5/24,13.69%,MCTP1;LILRB1;SNX33;RUBCN;NR1H2
prerank,muscle cell migration (GO:0014812),0.5693278313703687,1.2101022882859074,0.26653696498054474,0.551483445243642,1.0,3/10,5.43%,THBS4;ITGB1BP1;ROCK1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.42654114915188124,-1.209973627166528,0.2175,0.8031984759716779,1.0,7/21,11.86%,PTK2B;CSF1;MAPK3;AKIRIN1;CSF1R;MIF;MTUS1
prerank,ganglioside metabolic process (GO:0001573),-0.4353596342334557,-1.209961507542837,0.1882640586797066,0.8007354511723807,1.0,5/20,7.48%,HEXB;ST3GAL5;ST6GALNAC3;NEU1;ST6GALNAC4
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.516987085000427,-1.2095241500870195,0.23819742489270387,0.799843985481432,1.0,8/10,44.35%,RUVBL1;ZNHIT6;TAF9;ZNHIT3;PIH1D2;SHQ1;RUVBL2;PIH1D1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4469906989482859,1.2090513900963062,0.2278688524590164,0.5533396527202964,1.0,8/29,11.10%,RPS27A;RIPK1;TLR4;BIRC3;LY96;CD40;UBE2D3;CASP8
prerank,regulation of cellular component biogenesis (GO:0044087),0.42543823081609095,1.208556424076695,0.24121405750798722,0.553901740656477,1.0,7/39,5.43%,APOE;RAP1B;CD36;CCL19;RAPGEF2;RAP1A;ROCK1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5248808188524255,1.2085484354219562,0.2518939393939394,0.5533666137366017,1.0,7/13,14.28%,LDLR;ITGB1;CD36;FCER1G;SYK;SREBF2;ITGB2
prerank,oligodendrocyte differentiation (GO:0048709),-0.42618007448963674,-1.2083761761598935,0.20050125313283207,0.8015638264181905,1.0,15/19,45.54%,EIF2B3;NSUN5;TPPP;SOX10;SOX13;SOX8;EIF2B5;SLC8A3;EIF2B2;SHH;PRDM8;SOX6;HES5;PTPRZ1;MYRF
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5226639281412282,1.2081904955890737,0.25985663082437277,0.5536221167226651,1.0,2/13,4.23%,NRP1;NRARP
prerank,positive regulation of heart contraction (GO:0045823),0.4918211621717116,1.207544132247777,0.2411467116357504,0.5545360204438047,1.0,6/19,14.29%,ADM;ADRA1A;CHGA;KCNQ1;SCN3B;ATP2A2
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5000130828305138,-1.207287764644952,0.23326133909287258,0.8029664400568486,1.0,5/12,22.29%,PLEKHH2;PLEK;LIMA1;SH3BP1;WDR1
prerank,positive regulation of reproductive process (GO:2000243),-0.3836684213342132,-1.2071584897113088,0.19689119170984457,0.8009848004117534,1.0,8/31,16.13%,LHFPL2;SIRT2;TACR3;PLCB1;PDE3A;GLRA1;C1QBP;ACVR1B
prerank,response to alcohol (GO:0097305),-0.39183342867704607,-1.2066956035615461,0.21158690176322417,0.8002694874234124,1.0,7/27,13.67%,TGFBR1;GRIN3A;TGFBR3;CCL3;GRIN2A;GLRA1;TGFBR2
prerank,cellular response to mechanical stimulus (GO:0071260),0.4084540240668195,1.2064712773743038,0.20266272189349113,0.5563430451336422,1.0,12/46,12.91%,TLR8;TLR4;MAP3K1;BCL10;PDE2A;CD40;CNN2;CHEK1;PTGER4;CASP8;KCNK4;TNFRSF1A
prerank,epithelial cell morphogenesis (GO:0003382),0.5045329706344871,1.2063442480761641,0.2518796992481203,0.55604516806672,1.0,4/17,7.68%,CNMD;TNMD;GRHL2;COL22A1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.47651772843855267,-1.2060666434752876,0.2276595744680851,0.7999979254551822,1.0,7/14,23.16%,CSTF2;DDX1;FAM98B;CLP1;RTCB;TSEN54;TSEN15
prerank,cellular response to copper ion (GO:0071280),-0.4524847312047062,-1.2058225891532082,0.22510822510822512,0.7984464133257233,1.0,11/16,26.46%,PRNP;HSF1;MT2A;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4475417856076367,1.2056946700358917,0.24558587479935795,0.5569991812083878,1.0,14/29,23.79%,TCF7L2;TLE4;TCF7;CDC73;ASH2L;CREBBP;EP300;MYC;BCL9;TLE1;AXIN2;KAT5;TCF7L1;RBBP5
prerank,positive regulation of cellular process (GO:0048522),0.31287676144099347,1.205265608125003,0.06687565308254964,0.5573952274492565,1.0,76/565,10.42%,FOLR2;FCGR2B;EGFR;LRP6;LIFR;P2RX7;FGFR1;LILRA5;PTPRJ;COLEC12;CHP2;PPP3CA;IL15;KIF20B;GAS6;DOCK2;NUPR1;RPL23;LYN;GRK5;BST1;FER;TSLP;KRAS;KITLG;TNFRSF1B;CD36;FCER1G;FGF23;WNT2;TLR4;GRN;CDC42;ANKRD17;CAMK1D;THPO;DNPH1;ZFP36L1;ITGB1BP1;RPS6KA3;TNFRSF11A;LBP;TLR2;IRS2;INSR;S1PR2;PDGFRA;ACER3;TRIM32;BCL2;RPS4X;CHEK1;FOXM1;RPS15A;SDCBP;TNF;MTPN;TIPIN;CXCL16;IL6R;RPS9;ADRA1D;TSPYL5;ASH2L;MDM2;PDGFC;CCND2;CACUL1;CUL3;H3-3A;IGF1;SFRP1;RIPK2;RPS6;TSHR;SLC25A5
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.45265248603361197,1.2052204532015265,0.2353923205342237,0.5569270989878083,1.0,8/29,9.55%,IL15;FER;IFNAR1;PIAS1;CCR2;STAT4;IFNAR2;STAT6
prerank,cellular response to leucine (GO:0071233),-0.5128136943621326,-1.2049130156434207,0.2582781456953642,0.796777186091663,1.0,4/10,5.83%,RPTOR;UBR1;RRAGD;SESN3
prerank,response to leucine (GO:0043201),-0.5128136943621326,-1.2049130156434207,0.2582781456953642,0.796777186091663,1.0,4/10,5.83%,RPTOR;UBR1;RRAGD;SESN3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.4244702475191216,1.2045426413571032,0.2202572347266881,0.5578321878598084,1.0,12/36,16.03%,OPHN1;RYBP;LAMP3;WAC;NOP53;SDCBP;HFE;EIF3H;RPL11;PRKCG;USP25;HSP90AB1
prerank,sulfation (GO:0051923),0.5356202380931114,1.2044671361191754,0.26003824091778205,0.5574537328680153,1.0,3/11,13.74%,UST;SULT1A1;SULT6B1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4256739887548079,1.2040961722523518,0.2138157894736842,0.5576921098138153,1.0,6/37,8.05%,EDNRB;APOE;UGT1A8;PRKN;SDCBP;NCOR1
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3534445635464509,-1.202530588125715,0.17251461988304093,0.8029255629730868,1.0,7/41,8.70%,KCNMA1;KCNJ2;NOS1AP;ANK2;CTSS;AKAP6;ACTN2
prerank,response to copper ion (GO:0046688),-0.4264688682563869,-1.2021902809361105,0.24766355140186916,0.8016911372323978,1.0,13/20,26.46%,IL1A;PRNP;HSF1;MT2A;ATP7B;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.34035266940516956,-1.2021177388243378,0.15451895043731778,0.7995560304619678,1.0,19/52,20.14%,DDX5;DDX17;RBM25;RBFOX1;SRRM4;FXR2;HNRNPU;PUF60;FMR1;CELF4;KHDRBS3;RNPS1;NOVA2;SRSF12;HNRNPA1;RBM5;MBNL3;FXR1;CELF6
prerank,neural tube closure (GO:0001843),0.4260693025027269,1.2019801731591369,0.22168284789644013,0.5617943154712316,1.0,5/34,5.61%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5267143066192872,1.2019753324240061,0.2608695652173913,0.5612395093228391,1.0,4/12,8.52%,GRN;CLN5;CLN6;TMEM165
prerank,regulation of MAP kinase activity (GO:0043405),0.36621877510012657,1.201904175014261,0.18119891008174388,0.5608366927893772,1.0,13/92,9.45%,EGFR;APOE;FGFR1;PTPRJ;LYN;IRAK3;CDK12;DUSP1;CD40;PIK3R6;TNF;SH2B3;PDGFC
prerank,regulation of regulated secretory pathway (GO:1903305),-0.3754730169252286,-1.201844718051624,0.1937984496124031,0.798126729136072,1.0,14/34,27.20%,RIMS1;RIMS2;RAB27A;VPS18;SYT6;SYT8;RIMS3;SYT1;RAB15;SYT13;RIMS4;SYT7;SYT5;SYT17
prerank,regulation of steroid biosynthetic process (GO:0050810),0.5340078642282684,1.2016304298251328,0.258364312267658,0.5608890128783494,1.0,2/11,2.61%,NR1H4;BMP2
prerank,telomere maintenance (GO:0000723),-0.3418520703713137,-1.2014448557279696,0.1620795107033639,0.7970077620524256,1.0,13/50,13.31%,DNA2;XRCC5;CTC1;ATM;PARP1;STN1;PTGES3;BLM;LTO1;HUS1;PARP3;TERF2;XRCC6
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.37189710405047977,-1.201425242558793,0.1984732824427481,0.7946866979487266,1.0,7/34,8.36%,PDE4B;CALM2;SMAD7;ATP1B1;SLC8A1;ANK2;RGS2
prerank,establishment of protein localization to membrane (GO:0090150),0.38389999669117497,1.2007585681230335,0.18992805755395684,0.5622323863411176,1.0,18/66,15.81%,EGFR;RAB10;RFTN1;PIKFYVE;ZDHHC14;SDCBP;ZDHHC3;VPS37C;SEC63;MYO1C;CHM;ZDHHC24;RAB11A;RABGEF1;ZDHHC20;SYNE3;ICMT;ZDHHC2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.511088002684473,1.1997831442274134,0.24489795918367346,0.5638419432985624,1.0,5/16,15.74%,DPYD;DPYSL2;CRMP1;TET2;DPYSL5
prerank,regulation of microglial cell activation (GO:1903978),0.508978238437829,1.199507540471148,0.2687385740402194,0.5638740667275706,1.0,3/15,3.28%,LDLR;NR1D1;GRN
prerank,mRNA transport (GO:0051028),-0.29644332153311725,-1.199347123670965,0.11307420494699646,0.7996131603121126,1.0,38/101,26.40%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;KIF5C;SRSF2;FMR1;UPF1;RNPS1;NUP85;MCM3AP;U2AF1;UPF3B;CASC3;NCBP1;SEH1L;NXT1;THOC3;SRSF11;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,inhibitory synapse assembly (GO:1904862),-0.5138235140937712,-1.199277157778154,0.25854700854700857,0.797515897787298,1.0,7/11,27.97%,GABRB3;FGF13;GABRA2;GABRG2;WNT5A;PLXNB1;CBLN4
prerank,central nervous system development (GO:0007417),-0.2666068219954597,-1.1990532498699777,0.043478260869565216,0.7959542104391568,1.0,86/250,20.91%,CX3CR1;MBP;CHD7;NCKAP1;ADGRL3;MOG;ROBO2;EPHA7;ZFHX3;CNTNAP2;CDH2;PBX2;BPTF;ELP3;PITPNM1;AFF2;AATK;NDRG4;APOD;NF1;CIC;JRKL;CNTN4;SYNJ2;CNTN6;LOXL3;AHI1;RNF103;PPT1;BAG6;SERPINI1;MAL;RAB18;S100B;ZFHX2;GBA2;UTP3;ADAM22;SHROOM2;MEIS3;TBX6;SPOCK1;GRIN2A;TPPP;NKX2-2;SOX10;SMARCA1;PAX8;ALDH5A1;NPTX1;CTNS;PROX1;EML1;MEIS1;DSCAML1;ANKLE2;EEF1AKMT4-ECE2;ZIC1;TGFBR2;POU6F1;SHROOM4;MARCKS;DCLK1;SMG9;ADGRL2;DNAJC30;TBC1D23;CDK5RAP3;VCAN;SMO;VIT;BCAN;EGR2;SH3GL2;TPP1;PBX1;PLXNB2;NCAN;PTPN11;ZIC4;ROGDI;PAFAH1B3;HAP1;CDK5RAP1;SOX11;NNAT
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5432614094122048,1.1987224894340378,0.2655367231638418,0.5650763123315748,1.0,6/12,21.27%,ADSS2;LHPP;IMPDH2;ADSS1;GMPS;PAICS
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.34915204634229263,-1.1984164117421139,0.15588235294117647,0.7957918594253252,1.0,9/44,9.31%,KCNMA1;KCNJ2;ATP1B1;NOS1AP;ATP1B2;ANK2;AKAP6;ACTN2;WNK3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3770116619735284,1.198373271419639,0.2117310443490701,0.565253940408904,1.0,14/74,10.79%,DAB2;SPRED1;BMP2;ALX1;RGCC;IL17RD;SMAD4;SDCBP;VASN;CLASP1;USF3;PPP2CA;SFRP1;SPRED2
prerank,monoacylglycerol metabolic process (GO:0046462),-0.46789086268257024,-1.1978894143867813,0.23819742489270387,0.7952247948585178,1.0,5/13,17.01%,ABHD12;MGLL;ABHD16A;AWAT2;FAAH
prerank,ncRNA 3'-end processing (GO:0043628),-0.48016231604943943,-1.1970655492802582,0.24641148325358853,0.7956852175390676,1.0,5/14,24.97%,INTS6L;PTCD1;TRNT1;TOE1;INTS7
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.45788882370115036,1.1962758703913385,0.2504317789291883,0.5693864475489854,1.0,3/24,6.02%,APOE;CTSC;RHBDF1
prerank,positive regulation of cell motility (GO:2000147),0.3296644171029181,1.1962050611306134,0.1668639053254438,0.5689745089232013,1.0,20/205,5.91%,DAB2;NEDD9;EGFR;SEMA4A;CCR1;PPP3CA;MYADM;ITGB1;FER;CASS4;SYNE2;BMP2;DRD1;GRN;ADAM9;CCL19;INSR;RACK1;PDGFRA;TRIM32
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.418659591418545,1.1962037582378215,0.21658986175115208,0.5684159672796442,1.0,13/38,19.07%,ESR1;NR1H4;RIPK1;NR1D1;RIOK3;PPM1B;CASP8;ZC3H12A;PPM1A;PER1;NLRX1;TLE1;MAPKBP1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4231253760381667,1.1959001485492171,0.23565891472868217,0.5685397961199391,1.0,5/35,5.36%,IQGAP2;NRP1;NOTCH2;CDC42;PDGFRA
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.49419692304716384,1.1953463714077834,0.27906976744186046,0.5692349525279068,1.0,4/16,9.61%,PARP14;PIBF1;SH2B3;PPP2CA
prerank,response to organonitrogen compound (GO:0010243),0.42167419623002056,1.1953240979950532,0.2421875,0.5687201034427274,1.0,12/38,19.05%,IRAK3;NR1H4;RCN3;PRKN;RHBDD1;TRPM2;RNF185;MEAK7;KAT7;IL6;RRAGC;RNF139
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5308906005400722,1.195301557078156,0.26268115942028986,0.5682147198873453,1.0,2/12,3.78%,APP;RHOA
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4342322724552137,-1.1951320535505288,0.2330316742081448,0.8001061087009135,1.0,10/20,16.96%,NCKAP1;FMNL2;RHOQ;NCKAP1L;FHOD1;LLGL1;STRIP1;ARF6;LLGL2;PLEK
prerank,transepithelial transport (GO:0070633),-0.4533520314296402,-1.1950323664844413,0.22556390977443608,0.7981111158897044,1.0,6/15,18.58%,SLC1A3;SLC12A2;SLC1A1;ABCG2;CXADR;SLC1A2
prerank,negative regulation of hydrolase activity (GO:0051346),-0.34290054706863854,-1.1949933373945936,0.1887905604719764,0.7959221057289488,1.0,12/49,15.68%,F11R;MAP2;GMIP;RASA4;CPEB2;RDX;CST7;ARFGEF1;TERF2;CST3;HRAS;SLC39A14
prerank,calcium ion transmembrane transport (GO:0070588),0.36238894358799983,1.1946274063080993,0.20533333333333334,0.5691044371180001,1.0,19/86,14.61%,P2RX7;MCUB;ATP2B1;GAS6;ANO6;MCU;PARL;TRPV3;TMEM165;GRIN2D;TRPM2;TRPC7;SLC8B1;MICU3;ATP2B4;MCOLN2;SLC35G1;ATP2A2;PKD2
prerank,Rac protein signal transduction (GO:0016601),0.4899323060924243,1.1945900517528532,0.24548736462093862,0.5686112668649527,1.0,1/18,0.09%,EPS8
prerank,reverse cholesterol transport (GO:0043691),0.5286428803958588,1.1944827392654127,0.25673249551166966,0.5682675762998913,1.0,1/13,0.49%,APOE
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.37950355042661427,1.1943135507681946,0.2112676056338028,0.5681160669543439,1.0,14/74,11.28%,PF4;TCF7L2;SH3RF1;RIPK1;SIAH2;HMOX1;MCL1;GSK3B;BCL2;TNF;BIRC6;IGF1;CASP8;PHIP
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4235677022391472,1.1941036586778468,0.24646781789638933,0.568028978054695,1.0,9/40,11.70%,ANG;RPL39;LBP;TLR2;GBP7;DROSHA;RNASE6;ROMO1;CHGA
prerank,pre-miRNA processing (GO:0031054),0.5063750355095205,1.193933258588363,0.25830258302583026,0.5678443936441533,1.0,5/14,13.30%,PRKRA;TUT7;DROSHA;TUT4;MRPL44
prerank,phosphate ion homeostasis (GO:0055062),0.5426600944523559,1.1938187555927586,0.29250457038391225,0.5675500101656467,1.0,3/10,19.44%,FGF23;XPR1;ENPP1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3758633543929215,-1.1937682547870985,0.18980169971671387,0.7978359375970502,1.0,10/33,13.94%,PIK3CB;NYAP2;PLEKHA1;NF1;MYO16;PIK3C2B;SIRT2;PIK3R5;C1QBP;TYRO3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.43594641966845515,1.1936835401599728,0.2536115569823435,0.5672813570983604,1.0,8/30,11.10%,RPS27A;RIPK1;TLR4;BIRC3;LY96;CD40;UBE2D3;CASP8
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.506112183989708,1.192763830244178,0.24912280701754386,0.5686843947670237,1.0,6/16,16.43%,ADSS2;LHPP;IMPDH2;AMPD3;ADSS1;GMPS
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.33831840979884314,-1.1925062242425757,0.18181818181818182,0.7998766954915203,1.0,17/51,22.91%,CTNNB1;XRCC5;CTC1;SRC;HNRNPU;ATM;MAPK3;MAP2K7;STN1;TERF2;MAP3K4;HNRNPA1;CCT7;GNL3L;CCT2;ACD;CCT8
prerank,ruffle organization (GO:0031529),-0.45118936622868533,-1.192276890421945,0.2367816091954023,0.7983538055130497,1.0,7/16,18.99%,PLEKHA1;CSF1R;AIF1;ARF6;PLEK;LIMA1;CORO1B
prerank,negative regulation of cell junction assembly (GO:1901889),0.4574534513932928,1.1921964241019931,0.25585284280936454,0.5693995157102538,1.0,10/25,12.88%,ITGB1BP1;TLR2;ROCK1;TNF;DUSP22;RCC2;CORO1C;SLIT1;ROCK2;BCAS3
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4120629863085881,1.1921459249175608,0.22093023255813954,0.5689595015140353,1.0,8/48,8.71%,TLR8;PTPN22;LILRB1;TLR4;PDE4D;CCR2;CEBPG;TRIM27
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.502308085386211,-1.1920178804900499,0.2329896907216495,0.7970225952427303,1.0,7/11,21.52%,TGFBR1;SMAD7;ACVR1;TGFBR3;TGFBR2;TGFB2;TGFB1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.48045576019645064,1.1917814713408381,0.24820143884892087,0.5691843522516158,1.0,3/18,7.51%,PRKAG2;C1QTNF12;PRKCB
prerank,iron ion homeostasis (GO:0055072),0.3941052230406801,1.1914995135815678,0.21594202898550724,0.5693263667825894,1.0,21/58,18.59%,CP;HMOX1;B2M;FTL;NDFIP1;SMAD4;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;FTH1;TFR2;ABCB7;MYC;ATP6V0D1;NEO1;PICALM;SCARA5
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4421029985219128,1.1914241085347061,0.23164763458401305,0.5689398069426419,1.0,7/25,10.32%,MEF2C;GSK3B;MPP2;CHRNA4;MAPK8IP2;INSYN2A;GRIN2D
prerank,dendritic spine organization (GO:0097061),-0.39904969155721637,-1.191138330487704,0.22443890274314215,0.7977510510281063,1.0,8/26,7.74%,TREM2;DOCK10;DLG4;LGMN;DIP2A;SHANK1;EPHB1;PRNP
prerank,negative regulation of stem cell differentiation (GO:2000737),0.529760398112504,1.191033714644736,0.2833333333333333,0.5692962285042205,1.0,3/12,8.62%,ZFP36L2;JAG1;ESRRB
prerank,glucose metabolic process (GO:0006006),-0.3285671187233824,-1.1905002736483894,0.14334470989761092,0.7978084429296829,1.0,20/58,21.03%,LRP5;PGM1;ALDOA;MDH1;APOD;CRTC2;GAA;PGK1;ENO1;PCK2;ENO3;SLC37A4;TPI1;HECTD4;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,transcription by RNA polymerase I (GO:0006360),-0.36295021655941756,-1.1904422327129447,0.18010752688172044,0.7957773030485147,1.0,13/34,23.08%,GTF2H2;CCNH;MAPK3;UBTF;ERCC2;TAF1C;TAF1D;RRN3;TAF1;GTF2H4;POLR2L;POLR1C;TBP
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.4839377152053,1.1904158628906727,0.25259515570934254,0.5701615523931739,1.0,3/18,7.96%,GNAQ;RGS8;GNB1
prerank,positive regulation of hydrolase activity (GO:0051345),0.34635915473537315,1.190041701628641,0.18057285180572852,0.5704911638459395,1.0,22/137,6.15%,CHP2;SNX9;ARAP1;ITGB1;EVI5;MAPRE2;RPS3;RCN3;USP6NL;BMP2;CCL8;CCL19;RHOA;RAPGEF2;S100A10;RIC1;RAP1A;GSK3B;RACK1;DOCK11;RGS8;CD40
prerank,cell cycle G2/M phase transition (GO:0044839),-0.2811364350935458,-1.1895934070139726,0.0966183574879227,0.7964352698861866,1.0,41/129,25.09%,CSNK1E;SDCCAG8;CEP135;AKAP8L;ODF2;OPTN;DYNC1H1;SKP1;CEP192;CCNH;HAUS8;FBXL7;CEP250;WEE1;CCDC57;CEP63;PLK3;CCP110;PLCB1;AKAP8;HAUS7;CKAP5;HAUS3;MAPRE1;CHEK2;BRSK2;FBXL6;FBXL3;TAF2;LCMT1;DCTN2;BRSK1;MASTL;CNTRL;HAUS2;PLK4;DCTN1;HAUS6;CDK1;YWHAG;CCNA2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.5017348264524233,-1.1894725948742437,0.27450980392156865,0.7945547802080372,1.0,3/11,9.24%,TMEM67;CENATAC;BRCA1
prerank,regulation of dendritic spine development (GO:0060998),-0.4183413723939381,-1.1891814624811987,0.23148148148148148,0.7932868357004492,1.0,8/19,8.01%,TANC2;PTPRS;NLGN1;PPFIA2;KIF1A;GRIN3A;SHANK1;FMR1
prerank,cellular response to metal ion (GO:0071248),0.34429975578596483,1.1891561891369293,0.17413572343149808,0.5719058576148927,1.0,16/123,7.65%,EGFR;CHP2;IQGAP1;MEF2A;ALOX15;MEF2C;ALOX5AP;B2M;PRKN;AOC1;CPNE2;SLC25A24;CLIC4;CPNE7;CPNE8;HFE
prerank,membrane protein proteolysis (GO:0033619),0.4174338870298346,1.1890953623348142,0.22039473684210525,0.5715134874985995,1.0,15/37,22.05%,ADAM19;ADAM9;RHBDD1;PARL;PSEN1;SPPL2B;NCSTN;ERAP1;RELA;SPPL2A;PRKCQ;TRAF6;MBTPS2;ADAM17;NFKB1
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.45362337084330606,-1.1890187580512084,0.23922413793103448,0.7916499597170652,1.0,9/16,33.34%,ACACA;DIP2A;ACSS1;PPT1;SCD;SLC25A1;GCDH;CBR4;PPCS
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.47672859229433917,-1.1888083084693444,0.24778761061946902,0.7901588757849449,1.0,4/12,14.90%,SNAP25;SNAP47;STX3;STX2
prerank,nuclear body organization (GO:0030575),-0.4866823732896655,-1.1885411323117587,0.2564102564102564,0.7888693207684659,1.0,5/12,11.74%,AFF2;ETS1;USP50;SRPK2;HABP4
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3004920951903777,1.188526698362836,0.013039117352056168,0.5722189656378066,1.0,384/1646,19.46%,RBPJ;HDAC9;WWP1;CD38;ZEB2;MAF;TRPS1;ETV1;EGFR;LRP6;APOE;MAP3K5;KLF2;TCF7L2;TCF4;IRF4;MDFIC;FOXP1;FLI1;MEF2A;AHR;ZBTB16;RREB1;GAS6;FOXN2;TFEC;KMT2A;HIVEP2;NFXL1;ESR1;SMURF2;ZBTB20;RBBP8;HINT1;TCF12;MEF2C;NR1H4;CBFA2T3;NCOA2;CEBPB;PIAS1;MITF;OSR1;RYBP;TSHZ3;BMP2;PRICKLE1;ARID4B;KLF6;TBX15;CD74;PHF8;HOXD8;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR2C1;NR1D1;SNX6;AXIN1;WAC;CRK;RPS6KA3;BAZ2B;YWHAQ;TOX4;JARID2;BCL10;PHF20;NR3C1;TRIM56;NKAP;IRF2BP2;HEY2;CLOCK;CTDSP1;GRHL2;PBX3;DMRTA2;ARID1B;SPI1;KLF9;RB1;NCOA7;KDM7A;TCEA2;INSR;NFIC;CAMKK2;SMAD4;ARID5A;BATF2;PTPRK;ZFP2;ELF2;TRIM33;TGFBRAP1;IRX2;CBFB;NR4A1;FOSL2;TCF7;ATXN1;ZBTB25;DMAP1;EPC1;PIAS2;SETDB2;MED13L;FOXM1;ZNF235;ZNF568;TNF;CD80;KLF3;ZNF148;TSHZ1;LYL1;EPC2;KLF4;ZSCAN25;YY1;PRKCB;HTATIP2;THAP11;REL;MED16;SATB2;GATAD2A;TBL1XR1;STAT4;PSEN1;CEBPG;E2F5;NR4A2;LHX5;GMNN;ZBTB5;NCOR1;IRF2;KLF10;BTAF1;IRX5;ATF6;CDK14;ATRX;ZNF628;NCOA6;FOXC2;LIMD1;ESRRB;ARID3A;MIDEAS;BRIP1;BACH1;MDM2;HIVEP1;LCORL;OLIG2;TBL1X;MED18;LIN54;ESR2;LBH;MAPK14;HMG20A;LRRFIP1;MAMLD1;FOXJ3;ATF7;NFATC2;DYRK1A;MED20;MED6;LCOR;MLXIP;STAT6;PPP2CA;USP21;USP16;NR2F1;PURA;ILF3;ZNF205;RPL6;GCFC2;TESMIN;IGF1;SFRP1;JMJD1C;RFX2;RNF14;ARRB1;SPEN;RBM15;SP1;ANKRD49;RNF111;NUP62;ZNF296;RCOR2;SP100;CREBRF;MED26;TRIM16;ELF1;PCID2;TFDP1;ATXN1L;ZMYND15;PHC3;ETS2;PHIP;SHC1;CREBBP;SREBF2;CRYAB;BCL11B;MYBL2;FOXK2;NFIA;HINFP;FOXO3;SNX5;CDK17;NIBAN2;FOXK1;DEK;KDM5C;ATP2B4;LOXL2;TADA2B;TERF2IP;ZBTB8B;CHD2;KMT2E;ZFP3;SP3;FOXO1;NFIX;ELP4;CREB1;SFR1;KLF13;CCNQ;PEG3;PSPC1;CTBP2;ZBTB7C;XPC;ZNF326;RNF187;NR1H2;EP300;ZBTB10;RARA;KAT7;HIF3A;STAT3;JUND;MLF2;PROX2;KLF5;MBD1;EHMT1;BCOR;CRLF3;MED27;MMS19;USF1;KAT6A;HMGN5;ELOC;WWC1;NAB1;SNW1;ENY2;RGS14;MYC;NSD3;MTF1;MYT1;NR2C2;USP22;PEX14;SMARCD1;HDAC4;KDM2A;NLK;VGLL4;ZHX1;SFPQ;POU5F2;ARID1A;HEXIM2;RUNX3;ELK1;HCFC1;E2F8;KDM1A;USP47;ZNF569;HOXB3;ZFP62;CREB3L1;PPARGC1B;ZGPAT;PPM1A;RELA;PER1;ARNT;RCOR1;TBX2;NFATC3;ZNF177;BRD4;GLIS2;GPBP1;MED17;FOXP2;ZBTB7A;NR5A2;NACC1;SP8;PRKCQ;CARF;LHX1;NR2F2;ZNF22;GTF2H1;MEF2B;NR6A1;PA2G4;MECOM;ARID4A;ZFP28;IL6;ZBTB8A;GMEB1;ZNF32;PICALM;GZF1;ZBTB41;HSF5;BATF;ZBTB12;F2R;ZBTB40;ZBTB1;RFX3;MAFB;PERM1;PHF20L1;KDM4C;SRCAP;PHF5A;ATF2;ZBTB14;PLAG1;TRAF6;ID3;DVL3;THRA;PITHD1;SUMO1;RAI1;BRMS1;TLE1;TOX2;WDR77;SET;THRAP3;UXT;MECP2;CTCF;ZNF3;SFMBT1;SMAD1;INPP5K;RNF6;CIART;BCL3
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5429728573879494,1.1885028638801254,0.2595978062157221,0.571715274223698,1.0,7/11,22.10%,SMAD4;GLRX3;ATP2B4;FOXO1;LMNA;P2RX4;MLIP
prerank,neutrophil migration (GO:1990266),0.38845935783693364,1.1884986800705695,0.19765739385065886,0.5711722294217212,1.0,13/58,17.98%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24;CKLF;ITGB2;PPIA;CCL5;CCL25;IRAK4
prerank,positive regulation of kinase activity (GO:0033674),0.351223411521131,1.1883462704173067,0.20358514724711907,0.5709421890414841,1.0,17/107,9.86%,EGFR;FGFR1;IQGAP1;SNX9;PRKAG2;GAS6;RASSF2;CD74;CCL19;RAPGEF2;RAP1A;INSR;PDGFRA;TNF;DDR2;CACUL1;EPHB4
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.33835026881465086,-1.187806384509534,0.19533527696793002,0.7890737240281808,1.0,9/48,8.48%,CAPN3;PTK2B;CALM2;PLCG1;ANK2;UBASH3B;TRPC1;AKAP6;JPH1
prerank,natural killer cell mediated immunity (GO:0002228),-0.46013927323062154,-1.1876981993560207,0.2324561403508772,0.7872722597750552,1.0,2/15,0.67%,LYST;PLEKHM2
prerank,negative regulation of viral genome replication (GO:0045071),0.40721576571462803,1.1874276568479374,0.23937007874015748,0.5724793405761258,1.0,9/40,11.89%,IFITM3;OAS2;FAM111A;RNASEL;TNF;BST2;IFITM2;ILF3;BANF1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.41451042655665715,-1.1873164577081794,0.21739130434782608,0.786360041138758,1.0,12/23,28.30%,INTS3;WEE1;PLK3;BUB1B;BUB1;PABIR1;CDK5RAP3;ZFYVE19;ZW10;ZWINT;AURKB;CHMP4C
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.42470491704113333,1.1872133607533346,0.23981191222570533,0.5723887000202744,1.0,8/36,9.07%,GAS6;TSLP;RIPK1;PARP14;CD74;PRKN;CXCR4;UBE2K
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3480133685114373,1.1870040910698794,0.19920844327176782,0.5723023535935284,1.0,19/112,7.43%,NRROS;ZFP36L2;ITGB1;MEF2C;RPS27A;WNT2;ADAM9;CBL;ZFP36L1;RHOA;PDE2A;NR3C1;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;USP15;DUSP22
prerank,positive regulation of calcium ion import (GO:0090280),-0.4810230074246972,-1.1869881493271561,0.25740318906605925,0.7853500113154601,1.0,9/12,49.27%,CCL3;PDGFRB;STC1;RAMP3;CXCL12;ATP2A1;CCL2;PDGFB;CALCR
prerank,neuropeptide signaling pathway (GO:0007218),-0.3260774415018238,-1.1869827264340405,0.16770186335403728,0.7831976329581338,1.0,20/58,30.70%,SORL1;SORT1;SORCS1;HCRTR2;GLRB;ADCYAP1;SORCS3;GPR84;GLRA1;PENK;GLRA3;CPE;GPR149;OPRL1;GLRA2;PNOC;GRP;OPRD1;PDYN;OPRK1
prerank,filopodium assembly (GO:0046847),0.4966981707271557,1.1866673988064533,0.27580071174377224,0.5725248754387323,1.0,3/16,5.23%,FGD4;FGD6;S1PR2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.35232312972227453,-1.1864031595289222,0.20977011494252873,0.7829471959485166,1.0,13/37,18.31%,IFT81;IFT140;DYNLRB1;IFT88;IFT20;WDR19;DYNC2H1;SSX2IP;KIF3A;IFT52;KIF3B;IFT43;DYNC2I1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.46191098318946416,1.185277285366899,0.2695035460992908,0.5751525417893564,1.0,8/21,17.03%,ADAM19;ADAM9;PSEN1;SPPL2B;NCSTN;ERAP1;SPPL2A;PRKCQ
prerank,cellular response to reactive oxygen species (GO:0034614),0.3876377520272373,1.1849190751863568,0.22644163150492264,0.5754273672901994,1.0,18/59,16.80%,EGFR;MAP3K5;FER;RPS3;OSER1;RIPK1;CAMKK2;PTPRK;PDGFRA;PXN;TRPM2;ROMO1;AGAP3;NET1;PKD2;MAPK7;RELA;PRDX3
prerank,protein localization to Golgi apparatus (GO:0034067),-0.38999802919399307,-1.1845768585905248,0.2125340599455041,0.7869464243658851,1.0,6/27,8.32%,SORL1;ARL5C;OPTN;GCC2;BICD2;IFT20
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.48924463093708925,-1.1841564069483772,0.2700892857142857,0.7862098904965845,1.0,9/12,38.18%,CDC7;MCM3;MCM6;MCM2;MCM7;MCMDC2;GINS4;CDC45;MCM5
prerank,regulation of interleukin-17 production (GO:0032660),0.4337245238638686,1.1839651251676095,0.2318840579710145,0.5770611888559111,1.0,4/31,4.05%,IL15;NR1H4;TLR4;RFTN1
prerank,lipid modification (GO:0030258),0.4197778592890427,1.1839517469091814,0.2624,0.5765412823956986,1.0,4/37,2.12%,ALOX5;ALOX15;SGPP1;PLA2G7
prerank,aerobic respiration (GO:0009060),-0.41313970140232015,-1.183594209967699,0.24379232505643342,0.7858638948116319,1.0,12/20,39.94%,SDHB;NDUFS7;SLC25A14;UQCRC1;UQCRB;UQCR10;MTFR1;MTFR2;ATP5F1D;OXA1L;SURF1;SDHC
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.30586025561373686,-1.1834955099582878,0.1423487544483986,0.7840839452712717,1.0,33/82,31.88%,CSNK1E;SDCCAG8;CEP135;ODF2;DYNC1H1;TP53;CEP192;HAUS8;CEP250;CEP63;CCP110;HAUS7;CKAP5;HAUS3;MAPRE1;HMMR;DCTN2;CNTRL;HAUS2;KIF14;PLK4;DCTN1;HAUS6;CDK1;YWHAG;TUBA4A;CEP152;DYRK3;NEK10;CENPF;TUBA1A;TUBG1;AURKA
prerank,N-glycan processing (GO:0006491),0.482628248132601,1.183160183486498,0.272887323943662,0.5777653777153346,1.0,2/18,0.66%,MAN2A1;ST8SIA4
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.44440071225322403,1.1829447374931703,0.24878836833602586,0.5776540152684145,1.0,6/26,9.83%,MFHAS1;PTPN22;LBP;TLR2;NINJ1;RTN4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4863742435064023,-1.1828276474723014,0.2505175983436853,0.7841540456150181,1.0,5/12,24.54%,ABCG1;ITGB3;ITGAV;ABCA1;ABCA5
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.48053649616570826,-1.1826083675244827,0.2663755458515284,0.7827334111566004,1.0,5/13,24.28%,SORL1;EDEM1;BCAP31;CD81;TM9SF4
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.4414336426729374,1.182182678546513,0.2591362126245847,0.5788491624526311,1.0,4/27,5.63%,C3AR1;GPR65;DRD1;P2RY10
prerank,regulation of striated muscle contraction (GO:0006942),-0.3817591486739508,-1.1820549151988604,0.22682926829268293,0.7824053310417193,1.0,13/27,34.47%,CALM2;SMAD7;ANK2;GRK2;TNNI1;CALM3;SLC8A3;HCN4;RNF207;DMD;ASB3;MYL2;TNNT3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5016379315409044,1.1819558146166542,0.27848101265822783,0.5787931442108076,1.0,6/15,17.76%,TLR4;IL17RA;TNF;NOD2;STAT3;IL6
prerank,MAPK cascade (GO:0000165),0.318008124103884,1.1819069834622309,0.13800904977375567,0.5783546587742513,1.0,49/295,12.16%,RASGRP4;EGFR;FGFR1;MAP3K5;SPRED1;MEF2A;RGL1;ZFP36L2;PSMA7;MEF2C;RASAL2;RPS27A;NRAS;KRAS;SYNGAP1;RASA1;KITLG;SPTBN1;FGF23;PLVAP;ZFP36L1;RAPGEF2;IL17RD;FRS2;CCM2;IRS2;CAMKK2;MAPKAPK2;PDGFRA;GFRA3;PTPRA;MAP3K8;TNF;NRK;PSMB2;FYN;RANBP9;RASA2;MAP3K20;CUL3;IGF1;CALM1;PTGER4;PDE6D;SHC1;PSMA6;YWHAE;JAK1;MAP3K3
prerank,heart looping (GO:0001947),-0.36168566378636485,-1.181858041518698,0.20454545454545456,0.7810089842668778,1.0,16/39,23.49%,NDRG4;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;NOTCH1;SRF;MICAL2;ENG;BBS4;MKKS;CCDC40;STIL
prerank,negative regulation of axonogenesis (GO:0050771),-0.38532974089478533,-1.1812196579147516,0.22815533980582525,0.7809297316474244,1.0,10/27,16.34%,MAP2;PTPRS;DIP2B;FGF13;GDI1;LINGO1;MAG;OMG;ULK1;THY1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3859911184963002,-1.1811590040960773,0.2103960396039604,0.7790754940069656,1.0,7/26,18.54%,LARGE1;GK;SCCPDH;GAL3ST4;TPI1;ALG8;ST3GAL2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5068333076505636,1.1810850936567834,0.2793594306049822,0.5796986157856548,1.0,6/14,19.44%,SMPDL3A;CMPK1;AK8;AK3;AK4;ENPP1
prerank,regulation of proteolysis (GO:0030162),-0.3349091063033468,-1.1808285088294903,0.17699115044247787,0.7780940451761225,1.0,8/48,7.57%,ASPH;SERPINE2;CAPN3;GSAP;CLN3;TBC1D10A;CYFIP2;BAG6
prerank,regulation of neutrophil migration (GO:1902622),0.5558082879043851,1.1806089115208507,0.26627218934911245,0.5802641067456057,1.0,2/10,1.79%,MPP1;BST1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.45045538207983754,1.180544102169714,0.25083056478405313,0.5798600617319275,1.0,7/23,13.56%,GAS6;GHRL;CD33;CARD16;IGF1;ZC3H12A;FFAR1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5136710224118576,1.1803414652631168,0.2807017543859649,0.5797444037140563,1.0,2/13,4.54%,GAS6;LAMP1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4845990507689285,1.180173129550644,0.26394052044609667,0.5795467200744767,1.0,8/18,21.51%,NELL1;RIC1;MSN;WDR91;VGLL4;AMER1;EZR;FAF1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.38269055482065456,-1.1797938303503963,0.2222222222222222,0.7794661316074073,1.0,8/29,20.86%,RAB6B;TRAPPC3;COG3;VTI1B;NAPA;COG2;COPA;GOSR2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4167538222410439,1.179757113009969,0.23809523809523808,0.5799266073231112,1.0,4/35,6.28%,ALOX5;LTC4S;ALOX5AP;PAM
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.31296573065445626,-1.1797486274745754,0.13738019169329074,0.777536522520215,1.0,22/72,19.01%,GTF2H2;CUL4A;CCNH;COPS7A;COPS8;RBX1;ERCC6;COPS4;PPIE;ERCC2;LIG1;XAB2;XRCC1;HMGN1;UVSSA;PRPF19;RFC2;POLR2C;COPS6;GPS1;UBB;RFC1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3680295374314568,-1.1789761687399172,0.1907356948228883,0.7779248504376135,1.0,13/32,23.08%,GTF2H2;CCNH;MAPK3;UBTF;ERCC2;TAF1C;TAF1D;RRN3;TAF1;GTF2H4;POLR2L;POLR1C;TBP
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.39114253196051363,1.1783017175680022,0.2219020172910663,0.5826427850031329,1.0,7/49,6.29%,SGMS1;NUPR1;GSDME;MCL1;RACK1;BCL2L2;BCL2
prerank,lipid homeostasis (GO:0055088),0.38297857228567683,1.1781846753554739,0.24,0.5823528128673264,1.0,6/57,4.98%,APOE;FBXW7;ZBTB20;RCN3;IRS2;PNPLA8
prerank,regulation of macromolecule metabolic process (GO:0060255),0.33414671016636194,1.1781407120247334,0.17433414043583534,0.5819227845202477,1.0,33/170,16.10%,NELL1;APOE;APP;FOXP1;AHR;LDLR;CRIP1;RASA1;ZFP36L1;NFKBIZ;MTMR3;NKAP;CDK6;KIF16B;KDM6A;PSEN1;TRIM68;RO60;TRIM27;HMG20A;IGF1;HINFP;AFF1;ROCK2;ZC3H12A;PEG3;RNF187;ATXN7L3B;NOVA1;MYC;UBAP2;MTMR1;MKLN1
prerank,regulation of interferon-beta production (GO:0032648),0.39933508810227686,1.1776908914018605,0.2330246913580247,0.5824283545396088,1.0,10/46,7.55%,TLR8;OAS2;LILRB1;TLR4;TLR2;TRIM56;RIOK3;PPM1B;YY1;REL
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3975955104200693,1.1771087365640591,0.24423963133640553,0.5831672065576536,1.0,6/44,4.27%,APOE;PTPRJ;LYN;IRAK3;PTPN22;DUSP1
prerank,cellular response to hexose stimulus (GO:0071331),0.4583895019556046,1.176231382086193,0.27538726333907054,0.5846662218366285,1.0,4/23,5.17%,GAS6;ZBTB20;ERN1;RACK1
prerank,negative regulation of translation (GO:0017148),0.3624102457990702,1.176208112643553,0.20318725099601595,0.5841671101066002,1.0,35/87,23.47%,RPS3;DAPK1;EIF3E;SAMD4A;MRPL13;RACK1;ROCK1;MALSU1;RBM4;ILF3;DDX6;EIF4EBP2;NANOS3;ROCK2;EIF4EBP1;TRIM71;SHMT1;CNOT9;SYNCRIP;EIF2AK2;RNF139;EIF2AK4;EIF2AK3;CNOT8;CNOT1;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7;METTL16;EPRS1;PCIF1;CPEB3;FTO
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.465957194247575,1.175901597080883,0.26480836236933797,0.5842609256954789,1.0,4/21,5.68%,LRP6;AXIN1;GSK3B;FRAT1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.46906112568227337,1.1754753039152748,0.26916524701873934,0.584625136578792,1.0,5/22,12.21%,MDFIC;ITGB1BP1;RAB23;SP100;UFM1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.39657031078258725,1.175385392381576,0.2384737678855326,0.5843093533165994,1.0,7/45,8.24%,EGFR;IQGAP1;REPS2;CBL;KIF16B;GAB1;PIK3C2A
prerank,regulation of astrocyte differentiation (GO:0048710),-0.47377226332539824,-1.1753301588341607,0.24008350730688935,0.7877607630492367,1.0,2/12,0.79%,BIN1;SERPINE2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4353046103496676,1.1749795839199775,0.24373956594323873,0.5847139990784734,1.0,3/28,4.84%,APOE;APP;GSK3B
prerank,negative chemotaxis (GO:0050919),-0.3671886172270764,-1.1737060224294606,0.2335958005249344,0.7911690972988992,1.0,7/33,5.56%,SEMA4D;UNC5C;EPHA7;SEMA4C;ITGB3;ROBO1;SEMA4G
prerank,pharyngeal system development (GO:0060037),-0.4460162588324573,-1.1735428646221928,0.2554112554112554,0.7896664239018207,1.0,1/15,0.14%,TGFBR1
prerank,protein mannosylation (GO:0035268),-0.40460728659302614,-1.1731475084250842,0.21140142517814728,0.7888051629440157,1.0,9/22,24.00%,LARGE1;DPY19L4;TMTC4;DPY19L1;TMTC2;DPY19L3;TMTC1;DPM2;FKTN
prerank,regulation of urine volume (GO:0035809),0.5532916457323098,1.1730855919046168,0.31001890359168244,0.5884599455685742,1.0,2/10,4.47%,ADM;NPR3
prerank,cellular response to interleukin-4 (GO:0071353),0.5431802805542786,1.1728349542687357,0.31086142322097376,0.5884250527095083,1.0,3/10,9.55%,DCSTAMP;TCF7;STAT6
prerank,glycolipid biosynthetic process (GO:0009247),-0.3599639669559714,-1.1727699724739542,0.21465968586387435,0.7879761855333194,1.0,12/38,23.93%,LARGE1;ST3GAL5;PGAP2;SCCPDH;ST8SIA1;ST8SIA3;PIGL;ST3GAL2;PIGH;PGAP3;PIGB;DPM2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.34495942300755555,-1.1726926436521372,0.2148997134670487,0.7861542718404898,1.0,7/41,5.07%,TJP1;GCNT2;PTPN23;SMAD7;PLPP3;FLOT1;PIEZO1
prerank,dephosphorylation (GO:0016311),0.3337275899977942,1.172630500030417,0.21793275217932753,0.5883161402434494,1.0,26/147,11.07%,PTPRJ;PPP3CA;PTPN18;SGPP1;PTPN12;PTPN22;MTM1;DUSP28;MTMR3;DUSP12;DUSP1;CTDSP1;SSH2;PTPRK;PTPRA;PPM1B;HDHD2;PPP4R1;DUSP2;CTDSP2;LHPP;PPP2CA;PPP2CB;PPEF1;PPP4R2;PPP1CA
prerank,RNA splicing (GO:0008380),-0.29378495884334044,-1.1723452747665377,0.17279411764705882,0.7853365153827229,1.0,27/95,16.05%,IVNS1ABP;LUC7L3;FUS;SRRM1;DDX39B;RP9;TARDBP;DDX47;SNRNP48;SRPK1;SRSF2;GEMIN2;SNRPA1;SRSF10;PRPF4;WBP4;TCERG1;CCAR2;RNPS1;SRPK2;SNRPN;U2AF1;SF3B1;NCBP1;PRPF6;DDX23;ZMAT5
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3749200555246884,1.1720813705523994,0.225,0.5889335845847661,1.0,13/65,11.65%,NRROS;SPRED1;SMURF2;RPS27A;SNX6;IL17RD;SNX25;HTRA3;VASN;DAND5;SPRED2;EMILIN1;PMEPA1
prerank,cellular response to interleukin-6 (GO:0071354),0.4425967545360549,1.1719717274175223,0.24958402662229617,0.5886075575546268,1.0,5/26,5.16%,PID1;FER;CBL;SPI1;SMAD4
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5320791732867267,1.1717091618646964,0.29865125240847784,0.5886465350347213,1.0,1/10,0.26%,DSE
prerank,response to glucose (GO:0009749),0.39449163517571406,1.1716904320836445,0.24962406015037594,0.588130874312173,1.0,6/46,5.17%,TCF7L2;GAS6;ZBTB20;ERN1;IRS2;RACK1
prerank,protein modification process (GO:0036211),0.36743193245139294,1.1716897880296484,0.22662889518413598,0.587585280773613,1.0,19/76,15.86%,PADI4;ST8SIA4;ST3GAL1;LOX;DUSP12;SERP1;MANBA;MSRA;UBE2D3;FBXO11;GNMT;PPP4R2;STK38;LOXL2;ERO1A;RPN2;ICMT;USP25;FBXW2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4548571645716665,-1.1715643919974312,0.26450116009280744,0.7858113390273027,1.0,6/15,19.90%,CPEB2;ZFAND1;ATF3;HSF1;HNRNPA1;GSTO2
prerank,centromere complex assembly (GO:0034508),-0.3537074285082948,-1.1711379170214147,0.2297979797979798,0.7852369245015436,1.0,15/36,30.12%,CENPC;CENPE;NASP;KNL1;MIS18BP1;RUVBL1;DLGAP5;CENPX;CENPV;CENPN;CENPP;CENPH;CENPI;MIS18A;CENPF
prerank,regulation of transferase activity (GO:0051338),-0.43504068001142393,-1.1710541203257032,0.2505854800936768,0.7835071742430285,1.0,9/17,27.82%,LDB1;ATM;NLRC5;LDB2;PARP4;BAG5;SLAMF8;EMP2;JMJD8
prerank,negative regulation of proteolysis (GO:0045861),-0.36578497273080013,-1.1708798173392274,0.23218997361477572,0.7820210499925545,1.0,8/34,14.21%,SERPINE2;TMEM59;CLN3;CST7;BAG6;PRNP;CST3;GAS1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.48057899273652727,-1.1707247366862517,0.27232142857142855,0.7805743867714573,1.0,5/12,15.90%,MAP2;TBCD;EML2;MAPRE1;CLIP3
prerank,regulation of mononuclear cell migration (GO:0071675),0.44481882208849116,1.1700187191206317,0.2533112582781457,0.5908407837676559,1.0,7/23,16.92%,CMKLR1;LYN;TNF;MSN;STK10;MDK;CCL5
prerank,positive regulation of embryonic development (GO:0040019),0.4681802932221798,1.1699833132185975,0.2660098522167488,0.5903732601951069,1.0,6/19,17.12%,OSR1;RACK1;B4GALT5;NIBAN2;NR2C2;LHX1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3769862325822653,1.1699331110050868,0.24238026124818576,0.5899284651093266,1.0,14/70,12.91%,P2RX7;TNFRSF1B;RIPK1;MCL1;GSK3B;BCL2L2;BCL2;BAG3;TNF;IL6R;TNFSF12;CASP8;DIABLO;TNFRSF1A
prerank,negative regulation of blood coagulation (GO:0030195),0.4156529325659396,1.1696800190263168,0.24919093851132687,0.5899173556572915,1.0,4/38,5.36%,APOE;SERPINB2;C1QTNF1;PDGFRA
prerank,regulation of T cell cytokine production (GO:0002724),0.5120969671474621,1.169402498800845,0.2972972972972973,0.5899419745905351,1.0,4/15,7.65%,TNFRSF1B;B2M;CCR2;HFE
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.34121711303603897,1.1692892061911164,0.22681704260651628,0.5896553842262842,1.0,33/122,17.76%,EGFR;EIF3E;TLR4;NIBAN1;SAMD4A;CCL19;RGCC;RPL26;VIM;TLR2;IRS2;INSR;NMD3;TMEM106A;RPS4X;KLF4;MTPN;RPL5;LARP4B;IGF1;NAMPT;NOD2;LARP4;PIWIL2;KAT7;PRKD2;PRMT1;MYC;ABCB10;XBP1;PYM1;IL6;HGF
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.464065624899467,-1.1692402156643427,0.25663716814159293,0.7835014802574758,1.0,8/13,42.20%,UPP2;DUT;NT5M;UNG;NEIL2;NEIL1;DCTPP1;MBD4
prerank,regulation of protein secretion (GO:0050708),0.3409255639808223,1.1691239613357267,0.2095115681233933,0.5894742686762822,1.0,25/119,12.56%,APOE;ALOX5;ANG;EXPH5;ADAM9;HMGCR;CLOCK;RAP1A;TMED10;RHBDF1;DPH3;STXBP5;EIPR1;TNF;KCNG2;GOLPH3L;DNAJC1;CD33;IGF1;HADH;ACHE;SLC2A2;KCNB1;SLC8B1;DISP1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.47332911198532235,1.1686708210121488,0.27075812274368233,0.5899947869341263,1.0,3/18,5.16%,LILRB1;CD46;SMAD4
prerank,hyaluronan catabolic process (GO:0030214),0.47224674518104903,1.1683619550826505,0.2787456445993031,0.5901467250867184,1.0,2/18,2.34%,LYVE1;CD44
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.48741560670692585,-1.167897665037601,0.2839506172839506,0.7860314498572671,1.0,4/11,20.15%,HTRA2;ST18;PARK7;PRR7
prerank,regulation of embryonic development (GO:0045995),0.4174985173983872,1.1678398516223985,0.2469325153374233,0.5907811816919071,1.0,16/34,22.75%,INSR;RAB14;CLASP1;RPS6KA6;POGLUT1;B4GALT5;CCSAP;NIBAN2;EHMT1;NPHP3;NR2C2;LHX1;TRIP12;RACGAP1;NIPBL;WDPCP
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.43534078672695076,1.1670962564822565,0.25,0.5919175396456431,1.0,4/29,4.74%,RASGRP4;NOTCH2;LYN;IRS2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.409386814802509,1.1670471846173291,0.25308641975308643,0.5914710625461075,1.0,5/35,7.65%,HIP1;CBL;CCL19;B2M;HFE
prerank,cellular response to leucine starvation (GO:1990253),-0.4946513700303141,-1.16664461908413,0.2775330396475771,0.7879440419451914,1.0,7/10,19.38%,GCN1;IMPACT;RRAGD;SESN3;RRAGB;MTOR;SESN2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.4704192144149972,-1.165974818096012,0.24439461883408073,0.7881505937039391,1.0,4/13,15.24%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.531925964429026,1.1659368616596986,0.2894211576846307,0.5934425926105219,1.0,4/11,10.39%,PARP14;PARP8;PARP11;PARP16
prerank,vitamin D metabolic process (GO:0042359),0.4985007722672691,1.16555055107016,0.2962962962962963,0.5937313389640937,1.0,2/13,3.62%,FGF23;UGT1A4
prerank,regulation of telomerase activity (GO:0051972),-0.33378844782421274,-1.1650367979555556,0.20821114369501467,0.7892088299229604,1.0,11/45,14.79%,CTNNB1;XRCC5;SRC;TP53;ATM;MAPK3;MAP2K7;PTGES3;MAP3K4;CERS1;PARP4
prerank,cell projection assembly (GO:0030031),-0.4099578283010362,-1.1644057074285898,0.2534883720930233,0.78927459432394,1.0,8/22,19.14%,NCKAP1;NEFH;RHOQ;NCKAP1L;RHOH;PARVG;PDGFA;RHOG
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4714349638294919,1.1642780000012454,0.2765567765567766,0.5960844034292543,1.0,4/20,11.49%,APOE;NR1H4;SREBF2;FMO5
prerank,response to interleukin-1 (GO:0070555),0.371206408359699,1.1640560098284047,0.25071225071225073,0.596057959826017,1.0,28/73,23.72%,APP;GBP3;IRAK3;CCL8;NR1D1;CCL19;TNFRSF11A;RC3H1;CD40;CCL24;IGBP1;SFRP1;ZC3H12A;HDAC4;RELA;CCL5;ACOD1;CCL25;TRAF6;HAS2;SNCA;CCL14;NFKB1;CD47;IL1R1;TANK;MAPK11;TLE5
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.341250989378273,-1.1639963798132862,0.22010869565217392,0.7885965372936804,1.0,7/40,8.01%,PRKCD;CDK9;FXR2;ETAA1;MAPT;SIRT7;FMR1
prerank,positive regulation of GTPase activity (GO:0043547),-0.26727313109673584,-1.1637729763118059,0.11258278145695365,0.7873695811628536,1.0,41/188,11.56%,ARHGAP45;SIPA1L2;F11R;ARHGAP24;TBC1D16;MAP4K4;SEMA4D;ASAP3;TBC1D8;ARHGAP25;GARNL3;DOCK9;ITGA6;DOCK10;ARHGAP27;SGSM3;GMIP;TGM2;SGSM2;FERMT2;FLCN;NTRK3;TBC1D10A;NF1;RGS6;RASGRF1;ARHGAP22;TBC1D22A;CCL3;TBC1D22B;TIAM1;TBC1D9B;ADCYAP1;MMUT;TIAM2;AFDN;ABR;PKP4;EVI5L;TSC1;RAPGEF3
prerank,regulation of hormone secretion (GO:0046883),0.49290818550951443,1.163760619154554,0.301056338028169,0.5961639988468782,1.0,2/15,3.29%,FGF23;SNX6
prerank,regulation of microtubule nucleation (GO:0010968),-0.506145479954379,-1.1635835146231972,0.28695652173913044,0.7859910654923413,1.0,9/10,41.48%,PAK1;CKAP5;EML2;DCTN1;HSPA1A;HSPA1B;ARHGEF7;RANGRF;GIT1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4252873250375509,1.163164380908719,0.2676056338028169,0.5969559123624085,1.0,9/31,12.54%,YWHAQ;GSK3B;SFN;BCL2;ZNF205;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,negative regulation of anoikis (GO:2000811),0.494285169754332,1.1626464365946403,0.2756052141527002,0.5975338925013671,1.0,3/14,6.29%,ITGB1;MCL1;BCL2
prerank,protein localization to cilium (GO:0061512),-0.3610009780288618,-1.162534959674863,0.24528301886792453,0.7874048627453037,1.0,10/32,20.70%,BBS9;ATP6V1D;IFT140;IFT20;WDR19;INVS;TCTN1;TULP3;BBS4;ARL3
prerank,response to iron ion (GO:0010039),0.5254601527978298,1.1624284123923043,0.28413284132841327,0.5974886133165147,1.0,5/12,13.52%,B2M;BCL2;HFE;ACO1;TFR2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5129675093049662,1.1619909217932607,0.29609929078014185,0.5979721994634074,1.0,5/13,17.04%,MDFIC;RAB23;SP100;UFM1;NUP153
prerank,myotube cell development (GO:0014904),0.5468591910035346,1.1618353291189045,0.3346303501945525,0.5977732888035061,1.0,2/10,9.95%,MYORG;IGF1
prerank,positive regulation of type 2 immune response (GO:0002830),0.495358718535027,1.1614866511921125,0.308529945553539,0.5980079236669597,1.0,5/14,17.76%,CD74;DENND1B;NOD2;RARA;IL6
prerank,cellular response to alcohol (GO:0097306),0.3930785979964047,1.160991487896549,0.23660714285714285,0.598588168759492,1.0,11/42,11.83%,LRP6;CTNNA1;AHR;GNG2;KLF9;GNB1;SFRP1;SPIDR;PTGER4;JUP;GRAMD1B
prerank,regulation of tissue remodeling (GO:0034103),0.47663336895803116,1.160987628270334,0.2902097902097902,0.5980503351465681,1.0,4/18,14.35%,IL15;THBS4;DDR2;MDK
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4563646747080865,1.1600932768974677,0.2627986348122867,0.5995265786310864,1.0,2/24,1.24%,TRPS1;ZBTB16
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.33850276566549553,1.159616493416119,0.21052631578947367,0.6000688730837057,1.0,24/124,14.53%,AP2A2;TCF7L2;PPP3CA;CLTC;SMURF2;PSMA7;GNG2;PRICKLE1;CDC42;RHOA;PDE6A;CELSR1;AP2S1;PSMB2;GNB1;SFRP1;CALM1;PLCB3;PSMA6;TNRC6C;AP2B1;PSMD5;PSMD1;PSMA3
prerank,protein stabilization (GO:0050821),0.3262655621463207,1.159477631783446,0.1968019680196802,0.599857489659745,1.0,40/168,16.89%,HIP1;GNAQ;FBXW7;RPL23;RASSF2;PRKRA;GRN;PRKN;AFM;LAMP1;USP9X;CTNND1;STK3;NOP53;BAG3;SUGT1;RPL5;TBL1X;CCT6A;RPS7;RTN4;IGF1;LAMP2;WFS1;CRYAB;CREB1;TSPAN1;EP300;PARVA;RPL11;NLK;HCFC1;MCM8;HSP90AB1;PTEN;COG7;SEC16A;CCT3;MFSD1;FLOT2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3490927647570838,1.1591498087478356,0.24254742547425473,0.6000841126280442,1.0,20/105,14.53%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMD5;PSMD1;PSMA3
prerank,regulation of stress fiber assembly (GO:0051492),0.36422670329983164,1.1591020226654303,0.2390998593530239,0.5996510904926258,1.0,21/74,14.30%,NRP1;ARAP1;WASF2;GPR65;CDC42;RGCC;ARHGEF10L;RHOA;ITGB1BP1;S100A10;PAK2;ROCK1;CLASP1;SFRP1;PXN;PTGER4;PPFIA1;ROCK2;CGNL1;ARHGAP28;RHOC
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.461855709173175,-1.1587880780435098,0.26576576576576577,0.7978299151299637,1.0,3/13,5.77%,IRAK2;UNC93B1;PIK3R4
prerank,hyaluronan metabolic process (GO:0030212),0.4492149331558885,1.1586335216447572,0.282312925170068,0.6001700040240617,1.0,2/23,2.34%,LYVE1;CD44
prerank,negative regulation of GTPase activity (GO:0034260),-0.4045543639610739,-1.158246280815438,0.24069478908188585,0.797500574981927,1.0,9/22,20.30%,F11R;GMIP;RASA4;CPEB2;RDX;ARFGEF1;HRAS;PLXNB3;GPSM1
prerank,megakaryocyte differentiation (GO:0030219),0.5183505500124493,1.1580816174020312,0.29902912621359223,0.6008728142124355,1.0,2/11,9.29%,THPO;SH2B3
prerank,cellular macromolecule catabolic process (GO:0044265),0.3934330169204897,1.1580116031961134,0.2647058823529412,0.6004992295891427,1.0,11/49,12.03%,RIPK1;SIAH2;PRKN;SND1;MANBA;DNASE1L1;RNASE6;ADAMTS9;MTREX;NGLY1;DENND3
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4410821597105715,1.1575548741513852,0.2787682333873582,0.6009802356682411,1.0,9/24,19.44%,IRS2;GSK3B;INSR;PPP1R3C;IGF1;PPP1R3D;PPP1R3B;INPP5K;ENPP1
prerank,hemopoiesis (GO:0030097),0.3514413240363712,1.1572666829426244,0.24619640387275243,0.601082056395156,1.0,23/87,17.73%,RASGRP4;NOTCH2;ZBTB16;KMT2A;ZFP36L2;JAG1;KITLG;TPO;LYL1;NCOA6;ASH2L;SH2B3;SFRP1;CDK13;TET2;KAT6A;RUNX3;MKNK2;CD164;PRDX3;TIRAP;MECOM;ARMC6
prerank,myelination (GO:0042552),-0.32864345673670553,-1.1566855753593699,0.2028985507246377,0.8006236953450849,1.0,16/46,12.92%,PLP1;MBP;EPB41L3;PARD3;CMTM8;NF1;MAL;SIRT2;DEGS1;NFASC;ABCD2;TPPP;SCN8A;SOX10;BCAS1;PLLP
prerank,monocarboxylic acid transport (GO:0015718),0.38729719919802286,1.1566377475063936,0.2716236722306525,0.6019965422023434,1.0,7/51,8.57%,SLC10A6;SLC16A7;NR1H4;NCOA2;CD36;ABCC4;SLC10A3
prerank,regulation of vasoconstriction (GO:0019229),0.43728241625597836,1.1565022266033977,0.2771474878444084,0.601762015326429,1.0,4/27,8.68%,ATP2B1;ADM;ADRA1D;ADRA1A
prerank,dendritic spine morphogenesis (GO:0060997),-0.4583114133856144,-1.1564694598786933,0.28859060402684567,0.7993698050523975,1.0,8/15,18.03%,DOCK10;DLG4;DIP2A;SHANK1;EPHB1;CTNND2;EPHB2;PAK3
prerank,anterior/posterior pattern specification (GO:0009952),-0.32113637306803794,-1.1562444929674276,0.2132132132132132,0.7981812113315302,1.0,10/53,17.41%,TGFBR1;BASP1;LRP5;HOXC4;BHLHE41;DDIT3;CELSR2;HOXA3;HOXC5;HOXB9
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5436332023923739,1.156164163291275,0.311787072243346,0.6019687352531207,1.0,2/10,4.36%,RIPK1;PDE8A
prerank,rRNA methylation (GO:0031167),-0.3950559189832309,-1.1560662356662361,0.25059665871121717,0.7967234184998041,1.0,12/22,35.35%,NSUN5;FTSJ3;TFB2M;MRM3;MRM2;FDXACB1;MTERF4;EMG1;TFB1M;NOP2;FBL;METTL15
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.4704287671631324,-1.1559696654938822,0.2671081677704194,0.795055036119631,1.0,4/12,15.24%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,ameboidal-type cell migration (GO:0001667),0.381523303076782,1.155926275669824,0.25987841945288753,0.6019712170398486,1.0,7/51,9.67%,ITGA4;SEMA4A;PKN2;PDLIM1;SGPL1;AMOT;CORO1C
prerank,axonal transport (GO:0098930),-0.3521011489114625,-1.1557961964818344,0.21902017291066284,0.7937359122756324,1.0,9/36,13.92%,DST;DYNC1H1;KIF1A;AP3B2;MAPT;AP3D1;TMEM108;KIF3A;KIF3B
prerank,positive regulation of protein polymerization (GO:0032273),-0.31703561238549216,-1.155398684571769,0.19805194805194806,0.7931297074504905,1.0,7/65,2.26%,NAV3;BIN1;NCKAP1;EVL;PTK2B;PRKCE;PAK1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.46977590561405186,1.1550954184842204,0.27808471454880296,0.6033428012077493,1.0,5/17,9.36%,SASH1;CD36;NFKBIL1;LY96;CARD16
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3491019224850783,1.1550107441490123,0.24965893587994542,0.6024677553317319,1.0,20/104,14.53%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMD5;PSMD1;PSMA3
prerank,cellular response to lectin (GO:1990858),0.3491019224850783,1.1550107441490123,0.24965893587994542,0.6024677553317319,1.0,20/104,14.53%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMD5;PSMD1;PSMA3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5070544065517676,1.154634106999059,0.3172043010752688,0.6027907796010811,1.0,3/12,14.39%,TLR4;NOD2;RBP4
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4545314619516688,-1.1542369942979465,0.2793427230046948,0.7950081381941327,1.0,8/14,19.42%,SEC31A;SEC24A;TBC1D20;SCAP;SEC23B;SEC31B;SEC13;SEC24B
prerank,regulation of nervous system development (GO:0051960),-0.34152118128265596,-1.1539797046596738,0.22969187675070027,0.793927365833867,1.0,6/37,9.60%,CX3CR1;CTNNB1;BHLHE41;TENM4;NSUN5;SIRT2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.44272579563141856,1.1536351146535841,0.2824561403508772,0.6045387143070503,1.0,7/23,10.64%,APP;PRKAG2;AXIN1;S1PR2;UBE2K;RIPK2;CALM1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4253167152428921,-1.153502322248961,0.28741092636579574,0.7935531488427643,1.0,5/17,14.31%,CPSF6;CDK9;CTR9;HSF1;NCBP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.33130935394675814,1.1534980966095716,0.21804511278195488,0.6043332445893661,1.0,25/133,14.37%,MCUB;ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;MCU;CD40;BCL2;STIM1;CCR2;PSEN1;TMEM165;PLN;WFS1;TRPC7;SLC10A7;YWHAE;SLC8B1;MICU3;ATP2B4;SLC35G1;ATP2A2;PDZD8
prerank,calcium ion import across plasma membrane (GO:0098703),-0.44143317780697394,-1.1534804188036694,0.2843601895734597,0.7917150347105162,1.0,3/14,4.82%,SLC24A2;SLC8A1;CACNA2D1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.4500506982111157,1.1529553225307758,0.28711256117455136,0.6050914251174371,1.0,5/23,18.54%,ENDOG;DNASE1L1;DFFA;FBH1;KPNB1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.45929217932147054,-1.1525751187092428,0.29218106995884774,0.7928957833324228,1.0,6/12,11.47%,HNRNPU;NELFB;RNF168;RECQL5;TCERG1;NELFCD
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4549856601508004,1.1525565539716272,0.27863247863247864,0.6055064412971243,1.0,11/20,22.05%,ADAM9;RHBDD1;PSEN1;SPPL2B;NCSTN;RELA;SPPL2A;TRAF6;MBTPS2;ADAM17;NFKB1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.43793666362393957,1.1521039685156824,0.2711038961038961,0.6059894025825101,1.0,5/27,9.15%,MAP3K5;RPS27A;CCM2;MAP3K8;MAP3K20
prerank,cardiac muscle tissue development (GO:0048738),0.38176798188372685,1.1520488774171296,0.2572298325722983,0.6055689285587873,1.0,10/50,16.62%,NOTCH2;BMP2;HEY2;SMAD4;ADAMTS9;MAML1;GJA1;RBP4;BMPR1A;TBX2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3901083199827271,-1.1517051423741063,0.26262626262626265,0.7939619108967604,1.0,4/23,2.39%,JAK2;PTK2B;OCIAD1;IL10RA
prerank,ion transport (GO:0006811),-0.27796424414341814,-1.1514665318444757,0.18218623481781376,0.7928924199587887,1.0,31/111,18.75%,SLC1A3;SLC12A2;SLC24A3;SLC24A2;SLC8A1;SLC36A1;SLC9A8;TRPM3;PIEZO1;GABRB1;LASP1;SLC24A4;GLRB;VDAC1;SLC4A2;SLC25A26;SLC1A1;SLC25A22;SLC12A6;PIEZO2;SLC17A5;GLRA1;CTNS;TMEM63C;KCNN2;SLC9A1;SLC25A10;SLC20A2;SLC1A2;SLC24A5;SLC17A6
prerank,positive regulation of metabolic process (GO:0009893),0.34603711016764704,1.1513366962024156,0.24423337856173677,0.6066242274435051,1.0,19/103,10.97%,IRF4;CMKLR1;CEBPB;ADRB2;CD36;CAMK1D;GHRL;INSR;ADIPOR2;SYK;TNF;CXCR4;CCR2;PDGFC;BEND3;STAT6;TSHR;HADH;ACHE
prerank,phosphate ion transport (GO:0006817),-0.4344885520550338,-1.1509838789692701,0.30324074074074076,0.7926484594517815,1.0,7/16,21.20%,SLC25A3;SLC37A2;SLC25A14;SLC37A4;SLC25A10;SLC20A2;SLC37A3
prerank,histone deacetylation (GO:0016575),0.38915004521488566,1.1508448942259788,0.27813504823151125,0.6072323987769024,1.0,13/43,16.57%,HDAC9;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;MIER3;RCOR2;SMARCAD1;HDAC4;SFPQ;PER1;RCOR1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.48766964055232526,1.15062854545756,0.2849557522123894,0.6066315560960434,1.0,10/15,27.08%,ZFP36L2;ZFP36L1;NANOS3;TNRC6C;CNOT1;CPEB3;TOB1;AGO2;NANOS1;ZFP36
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.48766964055232526,1.15062854545756,0.2849557522123894,0.6066315560960434,1.0,10/15,27.08%,ZFP36L2;ZFP36L1;NANOS3;TNRC6C;CNOT1;CPEB3;TOB1;AGO2;NANOS1;ZFP36
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4539939909765811,1.1504724948596543,0.296551724137931,0.6064401038898602,1.0,5/21,14.37%,MCUB;MCU;SLC8B1;MICU3;PDZD8
prerank,protein targeting to lysosome (GO:0006622),-0.4054970589755018,-1.149443299778749,0.2716627634660422,0.7956941960109573,1.0,4/20,5.18%,SORL1;GNPTAB;SCARB2;GCC2
prerank,ribosomal large subunit assembly (GO:0000027),0.4428303334082983,1.149150084298203,0.272572402044293,0.6088996942106124,1.0,11/24,17.73%,RPL23A;RPL24;RSL24D1;NOP53;RPLP0;RPL5;RPL6;RPL10;RPL11;RRS1;DDX28
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3976521652037824,-1.1488079971706273,0.25790754257907544,0.7958698531571823,1.0,10/23,18.69%,CUL4A;COPS7A;PARP1;COPS8;DDB2;RBX1;COPS4;COPS6;GPS1;UBB
prerank,extracellular matrix assembly (GO:0085029),0.4393980856512361,1.1479814370512478,0.2962962962962963,0.6110101593160374,1.0,8/23,14.18%,GAS6;ATP7A;MFAP4;PXDN;EMILIN1;RAMP2;NTN4;TNXB
prerank,skeletal system morphogenesis (GO:0048705),0.3879562743850763,1.1479226111592036,0.2786624203821656,0.6106156672987455,1.0,7/42,10.01%,LRP6;FGFR1;ALX1;ANKRD11;PDGFRA;RFLNB;CYP26B1
prerank,synaptic vesicle transport (GO:0048489),-0.48595108027910594,-1.1477853576094845,0.2890295358649789,0.7972917656611528,1.0,4/11,6.32%,RAB27A;KIF5A;SPG11;KIF5C
prerank,positive regulation of bone resorption (GO:0045780),0.5182815516482399,1.1476667480250773,0.32105263157894737,0.6106568131315679,1.0,3/11,6.52%,DCSTAMP;TNFRSF11A;SYK
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3436251866899501,-1.1475122732953624,0.24736842105263157,0.7963049678864875,1.0,9/39,9.31%,FGF14;FGF12;PRKCE;YWHAH;SCN1B;HECW2;FGF13;HECW1;WNK3
prerank,axon guidance (GO:0007411),-0.25903794364961413,-1.1469106409853662,0.13157894736842105,0.796408618680494,1.0,35/201,7.85%,PTPRM;NCAM1;NRXN3;SEMA4D;UNC5C;PIK3CB;EVL;EFNA5;ROBO2;EPHA7;SCN1B;SRC;NRXN1;SEMA4C;GRB10;PLXNA2;PLCG1;ROBO1;LYPLA2;KIF5A;SEMA4G;PALLD;MAPK3;KIF5C;EPHB1;CNTN4;BDNF;CNTN6;BSG;EPHA10;RHOH;CNTN2;SHC3;UNC5D;LAMA2
prerank,ureteric bud development (GO:0001657),-0.4219203540746405,-1.146361846459923,0.26126126126126126,0.7962603613408804,1.0,4/17,4.84%,SALL1;NPNT;ROBO2;FGFR2
prerank,zinc ion homeostasis (GO:0055069),-0.3751381190788884,-1.145800325940525,0.24739583333333334,0.7961734204266943,1.0,15/28,26.46%,SLC30A9;ATP13A2;SLC39A13;SLC39A14;MT2A;TMC8;SLC39A6;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,regulation of sprouting angiogenesis (GO:1903670),0.40996729443495045,1.1456975302262333,0.2828125,0.6145862438159911,1.0,9/33,11.88%,ALOX5;KLF2;S100A1;EPN2;KLF4;SYNJ2BP;ADAMTS9;CEMIP2;JAK1
prerank,oligosaccharide metabolic process (GO:0009311),-0.33411012946617147,-1.1454538694144136,0.22468354430379747,0.7953174293818943,1.0,16/46,18.54%,ST3GAL6;ST6GALNAC3;MAN1B1;B3GALT1;NEU1;ST6GALNAC4;B3GALT5;GAL3ST4;B3GALT2;ST8SIA1;ST6GAL2;ST3GAL3;ST8SIA3;IDUA;FUT9;ST3GAL2
prerank,canonical Wnt signaling pathway (GO:0060070),0.3682967180321177,1.1452418393037544,0.2581560283687943,0.6150985843874986,1.0,12/68,11.07%,LRP6;TCF7L2;RARG;WNT2;AXIN1;GSK3B;FRAT1;TCF7;WNT6;NR4A2;SFRP1;PPP1CA
prerank,regulation of innate immune response (GO:0045088),0.381469674453993,1.145239797162077,0.2789317507418398,0.6145604296786839,1.0,16/57,17.05%,FCGR2B;TLR8;IRAK3;PTPN22;BIRC3;RIOK3;RNASEL;IFNAR2;CASP8;POLR3D;SAMHD1;ERAP1;HSP90AB1;TIRAP;CCL5;ACOD1
prerank,aggrephagy (GO:0035973),0.42957974118871345,1.1448187078622194,0.29131175468483816,0.6149484639403039,1.0,7/27,13.17%,WDFY3;RPS27A;PRKN;VIM;PCNT;DYNC1I2;UBE2N
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.49520863101090185,-1.1447657963373612,0.3150105708245243,0.7956803918554806,1.0,8/10,36.08%,SETD4;SETD3;SETD2;SETD6;SMYD2;METTL18;EEF1AKMT2;SETD7
prerank,cell projection organization (GO:0030030),-0.37382052028414875,-1.1446470121496486,0.24937027707808565,0.7941924081761704,1.0,8/30,7.34%,NCKAP1;ATP1B2;CSPG5;NEFH;RHOQ;NCKAP1L;P2RY12;RHOH
prerank,gland development (GO:0048732),-0.31465219294023516,-1.1443868581904704,0.2153846153846154,0.7931689982437324,1.0,12/59,19.19%,TGFBR1;SALL1;FGFR2;NF1;TGFBR3;PAX8;PROX1;CDK5RAP3;PHF2;WNT4;NOTCH4;DKK3
prerank,positive regulation of actin nucleation (GO:0051127),0.528247377264373,1.1443357271815828,0.33273703041144903,0.6154798473109677,1.0,2/11,2.43%,WASF2;FCHSD2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.46280763230279814,-1.1438877452652507,0.30151843817787416,0.7930386515633894,1.0,6/13,10.61%,JAK2;MGAT5;IL7R;DOT1L;PTPRT;JAK3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3049188288208604,-1.1435477533177298,0.22549019607843138,0.7923174186566246,1.0,18/69,13.94%,PLCL1;PLCB2;PIK3CB;PLCB4;NYAP2;PLEKHA1;PI4KA;NF1;MYO16;INPP5F;PIK3C2B;SIRT2;CSF1R;PLCB1;PLCH1;PIK3R5;C1QBP;TYRO3
prerank,sodium ion export across plasma membrane (GO:0036376),0.49564817823184026,1.1434895851089513,0.31021194605009633,0.6168605554887376,1.0,5/13,14.01%,FXYD2;SLC4A4;ATP1A4;ATP1A3;ATP1A1
prerank,amino acid import across plasma membrane (GO:0089718),-0.3906692586132741,-1.143305339796304,0.25742574257425743,0.7912623298437843,1.0,6/24,21.80%,SLC1A3;SLC36A1;SLC1A1;SLC7A8;SLC1A2;SLC22A4
prerank,innate immune response in mucosa (GO:0002227),0.5354670646407167,1.1428267289768315,0.3083941605839416,0.6177811971647222,1.0,1/10,2.51%,RPL39
prerank,regulation of phospholipase C activity (GO:1900274),0.49138759473390975,1.1424920794588838,0.299645390070922,0.6179415931705594,1.0,3/15,5.36%,FGFR1;ESR1;PDGFRA
prerank,histone modification (GO:0016570),0.33495184084804475,1.1420859092168485,0.24302788844621515,0.6183315384146396,1.0,29/109,17.83%,HDAC9;PADI4;USP3;ATXN7;PHF20;INCENP;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;USP21;USP16;MIER3;RCOR2;CREBBP;UBE2N;EP300;EHMT1;KAT6A;PRMT1;ENY2;NSD3;USP22;HDAC4;RCOR1;UBE2U;SGF29;UBE2A
prerank,long-term memory (GO:0007616),0.46753258463209,1.1420384997936461,0.2943201376936317,0.61791194551393,1.0,3/19,3.93%,APOE;LDLR;SLC2A4
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.4309695582148861,-1.1418600018258402,0.26976744186046514,0.7939148973806786,1.0,6/15,26.26%,CNOT7;NLRC5;STAT2;MUL1;METTL3;TTLL12
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5454311362335663,1.1417177666732914,0.34189723320158105,0.6180512053394662,1.0,3/10,8.58%,PTPN22;LBP;NINJ1
prerank,long-chain fatty acid transport (GO:0015909),0.42057365767731,1.1415984689177292,0.2967409948542024,0.6177935169171282,1.0,3/30,2.65%,APOE;PRKAG2;CD36
prerank,icosanoid secretion (GO:0032309),0.5184884919620177,1.1415234189412449,0.3187022900763359,0.6174231658369137,1.0,2/12,6.91%,PNPLA8;ABCC4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4459401817258721,1.1414042073713813,0.29131175468483816,0.6171571334669537,1.0,5/22,7.23%,MYADM;CD44;WNK1;TNF;KLF4
prerank,neuron development (GO:0048666),0.32955344361935457,1.1407940226756625,0.2534332084893883,0.6179339291427816,1.0,21/141,6.21%,ETV1;APOE;APP;OPHN1;LYN;RP1;MEF2C;CLN5;EHD1;RAPGEF2;LRP12;B4GALT6;PBX3;GSK3B;RB1;ROCK1;ATP7A;FRY;MANF;WNK1;BLOC1S5
prerank,regulation of cholesterol esterification (GO:0010872),0.5236167124549828,1.140650301255865,0.3365019011406844,0.6177219928224688,1.0,1/10,0.49%,APOE
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.4987001332946899,1.140348863486513,0.30467289719626167,0.6173364541148215,1.0,5/13,13.95%,IL15;SHC1;IL15RA;JAK1;STAT3
prerank,cellular response to interleukin-15 (GO:0071350),0.4987001332946899,1.140348863486513,0.30467289719626167,0.6173364541148215,1.0,5/13,13.95%,IL15;SHC1;IL15RA;JAK1;STAT3
prerank,sodium ion transport (GO:0006814),-0.2950267866923228,-1.1402956959680597,0.19696969696969696,0.797160990598665,1.0,11/85,7.41%,SLC12A2;SLC24A3;SLC24A2;ATP1B1;SCN1B;SLC8A1;SGK1;FGF13;SLC38A7;NALCN;SLC24A4
prerank,response to exogenous dsRNA (GO:0043330),0.46729429830257657,1.1399458120779993,0.30895795246800734,0.6176956438358862,1.0,3/18,4.05%,COLEC12;IRAK3;RFTN1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4884135542566284,1.1392449789398515,0.30782918149466193,0.6186962463423684,1.0,4/14,13.77%,CCL19;NFKBIZ;CD80;RARA
prerank,metal ion export (GO:0070839),0.4122443006937626,1.1391767008344131,0.29401993355481726,0.6183118971870432,1.0,10/31,17.57%,FXYD2;ATP7A;SLC4A4;KCNQ1;ATP2B4;ATP1A4;ATP1A3;ATP1A1;KCNK5;KCNE3
prerank,vesicle transport along microtubule (GO:0047496),-0.3916395778117958,-1.139035797626524,0.27386934673366836,0.7993609229731932,1.0,9/23,19.93%,DYNC1H1;KIF1A;CLN3;KIF5A;KIF1C;KIF3A;KIF3B;BICDL1;HAP1
prerank,base conversion or substitution editing (GO:0016553),-0.47591799729544304,-1.1389120347681445,0.3139784946236559,0.7979428173443437,1.0,5/11,27.43%,ADAR;ADARB2;ADARB1;METTL3;NUDT16
prerank,regulation of organelle organization (GO:0033043),0.3529756566261071,1.1382282824266234,0.2646657571623465,0.6199391020523208,1.0,10/80,5.77%,ZEB2;MYO5A;DIAPH1;MTM1;USP6NL;PRKN;PDE2A;PAK2;CLIC4;PARL
prerank,regulation of exocytosis (GO:0017157),-0.33173703269153854,-1.1381990494271486,0.21971830985915494,0.7984397749793202,1.0,20/46,20.82%,CADPS;CLASP2;RIMS2;RAB27A;RAB3C;LGI3;CPLX1;IL1RAPL1;VAMP2;RAB12;CFTR;SYT1;RAB15;CPLANE2;RAB8A;CPLX2;HAP1;CHMP6;CHMP3;RAB9A
prerank,ganglion development (GO:0061548),0.5237755590771788,1.1377070173638177,0.3364140480591497,0.6205700393613125,1.0,1/11,0.34%,NRP1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3037288576251311,1.1373662952977064,0.2084726867335563,0.6208082186217644,1.0,41/308,11.04%,DAB2;APOE;IRF4;CLEC6A;CMKLR1;IL15;ZBTB16;RREB1;GAS6;SMURF2;NCOA3;C1QTNF3;CEBPB;ADRB2;BMP2;CD36;ALX1;RGCC;LBP;GHRL;SMAD4;ROCK1;ADIPOR2;SYK;SDCBP;TNF;CXCR4;CCR2;ESRRB;ADRA1D;ADRA1A;PDGFC;STAT6;RTN4;TSHR;TRIM16;B4GALT5;PTGER4;HADH;ACHE;KMT5B
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.4736502103316248,-1.137116779949044,0.3117782909930716,0.8000092217865323,1.0,3/11,5.01%,CD274;TWSG1;VSIR
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3917100441521649,1.1369535417164838,0.282574568288854,0.6211847565230604,1.0,10/45,13.34%,APP;PUM2;RC3H1;MTPN;TDRD7;FOXO3;NANOS3;RPL10;TRIM71;LARP4
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4057477262239405,1.1369129204720183,0.3019169329073482,0.6207352154350412,1.0,14/37,20.11%,RPL23;RYBP;WAC;NOP53;SDCBP;RPL5;HFE;RPS7;EIF3H;RPL11;HSP90AB1;CSNK2A2;CSNK2A1;USP7
prerank,histone lysine demethylation (GO:0070076),0.4378481145880348,1.1368680158016684,0.3070469798657718,0.6202919899741591,1.0,9/25,18.63%,PHF8;KDM7A;KDM6A;KDM4D;JMJD1C;KDM5C;KDM2A;KDM1A;KDM4C
prerank,regulation of actin filament-based process (GO:0032970),0.36784895887929026,1.1368375016014332,0.26580459770114945,0.6198366089843768,1.0,11/70,8.03%,IQGAP2;IQGAP1;BST1;ARHGAP18;CRK;RHOA;ROCK1;CELSR1;CNN2;BST2;RHOBTB1
prerank,calcium ion import into cytosol (GO:1902656),-0.42567077550827137,-1.1365090693076516,0.31414868105515587,0.8002058087439459,1.0,3/15,4.82%,SLC24A2;SLC8A1;CACNA2D1
prerank,receptor recycling (GO:0001881),-0.4824647369918209,-1.13639821316198,0.3142857142857143,0.7987220178608914,1.0,5/10,32.38%,SORL1;EHD3;PHETA1;NSG1;REP15
prerank,response to muramyl dipeptide (GO:0032495),0.5048075008445966,1.1363612280400783,0.30115830115830117,0.620359277171732,1.0,5/12,12.78%,PTPN22;VIM;RIPK2;CHMP5;NOD2
prerank,regulation of cellular metabolic process (GO:0031323),0.3917978884345162,1.1362351260635806,0.270516717325228,0.6200916157005,1.0,5/45,6.68%,PID1;PRKN;PARL;KIF16B;FOXM1
prerank,positive regulation of vasoconstriction (GO:0045907),0.4973775705385934,1.135712712510661,0.3074141048824593,0.6207429393717805,1.0,5/13,23.74%,ADRA1D;ADRA1A;TBXA2R;F2R;CAV1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.45271562317588254,-1.1356035665430848,0.3173913043478261,0.7994080312202563,1.0,9/13,27.16%,NFU1;LTO1;YAE1;ISCA1;CIAO1;BOLA2;GLRX5;CIAO2B;CISD3
prerank,aortic valve morphogenesis (GO:0003180),0.4188704651880416,1.1355380827169241,0.29333333333333333,0.6205728831354075,1.0,7/30,11.89%,JAG1;HEY2;RB1;ROCK1;SLIT3;EMILIN1;ROCK2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.4512810308107257,1.1353712849000386,0.304421768707483,0.620448139004208,1.0,3/20,7.96%,GNAQ;RGS8;GNB1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.434707376902105,-1.135182242994827,0.3042505592841163,0.79894153208675,1.0,6/16,20.63%,LYST;PLEKHM2;CORO1A;VAMP2;VAMP7;ULBP1
prerank,defense response to symbiont (GO:0140546),0.3428537102251211,1.134651070340294,0.26405228758169935,0.6215711737591307,1.0,25/92,18.30%,TLR8;IFITM3;OAS2;LILRB1;SERINC3;TLR2;TRIM56;RNASEL;CD40;BCL2;BST2;RNASE6;IFNAR2;IRF2;IFITM2;ATG7;SAMHD1;MLKL;RELA;BNIP3;ACOD1;TLR7;IL6;SERINC5;EIF2AK2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4188390699784372,1.134549609271041,0.2973421926910299,0.621265097304371,1.0,7/26,13.79%,KMT2A;VCPKMT;TET3;WDR82;BEND3;KMT5B;TET2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3657357203488587,1.1344569377742773,0.282798833819242,0.620966875522674,1.0,11/57,11.10%,NLRC4;MAP3K5;DAPK1;BCL10;SYK;UACA;TNF;FYN;CYCS;RIPK2;CASP8
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.4223369613486592,-1.1343657705125145,0.29157175398633256,0.7997983605456275,1.0,5/18,10.54%,NAV3;HAVCR2;PRNP;HDAC7;CD34
prerank,cellular response to ATP (GO:0071318),0.4912966199463378,1.133940143360194,0.3052064631956912,0.6216214396830442,1.0,1/14,0.51%,P2RX7
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.49707542826847306,1.1335086636693983,0.3128390596745027,0.6220717858547247,1.0,7/13,18.72%,RHOA;TNF;ITGB2;MDK;RELA;IL6;TRAF6
prerank,coenzyme A metabolic process (GO:0015936),0.4955198450357296,1.1333984772812427,0.3188405797101449,0.6217827799681785,1.0,1/14,0.18%,SLC25A16
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.42745726336281176,1.1333438587517397,0.3010204081632653,0.621360009745158,1.0,7/26,15.44%,APP;PKN2;MDM2;CUL3;TTL;EIF4EBP1;USP22
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4027298461342799,1.1332461077099911,0.2737341772151899,0.621056588481517,1.0,9/36,12.39%,APOE;MEF2C;RGCC;TNF;SYNJ2BP;ADAMTS9;SP100;JUP;ATP2B4
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.4732945999785237,-1.1326992641776725,0.3218884120171674,0.8033057605607057,1.0,2/11,8.70%,BIN1;ACTN2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3604727046758888,1.1324965091670214,0.26901408450704223,0.6221067313726136,1.0,15/70,14.57%,CYBB;PSMA7;CD36;FCER1G;B2M;LNPEP;MFSD6;PSMB2;NCF2;SNAP23;PSMA6;PSMD5;PSMD1;PSMA3;CYBA
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.4366100929132424,-1.1321387029311198,0.2854122621564482,0.8033964440579873,1.0,5/14,20.61%,FUS;PARP1;ERCC6;RAD51AP1;WRAP53
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.40466257873325256,1.132041621460125,0.31695721077654515,0.622665892030023,1.0,7/32,9.67%,CASK;JAG1;RASA1;ITGB1BP1;DUSP22;RCC2;CORO1C
prerank,vasodilation (GO:0042311),0.4964416118559494,1.1312565561762562,0.3333333333333333,0.623908580912071,1.0,2/13,2.53%,KLF2;ADRB2
prerank,epidermal cell differentiation (GO:0009913),0.3925853270243887,1.130866670443865,0.29073482428115016,0.6242533658100936,1.0,5/41,5.25%,TXNIP;JAG1;ADAM9;KRT10;CLIC4
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3589744117384148,1.130821396136404,0.2776978417266187,0.6238379208837427,1.0,14/71,11.57%,CTSC;RPS27A;FBXL17;NR1D1;PRKN;RHBDD1;USP9X;CTSB;VPS4B;MDM2;CLPX;CASP8;NGLY1;PSMA6
prerank,nucleotide-excision repair (GO:0006289),-0.28194757995459857,-1.1307252413374835,0.21428571428571427,0.8060396009645349,1.0,30/101,19.01%,GTF2H2;CUL4A;TP53;CCNH;COPS7A;PARP1;COPS8;DDB2;RBX1;ERCC6;SLC30A9;COPS4;PPIE;ERCC2;HUS1;LIG1;XAB2;XRCC1;HMGN1;BRCA2;UVSSA;PRPF19;RFC2;POLR2C;COPS6;GPS1;POLE;POLL;UBB;RFC1
prerank,negative regulation of platelet activation (GO:0010544),0.4782280534627631,1.1303454121858116,0.3233644859813084,0.6243555901282363,1.0,5/16,9.29%,APOE;C1QTNF1;PDGFRA;ADAMTS18;SH2B3
prerank,oligodendrocyte development (GO:0014003),-0.431216765790143,-1.1301749957800946,0.2982062780269058,0.8061535362235054,1.0,5/15,11.31%,PLP1;EIF2B3;NSUN5;TPPP;SOX10
prerank,negative regulation of viral process (GO:0048525),0.3715307052328739,1.1297405204395796,0.2895927601809955,0.6251599434370266,1.0,14/57,15.00%,IFITM3;OAS2;LARP7;FAM111A;TRIM32;RNASEL;TNF;BST2;TRIM27;IFITM2;ILF3;BANF1;MID2;PPIA
prerank,regulation of mast cell degranulation (GO:0043304),0.4830223660417513,1.1291487389756174,0.33515482695810567,0.6259611241674055,1.0,6/14,19.54%,LYN;FER;SYK;UNC13D;FES;STXBP2
prerank,generation of neurons (GO:0048699),0.31974925234542867,1.1288891419630114,0.25089605734767023,0.6260265124029512,1.0,26/190,10.63%,NRP1;FGFR1;NAV1;OPHN1;MEF2C;SH3RF1;WNT2;RAPGEF2;LRP12;CDK6;HEY2;USP9X;CELSR1;DISC1;IRX2;MTPN;WNT6;NR4A2;LHX5;IRX5;TUBGCP2;OLIG2;ACSL3;CCK;DOCK7;MARK2
prerank,somite development (GO:0061053),-0.466229739727695,-1.128672268562657,0.3092105263157895,0.8092108213101139,1.0,6/11,36.72%,LOXL3;SMO;SOX11;MEOX2;SHH;SFRP2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5233217079044153,1.1282654403316732,0.34476190476190477,0.6268690416202635,1.0,3/10,10.71%,ATP7A;THAP4;KYAT1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4868608281002896,1.1273058516657746,0.3132969034608379,0.6279419148600044,1.0,4/15,8.37%,AP3B1;AP3M1;BLOC1S5;AP3S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4868608281002896,1.1273058516657746,0.3132969034608379,0.6279419148600044,1.0,4/15,8.37%,AP3B1;AP3M1;BLOC1S5;AP3S1
prerank,regulation of cell population proliferation (GO:0042127),0.2894456146859283,1.1271963751567757,0.16205128205128205,0.6276570321386294,1.0,121/691,15.63%,FOLR2;PF4;EGFR;LIFR;FGFR1;APP;PTPRJ;CHP2;TCF7L2;SGK3;IL15;KIF20B;NUPR1;RPL23;LYN;GRK5;BST1;FER;BNIPL;JAG1;RARG;ABI1;CBFA2T3;TSLP;KRAS;PIAS1;KITLG;BMP2;FGF23;PRKRA;WNT2;THPO;RGCC;ZFP36L1;RHOA;S100A11;ITGB1BP1;RAPGEF2;TNFRSF11A;FRK;NPR3;CDK6;GSDME;IRS2;GHRL;INSR;S1PR2;PTPRK;PDGFRA;ACER3;BCL2;RPS4X;FOXM1;RPS15A;SDCBP;KLF4;DUSP22;PDS5B;STAT4;TIPIN;BIRC6;KLF10;CDC73;IL6R;RPS9;CGREF1;ADRA1D;ADRA1A;TSPYL5;ASH2L;MDM2;CD33;THAP12;SH2B3;PDGFC;STAT6;CCND2;CACUL1;CUL3;IGF1;SFRP1;RPS6;TSHR;SLC25A5;NUP62;FTH1;JUP;PHIP;SHC1;KANK2;ROMO1;CDK13;STRN;TRIM71;NIBAN2;CDKN2C;NAMPT;DIS3L2;GLP2R;CTBP2;MEAK7;CRLF2;ZBTB7C;RNF187;RARA;STAT3;JUND;DERL2;HMGN5;PKD2;BMPR1A;PRMT1;IL13RA1;NOX4;FN1;MYC;MELTF;RNF41;HDAC4;PINX1;PTPN14
prerank,phosphorylation (GO:0016310),0.2957459597395144,1.1270614463471522,0.19188596491228072,0.6274492806580363,1.0,71/384,12.32%,POMK;FGFR1;APP;MAP3K5;STK17B;SGK3;PEAK1;CDC42BPG;PRKAG2;GAS6;GMFG;LYN;GRK5;FER;DAPK1;IRAK3;OXSR1;BMP2;PRKAG3;ERN1;MAP3K1;CDK12;IP6K3;FRK;CDK6;GSK3B;INSR;CAMKK2;GNPTG;PKN2;PAK2;MAPKAPK2;ROCK1;STK24;STK3;RNASEL;WNK1;VRK2;ACVR2A;SYK;CHEK1;FAM20A;ZAP70;NRK;PPP4R1;PRKCB;BIRC6;FYN;CDK14;CDK20;VRK1;LIMD1;MAP3K20;FGGY;DYRK1A;MAST1;ILF3;DGKH;MARK2;MAML1;STK10;CDK13;JAK1;ROCK2;STK36;MAP3K11;PRKACB;MKNK1;CDK17;TRIB2;STK38
prerank,protein deacetylation (GO:0006476),0.3795398425223605,1.127004014602854,0.2857142857142857,0.627049057717873,1.0,8/41,10.61%,HDAC9;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;MIER3;RCOR2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3765571879358255,-1.1267276336690046,0.26904761904761904,0.8138466874159778,1.0,12/24,25.37%,FECH;CPOX;FXN;ABCG2;COX15;FLVCR1;HMBS;ALAS2;UROD;PGRMC1;PPOX;ALAS1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.41437409231759,1.1265035065503564,0.3130016051364366,0.627595695260931,1.0,6/32,9.67%,RREB1;ACTR3;WASF2;CDC42;ARPC2;CORO1C
prerank,negative regulation of chemotaxis (GO:0050922),-0.362087852813073,-1.1263945585504076,0.2924281984334204,0.8131431463162947,1.0,13/31,28.31%,SEMA4D;ROBO2;SEMA4C;ROBO1;SEMA4G;AIF1;NOTCH1;CORO1B;SEMA4F;SEMA3B;SEMA3F;SEMA3A;SEMA3D
prerank,regulation of cytoskeleton organization (GO:0051493),0.3383696924040877,1.1262646303603847,0.27916120576671033,0.62763048875212,1.0,23/108,14.40%,IQGAP2;P2RX7;IQGAP1;DIAPH1;BST1;ARHGAP18;CRK;RHOA;GSK3B;PAK2;CLIC4;ROCK1;CELSR1;BST2;RHOBTB1;CLASP1;MARK2;ROCK2;ARHGAP17;RND3;SPEF1;RHOC;KATNBL1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4233807488329072,1.126068066678129,0.30066445182724255,0.627539396793163,1.0,1/27,0.05%,PID1
prerank,axon development (GO:0061564),-0.2908081333422275,-1.125704534848253,0.21694915254237288,0.8134371609871701,1.0,18/78,14.22%,RTN4RL1;PLP1;GRM7;CTNNA2;PARD3;MAP1B;NEFH;FGFR2;CNTN4;MAPT;NTNG1;S100B;LLGL1;AFG3L2;DSCAML1;APBB1;SLITRK5;ADGRB1
prerank,negative regulation of leukocyte migration (GO:0002686),0.5246286610722214,1.1254741080885862,0.33911368015414256,0.6283114473464325,1.0,3/10,11.24%,HMOX1;CD200R1;EMILIN1
prerank,mitochondrion distribution (GO:0048311),0.49542797642428826,1.1252307043597825,0.33025830258302585,0.6283231230107578,1.0,4/12,13.66%,MEF2A;MTM1;ARMC1;TRAK2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5206038774531648,1.125140782960084,0.3387096774193548,0.6280165178447803,1.0,2/10,7.96%,PDE6A;GNB1
prerank,mRNA catabolic process (GO:0006402),0.38377607147988074,1.124358005484537,0.2823529411764706,0.6292090343856389,1.0,10/44,13.36%,DHX34;ZFP36L2;ERN1;TUT7;RC3H1;TUT4;DCP2;ZC3H12D;DIS3L2;LSM2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4857994249362074,1.124202686927436,0.3213644524236984,0.6285162907935608,1.0,3/12,9.95%,CHP2;TNF;IGF1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4857994249362074,1.124202686927436,0.3213644524236984,0.6285162907935608,1.0,3/12,9.95%,CHP2;TNF;IGF1
prerank,mitochondrion localization (GO:0051646),0.4450901157704916,1.1230498797247106,0.3125,0.6305837420370757,1.0,5/19,13.66%,MEF2A;MTM1;MARK2;BRAT1;TRAK2
prerank,sensory perception of pain (GO:0019233),0.4524765085208531,1.1230288117829403,0.32538330494037476,0.6301033320446103,1.0,4/21,11.18%,P2RX7;CHRNA4;CCR2;KCNK4
prerank,regulation of osteoclast differentiation (GO:0045670),0.4125653358620989,1.121995973069195,0.315955766192733,0.6319260653523657,1.0,5/33,6.99%,CCR1;CEBPB;LILRB3;TLR4;TNF
prerank,renal water homeostasis (GO:0003091),-0.3797061398888366,-1.1214302110079393,0.2806603773584906,0.8257405476479841,1.0,7/23,16.32%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7;MYO5B;ADCY1
prerank,atrial septum development (GO:0003283),0.4880088482488336,1.1213722779883903,0.31144465290806755,0.6328206050544941,1.0,4/13,14.80%,NOTCH2;HEY2;DAND5;NPHP3
prerank,receptor clustering (GO:0043113),-0.3689936099565578,-1.1211600303733595,0.2794871794871795,0.8248957286064914,1.0,8/27,6.45%,DLG2;NLGN1;MAGI2;NRXN1;DLG4;DLG3;DVL1;DNAJA3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.41735982578421776,1.1211251898456156,0.30655737704918035,0.6328631798943678,1.0,1/28,0.05%,PID1
prerank,mRNA export from nucleus (GO:0006406),-0.27729535173537795,-1.1211104627486617,0.1948529411764706,0.8232213564316904,1.0,37/102,26.40%,THOC1;SRRM1;SRSF5;PABPN1;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;MCM3AP;U2AF1;UPF3B;CASC3;NCBP1;SEH1L;NXT1;THOC3;SRSF11;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4497747568333761,1.1208938402357675,0.30711610486891383,0.6328238211099438,1.0,4/18,10.97%,APOE;ADAM19;PSEN1;ACHE
prerank,sympathetic nervous system development (GO:0048485),0.47606037083378483,1.1208269099662593,0.33276157804459694,0.6324591254273577,1.0,1/15,0.34%,NRP1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5186030858640196,1.1205440600065766,0.3463687150837989,0.6315008019400861,1.0,1/11,0.18%,SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5186030858640196,1.1205440600065766,0.3463687150837989,0.6315008019400861,1.0,1/11,0.18%,SLC25A16
prerank,coenzyme A biosynthetic process (GO:0015937),0.5186030858640196,1.1205440600065766,0.3463687150837989,0.6315008019400861,1.0,1/11,0.18%,SLC25A16
prerank,amino sugar metabolic process (GO:0006040),0.530590434140541,1.120455082499021,0.35195530726256985,0.6311499250596343,1.0,4/10,14.27%,ST6GAL1;ST3GAL1;GFPT2;EXTL2
prerank,ether lipid metabolic process (GO:0046485),0.4777913180320368,1.120406229510174,0.336996336996337,0.6307296805778981,1.0,8/14,17.09%,AGMO;PLA2G7;PEX7;AGPS;PAFAH1B1;PLAAT3;FAR1;PEDS1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35264991471424256,1.1203319371679996,0.30962343096234307,0.6303915197236886,1.0,16/77,11.28%,TCF7L2;SH3RF1;RIPK1;SIAH2;PRKN;MCL1;RB1;BCL2L2;BCL2;TNF;BIRC6;NR4A2;MAPK8IP2;IGF1;SLC25A5;PHIP
prerank,regulation of monooxygenase activity (GO:0032768),0.42734038609129515,1.1200873936698628,0.31833910034602075,0.6303889320658049,1.0,8/23,20.51%,EGFR;CYGB;NOSTRIN;CALM1;WASL;LYPLA1;GDNF;SNCA
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.40783025492941327,-1.1200556147648588,0.3080684596577017,0.824757222552769,1.0,4/19,4.69%,DLG2;PARD3;DLG3;MTCL1
prerank,heart development (GO:0007507),0.3173068660469551,1.119369673964361,0.253416149068323,0.6314841888187317,1.0,28/150,15.26%,HDAC9;PDLIM5;MEF2A;CRIP1;MEF2C;OSR1;BMP2;MYH6;ALPK3;INSR;PDLIM1;KDM6A;CACYBP;NCOA6;FOXC2;EPHB4;DAND5;CASP8;WDR11;RAMP2;POPDC3;BCOR;RBP4;SMYD4;PKD2;GPC3;FN1;MYBPC3
prerank,negative regulation of macroautophagy (GO:0016242),0.4199978259561176,1.1191601272376164,0.29421487603305785,0.6314215791930827,1.0,6/26,13.41%,NUPR1;MTM1;FEZ2;SMCR8;UBQLN4;RUBCN
prerank,ureteric bud morphogenesis (GO:0060675),-0.4259881489552682,-1.1191075562869734,0.2975391498881432,0.8260545743266705,1.0,3/16,4.11%,SALL1;NPNT;FGF2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5118525025172111,1.1187800291066006,0.3370577281191806,0.6317452858233285,1.0,3/10,6.15%,LYN;LILRB1;CD40
prerank,negative regulation of response to wounding (GO:1903035),0.4431090433985404,1.118685480878866,0.3118466898954704,0.6314305868396124,1.0,3/19,3.53%,ALOX5;CASK;CRK
prerank,regulation of DNA replication (GO:0006275),0.3718163854529122,1.1186392298171157,0.2927927927927928,0.6310213303035326,1.0,11/49,14.46%,EGFR;ORC5;ANKRD17;S100A11;ESCO2;ESCO1;GMNN;PPP2CA;RBBP6;KAT7;TERF1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4562788925190254,1.1185476087008315,0.31956912028725315,0.6307429253529226,1.0,6/18,17.76%,LYN;CAMK1D;IL6R;SLC8B1;MDK;IL6
prerank,positive regulation of endothelial cell migration (GO:0010595),0.34905636977031507,1.118236814156587,0.26628895184135976,0.6309589042414212,1.0,16/84,12.88%,NRP1;FGFR1;FOXP1;SASH1;RIN2;GRN;ITGB1BP1;CD40;HSPB1;FOXC2;MAPK14;NUS1;SP1;ROCK2;ZC3H12A;BCAS3
prerank,smoothened signaling pathway (GO:0007224),-0.3559264115565556,-1.1173011392804517,0.2845953002610966,0.8301618993112465,1.0,14/32,28.89%,PTCHD1;DYRK2;SMO;GPC2;HIPK1;ULK3;GLI3;TMEM231;DISP2;TMEM17;STIL;TTBK2;TCTN2;B9D1
prerank,protein localization to chromatin (GO:0071168),0.45791577513019455,1.116532906631584,0.31272727272727274,0.6342331419852038,1.0,3/18,6.12%,ESR1;PPHLN1;MCM9
prerank,cortical cytoskeleton organization (GO:0030865),-0.3306768463308017,-1.1162535668483098,0.265625,0.8317732646182251,1.0,14/41,16.96%,EPB41L3;NCKAP1;FMNL2;NLGN1;RHOBTB2;RHOQ;NCKAP1L;FHOD1;RHOH;LLGL1;STRIP1;ARF6;LLGL2;PLEK
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5028849798818417,1.115318150099787,0.31851851851851853,0.6364069807527145,1.0,3/10,6.62%,KMT2A;SMAD4;CHEK1
prerank,homologous chromosome segregation (GO:0045143),-0.3865156238289713,-1.115240908986234,0.2962962962962963,0.8332382809337513,1.0,5/20,15.95%,CENPC;SIRT7;ZCWPW1;FANCD2;IHO1
prerank,regulation of membrane repolarization (GO:0060306),-0.4462737274157892,-1.1151287382087613,0.32461873638344224,0.8317915616275697,1.0,3/13,5.86%,KCNJ2;CACNA2D1;AKAP6
prerank,protein phosphorylation (GO:0006468),0.289168157822669,1.1150515278194901,0.2113127001067236,0.6364494686012809,1.0,83/478,12.32%,EGFR;FGFR1;APP;MAP3K5;STK17B;SGK3;PEAK1;CDC42BPG;PRKAG2;GAS6;GMFG;LYN;GRK5;FER;DAPK1;IRAK3;ABI1;OXSR1;BMP2;RIPK1;PRKAG3;ERN1;TLR4;CAMK1D;MAP3K1;CDK12;RPS6KA3;TLR2;IP6K3;FRK;CDK6;GSK3B;INSR;CAMKK2;PKN2;PAK2;INCENP;MAPKAPK2;PDGFRA;ROCK1;STK24;STK3;RNASEL;WNK1;VRK2;ACVR2A;SYK;CHEK1;FAM20A;USP15;ZAP70;NRK;PPP4R1;PRKCB;HTATIP2;BIRC6;FYN;ULK2;CDK14;CDK20;DDR2;VRK1;MAPK14;MAP3K20;DYRK1A;MAST1;RPS6KA6;ILF3;EPHB4;MARK2;MAML1;STK10;CDK13;JAK1;ROCK2;STK36;MAP3K11;PRKACB;MKNK1;CDK17;MAP3K3;TRIB2;STK38
prerank,regulation of mast cell activation (GO:0033003),0.5193247081258591,1.1148182128355526,0.35,0.6365032750552275,1.0,3/10,2.87%,LYN;TSLP;HAVCR1
prerank,negative regulation of phagocytosis (GO:0050765),0.4676111051978078,1.1146957492577687,0.3219761499148211,0.636255894864617,1.0,4/17,5.17%,FCGR2B;TLR2;SNX3;RACK1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4189898719688809,-1.1137351430571465,0.3044496487119438,0.8344964392660892,1.0,8/17,25.14%,EMC9;BAG6;EMC10;EMC1;GET4;EMC6;MMGT1;SGTA
prerank,response to acidic pH (GO:0010447),0.4820379120170524,1.1135967739579813,0.3136593591905565,0.6382145920025378,1.0,2/13,2.50%,RAB11FIP5;GPR65
prerank,nuclear membrane organization (GO:0071763),-0.40022658833922015,-1.1132794090833376,0.3419811320754717,0.8341565396322366,1.0,7/19,24.50%,AKAP8L;TARDBP;CHMP4B;NSFL1C;EMD;TOR1A;DCTN1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.3475593641870413,-1.1127359042051594,0.2671957671957672,0.8341173061790933,1.0,8/35,9.68%,ARHGAP24;RASAL3;LZTR1;SCAI;FLCN;STAMBP;KCTD13;STMN3
prerank,negative regulation of peptidase activity (GO:0010466),0.37655703225041276,1.1119236834777282,0.3183139534883721,0.6414817610761865,1.0,2/47,1.51%,SERPINB8;SERPINB2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4332925920676762,1.1113617397671671,0.3434343434343434,0.6422341791532604,1.0,4/24,7.25%,ACTR3;WASF2;CDC42;ARPC2
prerank,protein export from nucleus (GO:0006611),-0.36654791974845036,-1.111110415161992,0.2905759162303665,0.8374961881739438,1.0,11/27,32.12%,RANBP17;RANBP3L;EGR2;SMURF1;TGFB1;CSE1L;RANBP3;NUP214;CHP1;STRADB;PKD1
prerank,cellular response to interferon-gamma (GO:0071346),0.344579740018103,1.1110379956182916,0.3049932523616734,0.6424636546139408,1.0,14/88,8.31%,IRF4;OAS2;GBP3;DAPK1;CD44;CCL8;TLR4;CCL19;B2M;TLR2;GBP7;IRF2;CCL24;TRIM68
prerank,regulation of immunoglobulin production (GO:0002637),0.43565000800371567,1.1107557504475651,0.351575456053068,0.6426282489886627,1.0,5/23,17.76%,FCGR2B;RBP4;GPI;XBP1;IL6
prerank,regulation of membrane depolarization (GO:0003254),-0.39938509620817114,-1.1105874066021546,0.3123543123543124,0.8374250862021425,1.0,11/18,41.17%,SMAD7;SCN1B;CAMK2D;SCN2B;GPD1L;HCN4;FHL1;SCN10A;PTPN3;RANGRF;GJA5
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.4353567428779494,-1.1101094628909718,0.3580508474576271,0.8371465918096531,1.0,6/13,11.47%,HNRNPU;NELFB;RNF168;RECQL5;TCERG1;NELFCD
prerank,mammary gland epithelium development (GO:0061180),-0.428420599659444,-1.1100934046142596,0.32548179871520344,0.8353919100770731,1.0,11/14,34.34%,JAK2;CSF1R;ERBB4;ID2;WNT4;WNT7B;AKT1;EPHA2;LATS1;SCRIB;WNT3
prerank,cellular iron ion homeostasis (GO:0006879),0.36900289261455294,1.109989478002309,0.31478770131771594,0.6438369300981549,1.0,17/55,16.30%,CP;HMOX1;FTL;NDFIP1;SMAD4;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;FTH1;TFR2;ABCB7;MYC;ATP6V0D1
prerank,positive regulation of growth (GO:0045927),0.3503117506033123,1.1099470819113095,0.2935103244837758,0.6434048478411432,1.0,17/64,14.21%,EGFR;CDC42;DNPH1;RPS6KA3;RFTN1;INSR;TRIM32;BCL2;SDCBP;MTPN;CXCL16;H3-3A;SFRP1;WFS1;BRAT1;MFSD2A;DERL2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.31528421351465896,-1.1099266697485113,0.27247191011235955,0.8341228828898668,1.0,18/52,20.04%,EPB41L2;DPP10;PRKCE;TREM2;GNAI1;STX3;WNK3;PDPK1;STAC2;NUMA1;EPHA3;CLIP3;EPHB2;ARF6;STAC;SQSTM1;RHOG;SORBS1
prerank,cellular component assembly (GO:0022607),0.3003421066456148,1.1093806951294525,0.24769585253456222,0.6441370021226441,1.0,31/253,9.83%,EPS8;NEDD9;SNX9;GAS6;KMT2A;OPHN1;REPS2;RP1;VCPIP1;MITF;SPTBN1;CD74;SKAP2;CDC42;RHOA;LCP1;GRHL2;WIPF1;ST13;ACTB;REC8;CD40;DARS1;HFE;STX7;TUBGCP2;RANBP9;MDM2;PLS1;CFAP206;RTN4
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3193091044930554,1.1093748160714354,0.29161451814768463,0.6436332580068692,1.0,34/152,17.26%,ZEB2;EGFR;SMURF2;PSMA7;BMP2;AXIN1;NRARP;TLR2;GPRC5B;DISC1;FRAT1;WNK1;DEPDC1B;PPM1B;PSMB2;TBL1XR1;CDC73;SULF2;TBL1X;SFRP1;WLS;JUP;PSMA6;LRRK1;PLEKHA4;PSMD5;PSMD1;PSMA3;GPC3;USP47;PPM1A;AMER1;RNF146;LGR4
prerank,I-kappaB phosphorylation (GO:0007252),0.5081659905945739,1.1093687267302712,0.3351749539594843,0.6431251204719048,1.0,2/10,4.25%,TLR4;TLR2
prerank,regulation of ion transmembrane transport (GO:0034765),0.39815395329514763,1.1092399587891597,0.32263242375601925,0.6428771868971076,1.0,7/33,14.33%,P2RX7;ANO6;KCNJ14;WNK1;YWHAE;KCNQ1;NEDD4L
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.45240071276227206,1.1090657410033344,0.3321678321678322,0.6427588068094463,1.0,7/17,14.08%,S1PR2;ROCK1;TNF;VCL;ROCK2;TNFRSF1A;ADD1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.33920904714314354,-1.108844053851508,0.27808988764044945,0.8358222323662265,1.0,16/34,28.55%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;FLT3;ATG14;TGFB1;TNFAIP8L3;TEK;PIK3R2;PDGFRB;PIK3R3;PRKD1;IRS1
prerank,phosphatidic acid metabolic process (GO:0046473),-0.3161636357053998,-1.108501089582297,0.2664756446991404,0.8351660339106387,1.0,16/48,26.77%,LPCAT1;DGKB;PLA2G6;LIPH;GNPAT;DGKZ;DDHD1;PLA2G3;ACP6;AGPAT3;GPD1L;ABHD8;SLC27A1;DGKG;AGPAT2;DGKA
prerank,cellular protein modification process (GO:0006464),0.28268364706075294,1.1071026262255212,0.18126888217522658,0.6466670981712107,1.0,191/982,16.40%,F13A1;APOE;MAN2A1;PADI4;IGFBP4;FGFR1;APP;ST8SIA4;CP;MAP3K5;PTPRJ;STK17B;SGK3;PPP3CA;FBXW7;PEAK1;PTPN18;ZBTB16;CDC42BPG;PRKAG2;GAS6;GMFG;UST;PSMA7;LYN;GRK5;DNAJC3;PGAP1;FER;PTPN12;DAPK1;IRAK3;PTPN22;SHISA5;OXSR1;MTM1;BMP2;FUT4;PARP14;ASB14;FGF23;TGM7;PRKAG3;ERN1;PARP8;MAP3K1;ST3GAL1;CDK12;MTMR3;BTBD1;LOX;DUSP12;DUSP1;IP6K3;FRK;CDK6;KRT10;CTDSP1;SERP1;SSH2;GSK3B;RHBDD1;MANBA;INSR;CAMKK2;PKN2;PAK2;MAPKAPK2;PTPRK;NOTUM;ROCK1;KLHL13;STK24;STK3;KLHL5;RNASEL;FBXL5;WNK1;VRK2;ACVR2A;PTPRA;SYK;CHEK1;MSRA;FAM20A;ZAP70;WIPI1;PPM1B;NRK;UBXN7;PPP4R1;PRKCB;DUSP2;PSMB2;PIGU;CTDSP2;BIRC6;FYN;CDK14;FCGR3A;CDK20;VRK1;UBE2D3;MAP3K20;ALG5;DYRK1A;MAST1;COP1;RAB1A;LHPP;PPP2CA;PPP2CB;CUL3;ILF3;FBXO11;NUS1;GNMT;PARP16;PPEF1;PPP4R2;MARK2;ATG7;MAML1;B4GALT5;WFS1;PPP1CA;CHM;STK10;NGLY1;PSMA6;PTP4A2;CDK13;JAK1;ROCK2;DCAF6;STK36;MAP3K11;ENGASE;PRKACB;MKNK1;CDK17;TRIB2;STK38;NUCB1;LOXL2;ERO1A;FBXO10;CREB1;ATG10;LATS2;CDKL4;RARA;ASB12;RAB11A;HIF3A;SERPIND1;SUMF2;TGM4;PSMD5;PSMD1;RPN2;PSMA3;PRKD2;BMPR1A;GPC3;ELOC;PPP2R2A;FN1;ST3GAL4;GMFB;ASB4;MELTF;NLK;PTPN13;PRKCG;PTPN14;ICMT;WIPI2;USP25;RUNX3;FBXW2;GRK4;DUSP7;PTEN;UCHL3;PPM1A;MKNK2;PRRT1;COG7;ATG5;HSP90B1
prerank,protein localization to cell periphery (GO:1990778),0.32027726354893926,1.1066558171995198,0.2893725992317542,0.6472165329630817,1.0,35/133,16.89%,LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;ITGB1BP1;EHD1;RAPGEF2;S100A10;RAP1A;ROCK1;TNF;RABEP1;ZDHHC3;DENND4C;PIP5K1A;JUP;ROCK2;KCNB1;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;TMED2;TSPAN14;ZDHHC2;RAB3B;SEC16A;SLMAP;FLOT2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.43799032201819016,-1.1066312014072615,0.336864406779661,0.8395686865217485,1.0,8/14,35.99%,TGFBR1;PTPN11;GREM1;EFEMP1;PTHLH;RFLNA;WNT9A;SNAI2
prerank,positive regulation of DNA repair (GO:0045739),0.3797557054986304,1.1065050394402733,0.3111432706222865,0.6470387343679886,1.0,9/46,10.31%,EGFR;RPS3;BABAM2;FAM168A;FOXM1;BRCC3;DDX11;CEBPG;SPIDR
prerank,response to purine-containing compound (GO:0014074),0.4670248956486249,1.1062889954411494,0.35018050541516244,0.6469942786638999,1.0,2/17,3.29%,P2RX7;P2RY6
prerank,steroid biosynthetic process (GO:0006694),0.36330470323293257,1.1055237074262152,0.30666666666666664,0.6481654302677028,1.0,8/56,12.01%,PRKAG2;OSBPL9;HMGCR;HSD3B7;CYP27A1;PMVK;OSBPL1A;LBR
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.49611454382670217,1.1053860426890085,0.3575418994413408,0.6479458920193819,1.0,5/12,18.05%,CD36;TLR4;ZNF205;CYBA;SLC5A3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3636233838363308,1.10534560518226,0.3257918552036199,0.6475120889783651,1.0,14/54,11.97%,RPL23A;RPL26;SNU13;RPL24;RSL24D1;NOP53;RPL35A;RPLP0;MALSU1;RPL5;RPL14;RPL6;MRPL1;RPL10
prerank,positive regulation of signaling (GO:0023056),-0.3387079314884787,-1.1052605254434191,0.29395604395604397,0.84215608805945,1.0,10/37,17.28%,RIMS1;GRIK2;PTPN23;RIMS2;DLG4;KCTD13;INPP5F;LGI1;RIMS3;SYT1
prerank,actomyosin structure organization (GO:0031032),0.3477987211008219,1.104919108628782,0.3128415300546448,0.64799274398067,1.0,12/75,5.55%,FLII;EPB41L1;CDC42BPG;ITGB1;TMOD1;MYH6;MYOM2;TNNT1;RHOA;TMOD3;ROCK1;PDLIM1
prerank,positive regulation of neuron migration (GO:2001224),0.5030877803871163,1.104508272408966,0.3505535055350554,0.6483994819766735,1.0,2/11,3.93%,KIF20B;RAPGEF2
prerank,cellular response to inorganic substance (GO:0071241),0.43699817642142,1.1042058496432903,0.33513513513513515,0.6485123604520666,1.0,6/21,12.86%,AOC1;MTR;DDX11;ATRX;SPIDR;FOXO1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3847030365961355,-1.1037431956816197,0.3127962085308057,0.8454101629278236,1.0,6/21,5.88%,EXTL3;XYLT1;HS3ST5;HS3ST4;HS6ST1;SULF1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3705012236564247,1.1037268240982607,0.3117469879518072,0.6490623684910084,1.0,10/51,10.40%,SMURF2;CRIM1;BMP2;GDF3;SMAD4;TRIM33;ACVR2A;HTRA3;UBE2D3;DAND5
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4206223750396645,1.1035388619684028,0.3589315525876461,0.6489547676150584,1.0,7/25,14.62%,ITGA4;ITGB1;CD200R1;NINJ1;JUP;ITGB2;PARVA
prerank,pore complex assembly (GO:0046931),0.4410702837225295,1.1034790351489663,0.3362521891418564,0.6485548354235425,1.0,4/19,12.45%,P2RX7;ANO6;RTN4;NUP98
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4183459924745476,1.1033214548454042,0.3407534246575342,0.6483895297601759,1.0,5/24,6.99%,FBXW7;NUPR1;GRN;MCL1;TNF
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.46734916497573503,1.103274477264019,0.35398230088495575,0.6480018212515037,1.0,4/15,7.65%,IRAK3;LILRB1;TNF;HFE
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3366888182010889,1.103222056325741,0.3194444444444444,0.6476053185863898,1.0,12/86,10.46%,APOE;APP;SNX9;ALOX15;FER;RPS3;FCHSD2;RB1;PSEN1;CCL24;CLASP1;SYNPO
prerank,positive regulation of dephosphorylation (GO:0035306),-0.3657664669767513,-1.1030565757025665,0.32211538461538464,0.8458687504161521,1.0,15/27,22.34%,PRKCD;CALM2;SRC;PPP1R16B;NSMF;CAMTA1;PPP1R7;ANKLE2;PPP2R5A;CDCA2;PTPA;SPPL3;CALM3;TGFB1;PIN1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.45562810721215496,1.1024844569600116,0.3171171171171171,0.6487280087767138,1.0,3/17,3.44%,JAG1;TLR4;CD46
prerank,maturation of SSU-rRNA (GO:0030490),0.39989408114776115,1.1023831879695507,0.3466453674121406,0.6484562964970798,1.0,8/34,9.90%,RPS16;SNU13;RPS28;RPS8;RIOK3;RPS14;MRPS11;HEATR1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4489790158795527,1.1017291137157201,0.3241252302025783,0.6494066383627101,1.0,2/18,3.17%,FCGR2B;ERN1
prerank,negative regulation of cellular process (GO:0048523),0.2864335676586327,1.101120905776137,0.22914466737064415,0.6502582256210148,1.0,105/521,16.64%,TGFBI;FCGR2B;ALOX5;APP;PTPRJ;TXNIP;CASK;RIPOR2;NUPR1;LYN;BNIPL;RARG;ABI1;CBFA2T3;RASA1;TNFRSF1B;BMP2;LILRB1;PRKRA;DCSTAMP;PLXNC1;RGCC;S100A11;ITGB1BP1;RAPGEF2;PRKN;TLR2;DUSP1;PDE8A;FRK;CDK6;GSDME;RB1;SNX3;SMAD4;RACK1;PTPRK;NR4A1;BCL2;PLXNA4;FOXM1;BST2;KLF4;MALSU1;VPS4B;PDS5B;GMNN;ARHGDIA;KLF10;CDC73;SPOCD1;CGREF1;ADRA1A;CD33;ESR2;THAP12;SH2B3;PPP2CA;RTN4;SFRP1;PARP16;NUP62;SP100;WFS1;FTH1;SERTAD2;SLIT3;EMILIN1;ST7L;VPS13C;KANK2;CRYAB;PIP4P2;STRN;NIBAN2;CDKN2C;PPP1R13B;DIS3L2;DSCAM;PLXND1;GJA1;CTBP2;ZBTB7C;PIWIL2;SPEF1;NR1H2;CRLF3;MDK;CCN5;PKD2;TMEM109;ARHGDIB;NOX4;MYC;RNF41;PINX1;VGLL4;PTPN14;RUNX3;PTEN;ANP32B;ATG5;MIA3;CD164;BNIP3
prerank,regulation of filopodium assembly (GO:0051489),0.3842395789090429,1.100225911939949,0.33384853168469864,0.6516957120094102,1.0,5/38,5.33%,NRP1;RIPOR2;ARAP1;CDC42;DOCK11
prerank,neural crest cell migration (GO:0001755),0.3922008712135564,1.1000520861730756,0.319935691318328,0.6515860225221968,1.0,2/36,0.82%,NRP1;SEMA4A
prerank,protein localization to cell-cell junction (GO:0150105),-0.4346281659628386,-1.099934762139818,0.36511627906976746,0.8544846213248976,1.0,3/15,5.44%,F11R;TJP1;TJP2
prerank,intestinal absorption (GO:0050892),-0.43938532506032374,-1.0997755678711492,0.31567328918322296,0.8532340382193715,1.0,3/13,7.08%,F11R;TJP2;SLC2A5
prerank,protein localization to plasma membrane (GO:0072659),0.32267945204316445,1.0997229830133621,0.29128738621586475,0.6518075359021474,1.0,34/129,16.89%,LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;ITGB1BP1;EHD1;RAPGEF2;S100A10;RAP1A;ROCK1;TNF;ZDHHC3;DENND4C;PIP5K1A;JUP;ROCK2;KCNB1;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;TMED2;TSPAN14;ZDHHC2;RAB3B;SEC16A;SLMAP;FLOT2
prerank,secondary palate development (GO:0062009),-0.4352850982437074,-1.099501901027817,0.3512304250559284,0.8524410329582247,1.0,7/14,27.86%,CHD7;TGFBR3;TGFBR2;TGFB2;WNT5A;LEF1;WNT7A
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5090157959721786,1.099441646108697,0.3572815533980582,0.6519581231496925,1.0,4/10,16.54%,CD36;TLR4;CD68;MIA3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.37726092487027607,-1.0991215252601247,0.32265446224256294,0.8518779693781044,1.0,12/20,36.53%,TGFBR1;DNAJB2;ITCH;EPAS1;HIF1A;DCUN1D2;UBQLN1;DCUN1D5;HSPA1A;DCUN1D3;HSPA1B;EGR1
prerank,negative regulation of signaling (GO:0023057),-0.36741467293982094,-1.099009111623625,0.3241206030150754,0.8504813098592806,1.0,5/25,14.36%,OPTN;ACVR1;UBASH3B;GLRA1;AP1AR
prerank,protein maturation (GO:0051604),-0.2817275339952004,-1.0988904482636788,0.2627450980392157,0.8490904941041342,1.0,28/95,21.13%,SORL1;NFU1;CLN3;CTSS;APH1A;ADAMTS3;NAA40;F3;NAA60;MMP16;LMF1;DNAJB11;AFG3L2;AEBP1;ISCA1;EEF1AKMT4-ECE2;TSPAN33;NAA35;TYSND1;ADAM10;CPM;CPE;FURIN;STUB1;CIAO1;BOLA2;NNAT;NDUFAB1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2665288245122192,-1.0985706020363966,0.1990521327014218,0.8483681361245318,1.0,59/125,31.88%,CLASP2;DYNC1H1;CENPC;RANBP2;CENPE;WDR62;KNL1;NEK6;NUP85;TACC3;CKAP5;KIF11;EML1;BUB1B;MAPRE1;KIF3B;BUB1;SEH1L;DLGAP5;MAP4;SPDL1;NDC80;KIF2A;NUSAP1;INTS13;SKA2;BCCIP;NSL1;PTPA;CDCA8;RCC1;B9D2;SEC13;ZW10;SETD2;DCTN2;CENPN;CENPP;CENPH;ESPL1;STIL;BIRC5;ZWINT;MAD2L1;CEP126;CENPI;SPC25;AURKB;KIF2C;DYNLL2;TTK;CENPF;SGO1;PMF1;PPP1CC;CLIP1;NUF2;TUBG1;AURKA
prerank,heart contraction (GO:0060047),-0.3280749913597887,-1.0985618116313214,0.3247863247863248,0.8466301741550499,1.0,6/41,7.28%,ATP1B1;SCN1B;SLC8A1;SGCD;GRK2;GAA
prerank,cellular protein-containing complex assembly (GO:0034622),0.31097695055054625,1.0983106909002294,0.299625468164794,0.65401757925138,1.0,25/159,11.68%,HIP1;IMMP2L;TCF4;SNX9;FCHO2;EPS15;CLTC;ADRB2;UVRAG;AXIN1;SMAD4;TBCA;STXBP6;AP2S1;HIGD1A;RPL38;PIK3C2A;MAPK8IP2;RTN4;COX7A2L;CENPT;PXN;EIF4B;RAB5IF;TBCE
prerank,regulation of TORC1 signaling (GO:1903432),-0.3408670039286507,-1.0982246522421495,0.29714285714285715,0.8460041658807034,1.0,8/33,8.47%,GPR137B;GPR137C;RRAGD;STK11;ATM;FLCN;SESN3;CASTOR2
prerank,regulation of intracellular transport (GO:0032386),-0.32725498727761004,-1.0981674621283162,0.31129476584022037,0.8444397413457356,1.0,14/38,19.93%,MAP2;DYNC1H1;NEFH;ATP9A;INPP5F;DYNLT2B;GRIPAP1;NUMA1;ATP13A2;GAS1;DNAJC30;AAAS;PLA2G3;HAP1
prerank,regulation of cell adhesion (GO:0030155),0.3196770185953596,1.097960434189827,0.31876606683804626,0.6543249322929225,1.0,30/129,17.41%,TGFBI;PTPRJ;PPP3CA;MYADM;RIPOR2;LYN;RASA1;PLXNC1;ITGB1BP1;DUSP1;ROCK1;PLXNA4;TNF;CXCR4;ARHGDIA;PPP2CA;CYTH1;RSU1;ROCK2;DSCAM;PLXND1;MDK;PRKD2;ARHGDIB;ZDHHC2;MIA3;CD164;CCL5;PODXL;FES
prerank,plasma membrane organization (GO:0007009),0.35178931163882987,1.0979063288714883,0.3258258258258258,0.6539158500942582,1.0,11/61,11.84%,P2RX7;SNX9;ANO6;SPTBN1;PLSCR5;MYOF;SERP1;CXCR4;PACSIN2;SNX33;PLSCR4
prerank,regulation of protein sumoylation (GO:0033233),-0.4054962039061546,-1.0969828762580645,0.3225058004640371,0.8464275451380132,1.0,9/17,23.77%,CTNNB1;CAPN3;PARK7;MUL1;GNL3L;SAE1;UBA2;PIAS4;PIAS3
prerank,activation of protein kinase B activity (GO:0032148),0.4080104593580174,1.0969312232348476,0.34761120263591433,0.6555993164809079,1.0,7/29,15.00%,GAS6;ANG;ITGB1BP1;INSR;IGF1;OSBPL8;PPIA
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4445555764798932,1.0968732198700926,0.3309734513274336,0.6551941086221471,1.0,5/16,11.89%,MEF2A;ROCK1;MTPN;IGF1;ROCK2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3613282395269926,-1.0965674989399037,0.30670103092783507,0.8460433138861315,1.0,8/24,22.81%,IL1A;SULF1;BRCA1;HPSE;ATF4;CCBE1;TGFB1;HIF1A
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.4052452662310902,-1.0964696517861368,0.3597122302158273,0.8446215636470454,1.0,3/15,6.77%,SORT1;ZFYVE27;BDNF
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.4164783417882792,-1.096391514036586,0.33406593406593404,0.843136533207119,1.0,3/16,4.11%,SALL1;NPNT;FGF2
prerank,regulation of neurotransmitter transport (GO:0051588),0.44415829233912535,1.0962293679385018,0.34440559440559443,0.6561241115870508,1.0,3/16,7.85%,MCTP1;MEF2C;MCTP2
prerank,epithelial tube morphogenesis (GO:0060562),0.4024037287954501,1.0960349862306527,0.3227848101265823,0.6560497604379959,1.0,3/32,4.45%,MTSS1;MEF2C;CCM2
prerank,histone H3-K9 demethylation (GO:0033169),0.5059077196383979,1.0956555424278298,0.376953125,0.6563920810977748,1.0,6/11,18.63%,PHF8;KDM7A;KDM4D;JMJD1C;KDM1A;KDM4C
prerank,regulation of chemotaxis (GO:0050920),0.402467972972646,1.0954107960149955,0.3469387755102041,0.6564569410970448,1.0,5/30,7.48%,ZSWIM6;CCL19;PDGFRA;MYCBP2;CXCR4
prerank,positive regulation of viral genome replication (GO:0045070),-0.35295630171084463,-1.095351189439559,0.33002481389578164,0.8448764863163575,1.0,9/29,19.22%,ADAR;CNOT7;SRPK1;PPIE;SRPK2;ADARB1;TOP2A;TARBP2;TMEM39A
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.42831611704987116,1.0950993140319747,0.3427065026362039,0.656585813305955,1.0,8/21,11.89%,PEAK1;RHOA;ROCK1;PTPRA;VCL;CLASP1;CORO1C;ROCK2
prerank,regulation of hippo signaling (GO:0035330),0.44823539686980424,1.0947097100712557,0.3505338078291815,0.6569403923103097,1.0,8/17,20.04%,MOB3B;LIMD1;MAPK14;WWC1;VGLL4;MARK3;DLG5;WWC2
prerank,regulation of secretion by cell (GO:1903530),0.35557061532400536,1.0946699128843282,0.3303030303030303,0.6565001409526074,1.0,9/54,8.67%,MCTP1;MEF2C;RAB8B;RAB10;RIC1;RHBDF1;STXBP5;MCTP2;DNAJC1
prerank,apoptotic process (GO:0006915),0.30490064487549107,1.0946060720853295,0.28839390386869873,0.6561287521343682,1.0,23/203,9.83%,PAEP;TNFRSF25;HIP1;APP;NOTCH2;AHR;ZBTB16;IFT57;BNIPL;DAPK1;LIG4;RIPK1;PRUNE2;TLR2;STK3;BCL2;CHEK1;CXCR4;TNFSF12;ADRA1A;MDM2;PPP2CA;RTN4
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.33633524026827816,1.0940960225856893,0.3346883468834688,0.6566813223968296,1.0,22/93,17.97%,EGFR;APP;GAS6;RASSF2;CD44;AXIN1;RACK1;PDE4D;TNF;FNIP1;CNKSR3;RIPK2;DOCK7;ATP2B4;TERF2IP;CNOT9;PRKD2;HSP90AB1;PTEN;SPRY2;IL6;RAF1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.34158735170420557,1.0939062724608688,0.29863013698630136,0.6566246470797803,1.0,19/79,14.87%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;MFSD6;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;CAPZA1;AP2B1;CLTA;CAPZA2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4218543878679564,1.0935091978692577,0.34615384615384615,0.6570038363446502,1.0,7/23,16.45%,C1QTNF3;SPI1;UACA;PPM1B;ZC3H12A;PPM1A;RELA
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4814649701198048,-1.0928654964624935,0.3649484536082474,0.8513199406437078,1.0,5/10,24.44%,FMR1;CBARP;GPR35;CALM3;CRHR1
prerank,skeletal muscle contraction (GO:0003009),0.44386476383020274,1.0926922150666092,0.34385964912280703,0.658316225980454,1.0,2/19,3.13%,RCSD1;TNNT1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2919663012297619,-1.092576945765323,0.2711864406779661,0.8505065433298518,1.0,19/72,13.62%,NAV3;PRKCD;MAP2;TREM2;CLASP2;TBCD;CAMSAP1;FGF13;SHANK1;TWF2;PLEKHH2;IAPP;ARHGEF2;PFDN2;ARFGEF1;VBP1;CORO1A;EML2;MAPRE1
prerank,anion transport (GO:0006820),-0.3402714031354558,-1.0924970896332002,0.30659025787965616,0.8490107991053069,1.0,5/33,12.20%,SLCO2B1;VDAC1;SLC4A2;ABCG2;SLC17A5
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.35854303262909903,-1.092481929028966,0.3188405797101449,0.8473176671080792,1.0,8/25,20.92%,NOS1AP;FGF13;ANK2;CTNNA3;CACNA1C;CXADR;CAMK2D;CALM3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3842018255502665,-1.0923395827053621,0.36054421768707484,0.8460663042662181,1.0,4/21,6.17%,RASAL3;ARHGAP25;LZTR1;STAMBP
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4495050321369556,1.0921692641962857,0.3443708609271523,0.6589550593508351,1.0,3/17,2.43%,GMFG;WASF2;FCHSD2
prerank,determination of heart left/right asymmetry (GO:0061371),-0.33012316696778776,-1.0921609916229125,0.3130434782608696,0.8449365893720246,1.0,16/42,23.49%,NDRG4;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;NOTCH1;SRF;MICAL2;ENG;BBS4;MKKS;CCDC40;STIL
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3213837443193572,1.0919944277620914,0.3152454780361757,0.6588255822247758,1.0,28/129,17.26%,ZEB2;EGFR;SMURF2;PSMA7;AXIN1;NRARP;GPRC5B;FRAT1;WNK1;PPM1B;PSMB2;TBL1XR1;TBL1X;SFRP1;WLS;JUP;PSMA6;LRRK1;PLEKHA4;PSMD5;PSMD1;PSMA3;GPC3;USP47;PPM1A;AMER1;RNF146;LGR4
prerank,regulation of endothelial cell migration (GO:0010594),0.3356481734597157,1.091809389270481,0.32226832641770403,0.658713884737677,1.0,15/85,12.88%,NRP1;APOE;FOXP1;SASH1;RIN2;GRN;ITGB1BP1;PRCP;SYNJ2BP;FOXC2;ADAMTS9;SP100;ROCK2;ZC3H12A;BCAS3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32799686766557296,1.0914479376011172,0.31657608695652173,0.6590289103972673,1.0,22/101,14.61%,EGFR;FGFR1;ADRB2;RGCC;RHOA;RAPGEF2;INCENP;CD40;PIK3R6;TNF;CCND3;CCNYL1;PDGFC;CCND2;PPP2CA;PARP16;CALM1;ATP2B4;NOD2;CCNY;RALB;PKD2
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.38514513129741546,-1.0912501450410275,0.3349875930521092,0.8462401744722575,1.0,9/22,16.09%,MAP2;CAMSAP1;MAP1B;MAPT;AKAP13;MAPRE3;GBA2;AEBP1;PARK7
prerank,protein polyglutamylation (GO:0018095),-0.45325460003707135,-1.090632060919427,0.35106382978723405,0.8465239534257193,1.0,3/11,12.41%,TTLL11;TTLL7;TTLL1
prerank,regulation of T cell activation (GO:0050863),-0.3228672041666665,-1.0899105786774677,0.3096590909090909,0.8471898383632718,1.0,3/42,1.25%,SIRPA;PAG1;CCDC88B
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.25653214750032927,-1.089755304133332,0.24651162790697675,0.8459940172298894,1.0,39/128,25.09%,CSNK1E;SDCCAG8;CEP135;ODF2;OPTN;DYNC1H1;SKP1;CEP192;CCNH;HAUS8;FBXL7;CEP250;WEE1;CCDC57;CEP63;PLK3;CCP110;PLCB1;HAUS7;CKAP5;HAUS3;MAPRE1;CHEK2;BRSK2;FBXL6;FBXL3;TAF2;LCMT1;DCTN2;BRSK1;MASTL;CNTRL;HAUS2;PLK4;DCTN1;HAUS6;CDK1;YWHAG;CCNA2
prerank,regulation of cell projection organization (GO:0031344),-0.4369611346008088,-1.0892593517117541,0.36054421768707484,0.845873565061436,1.0,4/13,8.15%,SEMA4D;TREM2;MACF1;NTNG1
prerank,regulation of hemopoiesis (GO:1903706),0.498775625456311,1.089250690769933,0.3675373134328358,0.6634301083927352,1.0,4/10,18.43%,CBFB;PRKCB;CREBBP;MAFB
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.41242908652310306,1.0890971090870238,0.35067114093959734,0.6632666518796497,1.0,9/28,15.93%,SPI1;BCL2;BAG3;TNF;ZDHHC3;CASP8;DIABLO;TNFRSF1A;GABARAP
prerank,cellular response to radiation (GO:0071478),0.3779433089612667,1.088985988515512,0.33281972265023113,0.6630175047442982,1.0,10/40,13.19%,LIG4;CLOCK;RRH;GPR52;MAPK14;KDM4D;EEF1D;SPIDR;RHNO1;NET1
prerank,defense response to virus (GO:0051607),0.32778058211190436,1.0889442353237455,0.32763157894736844,0.6626028250714249,1.0,16/100,10.69%,TLR8;IFITM3;OAS2;LILRB1;SERINC3;TLR2;TRIM56;RNASEL;CD40;BCL2;BST2;RNASE6;IFNAR2;IRF2;IFITM2;ATG7
prerank,mesenchyme development (GO:0060485),-0.4240682797685855,-1.088529036463031,0.36446469248291574,0.8465385219087579,1.0,3/15,9.61%,TGFBR1;FGFR2;CRELD1
prerank,cellular response to sterol (GO:0036315),0.4698769634850607,1.0876641254287036,0.3467153284671533,0.6649839110133481,1.0,1/13,0.46%,LRP6
prerank,histone H3-K36 demethylation (GO:0070544),0.5010315888808188,1.0871712705563732,0.34386617100371747,0.6655698150513563,1.0,4/10,18.63%,PHF8;KDM7A;KDM2A;KDM4C
prerank,fatty acid transmembrane transport (GO:1902001),0.43683113149597574,1.0871528466306886,0.35800344234079173,0.6650875741550332,1.0,2/19,2.65%,PRKAG2;CD36
prerank,regulation of epithelial cell migration (GO:0010632),-0.30507238015732996,-1.0862302301662379,0.308868501529052,0.8523589466643957,1.0,9/51,5.80%,EVL;PRKCE;PTPN23;CLASP2;ENPP2;SRC;DUSP10;PLCG1;MACF1
prerank,limb development (GO:0060173),-0.3544776002687625,-1.0857528139110413,0.345,0.8523006316273807,1.0,5/28,11.08%,SALL1;CHD7;BMPR1B;IQCE;RSPO2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3779900972552979,-1.0850940284056028,0.35308056872037913,0.8526951911558434,1.0,6/22,9.10%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,carboxylic acid metabolic process (GO:0019752),0.3891248401663188,1.0850415418016672,0.3380281690140845,0.6693429961570206,1.0,7/33,14.43%,ST6GAL1;ST3GAL1;DAO;GNMT;GLUD1;SLC23A1;SLC23A2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.353891876478598,-1.084683415336727,0.3032581453634085,0.8522936778047793,1.0,8/27,19.27%,AK2;DCTD;TYMS;GLRX;DUT;DTYMK;NUDT13;GUK1
prerank,positive regulation of cellular component organization (GO:0051130),0.3233179680588302,1.0844809137431506,0.33157199471598414,0.670088609035807,1.0,11/107,8.23%,DAB2;APOE;RPS3;CCL19;GSK3B;RB1;INSR;RACK1;SYK;TNF;FNIP1
prerank,cellular response to amino acid starvation (GO:0034198),-0.2887934631607611,-1.0844582926444069,0.2982456140350877,0.8512937992234044,1.0,24/71,19.54%,TCIRG1;RPTOR;ATP6V1C1;GCN1;IMPACT;ATP6V1D;RRAGD;FLCN;SESN3;ATP6V1H;MAPK3;DAP;ATP6V1G1;CASTOR2;ATP6V0B;ATP6V0D2;ATP6V0C;SEH1L;MLST8;RRAGB;MTOR;SEC13;SESN2;ATF4
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3559919733734206,-1.0837892339239994,0.3275862068965517,0.8518210686726426,1.0,5/27,8.51%,ABHD12;ENPP2;SMPD4;PLA2G6;INPP5F
prerank,cellular response to estrogen stimulus (GO:0071391),0.4735778513404719,1.0837856763745974,0.3709090909090909,0.6711351501942769,1.0,6/14,13.77%,ARID5A;TRIM24;SFRP1;BCAS3;SFR1;RARA
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.24718835562802355,-1.0837584395535562,0.21428571428571427,0.8502581936559175,1.0,31/198,11.20%,HK2;INPP4B;CERK;INPP5D;PLCB2;PIK3CB;PLD4;PTPRD;PFKL;EPHA7;PAK1;GFPT1;DUSP10;PLCB4;PLPP3;PLCG1;PI4KA;ALDOA;LPL;MAPK3;GK;PGK1;PLPPR1;DUSP15;ALK;GPX4;PFKP;XYLB;MINPP1;PLCB1;PLCH1
prerank,lipid phosphorylation (GO:0046834),-0.4717779007473275,-1.0836021684855477,0.36929460580912865,0.8490345657592898,1.0,3/10,8.84%,DGKI;DGKB;DGKZ
prerank,morphogenesis of an epithelium (GO:0002009),0.4141278812569398,1.0835297391506835,0.33607907742998355,0.6712056978509316,1.0,4/25,8.29%,LRP6;ACTB;ARHGAP12;VCL
prerank,negative regulation of insulin secretion (GO:0046676),0.4423818206289929,1.0834840756316524,0.35051546391752575,0.6707773106992448,1.0,4/17,11.95%,PRKN;SFRP1;CHGA;KCNB1
prerank,positive regulation of phosphatase activity (GO:0010922),0.430588353317537,1.0832265387067859,0.3621908127208481,0.6708140787763558,1.0,3/21,2.61%,CHP2;MEF2C;BMP2
prerank,polyol biosynthetic process (GO:0046173),0.445917070162967,1.0828018715181464,0.3769633507853403,0.6712090263886934,1.0,3/16,6.27%,IP6K3;ACER3;CYP27A1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4353987469966949,-1.082371257374312,0.36721991701244816,0.8512688113108497,1.0,5/12,19.19%,ATP1B1;ATP1B2;WNK3;GLRX;FXYD1
prerank,regulation of cell migration (GO:0030334),0.2860878922556259,1.0822326850172852,0.30601092896174864,0.6719753789158754,1.0,48/382,10.05%,DAB2;MCTP1;NEDD9;EGFR;PTPRJ;SEMA4A;SGK3;CCR1;PPP3CA;SASH1;MYADM;RAP2B;ITGB1;FER;JAG1;MITF;CASS4;SYNE2;BMP2;CD74;FGF23;DRD1;GRN;ADAM9;PLXNC1;RHOA;INSR;RACK1;CLIC4;PTPRK;PDGFRA;ROCK1;STK24;TRIM32;PLXNA4;SDCBP;BST2;DUSP22;CXCL16;CCL24;VCL;AMOT;RCC2;PDGFC;CORO1C;NKD1;IGF1;SFRP1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3803099741019372,1.082062564002417,0.35331230283911674,0.6718500571604092,1.0,10/39,16.54%,STEAP3;RCN3;RAB8B;RAB10;AFM;CANX;PDIA4;RAB3B;GOLPH3;MIA3
prerank,chromatin remodeling at centromere (GO:0031055),-0.3426996711987295,-1.0818524540761119,0.32575757575757575,0.8512743506657133,1.0,12/31,28.09%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPV;CENPN;CENPP;CENPH;CENPI;MIS18A
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.37241385081160144,-1.0807876810449306,0.3367088607594937,0.8530100273652305,1.0,9/22,17.71%,MAGI2;NTRK3;BDNF;MAPT;TMEM108;WASF1;RAPGEF1;RAB35;SH3GL2
prerank,response to hydrogen peroxide (GO:0042542),0.3741380401113016,1.0799883591251689,0.3524229074889868,0.6759717389779236,1.0,15/45,18.15%,MAP3K5;RPS3;OSER1;RIPK1;ADAM9;HMOX1;STK24;FYN;TRPM2;NET1;MAPK7;RELA;PRDX3;IL6;APTX
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35248576851403735,1.0796359365892259,0.3459214501510574,0.6762485077247016,1.0,15/56,14.73%,EGFR;ANKRD17;RGCC;RB1;CDC27;NSMCE2;VPS4B;CCND3;RCC2;CCND2;CUL3;TFDP1;KMT2E;RAB11A;RAD51B
prerank,axonemal dynein complex assembly (GO:0070286),-0.35498284966233234,-1.079315406126312,0.32839506172839505,0.8560694605288207,1.0,17/27,43.68%,TTC12;CCDC39;DNAI4;DNAH8;DNAH5;ODAD1;ODAD2;CCDC40;DNAI3;SPAG1;DNAAF2;DNAH17;DNAAF1;CCDC65;DNAH1;CFAP100;DNAL1
prerank,kinetochore organization (GO:0051383),-0.43428340155309586,-1.0787665838350458,0.3865546218487395,0.8562382765927672,1.0,8/13,31.63%,CENPC;CENPE;DLGAP5;NDC80;CENPH;CDT1;CENPF;NUF2
prerank,response to light stimulus (GO:0009416),-0.3042094063385462,-1.0782796693495467,0.32934131736526945,0.8561616991864588,1.0,12/55,12.12%,GTF2H2;MAPK10;UBE2B;MAP2K7;DDB2;PRIMPOL;ERCC6;FECH;ERCC2;CCAR2;UVSSA;CIRBP
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.48111903297049996,1.077873538825207,0.379110251450677,0.6796714782146496,1.0,2/11,2.69%,EGFR;RIPK1
prerank,regulation of receptor internalization (GO:0002090),-0.33265484522632344,-1.0775304162492925,0.336,0.856821637554465,1.0,9/35,10.41%,RIN3;MAGI2;DLG4;FLOT1;AHI1;FMR1;ARRB2;ANKRD13B;ANKRD13D
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.30404022763107014,-1.0774865928843373,0.31378299120234604,0.8553038337941322,1.0,18/49,23.87%,LDLRAD4;SORL1;TREM2;IMPACT;SRC;ANKRD27;IAPP;HSF1;PYDC1;ULK1;PARK7;LCMT1;HDAC6;TFIP11;HMGB1;TMC8;DACT1;KIF14
prerank,positive regulation of protein acetylation (GO:1901985),-0.44712121880254596,-1.0774381614779756,0.359375,0.8537730648474892,1.0,3/12,11.56%,DIP2B;DIP2A;RAPGEF3
prerank,protein-containing complex disassembly (GO:0032984),0.3531657765776737,1.0774378975364272,0.34226190476190477,0.6801467433474437,1.0,17/54,18.88%,LRP6;RPL23;UVRAG;AXIN1;GSK3B;FRAT1;EPG5;LAMP2;PPP1CA;VPS16;MYC;WIPI2;GABARAP;AMER1;PYM1;VAMP8;DVL3
prerank,positive regulation of response to wounding (GO:1903036),0.41213148906475183,1.0772593694288675,0.36271186440677966,0.6800617131855022,1.0,3/24,3.57%,ITGB1;GRN;SCARF1
prerank,chromatin disassembly (GO:0031498),-0.4177680783903992,-1.0772301389697214,0.3761261261261261,0.8510825762675415,1.0,3/14,4.51%,SMARCB1;SMARCC2;SMARCE1
prerank,nucleosome disassembly (GO:0006337),-0.4177680783903992,-1.0772301389697214,0.3761261261261261,0.8510825762675415,1.0,3/14,4.51%,SMARCB1;SMARCC2;SMARCE1
prerank,positive regulation of protein processing (GO:0010954),0.4297573990611817,1.0768848976638794,0.35986159169550175,0.6803961659525524,1.0,2/19,4.90%,NLRC4;RHBDD1
prerank,regulation of interleukin-2 production (GO:0032663),0.36735035964260143,1.0767393831982053,0.3413848631239936,0.6802091928877944,1.0,8/43,8.71%,VSIG4;IRF4;RPS3;SPTBN1;PDE4D;CD80;CCR2;TRIM27
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4059725078320643,-1.0765417409205487,0.36768149882903983,0.851715279069958,1.0,5/16,20.36%,CADM1;NECTIN2;SLAMF6;RASGRP1;KLRD1
prerank,glycerol metabolic process (GO:0006071),-0.4670243569372535,-1.076484798299044,0.3728448275862069,0.8502507943817074,1.0,5/10,31.48%,GK;TPI1;ANGPTL3;GOT1;COQ2
prerank,intracellular lipid transport (GO:0032365),0.41888143677669876,1.0763762206539575,0.3806228373702422,0.6805290635405981,1.0,2/21,1.54%,PRKAG2;SGPP1
prerank,negative regulation of cell adhesion (GO:0007162),0.34560705879912906,1.076135679936924,0.34711964549483015,0.6805268587110582,1.0,10/72,7.97%,TGFBI;RIPOR2;JAG1;RASA1;PLXNC1;RHOA;ITGB1BP1;DUSP1;PLXNA4;ARHGDIA
prerank,vasculature development (GO:0001944),0.4505883435469905,1.076064482986755,0.3552397868561279,0.6801836432177725,1.0,2/16,5.36%,FBXW7;PDGFRA
prerank,regulation of ERAD pathway (GO:1904292),-0.4525699362746084,-1.0759568997250943,0.3737166324435318,0.850385436906284,1.0,4/11,12.01%,TMEM259;USP19;BAG6;UBXN1
prerank,regulation of establishment of planar polarity (GO:0090175),0.33097944590384515,1.0758014030116811,0.32118758434547906,0.6802464160420895,1.0,17/88,14.80%,AP2A2;CLTC;SMURF2;PSMA7;PRICKLE1;CDC42;RHOA;CELSR1;AP2S1;PSMB2;PSMA6;SPEF1;AP2B1;PSMD5;PSMD1;PSMA3;NPHP3
prerank,artery development (GO:0060840),-0.36417364507521344,-1.0757685316120094,0.3431372549019608,0.8493932046194366,1.0,5/23,5.72%,TGFBR1;SMAD7;ROBO2;ROBO1;NF1
prerank,intermediate filament organization (GO:0045109),0.4455173098127059,1.07566922890777,0.35334476843910806,0.6799956099210853,1.0,2/17,4.20%,MTM1;VIM
prerank,negative regulation of hemostasis (GO:1900047),0.4707096882661379,1.0754072266669534,0.3738140417457306,0.6800314407183474,1.0,1/12,0.49%,APOE
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4161880484291507,1.0749488266080052,0.3633217993079585,0.6805616507576452,1.0,5/24,8.44%,ITGA4;ITGB1;ROCK1;SYK;MSN
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3560760968804357,-1.074867700727316,0.337468982630273,0.850604151805487,1.0,10/27,30.52%,SLC1A3;SLC36A4;SLC1A1;SLC25A22;SLC7A8;SLC1A2;SLC25A13;SLC1A4;SLC25A29;SLC7A3
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3426074226889084,-1.0745733762158134,0.3399014778325123,0.8483725274263698,1.0,11/29,28.09%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPN;CENPP;CENPH;CENPI;MIS18A
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3426074226889084,-1.0745733762158134,0.3399014778325123,0.8483725274263698,1.0,11/29,28.09%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPN;CENPP;CENPH;CENPI;MIS18A
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3284216240430922,1.0745422529606892,0.3287101248266297,0.6809840754704198,1.0,10/92,3.87%,NRP1;FOXP1;SASH1;RREB1;MAPRE2;RIN2;DOCK1;GRN;ADAM9;ITGB1BP1
prerank,positive regulation of TOR signaling (GO:0032008),-0.3190854167751406,-1.0745103192413,0.32432432432432434,0.8469479118521999,1.0,7/40,5.48%,RPTOR;GPR137B;TREM2;GPR137C;RRAGD;NCKAP1L;FLCN
prerank,response to growth factor (GO:0070848),-0.3189615099841371,-1.07374177976775,0.3383233532934132,0.8477499814158604,1.0,10/41,16.55%,TGFBR1;CTNNB1;BMPR1B;ACVR1;TWF2;HTRA2;TGFBR2;ACVR1C;ACVR1B;TBC1D7
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.36585705381904254,1.0736697988638628,0.3476923076923077,0.6824805320513758,1.0,12/48,14.75%,SLC25A16;GUCY2D;ADCY9;ADSS2;PAPSS2;IMPDH2;SLC35B3;AMPD3;PANK1;ADSS1;NPPC;ACAT1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4443018259810876,1.07272913434994,0.37142857142857144,0.6840464662347273,1.0,3/16,7.57%,RB1;REC8;PDS5B
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.39592561141290694,-1.0726403117931635,0.3621495327102804,0.8497412749383911,1.0,5/17,20.36%,CADM1;NECTIN2;SLAMF6;RASGRP1;KLRD1
prerank,response to amino acid starvation (GO:1990928),-0.28474405500967137,-1.0725578040466968,0.30935251798561153,0.8483973622437302,1.0,24/72,19.54%,TCIRG1;RPTOR;ATP6V1C1;GCN1;IMPACT;ATP6V1D;RRAGD;FLCN;SESN3;ATP6V1H;MAPK3;DAP;ATP6V1G1;CASTOR2;ATP6V0B;ATP6V0D2;ATP6V0C;SEH1L;MLST8;RRAGB;MTOR;SEC13;SESN2;ATF4
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.4578146574915445,1.0725085242528587,0.3619047619047619,0.6839861998678731,1.0,2/12,1.94%,IQGAP1;JAG1
prerank,response to nitric oxide (GO:0071731),0.45791756659022237,1.0722527709929872,0.4130019120458891,0.6840790839757483,1.0,3/13,12.86%,CCL19;MTR;FOXO1
prerank,regulation of protein modification process (GO:0031399),0.3594354119145482,1.0721430663746967,0.3514328808446455,0.6838000459093098,1.0,13/50,13.05%,SPRED1;LYN;FER;NOP53;HSPB1;FNIP1;KDM4D;PPP2CA;CORO1C;ATG7;SPRED2;PHIP;ATG10
prerank,fibrinolysis (GO:0042730),0.46721595278104266,1.0715636380140603,0.3694852941176471,0.6846245483077824,1.0,1/13,1.51%,SERPINB2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.33643546809415975,1.0710323997775657,0.3419170243204578,0.6852845305577973,1.0,11/72,12.21%,FGFR1;SPRED1;FGF23;CBL;FRS2;KIF16B;HNRNPF;RAB14;POLR2B;SPRED2;TRIM71
prerank,regulation of T cell mediated immunity (GO:0002709),0.501378452247828,1.0709736688210305,0.40319715808170514,0.6849005071829669,1.0,2/10,7.60%,TNFRSF1B;CCR2
prerank,negative regulation of vascular permeability (GO:0043116),0.47546273558209395,1.0709002713691855,0.3761140819964349,0.6845276086155738,1.0,2/12,4.21%,PTPRJ;PDE2A
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.347312596764677,-1.0703229233795328,0.3538011695906433,0.8537880657737883,1.0,5/31,4.17%,ABI3;TANC2;NLGN1;PPFIA2;KIF1A
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4501631503248934,1.0701416497176082,0.3716475095785441,0.6857737446363331,1.0,3/16,8.13%,RREB1;METRNL;VSTM2A
prerank,retinal metabolic process (GO:0042574),-0.4411803393327723,-1.0700096795102894,0.3640552995391705,0.8531975332537893,1.0,2/12,5.33%,BCO2;RDH10
prerank,actin filament depolymerization (GO:0030042),-0.4406522539461203,-1.0699980677882208,0.3778705636743215,0.8516220313871405,1.0,5/11,22.29%,TWF2;MICAL3;MICAL2;TWF1;WDR1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.31947228605724187,1.0698611117291337,0.3383152173913043,0.6859158074120674,1.0,19/104,11.65%,SPRED1;SMURF2;CRIM1;RPS27A;BMP2;SNX6;GDF3;IL17RD;SMAD4;TRIM33;SNX25;ACVR2A;HTRA3;VASN;UBE2D3;DAND5;SPRED2;EMILIN1;PMEPA1
prerank,regulation of actin filament polymerization (GO:0030833),0.3368286114516808,1.0697762809579745,0.33677991137370755,0.6855794021295428,1.0,10/69,8.24%,SNX9;MYADM;ALOX15;FER;RASA1;FCHSD2;ARHGAP18;SSH2;MTPN;CCL24
prerank,GTP metabolic process (GO:0046039),0.45627147280430064,1.0695330235738993,0.37225042301184436,0.6856138510664123,1.0,7/15,18.39%,GNAI3;IMPDH2;RAB23;GTPBP1;EFL1;AK3;AK4
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3644641343352717,-1.0695094044435614,0.35516372795969775,0.8515835293731494,1.0,4/24,2.13%,F11R;TJP1;TMEFF2;CLASP2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2827805763901142,1.069239250778932,0.3133047210300429,0.6857726813391315,1.0,80/336,18.19%,VAV3;RNF169;FOXP1;CRIP1;SUSD6;RBBP8;LYN;USP3;RPS3;BABAM2;VCPIP1;TNFRSF1B;UVRAG;WAC;FAM111A;MCL1;MAPKAPK2;BCL2L2;POLE2;SFN;MCM9;NOP53;BCL2;CHEK1;WDR76;TOPBP1;YY1;CHRNA4;PDS5B;DDX11;PSEN1;RPA1;RAD54L;NCOA6;BACH1;SHPRH;ASH2L;MAPK14;RAD52;NFATC2;MTREX;USP16;UBQLN4;SPIDR;ZRANB3;KMT5B;POLE3;XPA;HINFP;POLH;CBX1;ZC3H12A;FOXO1;BRAT1;RBBP6;MUTYH;USP45;XPC;KIN;MMS19;RAD51B;USP28;PWWP3A;MYC;SAMHD1;FBH1;GTF2H3;MCM8;USP47;FANCL;ATR;UBE2U;ASF1A;GTF2H1;RFC3;UBE2A;BATF;ZBTB40;APTX;ZBTB1
prerank,negative regulation of translational initiation (GO:0045947),0.4778571726786432,1.0692036640991673,0.40111940298507465,0.6853386410187076,1.0,6/13,19.09%,EIF3E;RBM4;EIF4EBP2;EIF4EBP1;EIF2AK1;EIF2AK4
prerank,regulation of receptor binding (GO:1900120),0.49110409232735974,1.0691576243890022,0.37640449438202245,0.6849464002833469,1.0,3/10,14.29%,B2M;HFE;ATP2A2
prerank,axonogenesis (GO:0007409),-0.23733418959832275,-1.068961596144516,0.23943661971830985,0.8517504796672498,1.0,53/237,13.74%,NCAM1;NRXN3;SEMA4D;UNC5C;PIK3CB;EVL;EFNA5;CTNNA2;ROBO2;EPHA7;SCN1B;SRC;PARD3;NRXN1;SEMA4C;MAP1B;GRB10;PLCG1;NEFH;FGFR2;ROBO1;LYPLA2;KIF5A;SEMA4G;SPG11;PALLD;MAPK3;KIF5C;EPHB1;CNTN4;BDNF;CNTN6;BSG;EPHA10;CNTN2;SHC3;UNC5D;LAMA2;NTNG1;S100B;LLGL1;EFNB2;ENAH;LAMA3;AFG3L2;LGI1;AUTS2;GFRA1;EPHA3;SPTB;DSCAML1;APBB1;SLITRK5
prerank,sterol biosynthetic process (GO:0016126),0.38116413568447627,1.0688770316440501,0.3642276422764228,0.6850666772271352,1.0,13/33,24.92%,PRKAG2;HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4810020505072041,1.0686853527414497,0.38961038961038963,0.6849459050547819,1.0,3/11,13.91%,LDLR;NR1H2;MFSD2A
prerank,positive regulation of insulin secretion (GO:0032024),0.38281070834269026,1.068365908969902,0.37850467289719625,0.685139254507668,1.0,9/36,14.46%,TCF7L2;MCU;IRS2;GHRL;ANO1;DOC2B;GLUD1;RBP4;TRH
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.36091131187262104,1.0679160498327944,0.35585585585585583,0.6856283224687987,1.0,10/46,12.36%,CHP2;TCF7L2;GAS6;GSK3B;DMAP1;BAG3;PSEN1;JUP;YWHAE;ZC3H12A
prerank,camera-type eye morphogenesis (GO:0048593),0.49144358615872064,1.0677498562370993,0.41353383458646614,0.6855178498616312,1.0,1/10,0.46%,LRP6
prerank,regulation of cellular senescence (GO:2000772),-0.3428263262362989,-1.067114605734149,0.3291139240506329,0.8558863888664896,1.0,8/28,13.69%,ABI3;NUAK1;ZKSCAN3;CGAS;NEK6;AKT3;TERF2;YPEL3
prerank,regulation of endocytic recycling (GO:2001135),-0.44089234524370813,-1.0664723939360234,0.35913978494623655,0.856379543587557,1.0,4/11,8.70%,SORL1;ATP9A;INPP5F;ACTN2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3548849750979343,1.0663582229859414,0.36363636363636365,0.6880595974121869,1.0,22/52,22.16%,SAMD4A;TUT7;RC3H1;DCP1A;TUT4;DDX6;DCP2;EXOSC8;LSM4;LSM2;CNOT9;POLR2D;EXOSC1;HBS1L;CNOT11;CNOT6L;CNOT4;CNOT8;CNOT1;PATL1;PAN3;EXOSC3
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4533124085908516,1.0661038605101267,0.3891891891891892,0.6881272449235362,1.0,1/15,0.60%,FGFR1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3726688525065636,-1.065959567492955,0.3296943231441048,0.8563176507933901,1.0,7/20,21.90%,SKP1;HNRNPU;SUPT7L;ARL2BP;PARK7;BBS4;TAF8
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.28121210168946886,1.0650704455988653,0.32821075740944017,0.689996003988048,1.0,87/366,18.70%,APP;AHR;RREB1;FOXN2;NFXL1;ESR1;HINT1;MEF2C;NCOA2;CEBPB;MITF;ORC5;RYBP;BMP2;ANKRD17;NR3C1;CLOCK;SPI1;RB1;INSR;TGFBRAP1;TCF7;ATXN1;ESCO2;LYL1;MTPN;ESCO1;GMNN;IRF2;ATRX;ZNF628;LIMD1;ESRRB;BACH1;LIN54;ESR2;HMG20A;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;TESMIN;JMJD1C;RNF14;SP1;ATXN1L;CREBBP;MYBL2;FOXK2;NFIA;HINFP;FOXO3;NANOS3;RPL10;TERF2IP;SP3;RBBP6;PSPC1;EP300;KAT7;STAT3;MLF2;HMGN5;WWC1;NAB1;NSD3;MYT1;NR2C2;NLK;SFPQ;RUNX3;HCFC1;PPARGC1B;RELA;GPBP1;NR5A2;PRKCQ;ZNF22;METAP1;GZF1;RFX3;MAFB;PERM1;ATF2;PLAG1
prerank,positive regulation of chromosome organization (GO:2001252),0.4545737657544793,1.0649107953828107,0.3989169675090253,0.689844933135954,1.0,3/15,8.38%,LIG4;DDX11;ATRX
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4552987046182822,-1.0647752765330678,0.3862212943632568,0.8584565012397932,1.0,3/10,15.87%,WHRN;IFT88;ADGRV1
prerank,protein import into peroxisome membrane (GO:0045046),0.41825655585926835,1.0647041354815872,0.37181663837011886,0.6897949845551383,1.0,4/22,6.67%,RAB8B;SLC25A17;PXMP2;PEX26
prerank,negative regulation of DNA metabolic process (GO:0051053),0.41079365287154423,1.0644655097762328,0.3676222596964587,0.6898307286363278,1.0,6/24,12.64%,KMT2A;RPS3;ZRANB3;DFFA;NIBAN2;TERF2IP
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.40693309414481255,-1.0642498714850357,0.3830275229357798,0.8584910461872944,1.0,8/15,26.31%,NLGN1;CLN3;USP46;SYN3;CNTNAP4;HAP1;BAIAP3;STXBP1
prerank,cell-substrate junction assembly (GO:0007044),-0.32945800495915534,-1.0641249352545572,0.34782608695652173,0.8572680062329213,1.0,9/33,17.66%,DST;ITGA6;SRC;FERMT2;ACTN2;LAMA3;TRIP6;THY1;ITGB4
prerank,excitatory postsynaptic potential (GO:0060079),0.41958480438498325,1.0641219449676063,0.38324420677361853,0.6900998945995322,1.0,5/19,10.32%,MEF2C;GSK3B;MPP2;MAPK8IP2;GRIN2D
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.36892155907974633,1.0641104202055405,0.36334913112164297,0.6896120284225705,1.0,4/39,4.23%,NRP1;LRP6;BMP2;NRARP
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3918802613150256,-1.0640995135059998,0.36613272311212813,0.8557732931313506,1.0,7/18,22.91%,CEP135;TREM2;PTP4A3;CCT7;CCT2;WRAP53;CCT8
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.32792104093050456,1.0640916372975866,0.3423913043478261,0.689133670977845,1.0,10/85,7.55%,AP2A2;CLTC;SMURF2;PSMA7;PRICKLE1;CDC42;RHOA;CELSR1;AP2S1;PSMB2
prerank,extracellular matrix disassembly (GO:0022617),-0.2996265591872388,-1.063237152023764,0.36023054755043227,0.8570115823582121,1.0,24/53,35.94%,KLK2;TLL1;FLOT1;CTSS;BSG;ADAMTS4;MMP16;ADAM8;SCUBE1;ADAM10;FURIN;CTSK;A2M;HPN;MMP15;CAPNS1;MMP14;HTRA1;TLL2;KIF9;MMP8;ADAMTS15;TIMP1;CAPN1
prerank,skin development (GO:0043588),0.34318237648973626,1.0632112263385496,0.36623748211731044,0.6906265612746058,1.0,7/65,6.05%,TXNIP;JAG1;ADAM9;KRT10;CLIC4;ATP7A;SFN
prerank,response to interleukin-4 (GO:0070670),0.4983977324263579,1.0628829420337769,0.39332096474953615,0.6908600556766016,1.0,2/10,6.03%,DCSTAMP;TCF7
prerank,myelin maintenance (GO:0043217),-0.44878057459585086,-1.0626825806022935,0.40444444444444444,0.8572341563542422,1.0,3/10,10.64%,EPB41L3;DEGS1;ABCD2
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.39853046078035825,-1.0624405444182907,0.351288056206089,0.8564076098979936,1.0,3/15,9.26%,LARGE1;CHST1;CHST2
prerank,response to nutrient levels (GO:0031667),-0.4016635599370461,-1.0624236177111486,0.40089086859688194,0.8549011114888838,1.0,5/17,19.54%,RPTOR;EIF4G1;ULK1;MTOR;ATF4
prerank,regulation of microtubule-based movement (GO:0060632),-0.4408567825720616,-1.062208497463949,0.3978260869565217,0.8540575758319537,1.0,6/11,21.15%,MAP2;NEFH;DYNLT2B;CFAP298;HAP1;HDAC6
prerank,epiboly involved in wound healing (GO:0090505),0.4420204231677114,1.062009013947708,0.3829787234042553,0.6923327164573531,1.0,3/16,4.01%,CD44;RHOA;LCP1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3914270966229472,1.0614602719549993,0.3587662337662338,0.6930453881840238,1.0,10/29,18.02%,SPRED1;IL17RD;VASN;USF3;PPP2CA;SFRP1;SPRED2;PTEN;SPRY2;EFNA1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.31814297199895103,1.0610681350933713,0.35006605019815057,0.6934642877935958,1.0,23/107,16.47%,MAP3K5;ALOX15;CEBPB;RCN3;THBS4;ERN1;NIBAN1;PRKN;GSK3B;RHBDD1;BCL2;ATF6;WFS1;PDIA4;RNF185;UFM1;ERO1A;ATG10;ATP2A2;PPP1R15B;CREB3L1;HSP90B1;SEC16A
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.46422104997045016,1.0607370019718874,0.3837638376383764,0.6936941914387729,1.0,6/12,19.57%,MYCBP2;PAFAH1B1;SZT2;EPHB6;CHRNB2;SPTBN4
prerank,neuronal action potential (GO:0019228),-0.3628393395474107,-1.060701600378595,0.370757180156658,0.8571416487146181,1.0,9/22,40.26%,KCNA2;KCNA1;SCN8A;SCN1A;CACNA1H;MYH14;CACNA1G;ANK3;SCN10A
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.46113537075218247,-1.0605908663993426,0.38,0.8559131111805631,1.0,3/10,7.74%,CD274;PRKAR1A;PRNP
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4136067592700151,1.0604244158030147,0.38475177304964536,0.6938689517817355,1.0,5/21,15.21%,ZFP36L2;ZFP36L1;IGF1;PTGER4;MYC
prerank,negative regulation of cell projection organization (GO:0031345),-0.3041683544206353,-1.059909533281386,0.33238636363636365,0.8564460747319742,1.0,9/48,10.82%,RTN4RL1;MYLIP;PTPRS;YWHAH;PRAG1;PRNP;MAG;EFNB2;SPOCK1
prerank,apoptotic DNA fragmentation (GO:0006309),0.4438819225164498,1.0596676655148043,0.3951219512195122,0.6950680609819629,1.0,2/16,11.26%,ENDOG;DFFA
prerank,regulation of neurogenesis (GO:0050767),-0.29624002248097275,-1.0596211821067454,0.3322784810126582,0.8558486040610576,1.0,7/55,8.64%,CX3CR1;NUMB;SORL1;CTNNB1;TGM2;BHLHE41;NUMBL
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3285510187866548,-1.0591496508376022,0.3489583333333333,0.8557635734227373,1.0,7/32,3.88%,DLG2;PTK2B;GRIA2;NLGN1;DLG4;DLG3;GRIA4
prerank,protein dephosphorylation (GO:0006470),0.3054574568533329,1.0591364425271745,0.3609022556390977,0.6957158007991594,1.0,24/135,11.07%,PTPRJ;PPP3CA;PTPN18;PTPN12;PTPN22;MTM1;MTMR3;DUSP12;DUSP1;CTDSP1;SSH2;PTPRK;PTPRA;PPM1B;DUSP22;PPP4R1;DUSP2;CTDSP2;LHPP;PPP2CA;PPP2CB;PPEF1;PPP4R2;PPP1CA
prerank,positive regulation of cytokinesis (GO:0032467),0.3860809940293718,1.0586421889167248,0.39052287581699346,0.6963475259901569,1.0,6/32,11.94%,KIF20B;CDC42;RHOA;PKN2;CUL3;SVIL
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.34435785987242473,-1.0586395842055412,0.36272040302267,0.8558165987838428,1.0,17/29,37.42%,ACACA;PPT1;TECR;ACSL4;ACSL6;SCD;SLC25A1;ACSBG1;ELOVL1;GCDH;ACSF3;ELOVL7;CBR4;HACD2;ELOVL6;ELOVL2;HSD17B8
prerank,extracellular matrix organization (GO:0030198),-0.22804935543148125,-1.0584264499210085,0.23529411764705882,0.8549628994184563,1.0,80/276,22.20%,DST;TGFBR1;ITGB5;F11R;COL27A1;KLK2;NPNT;GPM6B;ADAMTSL1;JAM2;COL11A1;ITGA6;GFOD2;SPARC;SPP1;ADAMTS16;TLL1;ITGB3;FGF2;FLOT1;CTSS;ITGAX;P3H2;NF1;ADAMTS3;BSG;LOXL3;ADAMTS4;APLP1;ITGA5;LAMA2;PLOD3;MMP16;COL23A1;ADAMTS20;PECAM1;LAMA3;ADAM8;SCUBE1;NDNF;ADAMTS1;MATN4;SPOCK2;COL25A1;COL1A2;COL19A1;COL11A2;TNR;ADAM10;VCAN;COL8A1;VIT;BCAN;COL26A1;ITGB4;COL6A2;COL16A1;FURIN;COLGALT2;SERPINE1;PDGFA;BGN;ITGAV;COL4A2;COL6A3;FLRT2;P3H4;NCAN;COL4A6;COL9A3;TGFB2;ADAMTS2;CTSK;COL9A1;ITGAD;TGFB1;COL3A1;COL20A1;COL6A1;ITGA10
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4362008817670395,-1.0578656859739406,0.39601769911504425,0.8552294383113033,1.0,4/11,10.36%,F11R;TJP1;TJP2;AFDN
prerank,acylglycerol biosynthetic process (GO:0046463),0.4084720350033412,1.0573835586452527,0.39008264462809916,0.6988012620328796,1.0,3/23,4.41%,ANG;AGMO;MOGAT2
prerank,bone development (GO:0060348),0.359886606279467,1.0572009788625132,0.3588957055214724,0.6987215540747537,1.0,9/39,13.13%,LRP6;RPL13;NOTUM;VKORC1;SULF2;CYP26B1;PTGER4;SLC10A7;GJA1
prerank,base-excision repair (GO:0006284),-0.30492324442644964,-1.0571054868397023,0.3480825958702065,0.8561274623271707,1.0,16/48,23.13%,DNA2;PARP1;ERCC6;LIG1;POLG;XRCC1;NEIL3;RFC2;HUWE1;POLE;POLL;RFC1;ADPRS;PARG;APEX2;POLD4
prerank,bicellular tight junction assembly (GO:0070830),-0.3029658788342173,-1.0567171308387524,0.3588235294117647,0.8558375594214331,1.0,4/46,2.61%,F11R;TBCD;PARD3;CLDN11
prerank,regulation of acrosome reaction (GO:0060046),-0.45525882157090347,-1.0564981931120672,0.37782340862423,0.8549645556503924,1.0,2/10,12.51%,PLCB1;GLRA1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4069287889713224,-1.0564417662634715,0.4099099099099099,0.8536098247897518,1.0,2/15,4.84%,TGFBR1;FGFR2
prerank,cellular response to organic substance (GO:0071310),0.31281436206709207,1.0563906834860708,0.3761348897535668,0.6999743399297013,1.0,13/116,7.48%,PID1;PTPN18;PTPN20;NCOA3;PTPN12;NR1H4;NCOA2;RHOA;RACK1;ACVR2A;TNF;KLF4;CXCR4
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.34745918808312765,1.0563729184508053,0.3605150214592275,0.6994980223181735,1.0,11/54,12.91%,GAS6;RIPK1;PRKN;BIRC3;RACK1;SYK;TNF;UBE2K;CARD16;CASP8;TNFRSF1A
prerank,negative regulation of interferon-gamma production (GO:0032689),0.419149593546269,1.0554272711110473,0.3951612903225806,0.7011700181015819,1.0,4/23,3.17%,GAS6;NR1H4;LILRB1;TLR4
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3937576082938749,1.0551773593381235,0.37018425460636517,0.7012276626058458,1.0,6/27,10.79%,SPRED1;CD44;CD74;MDM2;DYRK1A;SPRED2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3198930089894259,-1.0549672792983347,0.37222222222222223,0.8568799775199291,1.0,9/39,15.04%,PIK3CB;EFR3B;PI4KA;SOCS2;TTC7B;SOCS7;PIK3C2B;PIP4K2B;PIP4K2C
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.33020293207073104,1.0548301178420565,0.34794520547945207,0.700983450293482,1.0,18/78,14.87%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;CAPZA1;AP2B1;CLTA;CAPZA2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.33020293207073104,1.0548301178420565,0.34794520547945207,0.700983450293482,1.0,18/78,14.87%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;CAPZA1;AP2B1;CLTA;CAPZA2
prerank,chromatin remodeling (GO:0006338),0.3193980263048705,1.0545613025575207,0.36595174262734587,0.7010631476503918,1.0,27/100,18.66%,PADI4;ESR1;HNRNPC;BAZ2B;JARID2;ARID1B;RB1;ACTB;KDM6A;SATB2;ATRX;KDM4D;POLE3;KDM5C;TADA2B;SMARCAD1;GATAD2B;MYC;SMARCD1;HDAC4;ARID1A;HCFC1;ZBTB7A;NPM3;ZBTB1;KDM4C;SRCAP
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3398173929144468,-1.0544967363136943,0.3918918918918919,0.8568481522078217,1.0,16/30,30.73%,DDX5;TP53;STK11;MYO6;MDM4;ACER2;FHIT;PYCARD;SESN2;USP10;GREM1;PDK2;PMAIP1;RRP8;E2F7;MYBBP1A
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.39304202239183267,1.0543023661127706,0.3706070287539936,0.701108114724932,1.0,5/27,11.64%,AHNAK;PDE4D;PLN;CALM1;YWHAE
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.34146201151925626,-1.054179206275259,0.38213399503722084,0.8563656975116715,1.0,7/29,9.10%,GTF2H2;CUL4A;CCNH;PARP1;DDB2;RBX1;ERCC2
prerank,cellular component disassembly (GO:0022411),-0.2993595464869928,-1.0538417444241373,0.36936936936936937,0.8558849597361481,1.0,24/53,35.94%,KLK2;TLL1;FLOT1;CTSS;BSG;ADAMTS4;MMP16;ADAM8;SCUBE1;ADAM10;FURIN;CTSK;A2M;DYRK3;MMP15;CAPNS1;MMP14;HTRA1;TLL2;KIF9;MMP8;ADAMTS15;TIMP1;CAPN1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2440234786205819,-1.0531061476147425,0.2849740932642487,0.8566701220695616,1.0,38/172,15.04%,LPCAT2;INPP4B;INPP5D;LPIN2;SLC44A2;LPCAT1;PIK3CB;DGKB;PITPNM1;PIP5K1C;PCYT2;SELENOI;PLEKHA1;FGF2;PCYT1B;PI4KA;CLN3;LIPH;PIK3R4;PITPNM3;PTDSS1;SYNJ2;GNPAT;INPP5F;DGKZ;PTDSS2;PIK3C2B;DDHD1;LPCAT3;PIK3R5;MTMR4;ETNK1;CHPT1;MBOAT7;CDS1;PIP4K2B;STARD7;PIP4K2C
prerank,regulation of gluconeogenesis (GO:0006111),0.38731021787238323,1.0527992544851947,0.3859060402684564,0.704038752421477,1.0,5/27,13.71%,C1QTNF3;C1QTNF12;GNMT;ARPP19;EP300
prerank,fatty acid biosynthetic process (GO:0006633),0.34586786179461854,1.0524154271508221,0.3914956011730205,0.7043713284031947,1.0,4/63,3.80%,ALOX5;LTC4S;ALOX15;HACD4
prerank,regulation of cell differentiation (GO:0045595),-0.24739741633886114,-1.0523967812564283,0.29347826086956524,0.8573647122533768,1.0,26/148,9.93%,TGFBR1;DDX5;BIN1;CDK9;DDX17;OCIAD1;CSF1;YWHAH;NLGN1;SMAD7;CLASP2;ZFHX3;BMPR1B;BIRC2;GPS2;FGFR2;NF1;RPS6KA1;TRIP4;BDNF;SIK1;TIAM1;ALK;AR;ZFHX2;PHLDB1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.35283672202006994,-1.052187173607902,0.38534278959810875,0.8565404883282116,1.0,10/24,23.39%,CTC1;SRC;HNRNPU;PARP1;STN1;TERF2;HNRNPA1;GNL3L;ACD;SLX4
prerank,positive regulation of T cell proliferation (GO:0042102),0.34770749521964,1.0520601909495124,0.39,0.7047159764765555,1.0,8/55,9.95%,IL15;RPS3;CD46;CCL19;SYK;CD80;CCR2;IGF1
prerank,T cell proliferation (GO:0042098),-0.4241328633312675,-1.0519285375281813,0.39325842696629215,0.8557972819278112,1.0,1/13,0.11%,CADM1
prerank,phospholipid catabolic process (GO:0009395),-0.3542754445228704,-1.0518816056368472,0.37708830548926014,0.8544360771893429,1.0,3/24,3.41%,ABHD12;ENPP2;SMPD4
prerank,eye photoreceptor cell development (GO:0042462),0.44725986781722654,1.0516606419101722,0.4028776978417266,0.705124438231873,1.0,2/15,7.09%,RP1;MYO7A
prerank,snRNA processing (GO:0016180),-0.39980447188140433,-1.0516385623685063,0.3925233644859813,0.8536914096565885,1.0,6/16,24.97%,INTS6L;INTS3;TOE1;INTS9;INTS11;INTS7
prerank,renal system development (GO:0072001),-0.29891202494916114,-1.0516174470116841,0.375,0.8522563356075961,1.0,8/52,12.73%,TGFBR1;SALL1;STAT1;IFT88;SULF1;BAG6;PAX8;PROX1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.35169614632426793,-1.051139677723128,0.366412213740458,0.8522130154753661,1.0,5/25,10.54%,TP53;BCL2L11;MLLT11;BMF;TNFSF10
prerank,central nervous system neuron development (GO:0021954),0.4451531691271179,1.0507700202873154,0.38178633975481613,0.7066821250047084,1.0,7/15,17.66%,RAPGEF2;B4GALT6;ATP7A;B4GALT5;HSP90AB1;PTEN;ARHGAP35
prerank,modulation by host of symbiont process (GO:0051851),-0.3329964778062552,-1.0505530527900873,0.36666666666666664,0.8526374707653954,1.0,17/31,37.54%,CX3CR1;TARDBP;SMARCB1;SAP30BP;CCL3;JUN;HDAC1;NAPEPLD;LEF1;CCNT1;HPN;CARD9;TFAP4;SMARCA4;HMGA2;CCL4;LRRC19
prerank,Golgi to plasma membrane transport (GO:0006893),0.35132966823773454,1.0504262595268539,0.3861236802413273,0.70699300111774,1.0,8/47,8.66%,RAB31;EXOC6B;SPTBN1;RAB10;STXBP6;EXOC4;RABEP1;GOLPH3L
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.40623341896199044,1.0504114858785367,0.4019607843137255,0.7065113843141182,1.0,9/24,16.55%,CNMD;TNMD;EPN2;PRKCB;EMILIN1;MMRN2;NIBAN2;PRKD2;ARNT
prerank,regulation of myotube differentiation (GO:0010830),0.4084579212376938,1.0500184272454227,0.3871527777777778,0.7069400250066868,1.0,1/24,0.10%,HDAC9
prerank,regulation of cellular component organization (GO:0051128),0.3028647108501012,1.049714353704679,0.382051282051282,0.7071288998910675,1.0,13/135,6.99%,HIP1;APOE;RAP1B;SGK3;OPHN1;IRAK3;CD36;IL17RB;RAPGEF2;RAP1A;ROCK1;AP2S1;TNF
prerank,melanosome organization (GO:0032438),-0.3463487574948466,-1.0494676816698625,0.37343358395989973,0.8545072319114675,1.0,6/26,10.57%,LYST;HPS4;AP3D1;AP1M1;SHROOM2;RAB38
prerank,fluid transport (GO:0042044),-0.4246285733115948,-1.0493207557972752,0.39539748953974896,0.8534695926419167,1.0,4/12,49.84%,PDPN;AQP4;AQP1;SLC4A11
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.37535662115889956,-1.0491611910083178,0.3543123543123543,0.8524725367603435,1.0,4/20,9.24%,DIP2B;DIP2A;MAPK3;BRCA1
prerank,positive regulation of telomerase activity (GO:0051973),-0.32534170861675044,-1.0489208387816789,0.3870967741935484,0.8517341989936151,1.0,12/33,27.89%,CTNNB1;XRCC5;MAPK3;MAP2K7;PTGES3;MAP3K4;CCT2;WRAP53;ACD;NVL;AURKB;GREM1
prerank,small GTPase mediated signal transduction (GO:0007264),0.3119368273073986,1.0488029487110544,0.37157757496740546,0.7086997585516244,1.0,22/103,14.87%,RGL1;RREB1;RIN2;NRAS;KRAS;SIAH2;ARHGAP18;ARHGAP31;RAPGEF2;GRAP;RB1;NUCB2;GNB1;MAPK14;IGF1;SHC1;RASSF1;NUCB1;NTN1;RALB;RALGDS;USP28
prerank,positive regulation of developmental process (GO:0051094),0.29542240481337184,1.0484847081789719,0.3656441717791411,0.708931558796649,1.0,43/164,20.45%,APOE;FGFR1;ZBTB16;RREB1;SMURF2;NCOA3;CEBPB;BMP2;RPS6KA3;PRKN;MCU;KRT10;INSR;TNF;PSEN1;ESRRB;CLASP1;CORO1C;RTN4;VLDLR;B4GALT5;KMT5B;NIBAN2;GJA1;MDK;BMPR1A;NR2C2;HSP90AB1;SLC6A6;BNIP3;LHX1;SHLD3;XBP1;PA2G4;LMNA;MFF;GDNF;DVL3;CCN2;DLG5;HMCES;DNM1L;SHLD2
prerank,receptor signaling pathway via STAT (GO:0097696),0.40314595459196595,1.048432184612868,0.391156462585034,0.7085461990296905,1.0,9/25,14.61%,IFNAR1;PIAS1;THPO;CCR2;STAT4;IFNAR2;STAT6;STAT3;PKD2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.34415173832339746,1.048265426448092,0.37349397590361444,0.7084162090957544,1.0,3/55,2.34%,LYVE1;HGSNAT;CD44
prerank,organic substance transport (GO:0071702),0.30471661770082625,1.0482147920827973,0.37371134020618557,0.7080014152134635,1.0,27/121,18.79%,PLTP;TXNIP;CALCRL;RCN3;RILP;SLC22A18;ABCA9;TCN2;ABCA6;ARRDC3;RAB7A;CMTM6;DISP1;RAMP2;GM2A;SLC6A2;MFSD2A;SLC23A1;SNX4;CLN8;HSP90B1;MIA3;SLC35F3;SLCO2A1;CHKA;ABCA4;TOM1
prerank,negative regulation of transferase activity (GO:0051348),-0.33947250445127697,-1.0481587009837934,0.376657824933687,0.852611690600937,1.0,9/28,16.09%,SMAD7;SRC;TP53;HNRNPU;EIF4A2;MAPT;CERS1;LIMK1;PARK7
prerank,phosphate ion transmembrane transport (GO:0035435),-0.4345417011968705,-1.0480914016130303,0.40898876404494383,0.851325567528693,1.0,7/12,21.20%,SLC25A3;SLC37A2;SLC25A14;SLC37A4;SLC25A10;SLC20A2;SLC37A3
prerank,positive regulation of locomotion (GO:0040017),-0.3445249088522325,-1.0480774063183094,0.39528795811518325,0.8499077540541449,1.0,7/27,13.72%,TREM2;CCDC25;P2RY12;STX3;CSF1R;AIF1;SPOCK2
prerank,ketone body metabolic process (GO:1902224),-0.44769302954053447,-1.0480539216140952,0.4149377593360996,0.8485223245460372,1.0,5/10,33.72%,ACSS3;HMGCLL1;OXCT1;AACS;BDH1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.277140682997151,-1.0478992213553089,0.33653846153846156,0.8475669787415937,1.0,26/69,29.89%,CDK9;RPAP2;INTS3;RPRD1A;CCNT2;POU2F2;ICE2;SRRT;NCBP1;POLR2C;INTS13;ELL2;ELL;TAF8;POLR2L;TAF9;TBP;INTS9;CCNK;INTS11;CCNT1;INTS7;POLR2I;TAF13;ICE1;SNAPC1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3178373049874858,1.0476970850358531,0.38231292517006804,0.7086423318957791,1.0,15/90,10.97%,IRF4;CMKLR1;CEBPB;ADRB2;CD36;GHRL;ADIPOR2;SYK;CXCR4;CCR2;PDGFC;STAT6;TSHR;HADH;ACHE
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4678857823342728,1.047649564784598,0.4149139579349904,0.7082404162543237,1.0,2/11,8.05%,PRKN;FYN
prerank,cellular lipid catabolic process (GO:0044242),0.3968555791758978,1.047568022763616,0.39195979899497485,0.7079214425508293,1.0,1/27,0.11%,AOAH
prerank,detection of mechanical stimulus (GO:0050982),-0.38023560525385913,-1.0472615679204949,0.4,0.8480606047852948,1.0,4/19,12.03%,CTNNB1;CDH2;PIEZO1;PIEZO2
prerank,cGMP metabolic process (GO:0046068),0.46639813741350233,1.046979163101608,0.3996282527881041,0.7086829217484433,1.0,3/12,13.97%,PDE2A;GUCY2D;NPPC
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3000455847473622,-1.0468850421876552,0.34710743801652894,0.8477321896937976,1.0,11/50,11.20%,PLCL1;ADAP2;PLCB2;PIK3CB;PLCB4;PI4KA;INPP5F;PIK3C2B;CSF1R;PLCB1;PLCH1
prerank,Fc receptor signaling pathway (GO:0038093),0.3117014562448161,1.0467821302883236,0.3829787234042553,0.7086201204712029,1.0,15/110,11.57%,VAV3;PPP3CA;PSMA7;LYN;FER;FCER1G;MAP3K1;BCL10;PAK2;SYK;PSMB2;NFATC2;CALM1;SHC1;PSMA6
prerank,regulation of viral transcription (GO:0046782),0.363796879154485,1.046759498498239,0.3969465648854962,0.7081565848018592,1.0,9/39,14.38%,MDFIC;IFITM3;LARP7;TRIM32;NELFA;TRIM27;POLR2B;MID2;POLR2D
prerank,cellular response to ionizing radiation (GO:0071479),0.3547052967658746,1.046720141966191,0.36706948640483383,0.7077208345444369,1.0,16/47,16.37%,LIG4;RPL26;CLOCK;TSPYL5;MDM2;MAPK14;MAP3K20;KDM4D;EEF1D;SPIDR;RHNO1;CRYAB;NET1;TMEM109;KDM1A;ATR
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3124497142069126,1.0463677760427998,0.377027027027027,0.70798401576262,1.0,15/109,11.57%,VAV3;PPP3CA;PSMA7;LYN;FER;FCER1G;MAP3K1;BCL10;PAK2;SYK;PSMB2;NFATC2;CALM1;SHC1;PSMA6
prerank,positive regulation of intracellular protein transport (GO:0090316),0.30254501423598784,1.0461175879073044,0.38022813688212925,0.7080534141035533,1.0,28/144,14.28%,CHP2;TCF7L2;FBXW7;KIF20B;GAS6;ITGB1BP1;YWHAQ;GSK3B;SFN;DMAP1;BCL2;BAG3;PSEN1;FYN;UBE2D3;PCNT;MYO1C;TFDP1;CASP8;JUP;SREBF2;YWHAE;KCNB1;ZC3H12A;PPP1R13B;BCAS3;PCM1;ITGB2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.402916472122537,-1.0459789932153465,0.41113490364025695,0.8491307366502113,1.0,9/14,37.44%,ENTPD6;ADPRM;NUDT1;ENTPD3;NUDT16;NUDT5;ENTPD2;ENTPD5;NUDT15
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.41462819545861096,-1.0454373936584418,0.38009049773755654,0.8493360397860317,1.0,4/14,8.70%,ATP1B1;ATP1B2;ANK2;ACTN2
prerank,cell proliferation in forebrain (GO:0021846),-0.44802278541305673,-1.0454120679754735,0.42244897959183675,0.848006603997149,1.0,5/10,27.86%,NUMB;NUMBL;AKNA;KIF14;WNT7A
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3712451965916563,1.0453915980694084,0.38225806451612904,0.7092219961098183,1.0,9/37,10.79%,APP;SPRED1;PRKAG2;AXIN1;S1PR2;UBE2K;RIPK2;CALM1;SPRED2
prerank,positive regulation of vascular permeability (GO:0043117),-0.4221492349851207,-1.0453046062310563,0.3959731543624161,0.8468853918323744,1.0,7/12,30.17%,TJP1;TJP2;PDE3A;TGFB1;ANGPT1;OCLN;TJP3
prerank,COPII-coated vesicle budding (GO:0090114),-0.2790788247267789,-1.045301036981848,0.36741214057507987,0.8454532004424783,1.0,24/68,20.86%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;SCAP;SEC23B;TRAPPC9;SEC31B;TRAPPC6A;GOLGA2;TRAPPC2;SEC13;SEC24B;BET1;TRAPPC2L;GOSR2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.37215162672549823,1.0452221608200376,0.38740157480314963,0.7091088655745735,1.0,9/34,11.28%,RGCC;RB1;INSR;CDC27;NSMCE2;CUL3;IGF1;NUP62;PHIP
prerank,phosphatidylcholine catabolic process (GO:0034638),0.48017733295916987,1.045027877430613,0.40977443609022557,0.7090236878302952,1.0,2/10,4.98%,PLA2G7;PNPLA8
prerank,presynaptic endocytosis (GO:0140238),0.39945270692972845,1.0448523971528705,0.40625,0.7089224335336662,1.0,4/24,7.75%,FCHO2;OPHN1;SYNJ1;CANX
prerank,mucosal immune response (GO:0002385),0.438329505521991,1.044825293306285,0.3979416809605489,0.7084867838869029,1.0,1/15,2.51%,RPL39
prerank,positive regulation of secretion by cell (GO:1903532),-0.2781777622788209,-1.0445743906341516,0.3675496688741722,0.8462302393882641,1.0,9/70,4.81%,FRMD4A;SLC12A2;CADPS;ABCG1;TREM2;CLASP2;RAB27A;IL1A;GRK2
prerank,dendrite self-avoidance (GO:0070593),-0.39120762851462837,-1.0440600517752816,0.44097995545657015,0.8463456557963025,1.0,6/16,13.33%,PALLD;CNTN4;CNTN6;BSG;CNTN2;DSCAML1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.38044414723343856,-1.0436831165422877,0.39325842696629215,0.8460560702092305,1.0,2/19,0.53%,F11R;TJP1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.31146237305351915,-1.0434770856110593,0.37425149700598803,0.8452468487031322,1.0,16/41,25.15%,SLC12A2;KCNJ2;ATP1B1;ATP1B2;SLC12A9;SLC12A6;KCNK9;ABCC9;KCNJ3;KCNJ10;KCNJ13;SLC12A4;KCNJ9;SLC12A5;KCNH2;SLC12A1
prerank,regulation of DNA repair (GO:0006282),0.36046364311636614,1.0433113160945195,0.3896499238964992,0.7114171042713344,1.0,10/44,13.81%,EGFR;RPS3;BABAM2;BRCC3;CEBPG;RAD52;POLH;DEK;UBE2N;KAT7
prerank,negative regulation of defense response to virus (GO:0050687),-0.4413887867592476,-1.0432153895656033,0.43259557344064387,0.8446554244267157,1.0,8/10,31.87%,C1QBP;ITCH;PCBP2;MUL1;TARBP2;ILRUN;TRAF3IP1;TSPAN6
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.46740065570868666,1.0430301157987258,0.4267399267399267,0.7115383398179012,1.0,3/11,12.27%,MAP3K5;STK24;DIABLO
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.42436196178862107,-1.042665045119017,0.3987473903966597,0.8448517397702782,1.0,3/12,4.91%,PTK2B;ANK2;UBASH3B
prerank,ganglioside biosynthetic process (GO:0001574),0.43888330756043376,1.0421756053841387,0.41519434628975266,0.7130123763030091,1.0,3/15,4.22%,ST8SIA4;ST3GAL1;B4GALT6
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3907438729056838,1.0419123429156825,0.42301458670988656,0.7131276827427262,1.0,7/27,10.24%,ALOX15;CEPT1;PNPLA8;PLA2G2D;CHKB;ETNPPL;PLAAT1
prerank,RNA stabilization (GO:0043489),-0.32760345652969786,-1.0418526645192874,0.3894736842105263,0.8459538705483873,1.0,6/33,13.89%,TENT5C;FUS;HNRNPU;TRDMT1;CIRBP;TAF15
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.36939378379615223,1.0413730014222007,0.408130081300813,0.7138910757330587,1.0,12/38,16.03%,KLF2;CD36;TLR4;INSR;TNF;KLF4;ASS1;ROCK2;ZC3H12A;ATP2B4;PKD2;HSP90AB1
prerank,prostaglandin metabolic process (GO:0006693),-0.34281882948554276,-1.0412344321964049,0.3940149625935162,0.8464445368295249,1.0,6/26,11.78%,HPGDS;DAGLB;PTGS1;PTGES3;PTGR2;MIF
prerank,carbohydrate biosynthetic process (GO:0016051),-0.36250528388796205,-1.0406738437158205,0.3872549019607843,0.8467407051952344,1.0,7/21,18.54%,ST3GAL6;B3GALT1;B3GALT5;B3GALT2;ST3GAL3;FUT9;ST3GAL2
prerank,cilium assembly (GO:0060271),-0.22756114875179734,-1.0404898786527401,0.3153153153153153,0.8458540534997236,1.0,101/296,28.37%,CSNK1E;ASAP1;CFAP74;SDCCAG8;BBS9;CEP135;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;ODF2;DYNC1H1;LRGUK;IFT81;CCDC66;ATP6V1D;CEP97;IFT140;RAB3IP;DYNLRB1;DZIP1;CEP162;IFT88;CEP192;TTC8;AHI1;HAUS8;CEP250;BBS7;IFT20;CCDC57;CEP63;MKS1;DYNLT2B;WDR19;CCDC39;SPAG16;CCP110;DYNC2H1;VANGL2;SSX2IP;KIF3A;TOGARAM1;HAUS7;CKAP5;HAUS3;TCTN1;MAPRE1;IFT52;KIF3B;WDR90;CDC14A;RPGRIP1;NUDCD3;CFAP298;CFAP410;CPLANE2;NOTCH1;IFT43;DYNC2I1;EHD3;B9D2;RAB8A;TMEM138;DNAH5;PLA2G3;BBS4;DCTN2;ARL3;HDAC6;TMEM231;MKKS;CEP89;IQCB1;CCDC40;GALNT11;TMEM17;CNTRL;HAUS2;FLNA;PTPDC1;PLK4;DCTN1;HAUS6;CDK1;YWHAG;KIFAP3;CEP126;EXOC3;UNC119B;CFAP70;CFAP46;TTC39C;IFT172;TTBK2;TUBA4A;CFAP43;TCTN2;CEP152;BBOF1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.3109780630044596,-1.039935504629681,0.3894080996884735,0.8462315368568738,1.0,6/38,8.70%,KCNMA1;KCNJ2;NOS1AP;ANK2;AKAP6;ACTN2
prerank,metal ion homeostasis (GO:0055065),-0.3079152405487683,-1.0396318208703645,0.39154929577464787,0.8457118020726627,1.0,8/40,12.71%,SLC12A2;SLC8A1;SLC12A9;KCNA1;TMTC2;SLC7A8;SLC12A6;COX11
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3421129535248563,1.038844614217631,0.3961988304093567,0.7191195804554276,1.0,10/55,8.51%,NUPR1;RPS3;RIPK1;BCL10;GSDME;PAK2;RACK1;BCL2;TNF;TNFSF12
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.33278615250958427,-1.0386235652719538,0.38961038961038963,0.8473319677598179,1.0,9/26,22.81%,IL1A;SULF1;BRCA1;SARS1;HPSE;ATF4;CCBE1;TGFB1;HIF1A
prerank,regulation of collagen biosynthetic process (GO:0032965),0.4149828642592922,1.0385294855886875,0.42586206896551726,0.7193292103118337,1.0,7/19,21.54%,RGCC;VIM;EMILIN1;CREB3L1;IL6;F2R;CIITA
prerank,regulation of axon extension (GO:0030516),-0.32004581842587343,-1.038450851800784,0.3681462140992167,0.8464664158777416,1.0,9/37,9.66%,MAP2;PTPRS;DIP2B;ZFYVE27;MACF1;TWF2;OLFM1;MAPT;MAG
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.44204047581089856,1.0382802317049507,0.4209621993127148,0.7193530659362378,1.0,2/14,3.87%,BST1;ITGB1BP1
prerank,cardiac muscle contraction (GO:0060048),-0.32148881121753214,-1.0381337933193677,0.40431266846361186,0.8460634385359748,1.0,5/34,7.28%,ATP1B1;SCN1B;SLC8A1;GRK2;GAA
prerank,protein-containing complex assembly (GO:0065003),0.2791736665715312,1.0381203909983905,0.3830275229357798,0.7192037994370996,1.0,35/259,9.73%,HGSNAT;P2RX7;TCF7L2;CTSC;SNX9;TLE4;KMT2A;REPS2;ANO6;MITF;RIPK1;CD74;SKAP2;AXIN1;ITGB1BP1;MCU;WIPF1;GSK3B;ST13;TMED10;TCF7;CD40;DARS1;TNF;HFE;CDC73;TUBGCP2;RANBP9;ASH2L;MDM2;TRAPPC4;TFG;TRAPPC10;RAB1A;CUL3
prerank,protein K48-linked ubiquitination (GO:0070936),0.34563852855428095,1.0378496581775267,0.3896499238964992,0.7193333260115566,1.0,20/54,19.90%,UBE2E3;PELI1;PRKN;UBE2Q2;TRIM32;UBE2D3;UBE2K;CUL3;AMFR;RNF115;UBE2R2;RNF187;BFAR;NEDD4L;RNF146;FBXO38;UBE2A;SKP2;RNF6;KBTBD7
prerank,negative regulation of lipid storage (GO:0010888),-0.3828912842043223,-1.0377568776027062,0.3792325056433409,0.8457790978584698,1.0,3/19,4.03%,ABCG1;TREM2;ITGB3
prerank,protein polyubiquitination (GO:0000209),0.2799697172109591,1.037691921651059,0.3888268156424581,0.7191636373645839,1.0,57/297,14.84%,WWP1;SASH1;FBXW7;SMURF2;PSMA7;ARIH1;RPS27A;FBXL17;UBE2E3;SIAH2;PELI1;RMND5A;PRKN;TRIM56;LNPEP;RC3H1;SPOP;UBE2Q2;CBFB;TRIM32;FBXL5;ANKIB1;BCL2;CDC27;PSMB2;TRIM68;SHPRH;TRIM27;RNF19B;MDM2;TPP2;UBE2D3;UBE2K;CUL3;MKRN1;FBXO11;RNF14;ZNRF2;AMFR;PSMA6;UBE3B;TRIM71;FBXO10;MKRN3;RNF115;UBE2R2;RBBP6;UBE2N;RNF187;RNF19A;BFAR;ANKRD39;NEDD4L;PSMD5;PSMD1;PSMA3;ANAPC1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.36450675917655123,-1.0375094796509796,0.39473684210526316,0.8451546278195728,1.0,7/20,18.54%,ST3GAL6;B3GALT1;B3GALT5;B3GALT2;ST3GAL3;FUT9;ST3GAL2
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4178273598792901,-1.0367342356170646,0.40611353711790393,0.8461353823384783,1.0,7/13,26.93%,TMEM259;BAG6;BCAP31;RNFT1;UBQLN1;SGTA;UBQLN2
prerank,regulation of protein kinase C signaling (GO:0090036),0.4448047595735123,1.0362576892819555,0.4392361111111111,0.7219464445049452,1.0,3/14,8.68%,MYADM;CD40;ADRA1A
prerank,regulation of protein import into nucleus (GO:0042306),0.37191052092089255,1.0358562843399608,0.4168012924071082,0.7223410338734291,1.0,9/36,12.36%,CHP2;MDFIC;DMAP1;BAG3;PSEN1;RAB23;JUP;UFM1;ZC3H12A
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3651376243736321,1.0358199748502535,0.4126506024096386,0.7219039903681772,1.0,6/37,9.01%,NUPR1;RPS3;GSDME;RACK1;BCL2;RPS7
prerank,regulation of spindle assembly (GO:0090169),-0.34719326170814224,-1.0357753347604677,0.3787128712871287,0.8476541862419009,1.0,5/25,6.22%,EML3;DYNC1H1;CEP97;HNRNPU;CHMP4B
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4472782739279269,1.0356252575857985,0.4137291280148423,0.7218244690816872,1.0,4/12,11.23%,KLF9;CTSB;THRB;GAS2L1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3265472816927505,1.0355330120080806,0.38950276243093923,0.7215225375682096,1.0,17/73,17.97%,EGFR;APP;GAS6;CD44;AXIN1;TNF;FNIP1;RIPK2;DOCK7;ATP2B4;TERF2IP;CNOT9;PRKD2;HSP90AB1;SPRY2;IL6;RAF1
prerank,cAMP biosynthetic process (GO:0006171),-0.44439046010039923,-1.035460726055614,0.4319526627218935,0.8472103304537885,1.0,4/10,16.32%,ADCY3;ADCY8;ADCY7;ADCY1
prerank,response to organic cyclic compound (GO:0014070),-0.29617964381680906,-1.0353835819707655,0.3948220064724919,0.846052471697416,1.0,10/52,11.02%,CTNNB1;SPP1;PAQR8;SOCS2;GGT5;IL18;KYNU;CCL3;GGT7;SLC1A1
prerank,mononuclear cell differentiation (GO:1903131),-0.3534301142733943,-1.03516608418619,0.4083129584352078,0.8453179871624805,1.0,7/24,10.25%,IRF8;PDE1B;TREM2;IKZF1;AXL;FLT3;CSF1R
prerank,histone H2A monoubiquitination (GO:0035518),-0.3917098917444347,-1.0350373669920496,0.40792540792540793,0.8443525533028134,1.0,10/17,26.81%,SKP1;DDB2;RNF168;PCGF5;PCGF6;PCGF2;RING1;BMI1;PCGF1;KDM2B
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.36613715862298873,1.0342656012158926,0.3896940418679549,0.723857433554625,1.0,8/34,10.44%,MEF2C;GSK3B;MPP2;CHRNA4;MAPK8IP2;INSYN2A;GRIN2D;GABRA3
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.41069728329409183,-1.0338903197729445,0.4298245614035088,0.8463798912538149,1.0,10/13,52.99%,CAMK4;ADAM8;TESPA1;BMP4;SHH;TOX;SOD1;VNN1;ZC3H8;CLPTM1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.42262507311924685,1.0337618565812423,0.4157509157509158,0.7244653859333848,1.0,3/17,9.86%,NRP1;NR4A1;EPHB4
prerank,regulation of response to cytokine stimulus (GO:0060759),0.413584842758943,1.03337594178246,0.4205128205128205,0.7248321754891491,1.0,5/19,10.78%,LIFR;CBFB;KLF4;SH2B3;ELF1
prerank,ceramide metabolic process (GO:0006672),-0.2982526265704526,-1.0332999001148357,0.39384615384615385,0.8469270215451785,1.0,21/49,22.37%,CERK;ST6GALNAC3;SMPD4;PLPP3;NSMAF;ASAH1;ASAH2;SAMD8;CERS4;DEGS1;ACER2;CERS5;CERS1;SGMS2;SMPD2;TLCD3B;SPTLC1;CERS2;ABCA2;PLPP2;AGK
prerank,mitochondrial genome maintenance (GO:0000002),0.46094903223222616,1.0329262921862694,0.4172661870503597,0.7253382677777883,1.0,5/11,19.59%,MEF2A;MGME1;LONP1;SLC25A4;SLC25A36
prerank,tight junction assembly (GO:0120192),-0.29038956485291645,-1.0325964001154149,0.3902439024390244,0.8476497735632743,1.0,4/49,2.61%,F11R;TBCD;PARD3;CLDN11
prerank,phospholipid dephosphorylation (GO:0046839),0.36241783165121444,1.0325926727955959,0.40445859872611467,0.7255733084140815,1.0,5/37,5.41%,SGPP1;MTM1;SYNJ1;MTMR3;OCRL
prerank,negative regulation of neuron projection development (GO:0010977),-0.29101134291569813,-1.032305845704696,0.3950617283950617,0.8471519459133359,1.0,11/56,10.82%,RTN4RL1;MYLIP;PTPRS;NLGN1;PRAG1;BCL11A;GDI1;LINGO1;MAG;EFNB2;SPOCK1
prerank,peroxisomal membrane transport (GO:0015919),0.3894975325081649,1.0322368613466453,0.4022801302931596,0.725846716698383,1.0,5/27,6.67%,RAB8B;SLC25A17;PXMP2;PEX7;PEX26
prerank,regulation of neurotransmitter secretion (GO:0046928),0.36659627124609273,1.032200370710589,0.4053156146179402,0.7254183169015903,1.0,4/32,7.85%,MCTP1;MEF2C;GSK3B;MCTP2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.42419975912864283,1.0320615169740817,0.41496598639455784,0.725195117134098,1.0,2/16,8.32%,LILRB1;STX7
prerank,protein transport (GO:0015031),0.2756863576120138,1.0318344870815401,0.4066298342541437,0.7251857693180622,1.0,48/332,10.48%,APOE;SNX9;TXNIP;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;STEAP3;CALCRL;RCN3;USP6NL;SPTBN1;RILP;CD36;CD74;ATP6V1B1;SNX6;RAB8B;RAB10;SNX27;EHD1;AP3B1;AFM;RIC1;TBC1D14;ATP6V0A1;TMED10;TBC1D2B;PRKCB;RABGAP1L;HFE;SGSM1;CANX;ARRDC3;RAB7A;STX7;ATP6V1A;GOLPH3L;RAB14;RAB1A;CMTM6;RAB23;ARL4A;LAMP2;VLDLR;WLS
prerank,gliogenesis (GO:0042063),-0.40343317580815674,-1.0314581824685733,0.42437923250564336,0.8482932106999378,1.0,2/15,2.57%,CD9;CDH2
prerank,muscle tissue morphogenesis (GO:0060415),0.4224568903847312,1.0310885228585553,0.42095238095238097,0.7263947022914508,1.0,2/16,4.52%,BMP2;HEY2
prerank,regulation of autophagy (GO:0010506),0.2845807344922857,1.0305320121632289,0.39767441860465114,0.7271467252418301,1.0,55/216,18.22%,FBXW7;PRKAG2;NUPR1;DAPK1;PTPN22;EEF1A1;ATP6V1B1;PRKAG3;LAMP3;ERN1;SNX6;TRIM65;PRKN;MTMR3;MCL1;GSK3B;ROCK1;TBC1D14;ATP6V0A1;BCL2;HSPB1;EXOC4;DRAM1;DRAM2;ATF6;PIK3C2A;TRIM68;ATP6V1A;TRIM27;SMCR8;TPCN1;SREBF2;FOXK2;FOXO3;SNX5;LAMTOR5;FOXK1;ZC3H12A;FOXO1;RUBCN;EP300;MID2;STAT3;VPS26A;RB1CC1;NPRL2;EXOC8;ATP6V0D1;TAB3;BNIP3;PIP4K2A;HGF;RHEB;WDR41;RRAGC
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4544691198924577,1.0304796889478696,0.4090909090909091,0.7267612336144929,1.0,3/12,5.72%,RAB10;CELSR1;ACTB
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.4540265115668532,-1.0303445620799005,0.44835164835164837,0.85023310697691,1.0,5/10,32.80%,IMPACT;ERRFI1;ENG;CHP1;MVP
prerank,monocyte differentiation (GO:0030224),-0.45256566545852245,-1.030176510727936,0.4336099585062241,0.8493064845480152,1.0,4/10,29.09%,PDE1B;CSF1R;MT1G;BMP4
prerank,RNA 3'-end processing (GO:0031123),-0.27564089161837674,-1.0301273891026332,0.4163934426229508,0.8480609618353157,1.0,22/69,21.90%,THOC1;SRRM1;SRSF5;PABPN1;DDX39B;SRSF3;RPRD1A;SRSF2;CSTF2;RNPS1;U2AF1;LIN28B;UPF3B;CASC3;NCBP1;CLP1;THOC3;SRSF11;SRSF9;POLDIP3;ALYREF;U2AF2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.43353384429535297,-1.0298616479674079,0.4543478260869565,0.8475250689457989,1.0,2/10,1.22%,SIRPA;PTPRS
prerank,regulation of cellular pH (GO:0030641),0.379741395517194,1.0296138357321463,0.41903171953255425,0.7282285190131793,1.0,7/29,14.03%,SLC9A9;SLC9A4;SLC4A4;SLC4A5;ATP1A4;SLC9A7;SLC9A6
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.38534160954236657,-1.0293062854223396,0.41501103752759383,0.8477723787494496,1.0,6/17,9.60%,EIF4G1;CALM2;SMAD7;PARD3;CADM4;SIRT2
prerank,histone mRNA catabolic process (GO:0071044),0.44839767899653493,1.029268451868226,0.4372822299651568,0.7285038014078808,1.0,5/15,16.41%,TUT7;TENT2;TUT4;DCP2;TUT1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.45088168722720684,-1.0290136707225916,0.4315068493150685,0.8472643039895381,1.0,3/10,12.25%,DLGAP2;DLGAP1;NPTX1
prerank,cytoplasmic translational initiation (GO:0002183),-0.3756774297140327,-1.0285916223314915,0.43424317617866004,0.8471373932899946,1.0,5/17,6.65%,EIF4G1;EIF4A1;EIF2B3;EIF4A2;EIF2D
prerank,negative regulation of cell cycle (GO:0045786),0.3236187444937612,1.028542043977376,0.39779005524861877,0.7296149129027982,1.0,16/73,16.14%,NUPR1;BMP2;LILRB1;HECA;DUSP1;CDK6;RB1;PTPRK;NR4A1;GMNN;PPP1R13B;LATS2;NPPC;HEXIM2;RUNX3;PTEN
prerank,lung development (GO:0030324),-0.31463774297184316,-1.0279651146965758,0.39344262295081966,0.8476878390853584,1.0,14/33,29.09%,FGF2;FGFR2;LOXL3;BAG6;CCDC39;PROX1;PDPN;ERRFI1;SOX11;CCDC40;FGF1;WNT7B;FGF7;BMP4
prerank,positive regulation of protein deacetylation (GO:0090312),-0.39915575528097835,-1.0275626348232214,0.4166666666666667,0.8474841434778717,1.0,5/14,23.94%,AKAP8L;SAP30BP;AKAP8;FNTA;CTBP1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.30810220730934496,-1.027553690192761,0.3903133903133903,0.8461508030735444,1.0,9/37,10.64%,SIRPA;PLD4;TREM2;CUEDC2;PDCD4;APOD;APPL1;ADCY7;ABCD2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4855641151739788,1.0274724808806994,0.42424242424242425,0.7315322119802192,1.0,2/10,4.85%,C5AR1;RB1
prerank,regulation of translation (GO:0006417),0.2873628802569118,1.0274552017718914,0.4072727272727273,0.7310629206673693,1.0,54/173,21.31%,APP;RPS3;DAPK1;EIF3E;NIBAN1;SAMD4A;RPL26;RPS6KA3;VIM;MRPL13;RACK1;RPS4X;HSPB1;MALSU1;MTPN;RPL5;LARP4B;RBM4;EIF1;ILF3;EIF4B;DDX6;FOXO3;NANOS3;RPL10;TRIM71;ETF1;LARP4;PIWIL2;SHMT1;CNOT9;EIF3H;EIF5;CSDE1;SYNCRIP;TRAP1;PYM1;IL6;METAP1;EIF2AK2;NSUN3;RNF139;EIF2AK4;GSPT1;BCL3;EIF2AK3;CNOT8;CNOT1;GIGYF2;ENC1;DAPK3;IGF2BP3;MTRF1;PUS7
prerank,negative regulation by host of viral transcription (GO:0043922),-0.40813063757487256,-1.0271869316268325,0.4337606837606838,0.8458103880320594,1.0,8/12,37.05%,TARDBP;CCL3;JUN;HDAC1;TFAP4;HMGA2;CCL4;PSMC3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2697930565615343,-1.027134027185002,0.3904109589041096,0.8445981904340227,1.0,17/76,14.13%,IRAK2;HAVCR2;CYLD;OTULIN;COMMD7;CCDC22;DAP;ARRB2;DDIT3;PRMT2;PARP10;NLRC5;MTURN;CD200;ADORA3;PYDC1;ITCH
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.34109169776586806,1.0265830490569274,0.41910631741140214,0.7325679378008482,1.0,10/47,13.71%,FBXW7;C1QTNF3;C1QTNF12;RAPGEF2;ERLIN1;FYN;ROCK2;ZC3H12A;ATP2B4;EP300
prerank,regulation of B cell differentiation (GO:0045577),0.42958587781486074,1.0264696461793723,0.41308089500860584,0.7323331749769073,1.0,5/17,10.05%,ZFP36L2;ZFP36L1;PPP2R3C;SYK;SFRP1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3658980487400806,-1.026463643477299,0.4222737819025522,0.8452609275156056,1.0,4/20,9.02%,PTDSS1;GSS;GATM;PTDSS2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.42135715325703554,1.0263533929209578,0.4379310344827586,0.7320581663767047,1.0,4/18,6.99%,ITGA4;ITGB1;ROCK1;TNF
prerank,regulation of peptide hormone secretion (GO:0090276),0.3248287701591668,1.0261415405509762,0.41374474053295934,0.7319937834958887,1.0,18/67,18.32%,ALOX5;CLOCK;RAP1A;EIPR1;TNF;KCNG2;HFE;HADH;SLC2A2;KCNB1;SLC8B1;TFR2;FFAR1;ITPR3;CCL5;IL6;RFX3;CACNA1A
prerank,regulation of erythrocyte differentiation (GO:0045646),0.36466234743905124,1.025979060587691,0.4180327868852459,0.7318702143637399,1.0,12/35,18.43%,LYN;ZFP36L1;CDK6;SPI1;ACVR2A;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;MAFB
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3894143873915594,1.0256569699460425,0.4209650582362729,0.7320692359110367,1.0,8/24,18.40%,FCER1G;B2M;MFSD6;HFE;CANX;SEC24D;ERAP1;TAPBP
prerank,spindle assembly (GO:0051225),-0.2752485016633136,-1.0255553340950998,0.3926174496644295,0.8465878320892315,1.0,30/67,23.01%,CLASP2;CEP192;HAUS8;TUBGCP5;CEP63;MAPRE3;NEK6;WRAP73;TOGARAM1;HAUS7;NUMA1;KIF11;TUBGCP3;HAUS3;MAPRE1;KIF3B;CHEK2;KIFC2;KIF2A;GOLGA2;HDAC3;BCCIP;AAAS;RCC1;KIFC1;TUBGCP6;MAP9;TOGARAM2;HAUS2;FLNA
prerank,dicarboxylic acid transport (GO:0006835),0.3798953341523349,1.0254674480167236,0.4192,0.7320094759792345,1.0,1/28,0.22%,FOLR2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3302465358508574,1.025380919039688,0.4208955223880597,0.7316914767083033,1.0,8/69,6.29%,APOE;LIG4;MEF2C;RASA1;GRN;SNX6;PRKN;BCL2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3984201078725981,1.0248422370089858,0.43157894736842106,0.7323892819004753,1.0,9/22,18.02%,LYN;TNF;RANBP9;SP1;ROCK2;RELA;PICALM;IFNGR1;EFNA1
prerank,glycerolipid metabolic process (GO:0046486),-0.4223350209571232,-1.024525794386232,0.43383947939262474,0.8483764569793625,1.0,5/11,30.49%,DGKB;DGKZ;DGKG;DGKA;DGKQ
prerank,negative regulation of developmental process (GO:0051093),0.3302595898494966,1.0244601438132201,0.40771349862258954,0.7327227231834812,1.0,17/69,16.98%,GAS6;BMP2;PRKN;CDK6;HEY2;SPI1;RC3H1;ROCK1;FOXM1;RPS6KA6;SFRP1;ROCK2;LOXL2;ANP32B;TBX2;BNIP3;ARPIN
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3199423034160882,1.023734761498738,0.42917847025495753,0.7337797330432735,1.0,7/75,4.85%,LRP6;APOE;PTPRJ;LYN;IRAK3;DUSP1;RB1
prerank,retinoid metabolic process (GO:0001523),0.324872902664231,1.02353989971273,0.4132581100141044,0.7337018164858634,1.0,14/71,18.33%,APOE;DHRS3;UGT1A7;UGT1A8;UGT1A1;SDC3;SDC4;CYP26B1;RBP4;GPC3;SCPEP1;RDH5;RBP1;ABCA4
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.3929949139459309,-1.0234443585088182,0.43908045977011495,0.8501888376351189,1.0,5/15,11.70%,TJP1;FGF2;PKM;ITGA5;PDPK1
prerank,regulation of DNA metabolic process (GO:0051052),-0.30333188199403643,-1.0233759541468996,0.4005602240896359,0.8490310641938073,1.0,8/44,8.71%,CDK9;XRCC5;THOC1;HDAC8;IL7R;SIRT7;TOM1L1;UPF1
prerank,wound healing (GO:0042060),-0.2798807972929106,-1.023307076602892,0.39751552795031053,0.8478909164098667,1.0,9/62,7.60%,DST;TGFBR1;PAK1;AHNAK2;ITGB3;FGF2;NF1;MACF1;DCBLD2
prerank,negative regulation of neuron death (GO:1901215),0.31435313522406266,1.0232695881158045,0.40620592383638926,0.7337859243219325,1.0,12/93,6.29%,APOE;LIG4;MEF2C;RASA1;TNFRSF1B;GRN;SNX6;PRKN;KIR3DL2;GSK3B;CD200R1;BCL2
prerank,axoneme assembly (GO:0035082),-0.3276726058934936,-1.0229403990420864,0.37628865979381443,0.8476887187981641,1.0,7/30,12.90%,CFAP74;LRGUK;TTC12;CCDC39;SPAG16;TOGARAM1;DNAI4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3747981649768645,-1.0229084841469038,0.44026548672566373,0.8464554183085655,1.0,9/17,39.62%,NOS1AP;AKAP6;VAMP2;KCNAB1;RNF207;KCNG1;ANK3;KCNS1;KCNE4
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.40282768596119906,1.0228847729581882,0.43257443082311736,0.7341525118170856,1.0,3/20,6.24%,FBXW7;BMP2;ERLIN1
prerank,modulation by host of viral genome replication (GO:0044827),0.43538209079184265,1.0227560102782223,0.4351851851851852,0.7339083370175998,1.0,4/13,12.63%,CCL8;PRKN;ZC3H12A;VAPA
prerank,piRNA metabolic process (GO:0034587),0.4108921251740394,1.0227291845001243,0.4392361111111111,0.7334455883736771,1.0,4/19,23.16%,MOV10L1;PIWIL2;TEX15;TDRKH
prerank,microtubule anchoring at centrosome (GO:0034454),0.4564036851657475,1.0224871213025106,0.43243243243243246,0.7334931803752586,1.0,3/10,14.13%,NIN;CEP19;PCM1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.3667988448095558,1.0224595920752997,0.4075907590759076,0.733056642803367,1.0,4/35,7.97%,NRP1;SEMA4A;PLXNA4;ARHGDIA
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3815901928290981,1.0215806400042489,0.4296998420221169,0.7345340741442221,1.0,6/31,8.60%,CRIM1;TNN;FGF23;CDK6;GDF10;LIMD1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3709678568795038,1.0212086416430932,0.44867549668874174,0.7348362470079222,1.0,8/36,8.54%,DEPTOR;SGMS1;RPS3;RB1;BCL2;TNF;NR4A2;MAPK8IP2
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4429942079483704,1.0208191134877938,0.4384057971014493,0.7351869753211077,1.0,3/13,9.06%,ESR1;NR3C1;ESR2
prerank,muscle cell development (GO:0055001),0.3709670599920667,1.020713882054153,0.4361525704809287,0.7349291784265177,1.0,8/30,13.23%,NRAP;MYH6;ALPK3;MYOF;HEY2;IGF1;RAMP2;NEB
prerank,organelle organization (GO:0006996),0.2694631456375394,1.0204991236715957,0.42391304347826086,0.7348925558143494,1.0,81/388,16.99%,TMCC1;FGD4;NEDD9;APOE;FGD6;DIAPH1;EPS15;RAB31;ATL1;LIG4;ATXN7;USP6NL;ARHGAP21;ARHGAP10;CDC42;ATP8B4;PRKN;TTC29;ATP7A;TMED10;PI4K2B;DPYSL2;PIKFYVE;PEX7;CNN2;CYP26C1;VPS4B;NIPSNAP2;GEM;RAB7A;CCL24;STX7;RANBP9;LIMD1;GOLPH3L;RAB30;RAB14;CLASP1;MAST1;CYCS;RAB1A;KIF4A;CENPT;POLG2;MTX1;PACSIN2;CHMP5;PHIP;VPS13C;FAM161B;CHGA;VAPA;PYROXD2;BCAS3;DIAPH3;LARP4;WASL;SIPA1L3;MDK;PDZD8;SPTBN5;TMED2;CEP78;PKD2;PLAAT3;PPIA;SYNE3;MYC;REEP6;PEX14;FGD3;HCFC1;VPS51;COG7;FAM161A;SEC16A;GOLPH3;MIA3;RAB32;PRDX3;CUL7
prerank,regulation of neuron death (GO:1901214),0.3133087993107561,1.0204808382014987,0.4122448979591837,0.7344294626192455,1.0,9/82,5.12%,FCGR2B;MAP3K5;C1QA;MEF2C;TNFRSF1B;PRKN;KIR3DL2;GSK3B;CD200R1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.44898517254044656,1.0204239441366456,0.42807625649913345,0.7340646855917454,1.0,6/13,18.39%,GNAI3;RAB23;GTPBP1;EFL1;AK3;AK4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.4502775900587275,-1.0203311626835354,0.432258064516129,0.852692610198971,1.0,5/10,23.28%,EMC9;EMC10;EMC1;EMC6;MMGT1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.43170525154695455,1.0202334096115104,0.44021739130434784,0.7339791906786224,1.0,2/15,6.97%,FGFR1;HSPB1
prerank,focal adhesion assembly (GO:0048041),0.40251902984563726,1.0202326645383117,0.41935483870967744,0.7334748249053383,1.0,5/21,10.30%,PEAK1;PTPRK;RCC2;PIP5K1A;THSD1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.27047323183834526,-1.0201737791426986,0.3696369636963696,0.8518203678065688,1.0,7/70,4.35%,LPCAT2;LPIN2;SLC44A2;LPCAT1;ENPP2;PCYT1B;PLA2G6
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3449214464884166,1.0201515073531218,0.4180451127819549,0.7331572428032815,1.0,2/47,1.51%,SERPINB8;SERPINB2
prerank,development of primary male sexual characteristics (GO:0046546),-0.30769718855684075,-1.0200506944728411,0.3900523560209424,0.8508067350454496,1.0,8/34,20.09%,LHFPL2;AR;NCOA4;MSH2;WNT4;COL9A3;TGFB2;WNT5A
prerank,SNARE complex assembly (GO:0035493),0.4741055221078101,1.0197830208183352,0.4419889502762431,0.7334880091621203,1.0,2/10,5.58%,UVRAG;STXBP6
prerank,regulation of cell cycle (GO:0051726),0.27348629426600923,1.0192070546708223,0.41751990898748575,0.7342740538174587,1.0,52/271,16.03%,LRP6;TCF7L2;NOTCH2;IQGAP1;KIF20B;NUPR1;RPL23;GRK5;FBXL17;BMP2;LILRB1;ERN1;ANKRD17;RGCC;DUSP1;CDK6;BIRC3;SND1;RB1;RACK1;PTPRK;NR4A1;TRIM32;NOP53;CHEK1;FOXM1;RPS15A;SDCBP;GMNN;MDM2;LIN54;MAP3K20;UHRF2;SFRP1;GAS2L1;RASSF1;MYBL2;NANOS3;CDKN2C;PPP1R13B;EP300;UHMK1;RARA;STAT3;JUND;CRLF3;PKD2;MYC;PRCC;RUNX3;HCFC1;HSP90AB1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.31168574892475276,1.0192014685755793,0.4130718954248366,0.7337856104746825,1.0,30/84,21.74%,APOE;RPS3;DAPK1;SAMD4A;MRPL13;RACK1;ROCK1;MALSU1;RBM4;ILF3;RTN4;IGF1;ORMDL1;DDX6;NANOS3;TRIM71;SHMT1;CNOT9;SYNCRIP;EIF2AK2;RNF139;EIF2AK3;CNOT8;CNOT1;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7;RTN3
prerank,neuron projection regeneration (GO:0031102),-0.43750304805521156,-1.01897023283057,0.43141153081510936,0.8527863325962827,1.0,1/10,0.26%,RTN4RL1
prerank,negative regulation of innate immune response (GO:0045824),0.3694111750366596,1.0188426524165868,0.4050632911392405,0.7340710785670024,1.0,4/34,7.07%,VSIG4;IRAK3;GRN;USP15
prerank,cell differentiation in spinal cord (GO:0021515),-0.44436004234348736,-1.0187554841240198,0.45770065075921906,0.8520810474487753,1.0,2/10,12.10%,MDGA2;SOX13
prerank,Golgi inheritance (GO:0048313),0.4635508977712494,1.018714816088231,0.45083487940630795,0.7338697155918227,1.0,2/11,8.59%,VCPIP1;VRK1
prerank,vesicle coating (GO:0006901),-0.2768386092360229,-1.0181904429573878,0.38823529411764707,0.8497487230608012,1.0,21/61,20.86%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;TRAPPC2;SEC13;SEC24B;BET1;TRAPPC2L;GOSR2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2768386092360229,-1.0181904429573878,0.38823529411764707,0.8497487230608012,1.0,21/61,20.86%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;TRAPPC2;SEC13;SEC24B;BET1;TRAPPC2L;GOSR2
prerank,COPII vesicle coating (GO:0048208),-0.2768386092360229,-1.0181904429573878,0.38823529411764707,0.8497487230608012,1.0,21/61,20.86%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;TRAPPC2;SEC13;SEC24B;BET1;TRAPPC2L;GOSR2
prerank,peptidyl-threonine modification (GO:0018210),-0.27915600567393917,-1.018150698127869,0.3987138263665595,0.8485376967896555,1.0,24/66,22.37%,TGFBR1;PRKCD;GALNT3;ACVR1;CDC42BPA;CIT;GALNT13;MAP3K12;WNK3;DYRK2;PDPK1;CDC42BPB;DYRK1B;TGFBR2;GALNTL6;CDK10;ULK1;ACVR1B;HIPK1;CAMK2D;MAPK8;TAF1;DYRK4;GALNT11
prerank,steroid catabolic process (GO:0006706),-0.44098673274643235,-1.0179473322350427,0.44171779141104295,0.8478184212894366,1.0,2/10,3.21%,YWHAH;SPP1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4545570951797242,1.0176007276568004,0.4420849420849421,0.7358608840854508,1.0,3/11,15.98%,ITM2B;NECAB2;ITM2C
prerank,Wnt signaling pathway (GO:0016055),0.3141550560515693,1.0175449739797167,0.4254742547425474,0.7354741091761917,1.0,14/92,10.48%,LRP6;TCF7L2;RARG;RPS27A;WNT2;AXIN1;GSK3B;SNX3;FRAT1;TCF7;WNT6;NR4A2;SFRP1;WLS
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.3622042131265737,-1.0175131317344557,0.4145785876993166,0.8478336016599324,1.0,4/19,4.07%,EXTL3;XYLT1;HS3ST5;HS6ST1
prerank,positive regulation of cell growth (GO:0030307),-0.2591595035816476,-1.0174929962890684,0.3843283582089552,0.846576489180566,1.0,25/96,17.28%,TGFBR1;RPTOR;SEMA4D;RIMS1;EIF4G1;RIMS2;HDGFL2;ZFYVE27;MACF1;AKAP6;RPS6KA1;TWF2;BDNF;MAPT;EXOSC9;HYAL1;DDX49;FXN;LGI1;LIMK1;NCBP1;PABIR1;ADAM10;CDKL5;SYT1
prerank,positive regulation of exosomal secretion (GO:1903543),0.4182246194988958,1.0173341627969548,0.40619307832422585,0.7354139385536902,1.0,7/15,21.80%,SDCBP;VPS4B;RAB7A;SDC4;STAM;PDCD6IP;TSG101
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.32724181714502576,-1.0172854787716759,0.40694789081885857,0.845860841358222,1.0,5/29,13.80%,LPCAT2;LPCAT1;PLA2G6;LPCAT3;MBOAT7
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.40669711454420104,-1.017246991962855,0.46187363834422657,0.8446569616456564,1.0,8/12,39.91%,UPP2;UMPS;UCKL1;CAD;DHODH;TK2;CDA;TK1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.3198126105178848,-1.0167482036816986,0.42424242424242425,0.844797972842057,1.0,12/33,21.73%,CTC1;STN1;ANKRD28;PTGES3;TNKS1BP1;TERF2;GAR1;DCLRE1B;RFC1;WRAP53;RAD51;ACD
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3993939115853552,1.0166037442810762,0.43094841930116473,0.7365163467312311,1.0,4/21,8.78%,RASSF2;RACK1;PDE4D;CNKSR3
prerank,negative regulation of cell differentiation (GO:0045596),0.287120206867653,1.0160442434112613,0.43047158403869407,0.7372659495298645,1.0,25/181,10.79%,EGFR;SPRED1;ZBTB16;ZFP36L2;JAG1;CRIM1;TNN;OSR1;XDH;FGF23;IL17RD;CDK6;TRIO;RB1;GDF10;TNF;CDC73;VASN;LIMD1;ESRRB;USF3;ASXL1;PPP2CA;SFRP1;SPRED2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3802519555964135,1.0158208557533113,0.4336569579288026,0.7372208012324427,1.0,5/26,12.39%,CHP2;GSK3B;TNF;IGF1;ATP2B4
prerank,regulation of Golgi organization (GO:1903358),0.42554528747698184,1.0157759291532262,0.4507042253521127,0.7368197704631868,1.0,2/17,2.50%,MYO5A;USP6NL
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3519571256620666,1.0155541035784141,0.4250386398763524,0.7368123150282699,1.0,7/39,9.67%,CASK;JAG1;RASA1;RHOA;ITGB1BP1;RCC2;CORO1C
prerank,leukocyte tethering or rolling (GO:0050901),0.42152024496765206,1.0155425491614567,0.45614035087719296,0.7363338506149607,1.0,4/17,6.99%,ITGA4;ITGB1;ROCK1;TNF
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3484242111666963,-1.0150484632689223,0.4302059496567506,0.8485267578541937,1.0,10/21,31.27%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF;FBXO5
prerank,ERAD pathway (GO:0036503),-0.262384930513514,-1.0146506405420397,0.4139194139194139,0.8483739170623318,1.0,39/83,28.34%,TMEM67;MAN1B1;UBE4A;AUP1;RNF103;USP19;BAG6;DNAJB2;EDEM1;UFD1;FBXO44;UBE2J1;UBXN4;NPLOC4;ECPAS;TRIM13;DNAJB14;RNF5;ERLEC1;BRSK2;GET4;STUB1;SYVN1;RNF103-CHMP3;FAM8A1;SELENOS;TMEM129;TOR1A;FOXRED2;FAF2;YOD1;UBQLN1;SEC61B;SGTA;UBQLN2;UBE2G2;FBXO2;DNAJC18;STT3B
prerank,regulation of synapse assembly (GO:0051963),0.34322809223918643,1.0142852506725326,0.4330827067669173,0.7386224860305999,1.0,5/46,4.91%,PDLIM5;APP;MEF2C;TLR2;GHRL
prerank,ncRNA metabolic process (GO:0034660),0.3597162457680311,1.0141913980032127,0.42487883683360256,0.7383201971272925,1.0,7/37,13.54%,PRKRA;MOV10L1;TUT7;DROSHA;TUT4;TRIM71;PIWIL2
prerank,regulation of viral genome replication (GO:0045069),0.3265726486924049,1.0141532396576796,0.4125766871165644,0.7378942363506785,1.0,10/56,11.89%,IFITM3;OAS2;FAM111A;PKN2;RNASEL;TNF;BST2;IFITM2;ILF3;BANF1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.37696684714903567,-1.0139591284672271,0.4469525959367946,0.8491016318703901,1.0,4/17,10.56%,FGF2;BTG1;AHI1;TMEM100
prerank,regulation of cell motility (GO:2000145),0.2980159678068197,1.0136711970927126,0.4270967741935484,0.7384776236121621,1.0,16/121,8.88%,EGFR;SGK3;DIAPH1;FGF23;ARHGAP18;PLXNC1;CCL19;CRK;RHOA;CDK6;PKN2;ROCK1;TRIM32;PLXNA4;AMOT;RCC2
prerank,stress fiber assembly (GO:0043149),0.42338710202573293,1.0134279929299435,0.4412811387900356,0.7380205684960423,1.0,6/15,10.24%,ITGB1;RHOA;PDLIM1;FHDC1;CUL3;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.42338710202573293,1.0134279929299435,0.4412811387900356,0.7380205684960423,1.0,6/15,10.24%,ITGB1;RHOA;PDLIM1;FHDC1;CUL3;ARRB1
prerank,regulation of organelle assembly (GO:1902115),-0.2683243650519003,-1.013342402600286,0.42071197411003236,0.8496148713128845,1.0,16/72,9.35%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;STX18;IFT140;IFT88;TBC1D10A;ATXN2L;RDX;TBC1D22A;IFT20;DYNLT2B;TBC1D22B;TBC1D9B
prerank,regulation of exosomal secretion (GO:1903541),0.3938907388490108,1.0131193556927935,0.42984014209591476,0.7382052372656089,1.0,5/19,9.13%,PRKN;SDCBP;VPS4B;RAB7A;SDC4
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.37792957046654735,-1.0130884465395709,0.4399092970521542,0.8490642144575996,1.0,6/16,15.45%,LARGE1;ST3GAL5;ST6GALNAC3;ST6GALNAC4;ST8SIA1;ST8SIA3
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.40127849404500604,1.0130797169857557,0.4461805555555556,0.7377909833677256,1.0,5/21,15.62%,PLA2G2D;PLAAT3;OSBPL8;OSBPL10;OSBPL5
prerank,actin filament-based transport (GO:0099515),0.40556433232351385,1.0129881902251914,0.43856655290102387,0.737483423452058,1.0,6/21,14.04%,MYO5A;SYNE2;MYO7A;MYO1C;MYO1E;WASL
prerank,regulation of intracellular pH (GO:0051453),0.36202786061150855,1.012900993119338,0.420032310177706,0.7371748274023713,1.0,7/34,14.03%,SLC9A9;SLC9A4;SLC4A4;SLC4A5;TMEM165;SLC9A7;SLC9A6
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2819476872209058,-1.0125650381297442,0.4424778761061947,0.8493131273771954,1.0,17/56,17.86%,GRID2;MAP4K4;PTPRD;NLGN1;CNTNAP2;NRXN1;FERMT2;FLOT1;EPHB1;BDNF;SYNDIG1;TSC1;IL1RAPL1;EPHB2;THY1;IL1RAP;COL16A1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3788057508376306,1.0123841098751285,0.4405594405594406,0.7378263539325247,1.0,7/26,12.82%,EGFR;ANKRD17;RGCC;CCND3;CCND2;TFDP1;KMT2E
prerank,regulation of programmed necrotic cell death (GO:0062098),0.40904571380732796,1.0120239610659707,0.437609841827768,0.7381215244439318,1.0,6/20,11.10%,NUPR1;RIPK1;PELI1;BIRC3;SDCBP;CASP8
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3094279875795352,1.0119970138036363,0.43351063829787234,0.7376913283814708,1.0,16/91,10.94%,APP;CP;HMOX1;FTL;NDFIP1;SMAD4;ATP7A;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;SLC39A12;FTH1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.30418050955649667,-1.0117237936168633,0.425414364640884,0.8503848738146581,1.0,9/39,11.00%,PIK3CB;GNAS;PLPP3;ITGB3;UBASH3B;TJP2;P2RY12;FERMT3;TLN1
prerank,cholesterol metabolic process (GO:0008203),0.31758431480442234,1.0116839821325723,0.4143884892086331,0.7378731727444581,1.0,17/68,20.95%,APOE;HMGCR;SCARF1;CLN6;CYP27A1;PMVK;OSBPL1A;HSD17B7;LBR;CLN8;OSBPL5;CEL;FDPS;DHCR7;PIP4P1;NSDHL;ACLY
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4212800643102045,-1.0115241412141918,0.4503311258278146,0.8497092502758946,1.0,5/11,13.77%,GTF2H2;GRK2;GRK3;ARRB2;SAG
prerank,proteoglycan biosynthetic process (GO:0030166),-0.324398630376307,-1.0114392968777894,0.4418604651162791,0.8486667225727335,1.0,13/31,22.78%,CHST11;EXTL3;XYLT1;BMPR1B;CANT1;GAL3ST4;HS3ST3B1;B4GALT7;PXYLP1;CHST10;UGDH;B3GALT6;B3GAT1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3203575784619293,-1.01140476083127,0.4241645244215938,0.8474706184648401,1.0,10/30,21.73%,CTC1;SRC;TP53;HNRNPU;STN1;TERF2;CERS1;HNRNPA1;GNL3L;ACD
prerank,cholesterol efflux (GO:0033344),0.413982579116076,1.0112717578210992,0.47038327526132406,0.7382893437796357,1.0,1/20,0.49%,APOE
prerank,phagosome maturation (GO:0090382),-0.3138869807954335,-1.0112091902394202,0.4224137931034483,0.8467543167819408,1.0,12/35,15.41%,TCIRG1;ATP6V1C1;ATP6V1D;ATP6V0A2;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C;CORO1A;RAB20
prerank,protein homooligomerization (GO:0051260),0.2992504715111072,1.0103535787747935,0.4183417085427136,0.7398980044821272,1.0,22/114,15.96%,NLRC4;EHD4;ATL1;ALOX5AP;EHD1;B2M;BCL10;MPP2;CLYBL;NINJ1;BEND3;USP16;GNMT;TRPM2;DISP1;TRMT61B;SHMT1;PKD2;PKD2L1;PRMT1;SAMHD1;MLKL
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.39489664301932814,1.0103470239356838,0.4446280991735537,0.7389203455301208,1.0,7/23,12.54%,YWHAQ;SFN;BCL2;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.39489664301932814,1.0103470239356838,0.4446280991735537,0.7389203455301208,1.0,7/23,12.54%,YWHAQ;SFN;BCL2;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,regulation of protein localization (GO:0032880),-0.2728941065660617,-1.0102355376234071,0.4524590163934426,0.8483159957949924,1.0,9/58,10.36%,CSNK1E;PLEKHM2;CTSD;MAP2;ITGB3;DVL1;PARP1;ADCYAP1;AFDN
prerank,organelle assembly (GO:0070925),-0.21546957840811312,-1.01018754372838,0.3924050632911392,0.8471725074773223,1.0,115/384,23.01%,ASAP1;CAPN3;BBS9;BIN2;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;SNF8;DYNC1H1;IRGM;IFT81;CCDC66;TMOD2;ATP6V1D;CENPC;HPS4;IFT140;RAB3IP;ATG2A;DZIP1;CEP162;IFT88;AUP1;ATXN2L;TTC8;CHMP4B;CHMP4A;MAPT;AHI1;ATG16L1;HAUS8;CEP250;BBS7;TUBGCP5;OGFOD1;IFT20;CCDC57;CEP63;MKS1;CENPE;DYNLT2B;WDR19;MAPRE3;VPS37A;SPAG16;CD34;DYNC2H1;RAB38;NEK6;WDR45;NSFL1C;SSX2IP;KIF3A;CIRBP;HAUS7;TUBGCP3;HAUS3;CORO1A;TCTN1;FARP2;MAPRE1;MAP1LC3A;IFT52;KIF3B;CDS1;GABARAPL1;WDR90;ATG9A;SQLE;CDC14A;DLGAP5;ULK1;CDS2;NUDCD3;CFAP298;CFAP410;ATXN2;TRAPPC6A;CPLANE2;NOTCH1;GOLGA2;IFT43;HDAC3;DYNC2I1;EMC6;EHD3;ATG14;RCC1;B9D2;RAB8A;TMEM138;DNAH5;PLA2G3;CHMP6;TUBGCP6;CHMP3;BBS4;RBM14;ARL3;HDAC6;TMEM231;MKKS;WDR45B;CEP89;IQCB1;GALNT11;G3BP1;TMEM17;PRRC2C;BSCL2;EDC3;HAUS2;FLNA
prerank,photoreceptor cell development (GO:0042461),0.432301362071636,1.0098529188508936,0.4473684210526316,0.7395440814955171,1.0,3/14,13.91%,RP1;MYO7A;MFSD2A
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.43347988901849,-1.0098400346153935,0.4866666666666667,0.8469126181738932,1.0,3/10,7.72%,GRB10;ITGB3;ITGA5
prerank,positive regulation of cartilage development (GO:0061036),0.42195533804198926,1.0095623061884424,0.4511545293072824,0.7396864240994049,1.0,4/17,14.35%,ZBTB16;BMP2;LOXL2;MDK
prerank,potassium ion transport (GO:0006813),-0.2452852406296062,-1.0094902644082717,0.4339622641509434,0.8467080219606349,1.0,16/120,9.78%,KCNMA1;SLC1A3;KCND2;KCNH7;KCNJ2;SLC24A3;SLC24A2;SLC9A8;KCNQ3;NALCN;SLC24A4;KCNQ5;KCNK2;KCNA2;KCNA1;KCNK12
prerank,regulation of protein processing (GO:0070613),0.39670135147870145,1.0092713274840077,0.4473684210526316,0.7398083853742973,1.0,2/21,4.90%,NLRC4;RHBDD1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.392165211770107,1.0088734628742395,0.4306049822064057,0.7402097687488406,1.0,9/23,23.89%,PDE6A;GUCY2D;PPEF1;CALM1;GRK4;METAP1;NMT1;NMT2;METAP2
prerank,histone mRNA metabolic process (GO:0008334),0.38015611596380405,1.0084993911776992,0.44390243902439025,0.7405645266812485,1.0,8/27,16.48%,TUT7;TENT2;CPSF3;TUT4;SNRPG;DCP2;TUT1;CPSF2
prerank,blood vessel endothelial cell migration (GO:0043534),0.39108936596006083,1.008304463446011,0.43859649122807015,0.7404971138529871,1.0,3/22,9.86%,NRP1;NR4A1;EPHB4
prerank,catecholamine metabolic process (GO:0006584),0.43763370336533847,1.0071966862892818,0.44502617801047123,0.7424714091216689,1.0,3/14,5.45%,DRD1;PRKN;ATP7A
prerank,inositol phosphate metabolic process (GO:0043647),-0.29451446873750375,-1.007154787617303,0.4633431085043988,0.8520226725119526,1.0,10/46,11.20%,INPP4B;INPP5D;PLCB2;PLD4;PLCB4;FGF2;PLCG1;MINPP1;PLCB1;PLCH1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.35721377996795184,-1.0070925516329567,0.4557522123893805,0.8509706226310743,1.0,8/19,21.73%,CTC1;SRC;HNRNPU;STN1;TERF2;HNRNPA1;GNL3L;ACD
prerank,defense response to fungus (GO:0050832),0.4072708502897906,1.0070588040587087,0.4504347826086956,0.7422892617795891,1.0,4/17,12.06%,CLEC6A;BCL10;CLEC4D;FAM3A
prerank,regulation of gastrulation (GO:0010470),0.43076751406916314,1.0066899149274418,0.45486725663716815,0.7426172586693318,1.0,4/14,9.74%,OSR1;RACK1;CLASP1;POGLUT1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.3368681048392402,-1.0066669723775687,0.4227053140096618,0.8509819077619455,1.0,11/25,20.04%,RIN3;DLG4;ITGB3;APOC1;ANKRD13B;ANKRD13D;ARF6;ATXN2;ITGAV;ANKRD13A;ABCA2
prerank,positive regulation of intracellular transport (GO:0032388),-0.30313792723015637,-1.0065824938001127,0.44886363636363635,0.8499385235205017,1.0,11/38,13.48%,SORL1;PRR5L;DYNC1H1;STX18;STK11;ACTN2;PLK3;ZFAND1;NUMA1;TBC1D20;VAMP2
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.29960595983155747,-1.0065786412642417,0.45294117647058824,0.848681835194068,1.0,14/42,17.80%,JAK2;NPNT;PIK3CB;GCNT2;TBCD;NF1;SPOCK1;MINK1;TSC1;NDNF;THY1;PDPN;VIT;NOTCH1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4306940699670311,-1.0064823410255896,0.47568710359408034,0.8476871538178959,1.0,4/10,18.60%,COMT;CHDH;SMOX;SARDH
prerank,regulation of axonogenesis (GO:0050770),-0.280024049111687,-1.006390115509928,0.41420118343195267,0.8466783287218563,1.0,20/51,22.09%,ROBO2;PAK1;CDH2;LRRC4C;PLXNA2;ROBO1;GDI1;MAP6;TIAM1;LINGO1;MAG;TIAM2;OMG;THY1;BRSK2;PAK3;PLXNB2;PLXNB3;BRSK1;PLXNB1
prerank,snRNA transcription (GO:0009301),-0.26634857789733857,-1.0062315861295172,0.4642857142857143,0.8458787593608166,1.0,26/70,29.89%,CDK9;RPAP2;INTS3;RPRD1A;CCNT2;POU2F2;ICE2;SRRT;NCBP1;POLR2C;INTS13;ELL2;ELL;TAF8;POLR2L;TAF9;TBP;INTS9;CCNK;INTS11;CCNT1;INTS7;POLR2I;TAF13;ICE1;SNAPC1
prerank,positive regulation of innate immune response (GO:0045089),0.37251344441065154,1.0061428706029136,0.44518272425249167,0.7432735178686944,1.0,6/30,12.67%,TLR8;LBP;SPI1;RIOK3;UBE2K;POLR3D
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.4375262028883772,-1.0058207523679887,0.45041322314049587,0.8445486981214512,1.0,1/10,8.02%,CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.4375262028883772,-1.0058207523679887,0.45041322314049587,0.8445486981214512,1.0,1/10,8.02%,CEP250
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3568277865254307,1.00556991046862,0.4189189189189189,0.7440830989732562,1.0,8/33,12.82%,EGFR;ANKRD17;RGCC;CCND3;CDC73;CCND2;TFDP1;KMT2E
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3673818765533355,1.005376299840303,0.4233937397034596,0.7439906691973892,1.0,3/28,3.25%,RASA1;FCHSD2;ARHGAP18
prerank,positive regulation of cell development (GO:0010720),-0.32024655983800954,-1.004057749495915,0.43315508021390375,0.848473470932946,1.0,5/31,11.16%,CX3CR1;NUMB;TGM2;NUMBL;PDE3A
prerank,macrophage differentiation (GO:0030225),0.4291531404106044,1.0037044324930162,0.43956043956043955,0.747217467177995,1.0,2/13,3.30%,IL15;CDC42
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.39798451602317053,1.0036083070632336,0.4339622641509434,0.7469412622877275,1.0,7/20,18.72%,RB1;IGF1;LAMTOR5;NIBAN2;EP300;GTF2B;TRAF6
prerank,prostaglandin biosynthetic process (GO:0001516),-0.36171660676151535,-1.003569035891023,0.4180522565320665,0.8485091902976335,1.0,5/18,11.78%,HPGDS;DAGLB;PTGS1;PTGES3;MIF
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4529659194501376,1.0033692546585824,0.4635036496350365,0.7469787250143363,1.0,3/11,3.53%,GAS6;LILRB1;CCL19
prerank,carnitine shuttle (GO:0006853),0.44907141993562155,1.0032203283555032,0.43570057581573896,0.7468345740488304,1.0,1/11,1.30%,PRKAG2
prerank,positive regulation of autophagy (GO:0010508),0.3156270571444058,1.0031936642868393,0.4767277856135402,0.7464041641535563,1.0,21/81,16.64%,DAPK1;SESN1;GNAI3;WAC;TRIM65;PRKN;GSK3B;CAMKK2;ROCK1;ATF6;PIK3C2A;TRIM68;TRIM27;TPCN1;FOXO3;ZC3H12A;FOXO1;MID2;NPRL2;PAFAH1B2;BNIP3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.43120350691272996,-1.0030477795817503,0.4585152838427948,0.8474708946752192,1.0,3/10,6.41%,PRKCD;PLA2G6;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.43120350691272996,-1.0030477795817503,0.4585152838427948,0.8474708946752192,1.0,3/10,6.41%,PRKCD;PLA2G6;NSMAF
prerank,regulation of pseudopodium assembly (GO:0031272),0.4560187075827239,1.0028055559684288,0.46153846153846156,0.7462520331452464,1.0,1/10,3.30%,CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4560187075827239,1.0028055559684288,0.46153846153846156,0.7462520331452464,1.0,1/10,3.30%,CDC42
prerank,nervous system development (GO:0007399),0.2622323752162466,1.0023001373575027,0.47644539614561027,0.7468722825931725,1.0,37/429,6.07%,WWP1;GDA;ZEB2;NELL1;EDNRB;NAV1;ST8SIA4;ADGRG6;NOTCH2;ITM2B;MBNL1;ZBTB16;OPHN1;JAG1;LIG4;MEF2C;CRIM1;FBXL17;DRD1;WNT2;NES;HMGCR;CLN5;RPS6KA3;JARID2;PRKN;BTBD1;INTU;GRHL2;PMP22;PCDHB13;FEZ2;MTR;CELSR1;GFRA3;DPYSL2;ATXN1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.41121306277710123,-1.002240105788311,0.48997772828507796,0.8485507070629565,1.0,3/12,11.80%,AKAP8L;SAP30BP;AKAP8
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.37284433489512475,1.002011006700132,0.4368,0.7469908603104869,1.0,5/27,8.30%,FCGR2B;GSK3B;DISC1;PSEN1;HOMER1
prerank,regulation of osteoblast differentiation (GO:0045667),0.3124902906115383,1.0020107118544141,0.4380165289256198,0.7464948504430828,1.0,13/82,9.95%,NELL1;MEF2C;CRIM1;TNN;BMP2;FGF23;CDK6;GDF10;ACVR2A;IL6R;DDR2;LIMD1;IGF1
prerank,necroptotic process (GO:0070266),0.4176366001087418,1.0018542405669177,0.447463768115942,0.7463289222201346,1.0,3/16,5.51%,RIPK1;TLR4;LY96
prerank,positive regulation of DNA metabolic process (GO:0051054),0.33284580920753126,1.0015761127032983,0.4583941605839416,0.7464462023071954,1.0,8/61,8.38%,EGFR;RPS3;BABAM2;RGCC;USP9X;BRCC3;CEBPG;ATRX
prerank,cytoskeleton organization (GO:0007010),0.2976721242590979,1.0014644358670006,0.4668400520156047,0.7462044969037679,1.0,24/114,14.37%,FGD4;NEDD9;APOE;FGD6;DIAPH1;ARHGAP10;RHOA;DPYSL2;PPP2R3C;CNN2;RHOBTB1;CCL24;RANBP9;LIMD1;MAST1;PACSIN2;PHIP;DIAPH3;RND3;LARP4;RHOC;SIPA1L3;MDK;PDZD8
prerank,neutrophil activation (GO:0042119),0.4530097027693326,1.0008313955512464,0.46641074856046066,0.7470417292175668,1.0,3/12,6.52%,IL15;FCER1G;SYK
prerank,bone morphogenesis (GO:0060349),0.4176115890789162,1.0007619831787604,0.4444444444444444,0.7467069901743314,1.0,1/14,0.46%,LRP6
prerank,cellular response to unfolded protein (GO:0034620),0.3798516665615439,1.0006412685236576,0.45791245791245794,0.7464741016030493,1.0,5/26,11.91%,ERN1;PRKN;RHBDD1;BAG3;HSPA13
prerank,regulation of postsynapse organization (GO:0099175),0.37168890742256994,1.0005184342994318,0.4578696343402226,0.7462649071905642,1.0,2/28,0.40%,PDLIM5;FCGR2B
prerank,mRNA metabolic process (GO:0016071),-0.25024177639607287,-1.0004924086417821,0.41825095057034223,0.8522018978379,1.0,26/90,23.60%,DDX5;SON;CPSF6;AKAP8L;SRRM4;SRSF5;HNRNPA2B1;TP53;SRSF2;GEMIN2;RIDA;TCERG1;U2AF1;HSF1;RNH1;NCBP1;PCBP2;SRSF11;SRSF9;PRMT9;U2AF2;METTL3;ALKBH5;NUDT12;SLBP;HNRNPA0
prerank,protein targeting to peroxisome (GO:0006625),0.37192906704866796,1.0001851063673515,0.4473257698541329,0.7464858713445346,1.0,5/29,6.67%,RAB8B;SLC25A17;PXMP2;PEX7;PEX26
prerank,secretory granule organization (GO:0033363),-0.41707491238665695,-0.9994144105018248,0.45490981963927857,0.8540442651059399,1.0,1/10,0.34%,LYST
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.44975094390355197,0.9993421443547472,0.4679715302491103,0.7478056647564825,1.0,2/12,3.48%,PTPRJ;CBL
prerank,peptidyl-lysine acetylation (GO:0018394),0.463780053805564,0.9987524788454646,0.4722753346080306,0.7486470145901529,1.0,4/10,13.81%,ESCO1;CREBBP;EP300;KAT7
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.37187654424836586,-0.9986114535897131,0.45739910313901344,0.8550255672153313,1.0,9/16,49.65%,SOX5;TGFB2;FOXC1;PTN;SOX6;SP7;DHX36;TCF15;RBM24
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.2876912697196774,-0.9984316867906053,0.4451219512195122,0.854293868898869,1.0,6/45,4.20%,IRF8;PRKCD;NCAM1;JAK2;STAT1;IRF3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.32776195386619805,0.9980172168947933,0.4542897327707454,0.7497791666503931,1.0,13/63,13.95%,NELL1;NUPR1;PTPN22;RIC1;MCL1;ROCK1;TBC1D14;BCL2;FOXK2;FOXK1;RUBCN;MFSD2A;STAT3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2749734756062794,-0.9978297803941135,0.44904458598726116,0.8536462682247636,1.0,22/56,31.89%,NUBPL;NDUFAF6;NDUFS7;NDUFV3;TMEM126A;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;TIMM21;ECSIT;NDUFAB1;NDUFS1;NDUFAF8;ACAD9;NDUFA6;DMAC2;NDUFAF3;NDUFV2
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2749734756062794,-0.9978297803941135,0.44904458598726116,0.8536462682247636,1.0,22/56,31.89%,NUBPL;NDUFAF6;NDUFS7;NDUFV3;TMEM126A;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;TIMM21;ECSIT;NDUFAB1;NDUFS1;NDUFAF8;ACAD9;NDUFA6;DMAC2;NDUFAF3;NDUFV2
prerank,fatty acid catabolic process (GO:0009062),-0.26902370569059464,-0.9978206208393543,0.4583333333333333,0.8524217148385945,1.0,26/67,30.01%,LPIN2;ACAD10;PHYH;ECHS1;ACADL;PCCB;AIG1;MMUT;ABCD2;ACADM;MTLN;FAAH;SLC27A2;ECI2;ILVBL;HACL1;SLC27A4;HSD17B10;CPT2;ACADVL;PECR;ACOT8;ABHD2;PCCA;MCEE;ECI1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.35378209385158643,-0.9976989446041298,0.458628841607565,0.8515297070325777,1.0,5/20,14.35%,BMPR1B;ACVR1;DSCAML1;LMX1B;MDFI
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.27556909563104515,-0.9974340989521906,0.4559748427672956,0.8510419412949414,1.0,18/57,28.63%,ADCY3;ADCY8;GRM7;GNAI1;P2RY12;CHRM3;ADCY7;PSAP;ADCY1;OPRL1;GNAL;FLNA;HTR1F;AKAP5;ADCY5;HTR1B;HTR4;GPR37L1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.36567144510251204,0.9972045215082376,0.4504201680672269,0.7510814681266803,1.0,7/29,13.35%,RIPK1;BCL10;PAK2;TNF;TNFSF12;SFRP1;WWOX
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.35499028636717644,-0.9969682076458082,0.4506329113924051,0.8511475850718756,1.0,2/21,0.89%,CX3CR1;CTNNB1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.23035799846854527,-0.9960827270122649,0.42483660130718953,0.852387858734395,1.0,56/184,24.96%,CSNK1E;ANAPC15;SDCCAG8;CEP135;ODF2;HECW2;DYNC1H1;SKP1;PSMD13;CEP192;PSMD12;APPL1;HAUS8;CEP250;CEP63;CENPE;ERCC2;SIRT2;PSMD9;CCP110;NEK6;ANAPC11;UBE2S;PSME3;HAUS7;CKAP5;HAUS3;BUB1B;MAPRE1;PSMA4;PSMD8;PSMF1;PSMD4;CDC14A;UBE2E1;RIOK2;NEK11;UBE2D1;ID2;PSMB8;PSME1;UBB;ANAPC5;ZW10;HMMR;DCTN2;CNTRL;HAUS2;KIF14;PLK4;PSMC2;DCTN1;HAUS6;CDK1;YWHAG;MAD2L1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.46108140763906175,0.9956780145457028,0.482421875,0.7539709835415832,1.0,1/10,0.63%,APP
prerank,sulfate transport (GO:0008272),0.4288850239709061,0.9954451155864837,0.4709090909090909,0.7540047146991992,1.0,8/14,26.95%,SLC26A11;SLC26A7;SLC25A30;RACGAP1;SLC13A4;SLC26A8;SLC25A11;SLC26A2
prerank,action potential (GO:0001508),-0.28328186060027766,-0.9953498310371147,0.48265895953757226,0.8532220809291777,1.0,8/44,11.25%,KCND2;KCNJ2;YWHAH;CLN3;AKAP6;KCNA2;KCNA1;SCN8A
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.3817046944883795,0.994950749511307,0.46153846153846156,0.7546016554348858,1.0,5/26,4.72%,IRAK3;CD36;TLR2;NFKBIL1;BIRC3
prerank,genitalia development (GO:0048806),-0.4102720902771996,-0.9946969803286412,0.4553191489361702,0.8538752795111816,1.0,3/12,20.09%,CHD7;PTPN11;WNT5A
prerank,in utero embryonic development (GO:0001701),0.3756303453000309,0.9941854882529296,0.4539130434782609,0.7558367800377446,1.0,5/25,6.90%,MBNL1;LIG4;BMP2;MYH6;ZNF568
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.35697404574538305,0.9940045171635815,0.4798061389337641,0.7557502398080715,1.0,9/36,15.54%,TCF7L2;PPP3CA;GNG2;PDE6A;GNB1;CALM1;PLCB3;TNRC6C;NLK
prerank,response to ATP (GO:0033198),0.40501570058521424,0.9936142011409593,0.4453924914675768,0.7561415310038662,1.0,1/18,0.51%,P2RX7
prerank,membrane repolarization during action potential (GO:0086011),-0.40547349068091176,-0.9934626154312461,0.4888392857142857,0.8561343717172173,1.0,2/13,2.06%,KCNJ2;ATP1B1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.32528161929610117,-0.993433198540506,0.4520884520884521,0.8549750366746454,1.0,5/27,5.58%,F11R;TJP1;TMEFF2;CLASP2;SHANK1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.40540827836445664,0.9929695427651686,0.45454545454545453,0.7570286973168728,1.0,3/17,11.34%,APOE;ERLIN1;SREBF2
prerank,calcium ion import (GO:0070509),-0.3124357556580809,-0.992962859293228,0.48525469168900803,0.85510968795993,1.0,7/28,12.26%,CACNB2;SLC8A1;TRPC4;CACNA1D;CACNA1E;CACNA1C;AFG3L2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3835853283455639,-0.9928032445662627,0.43507972665148065,0.854298915108986,1.0,4/15,7.89%,PRKCD;PLA2G6;NSMAF;SAMD8
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.375738694704783,0.9926740599638352,0.48961937716262977,0.7571713090361611,1.0,4/26,7.36%,PRKAG2;ADIPOR2;ERLIN1;ELOVL5
prerank,protein localization to membrane (GO:0072657),0.2764073781443781,0.9925350250695647,0.4878345498783455,0.7569591337427373,1.0,44/187,16.89%,ITGA4;LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;ITGB1BP1;EHD1;RAPGEF2;S100A10;RFTN1;RAP1A;SAV1;ROCK1;TNF;SYNJ2BP;TM9SF2;RABEP1;ZDHHC3;DENND4C;TM9SF3;PIP5K1A;JUP;ROCK2;KCNB1;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;ITGB2;TMED2;SYNE3;TSPAN14;ZDHHC2;RAB3B;SEC16A;RAB32;SLMAP;FLOT2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.39840179919258906,0.9923688134418291,0.4593698175787728,0.7568321441796906,1.0,1/19,0.76%,PTPRJ
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.40207925156258795,0.9918141572052406,0.45663716814159294,0.7575741820929336,1.0,4/18,11.95%,PRKN;SFRP1;CHGA;KCNB1
prerank,regulation of synapse organization (GO:0050807),0.3754487904437419,0.9915937088163589,0.4742268041237113,0.7575478720025043,1.0,3/26,6.99%,PDLIM5;MEF2C;TNF
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3688770214535554,-0.9913944887815771,0.4588235294117647,0.857208199712447,1.0,5/17,11.65%,NSA2;WDR12;MAK16;URB1;FTSJ3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.38748841500412906,0.99119223942037,0.45695364238410596,0.7579509072170391,1.0,8/22,25.15%,PSMA7;PSMB2;PSMA6;PSMA3;ENC1;PSMB9;PSMB4;PSME4
prerank,negative regulation of leukocyte activation (GO:0002695),0.42714105731301705,0.9910672426033655,0.4690909090909091,0.7577396154125892,1.0,2/15,3.28%,FCGR2B;GRN
prerank,positive regulation of isotype switching (GO:0045830),0.4137215881842803,0.9904053164000441,0.45750452079566006,0.7586546822295295,1.0,6/15,23.04%,CD40;KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.4633711439599786,0.990233682272909,0.4598393574297189,0.7585599358539095,1.0,3/10,12.36%,NFKBIZ;RC3H1;ZC3H12A
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2993120933542415,0.989521069492947,0.4702702702702703,0.7595976123908448,1.0,8/91,6.77%,HIP1;NRP1;OPHN1;RAB8B;RAB10;AP2S1;SYK;STXBP5
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.41357101719462175,-0.9893993687153066,0.5062761506276151,0.861710495189625,1.0,2/11,2.06%,KCNJ2;ATP1B1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3435473684619622,0.9893980310759033,0.459375,0.7593837045587769,1.0,4/43,9.32%,PID1;C1QTNF12;PRKCB;GKAP1
prerank,nucleic acid-templated transcription (GO:0097659),0.33420117758798784,0.9889617830071207,0.4407051282051282,0.7598725685062435,1.0,13/42,19.88%,MEF2A;THRB;EPC1;NR4A2;MED20;POLR2B;NFKBIB;POLR2D;MMS19;RRAGC;POLR2F;BCL3;DTX1
prerank,microtubule nucleation (GO:0007020),-0.3542401233511019,-0.988942572972105,0.41797752808988764,0.8618019151196772,1.0,7/19,20.29%,CLASP2;TUBGCP5;CCDC57;TPPP;TUBGCP3;GOLGA2;TUBGCP6
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3005526528593963,0.9888567671161044,0.45211267605633804,0.75960229037963,1.0,15/88,11.70%,RPS3;RGCC;GSK3B;RACK1;SYK;SDCBP;TNF;VPS4B;RAB7A;FNIP1;SDC4;SPIDR;SYNPO;EMILIN1;CHGA
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.35902292318250406,-0.9888456245461903,0.4863636363636364,0.860850004931393,1.0,8/19,20.02%,TP53;BAG6;DYRK2;MSH2;HIPK1;PYCARD;PHLDA3;AEN
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.30916498806674386,-0.988668952621033,0.48195876288659795,0.8601010628039152,1.0,7/32,14.91%,LPIN2;SLC44A2;LPCAT1;PCYT1B;LPCAT3;CHPT1;STARD7
prerank,macromolecule catabolic process (GO:0009057),0.37710711159425486,0.9883544457176848,0.4913494809688581,0.7602227506769422,1.0,7/26,10.17%,UVRAG;CLN5;CLN6;KIF16B;SNX25;TRIM24;CLPX
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3192844404196711,-0.9877851661755787,0.46938775510204084,0.8614696700566583,1.0,5/27,11.79%,PDE4B;FGF13;ANK2;CTNNA3;CACNA1C
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.30451116287313673,0.9877390435545399,0.48344370860927155,0.7610965368634338,1.0,11/94,6.29%,MAP3K5;CRIP1;HINT1;CEBPB;TNFRSF1B;ERN1;MCL1;BCL2L2;STK24;SFN;BCL2
prerank,mitochondrial fusion (GO:0008053),-0.36308213309434134,-0.9874175035887611,0.4844124700239808,0.8613461547509483,1.0,7/18,25.69%,MFN1;GDAP1;AFG3L2;MIGA2;FIS1;THG1L;USP30
prerank,positive regulation of DNA recombination (GO:0045911),-0.32868145244509717,-0.9873558894253274,0.45542168674698796,0.8602861676883363,1.0,5/27,9.10%,FUS;PARP1;ERCC6;ZCWPW1;ERCC2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.31439855574010406,-0.9872587098619596,0.4804177545691906,0.8593469030335407,1.0,10/30,23.08%,GTF2H2;CCNH;UBTF;ERCC2;TAF1C;TAF1D;GTF2H4;POLR2L;POLR1C;TBP
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.34417423155343563,-0.9872044568179493,0.4863013698630137,0.8558890647520673,1.0,9/20,30.12%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.34417423155343563,-0.9872044568179493,0.4863013698630137,0.8558890647520673,1.0,9/20,30.12%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.34417423155343563,-0.9872044568179493,0.4863013698630137,0.8558890647520673,1.0,9/20,30.12%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,regulation of cell division (GO:0051302),0.3113343991243371,0.9870325915428885,0.4614285714285714,0.7621807120060786,1.0,11/72,10.64%,TXNIP;NCOA3;UVRAG;RACK1;KLHL13;SFN;EFHC1;BIRC6;ESRRB;CETN2;CALM1
prerank,cell junction maintenance (GO:0034331),0.42920539455408635,0.9870248148586062,0.4896030245746692,0.7617072918326971,1.0,1/14,1.22%,MYADM
prerank,cellular response to interferon-beta (GO:0035458),-0.38741247895895403,-0.9869794124118577,0.4866666666666667,0.8552850578601183,1.0,3/14,6.32%,STAT1;IRGM;HTRA2
prerank,histone H4-K16 acetylation (GO:0043984),0.39469441733457394,0.9869557451904555,0.4714038128249567,0.7613686005102167,1.0,6/19,15.84%,KMT2A;PHF20;KANSL2;KANSL1;KAT7;HCFC1
prerank,response to thyroid hormone (GO:0097066),0.42151497200158006,0.9869442646163001,0.4803738317757009,0.7609081251605476,1.0,4/13,11.23%,KLF9;CTSB;THRB;GAS2L1
prerank,central nervous system neuron differentiation (GO:0021953),0.351318409463187,0.9868583332856556,0.4541139240506329,0.7606071714243899,1.0,5/33,7.90%,LRP6;OPHN1;WNT2;ATP7A;NR4A2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3344213819390626,0.9868173438639759,0.4756838905775076,0.7601928649771773,1.0,4/44,2.43%,SNX9;ALOX15;FER;FCHSD2
prerank,cellular protein localization (GO:0034613),0.26586254967940537,0.9867694959072489,0.5051194539249146,0.7598068181846275,1.0,36/285,10.00%,ITSN1;EGFR;SNX9;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;USP6NL;CD74;SNX6;SNX27;EHD1;AP3B1;RIC1;HEY2;PTPRK;TBC1D14;CELSR1;TMED10;TBC1D2B;MYO7A;WIPI1;RABGAP1L;PIGU;SGSM1;TM9SF2;VCL;STX7;AMOT;RAB14;RAB1A;TM9SF3;RAB23;ARL4A
prerank,carboxylic acid transmembrane transport (GO:1905039),0.34833747742781646,0.9866091920484487,0.4697885196374622,0.7596692399293927,1.0,11/40,17.68%,SLC16A7;SLC38A6;ABCC1;SLC38A1;SLC38A2;SLC23A1;SLC23A2;SLC7A7;SLC25A30;SLC5A6;SLC36A2
prerank,sensory perception of taste (GO:0050909),0.4608370391684189,0.9864650527787616,0.4943181818181818,0.759496536812055,1.0,2/10,14.64%,CD36;PKD2L1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4580092465266037,0.9863953793229225,0.4666666666666667,0.759167718949249,1.0,3/10,16.03%,LILRB1;FN1;HSP90AB1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.457525220445258,0.9861248309561336,0.46153846153846156,0.7592907526340341,1.0,1/10,1.74%,DPYD
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.31069566297859474,-0.9861195630509724,0.44559585492227977,0.8565007900268075,1.0,9/30,25.00%,PLD4;TP53;FLT1;FLT3;CSF1R;PLEK;TGFB1;PRRC2C;TNFRSF13B
prerank,regulation of receptor recycling (GO:0001919),-0.37243155297540237,-0.9858382724415293,0.4928571428571429,0.8560453927835738,1.0,4/16,14.36%,TBC1D16;OPTN;INPP5F;AP1AR
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.42373359330549365,-0.9856385029629584,0.508298755186722,0.8530063418938921,1.0,4/10,25.84%,DNA2;BLM;SLX4;EXO1
prerank,t-circle formation (GO:0090656),-0.42373359330549365,-0.9856385029629584,0.508298755186722,0.8530063418938921,1.0,4/10,25.84%,DNA2;BLM;SLX4;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.42373359330549365,-0.9856385029629584,0.508298755186722,0.8530063418938921,1.0,4/10,25.84%,DNA2;BLM;SLX4;EXO1
prerank,response to interferon-beta (GO:0035456),0.38294459194436586,0.9854726532731656,0.4670138888888889,0.7602274700357176,1.0,5/22,9.49%,IFITM3;BST2;IFNAR2;UBE2K;IFITM2
prerank,phagolysosome assembly (GO:0001845),0.43365868667405755,0.9853016708158345,0.4695817490494297,0.7601135382398285,1.0,4/12,8.98%,PIKFYVE;RAB7B;RAB7A;RAB14
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.3509106474022783,-0.9850119604771062,0.47785547785547783,0.8536092228578644,1.0,4/19,6.22%,EML3;CEP97;HNRNPU;CHMP4B
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3400280169012462,0.984936980473866,0.4859375,0.7603971807765695,1.0,4/41,7.36%,ALOX5;ALOX15;PNPLA8;ELOVL5
prerank,rRNA modification (GO:0000154),-0.3387261596691876,-0.9849035039783126,0.4619164619164619,0.8527282079100231,1.0,7/21,20.74%,FTSJ3;TFB2M;TSR3;GAR1;MRM2;MTERF4;THUMPD1
prerank,proteasomal protein catabolic process (GO:0010498),0.2745788027147636,0.9841094379643235,0.5059523809523809,0.7617271725289438,1.0,39/201,15.41%,WWP1;FBXW7;SMURF2;PSMA7;RCN3;FBXL17;SIAH2;NR1D1;PELI1;RMND5A;PRKN;CLOCK;RHBDD1;SPOP;APPBP2;PSMB2;TBL1XR1;SPOPL;MDM2;TBL1X;UBE2D3;UBE2K;COP1;CUL3;ARMC8;ZFAND2B;ARRB1;PSMA6;RNF185;TRIM71;AGAP3;RNF187;BFAR;NEDD4L;PSMD5;PSMD1;PSMA3;RNF122;RNF41
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3070275275563788,-0.9834643468394791,0.48195876288659795,0.8556657738713662,1.0,5/36,3.60%,SIRPA;CYLD;TREM2;DUSP10;GPS2
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2955247845345953,0.9833961792555526,0.4857142857142857,0.7628135835628532,1.0,18/98,12.54%,EGFR;ITGB1;SPTBN1;ITGB1BP1;YWHAQ;PRKN;SFN;BCL2;TNF;FYN;PLS1;MYO1C;TFDP1;CASP8;YWHAE;KCNB1;ATP2B4;PPP1R13B
prerank,cilium organization (GO:0044782),-0.21887940583934642,-0.9832610955846665,0.524390243902439,0.8550511927256734,1.0,73/209,27.30%,ASAP1;BBS9;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;ODF2;IFT81;CCDC66;ATP6V1D;IFT140;RAB3IP;DZIP1;CEP162;IFT88;TTC8;AHI1;CEP250;BBS7;IFT20;CCDC57;MKS1;DYNLT2B;WDR19;SPAG16;CCP110;DYNC2H1;SSX2IP;KIF3A;TCTN1;IFT52;KIF3B;WDR90;CDC14A;IQCG;ARMC2;NUDCD3;CFAP298;CFAP410;CPLANE2;NOTCH1;IFT43;DYNC2I1;EHD3;B9D2;RAB8A;TMEM138;DNAH5;PLA2G3;BBS4;ARL3;HDAC6;TMEM231;MKKS;CEP89;IQCB1;GALNT11;TMEM17;FLNA;PTPDC1;CFAP126;PLK4;CATIP;KIFAP3;CEP126;EXOC3;UNC119B;CFAP70;TTC39C;MNS1;IFT172;TTBK2
prerank,establishment of vesicle localization (GO:0051650),-0.3547379788664266,-0.9831362394206097,0.46292134831460674,0.8542013175849651,1.0,10/18,32.14%,RAB27A;KIF5A;SPG11;KIF5C;LIMK2;TOR1A;CCDC186;KIF5B;F8A1;SNAPIN
prerank,positive regulation of cyclase activity (GO:0031281),-0.377389894657865,-0.9826520076633103,0.4756380510440835,0.8543470884680825,1.0,6/14,24.80%,CACNA1D;NF1;MAPK3;CACNA1C;MAPK8;AKAP5
prerank,neurotransmitter transport (GO:0006836),-0.2579893284182355,-0.9825957341134899,0.4641638225255973,0.8532886897876276,1.0,22/73,22.21%,SLC1A3;RIMS1;SNAP25;NRXN1;PPFIA2;PPFIA4;DVL1;APBA1;SYN3;CPLX1;SLC1A1;GABRA2;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;SLC1A2;SLC17A6;CHAT;BRSK1;GAD1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3224160715592548,-0.982083121399488,0.4836272040302267,0.8535331509057346,1.0,4/27,2.24%,FGF12;YWHAH;SCN1B;SNTA1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3635303557906088,0.9819467546641071,0.4741235392320534,0.7654948879498119,1.0,5/28,5.86%,PRKAG2;NR1H4;MITF;TNFRSF1B;ADIPOR2
prerank,positive regulation of macroautophagy (GO:0016239),0.3311601401826168,0.9817471438051667,0.4933530280649926,0.7654474498317535,1.0,9/48,10.42%,SESN1;GNAI3;ADRB2;UVRAG;WAC;SPTLC2;BAG3;SMCR8;SLC25A5
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3598138389200873,0.981522883981339,0.4582651391162029,0.7654991108404203,1.0,9/30,16.03%,RYBP;WAC;NOP53;SDCBP;HFE;USP14;EIF3H;RPL11;HSP90AB1
prerank,regulation of neuron differentiation (GO:0045664),0.3078397278476878,0.9815041140314043,0.4789325842696629,0.7650455218260184,1.0,8/76,5.91%,FGFR1;TCF4;MEF2C;BMP2;RHOA;GPRC5B;ROCK1;TRIM32
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2937533891542179,0.981501538960266,0.48148148148148145,0.7645581697347056,1.0,19/114,14.53%,TNFRSF25;PSMA7;TNFRSF1B;RIPK1;PLVAP;TNFRSF11A;BIRC3;CD40;EDARADD;TNF;EDA;PSMB2;TNFSF12;PSMA6;FOXO3;TNFRSF1A;PSMD5;PSMD1;PSMA3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2615412371662547,0.9814358704004016,0.5067114093959731,0.7641943152780101,1.0,76/327,18.70%,AHR;RREB1;FOXN2;NFXL1;ESR1;HINT1;MEF2C;NCOA2;CEBPB;MITF;RYBP;BMP2;NR3C1;CLOCK;SPI1;RB1;INSR;TGFBRAP1;TCF7;ATXN1;LYL1;IRF2;ATRX;ZNF628;LIMD1;ESRRB;BACH1;LIN54;ESR2;HMG20A;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;TESMIN;JMJD1C;RNF14;SP1;ATXN1L;CREBBP;MYBL2;FOXK2;NFIA;HINFP;TERF2IP;SP3;PSPC1;EP300;KAT7;STAT3;MLF2;HMGN5;WWC1;NAB1;RALY;NSD3;MYT1;NR2C2;NLK;SFPQ;RUNX3;HCFC1;PPARGC1B;RELA;GPBP1;NR5A2;PRKCQ;ZNF22;GZF1;RFX3;MAFB;PERM1;ATF2;PLAG1
prerank,respiratory tube development (GO:0030323),-0.31766017393286244,-0.9810718648839601,0.4517766497461929,0.8551288060699601,1.0,12/28,29.09%,FGF2;FGFR2;LOXL3;BAG6;CCDC39;PROX1;PDPN;CCDC40;FGF1;WNT7B;FGF7;BMP4
prerank,global genome nucleotide-excision repair (GO:0070911),-0.32318175393861137,-0.980708439949132,0.4811083123425693,0.854931028800595,1.0,6/26,9.10%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,sphingolipid biosynthetic process (GO:0030148),-0.25400280475213644,-0.9805797151070196,0.5114754098360655,0.8541200066898811,1.0,23/71,20.99%,LARGE1;ST3GAL5;SPNS2;SMPD4;PPM1L;PLPP3;ASAH1;ASAH2;SAMD8;CERS4;DEGS1;ST8SIA1;ACER2;CERS5;CERS1;ST8SIA3;SGMS2;SMPD2;TLCD3B;SPTLC1;CERS2;KDSR;PLPP2
prerank,DNA recombination (GO:0006310),0.3473593663106807,0.9805026080056337,0.4773462783171521,0.7657441961474264,1.0,11/37,19.80%,ENDOG;LIG4;RPA1;RAD54L;RAD52;RHNO1;RAD51B;FBH1;DMC1;MRE11;RTEL1
prerank,positive regulation of glucose import (GO:0046326),0.39241590346014116,0.9803139050720048,0.4802158273381295,0.7656570177255638,1.0,6/21,14.94%,C1QTNF12;IRS2;INSR;IGF1;ARPP19;OSBPL8
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.44247214351120634,0.9798866026239865,0.4860335195530726,0.766093389238937,1.0,3/11,9.67%,RREB1;CD44;CORO1C
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3278559088087728,0.9796399185229049,0.47076023391812866,0.7661450915377405,1.0,6/51,7.24%,SNX2;KIF20B;GAS7;TRIO;ATP7A;NRK
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3802684611183556,-0.979423494860313,0.5010845986984815,0.8560840639868877,1.0,3/15,7.55%,ACACA;DIP2A;ACSS1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.36702407983726854,0.978876418203119,0.4672,0.7672881137957389,1.0,6/29,9.90%,RPS16;RPS21;RPS8;RPS14;MRPS11;HEATR1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.385084265127597,0.9786027393220249,0.4735099337748344,0.7673793334754911,1.0,11/21,23.37%,SAMD4A;TUT7;TUT4;CNOT9;CNOT11;CNOT6L;CNOT4;CNOT8;CNOT1;PAN3;CNOT2
prerank,negative regulation of cell motility (GO:2000146),0.29002492553529186,0.9783016816203418,0.4820717131474104,0.7675367249604365,1.0,13/108,8.29%,MCTP1;PTPRJ;RAP2B;JAG1;MITF;CD74;CRK;CLIC4;PTPRK;STK24;BST2;DUSP22;VCL
prerank,inorganic anion transport (GO:0015698),0.32627095413233764,0.9781878231059933,0.4918759231905465,0.7672991725689942,1.0,16/53,21.93%,ANO6;CLCNKB;CLIC4;ANO1;SLC26A11;TTYH3;BEST1;SLC26A7;CLCN1;XPR1;SLC25A30;CLIC5;ENPP1;RACGAP1;SLC13A4;SLC26A8
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.38276099930799556,0.978089720222967,0.4866785079928952,0.7670359871320758,1.0,8/22,16.30%,DUSP1;PPM1B;DUSP2;PPP2CA;PPP2CB;PPP1CA;DUSP7;PPM1A
prerank,ether lipid biosynthetic process (GO:0008611),-0.4249016472139035,-0.9776433356479852,0.5,0.8598693199351223,1.0,4/10,13.44%,LPCAT2;DHRS7B;GNPAT;CHPT1
prerank,regulation of microtubule-based process (GO:0032886),-0.3056649305779431,-0.9776090201479141,0.47633136094674555,0.8587746987275747,1.0,10/36,13.20%,EFNA5;CYLD;CLASP2;MACF1;BICD2;MAPT;MAP6;PHLDB1;TPPP;EPHA3
prerank,potassium ion transmembrane transport (GO:0071805),-0.23168362736347167,-0.9775257876781662,0.5432692307692307,0.8578054040051938,1.0,19/135,9.78%,SLC1A3;KCND2;KCNH7;SLC12A2;KCNJ2;SLC24A3;SLC24A2;ATP1B1;SLC9A8;ATP1B2;SLC12A9;KCNQ3;NALCN;SLC24A4;KCNQ5;KCNK2;KCNA2;KCNA1;KCNK12
prerank,positive regulation of integrin activation (GO:0033625),-0.4146966447010896,-0.9774417912681828,0.49266247379454925,0.8568810939876844,1.0,4/11,6.66%,SRC;FERMT2;PIEZO1;P2RY12
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.43282118714630713,0.9772883629909139,0.5063520871143375,0.7683221359718866,1.0,3/12,9.41%,PPHLN1;SETDB2;APOBEC1
prerank,protein targeting (GO:0006605),-0.2370814537992005,-0.9771256211816747,0.5102880658436214,0.8565475345018645,1.0,40/118,27.27%,SORL1;NLGN1;PARD3;FBXO7;HPS4;RAB3IP;MICALL1;PEX6;AKAP6;TIMM44;VPS37A;ZDHHC18;AP4B1;RTP4;EDEM1;GDAP1;TOMM40;SPCS1;AP1S3;SEC61A1;TIMM8B;AIP;TOMM20;ZDHHC1;ZFAND2A;ZDHHC15;HAP1;HACL1;KATNB1;BCAP31;PEX19;TOMM34;SRP14;ZDHHC22;PRKCI;FIS1;GOLGA7;TOMM5;GIPC1;NACAD
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2796450642715789,0.9770480773587827,0.5012820512820513,0.7683776444701491,1.0,18/128,7.65%,NRROS;SMURF2;ITGB1;RPS27A;BMP2;GDF3;ADAM9;CBL;RHOA;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;ACVR2A;USP15;DUSP22;HFE
prerank,regulation of mRNA catabolic process (GO:0061013),0.2861173696186102,0.9765869202084599,0.49148099606815204,0.7688997122796488,1.0,25/121,15.07%,ZFP36L2;PSMA7;RPS27A;SAMD4A;ZFP36L1;VIM;MAPKAPK2;PUM2;RC3H1;HSPB1;PSMB2;DCP1A;SERBP1;PCID2;DCP2;PSMA6;ZC3H14;ZC3H12A;EXOSC8;GTPBP1;EXOSC1;PSMD5;PSMD1;PSMA3;XPO1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.32796550646301403,-0.9764742312801731,0.5087719298245614,0.8571895000542736,1.0,6/26,13.48%,ATP1B1;ATP1B2;ANK2;CACNA1D;ACTN2;VAMP2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.41323260556106567,-0.976329578951667,0.4878048780487805,0.8564119454399747,1.0,7/10,31.94%,IMPACT;SIRT2;JUN;DNAJB1;VHL;HIF1AN;HSPA1A
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4239916858849081,0.9762008103112041,0.4874551971326165,0.7692863229168811,1.0,2/13,5.17%,PDE8A;RACK1
prerank,mRNA methylation (GO:0080009),0.40626199134510127,0.9759649826015994,0.4972972972972973,0.769342474651948,1.0,7/15,23.28%,WTAP;NSUN2;VIRMA;TRMT61B;TRMT61A;METTL16;PCIF1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.38429348908801864,0.9755393526854997,0.4798657718120805,0.7698180630677609,1.0,3/19,4.99%,FBXW7;PRKN;CAMKK2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.34613317156405765,0.9754437100080818,0.4716666666666667,0.7695381412327679,1.0,8/31,11.47%,OPHN1;CDC42;RHOA;SYNJ2BP;PARD3B;MSN;MARK2;MYO9A
prerank,regulation of lamellipodium assembly (GO:0010591),0.3585521592916415,0.9751519784603444,0.4953271028037383,0.7696721180539511,1.0,5/34,7.25%,FER;ACTR3;WASF2;CDC42;ARPC2
prerank,double-strand break repair (GO:0006302),-0.22630404049939082,-0.9746930254400806,0.49514563106796117,0.8596482594461285,1.0,38/158,17.91%,HERC2;DNA2;XRCC5;SETX;HELQ;ACTR8;ATM;AP5Z1;HPF1;PARP1;RMI1;RNF168;POLM;BLM;RECQL5;BRCA1;TNKS1BP1;HUS1;RAD51C;XRCC1;BRCA2;KDM4A;PRPF19;UBXN1;PPP5C;PARP3;PALB2;MORF4L1;XRCC6;APBB1;DDX1;CHEK2;PAXX;REV3L;TDP1;RAD51AP1;DCLRE1B;POLL
prerank,sphingolipid catabolic process (GO:0030149),-0.37167410098294307,-0.9743001715185872,0.47912087912087914,0.8595902510326918,1.0,6/15,13.05%,ENPP2;SMPD4;ASAH1;PPT1;ASAH2;ACER2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3658446462584534,0.9742471931176797,0.4776357827476038,0.7711407798148159,1.0,10/26,22.44%,CCL19;TRPM2;SLC8B1;ERO1A;IBTK;PKD2;ITPR3;F2R;PTPRC;PLCG2
prerank,TOR signaling (GO:0031929),-0.31942525023292023,-0.9741841102012281,0.513715710723192,0.8587502217139846,1.0,13/26,28.47%,RPTOR;PRR5L;CARD11;FLCN;MLST8;MTOR;SYAP1;RHEBL1;RPS6KB2;PRR5;RPS6KB1;LARP1;AKT1
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3306808837795405,-0.9740860883064761,0.5012224938875306,0.8578286064860696,1.0,5/24,12.41%,TTLL11;PARP1;TTLL7;GGCX;TTLL1
prerank,embryonic digestive tract development (GO:0048566),-0.3472221500407223,-0.9734507160776924,0.49760765550239233,0.8584636263479527,1.0,6/18,20.83%,SALL1;FGFR2;ID2;TGFB2;GLI3;SOX11
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.2310608584819221,-0.9728470832026689,0.5270935960591133,0.8590407745035925,1.0,54/145,31.88%,CSNK1E;SDCCAG8;CEP135;ODF2;DYNC1H1;SKP1;PSMD13;CEP192;PSMD12;RBX1;HAUS8;FBXL7;CEP250;CEP63;CDC7;PSMD9;RAD51C;CCP110;PSME3;HAUS7;CKAP5;HAUS3;MAPRE1;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1;HMMR;DCTN2;DTL;CNTRL;HAUS2;KIF14;PLK4;PSMC2;DCTN1;HAUS6;CDK1;YWHAG;PSMB10;STOX1;PSMD3;TUBA4A;CEP152;FHL1;PSMC5;CENPF;TUBA1A;PSME2;FBXO5;TUBG1;AURKA
prerank,negative regulation of transposition (GO:0010529),0.4092488305466665,0.9723326638063461,0.4844290657439446,0.7747784869474894,1.0,4/16,13.54%,TUT7;TUT4;SPOCD1;PIWIL2
prerank,positive regulation of transferase activity (GO:0051347),-0.22808216591467537,-0.9721382462166829,0.5638297872340425,0.8597547742608447,1.0,27/142,13.94%,MERTK;SORL1;CTNNB1;XRCC5;TREM2;EPHA7;PABPN1;HNRNPA2B1;ARRDC4;FGFR2;FLT1;NTRK3;MAPK3;MAP2K7;EPHB1;AXL;EPHA10;PTGES3;ALK;FLT3;CSF1R;ERBB4;CD200;MAP3K4;EPHA3;RFC2;TYRO3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.3973987883990314,0.9720077245862314,0.5,0.7750092066848785,1.0,10/19,24.76%,GNPDA1;GFPT2;PMM1;UAP1L1;GMPPB;NANS;RENBP;UGP2;UAP1;MPI
prerank,cellular defense response (GO:0006968),0.3452442156487994,0.9719721397391207,0.4953125,0.7745920993337982,1.0,8/40,10.98%,C5AR1;ITGB1;LBP;KIR3DL2;LY96;ZNF148;RAB23;NCF2
prerank,positive regulation of phospholipase activity (GO:0010518),0.3833288530352644,0.9717680067302809,0.4957841483979764,0.7745417274153299,1.0,3/22,5.36%,FGFR1;ESR1;PDGFRA
prerank,rRNA transcription (GO:0009303),0.4088074991175857,0.9717075114921299,0.4964788732394366,0.7741951191535934,1.0,4/17,12.61%,ANG;GTF3C3;GTF3C6;POLR1G
prerank,negative regulation of cell population proliferation (GO:0008285),0.2576021534763054,0.9714842048197508,0.543141592920354,0.774196441410704,1.0,90/351,22.41%,MTSS1;NELL1;APP;PTPRJ;NUPR1;LYN;ANG;BNIPL;RARG;ABI1;CBFA2T3;TNN;BMP2;PRKRA;RGCC;S100A11;HMOX1;ITGB1BP1;RAPGEF2;B2M;MCC;FRK;CDK6;GSDME;PTPRK;TRIM32;KLF4;PDS5B;KLF10;CDC73;CGREF1;ADRA1A;CD33;THAP12;SH2B3;SFRP1;NUP62;TFDP1;FTH1;KANK2;STRN;NIBAN2;CDKN2C;DIS3L2;CTBP2;ZBTB7C;RBP4;PKD2;NOX4;MYC;RNF41;PINX1;VGLL4;PTPN14;RUNX3;PTEN;CD164;FAP;GLMN;IL6;LMNA;RAF1;F2R;EIF2AK2;PTPN6;RNF139;CTCF;TRIB1;DLG5;MORC3;P3H1;PTPRU;BRD7;ACVRL1;GPNMB;EEF1E1;APPL2;TINF2;IGFBP6;BTG3;CDKN1C;OGN;ATF5;IRF1;INCA1;NPM1;CDKN1B;DLC1;PER2;AXIN2
prerank,negative regulation of heart contraction (GO:0045822),0.4377397799073202,0.9714633669145293,0.4670433145009416,0.7737484672084805,1.0,4/11,19.57%,PDE4D;PLN;ZC3H12A;SPTBN4
prerank,sodium ion import across plasma membrane (GO:0098719),0.3936455706088001,0.9711689729631309,0.4757785467128028,0.7739269729887168,1.0,4/17,14.03%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,protein oxidation (GO:0018158),0.4461955497637731,0.9711040447274115,0.5009140767824497,0.773586347593705,1.0,4/11,19.45%,LOX;LOXL2;PRDX3;TMX3
prerank,regulation of interferon-gamma production (GO:0032649),0.31117435872250165,0.9699534229445369,0.5099866844207723,0.7756273034303359,1.0,10/71,8.71%,TLR8;GAS6;NR1H4;PTPN22;LILRB1;TLR4;PDE4D;CCR2;CEBPG;TRIM27
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.42142118195734285,0.9697549749743445,0.48256880733944957,0.7755832417994538,1.0,2/14,9.36%,GAS6;CARD16
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.30773692138086944,-0.9693917619355155,0.5157894736842106,0.8661268356910099,1.0,11/32,20.02%,DDX5;TP53;STK11;BAG6;DYRK2;FHIT;MSH2;HIPK1;PYCARD;PHLDA3;AEN
prerank,protein ubiquitination (GO:0016567),0.2543721014528413,0.9693579039215271,0.5613107822410148,0.7759453616363883,1.0,95/471,16.15%,WWP1;SASH1;FBXW7;SMURF2;PSMA7;ARIH1;RPS27A;VCPIP1;SH3RF1;FBXL17;UBE2E3;SIAH2;CBL;WAC;PELI1;RMND5A;PRKN;BCL10;ZNRF3;RNF141;LNPEP;USP9X;RACK1;RC3H1;SPOP;TRIM33;KLHL13;UBE2Q2;CBFB;TRIM32;FBXL5;ANKIB1;MYCBP2;BCL2;CDC27;TRIM24;EIPR1;TRIM47;DTX2;PSMB2;BIRC6;CDC73;TRIM68;SHPRH;TRIM27;RNF19B;MDM2;TPP2;UBE2D3;UBE2K;UHRF2;CUL3;RNF38;ANAPC16;MKRN1;FBXO11;RNF14;ARRB1;ZNRF2;RNF111;AMFR;PSMA6;UBE3B;RNF185;TRIM71;MIB1;FBXO10;MKRN3;RNF115;UBE2R2;RBBP6;UBE2N;RNF187;RNF19A;BFAR;ASB12;HIF3A;NEDD4L;PSMD5;PSMD1;PSMA3;ELOC;KLHL24;MKRN2;RNF122;ASB4;RNF41;USP22;PEX14;TRIM25;FBH1;FBXW2;UBE2W;UCHL3;FANCL
prerank,angiogenesis involved in wound healing (GO:0060055),-0.4076035634491538,-0.9689796037530101,0.4946695095948827,0.8660558944174865,1.0,6/11,18.07%,ITGB3;CD34;MCAM;HPSE;NDNF;SRF
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2995720758040987,-0.9687058024367204,0.48704663212435234,0.8656583413040861,1.0,11/35,24.23%,CALM2;MAGI2;NUAK1;PPP1R11;TSC1;PPP6R1;PTPA;MTOR;CALM3;MASTL;PDGFRB
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.3916874906490949,0.9675246347465843,0.5070921985815603,0.7794765912434694,1.0,7/18,13.95%,FER;CBL;SPI1;SMAD4;IL6R;JAK1;STAT3
prerank,eosinophil migration (GO:0072677),0.4104489983993878,0.9673537433543806,0.5078809106830122,0.7788574963929954,1.0,2/14,8.24%,CCL8;CCL24
prerank,eosinophil chemotaxis (GO:0048245),0.4104489983993878,0.9673537433543806,0.5078809106830122,0.7788574963929954,1.0,2/14,8.24%,CCL8;CCL24
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3529021235423371,0.9673211198517059,0.49504950495049505,0.7784413753237799,1.0,7/29,13.30%,PRKRA;TUT7;PUM2;DROSHA;TUT4;TRIM71;MRPL44
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.32494424540389,0.9669448456946198,0.4857142857142857,0.7787549164778171,1.0,7/46,9.95%,TCF7L2;FOXP1;ANG;HMOX1;TNF;IL6R;IGF1
prerank,negative regulation of cell migration (GO:0030336),0.2766857281803832,0.9665321674887303,0.4993678887484197,0.7791083240442425,1.0,19/137,10.05%,MCTP1;PTPRJ;RAP2B;JAG1;TNN;MITF;CD74;HMOX1;ITGB1BP1;MCC;CLIC4;PTPRK;STK24;BST2;DUSP22;VCL;CLASP1;CORO1C;SFRP1
prerank,regulation of sodium ion transport (GO:0002028),-0.29872671611469914,-0.9656251799462697,0.5119363395225465,0.8729094512647301,1.0,7/34,9.31%,FGF12;NKAIN2;YWHAH;SCN1B;SNTA1;SIK1;WNK3
prerank,insulin receptor signaling pathway (GO:0008286),0.3059933558366233,0.9648668864111373,0.4985835694050991,0.7822877036172035,1.0,16/69,12.86%,FER;ATP6V1B1;IRS2;GSK3B;INSR;ATP6V0A1;GAB1;PIK3C2A;AP3S1;ATP6V1A;FOXC2;ZNF106;PHIP;SHC1;NAMPT;FOXO1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.30443347473505195,-0.964866635811603,0.48205128205128206,0.8738845196359928,1.0,5/32,5.86%,CAPN3;CALM2;PLCG1;TRPC1;AKAP6
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.28008361454808206,-0.964828599679774,0.5014084507042254,0.8728105324655157,1.0,14/46,26.77%,LPCAT1;DGKB;LIPH;GNPAT;DGKZ;DDHD1;ACP6;AGPAT3;GPD1L;ABHD8;SLC27A1;DGKG;AGPAT2;DGKA
prerank,long-chain fatty acid metabolic process (GO:0001676),0.30589792823698414,0.9648103229641599,0.5177809388335705,0.7819133680440149,1.0,5/64,7.36%,ALOX5;LTC4S;ALOX15;PNPLA8;ELOVL5
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.38112647073447986,0.9646794310498906,0.4957410562180579,0.7817169767424718,1.0,6/21,16.14%,RPL23;RPL5;RPS7;RAB1A;RPL11;PTEN
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4482778513478265,0.9644949313197414,0.5078431372549019,0.7816332738857807,1.0,4/10,16.54%,RIPOR2;CD200R1;WASL;MIA3
prerank,mitotic cytokinesis (GO:0000281),0.32531296710130897,0.9643718866934705,0.5023041474654378,0.7814172357171818,1.0,20/47,24.11%,SNX9;RASA1;SPTBN1;INCENP;ROCK1;EFHC1;KIF4A;SNX33;ROCK2;RHOC;STMN1;CUL7;KIF23;PDCD6IP;EFHC2;RACGAP1;CEP55;PLK1;JTB;UNC119
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4102334334996419,0.9643624636066126,0.48426573426573427,0.7809447742174069,1.0,4/14,8.81%,ALOX15;CEPT1;CHKB;ETNPPL
prerank,glucose transmembrane transport (GO:1904659),-0.3597481963729168,-0.9642969373187585,0.5010752688172043,0.8731992090813396,1.0,3/18,7.08%,SORT1;SLC2A9;SLC2A5
prerank,tRNA metabolic process (GO:0006399),-0.36216333436679193,-0.9642111922837324,0.5036144578313253,0.8722836422838292,1.0,12/17,34.13%,AARS1;SARS1;DARS2;POP1;RPP21;POP7;THG1L;KARS1;TRPT1;SSB;ADAT1;DTD2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.32584199425288596,-0.9641425514618676,0.5011990407673861,0.8713174680323788,1.0,8/23,24.73%,FGF2;ITGAX;PAX8;WNT5B;SMO;EGF;AGT;SOX8
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.3597581219192334,-0.9639553335452464,0.49882903981264637,0.8706658502998167,1.0,3/17,19.46%,LPCAT1;LPGAT1;PLA2G3
prerank,cell cycle checkpoint signaling (GO:0000075),-0.4047686270850885,-0.9639425775728744,0.5222929936305732,0.86953274030991,1.0,5/12,24.48%,WEE1;BUB1B;BUB1;ZW10;ZWINT
prerank,positive regulation of cell cycle process (GO:0090068),0.29411156223525353,0.9638609986750738,0.49320652173913043,0.781533771356824,1.0,17/91,11.94%,KIF20B;CDC42;RGCC;RHOA;INSR;PKN2;DDX11;ATRX;RCC2;MAP3K20;CUL3;IGF1;NUP62;PCID2;RHNO1;PHIP;SVIL
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.35847689709208785,-0.963632757538626,0.4840182648401826,0.8692492159165509,1.0,8/16,29.23%,NCL;CELF4;CIRBP;NCBP1;RBMXL1;TRA2A;TRA2B;PRDX6
prerank,regulation of interferon-alpha production (GO:0032647),-0.3248366403234406,-0.9636179240582424,0.5194508009153318,0.868123335572811,1.0,5/23,6.07%,PTPRS;HAVCR2;STAT1;IRF3;MAVS
prerank,endomembrane system organization (GO:0010256),0.27116625251171506,0.9633498444779518,0.5410447761194029,0.7821647638401467,1.0,42/178,20.32%,TMCC1;REEP3;ATL1;USP6NL;SPTBN1;ARHGAP21;CDC42;ATP8B4;MYOF;SRGN;SERP1;TMED10;PI4K2B;WASHC4;GOLPH3L;RAB30;CLASP1;RAB1A;SNX10;SNX33;VAPA;BCAS3;SPTBN5;TMED2;REEP6;VPS51;EXOC8;COG7;SEC16A;GOLPH3;MIA3;CUL7;DNAJC13;TOR1B;RAB22A;TMED5;UBXN2B;TRIP11;EIF2AK3;LMAN2;ATP8B2;DNM1L
prerank,regulation of phospholipase activity (GO:0010517),0.4464216312975492,0.9630786133884112,0.5078740157480315,0.7822818767896323,1.0,1/10,0.60%,FGFR1
prerank,regulation of integrin activation (GO:0033623),-0.3681689951746212,-0.9627883770670224,0.48711943793911006,0.8692652654878882,1.0,4/15,5.07%,FBLIM1;SRC;FERMT2;PIEZO1
prerank,cellular metal ion homeostasis (GO:0006875),0.2875261344150982,0.9624992786076502,0.503382949932341,0.78308032157115,1.0,19/102,14.33%,ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;CD40;STIM1;CCR2;TMEM165;TESMIN;SLC10A7;SLC8B1;ATP2B4;ATP1A4;ATP1A3;ATP1A1;ATP2A2;NEDD4L
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.32719538755439065,0.9623596904500229,0.49765990639625585,0.7828741855676549,1.0,7/43,9.95%,NELL1;MEF2C;BMP2;ACVR2A;IL6R;DDR2;IGF1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3180133227601664,0.9620941522094828,0.5007451564828614,0.7829699942984765,1.0,21/56,23.37%,SNX9;RASA1;SPTBN1;RHOA;INCENP;ROCK1;EFHC1;KIF4A;SNX33;ROCK2;RHOC;STMN1;CUL7;KIF23;PDCD6IP;EFHC2;RACGAP1;CEP55;BIN3;PLK1;JTB
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.34819480321251683,0.9618838986061662,0.5250403877221325,0.7829558656965564,1.0,7/32,12.15%,RB1;CDK14;ESRRB;BACH1;TFDP1;HINFP;CDK17
prerank,regulation of superoxide anion generation (GO:0032928),-0.3835041820254901,-0.9618391921108117,0.5276497695852534,0.8706895348202436,1.0,2/14,7.31%,PRKCD;MAPT
prerank,negative regulation of cation channel activity (GO:2001258),-0.32165384566662514,-0.9613178442686677,0.5155555555555555,0.870944412259405,1.0,11/26,34.91%,CALM2;FMR1;CBARP;EPHB2;GPR35;CALM3;UBQLN1;CRHR1;KCNAB1;GSTO1;EPO
prerank,regulation of stem cell population maintenance (GO:2000036),0.39498182510070384,0.9612514119156038,0.5117540687160941,0.7838230825015802,1.0,4/18,15.21%,NCOA3;ESRRB;LOXL2;MYC
prerank,regulation of stem cell differentiation (GO:2000736),0.2942868032761303,0.9611181044487719,0.522207267833109,0.7836216503857698,1.0,15/89,14.73%,KMT2A;ZFP36L2;PSMA7;JAG1;TCF12;PDGFRA;CBFB;PSMB2;ESRRB;NSUN2;PSMA6;PSMD5;PSMD1;PSMA3;BMPR1A
prerank,connective tissue development (GO:0061448),0.33900594020365254,0.9609195295897567,0.4975767366720517,0.7835779138219925,1.0,6/35,8.88%,ZBTB16;CD44;GHRL;ATP7A;SPTLC2;SULF2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2762803183178677,0.9600650654525201,0.530209617755857,0.7849696211354309,1.0,28/151,15.22%,APOE;SGMS1;SGPP1;CEPT1;MOCS1;HACD4;MGST3;GCH1;ACER3;SGPL1;SLC25A2;TYW1;SPTLC2;LCMT2;PAM;ELOVL5;CHKB;CERS6;MGST1;B4GALT5;ACHE;ASS1;VAPA;MFSD2A;GSTT1;ARG2;PRKD2;ST3GAL4
prerank,cellular response to light stimulus (GO:0071482),0.30512205975520046,0.9594348651027622,0.512022630834512,0.7858553409494016,1.0,20/66,20.29%,RPL26;RHBDD1;PDE6A;PTPRK;RRH;GPR52;YY1;GNB1;RHNO1;CREBBP;EP300;USP28;MYC;KDM1A;USP47;ATR;ZBTB1;EIF2AK4;GPR88;PCNA
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3545193722757467,0.9593086760340395,0.5064935064935064,0.7856418776734466,1.0,7/30,12.72%,SH3BP5;PARP14;PIBF1;SH2B3;PPP2CA;SFRP1;SH3BP5L
prerank,heart morphogenesis (GO:0003007),-0.27202712509893984,-0.9592685145703091,0.5194029850746269,0.8754234050764317,1.0,6/50,10.22%,TGFBR1;CHD7;ACVR1;OLFM1;TGFBR3;MDM4
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.31999582512564473,-0.9586001706135862,0.5216284987277354,0.8760301591918133,1.0,7/25,15.61%,SRRM1;GEMIN2;SRSF10;PRPF4;SF3B1;PRPF6;DDX23
prerank,activation of protein kinase activity (GO:0032147),-0.23591759852382618,-0.9585903556280556,0.5502008032128514,0.8749112252103459,1.0,31/106,21.96%,PRKCD;MAP4K4;JAK2;PTK2B;ADCY3;ADCY8;PAK1;PRKAR1A;ITGB3;PRKAR1B;STK11;NTRK3;IL18;COPS8;TOM1L1;ADCY7;MINK1;PDPK1;TGFBR2;PARK7;ADCY1;MLST8;PAK3;MTOR;TXN;TGFB2;WNT5A;PAK4;TLR3;PAK5;ECT2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.32480165004666006,0.9583516166257298,0.48773006134969327,0.7873034184798281,1.0,16/48,18.98%,ARID1B;ACTB;CHEK1;POLR1A;POLR1B;MYO1C;ELOF1;SERTAD2;DEK;POLR1G;EP300;SMARCD1;ARID1A;ASF1A;POLR2F;DDX21
prerank,Golgi ribbon formation (GO:0090161),-0.3770976869881486,-0.9583332656459251,0.5116279069767442,0.8744586344465974,1.0,4/13,17.88%,OPTN;GCC2;STX16;GOLGA2
prerank,cellular response to ketone (GO:1901655),0.3332470769120573,0.9577694846635798,0.5055118110236221,0.7880741307029041,1.0,9/35,11.89%,AHR;GNG2;NR3C1;KLF9;GNB1;MSN;SFRP1;PTGER4;ROCK2
prerank,calcium ion transport (GO:0006816),0.2841176379733076,0.9575873460744121,0.5233766233766234,0.7879894193140684,1.0,19/113,12.84%,P2RX7;CCR1;TPT1;GAS6;ANO6;CALCRL;STIM2;CCL8;STIM1;CHRNA4;PSEN1;FYN;TRPV3;TMEM165;TRPM2;TRPC7;ATP2B4;MCOLN2;RAMP2
prerank,programmed necrotic cell death (GO:0097300),0.3921751113477888,0.9562775623102385,0.496415770609319,0.7903627981734245,1.0,3/18,5.51%,RIPK1;TLR4;LY96
prerank,positive regulation of protein depolymerization (GO:1901881),0.43334564758082056,0.955495293897996,0.521484375,0.7915717816668775,1.0,1/11,3.46%,NES
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.28542345228095617,-0.9554265702063037,0.5162241887905604,0.8812916017684015,1.0,24/42,34.02%,FARSA;AARS1;CARS1;TARS2;NARS1;TARS1;YARS1;IARS2;SARS1;DARS2;AARS2;SARS2;PARS2;HARS2;FARSB;WARS1;VARS2;VARS1;PPA2;KARS1;NARS2;HARS1;AIMP2;AIMP1
prerank,response to gamma radiation (GO:0010332),0.36933649982637595,0.9554034463485644,0.5058823529411764,0.7912802718605844,1.0,10/24,16.37%,LIG4;RPL26;TSPYL5;MDM2;MAP3K20;CRYAB;TMEM109;MYC;KDM1A;ATR
prerank,arachidonic acid metabolic process (GO:0019369),0.337957673201781,0.9552697028950393,0.5265625,0.7910901374996958,1.0,3/35,4.98%,ALOX5;ALOX15;PNPLA8
prerank,regulation of dendrite extension (GO:1903859),-0.3453105524823068,-0.9545762400948372,0.5011037527593819,0.8824541276463711,1.0,2/18,2.20%,RIMS1;RIMS2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.29835938902722153,0.9543279989306265,0.5192837465564738,0.7926138205694224,1.0,11/75,10.16%,APP;MEF2A;OPHN1;ATL1;MEF2C;RAB10;RB1;ACTB;MAPK8IP2;CCK;DOCK7
prerank,regulation of actin filament-based movement (GO:1903115),-0.40573459163927006,-0.9538445822299757,0.5212121212121212,0.8832618021153773,1.0,2/10,4.59%,PDE4B;ANK2
prerank,intracellular sterol transport (GO:0032366),-0.3748663622634618,-0.9535702651860255,0.5348314606741573,0.8828295558244825,1.0,5/13,24.16%,ABCG1;OSBPL2;ARV1;STAR;ABCA1
prerank,cellular copper ion homeostasis (GO:0006878),0.41166861741004057,0.9533556612830845,0.4972875226039783,0.7942319056993168,1.0,2/14,5.45%,APP;ATP7A
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3201893636283893,0.9523957432400086,0.5286343612334802,0.7957465125865523,1.0,12/50,16.67%,HERC4;FBXL17;INTU;RACK1;TTC23;SFRP1;WDR11;CREBBP;STK36;GPC3;TXNDC15;GLIS2
prerank,negative regulation of cellular component organization (GO:0051129),0.2994814578433058,0.9522533648710316,0.5221606648199446,0.7955541019951464,1.0,9/74,6.99%,MCTP1;IRAK3;NR1H4;LILRB1;CDC42;GSK3B;RIOK3;NOP53;TNF
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.40160153500264195,0.9518511609836906,0.5,0.79589310445857,1.0,3/15,10.70%,NCOA3;SFN;TRIM16
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.34702234154825295,-0.9514803478942737,0.5547945205479452,0.8873270517401147,1.0,11/18,42.02%,COX19;COX16;FASTKD3;TIMM21;COX17;COX14;COA3;OXA1L;SURF1;COX20;COX18
prerank,ceramide biosynthetic process (GO:0046513),-0.2796090503307368,-0.9508627695133923,0.572347266881029,0.8879165684605895,1.0,17/40,19.85%,ST3GAL5;ST6GALNAC3;SMPD4;ASAH1;ST6GALNAC4;ASAH2;SAMD8;CERS4;DEGS1;CERS5;CERS1;ST8SIA3;SGMS2;SMPD2;TLCD3B;SPTLC1;CERS2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.37110692241077714,0.9508462367456066,0.5161812297734628,0.7975841439407334,1.0,4/22,8.05%,UGT1A8;UGT1A1;TNF;NCOR1
prerank,regulation of double-strand break repair (GO:2000779),0.337962574018852,0.95081925441924,0.5110062893081762,0.7971542949339981,1.0,13/39,20.74%,RNF169;CHEK1;FOXM1;DDX11;SPIDR;PPP4R2;DEK;TERF2IP;KDM1A;ACTR2;RTEL1;SHLD2;TRIP12
prerank,negative regulation of secretion (GO:0051048),0.4320673100096271,0.9506272735590385,0.5057034220532319,0.7970758116262924,1.0,4/10,22.00%,CD74;VAMP8;TIFAB;ERBB3
prerank,regulation of extracellular matrix organization (GO:1903053),0.3996598148238336,0.9506099751209317,0.5144927536231884,0.796628415576887,1.0,3/15,8.52%,RIC1;RB1;DDR2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.28628307581969326,-0.9503993864494201,0.5609065155807366,0.8880325431276709,1.0,7/39,6.71%,TANC2;MYO1F;PPFIA2;KIF1A;CLN3;MYO1B;MYO6
prerank,signal transduction in response to DNA damage (GO:0042770),-0.26650735400809816,-0.9502807387569886,0.5389048991354467,0.8872169274407459,1.0,13/49,14.20%,TP53;ATRIP;ATM;MYO6;ERCC6;DOT1L;CEP63;HUS1;MDM4;PRPF19;ACER2;GADD45A;CHEK2
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.32511469653762926,-0.9501426740978054,0.5509138381201044,0.8864390258622584,1.0,16/23,42.64%,SLC12A2;SLC12A9;SLC12A6;SLC9A1;SLC12A4;SLC12A5;KCNH2;SLC12A1;PDK2;CLCN3;TFAP2B;ATP6V0A4;SCNN1A;PDK4;SLC26A4;SLC12A3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2840993126510411,0.950069437395359,0.5539083557951483,0.7972446071916787,1.0,14/107,12.39%,ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;CD40;STIM1;CCR2;TMEM165;SLC39A12;SLC10A7;SLC8B1;ATP2B4
prerank,regulation of protein localization to cell surface (GO:2000008),0.33935894014000306,0.9500009174031256,0.5260663507109005,0.7969038941646912,1.0,5/33,7.65%,RAB11FIP5;KCNAB2;LEPROTL1;TNF;HFE
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3840979287106567,-0.9498310308857377,0.5227272727272727,0.8861688618957626,1.0,5/12,23.61%,ADCY8;PLA2G6;CFTR;C2CD2L;BAIAP3
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.39266128215183216,-0.9491417330316231,0.5397489539748954,0.8868992196578931,1.0,3/11,6.16%,JAK2;STAT1;IL12RB2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.3977474909529824,-0.9489900158515,0.5516483516483517,0.8861750748544961,1.0,4/12,8.68%,IL33;TREM2;IL18;CCL3
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4000305596617579,0.9488913232161125,0.49005424954792043,0.7987945634893028,1.0,3/16,9.12%,RIPOR2;MEF2C;MAPK14
prerank,mitochondrial transport (GO:0006839),0.3163949806462516,0.9487685064204131,0.5428571428571428,0.7985653240458656,1.0,4/53,6.81%,SLC25A16;SLC25A24;BCL2;PITRM1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3821060774002582,0.9484663072877577,0.5310344827586206,0.7987081745374884,1.0,5/22,18.72%,B2M;STX7;FBXO38;ZBTB1;TRAF6
prerank,regulation of peptidase activity (GO:0052547),-0.34064125095677955,-0.9481260176224271,0.5320665083135392,0.8873341889526891,1.0,7/19,19.30%,CST7;NRDC;ATP13A2;CST3;PSMB8;FURIN;HDAC1
prerank,L-serine metabolic process (GO:0006563),0.43364481122354825,0.9477171708561094,0.5262135922330097,0.7998341069156726,1.0,5/10,23.95%,SERINC3;SHMT1;SERINC5;SRR;PSPH
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.27945854963886074,-0.9471876284718641,0.5548780487804879,0.8887070710021546,1.0,7/41,11.01%,SLC24A2;SLC8A1;HTR2C;FGF2;CACNA2D1;ITPR2;GRIN2A
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.3028140056747505,-0.9463905750195982,0.5190217391304348,0.8896263644094627,1.0,8/29,19.13%,BAG6;SIRT7;ZCWPW1;FANCD2;SYCE2;IHO1;STAG3;P3H4
prerank,sensory perception of chemical stimulus (GO:0007606),0.4054845423401599,0.9462914566036652,0.5237226277372263,0.8024977039728759,1.0,2/15,2.65%,C5AR1;CD36
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.32616893010230014,0.9462366250755064,0.5245398773006135,0.8021439277681989,1.0,12/43,17.76%,FOXP1;ERN1;P2RY6;HMOX1;TNF;IL6R;IGF1;RBPMS2;GJA1;BMPR1A;CCL5;IL6
prerank,organelle fusion (GO:0048284),-0.32611477919992166,-0.9461447564646495,0.5321782178217822,0.8891152252387873,1.0,9/22,25.69%,MFN1;VPS18;GDAP1;AFG3L2;MIGA2;FIS1;VPS11;THG1L;USP30
prerank,nuclear migration (GO:0007097),0.418523909592071,0.9460987182077822,0.5345794392523364,0.8019525265965289,1.0,5/13,15.10%,SYNE2;DOCK7;PAFAH1B1;PCM1;SYNE3
prerank,RNA catabolic process (GO:0006401),0.32010726453486865,0.9460010397266889,0.5166163141993958,0.8016628153531988,1.0,9/46,13.36%,ZFP36L2;ERN1;SND1;RNASE6;MTREX;DCP2;ZC3H12D;DIS3L2;LSM2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.3862524678865205,-0.9459480740362173,0.5382882882882883,0.8885474416693347,1.0,2/13,7.31%,PRKCD;MAPT
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3908097223685984,0.945280372705007,0.501779359430605,0.8027437415642104,1.0,8/16,21.06%,IRAK3;INSR;TNF;ETF1;BNIP3;IGF1R;GSPT1;MTRF1
prerank,negative regulation of cellular component movement (GO:0051271),-0.3673890729191987,-0.9452749508948878,0.5124153498871332,0.8891717098485497,1.0,8/15,28.46%,CD9;SPOCK3;TGFBR3;PIN1;FRMD5;ACTN1;FBLN1;SPINT2
prerank,lysosome localization (GO:0032418),-0.28807012000852333,-0.9448509381963581,0.5424657534246575,0.88918567446791,1.0,17/37,36.28%,PLEKHM2;FLCN;MAP6;S100A13;FAM98A;DEF8;HDAC6;KLC2;KXD1;MILR1;KIF5B;TMEM106B;RAB3A;SNAPIN;HPS6;SPAG9;BLOC1S2
prerank,regulation of fibroblast migration (GO:0010762),-0.33516040427414684,-0.9445783404427476,0.5283018867924528,0.8888475284600049,1.0,5/20,7.15%,PRKCE;PRR5L;FGF2;CLN3;APPL1
prerank,sodium ion transmembrane transport (GO:0035725),0.291979682300638,0.9445635061290486,0.5193905817174516,0.803800540242588,1.0,18/84,16.55%,SLC9A9;FXYD2;ANO6;SLC9A4;SLC4A4;HCN3;SCN3B;SLC6A5;SLC6A2;ATP1A4;ATP1A3;ATP1A1;SLC9A7;SLC9A6;PKD2;PKD2L1;SLC6A11;SLC6A6
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.38072370447421844,0.9444834339142,0.547945205479452,0.8034789664431469,1.0,4/19,7.08%,GAS6;PPP2R3C;SYK;ZAP70
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3713072777538077,0.9431628406114009,0.5396551724137931,0.8058432328302431,1.0,2/20,3.80%,NRP1;S100A11
prerank,membrane lipid biosynthetic process (GO:0046467),0.3083170578280629,0.943106678775755,0.5289017341040463,0.8054824230311232,1.0,8/58,8.70%,SGMS1;SGPP1;HACD4;ACER3;SGPL1;SPTLC2;ELOVL5;CERS6
prerank,sphingosine metabolic process (GO:0006670),0.39042768209688616,0.9430956995995735,0.5267857142857143,0.8050128124518623,1.0,3/17,6.15%,SGPP1;ACER3;SPTLC2
prerank,nucleoside catabolic process (GO:0009164),0.4265447533939342,0.9427412771792789,0.5067178502879078,0.805277434177383,1.0,1/11,1.74%,DPYD
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.30795812402411604,-0.9425322080681365,0.55,0.8932950559195508,1.0,4/26,4.35%,LRP5;ADCY8;EFNA5;PLA2G6
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.38002474421903465,-0.9423758078981793,0.524416135881104,0.8925686035344199,1.0,3/13,14.31%,CPSF6;CSTF2;NCBP1
prerank,mitotic spindle organization (GO:0007052),-0.2167110395775051,-0.9422642154337912,0.655367231638418,0.8917199527668961,1.0,67/153,31.88%,CLASP2;DYNC1H1;CENPC;RANBP2;CEP192;CENPE;WDR62;KNL1;NEK6;NUP85;WRAP73;TOGARAM1;CKAP5;KIF11;EML1;BUB1B;MAPRE1;KIF3B;CHEK2;BUB1;SEH1L;DLGAP5;MAP4;KIFC2;SPDL1;NDC80;KIF2A;INTS13;GOLGA2;SKA2;BCCIP;NSL1;PTPA;CDCA8;AAAS;RCC1;B9D2;SEC13;KIFC1;ZW10;DCTN2;CENPN;CENPP;CENPH;MAP9;TOGARAM2;FLNA;STIL;BIRC5;ZWINT;MAD2L1;CEP126;CENPI;SPC25;AURKB;KIF2C;DYNLL2;TTK;CENPF;SGO1;PMF1;PPP1CC;MZT1;CLIP1;NUF2;TUBG1;AURKA
prerank,microtubule anchoring (GO:0034453),-0.3914736525104284,-0.9421925283867738,0.5698198198198198,0.8907642125821392,1.0,3/12,7.19%,CLASP2;GCC2;BICD2
prerank,mitochondrial gene expression (GO:0140053),0.3180527528024377,0.9416609842509815,0.5193199381761978,0.8071088360830241,1.0,10/42,14.28%,MRPL23;MRPS12;NDUFA7;MRPS11;RARS2;FOXO3;MRPL16;MRPS17;MRPS34;MRPS14
prerank,protein modification by small protein conjugation (GO:0032446),0.25070714690552875,0.9416273706658538,0.6185792349726776,0.8066988061855338,1.0,70/361,15.87%,WWP1;FBXW7;SMURF2;ARIH1;RPS27A;VCPIP1;PIAS1;FBXL17;UBE2E3;CBL;WAC;PRKN;URM1;BCL10;ZNRF3;USP9X;RACK1;TRIM33;KLHL13;UBE2Q2;TRIM32;FBXL5;MYCBP2;PIAS2;CDC27;TRIM24;NSMCE2;EIPR1;TRIM47;DTX2;BIRC6;NUP133;CDC73;TRIM68;SHPRH;TRIM27;MDM2;UBE2D3;UBE2K;UHRF2;CUL3;RNF38;ANAPC16;MKRN1;FBXO11;RNF14;ARRB1;RNF111;NUP62;ATG7;AMFR;UFM1;MIB1;NUP98;FBXO10;MKRN3;UBE2R2;ATG10;UBE2N;RNF187;ASB12;HIF3A;NEDD4L;ELOC;KLHL24;MKRN2;RNF41;PEX14;FBH1;UBE2W
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3933507225137684,-0.9414662561874082,0.5225806451612903,0.8915488316078325,1.0,5/11,18.94%,NCL;SMARCB1;SIRT7;MTOR;NOL11
prerank,regulation of ruffle assembly (GO:1900027),0.3610264669578929,0.9414244689135322,0.5276872964169381,0.8066479786426779,1.0,1/23,0.09%,EPS8
prerank,protein deubiquitination (GO:0016579),0.25666588648071,0.9414122134797168,0.5964912280701754,0.8061920482530903,1.0,53/242,16.57%,ESR1;SMURF2;PSMA7;USP3;RPS27A;BABAM2;VCPIP1;ATXN7;ADRB2;RIPK1;SIAH2;RHOA;PRKN;BIRC3;SNX3;USP9X;SMAD4;ACTB;BRCC3;USP15;YY1;PSMB2;MDM2;ASXL1;USP21;USP16;MINDY2;USP24;PSMA6;FOXK2;USP14;FOXK1;ZC3H12A;TADA2B;WDR20;USP45;EP300;USP9Y;PSMD5;PSMD1;PSMA3;USP28;ENY2;MYC;USP22;USP25;ABRAXAS2;HCFC1;USP47;PTEN;UCHL3;STAM;USP32
prerank,positive regulation of neuron projection development (GO:0010976),-0.2429709119660107,-0.9412962990933387,0.5932203389830508,0.8908945734410353,1.0,27/85,20.95%,PTK2B;SETX;ITGA6;SCN1B;MAGI2;TENM3;ATP1B2;NDRG4;SCARB2;NTRK3;TWF2;BDNF;SERPINI1;ALK;CAPRIN1;NDNF;EPHA3;RAPGEF1;FUT9;GPC2;ZDHHC15;DBN1;PLXNB2;PLA2G3;PLXNB3;WNT5A;TWF1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2851407454208195,0.9411300285444084,0.5570839064649243,0.8063275273633185,1.0,13/87,7.43%,NRROS;ITGB1;RPS27A;ADAM9;CBL;RHOA;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;USP15;DUSP22
prerank,regulation of ion transport (GO:0043269),0.2968258146641336,0.9408138527264696,0.5449358059914408,0.8065114038487936,1.0,9/76,7.65%,P2RX7;DRD1;KCNJ14;SNX6;B2M;PRKN;WNK1;CHRNA4;HFE
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3762191798218471,-0.9405809148058758,0.5524625267665952,0.8916355209850362,1.0,5/13,11.01%,ASPH;LGMN;TBC1D10A;CYFIP2;GRIN2A
prerank,translational elongation (GO:0006414),0.28111957211851957,0.9404242358846767,0.553475935828877,0.8068244762373313,1.0,19/101,14.28%,MRPL23;MRPS12;EEF1A1;EEFSEC;ERAL1;MRPL13;RACK1;MRPL33;MRPS25;MRPS11;EEF1D;MRPL1;MRPL49;MRPL16;MRPS17;GTPBP1;MRPL44;MRPS34;MRPS14
prerank,sensory organ development (GO:0007423),-0.2666666250076249,-0.9400895477939047,0.5726744186046512,0.8917941221458019,1.0,16/51,22.72%,CHD7;PBX2;BMPR1B;AHI1;RAB18;SHROOM2;MEIS3;PAX8;MEIS1;SMG9;HIPK1;PBX1;TGFB2;FOXC1;PBX4;SALL2
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3798972191798015,-0.9398207809615843,0.5413043478260869,0.8913770650712345,1.0,6/13,22.29%,TRIM28;TRIM13;TRIM11;TRIM21;CHMP3;TRIM8
prerank,regulation of cellular catabolic process (GO:0031329),0.30160414940838476,0.9390347023118892,0.5710186513629842,0.8094251917805716,1.0,10/62,8.94%,NUPR1;DAPK1;LAMP3;PRKN;MTMR3;ROCK1;HSPB1;DRAM1;DRAM2;SMCR8
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3809246942361159,-0.9390044970051601,0.5162689804772235,0.8923660888301369,1.0,2/13,2.22%,CALM2;SLC8A1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.42532738002284654,0.9388958095259665,0.5647969052224371,0.8092429965394005,1.0,2/11,5.17%,PRKN;RACK1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.3969324924282001,0.9386570820337399,0.5149384885764499,0.8092858008912674,1.0,1/15,0.66%,IL16
prerank,spliceosomal snRNP assembly (GO:0000387),-0.282001218522958,-0.9385801546771125,0.6036745406824147,0.8923869720603803,1.0,20/38,36.03%,GEMIN2;SRSF10;DDX20;PRPF19;CD2BP2;SRSF12;STRAP;TGS1;PRPF6;SART1;SART3;PRPF31;AAR2;SNUPN;SNRPC;SNRPF;GEMIN6;SNRPD3;GEMIN5;PRMT7
prerank,spinal cord development (GO:0021510),-0.37693478670648906,-0.9385530398997692,0.547945205479452,0.8913363428539525,1.0,4/12,20.83%,NF1;LOXL3;VIT;SOX11
prerank,regulation of DNA binding (GO:0051101),-0.2819975173673168,-0.9385361663947284,0.5649717514124294,0.8902616351491026,1.0,16/44,23.95%,JAK2;DOT1L;SIRT2;HABP4;JUN;MDFI;EDF1;SMO;EGF;TXN;MAPK8;FOXC1;TGFB1;HMGB1;LEF1;ILRUN
prerank,positive regulation of type I interferon production (GO:0032481),0.29564953949720074,0.9382817942105302,0.5666666666666667,0.8096190426068153,1.0,14/73,13.71%,TLR8;OAS2;PTPN22;TLR4;TLR2;TRIM56;RIOK3;LRRFIP1;STAT6;RIPK2;CREBBP;DHX33;POLR3D;EP300
prerank,cardiolipin metabolic process (GO:0032048),0.40945256031384253,0.9377309248155449,0.5335820895522388,0.8102983248276802,1.0,6/13,21.53%,PNPLA8;HADHA;HADHB;PTPMT1;TAMM41;LCLAT1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.288108423228103,0.9377031036376404,0.544,0.8098658780177098,1.0,21/80,18.02%,EIF3E;NIBAN1;SAMD4A;RPL26;VIM;RACK1;RPS4X;TNF;RPL5;LARP4B;SP1;ROCK2;TNFRSF1A;LARP4;PIWIL2;RELA;PYM1;IL6;PICALM;IFNGR1;EFNA1
prerank,artery morphogenesis (GO:0048844),0.346701175461116,0.9373182484332274,0.5284280936454849,0.8102394098259965,1.0,3/30,4.52%,NRP1;JAG1;HEY2
prerank,carboxylic acid transport (GO:0046942),-0.2648588276569689,-0.9372015991244442,0.5739130434782609,0.8926728461980616,1.0,14/55,17.28%,SLC16A6;SLC36A1;SLC16A3;CLN3;SLC36A4;SLC16A1;SLC1A1;SLC7A8;SLC17A5;SLC16A4;PSAP;SLC16A9;LLGL2;SLC25A10
prerank,anterior/posterior axis specification (GO:0009948),0.3971884030181623,0.9371415793467818,0.5452991452991452,0.8101404555538371,1.0,3/15,17.12%,HOXD8;WLS;LHX1
prerank,regulation of RNA splicing (GO:0043484),0.2988678628538368,0.9371068246590526,0.5463623395149786,0.8097108129996702,1.0,11/69,9.33%,AHNAK;MBNL1;ERN1;RPS13;LARP7;PTBP3;MBNL2;HNRNPF;PTBP2;GRSF1;DYRK1A
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.3420359152595869,-0.9370782116482719,0.5280373831775701,0.8918957274481045,1.0,8/17,24.59%,AUP1;UFD1;NPLOC4;SYVN1;SELENOS;TMEM129;FAF2;SEC61B
prerank,phagosome-lysosome fusion (GO:0090385),0.4280940120389033,0.9370694848156312,0.5146198830409356,0.8092861883656357,1.0,3/10,8.12%,PIKFYVE;RAB7B;RAB7A
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.34010170144789564,0.9367219723983573,0.539291217257319,0.8095466781287287,1.0,3/33,3.83%,ANG;MEF2C;HMOX1
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.3275700512330111,-0.9365820319315786,0.5603015075376885,0.8921034400991135,1.0,3/21,7.13%,HK2;TALDO1;RPIA
prerank,ear morphogenesis (GO:0042471),-0.3329461314689614,-0.9360754262504803,0.5227272727272727,0.8922851491636079,1.0,6/20,16.18%,CHD7;FGFR2;MYO6;PAX8;ZIC1;EPHB2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.356647389745961,0.9360272126870726,0.5257731958762887,0.8105675007722288,1.0,6/23,12.39%,GNG2;DRD1;PRKN;GNB1;KCNQ1;ATP2B4
prerank,negative regulation of coagulation (GO:0050819),0.4013354663059807,0.9358074554501168,0.5340909090909091,0.8105566074312017,1.0,1/14,0.49%,APOE
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.31620829512055904,0.9357752435185623,0.5378787878787878,0.8101312097573475,1.0,22/44,27.47%,ZFP36L2;ZFP36L1;RC3H1;ROCK1;NANOS3;ROCK2;ZC3H12A;GTPBP1;TNRC6C;CNOT8;CNOT1;GIGYF2;METTL16;CPEB3;FTO;TOB1;YTHDF3;AGO2;CELF1;NANOS1;ZFP36;YTHDF1
prerank,synaptic vesicle recycling (GO:0036465),0.33833840257020015,0.9352331025510079,0.5391014975041597,0.8108221550650448,1.0,4/31,7.75%,FCHO2;OPHN1;SYNJ1;CANX
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3782912880390549,0.9351858707815724,0.5352622061482821,0.8104368430520759,1.0,3/18,4.84%,RAP1B;RAP1A;GSK3B
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4035108361066403,-0.9349840589039552,0.5685840707964602,0.8939945765453605,1.0,5/11,22.19%,CPSF6;AKAP8L;DHX9;SETD2;NRDE2
prerank,negative regulation of cell growth (GO:0030308),-0.22741028658043896,-0.9349727036011408,0.6271929824561403,0.8929146596751704,1.0,25/121,17.01%,APBB2;MAP2;PTPRS;TP53;DIP2B;FGF13;BTG1;OSGIN2;STK11;FLCN;PPT1;DCBLD2;ENO1;CCAR2;DNAJB2;MAG;HYAL1;GNG4;APBB1;MINAR1;SMARCA2;BCL6;ULK1;ACVR1B;MUL1
prerank,polyol metabolic process (GO:0019751),-0.267614381770032,-0.9347758697744055,0.5884057971014492,0.8923308409647414,1.0,9/46,11.20%,INPP4B;INPP5D;PLCB2;PLD4;PLCB4;PLCG1;MINPP1;PLCB1;PLCH1
prerank,postsynaptic membrane organization (GO:0001941),-0.34790910077222525,-0.9343164326198505,0.5602678571428571,0.8924231657511934,1.0,6/17,13.24%,NLGN1;NRXN1;DLG4;DNAJA3;LRRC4;SHISA7
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3880112349757495,0.9341398594856746,0.5539823008849557,0.8122079743521071,1.0,2/16,4.20%,RGCC;VIM
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.4248177776320829,0.9341206224364745,0.5342205323193916,0.8117666032771971,1.0,4/11,18.74%,GNPDA1;GFPT2;UAP1L1;RENBP
prerank,monocarboxylic acid metabolic process (GO:0032787),0.275415538804422,0.9338471003906859,0.5736235595390525,0.8118650710763121,1.0,13/117,10.02%,AOAH;CD36;UGT1A7;UGT1A8;UGT1A1;PNPLA8;GLO1;SGPL1;PDHB;ACOT12;IGF1;CYP26B1;ACSL3
prerank,protein auto-ADP-ribosylation (GO:0070213),0.41306317831643624,0.9330073508060679,0.5572232645403377,0.8132249023719516,1.0,3/12,10.39%,PARP8;PARP11;PARP16
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.33778163070717315,-0.9326780945018754,0.5573770491803278,0.8956224457344865,1.0,3/17,1.36%,BIN1;SORL1;RTN1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.39619911962255516,0.93247179061855,0.5348399246704332,0.8138712769679508,1.0,1/15,0.45%,EGFR
prerank,DNA replication (GO:0006260),0.2725936705104752,0.9323400748688008,0.5710455764075067,0.8136681684220392,1.0,20/105,13.93%,RBMS1;RBBP8;ORC5;FAM111A;MCMBP;POLE2;ORC2;MCM9;CHEK1;TOPBP1;TIPIN;RPA1;BRIP1;TOP1MT;POLG2;RHNO1;POLE3;RPA3;KAT7;KIN
prerank,positive regulation of dendrite extension (GO:1903861),-0.3453119208344126,-0.9319508034911085,0.549889135254989,0.8963647613823047,1.0,2/17,2.20%,RIMS1;RIMS2
prerank,positive regulation of angiogenesis (GO:0045766),0.27961859500768493,0.9318187638795346,0.5480378890392422,0.814328188971406,1.0,24/108,14.60%,SASH1;ITGB1;S100A1;GRN;HMOX1;CD40;PIK3R6;HSPB1;STIM1;KLF4;PRKCB;GAB1;ADAM12;TNFSF12;FOXC2;NINJ1;MYDGF;SP1;JUP;JAK1;ZC3H12A;RAMP2;MDK;PRKD2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.39378371185083966,-0.931607140643278,0.5667396061269147,0.8961452991080291,1.0,5/11,21.19%,AUP1;BAG6;UFD1;RNF5;TOR1A
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.33822896233931465,0.9315847919616747,0.5530546623794212,0.8143502115219595,1.0,5/32,7.26%,BABAM2;NOP53;CHEK1;BRCC3;TOPBP1
prerank,neurotrophin signaling pathway (GO:0038179),-0.3178366498044892,-0.9312520337792256,0.5403899721448467,0.895965871950116,1.0,4/21,6.77%,SORT1;MAGI2;ZFYVE27;BDNF
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.25051469564735046,-0.931073897752548,0.58125,0.8953179725507294,1.0,15/62,15.54%,GTF2H2;CDK9;CCNT2;MLLT1;CCNH;SSRP1;NELFB;CTR9;ERCC2;PAF1;NELFCD;NCBP1;POLR2C;EAF1;ELOB
prerank,response to organophosphorus (GO:0046683),0.3921448959670617,0.93090266691539,0.5563258232235702,0.8152398064026385,1.0,1/16,0.51%,P2RX7
prerank,regulation of leukocyte migration (GO:0002685),0.3856541667294941,0.9307551619446757,0.5242537313432836,0.8150733188076532,1.0,2/16,3.83%,BST1;HMOX1
prerank,myelination in peripheral nervous system (GO:0022011),0.39814265834211715,0.9306922114669759,0.559322033898305,0.8147236552331738,1.0,1/13,0.88%,ADGRG6
prerank,visual perception (GO:0007601),0.2893434765112044,0.9300777096052244,0.5611038107752957,0.8155573560437045,1.0,11/84,11.47%,ATXN7;RAX;DHRS3;PITPNA;CRYBG3;MYO7A;DRAM2;ATF6;BEST1;WFS1;MYO9A
prerank,positive regulation of cellular component movement (GO:0051272),-0.30937060897735086,-0.9299301311530116,0.5488721804511278,0.8971402920843012,1.0,4/24,5.06%,TGFBR1;ETS1;CCDC25;STK11
prerank,negative regulation of hippo signaling (GO:0035331),0.4119979582693357,0.9297223711797219,0.5265151515151515,0.8158342397463989,1.0,7/12,20.04%,LIMD1;MAPK14;WWC1;VGLL4;MARK3;DLG5;WWC2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29012679509995837,0.9293940742553425,0.5679886685552408,0.8160148223124686,1.0,13/76,12.36%,FBXW7;PIAS1;PRICKLE1;AXIN1;BCL10;BIRC3;NDFIP1;MYCBP2;TSPYL5;CUL3;RIPK2;WFS1;ZC3H12A
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2906426226195052,-0.929111574633884,0.5710382513661202,0.8981449950418232,1.0,9/35,12.69%,EML3;DYNC1H1;GNAI1;CEP97;HNRNPU;CHMP4B;TACC3;NUMA1;PARP3
prerank,positive regulation of blood coagulation (GO:0030194),0.3860856996359169,0.9288810275392048,0.5365853658536586,0.8166309418658447,1.0,5/17,18.10%,ANO6;ENPP4;USF1;ST3GAL4;F2R
prerank,negative regulation of protein polymerization (GO:0032272),-0.3136561229286382,-0.9287074666663342,0.536986301369863,0.898073139433331,1.0,8/27,15.90%,PRKCD;MAP2;TBCD;TWF2;ARFGEF1;EML2;MAPRE1;CLIP3
prerank,protein O-linked mannosylation (GO:0035269),-0.34380359012751277,-0.9286941539060405,0.5609195402298851,0.897001750766915,1.0,3/18,9.87%,LARGE1;TMTC4;TMTC2
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.35565088705024506,-0.9285318017579719,0.5573033707865168,0.8963217218559932,1.0,8/16,26.85%,BLM;RECQL5;SSBP1;MCM6;RAD51;MCM2;MCM7;MCMDC2
prerank,regulation of cellular localization (GO:0060341),0.31178461390732237,0.9283629164954996,0.5317460317460317,0.8172037982835413,1.0,17/46,20.57%,LYN;FER;NR1H4;NR1D1;PRKN;MAD1L1;TTL;TRIM67;UNC13D;WWC1;REEP6;KDM1A;HSP90AB1;FES;DVL3;STXBP2;EPHA5
prerank,transcription by RNA polymerase III (GO:0006383),-0.3078740196324512,-0.9283066457886058,0.584,0.8958706563980825,1.0,11/27,30.45%,IVNS1ABP;GTF3C2;ICE2;POLR3G;ELL;POLR2L;BRF1;TBP;ICE1;SNAPC1;POLR3GL
prerank,phosphatidylserine metabolic process (GO:0006658),-0.2948150243412599,-0.928042980556279,0.5695538057742782,0.895478266677705,1.0,7/32,19.46%,ABHD12;PTDSS1;PTDSS2;LPCAT3;ABHD16A;SERINC1;PLA2G3
prerank,protein-containing complex subunit organization (GO:0043933),0.27517822612141785,0.928032367544305,0.5851063829787234,0.8174428885507985,1.0,15/109,8.74%,SNX9;KMT2A;REPS2;MITF;CD74;SKAP2;WIPF1;ST13;CD40;DARS1;HFE;NUP133;TUBGCP2;RANBP9;MDM2
prerank,error-prone translesion synthesis (GO:0042276),0.3557942931776433,0.9279054569059998,0.5451327433628319,0.8172270617206496,1.0,5/21,12.38%,RPS27A;POLE2;RPA1;POLH;RPA3
prerank,iron ion transport (GO:0006826),0.31660438571278815,0.9278931779206618,0.5647590361445783,0.8167719499703159,1.0,12/47,16.30%,CP;CLTC;STEAP3;ATP6V1B1;ATP6V0A1;HFE;ATP6V1A;FTH1;TFR2;ABCB7;MELTF;ATP6V0D1
prerank,inositol phosphate catabolic process (GO:0071545),0.42420172732370415,0.9274907408173235,0.5520446096654275,0.8171584374183022,1.0,5/12,22.87%,SYNJ1;OCRL;PTEN;INPP5K;INPP1
prerank,calcium ion transport into cytosol (GO:0060402),-0.3221971200912743,-0.927465359073536,0.5452380952380952,0.8959102379287976,1.0,5/21,11.79%,SLC8A1;CACNA2D1;JPH1;GRIN2A;CACNA1C
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3599616771982811,0.9274367862053557,0.55,0.8168115059557469,1.0,6/24,9.79%,PPHLN1;JARID2;SPI1;EPC1;TRIM27;H3-3A
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3698722358933355,-0.9273088661263507,0.5397849462365591,0.895244631779263,1.0,2/12,2.28%,CTNNB1;HDAC8
prerank,regulation of lymphocyte activation (GO:0051249),-0.3748028848558169,-0.9269187492114217,0.5605095541401274,0.8952451198258402,1.0,1/12,0.26%,PAG1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3381933550851686,0.9265248158600169,0.5451505016722408,0.818319082267475,1.0,12/30,24.92%,HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,heterochromatin organization (GO:0070828),0.3958252260232157,0.9263411030748833,0.5527210884353742,0.8182178049627783,1.0,4/14,17.56%,SETDB2;POLE3;LOXL2;MECOM
prerank,pancreas development (GO:0031016),0.4124730558636655,0.9262978280901399,0.5451127819548872,0.8178323205189137,1.0,1/12,0.84%,TCF7L2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4124089268649846,0.9259557697275914,0.5502742230347349,0.8180080306490078,1.0,3/12,9.95%,IRS2;INSR;IGF1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.37372631725912536,0.9259367611354258,0.5437392795883362,0.8175587519775889,1.0,3/18,7.60%,ZFP36L2;ZFP36L1;CCR2
prerank,negative regulation of RNA splicing (GO:0033119),0.3750609048104341,0.9258893239047061,0.5311942959001783,0.8171863191901534,1.0,4/19,8.01%,RPS13;PTBP3;SRSF4;PTBP2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.40596899640893597,-0.9256419316334433,0.5731958762886598,0.8974505759011453,1.0,3/10,9.13%,PRKCE;HECW2;HECW1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.41899016841639936,0.9252462528189992,0.5592233009708738,0.8180825902421603,1.0,1/11,2.02%,MEF2C
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.248394905381792,0.9243617729022703,0.6437158469945355,0.8194502934764187,1.0,66/341,15.10%,WWP1;RNF150;FBXW7;SMURF2;PSMA7;ARIH1;FBXL17;SIAH2;CBL;PELI1;RMND5A;PRKN;CLOCK;ZNRF3;NDFIP1;USP9X;RC3H1;SPOP;TRIM32;ANKIB1;CDC27;VPS4B;APPBP2;PSMB2;TBL1XR1;BIRC6;SPOPL;RNF19B;MDM2;TBL1X;UBE2D3;UBE2K;COP1;CUL3;ANAPC16;ARMC8;ZFAND2B;VPS37C;UBQLN4;FBXO11;RNF14;ARRB1;RNF111;AMFR;PSMA6;UBE3B;RNF185;TRIM71;MIB1;FBXO10;RNF115;UBE2R2;AGAP3;RBBP6;RNF187;RNF19A;BFAR;NDFIP2;NEDD4L;PSMD5;PSMD1;PSMA3;ELOC;ANAPC1;RNF122;WDR91
prerank,positive regulation of secretion (GO:0051047),0.4167162469324186,0.9241378061789698,0.5351043643263758,0.819412988494529,1.0,3/11,17.38%,ACSL3;TRH;XBP1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.2959706358698235,0.9235802533907386,0.5856741573033708,0.8201282996445353,1.0,12/67,14.57%,CYBB;PSMA7;CD36;B2M;PSMB2;NCF2;SNAP23;PSMA6;PSMD5;PSMD1;PSMA3;CYBA
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2845810362578774,0.9234247945623985,0.5954907161803713,0.8199963099591479,1.0,19/87,16.14%,ZFP36L2;PSMA7;RGCC;ZFP36L1;CDK6;RB1;KLF4;PSMB2;CDC73;KANK2;PSMA6;CDKN2C;PSMD5;PSMD1;PSMA3;PKD2;PINX1;USP47;PTEN
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3203049036698081,0.9230043998766426,0.5782945736434109,0.8203987029102433,1.0,8/42,11.70%,TLR4;LBP;DROSHA;RPL30;RNASE6;IL6R;ROMO1;CHGA
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.36466409475953954,-0.9227359549256011,0.5478260869565217,0.9040519615085191,1.0,5/13,20.04%,IL33;RAMP1;PLCB1;GOLGA2;ABCA2
prerank,mitotic recombination (GO:0006312),0.39278073463689145,0.9224309948298922,0.5233968804159446,0.8211969777234408,1.0,7/15,24.64%,NSMCE2;RAD52;DMC1;SMC6;XRCC3;RAD51D;ERCC1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.3773418033017829,-0.9223305873746755,0.556989247311828,0.9040417071235488,1.0,3/12,9.24%,HNRNPU;PCGF5;BRCA1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.33746590188200487,0.9222958967032387,0.5640194489465153,0.8210131172485895,1.0,4/30,8.66%,RAB31;SPTBN1;RAB10;GOLPH3L
prerank,V(D)J recombination (GO:0033151),0.4209208161410787,0.9221780256553929,0.5668549905838042,0.8207943375337926,1.0,2/11,13.05%,LIG4;XRCC4
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3508597506531702,-0.922064323343797,0.5606060606060606,0.9036588641981377,1.0,2/15,2.06%,KCNJ2;ATP1B1
prerank,metal ion transport (GO:0030001),-0.23710126441036095,-0.9218941168444563,0.6090534979423868,0.9030360166681337,1.0,18/86,12.91%,CDH23;SLC8A1;NIPA1;TRPC4;CACNA2D1;RAMP1;GRIN3A;CACNA1D;TRPC1;SLC30A9;CACNA1E;TRPC3;CCL3;CACNG7;CACNA1C;ATP2C1;CACNG8;TRPC5
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.31232691182265193,-0.9218725351415172,0.5853018372703412,0.9019881853884315,1.0,4/25,6.22%,LYST;SORT1;CHMP4B;CHMP4A
prerank,muscle cell differentiation (GO:0042692),0.333618051493476,0.9218370372019911,0.5564387917329093,0.8210065855300814,1.0,8/32,17.60%,MEF2C;NRAP;HEY2;NINJ1;NEB;POPDC3;KDM1A;GLMN
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3612577099325458,0.9218290778205255,0.5561139028475712,0.8205430386638247,1.0,1/22,0.13%,AHNAK
prerank,tRNA aminoacylation (GO:0043039),-0.2837496054382175,-0.9217689650557399,0.5686813186813187,0.9011424748069073,1.0,20/37,34.02%,FARSA;AARS1;CARS1;NARS1;TARS1;YARS1;IARS2;SARS1;DARS2;SARS2;HARS2;FARSB;WARS1;VARS1;PPA2;KARS1;QRSL1;HARS1;AIMP2;AIMP1
prerank,regulation of calcium ion import (GO:0090279),-0.31910422012112427,-0.9216040526041911,0.5301204819277109,0.900433848162962,1.0,5/21,12.24%,CTNNB1;PRNP;CCL3;WNK3;PLPP4
prerank,regulation of anoikis (GO:2000209),0.3712669380375259,0.9213789085772623,0.5452865064695009,0.8210050794783069,1.0,3/19,6.29%,ITGB1;MCL1;BCL2
prerank,chordate embryonic development (GO:0043009),0.2989843721465976,0.921350415193659,0.575075075075075,0.8205877679639303,1.0,12/55,14.61%,FGFR1;MBNL1;LIG4;BMP2;MYH6;GRHL2;ZNF568;SULF2;HINFP;TRIM71;RBP4;PKD2
prerank,regulation of telomere capping (GO:1904353),-0.3087154820987964,-0.9213498511777434,0.5848101265822785,0.9000052410146021,1.0,5/23,13.10%,ATM;MAPK3;MAP2K7;TERF2;MAP3K4
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3383376823235159,-0.9213129735898652,0.5662921348314607,0.8989971466563617,1.0,8/17,21.52%,BIN1;SERPINE2;TENM4;ID2;EGR2;NOTCH1;CLCF1;TGFB1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.3628370435170981,-0.9210807557565057,0.5747126436781609,0.898497630819105,1.0,10/13,40.01%,ALG1;ALG12;ALG8;ALG3;SRD5A3;ALG6;DPAGT1;ALG14;ALG13;MPDU1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.35263943489439414,0.9201809150487189,0.5363036303630363,0.8224893054719299,1.0,2/25,1.79%,CMKLR1;BST1
prerank,protein-DNA complex assembly (GO:0065004),0.2723204993902477,0.920016991700208,0.6121372031662269,0.8223754648802324,1.0,25/116,17.70%,PADI4;TCF4;PSMA7;RPS27A;ORC5;ORC2;PSMB2;RPA1;GMNN;ATRX;H3-3A;CETN2;PSMA6;XPA;RPA3;XPC;PSMD5;PSMD1;PSMA3;GTF2H3;MCM8;ANP32B;ASF1A;GTF2H1;DMC1
prerank,cholesterol biosynthetic process (GO:0006695),0.3352828082632649,0.9193449159008383,0.5538720538720538,0.8232958685024879,1.0,12/31,24.92%,HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,DNA repair (GO:0006281),-0.19716214099182217,-0.9191957552014214,0.7580645161290323,0.9023070155276905,1.0,62/284,17.33%,HERC2;GTF2H2;CSNK1E;DNA2;XRCC5;SETX;TP53;UBE2B;ACTR8;INTS3;ASCC1;ATRIP;ATM;HPF1;PARP1;DDB2;ENDOV;PRIMPOL;ERCC6;FANCE;DOT1L;SLC30A9;RNF168;BLM;UPF1;RECQL5;ERCC2;BRCA1;ALKBH2;MLH3;TNKS1BP1;HUS1;LIG1;RAD51C;TRIM28;XRCC1;BRCA2;KDM4A;FANCD2;UBXN1;PPP5C;PARP3;GADD45A;NEIL3;APBB1;RFC2;RPAIN;POLI;DDX1;FANCA;CHEK2;PARP4;FAAP100;ASCC2;PARK7;TDP1;RAD51AP1;CENPX;MSH2;HUWE1;DCLRE1B;POLE
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3254765121535755,0.9187684095467442,0.5705521472392638,0.8240234856125043,1.0,6/38,11.10%,RIPK1;HMOX1;GSK3B;SFRP1;SP100;CASP8
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4243916272999672,0.9186430192364051,0.5733082706766918,0.8233248652596454,1.0,5/11,22.87%,SYNJ1;OCRL;PTEN;INPP5K;INPP1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4243916272999672,0.9186430192364051,0.5733082706766918,0.8233248652596454,1.0,5/11,22.87%,SYNJ1;OCRL;PTEN;INPP5K;INPP1
prerank,gonad development (GO:0008406),-0.2690405995699582,-0.9184422242383732,0.5880758807588076,0.9031234830023439,1.0,10/41,21.37%,SALL1;BASP1;AR;NCOA4;MSH2;WNT4;COL9A3;TGFB2;WNT5A;MKKS
prerank,Golgi to lysosome transport (GO:0090160),0.4221935365610311,0.9181346561352316,0.5456273764258555,0.8238778946344711,1.0,2/11,4.54%,ANKFY1;LAMP1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.42851460433208116,0.9167236977513157,0.5535055350553506,0.8263896964064991,1.0,1/10,1.12%,FBXW7
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2757277143154632,0.9160096040661377,0.6185286103542235,0.8274483972079413,1.0,14/100,10.07%,EGFR;FGFR1;LYN;CBL;IRS2;INSR;PDGFRA;NOP53;TNF;GAB1;PDGFC;MYDGF;IGF1;PIP5K1A
prerank,diol metabolic process (GO:0034311),0.36658885277320225,0.9156867247160159,0.5672413793103448,0.8276296675006221,1.0,3/19,10.64%,SGPP1;GCH1;CALM1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.37953651047441894,0.9156438415597288,0.5482233502538071,0.8272447609091046,1.0,2/17,6.29%,SFN;BCL2
prerank,regulation of lipid storage (GO:0010883),0.35705503993457854,0.9148524613794257,0.5334448160535117,0.828386281367167,1.0,4/22,12.36%,FBXW7;TNF;VSTM2A;ZC3H12A
prerank,aorta development (GO:0035904),0.40217726281743654,0.9146842734062304,0.5534709193245778,0.82826788607683,1.0,5/14,16.62%,JAG1;PDE2A;ADAMTS9;PKD2;TBX2
prerank,protein insertion into ER membrane (GO:0045048),0.32236930043062945,0.9146569049271585,0.571875,0.8278323679634925,1.0,6/37,12.63%,APP;HMOX1;SERP1;TRAM2;EMC7;VAPA
prerank,mitochondrion organization (GO:0007005),0.2584183430695525,0.9137225553239934,0.6426767676767676,0.829331457511933,1.0,19/165,12.65%,PID1;IMMP2L;MEF2A;MTM1;PRKN;ATP7A;HIGD1A;PITRM1;NIPSNAP2;FMC1;CYCS;CHCHD3;COX7A2L;POLG2;MTX1;VPS13C;RAB5IF;MGME1;PYROXD2
prerank,organelle disassembly (GO:1903008),-0.2900478096085445,-0.9136610948516484,0.590027700831025,0.9145584181168616,1.0,14/33,28.43%,RETREG1;GFM2;MTIF2;ATG2A;EIF2D;PLK3;ZFAND1;ULK1;GOLGA2;DENR;UBA5;CDK1;KIF5B;DYRK3
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4301549206885495,0.913638983894218,0.5575868372943327,0.8290372205901197,1.0,1/10,1.24%,ZBTB16
prerank,glutathione metabolic process (GO:0006749),-0.27114307537892735,-0.9135316974696868,0.6117021276595744,0.9137896826030858,1.0,6/38,16.09%,HPGDS;GGT5;GSS;GGT7;CTNS;PARK7
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.269895858139031,-0.9130959776834159,0.601078167115903,0.9137923105982437,1.0,12/38,21.85%,CENPC;UBN1;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;ASF1B;CABIN1;CENPN;CENPP;CENPH
prerank,positive regulation of cellular senescence (GO:2000774),-0.3956975515789399,-0.9127915734214218,0.5747863247863247,0.91351717791606,1.0,3/10,13.69%,ABI3;CGAS;YPEL3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.32014100866605916,-0.912289168865921,0.5912408759124088,0.913698014715788,1.0,3/19,1.36%,BIN1;SORL1;RTN1
prerank,negative regulation of cell division (GO:0051782),0.4191123980095874,0.9122168896257075,0.5551257253384912,0.8315769776005517,1.0,3/11,15.89%,TXNIP;MYC;E2F8
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3527474404208198,-0.9116728887406651,0.5809312638580931,0.9142443467629712,1.0,4/13,8.47%,STK11;ATM;SESN3;CASTOR2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.29453078387099996,0.9110524476342037,0.6084425036390102,0.8335575554082495,1.0,13/66,12.82%,EGFR;ANKRD17;RGCC;CDK6;RB1;KLF4;CCND3;CDC73;CCND2;TFDP1;KANK2;CDKN2C;KMT2E
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.21983448364178373,-0.9109651022582659,0.7136929460580913,0.9150291605962971,1.0,24/119,15.04%,INPP4B;INPP5D;PIK3CB;PGAP2;PITPNM1;PIP5K1C;EFR3B;PLEKHA1;FGF2;PI4KA;SOCS2;PIK3R4;PITPNM3;TTC7B;SYNJ2;INPP5F;SOCS7;PIK3C2B;PIK3R5;MTMR4;MBOAT7;CDS1;PIP4K2B;PIP4K2C
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4041276055219614,-0.9108407168055112,0.6012793176972282,0.9142305500701506,1.0,3/10,9.13%,PRKCE;HECW2;HECW1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4142470933036137,0.9107448976528096,0.5891891891891892,0.8337399281550649,1.0,2/11,6.34%,PPHLN1;SETDB2
prerank,regulation of cellular response to stress (GO:0080135),0.2679078685874382,0.9105519994240999,0.6026666666666667,0.8336591380947664,1.0,21/115,12.45%,ALOX5;NUPR1;CEBPB;PRKN;MCL1;GSK3B;MAPKAPK2;MANF;BAG3;RPA1;NUP133;HSBP1;NUP62;CREBBP;AMFR;CRYAB;YWHAE;ROCK2;SLC38A2;RPA3;NUP98
prerank,secondary alcohol metabolic process (GO:1902652),0.3149206951439553,0.9104956792364248,0.5899843505477308,0.833319969008308,1.0,11/42,20.32%,APOE;UGT1A4;CLN6;CYP27A1;OSBPL1A;CLN8;OSBPL5;IDH1;PIP4P1;IDH2;NSDHL
prerank,ESCRT complex disassembly (GO:1904896),0.41406539049158164,0.9103693725786103,0.5649819494584838,0.8326113033276782,1.0,2/10,10.53%,VPS4B;CHMP5
prerank,ESCRT III complex disassembly (GO:1904903),0.41406539049158164,0.9103693725786103,0.5649819494584838,0.8326113033276782,1.0,2/10,10.53%,VPS4B;CHMP5
prerank,apoptotic cell clearance (GO:0043277),-0.2956384566068416,-0.910254516968747,0.5984455958549223,0.9145782845914279,1.0,12/30,19.14%,XKR6;TREM2;TGM2;ITGB3;RHOBTB2;XKR4;RHOH;TYRO3;ADGRB1;SCARB1;ITGAV;RHOG
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.3127568691384167,-0.9102318335308203,0.60880195599022,0.9135400237434854,1.0,6/22,11.65%,KRI1;WDR12;EXOSC9;NOP14;URB1;FTSJ3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.28191205493430854,0.9101059349998102,0.6,0.8326980164492654,1.0,20/86,16.55%,KLF2;PSMA7;RPS27A;HMOX1;HIGD1A;CHEK1;BAG3;PSMB2;LIMD1;BACH1;CREBBP;PSMA6;EP300;HIF3A;PSMD5;PSMD1;PSMA3;ELOC;MAPK7;ARNT
prerank,regulation of coagulation (GO:0050818),-0.38328477578644365,-0.9099594701733599,0.5866935483870968,0.9131276572234033,1.0,3/11,26.57%,HS3ST5;EPHB2;PROCR
prerank,phospholipid biosynthetic process (GO:0008654),0.3201767233339027,0.9099527321805303,0.6016129032258064,0.832537240283306,1.0,7/36,10.27%,SGMS1;CPNE7;AGPAT5;DOLPP1;PIP5K1A;HDHD5;NUS1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.39647898517594193,0.9095804388241151,0.5735294117647058,0.8328101024198229,1.0,3/13,14.28%,LAMP1;SYK;ITGB2
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3182531831347348,-0.9088818151151654,0.6109839816933639,0.9147019311932929,1.0,13/21,42.02%,COX19;COX15;COX16;FASTKD3;TIMM21;COA6;COX17;COX14;COA3;OXA1L;SURF1;COX20;COX18
prerank,peptidyl-lysine modification (GO:0018205),0.2769800523543425,0.9087464041703371,0.6236559139784946,0.8340544335066804,1.0,20/99,17.23%,HDAC9;PIAS1;LOX;ATP7A;PIAS2;NSMCE2;VCPKMT;ESCO1;NUP133;NUP62;PLOD1;LOXL2;NUP98;EEF1AKMT3;EP300;USPL1;HDAC4;SENP1;NUP153;SENP6
prerank,regulation of cellular response to heat (GO:1900034),-0.2377545003805871,-0.9086933676841491,0.6666666666666666,0.9140636698921603,1.0,22/77,20.21%,RPTOR;DNAJC7;NUP210;RANBP2;ATM;MAPK3;MAPT;PTGES3;CCAR2;CD34;NUP85;HSF1;IER5;SEH1L;MLST8;DNAJB1;MTOR;AAAS;SEC13;FKBP4;CAMK2D;BAG5
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.4244785448610686,0.9083362204064627,0.578268876611418,0.834440046386749,1.0,4/10,17.59%,TNFRSF1B;EMILIN1;TNFRSF1A;FAP
prerank,stress-activated MAPK cascade (GO:0051403),0.29585565002947734,0.9082772700702878,0.6065808297567954,0.8340989090513187,1.0,12/61,13.17%,MAP3K5;RPS27A;ZFP36L1;CCM2;MAP3K8;MAPK14;MAP3K20;RIPK2;PTGER4;MAP3K11;NOD2;UBE2N
prerank,regulation of heart contraction (GO:0008016),0.27742552044411434,0.9082700707266025,0.607681755829904,0.8336388217854555,1.0,18/90,14.94%,ATP2B1;FXYD2;S100A1;MYH6;PDE4D;TMEM65;STIM1;KCNG2;PLN;CALM1;KCNQ1;ATP2B4;NPPC;ATP1A4;ATP1A3;ATP1A1;ATP2A2;ITPR3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.39494217508602525,-0.9082126443298492,0.5666666666666667,0.9141570776320976,1.0,3/10,24.01%,NCKAP1L;TGFBR2;CD81
prerank,copper ion homeostasis (GO:0055070),0.36833573651770585,0.9081735543951867,0.5568965517241379,0.8333624752119126,1.0,2/17,5.45%,APP;ATP7A
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.3329157757632935,-0.9078461242340263,0.5981941309255079,0.9139625233520401,1.0,3/17,7.64%,NLGN1;RAB27A;SCAMP5
prerank,RNA interference (GO:0016246),0.36747415675706263,0.9078016324045372,0.5848056537102474,0.8336695647111303,1.0,3/17,13.30%,PRKRA;DROSHA;MRPL44
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.2863303278477874,-0.9074480756717247,0.5846560846560847,0.9138384503012063,1.0,14/31,33.86%,SCAMP5;SYT6;CBARP;SYT8;SYT1;SYT13;SYT7;SYT5;STXBP1;SYT17;CACNA1H;ADRA2A;STX1A;CACNA1G
prerank,glutamine family amino acid catabolic process (GO:0009065),0.39845754754082935,0.9072038871248538,0.5899653979238755,0.8344276694079261,1.0,3/13,13.04%,DAO;GLS2;GLUD1
prerank,response to ionizing radiation (GO:0010212),0.28835466769059637,0.9071007926273125,0.594017094017094,0.8341679171768476,1.0,17/70,15.21%,LIG4;BABAM2;CLOCK;BRCC3;TOPBP1;MAPK14;COP1;NHEJ1;KDM4D;EEF1D;SPIDR;RHNO1;BRAT1;XRCC4;NET1;USP28;MYC
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.30120231961593974,-0.9068401424557375,0.6101694915254238,0.9143169774432448,1.0,5/28,9.10%,IRAK2;CYLD;IRGM;OTULIN;AAMP
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3058352052001698,0.9068110562643527,0.5892053973013494,0.8342728229758425,1.0,10/52,12.54%,FBXW7;YWHAQ;SFN;BCL2;UBE2D3;TFDP1;CASP8;SREBF2;YWHAE;PPP1R13B
prerank,cellular response to chemical stress (GO:0062197),0.27595730994836976,0.9067141903625983,0.6163101604278075,0.8340220390274388,1.0,21/96,17.17%,CYBB;LRRC8D;SLC25A24;VRK2;MSRA;RAD52;CYCS;TXNRD2;ATG7;NCF2;FOXO3;RBM11;ZC3H12A;ERO1A;FOXO1;CYBA;PKD2;PPIA;NOX4;PRDX3;PRDX2
prerank,kidney development (GO:0001822),-0.24278829769049814,-0.90664433366083,0.6656151419558359,0.9136944023495558,1.0,10/65,12.73%,TGFBR1;SALL1;ROBO2;IFT88;NF1;SULF1;BAG6;VANGL2;PAX8;PROX1
prerank,cation transport (GO:0006812),-0.2079614949406373,-0.9064911889135137,0.7848837209302325,0.9130264308202222,1.0,27/167,16.73%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;SLC8A1;SLC36A1;SGK1;TRPM3;FGF13;CLN3;PIEZO1;SLC38A7;SLC36A4;KCNA2;KCNA1;SLC11A2;SLC1A1;SCN8A;SLC7A8;PIEZO2;TMEM63C;KCNS3;SCN1A;KCNK9;KCNN2;ABCC9;KCNK6
prerank,regulation of primary metabolic process (GO:0080090),0.2627947259825944,0.90602353651471,0.6280566280566281,0.8349944929670726,1.0,18/126,11.89%,APOE;LDLR;PSMA7;NCOA2;NR1D1;HMGCR;IRS2;PSMB2;TBL1XR1;NCOR1;NCOA6;TBL1X;PMVK;SP1;CREBBP;SREBF2;PSMA6;ROCK2
prerank,response to hydroxyurea (GO:0072710),0.40929425694157073,0.9060143775515115,0.5809859154929577,0.834528648072626,1.0,4/11,13.81%,DDX11;ATRX;SPIDR;KAT7
prerank,sister chromatid segregation (GO:0000819),-0.29196918384155324,-0.9053322680443481,0.6162464985994398,0.9148730957024448,1.0,15/31,32.47%,WRAP73;TOP2A;NDC80;NUSAP1;NSL1;CDCA8;KIFC1;ZW10;ESPL1;ZWINT;SPAG5;SGO1;LATS1;TUBG1;KIF18B
prerank,regulation of cholesterol transport (GO:0032374),-0.3281815117610082,-0.9053259480697912,0.5995370370370371,0.9138105066276829,1.0,9/20,32.66%,OSBPL6;APOC1;ABCB4;ABCA2;ARV1;ABCA5;ABCA13;LRP1;YJEFN3
prerank,stress granule assembly (GO:0034063),-0.3225492560861578,-0.9051492953842694,0.5717592592592593,0.9131613545831885,1.0,8/20,22.48%,DYNC1H1;ATXN2L;MAPT;OGFOD1;CIRBP;ATXN2;G3BP1;PRRC2C
prerank,metanephric mesenchyme development (GO:0072075),-0.3944196297472484,-0.905012202139852,0.5808510638297872,0.9124898846809596,1.0,2/10,2.99%,BASP1;STAT1
prerank,zinc ion transport (GO:0006829),-0.31751603508662846,-0.9049752008084921,0.6302083333333334,0.9115145726943304,1.0,8/21,31.48%,SLC30A9;SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,hepaticobiliary system development (GO:0061008),-0.32284040595783725,-0.9049395600466832,0.6235011990407674,0.9105508489752839,1.0,7/20,21.85%,NF1;TGFBR3;PROX1;CDK5RAP3;PHF2;WNT4;ARID5B
prerank,cellular response to acid chemical (GO:0071229),-0.29302936052491974,-0.9044304549781926,0.6067961165048543,0.9107823589377607,1.0,12/27,27.27%,RPTOR;IPO5;NSMF;RRAGD;GLRA1;RRAGB;MTOR;SESN2;GLRA2;CPEB1;RRAGA;SH3BP4
prerank,striated muscle contraction (GO:0006941),-0.2542554983151259,-0.9036030261093915,0.6606606606606606,0.9118118486362142,1.0,7/53,7.28%,ATP1B1;SCN1B;SLC8A1;ALDOA;GRK2;DTNA;GAA
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.31682138602164417,0.9034397341184369,0.5641838351822503,0.8392818726979648,1.0,5/36,8.66%,RAB31;SPTBN1;RAB10;RAB7A;GOLPH3L
prerank,sulfur compound transport (GO:0072348),0.3381450882155338,0.9034322133527737,0.5638474295190713,0.8388165601579649,1.0,11/27,21.93%,LRRC8D;SLC26A11;MGST1;SLC26A7;SLC25A30;SLC6A6;SLC35F3;SLC5A6;RACGAP1;SLC13A4;SLC26A8
prerank,regulation of cell communication (GO:0010646),-0.2833789735557761,-0.9033548907177004,0.6039325842696629,0.9114055448297164,1.0,10/35,16.24%,MGLL;SLC8A1;ANK2;GRK2;SOCS2;GRK3;SCG5;NCLN;CXADR;MTCH1
prerank,positive regulation of vacuole organization (GO:0044090),0.4196320271316858,0.9033455210367567,0.6072106261859582,0.8385229432480469,1.0,4/10,17.71%,GRN;ANXA2;RALB;PIP4K2A
prerank,hippo signaling (GO:0035329),-0.30228583179112484,-0.9032802052334877,0.600997506234414,0.910535982836596,1.0,7/26,12.00%,TJP1;FAT4;TJP2;WWTR1;YWHAB;TEAD1;DVL2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.30609108569728655,0.9030382585055908,0.5961251862891207,0.8386848227575063,1.0,8/46,8.54%,OPHN1;MEF2C;TSHZ3;DRD1;TNF;CCR2;HOMER1;MAPK8IP2
prerank,central nervous system myelination (GO:0022010),-0.37817715908073163,-0.9024823319709759,0.6167023554603854,0.911422348797181,1.0,3/11,11.31%,PLP1;TENM4;SOX10
prerank,transition metal ion transport (GO:0000041),-0.2731167699542956,-0.9024589763406156,0.5939226519337016,0.9104284801152676,1.0,9/35,12.91%,ATOX1;TTYH1;TRPC4;TRPC1;SLC30A9;TRPC3;SLC11A2;ATP2C1;TRPC5
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3294320918315037,-0.9024503743923277,0.6168674698795181,0.9093887097099984,1.0,7/18,19.40%,PTK2B;NLGN1;NRXN1;CACNG7;CACNG8;CACNG4;CACNG2
prerank,positive regulation of vasculature development (GO:1904018),0.273190340512324,0.9024349117867309,0.6239669421487604,0.839491930052585,1.0,18/94,12.84%,SASH1;ITGB1;GRN;HMOX1;CD40;PIK3R6;HSPB1;STIM1;PRKCB;GAB1;ADAM12;TNFSF12;NINJ1;MYDGF;SP1;JUP;ZC3H12A;RAMP2
prerank,supramolecular fiber organization (GO:0097435),0.24195648680260864,0.9023835429591978,0.7082872928176795,0.8391154347323541,1.0,62/333,16.03%,HIP1;TGFBI;APP;MYO5A;ITM2B;FLII;TMOD1;RPS27A;MTM1;CD36;FIGNL2;RIPK1;SIAH2;MYH6;DPT;CDC42;RHOA;B2M;PRKN;VIM;LOX;TMOD3;USP9X;ATP7A;KATNAL2;MYO7A;VPS4B;ARHGAP12;COL22A1;COL9A2;RHOBTB1;MFAP4;COL14A1;DDR2;TUBGCP2;MDM2;CORO1C;H3-3A;PXDN;MYO1C;MYO1E;EMILIN1;ARHGAP17;PLOD1;LOXL2;CORO7;RND3;CGNL1;COL24A1;P4HA2;KATNAL1;TPM3;PCM1;TNXB;RHOC;KLHL24;ELMO3;STMN1;TSPAN14;NCSTN;MARCKSL1;HSP90AB1
prerank,male meiosis I (GO:0007141),0.3727969052617004,0.9023769819282792,0.5475352112676056,0.8386515402814698,1.0,2/16,9.28%,MOV10L1;FOXJ3
prerank,xenobiotic transport (GO:0042908),0.37199675761631823,0.9023386681672604,0.5986038394415357,0.8382503490282651,1.0,3/17,13.13%,SLC22A18;ABCC1;GJA1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.36051213365073703,0.902331334268794,0.5897887323943662,0.8377929562341999,1.0,4/19,13.74%,SULT1A1;PAPSS2;SLC35B3;SULT6B1
prerank,lamellipodium assembly (GO:0030032),0.33618377214395145,0.9023105551169123,0.5792163543441227,0.8373543491245414,1.0,11/26,24.18%,ITGB1;VCL;S1PR1;PARVB;SPEF1;GOLPH3;ARFIP2;ARHGEF6;KIT;PTPRO;CCDC88A
prerank,cellular response to starvation (GO:0009267),0.25952470987116383,0.9020025756449374,0.6518987341772152,0.8375156402178462,1.0,41/147,19.09%,MAP3K5;PRKAG2;CEBPB;SESN1;ATP6V1B1;PRKAG3;MTMR3;AOC1;NPRL3;STK24;MIOS;WIPI1;KLF10;FNIP1;ATP6V1A;SFRP1;LAMP2;ATG7;GAS2L1;SREBF2;FOXO3;LAMTOR5;ZC3H12A;FOXO1;RALB;MFSD2A;SZT2;NPRL2;XPR1;WIPI2;GABARAP;ATP6V0D1;ATG5;XBP1;LARS1;RHEB;TBL2;RRAGC;EIF2AK2;ATF2;EIF2AK4
prerank,outflow tract septum morphogenesis (GO:0003148),0.344812539792391,0.9019981495323764,0.5697674418604651,0.8370503197351065,1.0,2/24,5.16%,NRP1;SMAD4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3669446016953606,-0.9019918672044541,0.5986842105263158,0.9094824045471007,1.0,5/12,25.14%,CHMP4B;CHMP4A;SEC61A1;SEC61B;SGTA
prerank,axonal fasciculation (GO:0007413),-0.3734378216805886,-0.9015544160940321,0.6027944111776448,0.9094684337833651,1.0,6/12,29.66%,CNTN4;EPHA3;EPHB2;NRCAM;EPHB3;AMIGO1
prerank,regulation of multicellular organismal development (GO:2000026),0.34350740353703507,0.9012980281433441,0.5779967159277504,0.8380060450138994,1.0,5/25,14.14%,OAS2;INSR;RAB14;CCSAP;EHMT1
prerank,positive regulation of nuclear division (GO:0051785),-0.29710659620103935,-0.9009587565529811,0.5695876288659794,0.9099073024832857,1.0,3/25,3.83%,TGFA;LRP5;IL1A
prerank,regulation of blood coagulation (GO:0030193),0.33619094933781685,0.9008573816777294,0.562610229276896,0.8384388500148331,1.0,6/27,18.10%,APOE;ENPP4;ST3GAL4;TFPI;FAP;F2R
prerank,protein heterotetramerization (GO:0051290),-0.36932359174287505,-0.9008118670668394,0.5939675174013921,0.9092568166535651,1.0,2/13,2.91%,CPSF6;FARSA
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.31587972782180107,-0.9004380979481883,0.5958904109589042,0.9091391368460059,1.0,3/20,5.56%,SEMA4D;SEMA4C;SEMA4G
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.34666171669155077,0.9004260620161026,0.5704697986577181,0.8388110570172655,1.0,3/23,5.44%,SMURF2;SMAD4;TRIM33
prerank,tRNA processing (GO:0008033),-0.2473289193602012,-0.9003198970235878,0.6531986531986532,0.9083769510184557,1.0,33/61,33.63%,AARS1;QTRT1;TRDMT1;PTCD1;CSTF2;TRNT1;SARS1;ANKRD16;POP1;DDX1;QTRT2;TRMT9B;FAM98B;CLP1;RPP21;METTL1;THUMPD1;CTU2;AARS2;RTCB;TSEN54;TRMT10B;TSEN15;POP7;THG1L;KARS1;ADAT2;PUS3;TRPT1;TRMT6;DTWD1;SSB;ADAT1
prerank,regulation of defense response to virus by host (GO:0050691),-0.28664447495882484,-0.9002256895337133,0.6475644699140402,0.9075656477000982,1.0,11/30,21.08%,STAT1;MAVS;RNF216;CGAS;PQBP1;ZDHHC1;MUL1;TARBP2;DHX9;PARP9;TRAF3IP2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4021398848804205,0.9001233095894173,0.5763636363636364,0.8389801694116268,1.0,4/11,15.76%,TIPIN;GMNN;ZRANB3;FBH1
prerank,insulin secretion (GO:0030073),0.36050815834450683,0.8992977537950506,0.5704347826086956,0.8401934200199171,1.0,1/19,0.52%,RAB11FIP5
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3863495962333895,0.8992052173106592,0.59375,0.8399057573109822,1.0,3/14,7.60%,OXSR1;WNK1;CCR2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3570598512567723,0.8989412800530056,0.5777777777777777,0.8399400876911748,1.0,6/19,13.56%,GHRL;CD33;CARD16;IGF1;ZC3H12A;FFAR1
prerank,chemical homeostasis (GO:0048878),0.29141979675179813,0.898925734608311,0.6141141141141141,0.8395057719839714,1.0,7/61,7.79%,FBXW7;ZBTB20;IRS2;PNPLA8;WNK1;SLC4A4;SLC4A5
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.24484951078717862,-0.8989184741609543,0.6655518394648829,0.9097379271572419,1.0,17/65,18.02%,INTS3;SKP1;PSMD13;PSMD12;RBX1;FBXL7;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PABIR1;CDK5RAP3;PSMB8;ZFYVE19;PSME1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3918336773159489,0.8985762056799268,0.5644283121597096,0.839769014928035,1.0,2/12,8.17%,ERN1;ATF6
prerank,iron ion transmembrane transport (GO:0034755),-0.3820842089148282,-0.8982153721063161,0.5785288270377733,0.9103876486961394,1.0,3/10,15.68%,SLC40A1;SLC11A2;SLC39A14
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3094957876816891,0.8981651674488695,0.6113744075829384,0.8401099740447523,1.0,9/45,12.37%,EGFR;RIPK1;ERN1;NMD3;GRSF1;DYRK1A;HEATR1;ZC3H18;SLC38A2
prerank,histone H2A acetylation (GO:0043968),-0.33775168679754686,-0.898097183330565,0.6194895591647331,0.9096467920778819,1.0,5/16,14.59%,MORF4L2;NAA40;BRD8;MORF4L1;RUVBL1
prerank,regulation of trophoblast cell migration (GO:1901163),0.38843017757660997,0.8976898034342635,0.5698529411764706,0.8405853326332913,1.0,3/14,14.77%,SMURF2;GJA1;ARHGDIB
prerank,histone H4 acetylation (GO:0043967),0.2982010552444034,0.8974405424793923,0.6057401812688822,0.8406107264485668,1.0,13/47,16.51%,KMT2A;PHF20;DMAP1;EPC1;BEND3;TRIM16;KANSL2;HAT1;KANSL1;EP300;KAT7;HCFC1;PER1
prerank,diol biosynthetic process (GO:0034312),0.3800592440922598,0.8974359940474349,0.5679245283018868,0.8401470692991856,1.0,3/15,6.15%,GCH1;ACER3;SPTLC2
prerank,response to hexose (GO:0009746),-0.2983791005979189,-0.8973914778221416,0.6132315521628499,0.9103396914708782,1.0,5/25,7.08%,PFKL;SELENOT;EIF2B3;LPL;SLC2A5
prerank,positive regulation of axon extension (GO:0045773),0.3624380316537381,0.8970840087994839,0.5865724381625441,0.8403923156967981,1.0,1/22,0.34%,NRP1
prerank,negative regulation of transmembrane transport (GO:0034763),0.41550772294859006,0.8969238062580209,0.5934291581108829,0.8402229893613833,1.0,2/10,7.51%,IRS2;PRKCB
prerank,cellular response to cadmium ion (GO:0071276),0.34078638488110613,0.8966794701241652,0.5797598627787307,0.8402726382867655,1.0,1/24,0.45%,EGFR
prerank,negative regulation of chemokine production (GO:0032682),-0.3540893898928448,-0.896416041137144,0.5879629629629629,0.9115418696510548,1.0,2/14,5.51%,SIRPA;APOD
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.41598556299441697,0.8963970241383508,0.6003717472118959,0.840361988151689,1.0,1/10,3.54%,RGCC
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.2795613741964742,-0.8963546803225257,0.638961038961039,0.9106718851165576,1.0,9/31,20.83%,TGFBR1;HOXC4;FGFR2;DSCAML1;HOXA3;TGFBR2;HOXB9;DYNC2I1;SOX11
prerank,alpha-amino acid catabolic process (GO:1901606),-0.28729562918501245,-0.8958226309333487,0.6016483516483516,0.9109413713231124,1.0,10/29,23.33%,KYNU;ACADSB;FAH;IL4I1;SARDH;ALDH4A1;PRODH;HSD17B10;HOGA1;MTRR
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3202788530494634,0.8956598424955206,0.6159874608150471,0.8413946287128045,1.0,5/33,8.51%,LYN;ADAM9;ITGB1BP1;SYK;FOXC2
prerank,Golgi organization (GO:0007030),-0.21888758079247678,-0.8952880582588643,0.7489539748953975,0.9112596424205792,1.0,33/112,22.28%,PLEKHM2;CLASP2;OPTN;CSNK1A1;COG3;GCC2;ATP8B1;LYSMD3;PLK3;VTI1B;COG4;SURF4;STX16;ARFGEF1;DYNC2H1;NSFL1C;RAB2A;COG2;ARL1;TBC1D20;NPLOC4;HUWE1;TMED1;TANGO2;TMED7;GOLGA2;DNAJC28;BET1;BAG5;ZW10;GOSR2;TRAPPC12;FBXW8
prerank,striated muscle cell differentiation (GO:0051146),0.3677429220566185,0.8952519030104311,0.5774134790528234,0.8417540130219601,1.0,2/16,2.61%,MEF2C;BMP2
prerank,chromosome organization (GO:0051276),-0.22509181455667296,-0.8950481666793232,0.7283464566929134,0.9108148865753865,1.0,34/99,22.22%,LDB1;HDAC8;CUL4A;SAFB;BRWD1;COPS7A;FAM50A;PARP1;COPS8;DDB2;GATAD1;RBX1;DOT1L;COPS4;HDAC11;LRWD1;HMGN1;HDAC5;TOP2A;PADI2;COPS6;NDC80;GPS1;MSH2;PHF1;HDAC3;CDCA8;UBB;CENPV;HDAC1;MTF2;CENPH;BAHD1;HMGN2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.39549313573946243,0.894991129046227,0.5834862385321101,0.8418044959692735,1.0,3/13,9.95%,IRS2;INSR;IGF1
prerank,embryonic skeletal system development (GO:0048706),-0.27150218203328896,-0.8949602374081856,0.6422287390029325,0.9099858989697328,1.0,10/35,20.83%,KIAA1217;XYLT1;HOXC4;SULF1;DSCAML1;HOXA3;HOXB9;DYNC2I1;WNT5A;SOX11
prerank,membrane assembly (GO:0071709),-0.2786685653946708,-0.8946091288517053,0.6752577319587629,0.9097917660367031,1.0,9/34,14.90%,PTPRD;NLGN1;NRXN1;FLOT1;CHMP4B;TLCD2;NSFL1C;IL1RAPL1;STX2
prerank,protein localization to microtubule organizing center (GO:1905508),0.37509410181280867,0.8940253390600483,0.5836363636363636,0.8432703338489158,1.0,4/15,14.13%,PIBF1;SNX10;CCDC14;PCM1
prerank,anterograde axonal transport (GO:0008089),-0.27067571420480185,-0.8938094176073458,0.6498599439775911,0.9106608595567632,1.0,9/37,13.92%,DLG2;KIF1A;KIF5A;KIF5C;AP3B2;AP3D1;KIF1C;KIF3A;KIF3B
prerank,nucleosome assembly (GO:0006334),0.3293173310250823,0.8937204685719417,0.5993485342019544,0.8433865870430024,1.0,11/31,22.27%,PADI4;ATRX;H3-3A;HAT1;ANP32B;ASF1A;IPO4;NAP1L2;CHAF1B;NPM1;GRWD1
prerank,mRNA 3'-end processing (GO:0031124),-0.2321917386875557,-0.8935580894107606,0.6907216494845361,0.9102308288808725,1.0,22/78,19.69%,CPSF6;THOC1;SRRM1;SRSF5;PABPN1;DDX39B;SRSF3;RPRD1A;SRSF2;CSTF2;RNPS1;PAF1;U2AF1;UPF3B;CASC3;NCBP1;CLP1;THOC3;SRSF11;SRSF9;AHCYL1;POLDIP3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.3964702274488739,0.8930108372616435,0.5913200723327305,0.8443660147405923,1.0,6/13,24.39%,GNPDA1;GFPT2;UAP1L1;RENBP;SLC35A3;UAP1
prerank,mitotic nuclear division (GO:0140014),0.28621376164443874,0.8929760142505794,0.6420612813370473,0.843961311671826,1.0,15/71,18.81%,EPS8;PIBF1;RHOA;STAG2;CLASP1;NUP62;STAG1;SPICE1;RAB11A;ABRAXAS2;CENPK;CCDC61;KPNB1;SMC4;NDEL1
prerank,regulation of pH (GO:0006885),0.3988010965308644,0.8929081547307728,0.608286252354049,0.8436206273106887,1.0,3/11,14.02%,ATP6V1B1;ATP1A4;SLC9A7
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.28164156581735844,0.8926972892367249,0.640218878248974,0.8435716051094633,1.0,7/73,7.55%,KMT2A;PSMA7;TCF12;KITLG;SPI1;CBFB;PSMB2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.392098221320768,-0.8924030059492898,0.6046966731898239,0.9119455592204975,1.0,6/10,36.31%,BRCA1;CTBP1;TAF7;THAP7;SIRT1;NOC2L
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.34526853026334653,0.8913313886199006,0.5728314238952537,0.8458617693793273,1.0,9/24,22.44%,CCL19;TRPM2;ERO1A;IBTK;PKD2;ITPR3;F2R;PTPRC;PLCG2
prerank,protein import into peroxisome matrix (GO:0016558),-0.36196526219504765,-0.891214054688173,0.6065934065934065,0.9138384408433431,1.0,3/12,11.79%,PEX5L;PEX6;PEX10
prerank,recombinational repair (GO:0000725),0.2761231322385041,0.8908424865050928,0.6262203626220363,0.8463922652793917,1.0,20/77,15.93%,RBBP8;MCM9;NSMCE2;YY1;RPA1;RAD52;KDM4D;SPIDR;RHNO1;RPA3;AP5S1;SFR1;UBE2N;MMS22L;SEM1;RAD51B;SAMHD1;SFPQ;FBH1;MCM8
prerank,peptidyl-serine modification (GO:0018209),-0.20508845674450438,-0.8907951018377525,0.8205128205128205,0.9137899083474518,1.0,31/166,13.67%,TGFBR1;PRKCD;CSNK1E;MAST4;PRKCE;GALNT3;SGK1;CSNK1A1;GRK2;STK38L;ATM;RPS6KA1;HPF1;PARP1;PDK3;GALNT13;CAMK4;MAP3K12;DCLK3;DYRK2;CDC7;NEK6;SRPK2;RPS6KA2;IKBKE;PDPK1;AKT3;NDNF;DYRK1B;MAP4K1;TGFBR2
prerank,protein localization to chromosome (GO:0034502),0.3249745593966038,0.8907244655838851,0.6163934426229508,0.8461610795337874,1.0,13/34,20.94%,ESR1;RB1;MCM9;RPA1;ATRX;TERF2IP;XRCC4;PINX1;MCM8;ATR;CTCF;TNKS2;TINF2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3888607484087798,0.8903760605253384,0.5822784810126582,0.8464037733276697,1.0,2/13,7.74%,HEY2;PSEN1
prerank,regulation of histone acetylation (GO:0035065),0.3147939330275428,0.8900799600796175,0.6265625,0.8465469827068395,1.0,6/33,12.46%,KMT2A;SPI1;CHEK1;IWS1;ARRB1;TADA2B
prerank,regulation of G0 to G1 transition (GO:0070316),0.3072611807344323,0.8899671375416431,0.6232114467408585,0.8462993716068068,1.0,7/38,11.08%,RBBP8;RYBP;EPC1;CHEK1;TFDP1;RHNO1;PHC3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3246015181785866,0.8897936268759262,0.5798192771084337,0.8461726319099974,1.0,4/33,2.69%,MAP3K5;RPS3;OSER1;RIPK1
prerank,protein kinase A signaling (GO:0010737),0.38828686543972474,0.8895640864826339,0.594,0.8461504515750109,1.0,5/12,25.72%,LCP1;PRKACB;EZR;RAB13;MYOM1
prerank,positive regulation of hormone secretion (GO:0046887),0.3625154113833738,0.8895333061612789,0.5791304347826087,0.8457311306935279,1.0,6/17,20.39%,C1QTNF3;HFE;TFR2;SNX4;VAMP8;NMB
prerank,aminoglycan biosynthetic process (GO:0006023),-0.25595848537164306,-0.8893117341943919,0.6685552407932012,0.9162242887525042,1.0,21/49,26.23%,XYLT1;GCNT2;HS3ST5;HS6ST1;B3GALT1;SDC2;B3GALT5;B3GALT2;HS3ST3B1;B3GNT2;B4GALT7;GPC6;PXYLP1;GPC2;GPC5;UGDH;B3GALT6;GPC1;HSPG2;HS3ST1;HAS1
prerank,negative regulation of DNA binding (GO:0043392),-0.2963901538256881,-0.8893084216944913,0.6413612565445026,0.9151943317733807,1.0,9/28,24.69%,JAK2;HABP4;JUN;MDFI;SMO;SOX11;LEF1;ILRUN;SIN3A
prerank,alanine transport (GO:0032328),-0.38714363024944354,-0.889272675828622,0.6024844720496895,0.9142334039894391,1.0,2/10,9.18%,SLC36A1;SLC36A4
prerank,negative regulation of neuron differentiation (GO:0045665),0.3415715439359419,0.8890167668595528,0.5877342419080068,0.8463129812825533,1.0,2/22,4.84%,B2M;GSK3B
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.38635353972399356,0.8888907925050636,0.5932203389830508,0.8460929936624662,1.0,2/13,3.60%,SPRED1;RPL26
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.41313523471083957,0.8886788056743163,0.5941747572815534,0.8460518555825004,1.0,1/10,1.55%,ESR1
prerank,regulation of blood circulation (GO:1903522),0.3217125045542905,0.8886596954393513,0.6243980738362761,0.8456335202057447,1.0,5/34,11.91%,S100A1;MYH6;KCNG2;PLN;KCNQ1
prerank,positive regulation of telomere capping (GO:1904355),-0.3234935219825622,-0.88860134611053,0.6153846153846154,0.9148042463614576,1.0,3/17,13.10%,MAPK3;MAP2K7;MAP3K4
prerank,P-body assembly (GO:0033962),0.3913101038361917,0.8885916247304078,0.5623800383877159,0.8453036630543739,1.0,4/12,12.92%,RC3H1;LIMD1;DDX6;LSM4
prerank,microtubule bundle formation (GO:0001578),-0.26186683269252586,-0.8884596166334596,0.6463414634146342,0.9141260624857841,1.0,10/42,12.36%,CFAP74;LRGUK;CCDC66;NCKAP5L;MTCL1;NCKAP5;SPAG16;TPPP;TOGARAM1;NUMA1
prerank,cellular response to retinoic acid (GO:0071300),-0.266519331958673,-0.8881191060458795,0.6584699453551912,0.9139048718234211,1.0,6/42,6.32%,PTK2B;SETX;BRINP3;ATM;TWF2;HTRA2
prerank,regulation of phospholipid metabolic process (GO:1903725),0.42576634485782217,0.8879213189609351,0.6123260437375746,0.8461622987693763,1.0,3/10,16.03%,MTMR3;MFSD2A;MTMR1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3264953779627319,-0.887828323704118,0.6270783847980997,0.9135632508378277,1.0,6/18,20.31%,TIMM44;TOMM40;GRPEL1;TOMM20;TOMM40L;TIMM21
prerank,nerve growth factor signaling pathway (GO:0038180),0.4084576153395071,0.8876662159756034,0.5834797891036907,0.8462002196448137,1.0,2/10,4.82%,RAPGEF2;RAP1A
prerank,positive regulation of chemotaxis (GO:0050921),0.30181461724313347,0.887579958669125,0.6204268292682927,0.8459068124979505,1.0,8/43,14.60%,NRP1;CCL19;HSPB1;CCR2;IL6R;DSCAM;MDK;PRKD2
prerank,transferrin transport (GO:0033572),0.31893202559229966,0.8866533441317874,0.6182965299684543,0.8473398550681325,1.0,6/33,8.41%,CLTC;STEAP3;ATP6V1B1;ATP6V0A1;HFE;ATP6V1A
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2874891756864859,0.8865406433647897,0.6168639053254438,0.8470983301885161,1.0,8/62,8.74%,TPT1;PRKN;MCL1;BCL2L2;TRIM32;BCL2;HSPB1;MDM2
prerank,cellular response to pH (GO:0071467),0.364539539596046,0.8863501662079847,0.6161971830985915,0.8470230333685145,1.0,1/17,0.52%,RAB11FIP5
prerank,negative regulation of dephosphorylation (GO:0035305),0.36211055078870086,0.8861703445837825,0.5947368421052631,0.8469146458809016,1.0,3/18,11.48%,MFHAS1;PPP1R26;ARPP19
prerank,positive regulation of organelle assembly (GO:1902117),-0.2592877881497012,-0.886054774904934,0.6348314606741573,0.9166768152721316,1.0,16/44,24.62%,ASAP1;DYNC1H1;STX18;CROCC;CCP110;ENTR1;NUMA1;PIP4K2B;PIP4K2C;LRSAM1;KCTD17;RAB3GAP2;BBS4;G3BP1;PLK4;TAPT1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3444649894931241,-0.8858485820170073,0.6247086247086248,0.916116270992146,1.0,4/14,10.25%,CSF1;MAPK3;AKIRIN1;CSF1R
prerank,positive regulation of peptidase activity (GO:0010952),0.3504810145141213,0.8854640716990847,0.6115107913669064,0.8478584747583828,1.0,2/20,3.28%,RCN3;GRN
prerank,response to cadmium ion (GO:0046686),0.33333994403393713,0.8851367802460752,0.6054888507718696,0.8480456141716801,1.0,1/26,0.45%,EGFR
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3109583767036739,-0.884494593444438,0.639618138424821,0.9183022879814262,1.0,9/22,19.18%,MAN1B1;MAN1C1;RNF103;EDEM1;TRIM13;MAN1A2;RNF5;UBB;SYVN1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.2937766799520095,0.8843165860999954,0.6331877729257642,0.8491953630648155,1.0,20/52,19.77%,DNAJC3;ERN1;SERP1;WIPI1;DDX11;CTDSP2;MYDGF;PARP16;SRPRB;WFS1;SHC1;ADD1;EXTL2;ATP6V0D1;CUL7;EXTL1;XBP1;LMNA;PPP2R5B;ERN2
prerank,regulation of kinase activity (GO:0043549),0.26895963625539693,0.8842959932147281,0.6617647058823529,0.8487621028770632,1.0,9/89,5.36%,EGFR;FGFR1;EEF1A1;CD74;IRS2;RB1;INSR;CAMKK2;PDGFRA
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3390810225821595,0.884163328335447,0.6013745704467354,0.848556762164099,1.0,7/24,20.29%,LIG4;RPS27A;RPA1;RPA3;RFC3;POLD2;PCNA
prerank,protein targeting to mitochondrion (GO:0006626),-0.24960740353174785,-0.8840638196850537,0.6834319526627219,0.9183342318925921,1.0,23/52,32.15%,FBXO7;HSPA4;SAMM50;TIMM44;GDAP1;TOMM40;TIMM8B;GRPEL1;AIP;TOMM20;TOMM40L;TIMM29;TIMM21;AGK;BCAP31;TOMM34;FIS1;TOMM5;IMMP1L;TIMM17B;TIMM13;DNLZ;CHCHD4
prerank,negative regulation of catalytic activity (GO:0043086),-0.2996080865321127,-0.8837070158778065,0.6335078534031413,0.9181758695311549,1.0,14/24,35.98%,TP53;CLN3;NOSIP;CCAR2;NOTCH1;PARP9;HDAC6;TMBIM1;PHPT1;CAND1;SIRT1;TIMP1;OXA1L;HP
prerank,metanephros development (GO:0001656),-0.2916621446898274,-0.8833098654767028,0.6666666666666666,0.9180641349510311,1.0,4/26,11.73%,BASP1;ROBO2;NF1;PAX8
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3344815937294695,0.8832869221944525,0.5993150684931506,0.8498094273455581,1.0,6/26,14.94%,C1QTNF12;IRS2;INSR;IGF1;ARPP19;OSBPL8
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3865433217117795,0.8831656543331982,0.573502722323049,0.8495830824598901,1.0,2/13,5.76%,NKAP;CBFB
prerank,inorganic cation transmembrane transport (GO:0098662),-0.1922648059987718,-0.88312617099743,0.8852459016393442,0.9174864789498859,1.0,48/268,16.73%,SLC1A3;KCND2;KCNH7;SLC12A2;KCNJ2;SLC24A3;SLC24A2;ATP1B1;SCN1B;SLC8A1;SLC36A1;SLC9A8;MCOLN3;TRPM3;SLC40A1;KCNQ3;TRPC4;CACNA1D;TRPC1;ATP6V1H;NALCN;SLC24A4;KCNQ5;TRPC3;SLC39A11;KCNK2;KCNA2;KCNA1;SLC11A2;KCNK12;SLC25A14;SCN8A;CACNA1C;ATP6V0C;ATP2C1;TRPC5;KCNS3;SCN1A;HVCN1;KCNK9;COX15;SLC39A13;SLC39A14;KCNN2;SLC6A1;ABCC9;SLC9A1;KCNK6
prerank,nuclear transport (GO:0051169),0.36259088182180893,0.8828090928312887,0.573943661971831,0.8497957856738575,1.0,7/16,22.19%,RSRC1;BANF1;NUP98;XPO1;RGS14;RBM15B;NPM1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.27508277340316156,-0.8826617929687126,0.6712328767123288,0.9175869721317148,1.0,4/31,6.62%,HNRNPA2B1;ATM;MAPK3;MAP2K7
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.26085874064109077,0.8826323465532464,0.6624843161856964,0.8496740314857644,1.0,14/124,6.21%,APOE;APP;OPHN1;LYN;EHD1;RAPGEF2;LRP12;TTC29;GSK3B;RB1;ROCK1;FRY;MANF;BLOC1S5
prerank,regulation of lipid metabolic process (GO:0019216),0.2700892225027996,0.8823559857635271,0.6574585635359116,0.8498010263235753,1.0,14/88,11.69%,PRKAG2;NCOA2;NR1D1;HMGCR;IRS2;TBL1XR1;NCOR1;NCOA6;TBL1X;PMVK;SP1;CREBBP;SREBF2;NPC2
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.33350848674929706,-0.8822766683749355,0.5897435897435898,0.9174360299764336,1.0,6/16,23.20%,NAA40;NAA60;NAA35;NAA25;NAA80;NAA30
prerank,negative regulation of organelle assembly (GO:1902116),0.3100706217567619,0.8821266304934606,0.6141479099678456,0.8497871555929798,1.0,5/35,8.94%,NUPR1;MTM1;FEZ2;SMAD4;SMCR8
prerank,chromatin assembly (GO:0031497),0.3150440916412806,0.8819502156341725,0.6288,0.8496809073269559,1.0,12/38,22.27%,PADI4;ATRX;LIN54;H3-3A;POLE3;ANP32B;ASF1A;CTCF;NAP1L2;CHAF1B;NPM1;GRWD1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3566610729840448,0.8815305177522529,0.6103448275862069,0.8500594245012152,1.0,4/18,12.12%,PHF8;RASL11A;HEATR1;DHX33
prerank,cell junction organization (GO:0034330),0.2796056250259471,0.8814822110519229,0.646896551724138,0.8496803840105981,1.0,9/71,7.74%,APP;C1QA;OPHN1;CDC42;RAB8B;RHOA;GRHL2;ACTB;PSEN1
prerank,glycine transport (GO:0015816),-0.3866364121245117,-0.8813919449917851,0.625,0.9184126640086687,1.0,2/10,11.60%,SLC36A1;SLC7A8
prerank,chondrocyte differentiation (GO:0002062),0.3229859422099257,0.8813289820388374,0.6507413509060955,0.8495115040987965,1.0,3/32,2.61%,MEF2C;OSR1;BMP2
prerank,acidic amino acid transport (GO:0015800),-0.324763812970601,-0.8812496755573955,0.6122448979591837,0.9177157694321683,1.0,7/17,27.19%,SLC1A3;SLC1A1;SLC25A22;SLC6A1;SLC1A2;SLC25A13;GIPC1
prerank,T cell receptor signaling pathway (GO:0050852),0.2517866441793241,0.8810787876099309,0.6566037735849056,0.8495213178965398,1.0,25/138,14.60%,PTPRJ;PSMA7;PTPN22;DENND1B;RFTN1;NFKBIZ;BCL10;THEMIS2;PAK2;RC3H1;PDE4D;WNK1;ZAP70;PSMB2;FYN;RIPK2;EIF2B1;PSMA6;ZC3H12A;UBE2N;FYB1;PSMD5;PSMD1;PSMA3;PRKD2
prerank,neural crest cell development (GO:0014032),-0.2597951326726428,-0.8810286915633153,0.6813186813186813,0.9172610148416105,1.0,7/44,11.31%,SEMA4D;CDH2;SEMA4C;KLHL12;SEMA4G;ERBB4;SOX10
prerank,positive regulation of cell division (GO:0051781),0.3148379055514656,0.8808885970740814,0.6477272727272727,0.8494295909894365,1.0,6/38,11.94%,KIF20B;CDC42;RHOA;PKN2;CUL3;SVIL
prerank,steroid metabolic process (GO:0008202),0.2768951729572631,0.8807371525996275,0.644640234948605,0.8492775490337426,1.0,8/72,10.01%,UGT1A7;UGT1A8;UGT1A1;CYP27A1;SULT1A1;CYP26C1;HSD17B7;CYP26B1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.37283516027383673,0.8806714746580789,0.5719360568383659,0.8489527335250153,1.0,5/15,13.51%,NYNRIN;LACTB2;ZC3H12D;ZC3H12A;RPP30
prerank,DNA catabolic process (GO:0006308),0.40262737597621023,0.880136714693258,0.5922330097087378,0.8495557785025244,1.0,2/11,15.76%,DNASE1L1;FBH1
prerank,macrophage activation involved in immune response (GO:0002281),0.38611015906495005,0.8800850037393518,0.6026871401151631,0.8491872461122671,1.0,3/13,6.52%,GRN;LBP;SYK
prerank,neuromuscular process (GO:0050905),-0.3338097396718389,-0.8800396937949836,0.6477024070021882,0.9185521170237021,1.0,7/16,24.50%,NRXN1;CLN3;SHANK1;KCNA1;TPP1;UBA5;DCTN1
prerank,cardiac ventricle development (GO:0003231),0.3590668008964082,0.8797955760710645,0.6198630136986302,0.8493329889481335,1.0,4/20,10.40%,PDE2A;HEY2;TMEM65;DAND5
prerank,peripheral nervous system development (GO:0007422),0.34210677150441793,0.8796529835718379,0.6243567753001715,0.8491416373295603,1.0,3/23,5.98%,ADGRG6;PMP22;GFRA3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.3632561758161569,-0.8795716100519052,0.6263048016701461,0.9186341784865891,1.0,3/12,24.62%,GPAA1;ANKRD13C;TAPT1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.32040334464437903,-0.8792376941376575,0.625,0.9183768263637598,1.0,4/18,8.96%,EHMT2;ASH1L;SETD4;SETD3
prerank,arachidonic acid secretion (GO:0050482),0.4128533827672476,0.8784217814870985,0.6091954022988506,0.8506585990953173,1.0,1/10,4.98%,PNPLA8
prerank,arachidonate transport (GO:1903963),0.4128533827672476,0.8784217814870985,0.6091954022988506,0.8506585990953173,1.0,1/10,4.98%,PNPLA8
prerank,protein acetylation (GO:0006473),0.3184910109447524,0.8782196642351846,0.6281645569620253,0.8506128385171257,1.0,9/30,16.36%,CLOCK;ESCO2;ESCO1;CREBBP;HAT1;FOXO1;EP300;KAT6A;GTF2B
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2959360671216843,0.8780078093535746,0.6205357142857143,0.8505373598949756,1.0,6/48,6.29%,CRIP1;TNFRSF1B;MCL1;BCL2L2;SFN;BCL2
prerank,fatty acid elongation (GO:0030497),0.3949316640385119,0.877957422345354,0.6256781193490054,0.8501685302749555,1.0,2/13,7.36%,HACD4;ELOVL5
prerank,response to metal ion (GO:0010038),0.28103065643925523,0.8778316687815736,0.6478260869565218,0.8499400334969447,1.0,17/67,15.34%,PPP3CA;CRIP1;ADAM9;PAM;BCL2;HFE;HOMER1;PPP2CA;PPP2CB;TESMIN;CALM1;PPP1CA;LOXL2;TFR2;NEDD4L;ITPR3;MTF1
prerank,positive regulation of rRNA processing (GO:2000234),-0.37980485862502855,-0.877762553164145,0.6263736263736264,0.9208221497409146,1.0,4/10,25.64%,SIRT7;WDR75;RIOK2;RIOK1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3693944533735707,0.8777171826358524,0.6181172291296625,0.8497071232292502,1.0,5/16,20.89%,LDLR;NR1H2;MFSD2A;CNEP1R1;ABHD5
prerank,defense response to tumor cell (GO:0002357),0.41258499413574984,0.877198378296416,0.6055363321799307,0.8502543202591274,1.0,3/10,7.23%,DAPK1;SPI1;KLF4
prerank,long-chain fatty acid import into cell (GO:0044539),0.4032916005499069,0.8770093951621643,0.5939278937381404,0.850190883139585,1.0,2/10,10.02%,CD36;ACSL3
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3567979051977236,0.8768537721671341,0.6285211267605634,0.8500419927001538,1.0,3/18,10.42%,GSK3B;ZNF205;SLC25A5
prerank,RNA modification (GO:0009451),-0.2499428798121744,-0.8767420711770272,0.7028753993610224,0.9222125909678744,1.0,20/54,22.26%,ADAR;AARS1;QTRT1;TRDMT1;NSUN5;FTSJ3;ADARB1;TSR3;MEPCE;ANKRD16;BCDIN3D;QTRT2;TRMT9B;MRM2;PUS7L;METTL1;THUMPD1;CTU2;AARS2;METTL3
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2669384405689727,-0.8767072516072296,0.6740331491712708,0.9212700968106604,1.0,11/36,20.92%,CALM2;EPHA7;IMPACT;TOM1L1;TNKS1BP1;PPP2R5C;PPP2R5A;ERRFI1;PDGFA;ENG;CALM3
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.24506032673692402,-0.8765095813127279,0.7003154574132492,0.9207237054571634,1.0,20/59,22.09%,TGFBR1;PRKCD;ACVR1;CDC42BPA;CIT;MAP3K12;WNK3;DYRK2;PDPK1;CDC42BPB;DYRK1B;TGFBR2;CDK10;ULK1;ACVR1B;HIPK1;CAMK2D;MAPK8;TAF1;DYRK4
prerank,regulation of endopeptidase activity (GO:0052548),0.2902707457372271,0.8763777056558243,0.6501501501501501,0.8505311340418042,1.0,3/59,4.72%,SERPINB8;SERPINB2;BIRC3
prerank,RNA metabolic process (GO:0016070),0.25391390958030785,0.8763690077407092,0.7030075187969925,0.8500875761396959,1.0,18/127,9.77%,DHX8;RBMS1;RNASE4;HNRNPC;SND1;DROSHA;RNASEL;ATXN1;TENT2;HNRNPF;NOL9;RNASE6;RNGTT;RBM4;WTAP;APOBEC1;MTREX;POLR2B
prerank,cellular response to UV (GO:0034644),0.27602813037479895,0.8755721398144561,0.6413502109704642,0.851235413893339,1.0,18/76,16.37%,CRIP1;RPL26;RHBDD1;PTPRK;CHEK1;YY1;MFAP4;CARD16;RHNO1;CREBBP;XPA;XPC;EP300;USP28;MYC;KDM1A;USP47;ATR
prerank,rRNA 3'-end processing (GO:0031125),0.4008893851600167,0.8754214066014425,0.5801526717557252,0.8510717672874004,1.0,2/10,12.51%,RPS21;EXOSC8
prerank,regulation of axon regeneration (GO:0048679),-0.35777416908487514,-0.8752661069343587,0.6346153846153846,0.9226021675477795,1.0,3/12,8.51%,RTN4RL1;PTPRS;INPP5F
prerank,vacuolar acidification (GO:0007035),0.3423326595472518,0.8749043209465953,0.6208112874779541,0.8516202146227346,1.0,5/21,5.98%,GRN;CLN5;CLN6;ATP6V0A1;DMXL1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.27326237463791686,-0.8747885378294421,0.6518105849582173,0.9226859426636772,1.0,9/32,24.34%,HK2;CCAR2;ERBB4;AIFM2;THEM4;NDUFS1;NAIF1;BBC3;FIS1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.27721812597288464,0.8746957923180156,0.6591549295774648,0.8515852737209098,1.0,11/72,9.95%,FGFR1;LYN;CBL;IRS2;INSR;PDGFRA;TNF;GAB1;PDGFC;MYDGF;IGF1
prerank,protein import (GO:0017038),0.27268218945347733,0.8746691721093154,0.6616231086657497,0.8511840747274477,1.0,12/84,11.80%,APOE;PRICKLE1;RAB8B;SLC25A17;PXMP2;SYK;IPO11;PEX26;NUP133;LAMP2;NUP62;SNX33
prerank,positive regulation of protein transport (GO:0051222),0.2791559561743056,0.8744043783124545,0.6511627906976745,0.8512021206773117,1.0,16/67,15.00%,KIF20B;ANG;EXPH5;ADAM9;RACK1;TMED10;TNF;GOLPH3L;CD33;IGF1;ACSL3;PCNT;ACHE;BCAS3;PCM1;PPIA
prerank,heterochromatin assembly (GO:0031507),-0.30604977737165756,-0.8743158683929901,0.6516290726817042,0.9228082280932528,1.0,13/20,34.65%,SIRT2;CENPV;HDAC1;BAHD1;NRDE2;MBD2;SMCHD1;RRP8;HELLS;CDKN2A;SIRT1;HMGA2;HMGA1
prerank,oxoacid metabolic process (GO:0043436),0.3262287891064126,0.874290047809738,0.6280193236714976,0.8509468798281716,1.0,5/27,13.74%,DAO;THAP4;SULT1A1;GNMT;SULT6B1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.3647405489886362,-0.8741143151037013,0.6282051282051282,0.9222963642413381,1.0,3/10,11.16%,PDE3B;UBE2B;PDE3A
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2844906694013639,0.8738960159946348,0.6441441441441441,0.8512485697314335,1.0,23/60,24.30%,TCF7L2;CEBPB;HEY2;CBFB;MED16;MED20;MED6;MED26;MED15;TNRC6C;MED27;PTEN;RELA;MED17;IL6;MECP2;MED14;NFKB1;MED7;MED24;AGO3;CCND1;SUB1
prerank,triglyceride metabolic process (GO:0006641),0.29781102570268153,0.873792351989872,0.6298003072196621,0.8510051458019693,1.0,3/48,4.41%,APOE;AGMO;MOGAT2
prerank,mRNA stabilization (GO:0048255),-0.26518537227803013,-0.8736325123897869,0.6914600550964187,0.9224043295466924,1.0,5/40,5.41%,TENT5C;FUS;TARDBP;HNRNPU;ELAVL4
prerank,bile acid biosynthetic process (GO:0006699),0.3433696758264399,0.8731128769418857,0.6003430531732419,0.8518625341185583,1.0,4/24,9.71%,OSBPL9;HSD3B7;CYP27A1;OSBPL1A
prerank,regulation of neuron migration (GO:2001222),0.3352390309018948,0.8730350663244081,0.6036184210526315,0.8515537606484779,1.0,3/26,3.93%,KIF20B;TNN;RAPGEF2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3216982665040886,0.8729923056148268,0.6238244514106583,0.8511771868455897,1.0,10/31,20.38%,CDK6;RB1;KLF4;CDC73;KANK2;CDKN2C;PKD2;PTEN;BRD7;GPNMB
prerank,positive regulation of DNA replication (GO:0045740),0.35955375146635,0.8729182832399918,0.6124314442413162,0.850867383350616,1.0,1/16,0.45%,EGFR
prerank,macroautophagy (GO:0016236),-0.20893865091171132,-0.8727264124033951,0.7964601769911505,0.9234791279392752,1.0,31/118,20.49%,TCIRG1;TECPR1;MTERF3;SRC;SNF8;RUBCNL;PRKAG1;CLN3;MFN1;PGAM5;PIK3R4;CHMP4B;CHMP4A;ATG16L1;VTI1B;VPS37A;VDAC1;TOMM40;ATP13A2;MAP1LC3A;GABARAPL1;PIP4K2B;ULK1;TOMM20;VIPAS39;SQSTM1;ULK3;ATG14;CHMP6;CHMP3;VAMP7
prerank,T cell mediated immunity (GO:0002456),0.37680551465676226,0.8724493056037199,0.6129629629629629,0.8513838565719972,1.0,2/13,3.44%,JAG1;CD46
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2924286719693521,0.8723639906150753,0.6501457725947521,0.8510869573390349,1.0,12/52,20.95%,FOLR2;MTHFD2L;SDHA;ASS1;GCLM;SHMT1;IDH1;OGDH;IDH2;MTHFD1L;ME1;ACLY
prerank,regulation of protein polymerization (GO:0032271),-0.2711562478682996,-0.8723282844284838,0.6576819407008087,0.9233573088136516,1.0,11/35,19.96%,MAP2;CAMSAP1;MAPT;PLEKHG2;MAPRE3;GBA2;TPPP;HAX1;PAK3;DBN1;PRUNE1
prerank,positive regulation of cell aging (GO:0090343),-0.3680295972985799,-0.8722194408422869,0.6359743040685225,0.9225882764958083,1.0,3/11,13.69%,ABI3;CGAS;YPEL3
prerank,cellular response to interleukin-1 (GO:0071347),0.25526437508585803,0.8722091037691702,0.7016229712858927,0.8509142507794405,1.0,28/143,17.11%,GBP3;PSMA7;IRAK3;RPS27A;CCL8;NR1D1;CCL19;PELI1;RC3H1;CD40;MAP3K8;PSMB2;CCL24;SFRP1;RIPK2;PSMA6;MAP3K3;ZC3H12A;NOD2;UBE2N;PSMD5;PSMD1;PSMA3;RELA;TAB3;CCL5;ACOD1;CCL25
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3129097707529932,0.8720710531726023,0.6155088852988692,0.8507371229516105,1.0,2/32,2.97%,P2RX7;DRD1
prerank,protein trimerization (GO:0070206),0.3777342811109188,0.8720106347122303,0.6178107606679035,0.8499451129659128,1.0,5/14,18.59%,ALOX5AP;CLYBL;DISP1;MLKL;SCARA5
prerank,protein homotrimerization (GO:0070207),0.3777342811109188,0.8720106347122303,0.6178107606679035,0.8499451129659128,1.0,5/14,18.59%,ALOX5AP;CLYBL;DISP1;MLKL;SCARA5
prerank,cellular response to dsRNA (GO:0071359),0.36782534797421834,0.8719901616008614,0.6124314442413162,0.8495399713291012,1.0,2/15,5.64%,COLEC12;RIOK3
prerank,cellular response to oxygen levels (GO:0071453),-0.3762185826570088,-0.8718893289194268,0.6502057613168725,0.9223417953215308,1.0,3/10,14.60%,ATP6V0A2;ATP6V1G1;TMEM199
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.34502225532111946,0.871843643929162,0.6285211267605634,0.8493863695660133,1.0,4/21,11.64%,MFHAS1;GSK3B;ARPP19;YWHAE
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2883329815041706,0.8718034067553668,0.6533127889060092,0.8489974674315369,1.0,10/54,15.28%,HGSNAT;EXT1;CLN6;SDC3;HS3ST2;SDC4;HS3ST3A1;XYLT2;GPC3;HEXA
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3891178912016715,0.8716935133333512,0.6330935251798561,0.8487570729653019,1.0,3/13,13.50%,HACD4;ELOVL5;TECRL
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.34396417058182394,0.8715296797346322,0.6167557932263814,0.8481767132697277,1.0,7/19,20.94%,ATRX;POLR2B;TERF2IP;POLR2D;TERF1;POLR2F;TINF2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.34396417058182394,0.8715296797346322,0.6167557932263814,0.8481767132697277,1.0,7/19,20.94%,ATRX;POLR2B;TERF2IP;POLR2D;TERF1;POLR2F;TINF2
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.2327031086343533,-0.8708046715586983,0.7380191693290735,0.9237268698829596,1.0,15/64,15.54%,GTF2H2;CDK9;CCNT2;MLLT1;CCNH;SSRP1;NELFB;CTR9;ERCC2;PAF1;NELFCD;NCBP1;POLR2C;EAF1;ELOB
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.21863991312874273,-0.8707264085779644,0.7700729927007299,0.9228870590181655,1.0,35/87,32.15%,SAMM50;COX19;NUBPL;UQCC1;SDHAF4;NDUFAF6;NDUFS7;NDUFV3;TMEM126A;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;COX16;NDUFB10;FASTKD3;SDHAF2;NDUFA8;TTC19;NDUFA10;TIMM21;ECSIT;NDUFAB1;COX17;NDUFS1;NDUFAF8;SLC25A33;ACAD9;NDUFA6;COX14;DMAC2;NDUFAF3;NDUFV2;COA3;CHCHD4
prerank,regulation of mRNA stability (GO:0043488),0.24943688945255413,0.8707210810995638,0.6908396946564885,0.8492982004919826,1.0,26/145,15.07%,ZFP36L2;PSMA7;RPS27A;SAMD4A;ZFP36L1;VIM;MAPKAPK2;PUM2;RC3H1;TENT5A;ROCK1;HSPB1;PSMB2;DCP1A;SERBP1;PCID2;DCP2;PSMA6;ROCK2;ZC3H14;EXOSC8;EXOSC1;PSMD5;PSMD1;PSMA3;XPO1
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.3404217951847675,-0.8700525101900135,0.6391982182628062,0.9234342033948275,1.0,9/14,33.11%,FASTKD1;TFB2M;MTERF2;TFAM;SLC25A33;MRPL12;TFB1M;PNPT1;FASTKD5
prerank,amino sugar biosynthetic process (GO:0046349),0.3925871089694617,0.8700080497636918,0.6115384615384616,0.8502237474931734,1.0,4/12,18.74%,GNPDA1;GFPT2;UAP1L1;RENBP
prerank,positive regulation of viral process (GO:0048524),-0.23674789353234066,-0.8699833980599521,0.7391304347826086,0.9226194919611781,1.0,16/60,19.22%,CDK9;ADAR;CNOT7;SRPK1;AXL;NELFB;PPIE;NELFCD;SRPK2;ADARB1;TBC1D20;TYRO3;POLR2C;TARBP2;DHX9;TMEM39A
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.37198213636751043,0.8699109370995217,0.6232638888888888,0.8499501370827895,1.0,2/14,4.16%,RPS3;BCL10
prerank,cation transmembrane transport (GO:0098655),-0.25498623897229455,-0.8698778657059252,0.7361111111111112,0.9218677156474856,1.0,17/44,37.12%,ATP1B1;TRPM3;SLC36A4;SLC7A8;ATP13A2;ABCC9;ABCC8;MFSD12;TRPM7;SLC25A29;CACNA1H;SLC7A3;TRPM6;P2RX3;SLC3A2;TRPM1;SLC25A19
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3281491801610715,-0.8689387297779064,0.6627634660421545,0.9229851616066443,1.0,6/17,17.51%,TWSG1;SULF1;FSTL1;XIAP;TMEM204;DOK5
prerank,histone H2A ubiquitination (GO:0033522),-0.32739076104979425,-0.8689372737428654,0.6450116009280742,0.9219904463831456,1.0,4/17,8.08%,UBE2B;SKP1;DDB2;RNF168
prerank,NAD biosynthetic process (GO:0009435),-0.30858702054183373,-0.8686829773349585,0.6526806526806527,0.9216304990988041,1.0,8/20,24.43%,KYNU;PARP10;NAXD;NMNAT1;PARP9;NUDT12;PTGIS;NADSYN1
prerank,positive regulation of RNA splicing (GO:0033120),-0.2787907284967395,-0.8686240290550986,0.6790123456790124,0.920762155639099,1.0,8/29,14.68%,SETX;NCL;HNRNPLL;CELF4;HABP4;CIRBP;NCBP1;RBMXL1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2581638296516224,-0.8682198740136281,0.6731301939058172,0.9206619424182362,1.0,6/39,9.10%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.30065962245035965,-0.8681230548069063,0.6312217194570136,0.9199199627272022,1.0,6/22,11.12%,THOC1;DDX39B;CCNT2;ERCC6;TCERG1;HMGN1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.4039426906342501,0.8675441491695288,0.5821167883211679,0.854103044235751,1.0,4/10,12.78%,TLR4;TLR2;NAMPT;NOD2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4051504046248332,0.8673316463411589,0.6161228406909789,0.8540512517514333,1.0,1/10,4.05%,PRKN
prerank,regulation of viral life cycle (GO:1903900),0.34463949773682384,0.8669980172303108,0.6334459459459459,0.8542509962535383,1.0,6/21,15.75%,LAMP3;TRIM68;TRIM27;KPNA2;PPIA;TRIM25
prerank,vesicle transport along actin filament (GO:0030050),0.3544849622535459,0.8669227040790742,0.6164383561643836,0.8539432623823354,1.0,5/19,14.04%,MYO5A;MYO7A;MYO1C;MYO1E;WASL
prerank,smooth muscle contraction (GO:0006939),0.376795192234063,0.8668647700570137,0.6141304347826086,0.8536067382554533,1.0,5/14,17.31%,ROCK1;PIK3C2A;ADRA1A;ROCK2;CHRNB2
prerank,response to peptide hormone (GO:0043434),-0.2502533422230133,-0.8668152295339491,0.7175572519083969,0.921793128551893,1.0,8/43,11.37%,SORT1;SRC;STAT1;GNAI1;EIF2B3;TGFBR3;STAT2;TSC1
prerank,regulation of vasculature development (GO:1901342),-0.278851358381065,-0.8667847417839872,0.6582278481012658,0.9208743180260098,1.0,4/26,5.72%,CTNNB1;ETS1;FGF2;NF1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.24767212804981875,0.8665150833085749,0.7309644670050761,0.8538503394607316,1.0,43/153,19.75%,SGK3;GAS6;RIPK1;ERN1;CAMK1D;RPS6KA3;GSK3B;PKN2;PAK2;MAPKAPK2;ROCK1;WNK1;PIKFYVE;VRK2;PRKCB;ULK2;VRK1;MAPK14;DYRK1A;MAST1;RPS6KA6;MARK2;ROCK2;MKNK1;STK38;LATS2;UHMK1;PRKD2;NLK;PRKCG;MKNK2;ATR;PRKCQ;CAB39;MARK3;HIPK3;CAMK2A;CSNK1G3;PLK2;MORC3;CSNK2A2;CSNK2A1;EIF2AK3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3668010823500766,0.866484503747357,0.6087719298245614,0.8534474937556756,1.0,2/14,5.96%,FXYD2;WNK1
prerank,lytic vacuole organization (GO:0080171),-0.2768343773443689,-0.8663564840097696,0.6528497409326425,0.9208473041585655,1.0,7/32,9.40%,GNPTAB;CLVS1;HPS4;CLN3;GAA;VPS18;ZKSCAN3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3140795195956848,-0.8663050491224045,0.644927536231884,0.9199815881405772,1.0,7/19,22.89%,PIK3CB;ROBO1;ADAMTS3;CADM4;TSPAN12;CCBE1;DCN
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.3599963981611469,0.8659213459217333,0.6200716845878136,0.8536247268344415,1.0,6/16,16.14%,ITGB1BP1;DUSP22;RCC2;CORO1C;BCAS3;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.3599963981611469,0.8659213459217333,0.6200716845878136,0.8536247268344415,1.0,6/16,16.14%,ITGB1BP1;DUSP22;RCC2;CORO1C;BCAS3;PTEN
prerank,regulation of myoblast differentiation (GO:0045661),0.32171217627379006,0.8657822700589854,0.6188925081433225,0.8534236496996518,1.0,3/32,3.73%,RIPOR2;MEF2C;ZFP36L1
prerank,selective autophagy (GO:0061912),0.28710709027983095,0.8657612330106251,0.6631259484066768,0.8530167636714459,1.0,14/56,16.38%,WDFY3;RPS27A;PRKN;VIM;ULK2;RAB7A;PCNT;DYNC1I2;UFM1;UBE2N;AMBRA1;RB1CC1;TEX264;ATG5
prerank,response to UV-B (GO:0010224),0.39150397356583855,0.8655520563419503,0.6290630975143403,0.852960702839124,1.0,2/12,8.46%,CRIP1;MFAP4
prerank,positive regulation of response to stimulus (GO:0048584),0.2985789901420297,0.8654994921202189,0.6599063962558502,0.8526079345416495,1.0,5/40,8.30%,FCGR2B;IL15;B2M;CD80;HOMER1
prerank,regulation of protein localization to membrane (GO:1905475),0.32456796526316334,0.8654489099185535,0.6564625850340136,0.8522470168717686,1.0,10/28,18.82%,SPTBN1;PRKN;ACTB;FYN;STX7;GPC3;NECAB2;ZDHHC2;SLC5A3;VAMP8
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.2935905337611187,-0.8653839843605924,0.6578313253012048,0.9210059855085633,1.0,12/25,34.19%,DNAJC7;PTGES3;SDF2;DNAJB14;DNAJB5;DNAJB1;HSPA9;DNAJC18;DNAJB13;SDF2L1;HSPA1A;HSPA1B
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.40664184914975754,0.8652729285717056,0.6303501945525292,0.8521352290659008,1.0,2/10,10.70%,NCOA3;TRIM16
prerank,nucleic acid metabolic process (GO:0090304),-0.23000929772873532,-0.865073130174961,0.7350993377483444,0.9206864028608494,1.0,22/69,25.93%,DNA2;HNRNPA3;HNRNPA2B1;HNRNPU;RECQL5;POLG;DDX1;NCBP1;POLR2C;PCBP1;PCBP2;HNRNPA1;HNRNPH1;ATXN2;DDX24;POLR2L;METTL3;DNASE1L2;HNRNPA0;DDX54;DUSP11;RAD50
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3265852998988787,0.8650276230889574,0.6436781609195402,0.8521626255622752,1.0,6/25,18.72%,HEY2;RB1;IGF1;NIBAN2;ZBTB7A;TRAF6
prerank,regulation of mitotic cell cycle (GO:0007346),-0.198163408104078,-0.8646104187031135,0.8648648648648649,0.9206823266872161,1.0,39/171,18.02%,TTC28;ANAPC15;CDK9;CYLD;BRINP3;LGMN;SKP1;BTG1;PSMD13;HNRNPU;SIK1;PSMD12;ASAH2;CUL9;CCDC57;ERCC2;PSMD9;NEK6;ANAPC11;UBE2S;PSME3;HSF1;BUB1B;PSMA4;PSMD8;GAS1;PSMF1;CDK11B;PSMD4;DLGAP5;UBE2E1;CDK10;NEK11;UBE2D1;ANGEL2;CDK5RAP3;PSMB8;INTS13;PSME1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2563580082464934,0.8645189589444531,0.6922060766182299,0.8526903655844542,1.0,16/104,12.49%,LRP6;ADRB2;UVRAG;RHOA;CDK12;RB1;INCENP;ACTB;CCND3;CCND2;PPP2CA;CCNJ;PARP16;CALM1;TRIB2;CDKN2C
prerank,atrioventricular valve morphogenesis (GO:0003181),0.3493924110502132,0.8644154139177477,0.631762652705061,0.8524486740623142,1.0,6/19,18.02%,BMP2;HEY2;SMAD4;SLIT3;BMPR1A;EFNA1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.31521277152349503,0.864245337564676,0.6611842105263158,0.852305846625811,1.0,9/33,13.71%,ESR1;NCOA2;AXIN1;CBFB;TRIM68;H3-3A;RNF14;UFM1;EP300
prerank,modification-dependent protein catabolic process (GO:0019941),0.24268975684963032,0.863696682789783,0.7334905660377359,0.8529068752230119,1.0,68/193,24.24%,RNF150;SMURF2;ARIH1;RPS27A;SIAH2;CBL;PRKN;ZNRF3;NDFIP1;RC3H1;TRIM32;ANKIB1;CDC27;BIRC6;RNF19B;MDM2;UBE2K;CUL3;ANAPC16;UBQLN4;FBXO11;RNF14;ARRB1;RNF111;AMFR;UBE3B;RNF185;MIB1;FBXO10;UBE2R2;RBBP6;RNF19A;BFAR;NDFIP2;NEDD4L;ELOC;ANAPC1;WDR91;TRIM25;RNF146;XBP1;UBE2A;UBE4B;ANAPC10;CNOT4;LONP1;ATXN3;TOLLIP;RNF6;TRPC4AP;TRIP12;SIAH1;UBR3;RNF130;RNF149;CHFR;PSMD11;NEDD4;ANAPC2;NUB1;FBXO8;RNF40;PLK1;FZR1;UBE2L6;ADRM1;UBC;BUB3
prerank,protein modification by small protein removal (GO:0070646),0.2350706753675251,0.8636262675218079,0.7563805104408353,0.8525861957441063,1.0,53/252,16.57%,ESR1;SMURF2;PSMA7;USP3;RPS27A;BABAM2;VCPIP1;ATXN7;ADRB2;RIPK1;SIAH2;RHOA;PRKN;BIRC3;SNX3;USP9X;SMAD4;ACTB;BRCC3;USP15;YY1;PSMB2;MDM2;ASXL1;USP21;USP16;USP24;PSMA6;FOXK2;USP14;FOXK1;ZC3H12A;TADA2B;WDR20;USP45;EP300;USP9Y;PSMD5;PSMD1;PSMA3;USP28;USPL1;MYC;USP22;SENP1;USP25;ABRAXAS2;HCFC1;USP47;PTEN;UCHL3;STAM;USP32
prerank,stem cell development (GO:0048864),-0.3286302501228036,-0.8627643428089852,0.6776470588235294,0.9237704282117316,1.0,9/16,36.51%,CDH2;KLHL12;SOX11;TAPT1;SOX8;WNT7A;KBTBD8;SNAI2;SHH
prerank,detection of calcium ion (GO:0005513),0.38426800750126533,0.8626531713416187,0.6355311355311355,0.8539717987066087,1.0,3/13,10.64%,KCNMB1;STIM1;CALM1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3167944329296576,-0.8625600812644563,0.6733780760626398,0.9232250655028343,1.0,7/18,19.30%,TMEM119;BHLHE41;BDNF;HDAC5;NOTCH1;HDAC3;HDAC1
prerank,visual system development (GO:0150063),0.3040066118131622,0.8617773884134303,0.6406995230524642,0.8552292634760771,1.0,5/37,8.17%,C1QA;GDF3;PBX3;ADAMTS18;ATF6
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.328161251361514,0.8617601506875137,0.6346153846153846,0.8548168660909433,1.0,5/23,12.23%,MEF2C;MAPK14;IGF1;MAML1;NIBAN2
prerank,mitochondrion disassembly (GO:0061726),0.3063483213886671,0.860856844020893,0.6369426751592356,0.8560652165581959,1.0,15/34,21.15%,PRKN;WIPI1;ULK2;MARK2;ATG7;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;BNIP3;ATG3;FUNDC1;FUNDC2;MAP1LC3B
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3270771798432497,0.8608448876037053,0.6175496688741722,0.8556381329931377,1.0,1/25,0.47%,EXT1
prerank,chromatin organization (GO:0006325),0.2514750614215801,0.8607073367175859,0.7151898734177216,0.8554502105400379,1.0,29/132,18.63%,PADI4;ESR1;BAZ2B;JARID2;SPI1;RB1;SETDB2;KDM6A;DDX11;SATB2;ATRX;HMG20A;KDM4D;KDM5C;LOXL2;TADA2B;EHMT1;SMARCAD1;PWWP3A;MYC;SMARCD1;HDAC4;ARID1A;HCFC1;ZBTB7A;MECOM;NPM3;ZBTB1;KDM4C
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3654395341312162,0.8605975432327556,0.6398601398601399,0.8552077745904618,1.0,3/15,9.01%,RPL23;RPL5;RPS7
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3002592025910988,0.8605503791944187,0.6746411483253588,0.8548308605449374,1.0,5/38,11.34%,FBXW7;PRKN;PARL;UBE2D3;SREBF2
prerank,actin filament network formation (GO:0051639),0.39101654861576884,0.8604989620352193,0.6233766233766234,0.8544746264750688,1.0,2/11,9.13%,LCP1;PLS1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.33473554724845983,0.8602704584370223,0.6335616438356164,0.8544572163484766,1.0,5/22,12.12%,PHF8;RASL11A;DDX11;HEATR1;DHX33
prerank,replication fork processing (GO:0031297),-0.26224345156139384,-0.8601150359557945,0.6725888324873096,0.9275854952649238,1.0,7/38,11.35%,DNA2;CDK9;THOC1;ETAA1;PRIMPOL;BLM;BRCA2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3675765639493763,0.8596289267811287,0.6041275797373359,0.8552300641105771,1.0,2/14,3.93%,ADRB2;RAPGEF2
prerank,protein O-linked glycosylation (GO:0006493),0.2588603747562247,0.8596253382454455,0.7023004059539919,0.8547903608393478,1.0,14/96,15.22%,POMK;ST6GAL1;LARGE2;ST3GAL1;C1GALT1;POGLUT3;TET3;POGLUT1;B4GALT5;PLOD1;TET2;FKRP;POMT2;ST3GAL4
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3952038267091683,0.8596144256579191,0.6116504854368932,0.8543634884001169,1.0,1/11,4.19%,LARP7
prerank,cellular response to hydroxyurea (GO:0072711),0.3950759424098016,0.8588624567758569,0.6239015817223199,0.8553672611423199,1.0,3/10,10.31%,DDX11;ATRX;SPIDR
prerank,RNA destabilization (GO:0050779),0.352377529003191,0.8586251757827326,0.6473684210526316,0.8553775124913968,1.0,10/18,27.47%,ROCK1;ZC3H18;ROCK2;DXO;GIGYF2;METTL16;FTO;YTHDF3;CELF1;YTHDF1
prerank,copper ion transport (GO:0006825),0.378277257697885,0.85844854256319,0.6030245746691871,0.8552743552956112,1.0,2/11,5.45%,STEAP3;ATP7A
prerank,positive regulation of exocytosis (GO:0045921),0.2974277418138074,0.8583271592220322,0.6645669291338583,0.8550669448949854,1.0,8/35,12.68%,EXPH5;STXBP5;SDCBP;VPS4B;RAB7A;SDC4;CLASP1;UNC13D
prerank,snRNA metabolic process (GO:0016073),-0.3207715415646242,-0.8581253813496192,0.6494117647058824,0.9308845106288426,1.0,6/17,24.97%,ZCCHC8;INTS3;MEPCE;INTS9;INTS11;INTS7
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.2781765147445906,-0.8579888852139955,0.6756756756756757,0.9301720729516494,1.0,6/29,13.89%,TENT5C;FUS;HNRNPU;FMR1;CIRBP;TAF15
prerank,N-terminal protein amino acid modification (GO:0031365),-0.3385557878935294,-0.8577669633332441,0.6482300884955752,0.9296999774124893,1.0,5/14,30.65%,NAA40;NAA60;NAA35;METAP1D;AANAT
prerank,cellular response to gamma radiation (GO:0071480),0.3532880461931685,0.8576874486749629,0.6419753086419753,0.8558686092187788,1.0,8/17,16.37%,RPL26;TSPYL5;MDM2;MAP3K20;CRYAB;TMEM109;KDM1A;ATR
prerank,substantia nigra development (GO:0021762),0.30057683976575,0.8574768639595121,0.6477093206951027,0.8558365399379017,1.0,11/37,14.18%,S100A1;CDC42;RHOA;YWHAQ;ACTB;ZNF148;CALM1;CCDC14;YWHAE;GLUD1;GNB4
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3140776596438199,0.8572225092544121,0.6503267973856209,0.855865005994176,1.0,9/31,20.88%,ERN1;PRKN;RHBDD1;BAG3;HSPA13;UBE2W;ATXN3;TMBIM6;HSPA2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3079533969139457,0.8569987492002603,0.6481178396072013,0.8558335319971673,1.0,14/33,23.32%,THPO;ACVR2A;RAB7B;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;FES;PITHD1;FAM210B;STAT5B;MAPK11
prerank,T cell migration (GO:0072678),0.3689870919316526,0.8568186491031483,0.64030131826742,0.8557349367733246,1.0,6/13,20.26%,ZAP70;CXCL16;MSN;S1PR1;GPR183;PIK3CD
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.39525958587234516,0.8563377725861117,0.6162570888468809,0.8561901765750212,1.0,2/10,8.88%,CDC42;RCC2
prerank,organophosphate biosynthetic process (GO:0090407),0.30172050151818,0.8561909228597545,0.6574675324675324,0.8560467755118312,1.0,6/37,10.07%,MOCS1;TPK1;IP6K3;AGPAT5;TKT;PIP5K1A
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3514249246706488,-0.8555346585959442,0.6624737945492662,0.9336879880560461,1.0,8/12,31.84%,CENPC;CENPE;SEH1L;NDC80;CDT1;KIF2C;NUF2;BOD1
prerank,androgen metabolic process (GO:0008209),-0.32278774337252003,-0.8555291741435542,0.6513317191283293,0.9327150221504372,1.0,13/18,51.30%,SPP1;SRD5A3;HSD17B10;HSD17B11;DHRS9;SHH;SRD5A2;MED1;HSD3B2;HSD17B3;AKR1D1;CYP19A1;HSD17B4
prerank,mitochondrial transcription (GO:0006390),-0.37207226409054805,-0.8553896944389641,0.643312101910828,0.9320372715043179,1.0,6/10,31.02%,TFB2M;MTERF2;TFAM;SLC25A33;MRPL12;TFB1M
prerank,positive regulation of mRNA processing (GO:0050685),-0.3018035906205324,-0.8551989275213105,0.6885644768856448,0.9314551480660558,1.0,6/21,14.68%,NCL;CELF4;PAF1;CIRBP;NCBP1;RBMXL1
prerank,hexose metabolic process (GO:0019318),0.2972554134116157,0.8549955496103846,0.6460587326120556,0.8578311854632781,1.0,8/39,14.07%,SORD;IRS2;GHRL;FUOM;GALK2;PMM1;BRAT1;ADPGK
prerank,integrated stress response signaling (GO:0140467),-0.3243828376875397,-0.8548635613891847,0.6623376623376623,0.9312105822555053,1.0,2/14,9.06%,IMPACT;DDIT3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.31784215565236307,0.8547891692139608,0.6223776223776224,0.8577563270663028,1.0,5/27,10.95%,EGFR;RIPK1;PUM2;LIMD1;DDX6
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.259589551227069,-0.8541537707731524,0.71671388101983,0.9317976317782753,1.0,11/38,22.95%,NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFAB1;NDUFS1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.3189921286501679,-0.8538250768172748,0.6577181208053692,0.9315355557772579,1.0,2/16,4.11%,PPP1R16B;FGF2
prerank,multivesicular body organization (GO:0036257),-0.2733818219702615,-0.8536467465651268,0.7340153452685422,0.9309424743223256,1.0,5/31,9.55%,SNF8;RAB27A;CHMP4B;CHMP4A;VPS37A
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3718051725391187,0.8534748109508407,0.6528028933092225,0.8598260002496885,1.0,3/14,7.60%,PTPN22;SYK;CCR2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.312714439511129,0.853039940789097,0.6510851419031719,0.860226603147075,1.0,6/28,12.36%,CHP2;DMAP1;BAG3;PSEN1;JUP;ZC3H12A
prerank,apical junction assembly (GO:0043297),0.2792815010605721,0.8528633596524339,0.6980854197349042,0.8601210641135711,1.0,9/53,14.30%,CTNNA1;RHOA;GRHL2;PKN2;PAK2;VCL;STRN;RAMP2;RHOC
prerank,divalent inorganic cation homeostasis (GO:0072507),0.31914906029981044,0.8527951483274095,0.6518771331058021,0.8598077654509418,1.0,5/25,14.75%,ATP6V1B1;PRKN;FAM20A;WFS1;CNNM4
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.26032269374451106,-0.852731955631577,0.725,0.9318702983430742,1.0,6/37,9.10%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,negative regulation of bone remodeling (GO:0046851),0.3925715763457868,0.8523295026927348,0.6361974405850092,0.8602255775350307,1.0,1/11,0.51%,P2RX7
prerank,membrane lipid catabolic process (GO:0046466),-0.36890986371669776,-0.8521240711139755,0.6666666666666666,0.9322262066998928,1.0,3/10,18.55%,ENPP2;PPT1;SMPD2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.2863505221322783,0.8520999115102199,0.6797583081570997,0.8601920192402162,1.0,4/53,2.19%,EGFR;SPRED1;RPS3;BABAM2
prerank,regulation of fatty acid oxidation (GO:0046320),0.36013054777371656,0.8520584667137757,0.6177536231884058,0.8598285370280715,1.0,1/16,1.30%,PRKAG2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3065713788417699,-0.8520404071234844,0.6728110599078341,0.9314639159251172,1.0,2/17,4.59%,SNTA1;ANK2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.30333635323587577,0.8518856944486045,0.6630094043887147,0.8597101309393628,1.0,6/33,10.66%,APOE;MCC;SYNJ2BP;ADAMTS9;CORO1C;SP100
prerank,endochondral bone morphogenesis (GO:0060350),-0.34938074330832736,-0.8518161529982167,0.6542669584245077,0.9309751235938649,1.0,8/11,32.09%,BMPR1B;TMEM119;FOXC1;INPPL1;COL13A1;SCX;BMP4;BMPR2
prerank,regulation of lymphocyte migration (GO:2000401),0.3804965559448855,0.8515973602234873,0.624750499001996,0.859761380627121,1.0,5/10,16.54%,MSN;STK10;SLC8B1;WASL;MIA3
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.32844786612903626,-0.8513804630946193,0.6765375854214123,0.9309012492629412,1.0,2/15,5.87%,TREM2;LPL
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.321769991238042,-0.8510362331331118,0.6884875846501128,0.9306254114925105,1.0,4/16,12.29%,SNF8;CHMP4B;CHMP4A;TMEM50B
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.23252124515103967,-0.8505924700960145,0.7763157894736842,0.9306866604948187,1.0,21/60,27.89%,CTNNB1;XRCC5;FGF2;ATM;MAPK3;MAP2K7;PTGES3;MAP3K4;RFC2;HNRNPA1;CCT7;CCT2;WRAP53;ACD;CCT8;CHTF18;NVL;PDGFRB;FBXO4;AURKB;GREM1
prerank,glycoprotein metabolic process (GO:0009100),0.2841361910537134,0.8502450692473458,0.707492795389049,0.8619153640044466,1.0,8/53,12.07%,MAN2A1;ST8SIA4;CNMD;MANBA;ADAMTS9;B4GALT5;NGLY1;ENGASE
prerank,purine ribonucleotide metabolic process (GO:0009150),0.27411714828302014,0.8496987014937095,0.7089337175792507,0.8624873726150343,1.0,18/68,20.95%,HINT1;GNAI3;SULT1A1;ADSS2;ACOT12;RAB23;AMPD3;GTPBP1;ADSS1;SULT6B1;NT5C2;ACAT1;EFL1;AK3;AK4;ENPP1;HPRT1;ACLY
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.28499179221490956,-0.8494199119285125,0.7,0.9321762358071054,1.0,4/23,12.15%,CADM1;NECTIN2;ARRB2;SLAMF6
prerank,positive regulation of protein ubiquitination (GO:0031398),0.26223790625272386,0.8489028592745498,0.7247579529737206,0.8635027753457882,1.0,12/80,10.93%,FBXW7;PRICKLE1;AXIN1;BCL10;BIRC3;NDFIP1;MYCBP2;ARRDC3;TSPYL5;CUL3;RIPK2;WFS1
prerank,cellular response to BMP stimulus (GO:0071773),0.26775098315247914,0.8486296036543105,0.6940836940836941,0.8635580585834074,1.0,13/66,14.73%,BMP2;GDF3;USP9X;SMAD4;ACVR2A;USP15;HFE;VSTM2A;HIVEP1;SFRP1;USP9Y;SLC33A1;BMPR1A
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3789680798695434,0.8485828974036129,0.6507352941176471,0.8631930427014067,1.0,3/11,14.90%,ZFP36L1;CDC73;PAPOLA
prerank,positive regulation of translation (GO:0045727),0.2572694706991613,0.8484250386386242,0.7191780821917808,0.8630572566432498,1.0,15/94,14.38%,EIF3E;NIBAN1;SAMD4A;RPL26;VIM;RPUSD3;RPS4X;RPL5;LARP4B;RPS9;USP16;LARP4;PIWIL2;UHMK1;POLR2D
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3134045338430615,0.8483672700674594,0.658578856152513,0.8627006302288155,1.0,6/26,11.89%,CDC42;PRKN;ROCK1;SYNPO;PTGER4;ROCK2
prerank,embryonic axis specification (GO:0000578),0.3613545725885798,0.8483012898334347,0.6176470588235294,0.8623703889013453,1.0,1/15,2.81%,HOXD8
prerank,regulation of mitotic nuclear division (GO:0007088),0.27710916077314834,0.8482240694524057,0.6861313868613139,0.8620703646693492,1.0,9/55,11.76%,KIF20B;RGCC;DUSP1;INSR;CHEK1;IGF1;NUP62;PHIP;CDK13
prerank,cognition (GO:0050890),0.2892849756147781,0.8479342302470222,0.6661608497723824,0.8621466758098332,1.0,10/42,18.03%,APP;C5AR1;TNF;CHRNA4;MFSD2A;CBR3;ST3GAL4;GPR155;CHRNB2;JAKMIP1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.3797167516677541,0.8478866233036523,0.6155268022181146,0.8617929121618711,1.0,2/11,10.64%,GCH1;CALM1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.38306124666081026,0.8477450911263339,0.6484375,0.8616439045424177,1.0,3/12,13.81%,TIPIN;GMNN;KAT7
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3967706350825058,0.8476565190365424,0.6197718631178707,0.8613697179974784,1.0,1/10,1.72%,LYN
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.19432527586346038,-0.8475290341578777,0.9346733668341709,0.935159600881237,1.0,44/173,22.51%,TGFA;PREB;KLHL12;DYNC1H1;BCAP29;NRBP1;TRAPPC3;ANK2;SEC31A;COG3;HYOU1;ANK1;VTI1B;COG4;CNIH1;NAPA;ERGIC3;SEC24A;RAB2A;COG2;TBC1D20;SPTB;F8;TEX261;USE1;TMED1;TMED7;TRAPPC6A;SPTBN2;GOLGA2;COPA;TRAPPC2;SEC13;SEC24B;BET1;ZW10;VAMP7;DCTN2;TRAPPC2L;GOSR2;GOPC;TRAPPC12;CAPZB;BCAP31
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3638896309318634,0.847528492150666,0.6429840142095915,0.8611515496111005,1.0,2/15,3.17%,CD36;TLR4
prerank,epithelium development (GO:0060429),-0.20849895263763035,-0.8474737860514167,0.8284518828451883,0.9343042239330888,1.0,30/107,24.86%,SALL1;JAK2;STAT1;NDRG4;FGFR2;DVL1;LOXL3;PGK1;AHI1;VDAC1;CASP6;CD34;SOX10;PAX8;PROX1;UPK1B;SMO;TPP1;ALDH1A2;WNT4;ERRFI1;TST;FN3K;SOX11;TGFB1;DACT1;STIL;ACADVL;SOX8;CDK1
prerank,muscle organ development (GO:0007517),0.27977304605410097,0.8474064847842883,0.6782608695652174,0.8609280901077243,1.0,5/54,3.78%,MEF2A;TCF12;MEF2C;MYH6;UTRN
prerank,protein processing (GO:0016485),-0.21470839722893234,-0.8473097921600051,0.8410852713178295,0.9337076970289997,1.0,21/102,18.06%,KLK2;LGMN;CLN3;VSIR;CTSS;APH1A;ADAMTS3;HTRA2;F3;MMP16;FXN;SEC11C;AFG3L2;AEBP1;SPCS1;EEF1AKMT4-ECE2;TYSND1;ADAM10;CPM;CPE;FURIN
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3694346634261466,-0.8469880634153463,0.6610169491525424,0.9333627944468784,1.0,2/10,1.12%,MAP4K4;IQSEC1
prerank,regulation of cell growth (GO:0001558),0.2333010196049043,0.8460010261713942,0.7973621103117506,0.8631133739992769,1.0,34/204,14.24%,EGFR;PTPRJ;SGK3;CDC42;DCSTAMP;DNPH1;IL17RB;RPS6KA3;RB1;SMAD4;RACK1;TRIM32;BCL2;SDCBP;BST2;MTPN;CXCL16;ESR2;NUBP1;PPP2CA;H3-3A;RTN4;SFRP1;SERTAD2;SLIT3;ST7L;EBAG9;CDKN2C;BRAT1;GJA1;NET1;MFSD2A;DERL2;CRLF3
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.3779004611131267,0.8459151810700547,0.6709323583180987,0.8628153033450822,1.0,2/12,7.19%,LYN;BST2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3133906929874668,0.8457890294089636,0.6486042692939245,0.8626106083838408,1.0,11/27,19.86%,CD44;RHOA;TNF;CCR2;ITGB2;MDK;RELA;PRKCQ;IL6;TRAF6;HAS2
prerank,protein acylation (GO:0043543),0.29521450163066904,0.8456703312119729,0.6804281345565749,0.8623797032082666,1.0,10/38,16.36%,CLOCK;ZDHHC14;ZDHHC3;CREBBP;FOXO1;EP300;KAT6A;ZDHHC20;ZDHHC2;GTF2B
prerank,proton transmembrane transport (GO:1902600),0.29690100562021765,0.8450061456169603,0.6534181240063593,0.8631926544160528,1.0,10/36,18.84%,ATP6V1B1;ATP5PO;ATP6V1A;ATP1A4;ATP1A3;ATP1A1;ATP6V0D1;SLC36A2;ATP5MF;SLC25A27
prerank,DNA metabolic process (GO:0006259),0.22700469955390382,0.8446142748352063,0.8184971098265896,0.8635005502915619,1.0,73/270,21.21%,TCF7L2;ENDOG;RBBP8;USP3;LIG4;RPS27A;ORC5;UVRAG;POLE2;DNASE1L1;ORC2;NOP53;CHEK1;PRIM2;TOPBP1;CHRNA4;PDS5B;RPA1;GMNN;RAD54L;BACH1;TOP1MT;RAD52;UHRF2;PURA;ZRANB3;SP100;KMT5B;POLE3;XPA;HINFP;POLH;RPA3;TERF2IP;UBE2N;MUTYH;USP45;XPC;KPNA2;MMS19;SMARCAD1;TERF1;POLE4;RAD51B;PWWP3A;SAMHD1;GTF2H3;MCM8;FANCL;TOP2B;ATR;UBE2U;PRIM1;MPG;ASF1A;GTF2H1;RFC3;DMC1;UBE2A;ZBTB1;LONP1;DDX21;SUMO1;MRE11;APEX1;POLD2;RTEL1;USP7;PCNA;TINF2;INIP;WDHD1;FBXO6
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3087702929880871,-0.8445773081459861,0.7012987012987013,0.9375630431029741,1.0,4/16,12.75%,HNRNPA2B1;ATM;PARP1;TERF2
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.2604721385242203,-0.844068468239438,0.7413333333333333,0.9376917184801127,1.0,11/35,23.13%,PARP1;LIG1;POLG;XRCC1;RFC2;POLE;POLL;RFC1;ADPRS;PARG;POLD4
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3006247667970923,-0.8435247908733252,0.6945701357466063,0.9378457287415316,1.0,4/21,10.16%,ADCY3;ADCY8;GUCY1B1;ADCY7
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.27687446757198075,0.8431326631535258,0.7082018927444795,0.8657937561184561,1.0,7/52,10.02%,EGFR;ITGB1;SPTBN1;RACK1;TNF;PLS1;ACSL3
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2504727548493648,0.8429970771819925,0.7252604166666666,0.8656083836031353,1.0,37/109,22.44%,INPP4A;PGAP1;MTM1;SYNJ1;FIG4;MTMR3;IP6K3;OCRL;PI4K2B;PIKFYVE;PIK3R6;PLCD1;PLA2G2D;PIK3C2A;RAB14;PIP5K1A;PLCB3;PIP4P2;PLEKHA4;PLAAT3;PLBD1;PTPN13;MTMR1;PTEN;PIP4K2A;INPP5K;PIP4P1;PIK3C3;PIK3CD;MTMR6;PLA2G4C;LCLAT1;PI4K2A;MTMR11;MTMR12;RAB5A;PLCG2
prerank,isotype switching (GO:0045190),0.38911007357887,0.8429018767424858,0.6468253968253969,0.8653326134019186,1.0,1/10,2.01%,LIG4
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2790120736682982,0.842733710756837,0.6828528072837633,0.8652069299267686,1.0,23/59,23.64%,TCF7L2;CEBPB;MITF;CBFB;MED16;MED20;MED6;MED26;MED15;TNRC6C;MED27;PTEN;RELA;MED17;IL6;THRA;MECP2;MED14;NFKB1;MED7;MED24;AGO3;CCND1
prerank,C-terminal protein amino acid modification (GO:0018410),0.39127678837605806,0.842570979385159,0.6499032882011605,0.8650566946152874,1.0,4/11,16.38%,ATG7;TTL;ICMT;ATG5
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.35551101116407563,0.8425556866049203,0.6432337434094904,0.8646539050634209,1.0,3/15,12.38%,HDC;MOXD1;SAT2
prerank,protein glycosylation (GO:0006486),0.24638232539671132,0.8425347679449919,0.7350318471337579,0.8642515271513622,1.0,22/125,15.22%,POMK;ST8SIA4;FUT4;LARGE2;ST3GAL1;MGAT2;SERP1;GFPT2;ALG9;TET3;TMEM165;ALG5;DOLPP1;POGLUT1;NUS1;B4GALT5;PLOD1;PMM1;TET2;POMT2;RPN2;ST3GAL4
prerank,apical protein localization (GO:0045176),-0.3614992202894838,-0.8424280945714732,0.6511156186612576,0.9392178663895194,1.0,5/10,14.84%,ATP8B1;MAL;SHROOM2;VANGL2;INSC
prerank,regulation of secretion (GO:0051046),0.3658430891879293,0.8424127585339938,0.6604477611940298,0.8640368439935706,1.0,3/13,11.91%,OAS2;ACSL3;KCNQ1
prerank,sprouting angiogenesis (GO:0002040),0.27483669060368215,0.8423450558938244,0.7057949479940565,0.8637249546040527,1.0,10/51,16.54%,NRP1;ITGB1BP1;NRARP;NR4A1;EPHB4;LOXL2;RAMP2;PARVA;E2F8;MIA3
prerank,regulation of protein ubiquitination (GO:0031396),0.2497223839378657,0.842208754331823,0.737597911227154,0.8635485059307315,1.0,16/108,10.93%,SASH1;FBXW7;RPS3;PRICKLE1;AXIN1;PRKN;BCL10;BIRC3;NDFIP1;MYCBP2;SPOPL;TSPYL5;CUL3;RIPK2;ARRB1;WFS1
prerank,protein K63-linked ubiquitination (GO:0070534),0.29089147113339003,0.8421716795171668,0.6822429906542056,0.8631792254518401,1.0,8/41,13.77%,UBE2E3;PELI1;PRKN;TRIM56;TRIM27;RNF115;UBE2N;BFAR
prerank,regulation of necroptotic process (GO:0060544),0.32615728054789345,0.8419738601439397,0.6638078902229846,0.8631021507241008,1.0,9/23,20.51%,RIPK1;PELI1;BIRC3;SDCBP;CASP8;MLKL;FLOT2;SLC25A4;PDCD6IP
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.37152207512494084,0.8419497082428117,0.6660447761194029,0.8627110789138155,1.0,4/13,13.95%,OAS2;CANX;JAK1;STAT3
prerank,regulation of dephosphorylation (GO:0035303),0.36304142158852315,0.841727009607225,0.6710526315789473,0.8626834556677202,1.0,4/15,9.26%,MTMR3;SMG6;PPP1R17;IGBP1
prerank,plasma membrane tubulation (GO:0097320),0.3678267289516973,0.8414156810963254,0.650994575045208,0.8628059177256798,1.0,3/13,11.80%,SNX9;PACSIN2;SNX33
prerank,protein targeting to membrane (GO:0006612),0.258680377853661,0.8407763606039272,0.7328767123287672,0.8635892617693048,1.0,21/83,18.01%,RAB8B;SLC25A17;PXMP2;PIKFYVE;ZDHHC14;PEX26;SDCBP;ZDHHC3;VPS37C;SEC63;MYO1C;CHM;ZDHHC24;RABGEF1;ZDHHC20;PEX14;ICMT;ZDHHC2;GET3;ATG3;PXMP4
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3526858773757562,0.8400720559578425,0.6596119929453262,0.8644753797875314,1.0,3/16,8.05%,UGT1A8;ERLIN1;NCOR1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.2572683432582602,-0.8396421867541031,0.7620320855614974,0.9441830779302279,1.0,6/35,11.05%,JAK2;OCIAD1;IL10RA;DOT1L;JAK3;ERBB4
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.2978431935922679,-0.839528179098358,0.6866359447004609,0.9434785841178073,1.0,7/20,27.29%,ACACA;PPT1;ACSL4;SCD;SLC25A1;DGAT2;GCDH
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.25025963593765216,-0.8394362609554551,0.7492795389048992,0.9426881280427556,1.0,9/42,11.38%,ACTR8;SMARCB1;SMARCC2;SMARCE1;ERCC6;CHD3;NASP;CECR2;SMARCA1
prerank,regulation of neuron apoptotic process (GO:0043523),0.2566178733452888,0.8394111084659538,0.7336122733612274,0.8652434586783656,1.0,10/96,6.99%,APOE;NUPR1;LIG4;MEF2C;RASA1;GRN;SNX6;PRKN;BCL2;TNF
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3520139124853331,-0.8393404240583001,0.6862302483069977,0.9418983888017848,1.0,5/11,27.89%,RIN3;MIF;PADI2;SLAMF8;GREM1
prerank,non-motile cilium assembly (GO:1905515),0.307381142475798,0.839332189125063,0.6613672496025437,0.8649287286039611,1.0,3/30,5.61%,IFT57;PIBF1;DISC1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.33814446402137516,0.838879125809397,0.6373056994818653,0.8653583454967904,1.0,2/19,3.54%,ADAM19;RGCC
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3750016174147538,0.8388128103386489,0.6561264822134387,0.8650357164731238,1.0,3/11,13.95%,PUM2;LIMD1;STAT3
prerank,regulation of keratinocyte migration (GO:0051547),-0.3505537877743231,-0.8388086777258479,0.6840909090909091,0.942008052550261,1.0,2/12,1.12%,MAP4K4;IQSEC1
prerank,lipid biosynthetic process (GO:0008610),0.2588260858987428,0.8383192813343724,0.7347517730496453,0.8655654326257731,1.0,8/77,10.07%,ALOX5;HMGCR;PDSS1;PAM;AGPS;AGPAT5;DOLPP1;PIP5K1A
prerank,cell-cell junction maintenance (GO:0045217),-0.3530290419278833,-0.8383100212021094,0.6822033898305084,0.942064841561519,1.0,3/11,10.25%,TJP1;FERMT2;CSF1R
prerank,signal peptide processing (GO:0006465),0.37708047851178483,0.8382119349433677,0.6422018348623854,0.8653392163331578,1.0,2/11,5.77%,CLN5;PARL
prerank,cellular response to UV-A (GO:0071492),-0.3515349540812871,-0.8375662939754236,0.6800847457627118,0.9426293332384617,1.0,6/11,50.97%,CERS1;OPN3;TIMP1;PPID;OPN5;MME
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3363053285125185,0.8374662071562171,0.6637323943661971,0.8662598709895055,1.0,2/20,4.03%,DENND1B;B2M
prerank,histone H2B ubiquitination (GO:0033523),0.3930321631119944,0.8372165377765511,0.6612021857923497,0.8662696935129272,1.0,2/10,8.18%,WAC;CDC73
prerank,oogenesis (GO:0048477),0.35549305443801943,0.8369919652949727,0.6523235800344234,0.8662767929699746,1.0,7/15,26.22%,NANOS3;HORMAD1;PIWIL2;MDK;MARF1;FMN2;NANOS1
prerank,carnitine metabolic process (GO:0009437),-0.3505854129692717,-0.8366722296084967,0.6853448275862069,0.9434916121350198,1.0,6/12,35.87%,ACADL;ACADM;CPT1C;CPT2;CPT1B;BBOX1
prerank,positive regulation of behavior (GO:0048520),0.384804354580986,0.8366465606867389,0.6455938697318008,0.8664948595664951,1.0,1/10,2.02%,MEF2C
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.33589820054950825,-0.8362043413920472,0.7167381974248928,0.943501460104533,1.0,5/13,23.84%,PARP10;NAXD;PARP9;NUDT12;PTGIS
prerank,tricarboxylic acid metabolic process (GO:0072350),0.37402970515853573,0.8360919826665634,0.6660447761194029,0.8670948694269819,1.0,7/12,20.95%,ACO1;ASS1;GLUD1;IDH1;IDH2;IREB2;ACLY
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3319942071097091,-0.8350941942209164,0.6865342163355408,0.9448158151516796,1.0,3/13,8.71%,PRR5L;CNOT7;UPF1
prerank,mitochondrial fission (GO:0000266),-0.3159624570096031,-0.8350008974250214,0.6682027649769585,0.9440575459001892,1.0,8/16,31.70%,DNM3;GDAP1;MUL1;FIS1;SLC25A46;MTFR1;MTFP1;MTFR2
prerank,regulation of synapse maturation (GO:0090128),-0.36153561874966367,-0.834893137455885,0.6764091858037579,0.9432981175570996,1.0,1/10,2.73%,NRXN1
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.25406006749478965,-0.8348017907115388,0.75,0.9425032852693922,1.0,9/36,14.20%,DNA2;ATRIP;ATM;ERCC6;DOT1L;CEP63;HUS1;PRPF19;CHEK2
prerank,tryptophan catabolic process (GO:0006569),-0.34401588970639896,-0.8343662202081817,0.6977777777777778,0.9424069471957706,1.0,5/11,35.67%,KYNU;IL4I1;AFMID;IDO2;HAAO
prerank,melanocyte differentiation (GO:0030318),0.37214341847605104,0.8339109220860995,0.6524064171122995,0.8706227145334106,1.0,2/11,2.35%,MEF2C;MITF
prerank,positive regulation of protein import (GO:1904591),0.30116665693660655,0.8339083222831412,0.6978653530377669,0.8701878798500076,1.0,6/30,12.36%,CHP2;DMAP1;BAG3;PSEN1;JUP;ZC3H12A
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3032670111734699,0.8338182179465794,0.6817472698907956,0.8699039531554018,1.0,6/31,16.14%,FBXW7;AXIN1;ARRDC3;RAB1A;UBE2N;PTEN
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.30928036676764137,-0.8336253937710731,0.6997690531177829,0.9429350164221879,1.0,9/17,31.84%,KNL1;HASPIN;SPDL1;ZW10;IK;CDK1;AURKB;TTK;BOD1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3872633247035376,0.8333401754414254,0.6745098039215687,0.8703365734665262,1.0,3/11,18.18%,CD46;BMPR1A;ATP6AP2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2396124609716246,0.8330924964060479,0.769712140175219,0.870354033307208,1.0,27/136,19.35%,TCF7L2;CMKLR1;GAS6;NUPR1;ESR1;IRAK3;NFKBIL1;SPI1;RB1;KLF4;CEBPG;ARRB1;SP100;WFS1;ZC3H12A;PKD2;PEX14;HDAC4;KDM1A;GLIS2;ACOD1;PIM1;ID3;SUMO1;BRMS1;EIF2AK4;TRIB1
prerank,melanosome transport (GO:0032402),0.3348461145325781,0.832829505540947,0.6781411359724613,0.8699562283320231,1.0,2/18,6.21%,MYO5A;BLOC1S5
prerank,pigment granule transport (GO:0051904),0.3348461145325781,0.832829505540947,0.6781411359724613,0.8699562283320231,1.0,2/18,6.21%,MYO5A;BLOC1S5
prerank,regulation of stem cell proliferation (GO:0072091),0.34114513150080256,0.832724652386866,0.6824561403508772,0.8697217234395053,1.0,8/17,26.06%,ZFP36L1;GJA1;KDM1A;EIF2AK2;PTPRC;AGO3;KDF1;TERT
prerank,skeletal muscle tissue development (GO:0007519),0.3025264073135159,0.8322556903344396,0.6869983948635634,0.8701296035130877,1.0,4/32,14.10%,MEF2C;MYORG;SVIL;POPDC3
prerank,respiratory electron transport chain (GO:0022904),0.35876389604983666,0.8320698384066769,0.6623616236162362,0.8700327814546466,1.0,5/14,17.85%,ETFA;ETFDH;SDHA;UQCRFS1;ETFB
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3101890384646101,0.8310768666506445,0.662828947368421,0.871408818783374,1.0,4/26,9.36%,IRAK3;NFKBIL1;PPM1B;CARD16
prerank,histone exchange (GO:0043486),-0.24812896471160492,-0.8305099627509795,0.7512820512820513,0.9482170110650762,1.0,12/37,28.09%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPN;CENPP;CENPH;CENPI;ACTR6;MIS18A
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2465481888348267,0.8303779884972181,0.7598978288633461,0.8722656792023834,1.0,23/113,17.36%,RAP1B;ESR1;RPS3;CD36;TLR4;LCP1;GSK3B;RACK1;SYK;TNF;RPA1;FNIP1;SPIDR;XPA;DHX33;RPA3;RHOC;IL5;TERF1;GTF2H3;ATR;TIRAP;GTF2H1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3078595856369252,0.8303011285877914,0.6923076923076923,0.871986443257234,1.0,7/29,16.82%,ESR1;AXIN1;CBFB;KANK2;UFM1;CNOT9;STRN3
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2207595572737212,-0.8294885155007207,0.8207885304659498,0.9492201280458141,1.0,23/69,24.86%,GPR137B;FERMT2;WWTR1;CROCC;MAPT;CEP250;STX3;ENTR1;NUMA1;TMEM35A;PARK7;LIMK2;CDK5RAP3;NDC80;GNL3L;ABCA7;SESN2;PARP9;TGFB1;TRAPPC12;GPD1L;TM9SF4;CDK1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.37882183887570886,0.8291372420987584,0.6616541353383458,0.873645785252312,1.0,1/11,2.57%,TPK1
prerank,positive regulation of T cell activation (GO:0050870),0.2665024410985266,0.8291156022753566,0.7203389830508474,0.873237555907989,1.0,20/62,23.04%,IL15;CD46;CCL19;CD80;ZAP70;CCR2;NOD2;MDK;FLOT2;CCL5;PRKCQ;XBP1;IL6;ZBTB1;PTPRC;ZMIZ1;IL7;CD47;NCK1;TFRC
prerank,negative regulation of synaptic transmission (GO:0050805),0.32510605685475047,0.8290307915455188,0.680327868852459,0.8729582526765455,1.0,7/23,21.16%,TMEM25;ACHE;PTEN;PRRT1;PLK2;SLC30A1;PICK1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.2789500577796568,-0.8289775432573372,0.7086419753086419,0.9492429070399251,1.0,6/22,15.83%,LAG3;DUSP10;VSIR;FANCA;BCL6;IL4I1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.350055656983035,-0.8287405911837665,0.7046413502109705,0.9487451831232532,1.0,5/11,36.72%,CD34;ARIH2;WNT5A;YJEFN3;SFRP2
prerank,ncRNA transcription (GO:0098781),0.3632813528582031,0.828658639577393,0.7012522361359571,0.8732440968115678,1.0,7/13,24.58%,ANG;POLR1G;USPL1;SNAPC2;NIFK;CAVIN1;SNAPC3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.29551009235300385,0.8284770185616762,0.6826625386996904,0.873159532144766,1.0,7/34,17.76%,PTPN22;NOD2;RBP4;GPI;SCIMP;XBP1;IL6
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2695276566037188,-0.8284240076339644,0.7248157248157249,0.9483943335019619,1.0,14/30,34.19%,DNAJC7;PTGES3;SDF2;DNAJB14;DNAJB5;DNAJB1;CCT2;HSPA9;DNAJC18;DNAJB13;SDF2L1;HSPA1A;CHCHD4;HSPA1B
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.29116440874716976,-0.8282171990631781,0.7065727699530516,0.9478725486025749,1.0,11/22,26.96%,NFU1;NUBPL;ISCU;FXN;NFS1;ISCA1;CIAO1;GLRX5;HSPA9;CIAO2B;CIAPIN1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.278508160361156,-0.8281259357953649,0.7239709443099274,0.9471097930729621,1.0,6/24,22.59%,CALM2;AKAP6;JPH1;CAMK2D;CALM3;JPH3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.2460974489902204,0.8273655467243117,0.7681159420289855,0.8747046006944281,1.0,12/110,8.23%,APOE;RPS3;CD36;CDC42;GSK3B;RB1;RACK1;RIOK3;NOP53;SYK;TNF;FNIP1
prerank,positive regulation of transporter activity (GO:0032411),0.3602436912652669,0.8272656069054223,0.6678899082568808,0.8744465883744003,1.0,1/13,1.44%,KMT2A
prerank,aminoglycan catabolic process (GO:0006026),0.3080347272521671,0.8270457650863652,0.693069306930693,0.874448442890969,1.0,3/28,9.13%,HGSNAT;SDC3;SDC4
prerank,cell differentiation in hindbrain (GO:0021533),0.37364568316419455,0.8269600462906941,0.687382297551789,0.8741629387647982,1.0,2/11,5.45%,OPHN1;ATP7A
prerank,pteridine-containing compound metabolic process (GO:0042558),0.3522571241386122,0.826734695871977,0.6642335766423357,0.8741274239975365,1.0,2/13,10.64%,GCH1;CALM1
prerank,protein localization to cell surface (GO:0034394),-0.27468478775371563,-0.8266807994227953,0.7356608478802993,0.9489590927640573,1.0,14/26,33.60%,CTNNB1;ANK2;ARF6;GGA3;PIGK;SMURF1;FLNA;ANGPT1;EMP2;GGA1;FGF7;MESD;JAM3;FBLN5
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3706507546757833,0.8264335740573868,0.6742857142857143,0.8742301237904848,1.0,5/12,24.46%,SERINC3;SERINC5;SRR;PSPH;SEPHS2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.26188507138531036,0.8264333111746691,0.7464985994397759,0.8737936634191465,1.0,13/75,14.03%,SLC9A9;FXYD2;KCNJ14;SLC9A4;TRPV3;SLC39A12;TRPM2;ATP2B4;ATP1A4;ATP1A3;ATP1A1;SLC9A7;SLC9A6
prerank,protein localization to lysosome (GO:0061462),-0.2718272451104426,-0.8260691019976371,0.7543859649122807,0.9491718396901101,1.0,8/28,17.05%,SORL1;SCARB2;GCC2;GLMP;ATP13A2;NCOA4;RNF128;GGA3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2779937507110157,0.8257106167086843,0.7057010785824345,0.8746503033083062,1.0,5/45,6.62%,ZFP36L2;HECA;RGCC;ZFP36L1;CHEK1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.28000216469885075,0.8252614668976272,0.7103658536585366,0.8750344158475692,1.0,8/48,15.27%,GAS6;IRAK3;PARP14;SH2B3;CARD16;SLIT3;NR1H2;SAMHD1
prerank,bile acid metabolic process (GO:0008206),0.3124835965972933,0.8247311976945848,0.6852459016393443,0.8755378756365775,1.0,4/27,9.71%,OSBPL9;HSD3B7;CYP27A1;OSBPL1A
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.2743721872731971,-0.8241713156246308,0.7414634146341463,0.9520419486854348,1.0,10/26,26.10%,ST3GAL6;CHST1;B4GALT4;CHST2;ST3GAL3;B3GNT2;ST3GAL2;FMOD;PRELP;B4GALT2
prerank,regulation of T cell differentiation (GO:0045580),0.30014772929262207,0.8239363821489916,0.6972049689440993,0.8764965434770833,1.0,11/33,23.43%,CBFB;TCF7;ZAP70;CCR2;NFATC2;MDK;XBP1;ZBTB1;ZMIZ1;IL7;TBX21
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.25911138644571957,0.8238953806790793,0.7383040935672515,0.8761406718170255,1.0,10/75,11.89%,RASGRP4;GRK5;PDE6A;GUCY2D;ROCK1;ZDHHC3;PDE6H;PPEF1;CALM1;ROCK2
prerank,positive regulation of DNA binding (GO:0043388),0.2986237204367194,0.8233793419341185,0.684640522875817,0.8765995985010578,1.0,8/31,18.72%,PRKN;RB1;CEBPG;IGF1;NIBAN2;PINX1;PLAUR;TRAF6
prerank,regulation of amyloid-beta formation (GO:1902003),0.29372572430957544,0.8229010347585931,0.7025316455696202,0.8769945884462077,1.0,12/34,18.02%,APOE;ROCK1;TMED10;TNF;RTN4;IGF1;SP1;ROCK2;RELA;PICALM;IFNGR1;EFNA1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.35963760914887255,-0.8227121467725914,0.6995708154506438,0.9540052331497497,1.0,5/10,34.60%,TST;MTRR;CBS;GADL1;CTH
prerank,histone H4-K8 acetylation (GO:0043982),0.3450295142778184,0.8225051602412463,0.661319073083779,0.8768262734500788,1.0,6/15,19.49%,PHF20;KANSL2;KANSL1;KAT7;HCFC1;JADE3
prerank,histone H4-K5 acetylation (GO:0043981),0.3450295142778184,0.8225051602412463,0.661319073083779,0.8768262734500788,1.0,6/15,19.49%,PHF20;KANSL2;KANSL1;KAT7;HCFC1;JADE3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.36525691202929367,0.8223017426003424,0.6778761061946903,0.8767646127225095,1.0,1/13,2.62%,PRICKLE1
prerank,nitrogen compound transport (GO:0071705),0.23738550552174925,0.8219221486738744,0.8133848133848134,0.8770192509291812,1.0,25/141,17.93%,TXNIP;SLC16A10;CALCRL;RCN3;RILP;TCN2;LRRC8D;SLC43A2;ABCC1;ARRDC3;RAB7A;CMTM6;SLC38A1;SLC38A2;RAMP2;SLC6A2;SLC23A1;SNX4;SLC7A7;HSP90B1;MIA3;SLC6A6;SLC35F3;SLC36A2;CERT1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.35800380554168154,0.8218940870881155,0.7107142857142857,0.8766372178925776,1.0,3/14,9.12%,HNRNPC;MAPKAPK2;MAPK14
prerank,negative regulation of nervous system development (GO:0051961),0.3430703001148746,0.8217839862892125,0.6875,0.8764071435416216,1.0,6/17,17.76%,B2M;TLR2;TNF;SLIT1;PCM1;IL6
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.20882356985772335,-0.8212350331218914,0.8726591760299626,0.9557921843908944,1.0,36/88,31.19%,FBXL18;CUL4A;SKP1;PSMD13;FBXW5;PSMD12;RBX1;FBXL7;PSMD9;CUL2;PSME3;FBXO44;PSMA4;PSMD8;PSMF1;FBXL2;PSMD4;PSMB8;FBXL6;PSME1;FBXL3;FBXO31;FBXL16;KIF14;PSMC2;PSMB10;FBXL12;FBXO4;PSMD3;FBXO2;FBXL14;BTRC;PSMC5;DMAC2;PSME2;FBXL22
prerank,regulation of rRNA processing (GO:2000232),-0.3194263686101937,-0.8212221756503452,0.7103960396039604,0.954861847791074,1.0,6/16,29.73%,SIRT7;WDR75;RIOK2;RIOK1;NUDT16;METTL18
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.27614211215813755,0.8212049150268738,0.7416267942583732,0.8770129644372985,1.0,13/47,18.30%,EGFR;FOXM1;MAPK8IP2;IGBP1;NOD2;FOXO1;PPIA;MYC;PER1;SCIMP;IGF1R;MID1;EIF2AK2
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2676471445907883,0.8208306405517071,0.7496423462088698,0.8772451902533694,1.0,7/57,7.72%,BABAM2;WAC;NOP53;CHEK1;BRCC3;TOPBP1;TIPIN
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3107435276836318,-0.820571172147373,0.6917808219178082,0.9551864397854005,1.0,6/16,14.72%,CTNNB1;WDR5;CTR9;BRCA1;AUTS2;DNMT1
prerank,regulation of macroautophagy (GO:0016241),0.24183136544792433,0.8204845764018982,0.7648578811369509,0.8773831869465689,1.0,12/105,8.94%,PRKAG2;SESN1;GNAI3;ATP6V1B1;PRKAG3;ERN1;SNX6;WAC;ATP6V0A1;EXOC4;ATP6V1A;SMCR8
prerank,response to cholesterol (GO:0070723),-0.30312311815847404,-0.8200832202513658,0.7307692307692307,0.9551409521269044,1.0,8/17,21.52%,TGFBR1;GRAMD1A;CCL3;GRAMD1C;TGFBR2;SMO;ABCA2;TGFB1
prerank,DNA methylation or demethylation (GO:0044728),0.3280849061544651,0.8200652486938712,0.6780575539568345,0.8772465389570934,1.0,7/19,14.14%,DMAP1;GATAD2A;SPOCD1;ATRX;BEND3;KMT2E;EHMT1
prerank,DNA alkylation (GO:0006305),0.3280849061544651,0.8200652486938712,0.6780575539568345,0.8772465389570934,1.0,7/19,14.14%,DMAP1;GATAD2A;SPOCD1;ATRX;BEND3;KMT2E;EHMT1
prerank,magnesium ion transport (GO:0015693),-0.328734372770051,-0.8177369886365564,0.7155361050328227,0.9586896804678663,1.0,7/12,42.01%,NIPA1;TUSC3;MMGT1;NIPAL4;NIPAL3;NIPA2;NIPAL1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3135731676862502,-0.8170420151101735,0.7203579418344519,0.9590085867041097,1.0,2/14,2.99%,JAK2;STAT1
prerank,neurogenesis (GO:0022008),0.28290694699299285,0.8168670465645961,0.7218844984802432,0.8824453256838185,1.0,8/43,13.66%,WNT2;CLN5;BTBD1;CDK6;CXCR4;DCHS1;VXN;TRAK2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3630634985039356,0.8167931701363637,0.6799242424242424,0.8816983666317237,1.0,3/11,16.73%,LARP7;CCT6A;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3630634985039356,0.8167931701363637,0.6799242424242424,0.8816983666317237,1.0,3/11,16.73%,LARP7;CCT6A;CCT3
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.38810041261664,0.8165212408100241,0.6698656429942419,0.881747447705921,1.0,3/10,14.97%,RARG;RARA;SNW1
prerank,regulation of store-operated calcium entry (GO:2001256),0.37760619011913127,0.8164155263089459,0.6988188976377953,0.8815006388711871,1.0,3/10,11.99%,STIM1;HOMER1;SLC8B1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2868880118604516,-0.8163785413856673,0.7429906542056075,0.9593136067726985,1.0,6/21,21.15%,BRCA1;SIRT2;ABCD2;SIRT5;PARK7;HDAC6
prerank,protein K11-linked ubiquitination (GO:0070979),0.30826442737712845,0.8156744885984277,0.7034596375617792,0.8823670312454248,1.0,8/27,18.26%,UBE2E3;PRKN;CDC27;UBE2D3;ANAPC1;UBE2W;UBE2A;ANAPC10
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3410700139710547,0.8151329439607791,0.6840277777777778,0.8828941938609571,1.0,7/17,21.46%,CYCS;COX7A2L;COX7C;COX10;NDUFA4;COX6C;COX5A
prerank,mesoderm formation (GO:0001707),0.3397745451795544,0.8149525442079661,0.6957295373665481,0.8827782405866659,1.0,1/17,1.85%,ITGB1
prerank,regulation of cell aging (GO:0090342),-0.3363715548517201,-0.8148985936003781,0.7177242888402626,0.9612442529361567,1.0,3/11,11.78%,NUAK1;NEK6;MIF
prerank,regulation of cytokinesis (GO:0032465),0.2533499061342876,0.8147973945235062,0.7372764786795049,0.882613279830664,1.0,11/78,11.94%,KIF20B;UVRAG;CDC42;RHOA;PKN2;KLHL13;BIRC6;CUL3;CETN2;CALM1;SVIL
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.255024687710461,0.8147575844276325,0.7542372881355932,0.8822578986112787,1.0,15/78,17.36%,EGFR;RGCC;ACTB;CCND3;CCNYL1;CCND2;CCNJ;CDKN2C;LATS2;CCNY;PKD2;HEXIM2;PTEN;NR2F2;GTF2H1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2853294379426264,0.8145501037543109,0.7275641025641025,0.8821999457693894,1.0,6/36,11.08%,RBBP8;RYBP;EPC1;CHEK1;TFDP1;PHC3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3367365805514143,0.8143360080535496,0.6867256637168142,0.8821483788731688,1.0,2/17,4.20%,RGCC;VIM
prerank,sulfur compound biosynthetic process (GO:0044272),0.24358393120339747,0.8142584909649266,0.775,0.8818570085993209,1.0,13/104,11.92%,DSE;UST;TPK1;ST3GAL1;MGST3;B4GALT6;CHST12;PAPSS2;MGST1;SLC35B3;B4GALT5;SLC10A7;GCLM
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.3106291758086541,0.8142028463475641,0.6994906621392191,0.8815274615110069,1.0,3/26,6.15%,GCH1;ACER3;SPTLC2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3357318757700245,0.8138999986229605,0.7223230490018149,0.881621125243923,1.0,2/19,3.17%,TLR8;TLR4
prerank,urogenital system development (GO:0001655),0.3700937137381034,0.8137594266875091,0.6914498141263941,0.8814472982783099,1.0,1/11,2.40%,OSR1
prerank,regulation of ATP metabolic process (GO:1903578),0.2717054669383713,0.8137024173019645,0.7443267776096822,0.8811221201494357,1.0,15/54,21.65%,PRKAG2;PGAM1;ATP7A;NUP133;BEND3;COX7A2L;NUP62;NUP98;EP300;ZBTB7A;NUP153;AK4;SLC2A6;NUP35;RAE1
prerank,embryonic digit morphogenesis (GO:0042733),0.3356489060863186,0.8136583872540656,0.6919191919191919,0.8807667611478774,1.0,4/18,11.33%,OSR1;INTU;MAP3K20;CREBBP
prerank,negative regulation of T cell differentiation (GO:0045581),-0.35108246747151395,-0.8132026166572849,0.7200811359026369,0.9634390268487331,1.0,1/10,2.38%,LAG3
prerank,translational termination (GO:0006415),0.24474894084943574,0.8126467643045908,0.7752659574468085,0.882084739740223,1.0,33/95,24.33%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;MRPS11;MRPL1;MRPL49;MRPL16;ETF1;MRPS17;MRPL44;MRPS34;MRPS14;MRPS30;MRPS31;MRPS15;MRPL4;GSPT1;MTRF1;MRPL30;MRPL28;MRPL48;MRPS27;TRMT112;MRPL40;MRPL22;CHCHD1;MRPS35;MRPS28;MRPS18C
prerank,sphingoid metabolic process (GO:0046519),0.35566446690457115,0.8120132825297299,0.6935483870967742,0.882743170971074,1.0,1/12,1.54%,SGPP1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.3519041501906571,0.8117422386232539,0.6719298245614035,0.8827766293549633,1.0,4/13,12.78%,TLR4;TLR2;NAMPT;NOD2
prerank,autophagy of nucleus (GO:0044804),0.33918979790485226,0.8115845782429656,0.6721611721611722,0.8826226908264077,1.0,7/16,18.00%,WIPI1;ULK2;ATG7;RB1CC1;WIPI2;ATG5;ATG3
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.320837794434082,-0.8115640260793442,0.7079646017699115,0.9655316791140832,1.0,6/14,14.72%,CTNNB1;WDR5;CTR9;BRCA1;AUTS2;DNMT1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2565936459983486,0.811276201086659,0.753120665742025,0.8827086326963779,1.0,23/72,20.29%,RGCC;RPL26;SFN;FOXM1;ATRX;ARID3A;MDM2;RPS6KA6;SP100;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;BATF;CNOT4;PLK2;BCL3;CNOT8;CNOT1;PCNA
prerank,long-term synaptic potentiation (GO:0060291),-0.2838276516196484,-0.810101861191427,0.7488151658767772,0.967299057902771,1.0,5/21,13.48%,PTK2B;SLC24A2;SHANK2;GRIN2A;VAMP2
prerank,lipoprotein catabolic process (GO:0042159),0.36641348018012254,0.8100844691579712,0.6911196911196911,0.8844125305996552,1.0,2/11,5.39%,APOE;NOTUM
prerank,"transcription, DNA-templated (GO:0006351)",0.22143755556277098,0.8097272205255417,0.8483754512635379,0.8846175234073882,1.0,54/207,20.00%,MAF;MEF2A;RREB1;TCEA2;NFIC;THRB;CBFB;EPC1;TRIM24;NELFA;MED16;RNGTT;NR4A2;IWS1;CDC73;RO60;GTF2A2;NCOA6;GTF3C3;GTF3C6;MED20;POLR2B;TFDP1;GTF2E2;EAF2;FOXO3;DEK;NFIX;KLF13;GTF2A1;NFKBIB;MBD1;POLR2D;MMS19;ELOC;GTF2H3;GTF2B;CRCP;LHX1;TAF12;GTF2H1;XBP1;RRAGC;HIPK3;TEFM;POLR2F;THRA;DDX21;BCL3;TRIP11;AFF4;DTX1;NELFE;CTDP1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3301110212970777,0.8096069185083079,0.7168458781362007,0.8843980346756901,1.0,5/17,18.30%,LYN;NOD2;SCIMP;MID1;EIF2AK2
prerank,positive regulation of histone acetylation (GO:0035066),-0.26894751085919893,-0.8091895101454545,0.789873417721519,0.9680557309293183,1.0,4/23,9.42%,SMARCB1;MAPK3;BRCA1;WBP2
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.3453190614007547,0.809022488756603,0.7178571428571429,0.8849787420187304,1.0,7/13,25.65%,RACK1;WFS1;BFAR;PPP1R15B;NCK1;UFL1;HSPA5
prerank,positive regulation of cation channel activity (GO:2001259),-0.23863166859551072,-0.8090170841083746,0.8028571428571428,0.9674201437447364,1.0,11/40,23.11%,CALM2;ANK2;CTSS;AKAP6;ACTN2;STAC2;EPHB2;STAC;HAP1;CALM3;STAC3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.29342624630814,-0.8089734441451824,0.7443946188340808,0.966552500436904,1.0,5/18,16.32%,ADCY8;CRTC2;CRTC1;CD200;ADCY1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.3072470072781527,-0.8089407657656638,0.7264770240700219,0.9656532789412907,1.0,7/15,39.62%,PAX8;SMO;AGT;SOX8;BMP4;VEGFA;NOG
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3314828763419041,0.8084323430185041,0.7066189624329159,0.885557835956046,1.0,5/17,21.53%,PLA2G2D;PLAAT3;PLBD1;PLA2G4C;LCLAT1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.30316463515267833,0.8083580089866036,0.7240773286467487,0.885266553604382,1.0,4/26,8.05%,PRKN;PDE8A;HSPB1;FYN
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3060805080090473,-0.8083074618842806,0.7146118721461188,0.9659122354963801,1.0,8/15,33.48%,HUS1;FANCD2;CHEK2;NEK11;RAD9A;EME1;MDC1;RAD17
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.2928323070912404,-0.8081148583148586,0.76,0.9653057700012387,1.0,1/18,0.36%,BIN1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2850907792105345,-0.8079355970028975,0.7427184466019418,0.9646707984296123,1.0,3/21,5.06%,EPHA7;BIRC2;USP50
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.30895011382574983,-0.8078594975730008,0.7146017699115044,0.9638529190739985,1.0,7/15,32.24%,LGMN;FGF2;NOTCH1;FGF1;PRKD1;SMOC2;MET
prerank,motile cilium assembly (GO:0044458),0.3661170180445975,0.8076555825889102,0.6948529411764706,0.8860336669874235,1.0,1/12,3.66%,SPATA6
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.30071432821126115,0.8073558902007131,0.7334384858044164,0.8860935752585046,1.0,3/30,4.84%,RIPK1;HMOX1;GSK3B
prerank,sensory perception of light stimulus (GO:0050953),0.2507361535983309,0.807284694512597,0.782608695652174,0.8857779107573673,1.0,11/87,11.47%,ATXN7;RAX;DHRS3;PITPNA;CRYBG3;MYO7A;DRAM2;ATF6;BEST1;WFS1;MYO9A
prerank,cellular response to drug (GO:0035690),0.3053118138047288,0.8072577074151035,0.6854304635761589,0.8853999113537934,1.0,2/25,2.02%,GAS6;MEF2C
prerank,mitochondrial translation (GO:0032543),0.23782437211075075,0.8072331363897545,0.8054123711340206,0.8850139315948223,1.0,31/104,22.90%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;NDUFA7;EARS2;MRPS11;MRPL1;RARS2;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14;MTIF3;MRPS30;MRPS31;MRPS15;MRPL4;MTRF1;MRPL30;MRPL28;MRPL48;MRPS27;MRPL40;MRPL22;CHCHD1
prerank,sensory perception (GO:0007600),0.27788678162075797,0.8072093066771963,0.7423780487804879,0.8846251982359428,1.0,5/45,7.60%,P2RX7;C5AR1;MYO7A;CHRNA4;CCR2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.30499620008145456,0.8071310106047018,0.7154882154882155,0.8843285841708608,1.0,7/23,24.70%,PNPLA8;PLA2G2D;PLAAT3;PLBD1;PLA2G4C;MBOAT1;MBOAT2
prerank,external encapsulating structure organization (GO:0045229),0.22371011699116222,0.8067676156870723,0.8493475682087782,0.8845605567070239,1.0,29/205,13.69%,TGFBI;ITGA4;APP;ADAM19;ADAMTSL5;ITGB1;ITGA9;CD44;ST7;LOX;ATP7A;ADAMTS19;ADAMTS18;COL22A1;COL9A2;ADAMTS10;ADAM12;COL14A1;DDR2;ADAMTS9;MIA;PXDN;COLQ;MMP25;MMP24;MMP28;NID2;ADAMTS17;COL24A1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3365379650647924,-0.8066705977283779,0.7188755020080321,0.965137161729738,1.0,5/11,34.53%,TIMM8B;TIMM29;AGK;TIMM13;TIMM10
prerank,presynapse organization (GO:0099172),0.373794937189048,0.8061800643243521,0.6685714285714286,0.8851526637820718,1.0,1/10,1.39%,C5AR1
prerank,protein kinase B signaling (GO:0043491),0.3131633198199517,0.8060579113108199,0.7220338983050848,0.8849181649443852,1.0,4/23,9.95%,GAS6;ZFP36L1;TNF;IGF1
prerank,positive regulation of cell adhesion (GO:0045785),0.25376927689496215,0.8054845230562935,0.7741046831955923,0.8854793496623017,1.0,7/74,8.51%,PTPRJ;PPP3CA;ALOX15;ADAM9;SYK;TNF;FOXC2
prerank,positive regulation of T cell differentiation (GO:0045582),-0.24089794422671912,-0.8036466820873556,0.7932011331444759,0.9696044250315907,1.0,10/36,20.51%,DUSP10;VSIR;NCKAP1L;RHOH;ADAM8;BCL6;IL4I1;SART1;TESPA1;GLI3
prerank,autophagy of mitochondrion (GO:0000422),0.2801509501905884,0.8036013710920016,0.7278481012658228,0.8882411230159791,1.0,15/38,21.15%,PRKN;WIPI1;ULK2;MARK2;ATG7;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;BNIP3;ATG3;FUNDC1;FUNDC2;MAP1LC3B
prerank,prostanoid biosynthetic process (GO:0046457),-0.31131723096241737,-0.8033251861564128,0.7235023041474654,0.9692496755509239,1.0,7/15,25.25%,DAGLB;PTGS1;PTGES3;MIF;PTGIS;PTGDS;PRXL2B
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.24100264116761488,0.8029925399779115,0.7895460797799174,0.8888531665842634,1.0,17/95,15.28%,DSE;EXT1;UST;ST3GAL1;B4GALT6;SDC3;CHST12;HS3ST2;SDC4;B4GALT5;SLC10A7;HS3ST3A1;XYLT2;GPC3;CHST3;ST3GAL4;HEXA
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23535616303149687,0.8028227056451537,0.8098859315589354,0.8887170713523523,1.0,29/132,15.16%,RPL23A;RPS15;ERAL1;RPSA;RPS28;RPL24;RSL24D1;NOP53;RPL38;RPLP0;PRPF18;RPL5;CELF3;CDC73;RPS14;SNRPG;RPS5;MRPS11;RPL6;GCFC2;GEMIN7;EIF4B;RPL10;LSM4;RAMAC;POLR2D;TXNL4A;RPL11;EIF5
prerank,regulation of protein acetylation (GO:1901983),0.36113500532239595,0.8024445833115569,0.7135135135135136,0.8889305552204348,1.0,3/12,16.38%,GSK3B;TERF2IP;FAM161A
prerank,regulation of gene silencing by RNA (GO:0060966),-0.22899325775713186,-0.802065466688826,0.8290155440414507,0.9696183589396782,1.0,19/50,29.16%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;AAAS;SEC13;AGO1;POLR2L;NDC1;NUP93;NUP50;POLR2I;NUP214;NUP54
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.22899325775713186,-0.802065466688826,0.8290155440414507,0.9696183589396782,1.0,19/50,29.16%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;AAAS;SEC13;AGO1;POLR2L;NDC1;NUP93;NUP50;POLR2I;NUP214;NUP54
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.31296121361858076,-0.8017215094583232,0.7522522522522522,0.9692802581382596,1.0,5/14,15.63%,WDR12;URB1;FTSJ3;BOP1;ZNHIT6
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.36397750468895673,0.8013886283548909,0.7028571428571428,0.8903068819441593,1.0,1/11,2.12%,PLA2G7
prerank,epidermis development (GO:0008544),0.26280559442020157,0.8013788045384822,0.735080058224163,0.8898875699500297,1.0,2/56,4.62%,EMP1;GRHL2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.31545161648444214,0.8012913748070233,0.718381112984823,0.8896045065300204,1.0,5/21,14.73%,ERN1;P2RY6;IGF1;GJA1;BMPR1A
prerank,regulation of mitochondrial depolarization (GO:0051900),0.3705206986268341,0.8012641638543462,0.6965648854961832,0.8892253251486764,1.0,2/10,6.29%,RACK1;BCL2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3565367884344092,0.8011817973443254,0.7161410018552876,0.8889278336097353,1.0,1/12,0.81%,COLEC12
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.2995702139060272,-0.8006310494747135,0.7545454545454545,0.9702239701302566,1.0,6/17,24.23%,CALM2;MAGI2;PTPA;MTOR;CALM3;PDGFRB
prerank,determination of bilateral symmetry (GO:0009855),-0.26721794715763136,-0.8005087185508198,0.7634146341463415,0.9695075121225865,1.0,8/24,23.49%,BBS7;KIF3B;NOTCH1;DNAH5;MKKS;ODAD2;GALNT11;STIL
prerank,endodermal cell differentiation (GO:0035987),-0.25341407566781965,-0.8001089284263665,0.8040712468193384,0.969226744845373,1.0,11/31,22.12%,ITGB5;COL11A1;ITGA5;CTR9;PAF1;LAMA3;COL8A1;ITGAV;COL4A2;SETD2;COL6A1
prerank,positive regulation of dendritic spine development (GO:0060999),0.3153556791230428,0.8000203646373266,0.7077464788732394,0.890504825932568,1.0,2/20,7.74%,APOE;PSEN1
prerank,pre-replicative complex assembly (GO:0036388),0.2582970173141157,0.7995418109100039,0.7861271676300579,0.890890600375189,1.0,11/64,15.93%,PSMA7;RPS27A;ORC5;ORC2;PSMB2;GMNN;PSMA6;PSMD5;PSMD1;PSMA3;MCM8
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.3249606943028245,-0.7995275654759542,0.7310924369747899,0.9692602569183286,1.0,4/12,21.01%,CALM2;CAMK2D;CALM3;GJD3
prerank,cellular response to heat (GO:0034605),0.2810364996661339,0.7992588334657207,0.729264475743349,0.8909692826546793,1.0,9/35,19.02%,HMOX1;ANO1;BAG3;HSBP1;YWHAE;POLR2D;HSP90AB1;ATXN3;SUMO1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.32760062972877235,-0.7987506673908891,0.7683741648106904,0.969670157784669,1.0,5/12,22.91%,CCT7;GNL3L;CCT2;WRAP53;CCT8
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.37004263526209513,0.798650077292031,0.6852589641434262,0.8915989950341712,1.0,3/10,15.92%,JARID2;ATRX;KDM1A
prerank,amide biosynthetic process (GO:0043604),-0.22571867978253626,-0.7983446419402771,0.8283132530120482,0.9694047175283006,1.0,17/47,22.37%,SMPD4;ASAH1;ASAH2;SAMD8;CERS4;DEGS1;CERS5;CERS1;NMRAL1;FURIN;SGMS2;SMPD2;TLCD3B;SPTLC1;CERS2;ASMT;AGK
prerank,transport across blood-brain barrier (GO:0150104),0.24653999727347792,0.7980956549234919,0.7871759890859482,0.8921118349029895,1.0,14/83,14.00%,SLC16A7;SLC28A2;CD36;SLC2A4;INSR;ABCC4;SLC29A1;ABCC1;SLC4A4;SLC38A1;SLC38A2;ATP2B4;MFSD2A;ATP1A4
prerank,double-strand break repair via homologous recombination (GO:0000724),0.241986039133355,0.7980189873079797,0.8081081081081081,0.8918189776163107,1.0,22/95,16.49%,RBBP8;REC8;MCM9;NSMCE2;YY1;RPA1;RAD54L;RAD52;KDM4D;SPIDR;RPA3;AP5S1;SFR1;UBE2N;MMS22L;SEM1;RAD51B;SAMHD1;SFPQ;FBH1;MCM8;GINS2
prerank,regulation of chromosome organization (GO:0033044),-0.2753751287107641,-0.7973955358201746,0.7376344086021506,0.9702057721229768,1.0,7/22,15.21%,XRCC5;HDAC8;MAPT;UPF1;TERF2;BUB1;SHCBP1L
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.3477218140726333,0.796828613781205,0.7274401473296501,0.8934080907098785,1.0,1/13,0.63%,APP
prerank,protein localization to vacuole (GO:0072665),0.3463007676537225,0.7964604451995488,0.7065217391304348,0.8936019858671255,1.0,5/13,16.84%,LMBRD1;RTN4;LAMTOR5;SZT2;MFSD1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.29240894388567956,0.7964227086731896,0.7553366174055829,0.8932304416848207,1.0,7/30,15.29%,ST6GAL1;MGAT2;ALG5;ASGR2;UGGT1;RPN2;MCFD2
prerank,cAMP metabolic process (GO:0046058),-0.3173164163626785,-0.7961506746169659,0.7321063394683026,0.9714185011227245,1.0,2/13,1.42%,ADCY3;ADCY8
prerank,peptide catabolic process (GO:0043171),0.3025120789063832,0.7960759283427314,0.7327586206896551,0.8933799033574724,1.0,3/23,10.29%,CPQ;LNPEP;ENPEP
prerank,early endosome to late endosome transport (GO:0045022),0.3224261433790501,0.7958016335190521,0.71280276816609,0.8934158672770608,1.0,12/20,27.29%,RILP;KIF16B;RAB7A;SNX16;WDR91;EEA1;PIK3C3;RAB5A;STX8;BECN1;LMTK2;HOOK3
prerank,regulation of cell cycle process (GO:0010564),0.23918797219011229,0.7957432207812895,0.8139223560910308,0.893090267720812,1.0,16/104,12.41%,KIF20B;UVRAG;CDC42;SND1;MAD1L1;KLHL13;CEP85;CHEK1;TIPIN;BIRC6;SFRP1;CETN2;CALM1;TTL;CDK13;HORMAD1
prerank,negative regulation of cell death (GO:0060548),0.24112381320523385,0.7957093917536502,0.7930574098798397,0.8927232859401527,1.0,25/88,20.52%,TNFRSF1B;PRKN;PDE8A;KIR3DL2;GSK3B;CD200R1;VPS4B;FYN;PARP16;NUP62;WFS1;KANK2;CHGA;SPEF1;CCN5;TMEM109;ATG5;BNIP3;MECOM;TXNDC12;CCN2;GPNMB;SNCA;BTBD10;DUS2
prerank,nitric oxide metabolic process (GO:0046209),0.34420208607106506,0.795634174507901,0.7124773960216998,0.892417882353038,1.0,2/14,14.58%,GCH1;ARG2
prerank,regulation of cardiac conduction (GO:1903779),0.2643787985171743,0.7952359926472501,0.7435897435897436,0.8926820547365838,1.0,11/54,14.94%,ATP2B1;FXYD2;TMEM65;STIM1;ATP2B4;NPPC;ATP1A4;ATP1A3;ATP1A1;ATP2A2;ITPR3
prerank,protein heterooligomerization (GO:0051291),-0.3024636992643744,-0.7950304097475788,0.7629107981220657,0.9724439562080607,1.0,8/17,32.12%,CPSF6;FARSA;TMEM120B;FARSB;KCNC2;CPSF7;CBR4;PKD1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.30051729429000673,-0.7949217392500559,0.7589498806682577,0.9717188816659462,1.0,3/15,15.83%,KYNU;FAH;IL4I1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.27082795772796076,-0.7946738321177648,0.7622377622377622,0.9712123896026539,1.0,6/23,16.32%,SMAD7;FGFR2;TGFBR3;PROX1;HOPX;ID2
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.27837272751546616,-0.7943701176906397,0.7613636363636364,0.9707969243808514,1.0,11/20,43.58%,STARD3;AKR1B1;FDX1;HSD17B10;STAR;CYP46A1;TSPOAP1;DHRS9;FDXR;HSD3B2;FDX2
prerank,inner dynein arm assembly (GO:0036159),-0.3426367554394406,-0.7938768124323822,0.7115789473684211,0.9707395223760764,1.0,6/10,41.64%,CCDC39;CCDC40;DNAI3;DNAAF1;DNAH1;CFAP100
prerank,regulation of presynapse assembly (GO:1905606),0.3245128333289527,0.7938110939140797,0.7727272727272727,0.8942787842577311,1.0,1/18,0.63%,APP
prerank,regulation of presynapse organization (GO:0099174),0.3245128333289527,0.7938110939140797,0.7727272727272727,0.8942787842577311,1.0,1/18,0.63%,APP
prerank,establishment of protein localization to organelle (GO:0072594),-0.20573433630289623,-0.7936967498246398,0.8719723183391004,0.9701258935357205,1.0,28/72,28.94%,HK2;IPO5;IL10RA;APPL1;RANBP17;NUP85;IPO13;IPO8;RPAIN;NXT1;LRSAM1;ZDHHC15;LAMP5;SEC13;PPP1R10;PEX19;TNPO2;E2F3;TSC2;CSE1L;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;NUP214
prerank,striated muscle tissue development (GO:0014706),-0.24704917090232917,-0.7932631270136095,0.7810026385224275,0.9699589466172561,1.0,5/29,12.46%,SGCD;IGSF8;CFLAR;SGCZ;ZBTB18
prerank,tryptophan metabolic process (GO:0006568),0.3639071093572471,0.7932345158003898,0.708029197080292,0.8948112831079206,1.0,2/11,10.71%,ATP7A;KYAT1
prerank,determination of left/right symmetry (GO:0007368),-0.2449538552593956,-0.7931857859545731,0.8467741935483871,0.969140529055155,1.0,11/36,23.49%,BBS7;CCDC39;KIF3B;SMO;NOTCH1;DNAH5;MKKS;ODAD2;CCDC40;GALNT11;STIL
prerank,positive regulation of ATPase activity (GO:0032781),-0.237342457844427,-0.7928356027338319,0.8239795918367347,0.9687649127353184,1.0,14/41,29.73%,ATP1B1;ATP1B2;HNRNPU;DNAJB2;SSBP1;DNAJB11;MSH2;DNAJB1;DHX9;DNAJC9;TPM1;UHRF1;MSH6;DYNLL2
prerank,protein localization to centrosome (GO:0071539),0.3224807916918306,0.7926009161282781,0.7360861759425493,0.8954356612449509,1.0,4/17,14.13%,PIBF1;SNX10;CCDC14;PCM1
prerank,RNA methylation (GO:0001510),-0.22091692261837628,-0.7920572227138261,0.869281045751634,0.9692213088748702,1.0,24/60,32.49%,TRDMT1;METTL2A;METTL2B;NSUN5;FTSJ3;TFB2M;TRMT12;MEPCE;ALKBH8;TGS1;BCDIN3D;MRM2;MTERF4;METTL1;METTL3;ZC3H13;CBLL1;WDR6;GTPBP3;TRMT44;TFB1M;NOP2;TRMT6;FBL
prerank,sphingosine biosynthetic process (GO:0046512),-0.3289933949576338,-0.7919750803611321,0.7210743801652892,0.9674781663332048,1.0,5/11,20.04%,ASAH1;ASAH2;ACER2;SPTLC1;ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),-0.3289933949576338,-0.7919750803611321,0.7210743801652892,0.9674781663332048,1.0,5/11,20.04%,ASAH1;ASAH2;ACER2;SPTLC1;ABCA2
prerank,histone methylation (GO:0016571),-0.25926742232178035,-0.7918132882703435,0.7882653061224489,0.9668207949856622,1.0,12/26,37.13%,EHMT2;SIRT7;PRMT2;CARM1;SMYD1;SETD6;EZH2;SMYD2;PRMT8;FBL;PRMT7;SUV39H2
prerank,peptidyl-lysine methylation (GO:0018022),-0.2650185679791309,-0.7917711453685732,0.7663043478260869,0.9659633960966842,1.0,13/26,37.13%,EHMT2;SETD4;SETD3;SMYD1;EEF2KMT;SETD2;SETD6;SMYD2;METTL18;EEF1AKMT2;SETD7;METTL21A;SUV39H2
prerank,histone lysine methylation (GO:0034968),0.28747552005587906,0.7916909021517767,0.7584541062801933,0.8965324529577511,1.0,5/33,8.97%,KMT2A;SETDB2;KDM6A;ASH2L;WDR82
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3077514478736941,-0.7915965852028759,0.7672413793103449,0.9653511658087368,1.0,7/15,23.16%,CSTF2;DDX1;FAM98B;CLP1;RTCB;TSEN54;TSEN15
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.22016740311347407,-0.7911159708296653,0.8604651162790697,0.9652631394083925,1.0,23/62,29.16%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;DHX9;AAAS;SEC13;FXR1;AGO1;TGFB1;POLR2L;NDC1;NUP93;NUP50;POLR2I;WTIP;NUP214;NUP54
prerank,glucan catabolic process (GO:0009251),-0.3007551659073663,-0.7909418574495515,0.7230769230769231,0.9646307336724158,1.0,9/15,33.18%,PHKB;GAA;PYGL;PHKA2;PGM2;PYGB;AGL;PHKG1;PYGM
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2530424466944268,0.7908728180906401,0.8011695906432749,0.8974687204596555,1.0,20/73,19.65%,PPHLN1;JARID2;SPI1;ACTB;EPC1;POLR1A;TRIM27;POLR1B;H3-3A;MYO1C;DEK;POLR1G;EP300;HDAC4;GLMN;POLR2F;DDX21;MECP2;CTCF;CREBZF
prerank,neuron projection fasciculation (GO:0106030),-0.34719511740188924,-0.7907788357955163,0.7302904564315352,0.9639902314463101,1.0,5/10,29.66%,CNTN4;EPHB2;NRCAM;EPHB3;AMIGO1
prerank,brain morphogenesis (GO:0048854),-0.3219824699894524,-0.7899535886278987,0.7451403887688985,0.9645191130705811,1.0,4/12,21.37%,CTNNA2;SPEF2;BBS4;MKKS
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.23482117420880066,0.7897209249816403,0.843915343915344,0.8988828021663834,1.0,18/101,13.69%,EIF3E;NIBAN1;SAMD4A;RPL26;CLN6;VIM;TRIM32;RPS4X;KLF4;RPL5;LARP4B;MSN;ATG7;CASP8;ATG10;LARP4;PIWIL2;NR1H2
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.21213874696680446,-0.7896008694185164,0.8733333333333333,0.9642092802811064,1.0,18/68,23.50%,GTF2H2;SETX;PABPN1;CCNH;UBTF;ERCC2;CSTF2;NCBP1;TAF1C;TAF1D;MAZ;CLP1;MTERF2;GTF2H4;POLR2L;POLR1C;TBP;SLBP
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2972146535263125,0.7893564728240031,0.7430441898527005,0.8990573232464841,1.0,9/25,18.60%,FBXL17;CUL3;NGLY1;RNF185;UGGT1;POMT2;UBE2W;LONP1;ATXN3
prerank,cellular amide metabolic process (GO:0043603),0.2359895659782836,0.7891182945123408,0.803763440860215,0.8990309551402059,1.0,9/102,10.24%,FOLR2;ST6GAL1;ST3GAL1;SGPL1;MTHFD2L;ACOT12;PPP2CA;ORMDL1;PLAAT1
prerank,DNA duplex unwinding (GO:0032508),-0.2273502674700656,-0.7890267636198913,0.8391812865497076,0.9642214709609711,1.0,19/50,26.85%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;BLM;RECQL5;ERCC2;SSBP1;DDX1;MCM6;DHX9;UBB;GTF2H4;RAD51;MCM2;MCM7;RAD50;MCMDC2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2532867504842339,0.7885509273379923,0.7842031029619182,0.8995327926741358,1.0,18/63,20.29%,WAC;RGCC;RPL26;SFN;ARID3A;MDM2;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;CNOT4;PLK2;CNOT8;CNOT1;PCNA
prerank,regulation of cellular protein localization (GO:1903827),0.26994002484873525,0.7885293021444914,0.7940298507462686,0.8991419931602788,1.0,11/45,16.03%,RAB11FIP5;VCPIP1;KCNAB2;LCP1;HFE;SPIDR;TRIM67;RALB;GPC3;KDM1A;HSP90AB1
prerank,regulation of nervous system process (GO:0031644),0.32409486067671944,0.7884101020540307,0.7213675213675214,0.8989044494493422,1.0,5/18,16.45%,APP;NPTX2;ROCK2;BEGAIN;DLGAP4
prerank,neuron differentiation (GO:0030182),0.225747175297369,0.788051410808854,0.8385093167701864,0.8990846771401089,1.0,16/165,8.87%,LRP6;OPHN1;MEF2C;PHOX2A;WNT2;PBX3;MANF;IRX2;WNK1;MYO7A;MTPN;WNT6;NR4A2;LHX5;IRX5;OLIG2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.31759521030708787,0.7873571904491833,0.7416520210896309,0.8998072318576951,1.0,5/17,17.13%,ADAM9;SYK;FOXC2;CCL5;PODXL
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.29891673396210494,0.7872368636058238,0.7236842105263158,0.8995809435670029,1.0,5/24,14.28%,ITGB1BP1;FYN;MYO1C;KCNB1;ITGB2
prerank,DNA double-strand break processing (GO:0000729),-0.28766253815992526,-0.787135595555899,0.7708779443254818,0.9664857330209854,1.0,4/18,9.24%,DNA2;ATM;BLM;BRCA1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34070996246494634,-0.7870963933722577,0.720164609053498,0.9656208455247176,1.0,2/10,3.51%,DUSP10;PDCD4
prerank,organic anion transport (GO:0015711),0.24541388276917436,0.7866438762940153,0.8066298342541437,0.900099968810963,1.0,14/76,18.67%,LRRC8D;SLC25A17;SLC25A24;ABCC4;SLC4A4;SLC4A5;MGST1;SLCO5A1;SLC2A2;SLC23A1;SLC26A7;SLCO2A1;LRRC8C;SLC25A4
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.24198061227953463,0.786588397115922,0.8257261410788381,0.8997569440300008,1.0,21/83,19.32%,PHF8;CDK6;RB1;CDK14;BACH1;CACUL1;CUL3;TFDP1;HINFP;EIF4EBP1;CDK17;TRIM71;CDKN2C;LATS2;CRLF3;MYC;BRD4;CUL5;CAMK2A;PLK2;GSPT1
prerank,positive regulation of immune system process (GO:0002684),0.3230221359260749,0.7865651798860512,0.7311233885819521,0.8993678485922555,1.0,1/16,1.12%,IL15
prerank,mitochondrial translational termination (GO:0070126),0.23965842342449056,0.7865303791016722,0.8272108843537415,0.8989933921953294,1.0,30/88,24.33%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;MRPS11;MRPL1;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14;MRPS30;MRPS31;MRPS15;MRPL4;MTRF1;MRPL30;MRPL28;MRPL48;MRPS27;MRPL40;MRPL22;CHCHD1;MRPS35;MRPS28;MRPS18C
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3167856821402139,0.7863172817138284,0.7359454855195912,0.8984731271354249,1.0,5/20,20.81%,MGST3;MGST1;GSTT1;ESD;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.3167856821402139,0.7863172817138284,0.7359454855195912,0.8984731271354249,1.0,5/20,20.81%,MGST3;MGST1;GSTT1;ESD;GSTA3
prerank,gas transport (GO:0015669),-0.33755700648708653,-0.7857138650096019,0.7612244897959184,0.9670399039470852,1.0,1/10,0.98%,IPCEF1
prerank,vesicle organization (GO:0016050),0.2680334860354309,0.7855460088382932,0.7864992150706437,0.8993311372782375,1.0,16/46,23.74%,EPS15;SRGN;PI4K2B;WASHC4;SNX10;SNX33;WASL;EXOC8;DNAJC13;RAB22A;SAR1B;PI4K2A;LAPTM4B;ARFGEF2;SAR1A;CAV1
prerank,extracellular structure organization (GO:0043062),0.21725321621633628,0.7853416546124111,0.8820754716981132,0.8992676832049147,1.0,29/204,13.69%,TGFBI;ITGA4;APP;ADAM19;ADAMTSL5;ITGB1;ITGA9;CD44;ST7;LOX;ATP7A;ADAMTS19;ADAMTS18;COL22A1;COL9A2;ADAMTS10;ADAM12;COL14A1;DDR2;ADAMTS9;MIA;PXDN;COLQ;MMP25;MMP24;MMP28;NID2;ADAMTS17;COL24A1
prerank,autophagosome maturation (GO:0097352),-0.24826474381976554,-0.7851938302034632,0.7973333333333333,0.9670056543642136,1.0,12/32,24.29%,TECPR1;RUBCNL;CLN3;VTI1B;MAP1LC3A;GABARAPL1;VIPAS39;ATG14;CHMP3;VAMP7;SNX14;UBQLN1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.29863023139228967,0.7851202089574341,0.7425742574257426,0.8991727681762575,1.0,5/26,9.73%,DUSP1;RB1;CDC27;NSMCE2;CUL3
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.28444071140848154,-0.7849801539131646,0.7584541062801933,0.9664315761203398,1.0,4/20,9.13%,PRKCE;HECW2;ACTN2;HECW1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.32243984097680356,0.7849107598752324,0.7366548042704626,0.8990794676075634,1.0,2/18,4.31%,PRKN;MCU
prerank,response to retinoic acid (GO:0032526),0.25764504727448856,0.7848567434871058,0.8023952095808383,0.8987444837769057,1.0,11/59,14.97%,LYN;RARG;WNT2;OVCA2;WNT6;ASXL1;TRIM16;CREB1;RARA;RBP4;SNW1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.33443649952069826,0.7847731950015443,0.7360594795539034,0.8984539856002025,1.0,1/14,1.74%,DPYD
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.34947918018802054,0.784418927671253,0.7239488117001828,0.8981832074825171,1.0,4/12,15.33%,ITGB1BP1;RCC2;CORO1C;MELTF
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.34947918018802054,0.784418927671253,0.7239488117001828,0.8981832074825171,1.0,4/12,15.33%,ITGB1BP1;RCC2;CORO1C;MELTF
prerank,establishment of melanosome localization (GO:0032401),0.3110179534560066,0.7843972653769656,0.733446519524618,0.897797063761935,1.0,2/19,6.21%,MYO5A;BLOC1S5
prerank,glycine metabolic process (GO:0006544),-0.3254950278372394,-0.7840154371851026,0.7478632478632479,0.9670984096451274,1.0,9/12,47.52%,RIDA;GCSH;SHMT2;GLDC;SDS;GCAT;DLD;AMT;BAAT
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.34452016902644245,0.7838123537412028,0.7170542635658915,0.8983537906348573,1.0,3/12,14.13%,NIN;CEP19;PCM1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.318673260809038,-0.7833285863596935,0.7557077625570776,0.9673147808401003,1.0,5/13,23.55%,UBA3;UBA7;SAE1;UBA2;UBA5
prerank,negative regulation of blood pressure (GO:0045776),0.35112126931564486,0.7831311002784852,0.7360594795539034,0.8990259764064238,1.0,2/13,15.73%,PRCP;SCPEP1
prerank,mesenchymal cell development (GO:0014031),-0.2842598601367786,-0.7829946065089987,0.7900677200902935,0.9669429838176802,1.0,7/18,24.73%,CDH2;KLHL12;NOTCH1;SOX11;FOXC1;TAPT1;SOX8
prerank,post-translational protein modification (GO:0043687),0.2101372383105132,0.7829119951587655,0.9110867178924259,0.8989492973932608,1.0,54/332,16.99%,APOE;IGFBP4;APP;CP;FBXW7;ZBTB16;GAS6;PSMA7;DNAJC3;SHISA5;ASB14;FGF23;BTBD1;RHBDD1;NOTUM;KLHL13;KLHL5;FBXL5;ESCO2;UBXN7;PSMB2;ESCO1;COP1;RAB1A;CUL3;FBXO11;WFS1;CHM;PSMA6;PTP4A2;DCAF6;NUCB1;FBXO10;ASB12;RAB11A;HIF3A;SERPIND1;SUMF2;PSMD5;PSMD1;PSMA3;GPC3;ELOC;FN1;ASB4;MELTF;ICMT;FBXW2;UCHL3;ATG5;HSP90B1;MIA3;DCAF8;CUL7
prerank,cell cycle G1/S phase transition (GO:0044843),0.2505348285781052,0.7828760994106118,0.7823613086770982,0.8985766772131868,1.0,17/61,19.32%,PHF8;CDK6;RB1;CACUL1;CUL3;HINFP;MAP3K11;EIF4EBP1;TRIM71;CDKN2C;LATS2;CRLF3;MYC;CUL5;CAMK2A;PLK2;GSPT1
prerank,epithelial cell development (GO:0002064),0.3173249786753602,0.7828106465502638,0.7380952380952381,0.8982590314374083,1.0,2/20,4.62%,EXPH5;GRHL2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.26159801064710686,-0.7822016421345677,0.8019323671497585,0.967345625594337,1.0,9/25,19.40%,NLGN1;SHANK1;GSG1L;CACNG7;MINK1;CACNG8;SHISA7;CACNG4;CACNG2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2931396260739191,0.7820546327526361,0.7568881685575365,0.899032616577632,1.0,3/29,7.80%,FBXW7;AXIN1;ARRDC3
prerank,nitric oxide biosynthetic process (GO:0006809),0.34421123799614295,0.7818727768605778,0.7197802197802198,0.8988737165955434,1.0,2/13,14.58%,GCH1;ARG2
prerank,melanosome localization (GO:0032400),0.30412921442116764,0.7814309141664709,0.7413194444444444,0.8991866855025071,1.0,2/21,6.21%,MYO5A;BLOC1S5
prerank,replicative senescence (GO:0090399),-0.3141125488395425,-0.7812644332127953,0.7827956989247312,0.9679748111891344,1.0,4/12,18.57%,TP53;ATM;CHEK2;SERPINE1
prerank,cellular response to misfolded protein (GO:0071218),-0.27705141185417376,-0.7809271258010689,0.7939110070257611,0.9676134628482986,1.0,9/20,28.21%,AUP1;BAG6;UFD1;DNAJB14;RNF5;STUB1;TOR1A;DNAJC18;RNF126
prerank,muscle tissue development (GO:0060537),-0.3158557718786552,-0.7804608610094381,0.7832167832167832,0.9674404695234357,1.0,5/13,29.09%,NF1;SMO;ENG;CSRP2;BMP4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3420348040531764,0.7801378759430547,0.728440366972477,0.9008457010176322,1.0,2/12,6.99%,CD44;TNF
prerank,DNA methylation (GO:0006306),0.29925696094053683,0.7800577408052004,0.7344028520499108,0.9005549820434762,1.0,7/23,14.14%,DMAP1;GATAD2A;SPOCD1;ATRX;BEND3;KMT2E;EHMT1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.33121509696055984,-0.7800517926874967,0.7685589519650655,0.9671969703415194,1.0,2/10,8.49%,GALNT3;GALNT13
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.34325265868958926,0.7798513399486977,0.7307692307692307,0.9004672812350225,1.0,2/13,6.44%,RPS21;NOL9
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3185063577553117,-0.7798329761797496,0.7747747747747747,0.9666367348771882,1.0,3/13,14.75%,CNOT7;TNRC6B;TNRC6A
prerank,regulation of spindle organization (GO:0090224),-0.28893086943961355,-0.7797897493203649,0.7843137254901961,0.9658005809866669,1.0,8/18,24.50%,DYNC1H1;GNAI1;TACC3;NUMA1;PARP3;FSD1;MAP9;DCTN1
prerank,muscle contraction (GO:0006936),0.22795014107534442,0.7796438479645684,0.8560311284046692,0.9003741177592335,1.0,19/126,15.53%,TMOD1;MYH6;MYOM2;TNNT1;MYOF;UTRN;VIM;TMOD3;ROCK1;VCL;ADRA1A;PXN;CALM1;CRYAB;ROCK2;NEB;TPM3;MYBPC3;CLCN1
prerank,camera-type eye development (GO:0043010),-0.258124973265284,-0.7791143657474184,0.80440097799511,0.9659831030378152,1.0,4/25,11.79%,TENM3;NF1;SHROOM2;CACNA1C
prerank,cellular response to virus (GO:0098586),0.2838181864815068,0.7787936768515895,0.7623456790123457,0.9013406720151389,1.0,8/30,18.29%,CCL19;GSDME;RIOK3;MAPK14;ZC3H12A;CCL5;IL6;RRP1B
prerank,entry into host (GO:0044409),0.3368427481881717,0.7787245591061903,0.722753346080306,0.9010175308528602,1.0,3/13,7.48%,CBL;CTNND1;CXCR4
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.29911126854606346,0.7782450508577914,0.7666666666666667,0.9013717565251116,1.0,8/22,18.10%,TSLP;IL10RB;TNF;CRLF2;CRLF3;CCL5;IL6;F2R
prerank,negative regulation of autophagy (GO:0010507),0.2582833290622038,0.7781720616605647,0.7690058479532164,0.9010670176919726,1.0,11/54,13.95%,NUPR1;PTPN22;MCL1;TBC1D14;BCL2;SMCR8;ATG7;FOXK2;FOXK1;RUBCN;STAT3
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2505267912219356,-0.7779403545263297,0.8076923076923077,0.9669846771422255,1.0,8/28,14.20%,ATRIP;ATM;ERCC6;DOT1L;CEP63;HUS1;PRPF19;CHEK2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.30340687901104757,0.7772673953509577,0.75,0.9020611058435279,1.0,2/22,4.76%,MYADM;SSH2
prerank,protein autoprocessing (GO:0016540),-0.2912736549503868,-0.7768989306593731,0.7775175644028103,0.9677123261443273,1.0,6/17,28.71%,HTRA2;FXN;AFG3L2;PIDD1;SPRTN;MYRFL
prerank,cellular response to interleukin-7 (GO:0098761),0.3274845416963684,0.7767499648694216,0.7246891651865008,0.9020341776715073,1.0,5/17,13.95%,TSLP;IRS2;JAK1;CRLF2;STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.3274845416963684,0.7767499648694216,0.7246891651865008,0.9020341776715073,1.0,5/17,13.95%,TSLP;IRS2;JAK1;CRLF2;STAT3
prerank,endodermal cell fate commitment (GO:0001711),-0.33195193737427864,-0.7765670214492842,0.733615221987315,0.9673290741381417,1.0,2/10,10.78%,CTR9;PAF1
prerank,maturation of LSU-rRNA (GO:0000470),-0.26146118278195485,-0.7762919982799039,0.8114143920595533,0.9668496807663034,1.0,7/26,15.63%,NSA2;WDR12;MAK16;URB1;FTSJ3;BOP1;ZNHIT6
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3011363954145888,0.7761636625806722,0.7542955326460481,0.90256990347862,1.0,4/22,11.89%,GSK3B;ROCK1;TNF;ROCK2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.22951062489051038,-0.7758807214919363,0.8681318681318682,0.9665920148806882,1.0,4/43,4.11%,DDX5;TP53;ETS1;FGF2
prerank,blood circulation (GO:0008015),0.2583401931019172,0.7758581053298119,0.78419452887538,0.9026518407690498,1.0,7/49,11.92%,C3AR1;MYOF;ITGB1BP1;ROCK1;PLN;ROCK2;GCLM
prerank,cellular response to purine-containing compound (GO:0071415),0.3645753109911849,0.7755008910252751,0.7212806026365348,0.9027994298325566,1.0,2/10,10.96%,P2RY6;TRPM2
prerank,snRNA 3'-end processing (GO:0034472),-0.2694525637313105,-0.7751484754286309,0.801909307875895,0.9668595361124429,1.0,2/19,8.12%,INTS6L;EXOSC9
prerank,autophagy of peroxisome (GO:0030242),-0.31656762361139307,-0.7751476245037036,0.7605321507760532,0.9659575983097453,1.0,2/12,5.77%,ATM;PIK3R4
prerank,nuclear envelope organization (GO:0006998),0.312545682680516,0.7746173507430446,0.7457337883959044,0.9038210114929507,1.0,1/20,1.28%,REEP3
prerank,tRNA methylation (GO:0030488),-0.24341444347510904,-0.7745512893440324,0.8411458333333334,0.9659720090015235,1.0,16/34,36.52%,DALRD3;TRDMT1;METTL2A;METTL2B;TRMT12;ALKBH8;BCDIN3D;METTL1;HSD17B10;PRORP;WDR6;GTPBP3;TRMT44;THUMPD3;FTSJ1;NSUN6
prerank,response to unfolded protein (GO:0006986),0.2644580407862664,0.7743764608469064,0.7844961240310078,0.903774423884163,1.0,5/48,6.97%,ERN1;PRKN;RHBDD1;BAG3;HSPB1
prerank,peptidyl-asparagine modification (GO:0018196),0.28189467497705706,0.7739592511512585,0.7738287560581584,0.9039974396423411,1.0,7/31,15.29%,ST6GAL1;MGAT2;ALG5;ASGR2;UGGT1;RPN2;MCFD2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3387870032860103,0.7738160646597746,0.724907063197026,0.903793059085503,1.0,2/12,6.24%,PIBF1;ERLIN1
prerank,mitotic cell cycle phase transition (GO:0044772),0.21439093969613987,0.7735136176855565,0.906508875739645,0.9038681889523986,1.0,34/203,15.21%,EPS8;FBXL17;PHF8;NES;CDK6;RB1;CDC27;FOXM1;CCND3;CDK14;CLASP1;CCND2;CCNJ;CACUL1;CUL3;CETN2;PCNT;DYNC1I2;ARPP19;YWHAE;HINFP;EIF4EBP1;TRIM71;CDKN2C;LATS2;PAFAH1B1;CCNY;PCM1;CRLF3;CEP78;HAUS5;ANAPC1;PPP2R2A;MYC
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.22021987087749972,-0.7730554234279159,0.8798701298701299,0.9674374526039259,1.0,13/55,18.02%,SKP1;PSMD13;PSMD12;RBX1;FBXL7;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,regulation of intracellular protein transport (GO:0033157),0.281951189781669,0.7726840732272737,0.7863924050632911,0.9047427906818177,1.0,10/32,20.10%,KIF20B;LCP1;PCNT;BCAS3;UHMK1;PCM1;PTPN14;NDEL1;OAZ2;OAZ1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.33930565267044527,0.7726001955807656,0.7605893186003683,0.9044473292057056,1.0,3/12,16.54%,DUSP1;WASL;MIA3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.26252065857945095,-0.7723776027258861,0.8308080808080808,0.9676002864980954,1.0,3/23,3.21%,JAK2;STAT1;IRGM
prerank,negative regulation of cell communication (GO:0010648),-0.271045716815439,-0.7722362965222632,0.7801932367149759,0.966932128219845,1.0,3/21,12.51%,ACVR1;UBASH3B;GLRA1
prerank,hexose transmembrane transport (GO:0008645),-0.2685921764131025,-0.7717448469273114,0.8215102974828375,0.9668026038072212,1.0,6/21,22.63%,SLC2A9;SLC2A5;SLC50A1;SLC45A3;SLC2A3;SLC45A1
prerank,intracellular protein transport (GO:0006886),0.20584423997576737,0.7716229298523695,0.9333333333333333,0.9055637835652633,1.0,35/304,10.65%,SNX9;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;USP6NL;PRICKLE1;CD74;SNX6;SNX27;EHD1;AP3B1;RIC1;TBC1D14;TMED10;SYK;IPO11;BAG3;AP4S1;TBC1D2B;RABGAP1L;SGSM1;RAB7A;NUP133;STX7;RAB14;RAB1A;RAB23;ARL4A;LAMP2;WLS;NUP62;MYO1C
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.28108205898302874,0.7714577463497588,0.7741935483870968,0.9054026179629225,1.0,8/33,16.14%,CDK6;RB1;KLF4;CDC73;KANK2;CDKN2C;PKD2;PTEN
prerank,protein ADP-ribosylation (GO:0006471),0.2849089064978222,0.7714206017196735,0.7318255250403877,0.9050418396929123,1.0,3/28,4.00%,PARP14;PARP8;PARP11
prerank,C4-dicarboxylate transport (GO:0015740),-0.3035012340443769,-0.7708019325047699,0.7712418300653595,0.9673243231657446,1.0,6/14,24.40%,SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC1A2;SLC25A13
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.25305240498026493,0.770785027704992,0.8060344827586207,0.9056258354933161,1.0,4/59,6.27%,ALOX5;OSBPL9;HSD3B7;CYP27A1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.3153922996796618,-0.7707424159209468,0.7782340862422998,0.9665344337884629,1.0,6/12,30.37%,STARD3;AKR1B1;FDX1;STAR;CACNA1H;TSPOAP1
prerank,regulation of transmembrane transport (GO:0034762),0.28293394023831775,0.7707213409759537,0.7680672268907563,0.9053161812227594,1.0,4/31,7.51%,KCNJ14;ACTB;BCL2;PRKCB
prerank,protein localization to organelle (GO:0033365),0.22381244220347613,0.7706709280965132,0.8675,0.9049763936835589,1.0,22/133,13.88%,APP;LAMP3;HMOX1;EHD1;UBAC2;LAMP1;SERP1;PIKFYVE;LMBRD1;RPA1;DCP1A;TRAM2;MDM2;LAMP2;PACSIN2;CD68;SNX10;YWHAE;XPA;VAPA;CNTLN;RAB11A
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2904835203898284,0.7699021503915223,0.757679180887372,0.9057560058607034,1.0,8/25,16.66%,CDK12;LARP7;NELFA;CDC73;EAF2;CDK13;EAPP;BRD4
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.2520385327855936,-0.7696949975015936,0.7961630695443646,0.967182444057012,1.0,4/26,5.85%,MBP;VSIR;USP50;APH1A
prerank,regulation of isotype switching (GO:0045191),0.32616537040933713,0.7695992120937479,0.7404021937842779,0.9057974884279445,1.0,5/14,23.04%,KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,regulation of nuclear division (GO:0051783),0.30768942518769404,0.7692250065670805,0.7562724014336918,0.9059360454332267,1.0,5/20,21.87%,KIF20B;CDK13;CUL7;DAPK3;BORA
prerank,nucleosome organization (GO:0034728),0.2521580164095058,0.768858075021787,0.8270348837209303,0.9060799494120597,1.0,18/55,22.27%,PADI4;DMAP1;ATRX;LIN54;H3-3A;POLE3;SMARCD1;ARID1A;ANP32B;ASF1A;SRCAP;SET;CTCF;NAP1L2;CHAF1B;ANP32E;NPM1;GRWD1
prerank,cGMP biosynthetic process (GO:0006182),0.3519020677575265,0.7682936723098942,0.7413793103448276,0.9065540950622012,1.0,2/10,13.97%,GUCY2D;NPPC
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23928971639253369,0.7678196994199193,0.8403361344537815,0.906899491727507,1.0,19/72,20.29%,RNASE4;RPS27A;DNASE1L1;RNASE6;RPA1;DCP1A;XPA;ZC3H12A;RPA3;HORMAD1;FBH1;GTF2H3;GTF2H1;RFC3;DXO;MRE11;ENPP1;POLD2;PCNA
prerank,organelle transport along microtubule (GO:0072384),0.2841091050085967,0.7676678875446052,0.7609756097560976,0.906719142197218,1.0,10/31,20.73%,ARHGAP21;CDC42;RAB1A;BORCS5;PAFAH1B1;TRAK2;PEX14;NDEL1;UXT;TRAK1
prerank,UV protection (GO:0009650),0.35660143547255724,0.7675911838503895,0.76007326007326,0.9064087821348478,1.0,2/10,11.66%,MFAP4;XPA
prerank,regulation of actomyosin structure organization (GO:0110020),0.3309371113928377,0.7675427642594315,0.7453183520599251,0.9060525228717845,1.0,4/13,11.89%,CDC42;ROCK1;PTGER4;ROCK2
prerank,telomere capping (GO:0016233),-0.29299417316488374,-0.7670631875795505,0.7835497835497836,0.9702442920832329,1.0,7/16,25.93%,CTC1;STN1;TERF2;DCLRE1B;TFIP11;ACD;RAD50
prerank,nuclear pore complex assembly (GO:0051292),0.35961960532834836,0.7666636108236153,0.7295238095238096,0.9070140425454768,1.0,3/10,17.04%,RTN4;NUP98;NUP153
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.21004716904957144,-0.7662883792812948,0.8814589665653495,0.9705179809658645,1.0,9/57,11.21%,TREM2;FBXO7;TP53;BCL2L11;HTRA2;MLLT11;BMF;TNFSF10;DDHD1
prerank,response to X-ray (GO:0010165),-0.30067110015050963,-0.7660022427218988,0.7728285077951003,0.9700132432045266,1.0,5/14,17.03%,XRCC5;ATM;BLM;XRCC6;MSH2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.2826829994712106,0.7658220697508925,0.7662771285475793,0.9079235666606383,1.0,4/29,5.16%,MYADM;PRKN;SSH2;SMAD4
prerank,purine-containing compound salvage (GO:0043101),0.3405868609788384,0.7656437869252952,0.7545126353790613,0.9077659738863708,1.0,2/12,10.61%,ADK;AMPD3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2936193315843185,0.7654225478673191,0.7523961661341853,0.9076853623154858,1.0,2/24,2.75%,PTPN22;LILRB1
prerank,alpha-amino acid metabolic process (GO:1901605),0.2612513326204785,0.7653249197931082,0.8151382823871907,0.9074056407819422,1.0,9/45,17.72%,ATP7A;THAP4;GNMT;KYAT1;ASS1;GLS2;GLUD1;NOX4;RIMKLA
prerank,positive regulation of receptor internalization (GO:0002092),0.2966531175983999,0.764530889272322,0.752542372881356,0.9082687306667792,1.0,3/22,10.24%,TBC1D5;INSR;ARRB1
prerank,protein secretion (GO:0009306),0.2486716710020328,0.7642000784909548,0.8002936857562408,0.9083637329461459,1.0,10/56,16.54%,STEAP3;RCN3;RAB8B;RAB10;CANX;WLS;PDIA4;RAB3B;GOLPH3;MIA3
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.32506019809161874,0.7641707497595698,0.7473118279569892,0.9079856208525868,1.0,2/15,4.74%,ADM;IRS2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.297315439700913,-0.7641568484697572,0.7940503432494279,0.9718647201817193,1.0,7/14,38.62%,COPS8;TLR3;TRAF2;MALT1;IRAK1;CARD10;MAP3K7
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.30552305389188456,0.7641014192017198,0.7889273356401384,0.9076770973103325,1.0,5/18,14.21%,RPS27A;AMFR;RNF185;UGGT1;DERL2
prerank,lipid translocation (GO:0034204),0.3030837601815939,0.7640404457552811,0.7671232876712328,0.9073569940554749,1.0,4/21,10.83%,ATP11C;ATP8B4;ABCC1;ATP10B
prerank,protein monoubiquitination (GO:0006513),0.27097126650525705,0.7637293773779692,0.7908805031446541,0.9074329709345865,1.0,9/36,16.15%,WAC;PRKN;CDC73;UBE2D3;CUL3;UBE2R2;TRIM25;UBE2W;FANCL
prerank,DNA conformation change (GO:0071103),0.3112211320433844,0.7632817929477156,0.7835051546391752,0.9076866768335343,1.0,4/17,16.17%,TOP1MT;HAT1;KAT6A;TOP2B
prerank,negative regulation of TOR signaling (GO:0032007),0.2705432888546551,0.7631386422224855,0.8034591194968553,0.9074696923213841,1.0,4/36,8.23%,DEPTOR;SESN1;NPRL3;FNIP1
prerank,neuromuscular synaptic transmission (GO:0007274),0.313510142327692,0.7624814669626387,0.7765567765567766,0.9080310491193534,1.0,4/18,17.31%,FCHSD2;ERC2;RIMBP2;CHRNB2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.328148385548216,-0.762329169883583,0.7381974248927039,0.9736948371577426,1.0,3/10,18.57%,PDE3B;ACER2;SERPINE1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.29435627986823076,-0.7623217847712981,0.8414918414918415,0.9728088309409397,1.0,2/16,7.08%,KLK2;SLC2A5
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.2695827262671654,0.7622271198208567,0.7893129770992366,0.9079748905228525,1.0,7/37,16.14%,MEF2C;ERN1;P2RY6;IGF1;GJA1;BMPR1A;PTEN
prerank,spermatid development (GO:0007286),-0.2399634406502281,-0.7616786062636487,0.8585365853658536,0.9728639669404867,1.0,7/32,24.06%,JAM2;NECTIN2;IQCG;NME5;BBS4;MKKS;SYCP3
prerank,endothelial cell differentiation (GO:0045446),0.34078083769419704,0.7612807480763936,0.7716535433070866,0.9089880525210741,1.0,1/12,1.94%,JAG1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3248607704671025,-0.761244188247315,0.7870563674321504,0.9726034081394349,1.0,5/10,30.49%,SIRT7;ZNF692;SELENOS;PDK2;DGKQ
prerank,glycerophospholipid metabolic process (GO:0006650),0.23842124573637488,0.7610827710517902,0.8548387096774194,0.9088531582853897,1.0,15/75,16.65%,PLA2G7;SYNJ1;IP6K3;CPNE7;PLCD1;PLA2G2D;DGKH;PIP5K1A;HDHD5;PLAAT1;PLCB3;PAFAH1B1;FAR1;PIGQ;PIGX
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.282930252485395,0.7605140456730282,0.7750410509031199,0.9092631205739602,1.0,12/31,22.16%,DCP1A;DDX6;DCP2;EXOSC8;DIS3L2;LSM4;LSM2;EXOSC1;HBS1L;CNOT8;PATL1;EXOSC3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.34341707490562057,0.7602771892642604,0.7669902912621359,0.9091981303461288,1.0,2/12,10.16%,MEF2C;DOCK7
prerank,regulation of centriole replication (GO:0046599),0.30619166215574806,0.7596929794917302,0.7754716981132076,0.9096636543423812,1.0,8/17,25.20%,CEP295NL;NUP62;SPICE1;CEP76;PLK2;NPM1;KAT2B;MDM1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2523797164277649,0.7593297672342875,0.8055555555555556,0.9097736375985969,1.0,17/54,20.29%,RGCC;RPL26;SFN;ARID3A;MDM2;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;CNOT4;PLK2;CNOT8;CNOT1;PCNA
prerank,growth hormone receptor signaling pathway (GO:0060396),0.32676522028298055,0.7590953459462116,0.7589285714285714,0.9097247262056007,1.0,4/14,13.95%,LYN;STAT6;PXN;STAT3
prerank,regulation of TOR signaling (GO:0032006),0.24091524654680088,0.7590698140463158,0.8424855491329479,0.9093520294538822,1.0,14/67,18.22%,DEPTOR;GAS6;NPRL3;MIOS;FNIP1;SMCR8;LAMTOR5;HTR6;NPRL2;GOLPH3;LARS1;GPAT3;RHEB;RRAGC
prerank,erythrocyte differentiation (GO:0030218),0.2562714213807514,0.7588380632676308,0.7954545454545454,0.9092812532986109,1.0,7/44,12.82%,LYN;MFHAS1;CEBPG;RPS14;SH2B3;SLC25A5;KMT2E
prerank,tRNA wobble uridine modification (GO:0002098),0.32393260391999495,0.758687674132475,0.7734082397003745,0.9091020428139936,1.0,4/14,13.91%,URM1;DPH3;ELP4;CTU1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.20221016564721747,-0.7583285961684488,0.9422382671480144,0.9761107150039697,1.0,19/69,22.95%,COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFAF1;UQCRB;AFG1L;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;SDHAF2;NDUFA8;UQCR10;NDUFA10;NDUFAB1;COA6;NDUFS1
prerank,diterpenoid metabolic process (GO:0016101),0.2509120611076523,0.757893359957669,0.8230994152046783,0.909842608752666,1.0,9/55,18.33%,APOE;DHRS3;SDC3;SDC4;RBP4;GPC3;RDH5;RBP1;ABCA4
prerank,iron-sulfur cluster assembly (GO:0016226),-0.262846743169047,-0.7578350251432276,0.8398058252427184,0.9758833765373212,1.0,12/24,26.96%,NFU1;NUBPL;ISCU;FXN;NFS1;ISCA1;CIAO1;BOLA2;GLRX5;HSPA9;CIAO2B;CIAPIN1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.32128006144984683,0.7578157214035582,0.7668488160291439,0.9095485290956933,1.0,5/16,18.75%,ATP5PO;ATP5MC2;ATP5F1E;ATP5MC1;ATP5MF
prerank,chromosome condensation (GO:0030261),0.2653412750124937,0.7573813780549743,0.8086124401913876,0.9097866644642755,1.0,15/36,26.31%,PHF8;RB1;INCENP;BANF1;SMC4;SET;CSNK2A2;CSNK2A1;ERN2;AIFM1;PLK1;CSNK2B;MCPH1;ACIN1;NCAPD3
prerank,peroxisome organization (GO:0007031),-0.254232788499417,-0.7571901988011835,0.8291457286432161,0.975965501930509,1.0,10/25,29.61%,PEX6;ABCD2;PEX10;PEX3;PEX11B;PEX19;FIS1;ACOT8;PEX11G;TMEM135
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.24813425659796695,0.7570235774824968,0.8335745296671491,0.9099118709298714,1.0,12/58,16.91%,LIG4;BABAM2;UVRAG;DCLRE1C;BRCC3;NSMCE2;NHEJ1;XRCC4;UBE2N;KDM2A;CYREN;ZBTB7A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.31913822083802995,-0.7567474451408082,0.7986270022883295,0.9757533005670929,1.0,4/11,11.35%,TP53;ATF6B;DDIT3;ATF3
prerank,nuclear pore organization (GO:0006999),0.3281612271768516,0.7563028863880978,0.7551401869158878,0.9105625451738054,1.0,5/14,21.50%,NUP133;RTN4;NUP98;NUP153;NUP35
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3109930350612256,0.756145889531173,0.7626168224299066,0.9103788342004381,1.0,5/18,17.25%,PRKN;HSPB1;PPIA;MAPK7;TRAP1
prerank,triglyceride biosynthetic process (GO:0019432),0.30780408477042165,0.7558735332623315,0.7807017543859649,0.9103646156516552,1.0,2/18,4.41%,AGMO;MOGAT2
prerank,ubiquinone metabolic process (GO:0006743),-0.28257040486989493,-0.7558254120336942,0.7736720554272517,0.9761892163661224,1.0,4/15,15.38%,COQ8B;PDSS2;AIFM2;COQ7
prerank,DNA dealkylation (GO:0035510),-0.3294003033981343,-0.7546538109911933,0.7983193277310925,0.9761543032662837,1.0,5/10,27.83%,ASCC1;ALKBH2;ASCC2;ALKBH5;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.3294003033981343,-0.7546538109911933,0.7983193277310925,0.9761543032662837,1.0,5/10,27.83%,ASCC1;ALKBH2;ASCC2;ALKBH5;ALKBH1
prerank,neural tube development (GO:0021915),-0.2840552449230823,-0.7543760206624643,0.8004434589800443,0.9756617146926385,1.0,7/15,23.49%,DVL1;PROX1;ALDH1A2;SOX11;TGFB1;DACT1;STIL
prerank,regulation of translational initiation (GO:0006446),0.2406208497621625,0.7531237584747832,0.861271676300578,0.9140131995108088,1.0,16/63,16.92%,DNAJC3;CEBPB;EIF3E;HSPB1;RBM4;EIF1;EIF4B;EIF4EBP2;EIF4EBP1;UHMK1;POLR2D;EIF3H;EIF5;PPP1R15B;CSDE1;CCL5
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.29043790771677525,0.7529294126225853,0.8151986183074266,0.9138883049431211,1.0,6/26,13.17%,RPS27A;ALPK1;RIPK2;CASP8;NOD2;UBE2N
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.29618578067716644,-0.7528390175409597,0.8084112149532711,0.9769197696193122,1.0,3/15,14.75%,CNOT7;TNRC6B;TNRC6A
prerank,phospholipid homeostasis (GO:0055091),-0.31450010536275114,-0.7524679170207835,0.7865853658536586,0.9765329634387848,1.0,2/11,6.47%,ABCG1;TLCD2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2967697645777495,-0.7513230309249264,0.7934782608695652,0.9772186312972494,1.0,7/13,27.74%,EDEM1;UBE2J1;ERLEC1;BRSK2;BCAP31;YOD1;UBE2G2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.29947394364160584,-0.7510282556297019,0.8174097664543525,0.9767260626297373,1.0,5/14,21.73%,XRCC5;BRCA2;TERF2;TPP1;ACD
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.29496194139964454,-0.7505318063929792,0.7847222222222222,0.9765181211292893,1.0,9/14,36.71%,FGF2;SULF1;GPC1;SPRY1;SPRY4;GATA3;SPRY3;APLN;FUZ
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.21220250801982915,-0.750407371755943,0.9369369369369369,0.9757757312792166,1.0,22/50,37.16%,CCNG2;CCNT2;CCNH;BLM;GADD45A;CDK5RAP3;BCCIP;CDK5R2;CCNG1;CCNK;CDKN3;CCNT1;CCNA2;STOX1;CAMK2N1;CCNE1;CCNB2;SERTAD1;CDK7;CDC25C;CDC37;CCNB1
prerank,cellular response to hypoxia (GO:0071456),0.22210769985986076,0.7497502267197437,0.8897535667963683,0.9180998362543433,1.0,28/126,18.39%,PSMA7;RPS27A;RGCC;ZFP36L1;HMOX1;NOP53;HIGD1A;PSMB2;LIMD1;BACH1;MDM2;CARD16;SFRP1;CREBBP;PSMA6;FAM162A;EP300;HIF3A;PSMD5;PSMD1;PSMA3;ELOC;MYC;ARNT;BNIP3;LMNA;TBL2;AK4
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.2495637005645076,-0.7496718185807095,0.8254716981132075,0.9759212451428277,1.0,10/26,33.23%,CALM2;FMR1;CBARP;GPR35;CALM3;UBQLN1;CRHR1;TLR9;GSTO1;ADRA2A
prerank,amyloid precursor protein catabolic process (GO:0042987),0.31923754879878896,0.7495115800693102,0.7635658914728682,0.9180362083893412,1.0,3/14,9.33%,ADAM19;PSEN1;DYRK1A
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.21413248571751312,0.7493095274824393,0.8975,0.9179130703164515,1.0,35/148,20.44%,PRKAG2;RPL23;RBBP8;PRKAG3;RPS15;RPL37;RPS20;PHF20;NOP53;CHEK1;TOPBP1;RPL5;RPA1;BRIP1;MDM2;MAPK14;RHNO1;RPA3;PPP1R13B;EP300;EHMT1;KAT6A;RPL11;ATR;TAF12;RFC3;RRS1;PIP4K2A;PIP4P1;MRE11;CSNK2A2;CSNK2A1;USP7;BRD7;JMY
prerank,establishment of mitotic spindle localization (GO:0040001),-0.24292778371098803,-0.7488152605910738,0.8663484486873508,0.9762388361581056,1.0,11/28,24.96%,CLASP2;NSFL1C;NUMA1;INSC;SPDL1;NDC80;NUSAP1;ZW10;ESPL1;DCTN1;MAD2L1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.35390634491980094,0.7487874202216717,0.7732342007434945,0.9182717411416919,1.0,3/10,11.64%,SESTD1;PLN;YWHAE
prerank,positive regulation of histone methylation (GO:0031062),0.2949844638111363,0.748001036243525,0.7956081081081081,0.919004243009068,1.0,3/24,5.16%,KMT2A;JARID2;SMAD4
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.32411355651774554,-0.7470936003962128,0.823404255319149,0.9776874669860053,1.0,3/10,16.51%,LPGAT1;ABCD2;SLC45A3
prerank,vascular transport (GO:0010232),0.23127414933264312,0.7464587398714784,0.8543956043956044,0.9208224458109943,1.0,13/81,14.00%,SLC16A7;SLC28A2;SLC2A4;INSR;ABCC4;SLC29A1;ABCC1;SLC4A4;SLC38A1;SLC38A2;ATP2B4;MFSD2A;ATP1A4
prerank,cellular response to glucose starvation (GO:0042149),0.2615913695831559,0.7464089925008341,0.8405572755417957,0.9204687111389391,1.0,4/41,4.07%,PRKAG2;SESN1;PRKAG3;MTMR3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.28184040986923187,-0.7462737828224737,0.8066666666666666,0.9779284722092078,1.0,3/16,7.45%,SCARB2;PDK1;PDK3
prerank,serine family amino acid catabolic process (GO:0009071),0.34537357917092015,0.7461620079252439,0.779245283018868,0.9204139235414245,1.0,2/10,13.59%,DAO;SHMT1
prerank,DNA geometric change (GO:0032392),-0.2543957804222243,-0.7451302732599465,0.8201970443349754,0.9786215086830055,1.0,9/24,25.93%,DNA2;HNRNPA2B1;BLM;RECQL5;DDX1;DHX9;HMGB1;HMGB3;RAD50
prerank,digestive tract development (GO:0048565),0.27077779060742807,0.7438091558409995,0.8076256499133448,0.9233173046619811,1.0,1/32,0.44%,EDNRB
prerank,negative regulation of cell cycle process (GO:0010948),-0.20461578521711724,-0.743596331668696,0.9042904290429042,0.9797781304245811,1.0,25/61,31.36%,EHMT2;MGA;TOM1L1;PCGF6;BRCA1;CDC7;CCP110;PCGF2;CBX5;TERF2;RING1;ZFYVE19;RAD51;BMI1;ESPL1;PPP1R10;EZH2;AURKB;CHMP4C;YAF2;BMP4;PHC1;E2F7;FBXO5;CBX3
prerank,platelet aggregation (GO:0070527),0.2683164037883833,0.7435665349996777,0.8051529790660226,0.9232398584178554,1.0,5/33,8.29%,RAP2B;PDGFRA;ACTB;HSPB1;VCL
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.2551963846012167,0.7432605745050253,0.8368580060422961,0.9232544293070304,1.0,5/43,7.26%,BABAM2;NOP53;CHEK1;BRCC3;TOPBP1
prerank,BMP signaling pathway (GO:0030509),0.23532090270273434,0.7426925985411467,0.88,0.9236429291232489,1.0,8/62,8.79%,BMP2;GDF3;USP9X;SMAD4;ACVR2A;USP15;HFE;HIVEP1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.289409213603533,0.7425868135054324,0.7979966611018364,0.923376367049848,1.0,6/23,19.44%,HERC4;RACK1;GPC3;GPR161;GLIS2;ENPP1
prerank,cellular amino acid catabolic process (GO:0009063),0.2304847143979041,0.7424879981675063,0.900804289544236,0.9230954716368436,1.0,12/87,15.19%,HAL;HDC;DAO;HIBADH;KYAT1;HIBCH;ACAD8;GLS2;GLUD1;SHMT1;ACAT1;HNMT
prerank,regulation of cell cycle phase transition (GO:1901987),-0.18598914066351965,-0.7424296626281244,0.9538461538461539,0.9804794181265045,1.0,20/91,18.02%,ANAPC15;TP53;SKP1;PSMD13;PSMD12;ERCC2;PSMD9;ANAPC11;UBE2S;PSME3;BUB1B;PSMA4;PSMD8;PSMF1;PSMD4;UBE2E1;NEK11;UBE2D1;PSMB8;PSME1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.34566347093564115,0.7421249935182508,0.764367816091954,0.9232042898569243,1.0,3/10,13.95%,LYN;STAT6;STAT3
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.2685884810340406,-0.7416988795087746,0.8505747126436781,0.9797020800612095,1.0,9/20,28.97%,BCKDHA;ECHS1;ACADSB;IVD;SLC25A44;HSD17B10;BCKDHB;BCAT1;MCCC2
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.2685884810340406,-0.7416988795087746,0.8505747126436781,0.9797020800612095,1.0,9/20,28.97%,BCKDHA;ECHS1;ACADSB;IVD;SLC25A44;HSD17B10;BCKDHB;BCAT1;MCCC2
prerank,regulation of cell death (GO:0010941),0.22514841585138962,0.7414283036067251,0.8929068150208623,0.923795972744809,1.0,26/94,22.79%,TNFRSF1B;CD36;PRKN;PDE8A;SLC25A24;ACER3;VPS4B;RIPK2;PARP16;CRYAB;ZC3H12A;SPEF1;CCN5;TMEM109;ATG5;SNCG;BNIP3;CCL5;TXNDC12;CCN2;SNCA;DUS2;FAF1;CDKN1B;AXIN2;NCK1
prerank,potassium ion export across plasma membrane (GO:0097623),0.32468988801032805,0.7410187198256069,0.7728937728937729,0.9239567739328528,1.0,3/13,17.57%,KCNQ1;KCNK5;KCNE3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3439844663173377,0.7408826219866931,0.7480314960629921,0.923733833366775,1.0,3/10,10.66%,FOXM1;RPS6KA6;SP100
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.31873956782522483,-0.7393874213267333,0.8030634573304157,0.9819414427598933,1.0,2/10,8.66%,PIK3CB;CADM4
prerank,glucose import (GO:0046323),-0.293541742274375,-0.7393195443974476,0.8160676532769556,0.9811625597847999,1.0,4/13,24.02%,SORT1;SLC27A4;SLC2A3;SLC27A1
prerank,protein-DNA complex disassembly (GO:0032986),-0.27682627910952506,-0.7390377754190849,0.8484162895927602,0.9806337186205354,1.0,3/16,4.51%,SMARCB1;SMARCC2;SMARCE1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2900394100926251,0.7386556029632337,0.8171140939597316,0.9264330578832056,1.0,4/22,15.92%,NES;TRIM71;MDK;KDM1A
prerank,positive regulation of viral transcription (GO:0050434),0.27480908282587085,0.7385304255587043,0.824212271973466,0.9262062927514935,1.0,7/25,20.00%,MDFIC;NELFA;POLR2B;POLR2D;POLR2F;NELFE;CTDP1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.29862498151122385,-0.7383460521313218,0.8148936170212766,0.9806788573180056,1.0,4/12,24.73%,PAX8;SMO;AGT;SOX8
prerank,response to UV (GO:0009411),0.22270688495313068,0.7380675200518882,0.8923705722070845,0.9264030053851172,1.0,25/95,19.46%,EGFR;RPL26;RHBDD1;PTPRK;TRIM32;YY1;MFAP4;ZRANB3;RHNO1;CREBBP;XPA;POLH;EP300;USF1;USP28;MYC;KDM1A;USP47;ATR;RELA;UBE2A;UBE4B;ZBTB1;EIF2AK4;BCL3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.32095263464238166,0.7378255472007276,0.8074866310160428,0.9263115155879531,1.0,5/14,19.68%,PRKN;CREB3L1;XBP1;TXNDC12;TMBIM6
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3363182945867126,0.7374511212886629,0.7866666666666666,0.9259967502545409,1.0,3/11,13.83%,RBM4;TRIM71;TNRC6C
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3363182945867126,0.7374511212886629,0.7866666666666666,0.9259967502545409,1.0,3/11,13.83%,RBM4;TRIM71;TNRC6C
prerank,peptidyl-methionine modification (GO:0018206),-0.30558002914937965,-0.7373490237875667,0.8246753246753247,0.9811299101207223,1.0,4/12,26.09%,NAA60;NAA25;NAA30;METAP1D
prerank,regulation of exit from mitosis (GO:0007096),-0.21998531317708414,-0.736653327929124,0.9164345403899722,0.9811444178621157,1.0,11/38,20.24%,ANAPC15;SIRT2;ANAPC11;UBE2S;BUB1B;CDC14A;UBE2E1;UBE2D1;UBB;ANAPC5;ZW10
prerank,positive regulation of macrophage activation (GO:0043032),0.3052266800571813,0.7364272214155627,0.7878787878787878,0.9269724765620097,1.0,2/17,4.13%,TLR4;LBP
prerank,histone acetylation (GO:0016573),0.23211318063705905,0.7357921454540015,0.8688046647230321,0.9274858648490344,1.0,18/69,19.49%,PHF20;SPI1;DMAP1;EPC1;BEND3;TRIM16;POLE3;CREBBP;HAT1;EP300;KAT7;KAT6A;PER1;TAF12;SGF29;PHF20L1;ATF2;JADE3
prerank,diacylglycerol metabolic process (GO:0046339),-0.2493510759639332,-0.7356068454407924,0.8392434988179669,0.9816520286252206,1.0,4/23,9.33%,DGKI;DGKB;DGKZ;DAGLA
prerank,cardiocyte differentiation (GO:0035051),-0.31632534018249325,-0.7353288679106592,0.8178053830227743,0.9811203697869317,1.0,4/10,20.07%,SIK1;AKAP13;EEF1AKMT4-ECE2;TGFB2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3110391492563918,0.7345869085957419,0.7907801418439716,0.9286923571628282,1.0,4/16,15.02%,PDE6H;CHGA;ACP3;NECAB2
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2327987872316124,-0.733855803243933,0.8957219251336899,0.9812842893501882,1.0,15/31,38.09%,GTF2H2;CCNH;ERCC2;NCBP1;POLR2C;GTF2H4;POLR2L;POLR2I;RNMT;POLR2H;CDK7;ERCC3;GTF2F1;NCBP2;POLR2G
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2327987872316124,-0.733855803243933,0.8957219251336899,0.9812842893501882,1.0,15/31,38.09%,GTF2H2;CCNH;ERCC2;NCBP1;POLR2C;GTF2H4;POLR2L;POLR2I;RNMT;POLR2H;CDK7;ERCC3;GTF2F1;NCBP2;POLR2G
prerank,endocardial cushion development (GO:0003197),-0.25982642236215614,-0.733434346791914,0.8444976076555024,0.9809357858046344,1.0,6/21,20.07%,ACVR1;CRELD1;MDM4;NOTCH1;ENG;TGFB2
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.1966567398370109,-0.7332791653012093,0.954983922829582,0.9802577264647095,1.0,15/65,19.35%,KCND2;TP53;HYOU1;CPEB2;PGK1;SIRT2;MDM4;EGLN2;TSC1;ADAM8;NDNF;NPEPPS;STUB1;MTOR;EPAS1
prerank,import into nucleus (GO:0051170),-0.18969854433501238,-0.7332324959311477,0.9571428571428572,0.9794375842428916,1.0,36/73,36.40%,IPO5;GEMIN2;BACH2;APPL1;RANBP17;DDX20;NUP85;IPO13;IPO8;RPAIN;HNRNPA1;NXT1;SEC13;PPP1R10;TNPO2;E2F3;TSC2;CSE1L;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;NUP214;SNUPN;EIF4ENIF1;NUP88;SNRPF;GEMIN6;SNRPD3;GEMIN5;RAN;FAM53C;SPRN
prerank,eye development (GO:0001654),-0.21038087011446552,-0.7331184068782808,0.9345794392523364,0.9787070016472804,1.0,15/54,22.72%,PBX2;BMPR1B;RAB18;SHROOM2;MEIS3;CACNA1C;MEIS1;SMG9;HIPK1;PBX1;TGFB2;FOXC1;CRYBA4;PBX4;SALL2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.30181546120834396,-0.7327885292779241,0.835214446952596,0.9782307810778945,1.0,4/12,23.68%,SCN1B;WNK3;AHCYL1;GPD1L
prerank,establishment of spindle orientation (GO:0051294),-0.24187087628961335,-0.7323901109667855,0.8686131386861314,0.9778543431625746,1.0,11/28,24.96%,LLGL1;NSFL1C;NUMA1;INSC;MAP4;SPDL1;LLGL2;NDC80;ZW10;DCTN1;MAD2L1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.30841721093494096,-0.7322244320723461,0.8376068376068376,0.9763259198138043,1.0,1/11,1.83%,CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.30841721093494096,-0.7322244320723461,0.8376068376068376,0.9763259198138043,1.0,1/11,1.83%,CALM2
prerank,DNA replication checkpoint signaling (GO:0000076),-0.27022385096536117,-0.7320944305970336,0.836405529953917,0.9756232564044293,1.0,10/16,39.15%,DNA2;HUS1;RAD9A;TICRR;CDT1;ORC1;RAD17;TIMELESS;CDC45;NAE1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2521233770696354,-0.7318424178077622,0.8561320754716981,0.975097101665536,1.0,2/24,1.73%,IRAK2;CYLD
prerank,regulation of protein localization to nucleus (GO:1900180),0.25307599986927076,0.7318243092162746,0.8573529411764705,0.9320388373063097,1.0,3/43,4.84%,CTNNA1;MFHAS1;GSK3B
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19698090536308005,0.7309242557647524,0.9755011135857461,0.9328228583936561,1.0,49/314,15.05%,WWP1;FBXW7;SMURF2;PSMA7;RPS27A;FBXL17;SIAH2;SEL1L2;PELI1;RMND5A;PRKN;CLOCK;RB1;SPOP;FBXL5;ERLIN1;CDC27;APPBP2;PSMB2;TBL1XR1;SPOPL;MDM2;RNF121;TBL1X;UBE2D3;UBE2K;COP1;RHBDD2;CUL3;ANAPC16;ARMC8;ZFAND2B;ARRB1;WFS1;AMFR;FBXO48;PSMA6;RNF185;TRIM71;AGAP3;RNF187;BFAR;DERL2;NEDD4L;PSMD5;PSMD1;PSMA3;ANAPC1;RNF122
prerank,pentose-phosphate shunt (GO:0006098),-0.30757089896873,-0.7309136110265122,0.7853881278538812,0.9754153762257148,1.0,4/11,20.69%,TALDO1;RPIA;PGM2;PGD
prerank,bicarbonate transport (GO:0015701),-0.2445900775095416,-0.7286900488588904,0.8712871287128713,0.9772717583961753,1.0,6/25,20.46%,SLC4A10;SLC4A2;CYB5R1;CA2;CFTR;SLC4A3
prerank,carbohydrate transport (GO:0008643),0.32531122889478004,0.7283841573827129,0.7766990291262136,0.9358919513955298,1.0,3/11,14.43%,SLC2A2;SLC23A1;SLC23A2
prerank,lysosome organization (GO:0007040),0.25845617154825,0.7282782956912481,0.8548387096774194,0.9355940763452353,1.0,6/36,10.83%,GRN;CLN5;CLN6;MYO7A;TMEM165;ATP10B
prerank,"wound healing, spreading of cells (GO:0044319)",0.2806079267796676,0.7280345786346264,0.822742474916388,0.9354853737282972,1.0,3/24,4.01%,CD44;RHOA;LCP1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.2701246931304497,-0.7280136108726802,0.8597701149425288,0.977207515767464,1.0,6/18,20.07%,ACVR1;MDM4;TGFBR2;NOTCH1;ENG;TGFB2
prerank,cellular response to nutrient levels (GO:0031669),0.2303305775553412,0.7276148899220998,0.8720238095238095,0.9356301341452599,1.0,17/62,18.22%,STK24;WIPI1;KLF10;FNIP1;SFRP1;LAMP2;ATG7;CD68;GAS2L1;SREBF2;KCNB1;FOXO1;RALB;MFSD2A;WIPI2;XBP1;RRAGC
prerank,positive regulation of double-strand break repair (GO:2000781),-0.2226727723616011,-0.7272839460304374,0.8947368421052632,0.9772314895144967,1.0,5/39,7.94%,FUS;SLF2;PARP1;ERCC6;ZCWPW1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3039204283262964,-0.7260674219881075,0.836864406779661,0.9778038273553884,1.0,2/11,8.49%,MAVS;CAMK4
prerank,glycogen catabolic process (GO:0005980),-0.2736946862066324,-0.725409523931307,0.8228941684665226,0.9776988143824109,1.0,9/15,33.18%,PHKB;GAA;PYGL;PHKA2;PGM2;PYGB;AGL;PHKG1;PYGM
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.31475685290714406,-0.7248653561717627,0.8104166666666667,0.9775045602856545,1.0,3/10,14.31%,PAF1;HSF1;NCBP1
prerank,renal filtration (GO:0097205),0.334873170985091,0.7242600069400197,0.7642585551330798,0.9396674245724771,1.0,3/10,10.66%,XPNPEP3;SULF2;MYO1E
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2513207343622087,0.7240873357637405,0.8642745709828393,0.9394771524345412,1.0,8/39,15.51%,FXYD2;RIPK1;UTRN;HOMER1;YWHAE;SCN3B;NEDD4L;FXYD5
prerank,homocysteine metabolic process (GO:0050667),-0.3143550447855784,-0.7235320050948293,0.8041666666666667,0.9782087817965978,1.0,5/11,34.60%,MMUT;TST;MTRR;CBS;CTH
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.32506420114492174,0.7231171448521322,0.7652671755725191,0.9403135795257859,1.0,3/11,10.66%,FOXM1;RPS6KA6;SP100
prerank,mitochondrion transport along microtubule (GO:0047497),-0.28731262368104693,-0.7229170899350835,0.8473451327433629,0.9781277536494334,1.0,3/13,22.81%,MAPT;UBB;HIF1A
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.293141023195143,-0.7219205757294598,0.8223684210526315,0.9784858400898995,1.0,4/12,25.88%,APOC1;LPCAT3;APOC4;MTTP
prerank,negative regulation of neurogenesis (GO:0050768),0.2591025483773045,0.7214358093053571,0.8466557911908646,0.9421094524057338,1.0,6/34,9.83%,RHOA;RAPGEF2;B2M;TNF;ARHGDIA;RTN4
prerank,negative regulation of fat cell differentiation (GO:0045599),0.2553015199243694,0.7213161385662895,0.842948717948718,0.9418496152086644,1.0,6/34,12.86%,ZFP36L2;TRIO;TNF;ASXL1;TRIB2;FOXO1
prerank,nucleocytoplasmic transport (GO:0006913),0.24973706573644577,0.7212078907934673,0.8602825745682888,0.9415717560829071,1.0,13/40,22.19%,ATXN1;HTATIP2;SNRPG;RSRC1;GEMIN7;NUP98;XPO1;RGS14;LSG1;SNRPE;SNRPD2;RBM15B;NPM1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.2901524406353983,0.7210001725837148,0.8225255972696246,0.941427153807965,1.0,6/18,19.29%,VPS4B;RCC2;RAB11A;RAD51B;BRD4;MECP2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3126363108245317,-0.7209390077797395,0.8357894736842105,0.9787797578839205,1.0,4/10,22.91%,CCT7;CCT2;WRAP53;CCT8
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3017460877990582,0.7208869618802951,0.798951048951049,0.9411670110408623,1.0,5/18,18.71%,BCL2;SLC25A5;BNIP3;SLC25A4;CAMK2A
prerank,DNA-dependent DNA replication (GO:0006261),0.20953427430186972,0.7208507324495924,0.9286640726329443,0.940794841074319,1.0,25/128,17.41%,PSMA7;RPS27A;ORC5;MCMBP;POLE2;ORC2;PRIM2;TOPBP1;PSMB2;RPA1;GMNN;PURA;POLG2;POLE3;PSMA6;RPA3;MGME1;PSMD5;PSMD1;PSMA3;POLE4;MCM8;GINS2;PRIM1;RFC3
prerank,mitochondrial translational elongation (GO:0070125),0.21904988514647053,0.7205939851661514,0.9160935350756534,0.9406948969341856,1.0,28/88,24.33%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRPS11;MRPL1;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14;MRPS30;MRPS31;MRPS15;MRPL4;MRPL30;MRPL28;MRPL48;MRPS27;MRPL40;MRPL22;CHCHD1;MRPS35;MRPS28;MRPS18C
prerank,peptidyl-amino acid modification (GO:0018193),0.3329994297746343,0.7202912142655817,0.8135922330097087,0.9406554357926298,1.0,4/10,23.89%,ATP7A;METAP1;TTLL4;METAP2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.21501145513490144,-0.7198454094134775,0.948170731707317,0.9792698106323527,1.0,6/40,11.23%,TP53;BCL2L11;MLLT11;BMF;TNFSF10;FXN
prerank,aerobic electron transport chain (GO:0019646),-0.19227438335908,-0.7195210416619844,0.9563636363636364,0.9787913147945364,1.0,17/68,21.13%,COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFAF1;UQCRB;AFG1L;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;SDHAF2;NDUFA8;UQCR10;NDUFA10;NDUFAB1
prerank,cellular response to superoxide (GO:0071451),0.3349434183333456,0.7192967301113012,0.8204667863554758,0.9415195933767495,1.0,2/10,17.17%,ATP7A;PRDX2
prerank,mRNA modification (GO:0016556),0.2786261258246698,0.7185175191000884,0.8449477351916377,0.9421013937985896,1.0,8/22,23.28%,WTAP;NSUN2;VIRMA;TRMT61B;PUS7;TRMT61A;METTL16;PCIF1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.29401049081099995,0.7178288162309575,0.836036036036036,0.9425697080013354,1.0,3/18,8.32%,SPTBN1;ACTB;STX7
prerank,retinol metabolic process (GO:0042572),0.3090210889218735,0.7176685388549258,0.8216216216216217,0.9423577138854372,1.0,2/14,14.39%,DHRS3;RBP4
prerank,regulation of lipase activity (GO:0060191),-0.2886639113468986,-0.7176237274304473,0.8205689277899344,0.9801190515131654,1.0,4/13,18.06%,LPL;LMF1;ANGPTL3;FURIN
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.3092301521640822,-0.716501361581347,0.8312236286919831,0.9805487368741529,1.0,7/10,37.18%,PRKCE;SLC45A3;AKT1;IRS1;PMAIP1;GPLD1;PTH1R
prerank,steroid hormone biosynthetic process (GO:0120178),-0.23190465247353648,-0.7163722388161515,0.8864734299516909,0.979830438323087,1.0,16/29,43.58%,STARD3;AKR1B1;FDX1;SRD5A3;STAR;HSD17B2;HSD17B1;TSPOAP1;HSD17B11;HSD17B8;SRD5A2;FDXR;MED1;HSD3B2;HSD17B14;FDX2
prerank,indolalkylamine catabolic process (GO:0046218),-0.2995339560649289,-0.7162721877204146,0.8408602150537634,0.9790964338520465,1.0,4/10,35.67%,KYNU;IL4I1;IDO2;HAAO
prerank,peptidyl-proline modification (GO:0018208),-0.2399917179255405,-0.7160365359780535,0.87,0.9785162008050138,1.0,13/25,38.32%,P3H2;PPIL3;PPIE;OGFOD1;FKBP7;FKBP4;PIN1;PPIL6;PPIC;FKBP10;PPIL1;PPIG;PPWD1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.27209510479116883,0.7158042838026996,0.832520325203252,0.9443726207821159,1.0,6/25,22.44%,B2M;NOD2;SCIMP;TRAF6;KIT;PLCG2
prerank,error-free translesion synthesis (GO:0070987),0.27431157631352937,0.7155868948720844,0.8362369337979094,0.9442508380668326,1.0,4/22,12.38%,RPS27A;RPA1;POLH;RPA3
prerank,fatty acid oxidation (GO:0019395),0.23666137981706467,0.7151337500643071,0.8701492537313433,0.9444134664586612,1.0,8/57,14.75%,ALOX15;SLC25A17;EHHADH;ADIPOR2;HADHA;HADH;HADHB;ACAT1
prerank,regulation of protein targeting to membrane (GO:0090313),0.26627939269286716,0.7148009262354633,0.8235294117647058,0.9443925490347537,1.0,7/28,19.36%,ITGB1BP1;FYN;MYO1C;KCNB1;ITGB2;MFF;INPP5K
prerank,protein localization to kinetochore (GO:0034501),-0.2801162602618634,-0.7143671900015539,0.8318777292576419,0.9796283271127008,1.0,7/14,29.76%,KNL1;SPDL1;ZW10;IK;CDK1;AURKB;TTK
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.2896003007279607,0.7143049063655402,0.8081705150976909,0.9445836131530078,1.0,7/18,18.02%,TNF;SP1;ROCK2;RELA;PICALM;IFNGR1;EFNA1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2681410551632513,0.712012432671161,0.8559463986599665,0.9470640240280109,1.0,11/29,22.16%,DCP1A;DDX6;DCP2;EXOSC8;LSM4;LSM2;EXOSC1;HBS1L;CNOT8;PATL1;EXOSC3
prerank,activation of adenylate cyclase activity (GO:0007190),0.25386091439362796,0.7117843316879855,0.8576104746317512,0.9469284367691972,1.0,4/35,6.18%,ADRB2;DRD1;ADCY9;ACR
prerank,ATP synthesis coupled proton transport (GO:0015986),0.29306430016180973,0.7112259975346386,0.8076923076923077,0.9471762828314984,1.0,5/17,18.75%,ATP5PO;ATP5MC2;ATP5F1E;ATP5MC1;ATP5MF
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.22769467118366588,0.7109877059154278,0.8857142857142857,0.9470474378354485,1.0,11/66,13.81%,CHP2;LARP7;NMD3;DMAP1;BAG3;PSEN1;CCT6A;JUP;LAMTOR5;ZC3H12A;KAT7
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.23308925623663335,-0.7109662567908293,0.8840579710144928,0.9826044589836969,1.0,6/27,14.59%,MORF4L2;BAG6;MRGBP;BRD8;MORF4L1;RUVBL1
prerank,embryonic organ morphogenesis (GO:0048562),0.2453895072459491,0.7108179404518172,0.8870229007633588,0.9468272512757471,1.0,3/42,5.36%,RARG;ALX1;PDGFRA
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.25199828888542974,-0.7107379641040351,0.8640552995391705,0.9820088636294441,1.0,6/21,25.07%,LPIN2;FAH;FAAH;HOGA1;AGXT;ACOT8
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.2543614364477402,0.7107214424378289,0.8580750407830342,0.946528700127917,1.0,8/33,16.45%,NR3C1;SPI1;TNF;KLF4;FOXO3;STAT3;KLF5;RELA
prerank,telomere maintenance via recombination (GO:0000722),0.32810379341549917,0.7106930385893934,0.8345323741007195,0.9461518887389465,1.0,5/11,24.64%,NSMCE2;SMC6;XRCC3;RAD51D;ERCC1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.295601356637183,0.7104999018607138,0.829225352112676,0.9459861466067653,1.0,5/15,14.80%,ZNRF3;SFRP1;SPEF1;GPC3;NPHP3
prerank,positive regulation of wound healing (GO:0090303),0.2518145253907404,0.7104186760139338,0.8582930756843801,0.9456712480498578,1.0,4/36,10.32%,RREB1;ITGB1;FOXC2;ENPP4
prerank,nucleotide metabolic process (GO:0009117),0.2797745936138761,0.7100727160101324,0.8391376451077943,0.9456978781521322,1.0,8/23,22.00%,REXO2;CMPK1;NMNAT3;NMNAT2;AK8;AK4;ME1;RNASEH2B
prerank,cellular component maintenance (GO:0043954),0.31616885791422866,0.7097199699138336,0.8073217726396917,0.9457216342530176,1.0,4/12,21.16%,INSR;FYN;IGF1R;PICK1
prerank,mitotic spindle assembly (GO:0090307),0.24649018661011063,0.7093776916776757,0.8721461187214612,0.9457007327660181,1.0,12/42,18.54%,PIBF1;RHOA;STAG2;CLASP1;KIF4A;STAG1;SPICE1;RAB11A;ABRAXAS2;CCDC61;KIF23;KPNB1
prerank,monosaccharide transmembrane transport (GO:0015749),0.29942033318787653,0.7089318669918673,0.8067542213883677,0.9458094283243066,1.0,6/16,20.13%,SLC2A2;SLC23A1;SLC23A2;SLC2A12;SLC5A3;SLC2A6
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.288313853208858,-0.7087598882559837,0.8436123348017621,0.9833184470165014,1.0,5/12,28.85%,SKP1;UBE2S;GOLGA2;GORASP1;BTRC
prerank,protein tetramerization (GO:0051262),-0.1889936626662279,-0.7086511813849832,0.9633699633699634,0.98256990050701,1.0,5/67,4.60%,CPSF6;KCNJ2;FARSA;ACACA;ALDOA
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.22462439460559552,0.7083336920173349,0.9229691876750701,0.9460826572082691,1.0,9/70,14.53%,KMT2A;PSMA7;TCF12;CBFB;PSMB2;PSMA6;PSMD5;PSMD1;PSMA3
prerank,extracellular transport (GO:0006858),-0.2852122589121797,-0.7080607924950407,0.8434782608695652,0.9823704561904992,1.0,6/12,36.06%,SPEF2;CCDC40;CABYR;ARRDC1;DNAAF2;SPA17
prerank,membrane fusion (GO:0061025),0.25497139405099745,0.7080156096572555,0.8378378378378378,0.9460592526462572,1.0,12/33,22.36%,DCSTAMP;MYOF;RABEP1;SNAP23;VAPA;RABIF;UBXN2B;DNM1L;SNAP29;USO1;STX11;DYSF
prerank,negative regulation of histone methylation (GO:0031061),-0.3093011322590204,-0.7074006995355856,0.8218623481781376,0.9822364245056906,1.0,5/10,20.20%,WDR5;BRCA1;DNMT1;PHF1;MTF2
prerank,reticulophagy (GO:0061709),-0.29203000317391103,-0.7071990491445481,0.8491379310344828,0.9815985983515009,1.0,2/12,4.96%,RETREG1;ATG2A
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.26535937006897314,-0.7066908490491527,0.8498845265588915,0.9812904696081496,1.0,7/16,36.76%,RMI1;TOP2A;CENPX;SLX4;EME1;ERCC4;CENPS
prerank,JNK cascade (GO:0007254),0.2440638709726381,0.7058036684379643,0.8701700154559505,0.9483163653470472,1.0,7/40,13.17%,MAP3K5;RPS27A;RIPK2;PTGER4;MAP3K11;NOD2;UBE2N
prerank,negative regulation of ion transport (GO:0043271),0.27238813288726677,0.7055340997591925,0.8491525423728814,0.9482270827587024,1.0,4/24,8.84%,LILRB1;WNK1;CD33;PLN
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2667698767842309,0.7054020091703436,0.8637873754152824,0.9479702252014022,1.0,8/25,21.27%,ADK;AMPD3;SHMT1;GMPS;PRPS1L1;PRPS1;HPRT1;PAICS
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3009449147968573,0.7052140815953534,0.839851024208566,0.9477708745582493,1.0,2/14,11.48%,IRS2;ARPP19
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.28104658766979707,0.7048974437332033,0.8177339901477833,0.9477515084223969,1.0,4/20,14.29%,BCL2;PSEN1;WFS1;ATP2A2
prerank,midbody abscission (GO:0061952),-0.25977224635107765,-0.7046454826603172,0.8676122931442081,0.982652678555911,1.0,9/17,34.56%,CHMP4B;CHMP4A;MITD1;CHMP6;CHMP3;CHMP4C;CHMP1B;KIF20A;CHMP2A
prerank,digestive tract morphogenesis (GO:0048546),-0.2745810543273066,-0.7042699838953554,0.8488372093023255,0.9822274551753837,1.0,4/14,20.83%,FGFR2;BBS7;ID2;SOX11
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2823529982242906,-0.7039386118892339,0.8623853211009175,0.9817488488963256,1.0,2/13,4.79%,IPO5;RANBP2
prerank,tRNA wobble base modification (GO:0002097),0.3003771234939022,0.7038876569102488,0.8369565217391305,0.9485324274716507,1.0,4/14,13.91%,URM1;DPH3;ELP4;CTU1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.259569466678177,0.7037561611429075,0.8708661417322835,0.9482593415839958,1.0,10/31,23.04%,KMT5B;RBP4;GPI;SHLD3;XBP1;IL6;HMCES;SHLD2;PTPRC;TFRC
prerank,mitochondrial membrane organization (GO:0007006),0.2544221127044482,0.7035620374731248,0.8446153846153847,0.9480748641526824,1.0,8/32,18.67%,APOOL;BCL2;CHCHD3;MTX1;SLC25A5;BNIP3;TMEM11;SLC25A4
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2795726870722864,0.7017737088745992,0.8307426597582038,0.9498073318303711,1.0,5/18,15.21%,TRIM32;CDC73;SFRP1;FTH1;MYC
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2602206531775947,-0.7015526970861452,0.8598574821852731,0.9834094749973433,1.0,10/18,36.78%,TECR;ACSL4;ACSL6;ACSBG1;ELOVL1;ACSF3;ELOVL7;HACD2;ELOVL6;ELOVL2
prerank,ion homeostasis (GO:0050801),-0.2255655657227406,-0.7015477669062233,0.9076517150395779,0.9825684935609974,1.0,12/30,29.83%,SLC4A10;AP3D1;WNK3;SLC4A2;CAMK2D;UNC80;SLC4A3;SLC12A5;KLHL3;HCN4;SLC30A3;FHL1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.28992307544940227,-0.7014430345672238,0.8521560574948666,0.9818156247619105,1.0,2/11,10.61%,SMAD7;JAK3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.2799251505134315,0.7010627402672384,0.8388791593695272,0.9502058985717885,1.0,10/20,26.15%,MOV10L1;LIMD1;HELZ;TNRC6C;CNOT8;CNOT1;AGO3;AJUBA;AGO2;CELF1
prerank,protein methylation (GO:0006479),-0.20671485492424047,-0.7000982411604366,0.9518716577540107,0.9823834374799383,1.0,18/40,37.30%,EHMT2;SETD3;PRMT2;METTL22;CARM1;FAM98B;FAM98A;EEF2KMT;LCMT1;PCMT1;EZH2;RAB6A;PRMT8;EEF1AKMT2;SNRPD3;PRMT7;METTL21A;CAMKMT
prerank,peptide metabolic process (GO:0006518),0.21541133000817406,0.6994835914971695,0.9321074964639321,0.9516838921770401,1.0,7/75,11.39%,CPQ;CLN5;LNPEP;PARL;PSEN1;ENPEP;ETHE1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.31897765940889444,0.6992981750979844,0.8122743682310469,0.9514935155336346,1.0,5/11,21.02%,ATRX;H3-3A;HAT1;ASF1A;IPO4
prerank,protein N-linked glycosylation (GO:0006487),0.22409741414428586,0.6991708751293534,0.9088319088319088,0.9512302213862357,1.0,13/66,15.29%,ST6GAL1;ST3GAL1;MGAT2;GFPT2;ALG9;TMEM165;ALG5;DOLPP1;ASGR2;PMM1;UGGT1;RPN2;MCFD2
prerank,translesion synthesis (GO:0019985),-0.2056401991814849,-0.698523259564561,0.9444444444444444,0.9831119267659777,1.0,17/42,27.06%,PRIMPOL;PARP10;UFD1;NPLOC4;RFC2;POLI;RCHY1;REV3L;UBB;RFC1;POLN;DTL;PCLAF;POLD4;USP10;SPRTN;FAAP20
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.32680577783214826,0.6984775055602724,0.8148148148148148,0.9515972981614501,1.0,2/10,9.67%,ATP5PO;ATP5MC2
prerank,modulation by symbiont of entry into host (GO:0052372),0.29311023996882685,0.698451992084125,0.8181818181818182,0.9512112323115889,1.0,4/16,15.75%,TRIM68;TRIM27;EXOC2;TRIM25
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.2265595601871771,0.698257304335624,0.900593471810089,0.9510246939440689,1.0,3/61,2.04%,PRKAG2;PSMA7;NR1H4
prerank,protein localization to nucleus (GO:0034504),-0.17286105377100877,-0.6981310025809415,0.9919028340080972,0.982632749919007,1.0,36/102,29.09%,IPO5;SKP1;HNRNPU;DVL1;APPL1;RANBP17;SUPT7L;PAF1;NUP85;IPO13;IPO8;RPAIN;NOL8;ARL2BP;NXT1;INTS13;CTDNEP1;ABCA7;SEC13;BBS4;TOR1A;TAF8;PPP1R10;TNPO2;E2F3;TSC2;CSE1L;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;NUP214;BMP4
prerank,positive regulation of protein sumoylation (GO:0033235),0.313986403208668,0.6980821625641797,0.812133072407045,0.9508072539551709,1.0,1/10,2.32%,PIAS1
prerank,natural killer cell activation (GO:0030101),-0.24051350551944048,-0.6975721908223393,0.87468671679198,0.9823741057939384,1.0,7/23,20.63%,IL21R;AXL;BAG6;RABL3;PBX1;RASGRP1;ULBP1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.2936465033943224,-0.6975389983026742,0.8502109704641351,0.9815716379127704,1.0,2/10,19.54%,DDIT3;ATF4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2731092480261967,0.6966902770164065,0.8690265486725663,0.9520028600503567,1.0,2/22,7.60%,ESR1;MED16
prerank,aminoglycan metabolic process (GO:0006022),-0.29920980968879257,-0.6955986453163836,0.848421052631579,0.9826606108739149,1.0,4/10,22.78%,XYLT1;B4GALT7;B3GALT6;B3GAT1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.308630197949012,0.6953746192749178,0.8277777777777777,0.9530869027616408,1.0,3/12,11.84%,C1QTNF12;GKAP1;SNX5
prerank,endoderm formation (GO:0001706),0.2533532014865319,0.6951479012942875,0.8713826366559485,0.9529276032654499,1.0,3/35,7.51%,ITGA4;DUSP1;DUSP2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.26036860757234986,0.6951088565486133,0.8719611021069692,0.9525551256894728,1.0,8/27,20.24%,RGCC;SMG6;NIBAN2;PRKD2;MYC;PINX1;HGF;ACVRL1
prerank,negative regulation of growth (GO:0045926),0.205189954409121,0.6949779755236056,0.9574742268041238,0.9522839506635719,1.0,16/121,13.13%,PTPRJ;NOTCH2;DCSTAMP;RB1;SMAD4;RACK1;BST2;ESR2;PPP2CA;RTN4;SFRP1;SERTAD2;SLIT3;ST7L;CDKN2C;GJA1
prerank,proteolysis (GO:0006508),0.18923634351803179,0.6944871076620541,0.986857825567503,0.9524425610544541,1.0,38/252,17.76%,CTSC;CPQ;ADAM19;ENDOU;SRGN;XPNPEP3;FAM111A;LNPEP;CTSB;PRCP;PARL;CAPN5;HTRA3;ZMPSTE24;PITRM1;PSEN1;RNPEP;MDM2;TBL1X;ADAMTS9;CLPX;ENPEP;CASP8;PSMA6;MMP25;MMP24;ATG4C;SPPL2B;SENP1;USP25;NCSTN;ERAP1;FBXW2;SPPL2A;CUL7;SENP6;FAP;HGF
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.26466889428966806,-0.693525837950049,0.8545454545454545,0.9838686316656663,1.0,6/16,32.72%,PIGL;PIGH;PIGB;DPM2;PIGV;PIGC
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.27223488643053917,-0.6928212715608931,0.8557919621749409,0.9837170310187073,1.0,1/14,0.93%,ACOX3
prerank,tetrahydrofolate metabolic process (GO:0046653),0.31526572474492565,0.6928071842276906,0.8158914728682171,0.9539350986371923,1.0,4/10,23.54%,MTHFD2L;SHMT1;MTHFD1L;MTHFS
prerank,photoperiodism (GO:0009648),0.2557498454892069,0.6926422133980712,0.859271523178808,0.9537185535720402,1.0,4/28,11.07%,FBXL17;CLOCK;RBM4;PPP1CA
prerank,glycoprotein catabolic process (GO:0006516),0.2900738647609426,0.6922429443484767,0.8203389830508474,0.9537581820682323,1.0,5/17,21.21%,MANBA;ADAMTS9;NGLY1;NEU4;FBXO6
prerank,tyrosine metabolic process (GO:0006570),0.31606918180927374,0.6908988209907453,0.8109090909090909,0.9548489143686828,1.0,1/11,5.78%,THAP4
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.30910622928652554,0.6907493039236189,0.8351449275362319,0.954169029999954,1.0,2/12,12.39%,GSK3B;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.30910622928652554,0.6907493039236189,0.8351449275362319,0.954169029999954,1.0,2/12,12.39%,GSK3B;ATP2B4
prerank,GPI anchor metabolic process (GO:0006505),0.26178939095763676,0.690191035053103,0.8708609271523179,0.9543764107609158,1.0,4/26,15.47%,PGAP1;PIGU;PGAP4;PIGQ
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.29704475389431917,0.6894275902584163,0.8500948766603416,0.9547843022308652,1.0,5/13,26.77%,SULT1A1;SULT6B1;ENPP1;SULT4A1;BPNT1
prerank,DNA strand elongation (GO:0022616),-0.2516882197115366,-0.6888181767410468,0.8939051918735892,0.986710002042168,1.0,6/18,26.85%,MCM3;GINS3;DCLRE1B;MCM7;RAD50;MCMDC2
prerank,mismatch repair (GO:0006298),0.26220263238248986,0.6884296760502325,0.8552412645590682,0.9554504255584141,1.0,9/27,22.68%,MCM9;RPA1;RPA3;MUTYH;XPC;POLD2;PCNA;MLH1;RNASEH2A
prerank,O-glycan processing (GO:0016266),0.22575018751332893,0.6880979594998149,0.9250374812593704,0.9554073823173515,1.0,3/54,3.81%,ST6GAL1;ST3GAL1;C1GALT1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2801145850486214,0.6878081176787482,0.8624338624338624,0.9553013044207546,1.0,6/17,21.57%,THPO;GJA1;KAT7;KDM1A;N4BP2L2;PTPRC
prerank,transcription preinitiation complex assembly (GO:0070897),0.307008599188356,0.6871928543837392,0.8418079096045198,0.9555703181154646,1.0,3/12,17.32%,GTF2A2;GTF2B;TAF12
prerank,cellular response to increased oxygen levels (GO:0036295),0.30596307341836226,0.6865885852170454,0.8421052631578947,0.9558213593910997,1.0,7/11,25.86%,ATP6V1A;ATG7;FOXO1;ATP6V0D1;CAV1;CCDC115;FAS
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.27506413147153114,0.6863390599924448,0.8490566037735849,0.955673246613154,1.0,12/20,27.84%,LATS2;HEXIM2;PTEN;NR2F2;CDKN1C;INCA1;CDKN1B;PLK1;CEBPA;HEXIM1;APC;HHEX
prerank,positive regulation of translational initiation (GO:0045948),-0.25187629047771726,-0.6860249726067326,0.8732057416267942,0.9884685027744968,1.0,7/18,27.73%,HABP4;MTOR;RPS6KB2;EIF2B5;BOLL;RPS6KB1;LARP1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.23394669070828011,-0.6858167684693331,0.9029345372460497,0.9878230977461446,1.0,15/23,40.35%,OTUD5;USP50;OTUB1;USP34;USP5;USP33;YOD1;USP8;OTUD3;OTUD7B;OTUD7A;BAP1;OTUB2;OTUD4;TNFAIP3
prerank,amino acid transport (GO:0006865),0.23301140241449453,0.684848525482029,0.9156626506024096,0.9568614653140282,1.0,8/49,17.68%,SLC16A10;SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.28465491199092985,0.684391049529716,0.8377358490566038,0.9569451895260187,1.0,5/17,17.05%,NR3C1;ATP1A3;ATP1A1;TFPI;ACOD1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.2751526965978549,0.6842232428434598,0.8806228373702422,0.9567143024589609,1.0,6/18,23.11%,ATP7A;TNF;NOD2;GDNF;SIRT3;POR
prerank,response to progesterone (GO:0032570),-0.2535172491783409,-0.6841248226225235,0.8820638820638821,0.9886175093198887,1.0,8/18,34.96%,SRC;WBP2;TGFB2;TGFB1;CATSPERD;ABHD2;UBE3A;TGFB3
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.25619266576942756,0.6836996362379644,0.8776167471819646,0.9568557746467663,1.0,4/29,9.05%,LAMP1;SPI1;STX7;RAET1E
prerank,regulation of oxidoreductase activity (GO:0051341),0.3058001135356094,0.683444364955041,0.8421052631578947,0.956705671960591,1.0,3/13,14.78%,ATP7A;NOD2;SZT2
prerank,liver development (GO:0001889),-0.21768950189679143,-0.6828296674835531,0.9346049046321526,0.9889722542805809,1.0,10/32,22.06%,NF1;TGFBR3;CCDC39;PCK2;PROX1;CDK5RAP3;PHF2;WNT4;ARID5B;CCDC40
prerank,regulation of cilium movement (GO:0003352),-0.297589031425802,-0.6815306079215948,0.8652631578947368,0.9893046119658291,1.0,5/10,27.69%,CCDC39;CFAP298;ODAD2;CCDC40;CFAP43
prerank,regulation of protein localization to centrosome (GO:1904779),0.31512285678716606,0.6814413118200177,0.8593155893536122,0.9583753206104959,1.0,2/10,10.54%,GSK3B;NUP62
prerank,regulation of defense response to virus (GO:0050688),-0.2675455998037456,-0.6810190469203897,0.8891352549889135,0.9888963618015241,1.0,8/14,31.62%,RNF216;C1QBP;ITCH;PCBP2;DHX9;ILRUN;IFNLR1;TRAF3IP1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.2839796021731281,0.6803142032202846,0.8705882352941177,0.9591671321109713,1.0,1/17,2.02%,MEF2C
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.2883125670932851,0.680158924361874,0.8745454545454545,0.9589171832138531,1.0,3/15,10.82%,RAB10;ZFAND2B;SRPRB
prerank,histone ubiquitination (GO:0016574),0.2693321816882838,0.6800363393218705,0.8607809847198642,0.9586330579461181,1.0,8/21,23.00%,WAC;CDC73;UBE2N;USP22;UBE2U;UBE2A;ATXN7L3;RNF40
prerank,RNA biosynthetic process (GO:0032774),0.24310742044990205,0.6799088170668767,0.8725165562913907,0.9583496434571339,1.0,6/31,17.32%,TCEA2;PRIM2;NCOA6;GTF2B;PRIM1;TAF12
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.30846155046263973,0.6795095869969076,0.8574257425742574,0.9583432380693746,1.0,4/10,21.16%,DGKH;F2R;DGKD;PICK1
prerank,cellular senescence (GO:0090398),-0.21964348254317487,-0.6793687336230364,0.9261363636363636,0.9895859293697551,1.0,6/27,18.08%,PRKCD;TERF2;HRAS;ID2;SRF;ULK3
prerank,protein destabilization (GO:0031648),0.24814176914257835,0.6791429821709216,0.8968903436988543,0.958321984868836,1.0,13/32,23.26%,NR1D1;PRKN;CDC73;MDM2;CUL3;CREBBP;EP300;RNF139;SNCA;SERF2;CCDC88C;HTT;PLK1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.30396573241836644,0.6790232460994741,0.8671726755218216,0.9580307214978758,1.0,1/11,2.30%,RASA1
prerank,adipose tissue development (GO:0060612),-0.2908235309473836,-0.6789911573904126,0.8544303797468354,0.9890807264579007,1.0,5/11,24.73%,LRP5;DYRK1B;ARID5B;DGAT2;SOX8
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2922513239037582,0.6785555642082961,0.8514492753623188,0.9581260271015009,1.0,1/13,2.82%,RTL10
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.27490926721137826,-0.6780755661688239,0.8777292576419214,0.9890480252755312,1.0,2/12,8.66%,PIK3CB;CADM4
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.28880836563897816,0.6777826627967751,0.8713768115942029,0.9585248856480679,1.0,2/15,9.95%,PRKN;IGF1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.27306412108271017,0.6774378602850408,0.8669001751313485,0.9584836659876717,1.0,19/19,72.73%,HYKK;PHYKPL;OGDH;DDO;GOT2;SDSL;AADAT;MAT1A;DLST;ASPA;CRYM;DLD;SDS;AASS;PIPOX;ALDH7A1;SLC25A21;GOT1;GCDH
prerank,regulation of centrosome duplication (GO:0010824),-0.22148427383398867,-0.676983065560909,0.9267676767676768,0.989235294763909,1.0,4/29,8.05%,TMEM67;FBXW5;CHMP4B;CENATAC
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.28478151682571573,0.6765367772251499,0.868231046931408,0.9589982798587632,1.0,14/14,71.55%,ENPEP;CORIN;NOS3;EDN1;AGTR1;ACE2;AVPR1A;EDN2;EDN3;OXTR;ACE;AVPR2;RASL10B;ECE1
prerank,primary miRNA processing (GO:0031053),0.3086049890147835,0.6764076509256967,0.8436293436293436,0.9587082792147064,1.0,4/10,19.34%,DROSHA;MRPL44;DGCR8;SMAD1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.23001215799534744,-0.6757481716772441,0.9217171717171717,0.9894528901925911,1.0,5/24,24.02%,LPCAT1;LPGAT1;CDS2;PLA2G3;SLC27A1
prerank,tRNA 5'-end processing (GO:0099116),-0.26757933096547204,-0.6737249107755519,0.9013452914798207,0.9903728077635837,1.0,6/15,24.58%,RPP14;POP1;RPP21;HSD17B10;PRORP;POP7
prerank,regulation of glycogen metabolic process (GO:0070873),0.2984156200039613,0.6736265788779088,0.8514851485148515,0.9610794284309103,1.0,4/12,19.36%,PPP1R3C;PPP1R3D;PPP1R3B;INPP5K
prerank,gene silencing by miRNA (GO:0035195),0.24507093642232353,0.6734914772728992,0.9095394736842105,0.9607924807063055,1.0,6/32,13.83%,PRKRA;PUM2;RBM4;LIMD1;TRIM71;TNRC6C
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.31076100770048615,0.6716299381095194,0.8549019607843137,0.9621730723584151,1.0,4/10,19.80%,DCLRE1C;TERF2IP;APEX1;RTEL1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.2987385056299758,0.6712608145086403,0.8352490421455939,0.9621234543053145,1.0,4/12,19.47%,ATP7A;TRH;HNMT;OAZ2
prerank,positive regulation of leukocyte migration (GO:0002687),0.2530125405108071,0.6710358366491211,0.8921568627450981,0.9619283592109653,1.0,6/27,17.76%,PLVAP;TNF;IL6R;MDK;MIA3;IL6
prerank,negative regulation of telomere maintenance (GO:0032205),0.2768924640463215,0.669661587466907,0.8584558823529411,0.9628910861804667,1.0,8/15,25.00%,SMG6;TERF2IP;TERF1;PINX1;RTEL1;TNKS2;ERCC1;NBN
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.2609571156862369,0.6693832681737936,0.8827470686767169,0.9627239843682694,1.0,8/21,23.64%,VPS4B;RCC2;RAB11A;RAD51B;BRD4;MECP2;NPM1;CCND1
prerank,protein import into nucleus (GO:0006606),0.2150424313444849,0.669204238134888,0.9452247191011236,0.9624781318749658,1.0,10/66,14.31%,RPL23;PRICKLE1;KPNA4;SYK;IPO11;NUP133;NUP62;CBLB;STAT3;KPNA2
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.29126846450397803,-0.6691414881461434,0.8626262626262626,0.9933989551115928,1.0,5/10,29.39%,GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,protein alkylation (GO:0008213),-0.22692598070199013,-0.6691280694515525,0.926605504587156,0.9925732784131625,1.0,13/22,39.61%,PRMT2;METTL22;FAM98B;FAM98A;EEF2KMT;LCMT1;PCMT1;PRMT8;EEF1AKMT2;SNRPD3;METTL21A;CAMKMT;SNRPB
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.19034670594919692,-0.6691214231370166,0.9671641791044776,0.9917415443088043,1.0,11/50,18.02%,AZIN1;PSMD13;PSMD12;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.27210194532241455,0.6689244986679989,0.8853046594982079,0.9623547016667137,1.0,3/18,11.31%,PTPN22;WNK1;ASS1
prerank,mammary gland development (GO:0030879),-0.23381710567947633,-0.6686058720810928,0.900990099009901,0.991323515801023,1.0,4/21,18.93%,JAK2;ERBB4;WNT4;NOTCH4
prerank,sensory perception of mechanical stimulus (GO:0050954),0.20563631704647584,0.6677243779781701,0.9639519359145527,0.9631146048423168,1.0,9/85,11.91%,RIPOR2;CCDC50;ATP6V1B1;GSDME;GRAP;MYO7A;TBL1X;WFS1;KCNQ1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.2564247026934213,0.66767187149963,0.8846787479406919,0.9627500211143762,1.0,1/24,1.34%,GAS6
prerank,regulation of lipid kinase activity (GO:0043550),-0.27940920436452354,-0.6676042369014819,0.8793103448275862,0.9912898919689807,1.0,5/11,25.41%,RBL2;PPP2R5A;EEF1A2;PIK3R2;PIK3R3
prerank,multivesicular body assembly (GO:0036258),-0.21431212986882903,-0.6672094574431015,0.948849104859335,0.9908105350223722,1.0,4/30,9.55%,SNF8;CHMP4B;CHMP4A;VPS37A
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2299036480842503,0.6660849882930439,0.9321486268174475,0.9638319671921411,1.0,9/40,16.37%,FAM111A;MCM9;DDX11;TIPIN;ATRX;ZRANB3;MMS22L;FBH1;ATR
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.27394889227230607,0.6660802095507798,0.8643478260869565,0.9634227315979056,1.0,2/18,9.95%,RPS3;IGF1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.2722279642695312,-0.6657485604703491,0.8969298245614035,0.9911827263150828,1.0,2/11,9.60%,TP53;SIRT2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.30385656132051697,0.6641799155146219,0.8759398496240601,0.9648214468306813,1.0,4/11,17.84%,LEPROTL1;SNX33;NEDD4L;PICALM
prerank,cristae formation (GO:0042407),0.24594207995613135,0.6633869181684164,0.893719806763285,0.9651218959114676,1.0,8/27,18.75%,ATP5PO;APOOL;ATP5MC2;CHCHD3;ATP5F1E;UQCC3;ATP5MC1;ATP5MF
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2561845729234378,0.6624654939805718,0.8875638841567292,0.9651787843011725,1.0,5/22,15.81%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2561845729234378,0.6624654939805718,0.8875638841567292,0.9651787843011725,1.0,5/22,15.81%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.28001885496386947,-0.6623720170228508,0.8952772073921971,0.9930548252427014,1.0,1/10,3.77%,TP53
prerank,autophagosome assembly (GO:0000045),0.22325001186405655,0.6600830465223777,0.9489953632148377,0.9669965336108692,1.0,21/52,25.49%,WIPI1;ULK2;RAB7A;RAB1A;RAB23;ATG7;ATP2A2;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;ATG3;UBXN2B;PIK3C3;MAP1LC3B;RAB19;TP53INP2;ATG16L2;TMEM41B;BECN1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.24418028355954358,0.6596785941218599,0.9184339314845025,0.9669414949988695,1.0,3/30,5.44%,SMURF2;SMAD4;TRIM33
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.28986231644261995,0.6591083173556994,0.8839779005524862,0.967020072860477,1.0,3/13,11.84%,C1QTNF12;GKAP1;SNX5
prerank,eye morphogenesis (GO:0048592),0.2607863611247674,0.659016223800133,0.8637931034482759,0.9666902472017332,1.0,3/19,13.95%,RARG;NKD1;STAT3
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2305818011909796,0.6585021319959183,0.9165329052969502,0.9667482279226634,1.0,11/41,21.65%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;ZBTB7A;NUP153;SLC2A6;NUP35;RAE1
prerank,glial cell differentiation (GO:0010001),0.24462519258711057,0.6582437587008936,0.9011164274322169,0.9665609083823424,1.0,4/28,13.95%,ADGRG6;METRN;MMP24;STAT3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.2677133024183335,0.6581611583925769,0.8636363636363636,0.9662220792527431,1.0,2/18,7.48%,TNFRSF1B;CXCR4
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.28022026995065374,-0.6578512030006699,0.9026369168356998,0.9957071435689824,1.0,3/10,13.74%,UFD1;C1QBP;NPLOC4
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.2827569902838694,0.6577609842673341,0.8641975308641975,0.9661821691944918,1.0,5/14,23.04%,KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,inner mitochondrial membrane organization (GO:0007007),0.21907752029603564,0.6573164937577877,0.926605504587156,0.9661702205607674,1.0,11/47,18.75%,ATP5PO;APOOL;ATP5MC2;CHCHD3;MTX1;ROMO1;ATP5F1E;UQCC3;TMEM11;ATP5MC1;ATP5MF
prerank,protein lipidation (GO:0006497),0.21833673471733842,0.6572697431212345,0.9578947368421052,0.9658036189652114,1.0,12/59,16.38%,ZDHHC14;WIPI1;PIGU;ZDHHC3;ATG7;ATG10;PGAP4;ZDHHC20;PIGQ;WIPI2;ZDHHC2;ATG5
prerank,regulation of histone methylation (GO:0031060),0.28652610380931337,0.6570523715465963,0.855787476280835,0.9655928579509601,1.0,1/13,4.04%,JARID2
prerank,response to zinc ion (GO:0010043),0.2490092388657047,0.6566330074515111,0.8915857605177994,0.9655811759087687,1.0,2/25,6.28%,CRIP1;PAM
prerank,regulation of catabolic process (GO:0009894),0.269390472899346,0.6564037585454089,0.8738738738738738,0.96537571688093,1.0,5/18,17.59%,ITGB1;MDM2;NEDD4L;ZDHHC2;FAP
prerank,neurotransmitter biosynthetic process (GO:0042136),0.28088585865761734,0.6556591494713252,0.8783068783068783,0.9656528664776336,1.0,2/14,10.97%,MOXD1;ACHE
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2230569532771603,-0.6549734331960874,0.9296116504854369,0.9970539718002528,1.0,12/23,36.78%,TECR;ACSL4;ACSL6;ACOT7;DGAT2;ACSBG1;ELOVL1;ACSF3;ELOVL7;HACD2;ELOVL6;ELOVL2
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2584223225185281,-0.6547069032608239,0.897025171624714,0.9964193829906283,1.0,5/13,33.28%,PHYH;GPT2;GOT1;ADHFE1;D2HGDH
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2376347924756359,0.6544683382434937,0.9158415841584159,0.9663407698393977,1.0,2/29,2.89%,BMP2;MYH6
prerank,sensory perception of sound (GO:0007605),0.19996509273984386,0.6539300598542287,0.9733333333333334,0.9664109522689777,1.0,9/88,11.91%,RIPOR2;CCDC50;ATP6V1B1;GSDME;GRAP;MYO7A;TBL1X;WFS1;KCNQ1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.24540610492235895,0.6538579692133226,0.9208261617900172,0.9660622221082575,1.0,10/25,23.32%,ACVR2A;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;FAM210B;STAT5B;MAPK11
prerank,mitotic metaphase plate congression (GO:0007080),-0.18367720832808682,-0.6527887066790033,0.9764705882352941,0.99701523704774,1.0,14/51,20.61%,EML3;CENPC;CHMP4B;CHMP4A;CENPE;SEH1L;SPDL1;NDC80;CDCA8;KIFC1;CHMP6;ZW10;CHMP3;DCTN2
prerank,histone monoubiquitination (GO:0010390),0.25342324394891014,0.6515211259074365,0.9101497504159733,0.9676552899230448,1.0,3/24,8.18%,RYBP;WAC;CDC73
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.19912467262876807,0.6504840441884601,0.9651474530831099,0.9681519823290649,1.0,30/94,25.15%,PSMA7;IRAK3;RPS27A;PELI1;MAP3K8;PSMB2;RIPK2;PSMA6;MAP3K3;NOD2;UBE2N;PSMD5;PSMD1;PSMA3;RELA;TAB3;IRAK4;TRAF6;TOLLIP;PSMD2;PSMD11;PSMB9;NFKB1;IL1R1;PSMB4;UBC;PSMD10;FBXW11;MYD88;PSME4
prerank,regulation of mitochondrial translation (GO:0070129),-0.23071881361781738,-0.6493817890827035,0.9290617848970252,0.9987047567165979,1.0,10/21,34.29%,RMND1;MTG2;C1QBP;FASTKD3;MTG1;ALKBH1;COA3;SHMT2;TRUB2;UQCC2
prerank,protein K63-linked deubiquitination (GO:0070536),-0.20720012269660845,-0.6489793347005034,0.9701492537313433,0.998159679644649,1.0,4/31,6.17%,CYLD;OTUD5;USP50;STAMBP
prerank,positive regulation of viral life cycle (GO:1903902),-0.21904537409675573,-0.6482423899865655,0.9492753623188406,0.9978264098197529,1.0,5/22,20.36%,AXL;FMR1;TYRO3;TRIM11;CHMP3
prerank,regulation of telomere maintenance (GO:0032204),-0.21087073907663484,-0.6473814611554954,0.9630541871921182,0.9976137924079005,1.0,4/26,12.75%,XRCC5;HDAC8;UPF1;TERF2
prerank,protein sumoylation (GO:0016925),-0.18449178324073484,-0.6470529225245049,0.9749303621169917,0.9970194528346124,1.0,18/49,29.16%,NUP210;RANBP2;BCL11A;TRIM28;NUP85;SEH1L;EGR2;AAAS;SAE1;UBA2;EYA1;PIAS4;PIAS3;NDC1;NUP93;NUP50;NUP214;NUP54
prerank,apoptotic nuclear changes (GO:0030262),0.25027744131133706,0.6463534464024858,0.8954041204437401,0.9712465684676311,1.0,1/24,1.51%,ENDOG
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.20483822775447486,-0.6448252957139136,0.967391304347826,0.9977611530970063,1.0,8/31,20.31%,PEX6;TIMM44;PEX10;TOMM40;GRPEL1;TOMM20;TOMM40L;TIMM21
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.24391191031755102,-0.644322556296282,0.9105145413870246,0.9972786571491381,1.0,2/16,4.59%,BCAP29;ANK2
prerank,negative regulation of cell aging (GO:0090344),0.27223092340189725,0.6439197816562868,0.8838475499092558,0.9728363146612798,1.0,3/16,12.16%,CDK6;FOXM1;MAP3K3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.1804844594423194,-0.6427719818294213,0.9814814814814815,0.9975511333355351,1.0,11/53,18.02%,AZIN1;PSMD13;PSMD12;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.2561343701628435,-0.642277382181065,0.9200863930885529,0.997065943831269,1.0,3/14,14.31%,CPSF6;CSTF2;NCBP1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.261204573477645,0.641443612300479,0.875,0.9744151494937211,1.0,4/18,16.73%,CCT6A;DCP2;NOP10;CCT3
prerank,regulation of protein neddylation (GO:2000434),-0.276342331799986,-0.6403301123805256,0.9127659574468086,0.9975111621609918,1.0,7/10,34.41%,EPAS1;COPS9;HIF1A;DCUN1D2;DCUN1D5;DCUN1D3;DCUN1D4
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.2501747586708328,0.63953812567197,0.9037162162162162,0.9755489169149356,1.0,5/21,19.48%,TTC23;SFRP1;STK36;TXNDC15;DLG5
prerank,heart process (GO:0003015),-0.2469739463516915,-0.6388619886985787,0.9068736141906873,0.9976399274351101,1.0,10/14,46.64%,SGCD;SGCZ;GPX1;MYL2;PPCS;RAMP3;ACE;SOD1;TNNI3;SGCG
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.2768584364645407,-0.6379851683673646,0.8857142857142857,0.9973900811343861,1.0,2/11,23.42%,RTP4;PKD1L3
prerank,positive regulation of hemostasis (GO:1900048),0.29209195832626333,0.6373369163381044,0.8774703557312253,0.9764616879976002,1.0,3/10,18.10%,ENPP4;ST3GAL4;F2R
prerank,positive regulation of coagulation (GO:0050820),0.29209195832626333,0.6373369163381044,0.8774703557312253,0.9764616879976002,1.0,3/10,18.10%,ENPP4;ST3GAL4;F2R
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.29090147795092236,0.6371079079512041,0.8787878787878788,0.9762291135227685,1.0,2/10,14.21%,UBAC2;DERL2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2678494580553046,-0.6368488930413798,0.9029535864978903,0.9964729351926375,1.0,3/11,14.90%,PTK2B;JAK3;IL2RG
prerank,cellular response to interleukin-2 (GO:0071352),-0.2678494580553046,-0.6368488930413798,0.9029535864978903,0.9964729351926375,1.0,3/11,14.90%,PTK2B;JAK3;IL2RG
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2523554360166572,-0.6367202840063094,0.9217758985200846,0.995738425816114,1.0,3/14,15.98%,RMND1;C1QBP;FASTKD3
prerank,regulation of DNA recombination (GO:0000018),0.2340737186654022,0.6352840636093893,0.9264705882352942,0.97727068699585,1.0,11/32,20.45%,CHEK1;SPIDR;ZRANB3;PPP4R2;TERF2IP;KPNA2;SMARCAD1;KDM1A;MRE11;RTEL1;SHLD2
prerank,autophagosome organization (GO:1905037),0.2161039706813436,0.6349283113604698,0.9553158705701078,0.9771129001430159,1.0,21/50,25.49%,WIPI1;ULK2;RAB7A;RAB1A;RAB23;ATG7;ATP2A2;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;ATG3;UBXN2B;PIK3C3;MAP1LC3B;RAB19;TP53INP2;ATG16L2;TMEM41B;BECN1
prerank,polyamine metabolic process (GO:0006595),-0.2555422152069323,-0.6344228605068379,0.9212765957446809,0.9963532375229788,1.0,6/13,29.46%,SAT1;SMOX;SMS;HDAC6;ODC1;SRM
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2826302594862288,0.6342008457180206,0.8799249530956847,0.9772666557006014,1.0,3/11,16.73%,CCT6A;TERF1;CCT3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.22757078276790244,-0.6341630241646308,0.9388753056234719,0.9956725183153775,1.0,5/19,17.91%,GMPR;TYMS;DGUOK;GMPR2;POLL
prerank,regulation of water loss via skin (GO:0033561),0.27333848398240423,0.6330408697484246,0.8994614003590664,0.977326583841497,1.0,5/15,26.00%,SFN;STMN1;UGCG;LSR;KDF1
prerank,establishment of skin barrier (GO:0061436),0.27333848398240423,0.6330408697484246,0.8994614003590664,0.977326583841497,1.0,5/15,26.00%,SFN;STMN1;UGCG;LSR;KDF1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.29123776048204875,0.6328791365281997,0.9068825910931174,0.9770262277716318,1.0,10/10,70.89%,KCNE3;SUMO1;CAV1;KCNRG;KCNE1;KCNE5;KCNE2;KCNE4;ANK3;KCNAB1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.233815448027556,-0.6325810885449061,0.9498806682577565,0.9958625040911954,1.0,6/18,26.85%,LIG1;MCM3;GINS3;POLE;MCM7;MCMDC2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2594364185987406,0.6322949280843164,0.9111111111111111,0.9770524160905172,1.0,5/15,22.44%,CDC73;CUL3;KLHL18;NPM1;PLCG2
prerank,neutral amino acid transport (GO:0015804),0.23638121680712113,0.6319261860122011,0.9328859060402684,0.9769014632755059,1.0,6/28,17.68%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC6A6;SLC36A2
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2508933413166028,-0.6318633018964294,0.9049773755656109,0.995496218154276,1.0,5/13,24.28%,STX3;TMEM35A;ABCA7;GPD1L;TM9SF4
prerank,stabilization of membrane potential (GO:0030322),-0.23648325056406896,-0.6312423546105563,0.9370786516853933,0.9950520082322863,1.0,8/16,34.82%,KCNK2;KCNK12;KCNK9;KCNK6;KCNK10;KCNK3;CHCHD10;KCNK7
prerank,ncRNA catabolic process (GO:0034661),0.24110591725700734,0.6305420139482035,0.9301948051948052,0.9775335265417436,1.0,11/28,25.63%,SND1;TUT4;MTREX;EXOSC8;DIS3L2;ERN2;TRIR;EXOSC3;TENT4B;EXOSC7;RBM7
prerank,regulation of mitochondrial fission (GO:0090140),0.24533706983444128,0.6303930229905372,0.9246231155778895,0.9772304220100073,1.0,2/24,4.31%,PRKN;MCU
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.2864011697671995,0.6302600615864312,0.8907721280602636,0.9769244063480226,1.0,4/11,21.89%,FYN;ABCB7;TRAP1;MPV17L
prerank,telomere maintenance via telomerase (GO:0007004),-0.20395968009155918,-0.6296153254537495,0.9543269230769231,0.9952434885451644,1.0,8/28,21.73%,ANKRD28;PTGES3;TNKS1BP1;TERF2;GAR1;RFC1;WRAP53;ACD
prerank,synaptonemal complex organization (GO:0070193),-0.24297866265249798,-0.6283954280300688,0.9354838709677419,0.9943163272751147,1.0,4/15,19.13%,BAG6;SYCE2;STAG3;P3H4
prerank,synaptonemal complex assembly (GO:0007130),-0.24297866265249798,-0.6283954280300688,0.9354838709677419,0.9943163272751147,1.0,4/15,19.13%,BAG6;SYCE2;STAG3;P3H4
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.16608322879203272,-0.6278522596202218,0.9932203389830508,0.9938223615925409,1.0,24/72,31.11%,BIRC2;SKP1;PSMD13;PSMD12;COPS8;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1;TLR3;MAP3K14;PSMC2;PSMB10;PSMD3;TRAF2;AKT1;BTRC;PSMC5;MALT1;PSME2
prerank,nucleus organization (GO:0006997),0.21479387497261865,0.6273756659555452,0.9546875,0.9786220080844262,1.0,6/47,12.45%,REEP3;ATXN7;VPS4B;NUP133;CHMP5;NUP98
prerank,negative regulation of DNA recombination (GO:0045910),0.2139666955194085,0.6269973548884413,0.9611650485436893,0.9785005460545395,1.0,13/43,20.94%,ATRX;POLR2B;UBQLN4;ZRANB3;TERF2IP;POLR2D;TERF1;FBH1;SHLD3;POLR2F;RTEL1;SHLD2;TINF2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.2904802108911061,0.6267876755960535,0.8639846743295019,0.9782567365553612,1.0,2/10,16.23%,RPUSD3;NOP10
prerank,positive regulation of catalytic activity (GO:0043085),0.2220980391487854,0.6267663619879192,0.9445350734094616,0.9778573117931256,1.0,9/37,18.05%,ATP7A;PSEN1;MAPK14;NHEJ1;NOD2;BCAS3;XRCC4;NCSTN;SLC5A3
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.2834647131039094,0.6248821642759089,0.8872180451127819,0.9787977168538762,1.0,4/11,18.34%,CYCS;UQCRFS1;UQCC3;UQCRC2
prerank,membrane depolarization (GO:0051899),0.22815826868470115,0.6244145915167871,0.9414634146341463,0.9787237691150801,1.0,1/32,0.51%,P2RX7
prerank,postreplication repair (GO:0006301),0.2133395701870232,0.6243783657007462,0.9500780031201248,0.978341793179497,1.0,17/45,24.13%,RPS27A;RPA1;POLH;RPA3;UBE2N;WDR33;TRIM25;RFC3;NSMCE1;UBE2A;ZBTB1;POLD2;PCNA;UBE2V2;REV1;UBE2L6;UBC
prerank,mesenchyme morphogenesis (GO:0072132),-0.23477810214165953,-0.6228673477423113,0.9270588235294117,0.9958962072425376,1.0,5/17,20.07%,ACVR1;MDM4;NOTCH1;ENG;TGFB2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.246881242080644,0.6226619243024621,0.8988195615514334,0.9791157807830057,1.0,13/22,28.33%,LATS2;HEXIM2;PTEN;NR2F2;CDKN1C;INCA1;CDKN1B;PLK1;CEBPA;HEXIM1;APC;HHEX;CDKN1A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2287331294849982,-0.6217643267913607,0.9419354838709677,0.9957758203678682,1.0,6/17,28.47%,TREM2;HTRA2;NME5;BAG5;UBQLN1;AKT1
prerank,negative regulation of locomotion (GO:0040013),0.2806445570353728,0.6216807113773041,0.8992537313432836,0.9794041592921946,1.0,1/12,3.53%,CRK
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.22788790521764227,-0.6213671919477884,0.9202898550724637,0.9951915061374927,1.0,7/17,23.98%,ALG1;ALG12;ALG8;ALG3;DOLK;SRD5A3;MVD
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.2648860591674809,-0.6206223406762628,0.9334811529933481,0.9947641730377548,1.0,6/11,29.95%,PLCB1;GIGYF1;TSC2;AKT1;IRS1;GHR
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.267522432124047,0.6202861535394442,0.9186691312384473,0.9799571985636348,1.0,2/12,8.59%,PRKCB;VRK1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.19892351258763563,-0.619907268786678,0.953551912568306,0.9943591902636486,1.0,8/29,22.26%,CNOT7;MAVS;NLRC5;STAT2;MUL1;PTPN11;WNT5A;METTL3
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.24655892978478341,-0.6190045694899076,0.933920704845815,0.9940284270708868,1.0,6/13,33.86%,SCAMP5;SYT1;CACNA1H;HYAL3;STX1A;CACNA1G
prerank,nucleotide biosynthetic process (GO:0009165),0.24719179343470307,0.6183560544165895,0.9396551724137931,0.9808313062400186,1.0,6/18,20.69%,NMNAT3;NMNAT2;PRPS1L1;PRPS1;HPRT1;ME1
prerank,negative regulation of phosphatase activity (GO:0010923),0.23036656976401088,0.6175826204778412,0.919672131147541,0.9809601530522165,1.0,2/25,4.84%,PPP1R26;GSK3B
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.1930869708533507,-0.6165345042082466,0.9821882951653944,0.9945247061885931,1.0,7/33,17.07%,FLCN;IAPP;MAPT;FXN;MUL1;TMEM14A;HUWE1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.22220607793640032,0.6162504430806637,0.9405144694533762,0.9814317523379907,1.0,8/33,22.44%,FBXW7;CDC73;ATP2B4;PTEN;PTPN6;APPL2;CDKN1B;PLCG2
prerank,amino acid transmembrane transport (GO:0003333),0.21413293954141327,0.6159496600604204,0.9585889570552147,0.9812278668678985,1.0,7/45,17.68%,LRRC8D;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,regulation of viral release from host cell (GO:1902186),-0.21595890045726657,-0.6157965322167722,0.9489795918367347,0.9941101079208565,1.0,6/21,22.29%,TRIM28;TRIM13;TRIM11;TRIM21;CHMP3;TRIM8
prerank,establishment of mitotic spindle orientation (GO:0000132),0.23361348754827266,0.6156620891794727,0.9437609841827768,0.9810030225342086,1.0,8/23,25.03%,ITGB1;GJA1;PAFAH1B1;NDEL1;UBXN2B;HTT;PLK1;FBXW11
prerank,nuclear membrane disassembly (GO:0051081),-0.23468598753966136,-0.615316037452213,0.9241379310344827,0.9935674107513781,1.0,7/14,32.92%,AKAP8L;NEK6;CTDNEP1;DCTN1;CDK1;CCNB2;LPIN1
prerank,peptide hormone secretion (GO:0030072),-0.20486295007352273,-0.6143386804248488,0.9777777777777777,0.9932556186305214,1.0,3/26,9.76%,RIMS2;PTPRN;ADCYAP1
prerank,mitotic cytokinetic process (GO:1902410),0.24282405711643162,0.6133681719920397,0.929553264604811,0.9821296600704278,1.0,3/20,10.53%,RHOA;VPS4B;CHMP5
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.21486584638855322,0.6131178372083836,0.9681528662420382,0.9818799206467795,1.0,8/41,17.04%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;ZBTB7A;NUP153
prerank,T cell homeostasis (GO:0043029),-0.2622288669688529,-0.613066754535025,0.916,0.9930800798201852,1.0,7/10,42.08%,NCKAP1L;JAK3;AKT1;PMAIP1;FOXP3;FADD;RIPK3
prerank,plasma membrane repair (GO:0001778),0.2705717246674738,0.6122516866142101,0.9178356713426854,0.9820169847291428,1.0,1/13,3.75%,MYOF
prerank,tRNA modification (GO:0006400),0.19648173300784097,0.6121796248155514,0.9829302987197724,0.9816539505245364,1.0,11/62,14.16%,DTWD2;URM1;TYW1;LCMT2;TRMO;NSUN2;ELP5;TRMT61B;CTU1;CDKAL1;TRIT1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.27569013824345256,0.6120068327887984,0.9041353383458647,0.9813603092065224,1.0,1/11,4.32%,IP6K3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.23332397798486032,-0.6113807017483162,0.9478260869565217,0.9931610283651652,1.0,5/14,32.41%,CCDC22;MDFI;SUFU;PKD1;NFKBIE
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2184980957284458,-0.6111891378737366,0.9664948453608248,0.9924638227970852,1.0,6/21,20.52%,BCL2L11;DDIT3;CREB3;PARK7;SYVN1;SELENOS
prerank,renal absorption (GO:0070293),-0.26475249653812616,-0.6111104459083345,0.926829268292683,0.9916917992162528,1.0,1/10,2.95%,SGK1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.22252995939933665,0.6110161921778453,0.937799043062201,0.9815862103151908,1.0,3/30,11.34%,FBXW7;UBE2D3;SREBF2
prerank,negative regulation of biosynthetic process (GO:0009890),0.25838715511845617,0.6109879005716977,0.9193548387096774,0.9811946749122632,1.0,5/16,21.54%,EMILIN1;ABCB7;TRAP1;IL6;CIITA
prerank,cilium movement (GO:0003341),0.20890930500536822,0.6107427615074396,0.9596899224806201,0.9809495369245841,1.0,11/47,20.49%,TTC29;TEKT5;CFAP206;CFAP91;ODAD3;SPEF1;CFAP53;DNAH11;DNAAF5;SPAG17;ADCY10
prerank,cellular respiration (GO:0045333),-0.18086001879708527,-0.6100333210540735,0.9767441860465116,0.9914343336788932,1.0,17/41,35.13%,SDHAF4;SDHB;NDUFS7;SLC25A14;UQCRC1;UQCRB;COX15;MTLN;UQCR10;NDUFS1;SLC25A13;MTFR1;PPARGC1A;MTFR2;ATP5F1D;ETFRF1;OXA1L
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.27117198262817443,0.6084439158007865,0.8985765124555161,0.9820271959630277,1.0,1/12,4.74%,IRS2
prerank,lysine metabolic process (GO:0006553),0.2729441305712493,0.6082558504087446,0.9131238447319778,0.9813274056442869,1.0,12/12,72.73%,HYKK;PHYKPL;OGDH;AADAT;DLST;CRYM;DLD;AASS;PIPOX;ALDH7A1;SLC25A21;GCDH
prerank,lysine catabolic process (GO:0006554),0.2729441305712493,0.6082558504087446,0.9131238447319778,0.9813274056442869,1.0,12/12,72.73%,HYKK;PHYKPL;OGDH;AADAT;DLST;CRYM;DLD;AASS;PIPOX;ALDH7A1;SLC25A21;GCDH
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.24549947335781053,-0.60728644927852,0.9277389277389277,0.9920056383383706,1.0,5/13,34.71%,GAD1;ACOT8;GOT1;ACSF3;ACOT4
prerank,rRNA catabolic process (GO:0016075),-0.22772623115720342,-0.6068902467926302,0.9576837416481069,0.991398106410163,1.0,2/16,9.89%,EXOSC9;DIS3
prerank,protein localization to phagophore assembly site (GO:0034497),-0.25495227754314453,-0.606669781762571,0.9257731958762887,0.9907051407045998,1.0,5/11,30.81%,WDR45;ATG9A;WDR45B;PACS2;ATG9B
prerank,regulation of chromosome segregation (GO:0051983),0.2556531990580754,0.605947421916665,0.9147005444646098,0.9823650887325831,1.0,5/16,19.78%,PUM2;HORMAD1;CSNK2A2;CSNK2A1;SMC6
prerank,negative regulation of double-strand break repair (GO:2000780),0.22274712151640494,0.6053009437773186,0.9595959595959596,0.9823600846395603,1.0,7/30,20.74%,RNF169;UBQLN4;FBH1;CYREN;SHLD3;SHLD2;TRIP12
prerank,regulation of feeding behavior (GO:0060259),0.27332829052877167,0.6051370038602101,0.9095940959409594,0.9820632280636686,1.0,3/11,21.85%,STAT3;EIF2AK4;AGRP
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.24760920801112443,0.6046169469369479,0.9284403669724771,0.9819573858902894,1.0,4/18,17.66%,RIPOR2;CUL3;STMN1;ARHGAP35
prerank,DNA modification (GO:0006304),-0.20853079607573793,-0.60397612878994,0.9697674418604652,0.99122569864847,1.0,4/22,13.46%,PARP1;PARP3;TERF2;NEIL3
prerank,DNA packaging (GO:0006323),0.24839783207583332,0.6026982623466226,0.9033391915641477,0.9827206670319577,1.0,5/16,21.95%,BANF1;HAT1;KAT6A;AIFM1;CHAF1B
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.18535451835404107,0.6026611360546802,0.9879194630872483,0.9823351996524905,1.0,12/84,14.84%,PSMA7;RPS27A;RB1;CDC27;PSMB2;CUL3;ANAPC16;PSMA6;PSMD5;PSMD1;PSMA3;ANAPC1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.25911379841066884,0.6023929353490841,0.9195612431444241,0.982088822358881,1.0,1/14,2.02%,MEF2C
prerank,regulation of dopamine secretion (GO:0014059),0.22897431189337095,0.6007375360640702,0.925,0.9826517263502973,1.0,10/25,25.66%,PRKN;CHRNA4;CHRNB2;SYT3;GDNF;SNCA;SYT11;SYT12;SYT10;DRD3
prerank,anion transmembrane transport (GO:0098656),0.1918198189265141,0.600613059478062,0.9830747531734838,0.9823198225195225,1.0,11/67,18.67%,SLC16A7;LRRC8D;ABCC1;SLC25A5;SLC6A5;SLC23A1;SLC23A2;SLC25A30;SLC5A6;LRRC8C;SLC25A4
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.23684862290043462,-0.5988518534245119,0.9492273730684326,0.99279641395855,1.0,1/13,1.14%,ANAPC15
prerank,glutamate metabolic process (GO:0006536),-0.2144577894304049,-0.5986889345694928,0.9671717171717171,0.992068374214632,1.0,6/19,28.19%,ALDH18A1;ALDH5A1;PRODH;GAD1;GCLC;GOT1
prerank,organic cation transport (GO:0015695),-0.21332220285214765,-0.5978297447940495,0.9600886917960089,0.9916518845738216,1.0,2/20,10.46%,SLC44A2;SLC25A26
prerank,tRNA 5'-leader removal (GO:0001682),-0.24519826657674598,-0.5977826968234057,0.9397849462365592,0.9908704554122469,1.0,5/13,24.58%,RPP14;POP1;RPP21;PRORP;POP7
prerank,outer dynein arm assembly (GO:0036158),-0.23745879351693086,-0.5975270642029077,0.9345372460496614,0.9901784132175664,1.0,4/14,21.77%,DNAH8;DNAH5;ODAD1;ODAD2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.2599618038838044,0.5969083781284255,0.926605504587156,0.9840622359938119,1.0,1/12,3.49%,WAC
prerank,GPI anchor biosynthetic process (GO:0006506),0.2206798757393257,0.5958016031843444,0.9589490968801314,0.9842623489266364,1.0,5/30,16.65%,PGAP1;PIGU;PGAP4;PIGQ;PIGX
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2390014079436935,-0.5947473282845549,0.9503386004514672,0.9905797090931429,1.0,2/13,16.52%,NECTIN2;MR1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.23294776997836186,0.5944075522381099,0.9328859060402684,0.9846390705896769,1.0,2/21,7.60%,MITF;MED16
prerank,mitotic chromosome condensation (GO:0007076),0.21946313469389944,0.5931382933882821,0.9548494983277592,0.9849193396014848,1.0,2/26,4.85%,PHF8;RB1
prerank,primary alcohol metabolic process (GO:0034308),0.22783596237368392,0.5915962260820681,0.9460370994940978,0.985364881575807,1.0,3/25,14.39%,DHRS3;IGF1;RBP4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.1957973488172754,-0.5907692789426562,0.9920424403183024,0.9915551289182748,1.0,7/28,21.70%,ERCC6;SIRT7;HSF1;PARP3;PARP9;WRAP53;TFIP11
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.23264562845669906,-0.5902495318356982,0.9578454332552693,0.9909911173569974,1.0,5/14,34.90%,BCL2L11;TMEM33;FICD;DDRGK1;PTPN1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.24984503606480735,-0.5892100790499712,0.9369565217391305,0.9906568399999333,1.0,6/10,38.78%,CDC7;SSBP1;CDT1;E2F7;STOML2;DBF4
prerank,pseudouridine synthesis (GO:0001522),-0.2388128241028773,-0.58865092410836,0.9419354838709677,0.9900986981012506,1.0,7/13,39.89%,GAR1;PUS1;PUS7L;PUS3;TRUB2;NHP2;DKC1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.23733076960695249,-0.5885631479599693,0.9339019189765458,0.9893455217173962,1.0,6/12,39.15%,HUS1;CHEK2;TICRR;ORC1;RAD17;NAE1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.24017448599567534,0.5874435497773327,0.9298561151079137,0.9871353280896568,1.0,4/18,15.11%,IWS1;NUP133;PCID2;ENY2
prerank,response to peptide (GO:1901652),0.20922784025234492,0.5873517623776509,0.9638752052545156,0.9867745226980642,1.0,7/33,13.95%,STAT4;FYN;STAT6;EIF2B1;NOD2;KAT7;STAT3
prerank,tRNA transport (GO:0051031),-0.17789680373609443,-0.5835983332098291,0.9840425531914894,0.990535003062282,1.0,19/35,39.99%,NUP210;RANBP2;NUP85;SEH1L;TOMM20;AAAS;SEC13;NDC1;NUP93;NUP50;NUP214;NUP54;NUP88;SSB;RAN;TOMM20L;NUP205;NUP107;YBX1
prerank,negative regulation of nuclear division (GO:0051784),0.2626202987582381,0.5826550085459646,0.9122486288848263,0.9887930890488317,1.0,1/11,6.62%,CHEK1
prerank,regulation of glucose metabolic process (GO:0010906),0.2088784391778785,0.5816408903938136,0.9736842105263158,0.9888969420384212,1.0,5/34,12.28%,PRKN;IRS2;GNMT;FOXK2;FOXK1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.196311807715504,0.5785558669855554,0.9813084112149533,0.9899943502748214,1.0,8/48,17.04%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;ZBTB7A;NUP153
prerank,quinone biosynthetic process (GO:1901663),0.24694894018228866,0.5782788873580533,0.944153577661431,0.9897066300867835,1.0,6/14,23.57%,PDSS1;UBIAD1;COQ9;COQ5;COQ8A;COQ3
prerank,meiosis I (GO:0007127),0.2238644637288416,0.5773940409075482,0.9463087248322147,0.9897234705276581,1.0,2/23,9.28%,MOV10L1;FOXJ3
prerank,positive regulation of cell killing (GO:0031343),0.2498921131055453,0.5772125687878394,0.9320388349514563,0.9893922002423381,1.0,2/13,14.57%,SYK;CYBA
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.2369839908646333,-0.5764671787253765,0.9481981981981982,0.9924421915155411,1.0,6/12,38.06%,LPCAT3;CLCN2;ABCA2;DGKQ;RAN;MBTPS1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.25331379471552273,-0.5762548892924331,0.9352051835853131,0.9917150562844403,1.0,5/10,27.29%,ACADL;ACADM;IVD;ACADVL;GCDH
prerank,"base-excision repair, AP site formation (GO:0006285)",0.23523100514430548,0.5756557454369354,0.9630314232902033,0.9897464715886686,1.0,5/17,20.94%,TERF2IP;MUTYH;TERF1;MPG;TINF2
prerank,mitotic sister chromatid segregation (GO:0000070),0.17516728020505204,0.5754227163886497,0.9986702127659575,0.9894469234702297,1.0,24/98,21.88%,PHF8;PIBF1;RB1;REC8;VPS4B;PDS5B;CUL3;CHMP5;NUP62;DIS3L2;RAB11A;PINX1;CENPK;RRS1;KIF23;KPNB1;SMC4;SET;CSNK2A2;CSNK2A1;PDCD6IP;NIPBL;MIS12;CEP55
prerank,axonal transport of mitochondrion (GO:0019896),-0.23952517114641214,-0.5731501725712642,0.951271186440678,0.9919937960124361,1.0,3/11,22.81%,MAPT;HAP1;HIF1A
prerank,erythrocyte development (GO:0048821),0.2634673443436269,0.5727251820610354,0.9554263565891473,0.9903062123868498,1.0,3/10,17.14%,SH2B3;ZBTB7A;ABCB10
prerank,serine family amino acid metabolic process (GO:0009069),0.23457006216879567,0.5714418250977271,0.9459459459459459,0.9904918830760298,1.0,3/16,13.59%,DAO;SEPSECS;SHMT1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.2636366240147302,0.5709060427942806,0.9431818181818182,0.9903300220291656,1.0,3/10,17.13%,WNK1;CCL5;PODXL
prerank,regulation of catecholamine secretion (GO:0050433),0.21132018618945764,0.570463238076225,0.9770867430441899,0.9901249454268414,1.0,11/29,25.66%,PRKN;CHRNA4;CHGA;KCNB1;CHRNB2;SYT3;SNCA;SYT11;SYT12;SYT10;DRD3
prerank,ethanol metabolic process (GO:0006067),0.2559118020754551,0.5699076081430932,0.9429657794676806,0.9899695593635842,1.0,1/12,6.33%,SULT1A1
prerank,mitotic nuclear membrane organization (GO:0101024),0.18866955738750502,0.5694395207558878,0.9792592592592593,0.9893485922888644,1.0,11/51,19.02%,REEP3;NUP133;VRK1;PPP2CA;BANF1;LBR;NUP98;PPP2R2A;LMNA;KPNB1;SUMO1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.18866955738750502,0.5694395207558878,0.9792592592592593,0.9893485922888644,1.0,11/51,19.02%,REEP3;NUP133;VRK1;PPP2CA;BANF1;LBR;NUP98;PPP2R2A;LMNA;KPNB1;SUMO1
prerank,ubiquinone biosynthetic process (GO:0006744),0.23788754094776812,0.5683778838841255,0.9404761904761905,0.9894070151490927,1.0,6/15,23.57%,PDSS1;UBIAD1;COQ9;COQ5;COQ8A;COQ3
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.23580832512195182,0.5683381941258966,0.9413793103448276,0.9890204312238032,1.0,4/15,18.39%,CMPK1;AK8;ENTPD1;AK4
prerank,nucleoside salvage (GO:0043174),-0.24090064926588792,-0.5675360015195452,0.9458874458874459,0.9931830120152598,1.0,5/10,39.91%,UPP2;UCKL1;TK2;CDA;TK1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.20272098742666939,-0.5658767361705769,0.9811320754716981,0.9929772358677851,1.0,7/18,34.78%,NAALAD2;SMS;SLC25A13;GOT1;FOLH1;GADL1;NIT2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2085323833455308,0.5656507691885677,0.9723661485319517,0.9897747853651877,1.0,10/29,20.94%,RPA1;TERF2IP;TERF1;PPIA;PINX1;HSP90AB1;NOP10;MRE11;RTEL1;TINF2
prerank,negative regulation of cellular senescence (GO:2000773),-0.22658367603703547,-0.5647140783278679,0.9655172413793104,0.9925692135137677,1.0,10/13,41.85%,ZKSCAN3;AKT3;TERF2;FBXO5;RBL1;SIRT1;HMGA2;TWIST1;YBX1;SLC30A10
prerank,atrioventricular valve development (GO:0003171),0.2433660537575761,0.5645610928284446,0.9477611940298507,0.9898175235687244,1.0,3/14,14.73%,BMP2;SLIT3;BMPR1A
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.17442800511742307,-0.5643696867863323,0.9945054945054945,0.9918961733240504,1.0,9/33,28.19%,ALDH18A1;ALDH5A1;SIRT4;ALDH4A1;PRODH;DDAH1;CAD;GCLC;GOT1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.25117914456079826,0.5629895663328985,0.948905109489051,0.9900409885487829,1.0,3/12,15.63%,RBM4;UHMK1;PTPN14
prerank,zinc ion transmembrane transport (GO:0071577),-0.19466946705911414,-0.5629586152043128,0.9738903394255874,0.9915647999736454,1.0,7/22,31.48%,SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,interstrand cross-link repair (GO:0036297),0.18603749316453508,0.5623492793693992,0.9896296296296296,0.9898870293244192,1.0,10/53,17.22%,RPS27A;DCLRE1C;MCM9;RPA1;XPA;RPA3;MCM8;FANCL;ATR;FANCI
prerank,gastrulation (GO:0007369),0.23546342925544328,0.5601671258788593,0.9481481481481482,0.9903512468253362,1.0,4/15,17.12%,LMBRD1;GPC3;NPHP3;LHX1
prerank,regulation of activated T cell proliferation (GO:0046006),0.2083543215785155,0.5597680811168274,0.9713831478537361,0.9900955682023495,1.0,3/30,9.95%,RPS3;RC3H1;IGF1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.25081295064448494,0.559152145978451,0.9475587703435805,0.9899285714136867,1.0,1/12,7.60%,CCR2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.2347431414901159,0.5582233502013713,0.951304347826087,0.9898818257189548,1.0,5/15,17.76%,DDR2;CLASP1;MELTF;FAP;IL6
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.22303686796457986,-0.5567410453655021,0.9595505617977528,0.9927299895734308,1.0,4/12,28.28%,PRPSAP1;GART;PRPSAP2;AMPD2
prerank,response to ketone (GO:1901654),0.21412806445682908,0.5550996948169193,0.9780405405405406,0.9907349444904431,1.0,3/24,11.19%,CCL19;CATSPER3;SLIT3
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.21801765792280975,0.5544261093352559,0.96875,0.9905982245631076,1.0,3/22,10.64%,RASSF2;PDGFC;CALM1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.25246721377910725,0.5518466937008714,0.9369202226345084,0.991144062707083,1.0,5/12,22.21%,GMDS;GFPT2;EXTL2;UGP2;SLC35A3
prerank,positive regulation of lipid localization (GO:1905954),-0.2315161002357586,-0.5515418786484021,0.9641255605381166,0.993455813892203,1.0,2/11,11.69%,LPL;IKBKE
prerank,nuclear membrane reassembly (GO:0031468),0.18122734661258869,0.5514977451773811,0.9895988112927192,0.990865407121501,1.0,12/54,19.43%,REEP3;NUP133;VRK1;PPP2CA;BANF1;LBR;NUP98;PPP2R2A;LMNA;KPNB1;SUMO1;UBXN2B
prerank,termination of RNA polymerase II transcription (GO:0006369),0.20137682236282928,0.5504439997826813,0.9811616954474097,0.9908657938549067,1.0,11/33,23.12%,CPSF3;SNRPG;SCAF8;MED18;PAPOLA;WDR33;CPSF2;CSTF2T;SNRPE;CSTF3;LSM11
prerank,UV-damage excision repair (GO:0070914),0.24687208999838078,0.5487361565462257,0.9428571428571428,0.9910505172611159,1.0,2/12,13.61%,XPA;XPC
prerank,negative regulation of histone modification (GO:0031057),0.23555574669689705,0.5473080706488935,0.9661654135338346,0.9911157582031999,1.0,1/14,4.04%,JARID2
prerank,ncRNA export from nucleus (GO:0097064),-0.16656809697539954,-0.5465846784629281,0.9972527472527473,0.9940922131111521,1.0,18/36,39.73%,NUP210;RANBP2;NUP85;TSC1;SEH1L;AAAS;SEC13;NDC1;NUP93;NUP50;NUP214;NUP54;NUP88;SSB;RAN;NCBP2;NUP205;NUP107
prerank,negative regulation of ATPase activity (GO:0032780),0.2237882778618934,0.5450875264181642,0.9685185185185186,0.9914690656238078,1.0,2/16,8.84%,VCPKMT;PLN
prerank,epithelial structure maintenance (GO:0010669),0.24544649129176344,0.5449281251585435,0.9581749049429658,0.9911193942177308,1.0,2/11,14.39%,NOD2;RBP4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.24161220372128706,0.5444928216423071,0.9558541266794626,0.9908558919166275,1.0,1/13,3.39%,SMPDL3A
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.2459368560649886,0.5432669764007136,0.9646840148698885,0.9908619756040721,1.0,1/12,7.36%,ELOVL5
prerank,methylguanosine-cap decapping (GO:0110156),0.24936023571285282,0.5405820092108359,0.9478764478764479,0.9913676095717195,1.0,2/10,11.44%,DCP1A;DCP2
prerank,protein homotetramerization (GO:0051289),0.1800992426138309,0.5382698219529511,0.9899135446685879,0.9916955851186586,1.0,8/49,15.27%,B2M;USP16;GNMT;TRPM2;SHMT1;PKD2;PKD2L1;SAMHD1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.24747508222165016,0.5364836428214005,0.9516441005802708,0.9918609935085375,1.0,3/11,17.17%,PXDN;PRDX3;PRDX2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.18937202193569336,0.5344380395036836,0.9813953488372092,0.9920704329311304,1.0,7/37,18.12%,SND1;DNASE1L1;RNASE6;MTREX;NUDT18;RNASE3;ENTPD1
prerank,basement membrane organization (GO:0071711),0.22585629116751577,0.533071222750744,0.9660107334525939,0.9920904336693965,1.0,4/14,14.06%,PXDN;NID2;RAMP2;NTN4
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.18479563081070546,0.5329799758765206,0.993798449612403,0.9917053837698394,1.0,12/42,20.45%,CHEK1;UBQLN4;SPIDR;PPP4R2;TERF2IP;MMS19;FBH1;KDM1A;ACTR2;SHLD3;RTEL1;SHLD2
prerank,regulation of fibrinolysis (GO:0051917),-0.21180619320322627,-0.5326999391010846,0.9772727272727273,0.9967668185626595,1.0,9/13,47.46%,SERPINE1;APOH;SERPINF2;F11;KLKB1;PLG;F12;THBS1;HRG
prerank,fatty acid beta-oxidation (GO:0006635),0.17890525263626672,0.5326354767729621,0.9940828402366864,0.9914058142491156,1.0,12/51,20.40%,SLC25A17;EHHADH;ETFA;ETFDH;HADHA;HADH;HADHB;ACAT1;ETFB;ECHDC1;ACOX1;MCAT
prerank,regulation of centrosome cycle (GO:0046605),-0.1892422242053616,-0.5325979776524024,0.9929742388758782,0.9960041181750809,1.0,11/21,38.37%,FBXW5;CHMP4B;CHMP3;CHMP4C;CHMP1B;AURKA;SIRT1;CHMP2A;GEN1;CEP131;PKHD1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.22733954019307606,-0.5293246897576674,0.9760348583877996,0.9959751047411974,1.0,2/10,20.04%,APOC1;ABCA2
prerank,response to steroid hormone (GO:0048545),0.19208151306637694,0.5257324669608537,0.984822934232715,0.9929684786590561,1.0,6/31,16.43%,NR3C1;CATSPER3;ATP1A3;ATP1A1;CATSPER2;TFPI
prerank,cilium-dependent cell motility (GO:0060285),0.20569594213927764,0.524231662437825,0.9702797202797203,0.9929749894285259,1.0,2/22,8.73%,EFHC1;TEKT5
prerank,positive regulation of acute inflammatory response (GO:0002675),0.23002446739959054,0.5193985807222048,0.9694793536804309,0.9938626577074959,1.0,2/14,17.76%,TNF;IL6
prerank,negative regulation of histone acetylation (GO:0035067),-0.22541571160050383,-0.5190816474881592,0.9799599198396793,0.99720950705271,1.0,7/11,36.31%,BRCA1;CTBP1;SIN3A;TAF7;THAP7;SIRT1;NOC2L
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.22072646856002792,0.5188479938542729,0.9640831758034026,0.9935945292449793,1.0,4/16,20.45%,KDM4D;KMT5B;SHLD3;SHLD2
prerank,regulation of muscle contraction (GO:0006937),0.19486556578590114,0.5170974466182214,0.9913194444444444,0.9936299805080104,1.0,1/26,3.13%,TNNT1
prerank,intracellular protein transmembrane transport (GO:0065002),0.17825535154716496,0.5163416624529036,0.9954198473282443,0.9934057332386257,1.0,15/42,26.43%,PEX7;PEX26;ZFAND2B;SEC63;ROMO1;PEX14;DNAJC15;AIFM1;PEX12;GRPEL2;SEC62;DNAJC19;TOMM70;HSPA5;SEC61G
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.18498530419094916,-0.5135158369238985,0.9801762114537445,0.997434295653164,1.0,9/18,38.95%,CCDC39;SPEF2;CCDC40;CABYR;NEK10;DNAAF2;SPA17;AQP4;DNAAF1
prerank,sulfur amino acid metabolic process (GO:0000096),0.19390247278404743,0.5120198996906637,0.9864176570458404,0.9940313490982946,1.0,4/24,16.69%,MTR;MSRA;NOX4;MPST
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.22090994119823254,0.5080586172000262,0.9927927927927928,0.9945463175289676,1.0,2/14,13.91%,IRS2;MFSD2A
prerank,motor neuron axon guidance (GO:0008045),0.21331782510068778,0.5063948668845224,0.9860627177700348,0.9944912474667417,1.0,3/15,17.12%,SLIT1;NTN1;LHX1
prerank,amyloid-beta metabolic process (GO:0050435),0.2094060654138102,0.5062119181881628,0.9848484848484849,0.9941321707480194,1.0,3/16,15.77%,PSEN1;DYRK1A;NCSTN
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.2087226943810896,0.5049515235416625,0.9804618117229129,0.9940077446417661,1.0,2/15,13.69%,ELOVL5;NR1H2
prerank,hydrogen peroxide metabolic process (GO:0042743),0.20663284525539413,0.5024354050961751,0.9806338028169014,0.99415680030409,1.0,5/19,19.38%,PXDN;CYBA;PRDX3;PRDX2;ACOX1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.21171174933607573,-0.5021738282886687,0.9833333333333333,0.9985219607590448,1.0,5/11,34.85%,PTPRT;VHL;ADIPOR1;SOCS3;SOCS1
prerank,tRNA export from nucleus (GO:0006409),0.1833646932378702,0.5003332884049632,0.9934747145187602,0.9937918446121596,1.0,4/32,12.45%,NOL6;NUP133;NUP62;NUP98
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.1833646932378702,0.5003332884049632,0.9934747145187602,0.9937918446121596,1.0,4/32,12.45%,NOL6;NUP133;NUP62;NUP98
prerank,protein palmitoylation (GO:0018345),0.18183838581962355,0.4986035898727189,0.9872813990461049,0.9937346091784195,1.0,5/30,15.81%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.1715314819759785,0.49663167435373073,0.9984152139461173,0.9937459801019032,1.0,12/42,24.13%,RPS27A;RPA1;POLH;RPA3;TRIM25;RFC3;ZBTB1;POLD2;PCNA;REV1;UBE2L6;UBC
prerank,protein prenylation (GO:0018342),-0.21125245214429078,-0.49146876035511244,0.9921259842519685,0.9993229493918339,1.0,5/10,38.51%,RABGGTB;FNTA;PTAR1;RABGGTA;FNTB
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.18195677737022617,0.49134588176589944,0.9966887417218543,0.9943455050821898,1.0,3/27,11.07%,FBXL17;RBM4;PPP1CA
prerank,regulation of acute inflammatory response (GO:0002673),0.20518596964840796,0.48959369710118755,0.9756521739130435,0.9942473593065929,1.0,1/18,6.89%,PLA2G2D
prerank,inorganic ion transmembrane transport (GO:0098660),-0.1981480180424202,-0.48939311238535793,0.989010989010989,0.9988131608257655,1.0,8/12,48.46%,ABCC9;ABCC8;CACNA1H;P2RX3;TRPM4;RHAG;KCNJ8;ATP1B4
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.18122537376511344,0.48766024525177615,0.9952229299363057,0.9941969666603176,1.0,4/30,13.90%,HACD4;ELOVL5;TECRL;SLC27A6
prerank,regulation of transposition (GO:0010528),0.2143271557003893,0.4863858745442269,0.9801801801801802,0.9940140485101409,1.0,2/13,13.54%,SPOCD1;PIWIL2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.19158118163000046,0.47671045913729954,0.9829642248722317,0.9951797895518708,1.0,5/20,17.50%,SULF2;PRKD2;DSTYK;CREB3L1;SPRY2
prerank,cochlea morphogenesis (GO:0090103),-0.20664632020358747,-0.47375934303853,0.989648033126294,0.9998540445589188,1.0,5/10,50.66%,MYO3B;HPN;POU3F4;TBX1;TBX18
prerank,positive regulation by host of viral transcription (GO:0043923),0.2036090379823444,0.472254955980851,0.9822380106571936,0.9954338242088616,1.0,5/15,20.00%,SP1;EP300;SNW1;RRP1B;CTDP1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.1992707595613244,0.47170950707675807,0.989247311827957,0.9951078378769784,1.0,3/15,16.73%,CCT6A;NOP10;CCT3
prerank,positive regulation of dendrite development (GO:1900006),-0.20191955133590167,-0.4616867596296553,0.9938775510204082,1.0,1.0,2/10,18.22%,ALK;ZDHHC15
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.17356036207235906,-0.45936332792679563,0.9912280701754386,0.9996361458845499,1.0,8/16,37.40%,CGAS;PARPBP;RADX;RMI2;POLQ;SMCHD1;RIF1;MAD2L2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.17892247493129163,-0.4417671702961096,0.9896265560165975,1.0,1.0,1/12,7.73%,GSS
prerank,microtubule-based transport (GO:0099111),-0.18071631596854165,-0.44143567067626616,0.9934640522875817,0.9993031245756723,1.0,6/12,36.95%,SPEF2;CCDC40;CABYR;DNAAF2;SPA17;DYNC1I1
prerank,male gonad development (GO:0008584),0.15251332715331783,0.43173286844864317,0.9984051036682615,0.998915313215566,1.0,2/34,9.25%,KITLG;MAMLD1
prerank,glutathione biosynthetic process (GO:0006750),-0.17892732557347754,-0.4303380841903978,0.9938775510204082,0.9991096355746361,1.0,1/11,7.73%,GSS
prerank,DNA biosynthetic process (GO:0071897),0.17817878628837988,0.42889324485963143,0.9962476547842402,0.9987135673118919,1.0,4/16,19.53%,POLH;PPIA;RFC3;POLD2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.1807395316717935,0.4229354425676458,0.99812382739212,0.9987259107949821,1.0,13/13,81.94%,RELA;NFATC3;PPARG;SOX9;NFIB;POU5F1;PDGFB;NFATC4;REST;PPARD;PPARA;BMP4;SRF
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.16622003295153676,0.41952778155426157,0.9966101694915255,0.9985364998007504,1.0,7/22,24.41%,ROCK1;CDKN2C;INPP5K;CDKN1C;CDKN1B;DYNLL1;STAP1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.16604612810580024,0.4169277636914711,1.0,0.9982794445096912,1.0,5/20,21.57%,FKBP5;PPIA;NKTR;FKBP1A;CWC27
prerank,regulation of actin nucleation (GO:0051125),-0.16986817325800377,-0.41375546144746583,1.0,0.9989676845809049,1.0,12/12,83.03%,CORO1A;CORO1B;ARFIP1;WASHC5;SCIN;ARF1;WHAMM;VIL1;GSN;PICK1;ARFIP2;ARPIN
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.15098297941272,0.3874172607996642,0.9983739837398374,0.9991155423680673,1.0,3/22,17.58%,VKORC1;UBIAD1;RBP1
